Citrus Sinensis ID: 008055
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 579 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C8M9 | 719 | Protein STRUBBELIG-RECEPT | yes | no | 0.982 | 0.791 | 0.715 | 0.0 | |
| Q9LUL4 | 717 | Protein STRUBBELIG-RECEPT | no | no | 0.960 | 0.775 | 0.701 | 0.0 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.949 | 0.782 | 0.516 | 1e-155 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.917 | 0.759 | 0.508 | 1e-150 | |
| Q6R2K2 | 687 | Protein STRUBBELIG-RECEPT | no | no | 0.889 | 0.749 | 0.482 | 1e-136 | |
| Q6R2K3 | 776 | Protein STRUBBELIG-RECEPT | no | no | 0.941 | 0.702 | 0.422 | 1e-115 | |
| Q06BH3 | 775 | Protein STRUBBELIG-RECEPT | no | no | 0.943 | 0.704 | 0.413 | 1e-105 | |
| Q9FG24 | 735 | Protein STRUBBELIG-RECEPT | no | no | 0.932 | 0.734 | 0.390 | 8e-98 | |
| Q8RWZ1 | 768 | Protein STRUBBELIG OS=Ara | no | no | 0.545 | 0.411 | 0.487 | 6e-86 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.533 | 0.677 | 0.425 | 2e-66 |
| >sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/583 (71%), Positives = 480/583 (82%), Gaps = 14/583 (2%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
LKYLN+ HNQ +GQ+ F +L SL+TLD SFN+ + +LP +FSSL+SL SLYLQNNQFS
Sbjct: 144 LKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPATFSSLTSLKSLYLQNNQFS 203
Query: 64 GTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPARKNN 123
GT+DVLA LPL+ LNIANN FTGW+P LK I L KDGNS+++GPAPPPPPGTPP R +
Sbjct: 204 GTVDVLAGLPLETLNIANNDFTGWIPSSLKGITLIKDGNSFNTGPAPPPPPGTPPIR-GS 262
Query: 124 PKHKSDSNKSPSESE----GGSKKSGIGGGGIAGILISLFVVGGI-VAFFLVKRRRSRRS 178
P KS +S S E G SKKSGIG G IAGI+ISL VV + VAFFL +R++S+RS
Sbjct: 263 PSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISLLVVTALLVAFFLFRRKKSKRS 322
Query: 179 S-TDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFD 237
S DIEK DNQPF +SN+ E +QSSSS++TK DT++SINLRPPPIDR+KSFD
Sbjct: 323 SPMDIEKTDNQPFT---LASNDFHENNSIQSSSSVETKKLDTSLSINLRPPPIDRNKSFD 379
Query: 238 EEDFSKKSIVVKKA-VKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGK 296
+ED ++K I VKK+ V P+NV YS+ADLQ+ATGSF+V+NLLGEGTFGRVYRA+F DGK
Sbjct: 380 DEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGK 439
Query: 297 VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356
VLAVKKIDSSALP M DDFIEMVS I+ L HPN+ +LVGYC+E+GQHL+VYEF KNGSL
Sbjct: 440 VLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSL 499
Query: 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ 416
HDFLHLS+E++K L+WNSRVKIALGTARALEYLHEVCS S+V KNIKSANILLD+ELNP
Sbjct: 500 HDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPH 559
Query: 417 LSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
LSD GLAS +P A+E LN GY APEV+MSGQY++KSD+YSFGVVMLELLTGRKPFD
Sbjct: 560 LSDSGLASFLPTANELLNQ-TDEGYSAPEVSMSGQYSLKSDIYSFGVVMLELLTGRKPFD 618
Query: 477 SSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
S+R R EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP
Sbjct: 619 STRSRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 678
Query: 537 PMSEVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQDYM 579
PMSEVVQALV LVQRANMSKRT+G D P+ G T DYM
Sbjct: 679 PMSEVVQALVVLVQRANMSKRTVGVD--PSQRAGSADTTSDYM 719
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/566 (70%), Positives = 467/566 (82%), Gaps = 10/566 (1%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M LKYLN+AHNQL+ QL F +L SLS LDLS N G+LP + SSL+S S+YLQNN
Sbjct: 140 MAPLKYLNLAHNQLK-QLAIDFTKLTSLSILDLSSNAFIGSLPNTCSSLTSAKSIYLQNN 198
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QFSGTID+LA LPL+NLNIANNRFTGW+P+ LK INLQKDGN +SGPAPPPPPGTPP
Sbjct: 199 QFSGTIDILATLPLENLNIANNRFTGWIPDSLKGINLQKDGNLLNSGPAPPPPPGTPPIS 258
Query: 121 KNNPKHKSDSNKSPSESEGGSKKS----GIGGGGIAGILISLFVVGGIVAFFLVKRRRSR 176
K++P KS + + S + + K G+G GG+AGI+ISL VV ++AFFL+KR+RS+
Sbjct: 259 KSSPTPKSGNRGNRSNGDSSNSKDSSKSGLGAGGVAGIVISLIVVTAVIAFFLIKRKRSK 318
Query: 177 RSS-TDIEKLDNQPFAPLAASSNEV-QELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHK 234
RSS TDIEK DN P+ +SN+ QE K VQ+ ++TK DT++S+NLRPPP +RHK
Sbjct: 319 RSSSTDIEKTDNNINQPIILASNDFHQENKSVQNPPLVETKKLDTSLSMNLRPPPSERHK 378
Query: 235 SFDEEDFS-KKSIVVKKA-VKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF 292
SFD++D + +K IV KKA V P+NV +Y+++DLQ+AT SF+V+NLLGEGTFGRVYRAQF
Sbjct: 379 SFDDDDSTMRKPIVAKKAAVVVPSNVNTYTVSDLQVATNSFSVDNLLGEGTFGRVYRAQF 438
Query: 293 ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352
DGKVLAVKKIDSSALP++ DDF E+VS I+ L H N+ +L GYCSE+GQHL+VYEF +
Sbjct: 439 EDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHENVTKLDGYCSEHGQHLVVYEFHR 498
Query: 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412
NGSLHDFLHL++E++KPLIWN RVKIALGTARALEYLHEVCS S+VHKNIKSANILLD+E
Sbjct: 499 NGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYLHEVCSPSIVHKNIKSANILLDSE 558
Query: 413 LNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
LNP LSD GLAS +P A+E LN + GY APE +MSGQY++KSDVYSFGVVMLELLTGR
Sbjct: 559 LNPHLSDSGLASFLPTANELLNQN-DEGYSAPETSMSGQYSLKSDVYSFGVVMLELLTGR 617
Query: 473 KPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEP 532
KPFDS+R R EQSLVRWATPQLHDIDAL KMVDPALKGLYPVKSLSRFADVIALCVQPEP
Sbjct: 618 KPFDSTRSRSEQSLVRWATPQLHDIDALGKMVDPALKGLYPVKSLSRFADVIALCVQPEP 677
Query: 533 EFRPPMSEVVQALVRLVQRANMSKRT 558
EFRPPMSEVVQALV LVQRANMSKRT
Sbjct: 678 EFRPPMSEVVQALVVLVQRANMSKRT 703
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 547 bits (1410), Expect = e-155, Method: Compositional matrix adjust.
Identities = 301/583 (51%), Positives = 398/583 (68%), Gaps = 33/583 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M +L Y+N++ N L + D+F SL+TLDLS N SG+LP S S++S+LS LY+QNN
Sbjct: 142 MGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSLSTVSTLSVLYVQNN 201
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSSGPAPPPPPGTPPA 119
Q +G+IDVL+ LPL LN+ANN F G +P++L +I L DGNS+ + PA P P P
Sbjct: 202 QLTGSIDVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFDNVPASPQP--ERPG 259
Query: 120 RKNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISLFVVGGIVAFFLV----KRRRS 175
+K P S K SE + G+ GG + GI+ V GI+A L K++R
Sbjct: 260 KKETPS-GSKKPKIGSEEKSSDSGKGLSGGVVTGIVFGSLFVAGIIALVLYLCLHKKKRK 318
Query: 176 RRSSTDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKS 235
R ST +Q PL+ + EVQE ++ +S D L+ P ++
Sbjct: 319 VRGSTRA----SQRSLPLSGTP-EVQEQRVKSVASVAD-----------LKSSPAEKVTV 362
Query: 236 FDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADG 295
D K+ + + +++P + Y+++ LQ+AT SF+ EN++GEG+ GRVYRA+F +G
Sbjct: 363 ----DRVMKNGSISR-IRSPITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNG 417
Query: 296 KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGS 355
K++A+KKID++AL + D+F+E VSN+S+L HPNI+ L GYC+E+GQ LLVYE+ NG+
Sbjct: 418 KIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGN 477
Query: 356 LHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415
L D LH +D+ + L WN+RVK+ALGTA+ALEYLHEVC S+VH+N KSANILLD ELNP
Sbjct: 478 LDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNP 537
Query: 416 QLSDCGLASNMPNADEALNND-AGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRK 473
LSD GLA+ PN + ++ GS GY APE A+SG Y +KSDVY+FGVVMLELLTGRK
Sbjct: 538 HLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRK 597
Query: 474 PFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPE 533
P DSSR R EQSLVRWATPQLHDIDAL+KMVDP+L G+YP KSLSRFAD+IALC+QPEPE
Sbjct: 598 PLDSSRTRAEQSLVRWATPQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPE 657
Query: 534 FRPPMSEVVQALVRLVQRANMSKRTIGNDQGPT--TPRGDNQD 574
FRPPMSEVVQ LVRLVQRA++ KR +D G + TP ++ D
Sbjct: 658 FRPPMSEVVQQLVRLVQRASVVKRRSSDDTGFSYRTPEHEHVD 700
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 289/568 (50%), Positives = 376/568 (66%), Gaps = 37/568 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
MK L+ +N+ N+L G+L DMF +L L TLD S N LSG LPQSF++L+SL L+LQ+N
Sbjct: 137 MKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFANLTSLKKLHLQDN 196
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNIN-LQKDGNSWSSGPAPPPPPGTPPA 119
+F+G I+VL NL +D+LN+ +N+F GW+P +LK+I+ L GN WS+ APPPPPG
Sbjct: 197 RFTGDINVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGNDWSTETAPPPPPGVKYG 256
Query: 120 RKNNPKHKSDSNKSPSESEGGSKKSGIG---GGGIAGILISLFVVGGIVAFFLVKRRRSR 176
RK S +GG +G G G G+L+ + IV LV +++S
Sbjct: 257 RK-----------SSGSKDGGGITAGTGMVIAGACLGVLVLI-----IVLIALVSKKKSS 300
Query: 177 RSSTDIEKLDNQPFAPL---AASSNEVQELKLVQSSSSIDTKTFDTA-------VSINLR 226
S I++ DN P S QEL++ + D K+ D+ S L+
Sbjct: 301 LSPHFIDE-DNSHHTPKFKSLTSHGSAQELRVDFGNDYKDGKSGDSGDENIHRIGSKGLK 359
Query: 227 PPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
R SF + +F+ K + K + + + ++DLQ AT +F+ NLLGEG+ GR
Sbjct: 360 HYVSSRVMSFTDTEFANK--LNAKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGR 417
Query: 287 VYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346
VYRA+++DG+ LAVKKIDS+ S + +V ++S++ H NI ELVGYCSE G ++L
Sbjct: 418 VYRAKYSDGRTLAVKKIDSTLFDSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNML 477
Query: 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406
VYE+ +NGSLH+FLHLSD +KPL WN+RV+IALGTARA+EYLHE CS SV+HKNIKS+N
Sbjct: 478 VYEYFRNGSLHEFLHLSDCFSKPLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSN 537
Query: 407 ILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVML 466
ILLD +LNP+LSD GL+ + L G GY APE Y KSDVYSFGVVML
Sbjct: 538 ILLDADLNPRLSDYGLSKFYLRTSQNL----GEGYNAPEARDPSAYTPKSDVYSFGVVML 593
Query: 467 ELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIAL 526
ELLTGR PFD +PR E+SLVRWATPQLHDIDAL+ + DPAL GLYP KSLSRFAD+IAL
Sbjct: 594 ELLTGRVPFDGEKPRPERSLVRWATPQLHDIDALSNIADPALHGLYPPKSLSRFADIIAL 653
Query: 527 CVQPEPEFRPPMSEVVQALVRLVQRANM 554
CVQ EPEFRPPMSEVV+ALVR+VQR++M
Sbjct: 654 CVQVEPEFRPPMSEVVEALVRMVQRSSM 681
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1251), Expect = e-136, Method: Compositional matrix adjust.
Identities = 281/582 (48%), Positives = 372/582 (63%), Gaps = 67/582 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M L YLN+ N L G+L+DMF +LP L T+DLS N L+G LPQSF++L+ L +L+LQ N
Sbjct: 140 MNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQSFANLTGLKTLHLQEN 199
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSSGPAPPPPPGTPP 118
QF G+I+ L +LP +D++N+ANN+FTGW+P +LKNI NL+ GN WSSG AP PPPGT
Sbjct: 200 QFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNKWSSGRAPSPPPGTRH 259
Query: 119 ARKNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISLFVVGGIVAFF----LVKRRR 174
+N+ S+K+ + G++I++ +GG++ F L+ RR+
Sbjct: 260 IDRNSSGGGGGSSKALT----------------LGVIIAVSSIGGLILFAGLIALISRRK 303
Query: 175 SRRSST---DIEKLDNQP---FAPLAA------SSNEVQELKLVQSSSSIDTK------- 215
+ S+ D EK N+ F P ++ + E + K V S++S++TK
Sbjct: 304 NSNDSSHFFDDEKGTNRSKPLFTPQSSQMLQFDNMEEFKNQKTVDSNTSLETKPSVKRTS 363
Query: 216 --------TFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQ 267
TF S + P S D D + VKA +S+ADLQ
Sbjct: 364 SVSFKNSPTFHLIPSTQVAATPDRSSTSQDSPD--------TRGVKA------FSLADLQ 409
Query: 268 MATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH 327
F+ LLGEGT GRVY+A+F DG+ AVK+IDSS L ++F +VS+IS +H
Sbjct: 410 NTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSISSIH 469
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
H N+ ELVGYCSE G+++LVYE+ +GSLH FLHLSD+ +KPL WN+R++IALGTA+A+E
Sbjct: 470 HKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTAKAIE 529
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA 447
YLHE CS +VHKNIKS+NILLDNELNP+LSD GLA N + + G GY APE
Sbjct: 530 YLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLA----NFHHRTSQNLGVGYNAPECT 585
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
Y KSDVYSFGVVMLELLTGRKP+DS RP+ EQSLVRWA PQL D+D L +MVDPA
Sbjct: 586 DPSAYTQKSDVYSFGVVMLELLTGRKPYDSGRPKAEQSLVRWAKPQLKDMDTLDEMVDPA 645
Query: 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
L GLY +S+S FAD++++CV EP RPP+S VV+AL RLV
Sbjct: 646 LCGLYAPESVSSFADIVSICVMTEPGLRPPVSNVVEALKRLV 687
|
Acts as a direct positive regulator of leaf size but not leaf shape. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1072), Expect = e-115, Method: Compositional matrix adjust.
Identities = 267/632 (42%), Positives = 350/632 (55%), Gaps = 87/632 (13%)
Query: 1 MKTLKYLN---IAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYL 57
+ TL +LN + N L G+L D+F L L LD+S N +SG LP S +L +L++L +
Sbjct: 140 LGTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRV 199
Query: 58 QNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWS----------- 105
QNNQ SGT+DVL LPL +LNI NN F+G +P++L +I +GN ++
Sbjct: 200 QNNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATMINSTSTAP 259
Query: 106 --------SGPAPPPP-PGTPPARKNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILI 156
+ PAP P G PP N +++ PS+SEG S ++ G I
Sbjct: 260 SLSPSLSPTKPAPTRPFSGVPPPP--NERNRGKVADGPSDSEGSSSENSKGKNSSHTKKI 317
Query: 157 SLFVVGGIVAFFL-----------VKRRRSR-------------RSSTDIEKLDNQPFAP 192
L G++ F + RRR R S + + P P
Sbjct: 318 ILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRGSRENALENGTPVLP 377
Query: 193 LAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFD--------------- 237
S +VQ ++ + K + RP PI R +S D
Sbjct: 378 PPGRSEKVQREPFKKAGE--EPKVLHDLERLR-RPAPISRQESQDIDFSMLMPPPPPPPP 434
Query: 238 -------EEDFSKKSIV-----VKKAV--KAP-TNVTSYSIADLQMATGSFNVENLLGEG 282
+E + I+ VKK + P T+V YSIA LQ T SF ENL+G G
Sbjct: 435 PPPPPPLDEKVTVMPIISPERPVKKTSPKRLPLTSVKHYSIASLQQYTESFAQENLIGSG 494
Query: 283 TFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342
G VYRA+ +GK+ AVKK+D A + +FIE+V+NI + H NI+ELVGYC+E+
Sbjct: 495 MLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHD 554
Query: 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI 402
Q LLVYE+ NG+L D LH DE K L WN+RV +ALG ARALEYLHEVC ++H+N
Sbjct: 555 QRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNF 614
Query: 403 KSANILLDNELNPQLSDCGLASNMPNADEALNND---AGSGYGAPEVAMSGQYNIKSDVY 459
KSAN+LLD++L+ +SDCGLA + + + + A GYGAPE SG Y +SDVY
Sbjct: 615 KSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYGYGAPEFD-SGIYTWQSDVY 673
Query: 460 SFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSR 519
SFGVVMLELLTGR +D R R EQ LVRWA PQLHDIDAL KMVDP+L G YP KSLS
Sbjct: 674 SFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALGKMVDPSLNGQYPAKSLSH 733
Query: 520 FADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
FAD+I+ CVQ EPEFRP MSEVVQ L+ +++R
Sbjct: 734 FADIISRCVQSEPEFRPLMSEVVQDLLDMIRR 765
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 382 bits (982), Expect = e-105, Method: Compositional matrix adjust.
Identities = 257/621 (41%), Positives = 344/621 (55%), Gaps = 75/621 (12%)
Query: 12 NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLAN 71
N L G++ D+F L + +DLS N LSG LP S +LS+L+SL LQNN SG +DVL +
Sbjct: 156 NLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQNLSTLTSLLLQNNHLSGELDVLQD 215
Query: 72 LPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSSGPAP-------------------P 111
LPL +LN+ NN F G +PE+L +I N K GN ++ AP P
Sbjct: 216 LPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNVTIAPSPSPETPPSPTSPKRPFFGP 275
Query: 112 PPPGTPPARKNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISL-----FVVGGIVA 166
P P S+ PS K+ I I IS+ FVV +V
Sbjct: 276 PSPNASAGHGQAHVRSPPSDHHPSRPTPQGKEDSFTSKRI--IWISILGAFSFVVLALVC 333
Query: 167 FFLVKRRRSRRSSTDIEKLD-----------------NQPFAPLAASSNEVQELKL---- 205
L+ R+ R D E+L N P + + N+ +E +
Sbjct: 334 --LLCGRKCLRKREDSEQLSKPHLTSEYGRAREGSRSNASMLPPSNTFNKDKEARPKERV 391
Query: 206 ---------VQSSSSIDTKTFDTAVSIN------LRP---PPIDR--HKSFDEEDFSKKS 245
+ S ++K + +N + P PPI R K+ + + S K
Sbjct: 392 GGASKLHGGAERSVGSESKQESHEIDMNGNAMDLMHPSSIPPIKRVIAKATEPAEASLKR 451
Query: 246 IVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDS 305
K+ T V +++A LQ T SF+ ENL+G G G VYRA+ GK+ AV+K+D
Sbjct: 452 -TTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDK 510
Query: 306 SALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE 365
+ E F+E+V+NI ++ H NI++LVG+CSE+ Q LL++E+ +NG+LHD LH+ D
Sbjct: 511 KSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDR 570
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425
L WN RV+IAL A+ALEYLHE+C +H+N KSANILLD+++ +SDCGLA
Sbjct: 571 LKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPL 630
Query: 426 MPN-ADEALNND--AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
+ + A L+ A GYGAPE G Y +K DVYSFGVVMLELLTGRK +D R R
Sbjct: 631 ISSGAVSQLSGQLLAAYGYGAPEFEY-GIYTMKCDVYSFGVVMLELLTGRKSYDKKRDRG 689
Query: 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542
EQ LVRWA PQLHDIDALAKMVDP+LKG YP KSLS FADVI+ CVQ EPE+RP MSEVV
Sbjct: 690 EQFLVRWAIPQLHDIDALAKMVDPSLKGDYPAKSLSHFADVISRCVQSEPEYRPLMSEVV 749
Query: 543 QALVRLVQRANMSKRTIGNDQ 563
Q L ++QR + + G++Q
Sbjct: 750 QDLSDMIQREHRRNDSNGDNQ 770
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (918), Expect = 8e-98, Method: Compositional matrix adjust.
Identities = 224/573 (39%), Positives = 329/573 (57%), Gaps = 33/573 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M +L+ LN++HN L G L ++F L + +DLSFN L+G+LP SF +L +L+SLYLQNN
Sbjct: 140 MTSLQSLNLSHNSLSGPLGNVFSGL-QIKEMDLSFNNLTGDLPSSFGTLMNLTSLYLQNN 198
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSSGPAPPP---PPGT 116
+ +G++ LA+LPL +LNI +N+F+G +P ++I +L GN + P P P
Sbjct: 199 RLTGSVIYLADLPLADLNIEDNQFSGIIPSHFQSIPHLWIWGNKFHVEPNYKPWKFPLDV 258
Query: 117 PPARKNNPKHKSDSNKS------PSESEGGSKKSGIGGGGIAGILISLFVVGGIVAFFLV 170
P +N+ + + + + P + KK GIG G ++ L ++G A F V
Sbjct: 259 RPLIQNDTGYPTTESSAIMNFPRPETQKVKKKKKGIGAGSTFLLVGGLALLGTFFALFAV 318
Query: 171 KRRRSRRSSTDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPI 230
R RR+ Q A + S+N + V + T D +PPP
Sbjct: 319 -RMNHRRA---------QNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQIKRFQPPPA 368
Query: 231 DRHKSFDEE----DFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
+ + D S + + P+ +S A+LQ+AT F+ ENLLGEG G
Sbjct: 369 PQLRHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGS 428
Query: 287 VYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346
VYRA+ DG+ V+ I S+L + F E++ S+L HPNI+ L+G+C E G+HLL
Sbjct: 429 VYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLL 488
Query: 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406
VYE+ + SL++ +H DE KPL W R++IA+G ARAL+YLH + H ++K+ N
Sbjct: 489 VYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATN 546
Query: 407 ILLDNELNPQLSDCGLASNMPNADEALNNDAG------SGYGAPEVAMSGQYNIKSDVYS 460
ILLD EL P+++DCGLAS P ++ A +GY APE G KSD Y+
Sbjct: 547 ILLDEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYIAPEHGQPGSSGTKSDTYA 606
Query: 461 FGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRF 520
GV++LELLTGRK FDSSRPR EQ LV+WA+ +LHD +L +M+D + G + + S++
Sbjct: 607 LGVLLLELLTGRKAFDSSRPRGEQLLVKWASTRLHDRRSLEQMIDGGIAGTFSSRVASQY 666
Query: 521 ADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553
AD+I+LC Q E EFRPP+SE+V+AL L+Q+ N
Sbjct: 667 ADIISLCTQAEKEFRPPVSEIVEALTALIQKQN 699
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q8RWZ1|SUB_ARATH Protein STRUBBELIG OS=Arabidopsis thaliana GN=SUB PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 159/326 (48%), Positives = 226/326 (69%), Gaps = 10/326 (3%)
Query: 225 LRPPPIDRHKSFDEEDF-SKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGT 283
L+ PP + F D SK++ + + ++ T ++IA LQ T +F+ EN++GEG+
Sbjct: 452 LQQPP----RQFQSNDTASKRAAHFPPGLNSSSSATVFTIASLQQYTNNFSEENIIGEGS 507
Query: 284 FGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343
G VYRA+ GK LAVKK+ ++ ++ +F+ +VSN+ +L +I+EL+GYC+E+GQ
Sbjct: 508 IGNVYRAELRHGKFLAVKKLSNTINRTQSDGEFLNLVSNVLKLKRGHILELLGYCNEFGQ 567
Query: 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIK 403
LLVYE+ NGSL D LHL + +K L WN R+ IALG ++AL++LHEVC VVH+N K
Sbjct: 568 RLLVYEYCPNGSLQDALHLDRKLHKKLTWNVRINIALGASKALQFLHEVCQPPVVHQNFK 627
Query: 404 SANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGV 463
S+ +LLD +L+ +++D GLA +P + +GY APEV G Y +SDV+S GV
Sbjct: 628 SSKVLLDGKLSVRVADSGLAYMLPPRPTS----QMAGYAAPEVEY-GSYTCQSDVFSLGV 682
Query: 464 VMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADV 523
VMLELLTGR+PFD +RPR Q+L +WA P+LHDIDAL +MVDP+L G YP+KSLSRFAD+
Sbjct: 683 VMLELLTGRRPFDRTRPRGHQTLAQWAIPRLHDIDALTRMVDPSLHGAYPMKSLSRFADI 742
Query: 524 IALCVQPEPEFRPPMSEVVQALVRLV 549
I+ +Q EP FRPP+SE+VQ L ++
Sbjct: 743 ISRSLQMEPGFRPPISEIVQDLQHMI 768
|
Regulates the expression of transcription factors that define the cell fates. Seems to be required for the regulation of cell shape and the orientation of the mitotic division plane. Involved in root hair specification, in the formation of the outer integument and the shape of organs such as carpels and petals and is necessary for the shape and height of the stem. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 134/315 (42%), Positives = 196/315 (62%), Gaps = 6/315 (1%)
Query: 242 SKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAV 300
SK+ +++ + +++ +L AT +F+ + LGEG FGRVY+ + + G+V+AV
Sbjct: 55 SKRELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAV 114
Query: 301 KKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL 360
K++D + L +F+ V +S LHHPN++ L+GYC++ Q LLVYEF GSL D L
Sbjct: 115 KQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL 172
Query: 361 HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420
H D + L WN R+KIA G A+ LE+LH+ + V++++ KS+NILLD +P+LSD
Sbjct: 173 HDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDF 232
Query: 421 GLASNMPNADEALNND---AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
GLA P D++ + GY APE AM+GQ +KSDVYSFGVV LEL+TGRK DS
Sbjct: 233 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 292
Query: 478 SRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
P EQ+LV WA P +D K+ DP LKG +P ++L + V ++C+Q + RP
Sbjct: 293 EMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPL 352
Query: 538 MSEVVQALVRLVQRA 552
+++VV AL L +A
Sbjct: 353 IADVVTALSYLANQA 367
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 579 | ||||||
| 297742917 | 708 | unnamed protein product [Vitis vinifera] | 0.991 | 0.810 | 0.765 | 0.0 | |
| 224138524 | 714 | predicted protein [Populus trichocarpa] | 0.993 | 0.805 | 0.787 | 0.0 | |
| 449447966 | 621 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.974 | 0.908 | 0.742 | 0.0 | |
| 449491820 | 715 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.977 | 0.791 | 0.741 | 0.0 | |
| 147853718 | 672 | hypothetical protein VITISV_027894 [Viti | 0.981 | 0.845 | 0.718 | 0.0 | |
| 255585243 | 607 | leucine-rich repeat transmembrane protei | 0.951 | 0.907 | 0.774 | 0.0 | |
| 449453405 | 726 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.993 | 0.792 | 0.719 | 0.0 | |
| 449517912 | 726 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.993 | 0.792 | 0.717 | 0.0 | |
| 225441953 | 686 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.943 | 0.795 | 0.720 | 0.0 | |
| 357514385 | 716 | Protein STRUBBELIG-RECEPTOR FAMILY [Medi | 0.989 | 0.800 | 0.711 | 0.0 |
| >gi|297742917|emb|CBI35784.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/579 (76%), Positives = 501/579 (86%), Gaps = 5/579 (0%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M +LKYLNI+HNQLQGQL DMF QL SL+TLD S N+L+G+LP+SFSSLSS+++++LQNN
Sbjct: 132 MISLKYLNISHNQLQGQLGDMFSQLSSLTTLDFSLNSLTGDLPESFSSLSSITTMFLQNN 191
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QF+G+I+VLA+LPL+ LN+ANN FTGW+PE LKNINLQKDGNSWSSGPAPPPPPGTPP
Sbjct: 192 QFTGSINVLASLPLETLNVANNHFTGWIPESLKNINLQKDGNSWSSGPAPPPPPGTPPVS 251
Query: 121 KNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISL-FVVGGIVAFFLVKRRRSRRSS 179
+ PKHKS N PS GGS GGG ++ V+G I+ FFLVKRR SRR S
Sbjct: 252 RTPPKHKSGGNDGPSGGGGGSGGKSGIGGGGIAGIVISILVIGAIITFFLVKRR-SRRPS 310
Query: 180 TDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEE 239
D+EK D+QPFAPLA S EVQE+K +Q+SS+I+TKT++ + SINLRPPPIDRHKSFDEE
Sbjct: 311 MDVEKHDDQPFAPLA--SKEVQEMKSIQASSTINTKTYEPSASINLRPPPIDRHKSFDEE 368
Query: 240 DFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLA 299
D KK I+ KKA AP N SYSIADLQMATGSF+VENL+GEG+FGRVY+AQF DGKV+A
Sbjct: 369 DLPKKPIITKKANTAPINAISYSIADLQMATGSFSVENLIGEGSFGRVYQAQFDDGKVVA 428
Query: 300 VKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDF 359
VKKIDSSALP + +DF E+VSNISQLHHPN+ ELVGYCSE+GQHLLVYEF KNGSLHDF
Sbjct: 429 VKKIDSSALPDQFSEDFTEIVSNISQLHHPNVTELVGYCSEHGQHLLVYEFHKNGSLHDF 488
Query: 360 LHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419
LHLSDE +KPL WN+RVKIALGTARALEYLHEVCS S+VHKN KSANILLD ELNP L+D
Sbjct: 489 LHLSDEYSKPLTWNTRVKIALGTARALEYLHEVCSPSIVHKNFKSANILLDTELNPHLTD 548
Query: 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR 479
CGLAS +PNAD+ LN++AGSGY APEVAMSGQY +KSDVYSFGVVMLELL+GRKPFDSSR
Sbjct: 549 CGLASFIPNADQVLNHNAGSGYSAPEVAMSGQYTLKSDVYSFGVVMLELLSGRKPFDSSR 608
Query: 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539
R EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS
Sbjct: 609 SRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 668
Query: 540 EVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQDY 578
EVVQALVRLVQRANMSKRTI N+QG +PRGDN DTQD+
Sbjct: 669 EVVQALVRLVQRANMSKRTISNEQG-ASPRGDNPDTQDH 706
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138524|ref|XP_002326624.1| predicted protein [Populus trichocarpa] gi|222833946|gb|EEE72423.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/580 (78%), Positives = 517/580 (89%), Gaps = 5/580 (0%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M++L YLN+ HNQLQ QL DMFGQL SLSTLD+SFN L+G+LP+SFSSLSS+ S+YLQ+N
Sbjct: 139 MRSLTYLNLGHNQLQSQLGDMFGQLTSLSTLDVSFNLLTGDLPESFSSLSSMKSMYLQSN 198
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QF+G IDVLANLPL+NLN+ANNRFTGW+P QL ++NLQKDGN+W+SGPAPPPPPGTPPA
Sbjct: 199 QFTGAIDVLANLPLENLNVANNRFTGWIPSQLNSVNLQKDGNNWNSGPAPPPPPGTPPAH 258
Query: 121 KN-NPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISLFVVGGIVAFFLVKRRRSRRSS 179
K + K + + S S + GGSKKSGIG GGIAGI+IS+F+VGGIVAFFLVKRR SRRSS
Sbjct: 259 KGPSQKSGGNDSSSGSGAGGGSKKSGIGAGGIAGIIISIFLVGGIVAFFLVKRR-SRRSS 317
Query: 180 TDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEE 239
DIEKLDNQP APL+ S+N+V E+K +Q+SS+++TK FDT+ SINLRPPPIDRHKSFDEE
Sbjct: 318 -DIEKLDNQPLAPLS-STNDVPEMKSMQTSSAVNTKIFDTSASINLRPPPIDRHKSFDEE 375
Query: 240 DFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLA 299
+FS K +VVKK V P NVTSYS+ADLQMATGSF+V++LLGEG FGRVYRA+F DGKV+A
Sbjct: 376 EFSPKPVVVKKPVTTPINVTSYSVADLQMATGSFSVDHLLGEGLFGRVYRAEFDDGKVVA 435
Query: 300 VKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDF 359
VKK+DS+ LPS+M DDF E+V++IS LHHPN+ ELVGYCSE+GQHLLVYEF KNGSLHDF
Sbjct: 436 VKKLDSATLPSDMSDDFTEIVASISLLHHPNVTELVGYCSEHGQHLLVYEFHKNGSLHDF 495
Query: 360 LHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419
LHLSDE +KPLIWNSRVKIALGTARALEYLHEVCS S+VHKNIKSANILLD ELNP LSD
Sbjct: 496 LHLSDEYSKPLIWNSRVKIALGTARALEYLHEVCSPSIVHKNIKSANILLDTELNPHLSD 555
Query: 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR 479
GLAS +P+AD+ LN +AGSGYGAPEVAMSG Y +KSDVYSFG VMLELLTGRKPFDSSR
Sbjct: 556 SGLASCLPHADQVLNQNAGSGYGAPEVAMSGHYTLKSDVYSFGAVMLELLTGRKPFDSSR 615
Query: 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539
PR EQSLVRWATPQLHDIDAL+KMVDP LKGLYPVKSLSRFADVIALCVQPEPEFRPPMS
Sbjct: 616 PRSEQSLVRWATPQLHDIDALSKMVDPELKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 675
Query: 540 EVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQDYM 579
EVVQALVRLVQRANMSKRTIGN+QG TPR N DTQDYM
Sbjct: 676 EVVQALVRLVQRANMSKRTIGNEQG-ETPRTVNPDTQDYM 714
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449447966|ref|XP_004141737.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/571 (74%), Positives = 484/571 (84%), Gaps = 7/571 (1%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+L+YLNI+HNQLQ LND++GQL SLS LDLSFN +SGNLPQSFSSLS +SS+YLQNNQF
Sbjct: 49 SLQYLNISHNQLQDPLNDVYGQLTSLSILDLSFNAMSGNLPQSFSSLSGISSMYLQNNQF 108
Query: 63 SGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPARKN 122
+GTIDVLA LPLDNLN+ NNRFTGW+PE LKNINLQK+GNSW++GPAPPPPPGTPPA +
Sbjct: 109 TGTIDVLATLPLDNLNVENNRFTGWIPEPLKNINLQKNGNSWNTGPAPPPPPGTPPATRR 168
Query: 123 NPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISLFVVGGIVAFFLVKRRRSRRSSTDI 182
N H + S S G +KSGI GG IAGI+IS+ VVG +VAFFLV RRRS+R TDI
Sbjct: 169 NRSHNPGGSPSNGSSSEG-QKSGISGGAIAGIIISVLVVGAVVAFFLV-RRRSKRPLTDI 226
Query: 183 EKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEEDFS 242
EKLDNQP PL ++ QE K SSS+ +F+++ +INL+PPPIDRHKSFDE+DF+
Sbjct: 227 EKLDNQPLQPLKMTA--AQETKSEDSSSTFYPTSFESSAAINLKPPPIDRHKSFDEDDFA 284
Query: 243 KKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKK 302
K++ V K + AP NV SYSIADLQMATGSFNV+NLLGEG+FGRVYRA+F DGKVLAVKK
Sbjct: 285 KRAPVKKASAAAPINVKSYSIADLQMATGSFNVDNLLGEGSFGRVYRAEFDDGKVLAVKK 344
Query: 303 IDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHL 362
I+SSALP E+ +DF ++VS +SQLHHPN+ ELVGYCSE+GQHLLVYEF +NGSL+D LHL
Sbjct: 345 INSSALPRELSEDFTDIVSKVSQLHHPNVTELVGYCSEHGQHLLVYEFHRNGSLYDVLHL 404
Query: 363 S--DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420
S DE NKPLIWN RVKIALGTARALEYLHEVCS S+VH+NIKSANILLD EL+P LSD
Sbjct: 405 SLSDEYNKPLIWNLRVKIALGTARALEYLHEVCSPSIVHRNIKSANILLDAELSPHLSDS 464
Query: 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
GL S +PNAD+A++ SGY APEV MSGQY +KSDVYSFGVVMLELLTGRKPFDSSRP
Sbjct: 465 GLESFIPNADQAMDGSGSSGYTAPEVTMSGQYTLKSDVYSFGVVMLELLTGRKPFDSSRP 524
Query: 481 RLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE 540
R EQSLVRWATPQLHDIDAL KMVDP LKGLYPVKS+SRFADVIALCVQ EPEFRPPMSE
Sbjct: 525 RSEQSLVRWATPQLHDIDALTKMVDPELKGLYPVKSISRFADVIALCVQTEPEFRPPMSE 584
Query: 541 VVQALVRLVQRANMSKRTIGNDQGPTTPRGD 571
VV+ALVRLVQRANMSKRT GND T+PRG+
Sbjct: 585 VVEALVRLVQRANMSKRTYGNDNA-TSPRGE 614
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449491820|ref|XP_004159012.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2090), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/573 (74%), Positives = 485/573 (84%), Gaps = 7/573 (1%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M +L+YLNI+HNQLQ LND++GQL SLS LDLSFN +SGNLPQSFSSLS +SS+YLQNN
Sbjct: 141 MTSLQYLNISHNQLQDPLNDVYGQLTSLSILDLSFNAMSGNLPQSFSSLSGISSMYLQNN 200
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QF+GTIDVLA LPLDNLN+ NNRFTGW+PE LKNINLQK+GNSW++GPAPPPPPGTPPA
Sbjct: 201 QFTGTIDVLATLPLDNLNVENNRFTGWIPEPLKNINLQKNGNSWNTGPAPPPPPGTPPAT 260
Query: 121 KNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISLFVVGGIVAFFLVKRRRSRRSST 180
+ N H + S S G +KSGI GG IAGI+IS+ VVG +VAFFLV RRRS+R T
Sbjct: 261 RRNRSHNPGGSPSNGSSSEG-QKSGISGGAIAGIIISVLVVGAVVAFFLV-RRRSKRPLT 318
Query: 181 DIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEED 240
DIEKLDNQP PL ++ QE K SSS+ +F+++ +INL+PPPIDRHKSFDE+D
Sbjct: 319 DIEKLDNQPLQPLKMTA--AQETKSEDSSSTFYPTSFESSAAINLKPPPIDRHKSFDEDD 376
Query: 241 FSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAV 300
F+K++ V K + AP NV SYSIADLQMATGSFNV+NLLGEG+FGRVYRA+F DGKVLAV
Sbjct: 377 FAKRAPVKKASAAAPINVKSYSIADLQMATGSFNVDNLLGEGSFGRVYRAEFDDGKVLAV 436
Query: 301 KKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL 360
KKI+SSALP E+ +DF ++VS +SQLHHPN+ ELVGYCSE+GQHLLVYEF +NGSL+D L
Sbjct: 437 KKINSSALPRELSEDFTDIVSKVSQLHHPNVTELVGYCSEHGQHLLVYEFHRNGSLYDVL 496
Query: 361 HLS--DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418
HLS DE NKPLIWN RVKIALGTARALEYLHEVCS S+VH+NIKSANILLD EL+P LS
Sbjct: 497 HLSLSDEYNKPLIWNLRVKIALGTARALEYLHEVCSPSIVHRNIKSANILLDAELSPHLS 556
Query: 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
D GL S +PNAD+A++ SGY APEV MSGQY +KSDVYSFGVVMLELLTGRKPFDSS
Sbjct: 557 DSGLESFIPNADQAMDGSGSSGYTAPEVTMSGQYTLKSDVYSFGVVMLELLTGRKPFDSS 616
Query: 479 RPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538
RPR EQSLVRWATPQLHDIDAL KMVDP LKGLYPVKS+SRFADVIALCVQ EPEFRPPM
Sbjct: 617 RPRSEQSLVRWATPQLHDIDALTKMVDPELKGLYPVKSISRFADVIALCVQTEPEFRPPM 676
Query: 539 SEVVQALVRLVQRANMSKRTIGNDQGPTTPRGD 571
SEVV+ALVRLVQRANMSKRT GND T+PRG+
Sbjct: 677 SEVVEALVRLVQRANMSKRTYGNDNA-TSPRGE 708
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853718|emb|CAN80221.1| hypothetical protein VITISV_027894 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2086), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/594 (71%), Positives = 485/594 (81%), Gaps = 26/594 (4%)
Query: 7 LNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI 66
LN+A N G + + SL LD S N+L+G+LP+SFSSLSS+++++LQNNQF+G+I
Sbjct: 81 LNLAGNGFNGGIPYSISLMISLKYLDFSLNSLTGDLPESFSSLSSITTMFLQNNQFTGSI 140
Query: 67 DVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPARKNNPKH 126
+VLA+LPL+ LN+ANN FTGW+PE LKNINLQKDGNSWSSGPAPPPPPGTPP + PKH
Sbjct: 141 NVLASLPLETLNVANNHFTGWIPESLKNINLQKDGNSWSSGPAPPPPPGTPPVSRTPPKH 200
Query: 127 KSDSNKSPSESEGGSKKSGIGGGGIAGILISL-FVVGGIVAFFLVKRRRSRRSSTDIEKL 185
KS N PS GGS GGG ++ V+G I+ FFLVKRR SRR S D+EK
Sbjct: 201 KSGGNDGPSGGGGGSGGKSGIGGGGIAGIVISILVIGAIITFFLVKRR-SRRPSMDVEKH 259
Query: 186 DNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEEDFSKKS 245
D+QPFAPLA S EVQE+K +Q+SS+I+TKT++ + SINLRPPPIDRHKSFDEED KK
Sbjct: 260 DDQPFAPLA--SKEVQEMKSIQASSTINTKTYEPSASINLRPPPIDRHKSFDEEDLPKKP 317
Query: 246 IVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDS 305
I+ KKA AP N SYSIADLQMATGSF+VENL+GEG+FGRVY+AQF DGKV+AVKKIDS
Sbjct: 318 IITKKANTAPINAISYSIADLQMATGSFSVENLIGEGSFGRVYQAQFDDGKVVAVKKIDS 377
Query: 306 SALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE 365
SALP + +DF E+VSNISQLHHPN+ ELVGYCSE+GQHLLVYEF KNGSLHDFLHLSDE
Sbjct: 378 SALPDQFSEDFTEIVSNISQLHHPNVTELVGYCSEHGQHLLVYEFHKNGSLHDFLHLSDE 437
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425
+KPL WN+RVKIALGTARALEYLHEVCS S+VHKN KSANILLD ELNP L+DCGLAS
Sbjct: 438 YSKPLTWNTRVKIALGTARALEYLHEVCSPSIVHKNFKSANILLDTELNPHLTDCGLASF 497
Query: 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS 485
+PNAD+ LN++AGSGY APEVAMSGQY +KSDVYSFGVVMLELL+GRKPFDSSR R EQS
Sbjct: 498 IPNADQVLNHNAGSGYSAPEVAMSGQYTLKSDVYSFGVVMLELLSGRKPFDSSRSRSEQS 557
Query: 486 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQ---------------- 529
LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQ
Sbjct: 558 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQVRCLVKVKSADGFIIL 617
Query: 530 -----PEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQDY 578
PEPEFRPPMSEVVQALVRLVQRANMSKRTI N+QG +PRGDN DTQD+
Sbjct: 618 FQLLMPEPEFRPPMSEVVQALVRLVQRANMSKRTISNEQG-ASPRGDNPDTQDH 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585243|ref|XP_002533323.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] gi|223526845|gb|EEF29059.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/555 (77%), Positives = 488/555 (87%), Gaps = 4/555 (0%)
Query: 25 LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRF 84
L +L LD+SFN L GNLP SF +LSS++S+YLQNN+F+GTIDVLA+LPL NLN+ANN+F
Sbjct: 57 LTALINLDVSFNQLPGNLPWSFRNLSSMTSMYLQNNRFTGTIDVLADLPLKNLNVANNQF 116
Query: 85 TGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPARKNNPKHKSDSNKSPSESEGGSKKS 144
TGW+P+QLK I+ Q DGN+WSSGPAPPPPPGTPPA +N +N SKKS
Sbjct: 117 TGWIPQQLKEIHPQMDGNNWSSGPAPPPPPGTPPAPRNRGHKSGGNNSPSGSDGSSSKKS 176
Query: 145 GIGGGGIAGILISLFVVGGIVAFFLVKRRRSRRSSTDIEKLDNQPFAPLAASSNEVQELK 204
GIG GGIAGI+IS+ VVGGI AFF+ KRR S+RSS+DIEKLDN+PFAPLA SNEVQE+K
Sbjct: 177 GIGAGGIAGIIISILVVGGIAAFFIAKRR-SKRSSSDIEKLDNEPFAPLA--SNEVQEMK 233
Query: 205 LVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIA 264
+Q +++ TKTFDT+ SINLRPPPIDRHKSFDE+DFSKK +VVKK V AP +VT+YSIA
Sbjct: 234 AIQPPTTVSTKTFDTSASINLRPPPIDRHKSFDEDDFSKKPVVVKKPVTAPLDVTTYSIA 293
Query: 265 DLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS 324
DLQ+ATGSF++++LLGEG+FGRVYRAQF GKVLAVKKIDSS L S M DDFIEM+S IS
Sbjct: 294 DLQIATGSFSIDHLLGEGSFGRVYRAQFDGGKVLAVKKIDSSTLSSNMSDDFIEMISKIS 353
Query: 325 QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR 384
+LHHPN+ EL+GYCSE+GQHLLVYEF K+GSLHDFLHLSDED+KPLIWN+RVKIALGTAR
Sbjct: 354 ELHHPNVTELMGYCSEHGQHLLVYEFHKSGSLHDFLHLSDEDSKPLIWNTRVKIALGTAR 413
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAP 444
ALEYLHEVCS S++HKNIKSANILLD ELNP LSD GLAS +PNA++ALNN+AGSGYGAP
Sbjct: 414 ALEYLHEVCSPSIIHKNIKSANILLDTELNPHLSDSGLASFLPNAEQALNNNAGSGYGAP 473
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
EVAMSGQY +KSDVYSFGVVMLELLTGRKPFDSSRPR EQSLVRWATPQLHDIDAL+KMV
Sbjct: 474 EVAMSGQYTLKSDVYSFGVVMLELLTGRKPFDSSRPRSEQSLVRWATPQLHDIDALSKMV 533
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQG 564
DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRT+GNDQG
Sbjct: 534 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTVGNDQG 593
Query: 565 PTTPRGDNQDTQDYM 579
+ + DN D DYM
Sbjct: 594 ASR-QVDNADAHDYM 607
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449453405|ref|XP_004144448.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 6-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2066), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/584 (71%), Positives = 485/584 (83%), Gaps = 9/584 (1%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M L LN++HNQLQ Q+NDMF +L SL+ LD+SFN LSG LPQSFS+L+SL++++LQNN
Sbjct: 143 MSLLISLNMSHNQLQNQVNDMFWKLSSLAMLDVSFNFLSGALPQSFSNLTSLNAMFLQNN 202
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QFSGTIDVLANLPL NLN+ NN FTGWVPE+LKNIN+Q+ GNSWS G APPPPPGTPPA
Sbjct: 203 QFSGTIDVLANLPLQNLNVENNHFTGWVPERLKNINIQEGGNSWSFGLAPPPPPGTPPAN 262
Query: 121 KNNPKHKSDSNKSPSESE---GGSKKSGIGGGGIAGILISLFVVGGIVAFFLVKRRRSRR 177
+N HK+ ++ SP S+ GGS +SGIGGG IAGILIS+ VVG I+A+ L KRR S+R
Sbjct: 263 QNYRYHKAGNSYSPLSSDAAGGGSNRSGIGGGAIAGILISVLVVGAILAYLLAKRR-SKR 321
Query: 178 SSTDIEKLDNQPFAPLAASSNEVQ----ELKLVQSSSSIDTKTFDTAVSINLRPPPIDRH 233
STDIEK + ++ +SNEVQ E+KLV +SSS D K D+ SINL+PPPIDRH
Sbjct: 322 PSTDIEKQKHGNLPIVSPASNEVQDALAEMKLVHTSSSFDAKELDSPASINLKPPPIDRH 381
Query: 234 KSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFA 293
KSFD+ D SK +V K V AP +V SYSIADLQMATGSFNVENLLGEG GRVYRAQF
Sbjct: 382 KSFDDNDTSKVPVVKKTNVTAPISVKSYSIADLQMATGSFNVENLLGEGPLGRVYRAQFN 441
Query: 294 DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353
DGKVLAVKKIDS+A E+ +DF E+V+NISQLHHPN+ EL GYCSE+G HLL+YEF KN
Sbjct: 442 DGKVLAVKKIDSAAFHRELLEDFTEIVANISQLHHPNVTELTGYCSEHGLHLLIYEFHKN 501
Query: 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413
GSLHDFLH+SDE +KPL WNSRVKIALGTARALEYLHEVC+ SVVH+NIKSANILLD E+
Sbjct: 502 GSLHDFLHISDEYSKPLTWNSRVKIALGTARALEYLHEVCAPSVVHRNIKSANILLDAEM 561
Query: 414 NPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRK 473
NP LSDCGLAS + N D AL+ AGSGY APEV MSGQY +KSDVYSFGVVMLELL+GRK
Sbjct: 562 NPHLSDCGLASFITNLDHALDQQAGSGYSAPEVTMSGQYTLKSDVYSFGVVMLELLSGRK 621
Query: 474 PFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPE 533
PFDSSRPR EQSLVRWATPQLHDIDAL KMVDPALKGLYPVKSLSRFADV+ALCVQPEPE
Sbjct: 622 PFDSSRPRAEQSLVRWATPQLHDIDALTKMVDPALKGLYPVKSLSRFADVVALCVQPEPE 681
Query: 534 FRPPMSEVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQD 577
FRPPMSEVV+ALVRLVQR+NMS+RT G+D G ++ R D+ + ++
Sbjct: 682 FRPPMSEVVEALVRLVQRSNMSRRTFGSDHG-SSFRTDDLEARE 724
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449517912|ref|XP_004165988.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 6-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/584 (71%), Positives = 485/584 (83%), Gaps = 9/584 (1%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M L LN++HNQLQ Q+NDMF +L SL+ LD+SFN LSG LPQSFS+L+SL++++LQNN
Sbjct: 143 MSLLISLNMSHNQLQNQVNDMFWKLSSLAMLDVSFNFLSGALPQSFSNLTSLNAMFLQNN 202
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QFSGTIDVLANLPL NLN+ NN FTGWVPE+LKNIN+Q+ GNSWS G APPPPPGTPPA
Sbjct: 203 QFSGTIDVLANLPLQNLNVENNHFTGWVPERLKNINIQEGGNSWSFGLAPPPPPGTPPAN 262
Query: 121 KNNPKHKSDSNKSPSESE---GGSKKSGIGGGGIAGILISLFVVGGIVAFFLVKRRRSRR 177
++ HK+ ++ SP S+ GGS +SGIGGG IAGILIS+ VVG I+A+ L KRR S+R
Sbjct: 263 QSYRYHKAGNSYSPLSSDAAGGGSNRSGIGGGAIAGILISVLVVGAILAYLLAKRR-SKR 321
Query: 178 SSTDIEKLDNQPFAPLAASSNEVQ----ELKLVQSSSSIDTKTFDTAVSINLRPPPIDRH 233
STDIEK + ++ +SNEVQ E+KLV +SSS D K D+ SINL+PPPIDRH
Sbjct: 322 PSTDIEKQKHGNLPIVSPASNEVQDALAEMKLVHTSSSFDAKELDSPASINLKPPPIDRH 381
Query: 234 KSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFA 293
KSFD+ D SK +V K V AP +V SYSIADLQMATGSFNVENLLGEG GRVYRAQF
Sbjct: 382 KSFDDNDTSKVPVVKKTNVTAPISVKSYSIADLQMATGSFNVENLLGEGPLGRVYRAQFN 441
Query: 294 DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353
DGKVLAVKKIDS+A E+ +DF E+V+NISQLHHPN+ EL GYCSE+G HLL+YEF KN
Sbjct: 442 DGKVLAVKKIDSAAFHRELLEDFTEIVANISQLHHPNVTELTGYCSEHGLHLLIYEFHKN 501
Query: 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413
GSLHDFLH+SDE +KPL WNSRVKIALGTARALEYLHEVC+ SVVH+NIKSANILLD E+
Sbjct: 502 GSLHDFLHISDEYSKPLTWNSRVKIALGTARALEYLHEVCAPSVVHRNIKSANILLDAEM 561
Query: 414 NPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRK 473
NP LSDCGLAS + N D AL+ AGSGY APEV MSGQY +KSDVYSFGVVMLELL+GRK
Sbjct: 562 NPHLSDCGLASFITNLDHALDQQAGSGYSAPEVTMSGQYTLKSDVYSFGVVMLELLSGRK 621
Query: 474 PFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPE 533
PFDSSRPR EQSLVRWATPQLHDIDAL KMVDPALKGLYPVKSLSRFADV+ALCVQPEPE
Sbjct: 622 PFDSSRPRAEQSLVRWATPQLHDIDALTKMVDPALKGLYPVKSLSRFADVVALCVQPEPE 681
Query: 534 FRPPMSEVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQD 577
FRPPMSEVV+ALVRLVQR+NMS+RT G+D G ++ R D+ + ++
Sbjct: 682 FRPPMSEVVEALVRLVQRSNMSRRTFGSDHG-SSFRTDDLEARE 724
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225441953|ref|XP_002263152.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 6-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2021), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/579 (72%), Positives = 474/579 (81%), Gaps = 33/579 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M +LKYLNI+HNQLQGQL DMF QL SL+TLD S N+L+G+LP+SFSSLSS+++++LQNN
Sbjct: 138 MISLKYLNISHNQLQGQLGDMFSQLSSLTTLDFSLNSLTGDLPESFSSLSSITTMFLQNN 197
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPAR 120
QF+G+I+VLA+LPL+ LN+ANN FTGW+PE LKNINLQKDGNSWSSGPAPPPPPGTPP
Sbjct: 198 QFTGSINVLASLPLETLNVANNHFTGWIPESLKNINLQKDGNSWSSGPAPPPPPGTPPVS 257
Query: 121 KNNPKHKSDSNKSPSESEGGSKKSGIGGGGIAGILISL-FVVGGIVAFFLVKRRRSRRSS 179
+ PKHKS N PS GGS GGG ++ V+G I+ FFLVKRR SRR S
Sbjct: 258 RTPPKHKSGGNDGPSGGGGGSGGKSGIGGGGIAGIVISILVIGAIITFFLVKRR-SRRPS 316
Query: 180 TDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEE 239
D+EK D+QPFAPLA S EVQE+K +Q+SS+I+TKT++ + SINLRPPPIDRHKSFDEE
Sbjct: 317 MDVEKHDDQPFAPLA--SKEVQEMKSIQASSTINTKTYEPSASINLRPPPIDRHKSFDEE 374
Query: 240 DFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLA 299
D KK I+ KKA AP N SYSIADLQMATGSF+VENL+GEG+FGRVY+AQF DGKV+A
Sbjct: 375 DLPKKPIITKKANTAPINAISYSIADLQMATGSFSVENLIGEGSFGRVYQAQFDDGKVVA 434
Query: 300 VKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDF 359
VKKIDSSALP + +DF E+VSNISQLHHPN+ ELV
Sbjct: 435 VKKIDSSALPDQFSEDFTEIVSNISQLHHPNVTELV------------------------ 470
Query: 360 LHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419
DE +KPL WN+RVKIALGTARALEYLHEVCS S+VHKN KSANILLD ELNP L+D
Sbjct: 471 ----DEYSKPLTWNTRVKIALGTARALEYLHEVCSPSIVHKNFKSANILLDTELNPHLTD 526
Query: 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR 479
CGLAS +PNAD+ LN++AGSGY APEVAMSGQY +KSDVYSFGVVMLELL+GRKPFDSSR
Sbjct: 527 CGLASFIPNADQVLNHNAGSGYSAPEVAMSGQYTLKSDVYSFGVVMLELLSGRKPFDSSR 586
Query: 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539
R EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS
Sbjct: 587 SRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 646
Query: 540 EVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQDY 578
EVVQALVRLVQRANMSKRTI N+QG +PRGDN DTQD+
Sbjct: 647 EVVQALVRLVQRANMSKRTISNEQG-ASPRGDNPDTQDH 684
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357514385|ref|XP_003627481.1| Protein STRUBBELIG-RECEPTOR FAMILY [Medicago truncatula] gi|355521503|gb|AET01957.1| Protein STRUBBELIG-RECEPTOR FAMILY [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/579 (71%), Positives = 479/579 (82%), Gaps = 6/579 (1%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+L LN HNQ Q LN F +L SL+T D+SFN+L+G+LPQ+ +SLSS+S++ LQNNQF
Sbjct: 139 SLISLNFGHNQFQQALNLNFQKLTSLTTFDVSFNSLTGDLPQTMNSLSSISTMNLQNNQF 198
Query: 63 SGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPPARKN 122
+GTID+LA+LPLDNLNI NN FTGW+PEQLKNINLQK+GNSWSSGPAPPPPPGTPP KN
Sbjct: 199 TGTIDILADLPLDNLNIENNHFTGWIPEQLKNINLQKNGNSWSSGPAPPPPPGTPPVTKN 258
Query: 123 NPKHKSDSNKSPSESEGGSKKSGIGGGGIAGI---LISLFVVGGIVAFFLVKRRRSRRSS 179
HKS SPS G S S G G I +IS+ VVG IVAFFLVK+R ++S
Sbjct: 259 KGNHKSGGGHSPSSDSGSSDGSKKSGIGGGAIAGIVISILVVGAIVAFFLVKKRSKKKSF 318
Query: 180 TDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDT-AVSINLRPPPIDRHKSFDE 238
D+EKLDNQP APL +SNEV Q+SS ID KTFDT A +I+L+PPP DR+KSFDE
Sbjct: 319 GDVEKLDNQPLAPL--TSNEVHGRNSTQTSSVIDLKTFDTSAAAISLKPPPFDRNKSFDE 376
Query: 239 EDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVL 298
++ KK IVVKK V P N+ SYSIADLQ+ATGSF+V++LLGEG+FGRVYRAQF DG+VL
Sbjct: 377 DELPKKPIVVKKTVAPPANLKSYSIADLQIATGSFSVDHLLGEGSFGRVYRAQFDDGQVL 436
Query: 299 AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHD 358
AVKKIDSS LP+ + DDF+E+VSN+S+LHHPN+ EL+GYCSE+GQHLLVYE+ KNGSLHD
Sbjct: 437 AVKKIDSSVLPNNLSDDFMEIVSNLSRLHHPNVTELIGYCSEHGQHLLVYEYHKNGSLHD 496
Query: 359 FLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418
FLHL D+ KPLIWNSRVK+ALG ARALEYLHE+CS SVVHKNIK+ANILLD +LNP LS
Sbjct: 497 FLHLPDDYIKPLIWNSRVKVALGIARALEYLHEICSPSVVHKNIKAANILLDADLNPHLS 556
Query: 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
D GLAS +PN ++ LNN++GSGY APEV ++GQY +KSDVYSFGVVMLELL+GRKPFDSS
Sbjct: 557 DSGLASYIPNTNQVLNNNSGSGYDAPEVGLTGQYTLKSDVYSFGVVMLELLSGRKPFDSS 616
Query: 479 RPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538
R R EQSLVRWATPQLHDIDALAKMVDPAL+G+YPVKSLSRFADVIALCVQ EPEFRPPM
Sbjct: 617 RSRFEQSLVRWATPQLHDIDALAKMVDPALEGMYPVKSLSRFADVIALCVQSEPEFRPPM 676
Query: 539 SEVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQD 577
SEVVQALVRLVQR NMSKRT G DQG + GD+QD+ D
Sbjct: 677 SEVVQALVRLVQRTNMSKRTFGADQGGSNRGGDDQDSLD 715
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 579 | ||||||
| TAIR|locus:2024837 | 720 | SRF6 "STRUBBELIG-receptor fami | 0.982 | 0.790 | 0.625 | 9e-180 | |
| TAIR|locus:2091015 | 717 | SRF7 "STRUBBELIG-receptor fami | 0.968 | 0.782 | 0.621 | 8.3e-177 | |
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.552 | 0.455 | 0.641 | 2.4e-127 | |
| TAIR|locus:2207280 | 699 | SRF5 "STRUBBELIG-receptor fami | 0.663 | 0.549 | 0.533 | 6.7e-119 | |
| TAIR|locus:2089210 | 687 | SRF4 "STRUBBELIG-receptor fami | 0.920 | 0.775 | 0.443 | 1.4e-116 | |
| TAIR|locus:2125566 | 776 | SRF3 "STRUBBELIG-receptor fami | 0.509 | 0.380 | 0.588 | 1.4e-99 | |
| TAIR|locus:2051404 | 775 | SRF1 "STRUBBELIG-receptor fami | 0.578 | 0.432 | 0.520 | 6.8e-98 | |
| TAIR|locus:2202084 | 768 | SUB "STRUBBELIG" [Arabidopsis | 0.499 | 0.376 | 0.517 | 7.8e-94 | |
| TAIR|locus:2170219 | 735 | SRF2 "STRUBBELIG-receptor fami | 0.628 | 0.495 | 0.412 | 5.7e-84 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.504 | 0.715 | 0.476 | 6.7e-65 |
| TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1745 (619.3 bits), Expect = 9.0e-180, P = 9.0e-180
Identities = 365/584 (62%), Positives = 418/584 (71%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLXXXXXXXXXXXXXXXXXXXXXXXXX 63
LKYLN+ HNQ +GQ+ F +L SL+TLD SFN+
Sbjct: 144 LKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLPATFSSLTSLKSLYLQNNQFS 203
Query: 64 GTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSXXXXXXXXXXXXXRKNN 123
GT+DVLA LPL+ LNIANN FTGW+P LK I L KDGNS+++ R +
Sbjct: 204 GTVDVLAGLPLETLNIANNDFTGWIPSSLKGITLIKDGNSFNTGPAPPPPPGTPPIR-GS 262
Query: 124 PKHKSDSNKSPXXXXXXXXXXXXXXXXXXXXXXXXF-----VVGGIVAFFLVKRRRSRRS 178
P KS +S V +VAFFL +R++S+RS
Sbjct: 263 PSRKSGGRESRSSDESTRNGDSKKSGIGAGAIAGIIISLLVVTALLVAFFLFRRKKSKRS 322
Query: 179 ST-DIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFD 237
S DIEK DNQPF LA SN+ E +QSSSS++TK DT++SINLRPPPIDR+KSFD
Sbjct: 323 SPMDIEKTDNQPFT-LA--SNDFHENNSIQSSSSVETKKLDTSLSINLRPPPIDRNKSFD 379
Query: 238 EEDFXXX-XXXXXXXXXXPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGK 296
+ED P+NV YS+ADLQ+ATGSF+V+NLLGEGTFGRVYRA+F DGK
Sbjct: 380 DEDSTRKPIAVKKSTVVVPSNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGK 439
Query: 297 VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356
VLAVKKIDSSALP M DDFIEMVS I+ L HPN+ +LVGYC+E+GQHL+VYEF KNGSL
Sbjct: 440 VLAVKKIDSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSL 499
Query: 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ 416
HDFLHLS+E++K L+WNSRVKIALGTARALEYLHEVCS S+V KNIKSANILLD+ELNP
Sbjct: 500 HDFLHLSEEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPH 559
Query: 417 LSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
LSD GLAS +P A+E LN GY APEV+MSGQY++KSD+YSFGVVMLELLTGRKPFD
Sbjct: 560 LSDSGLASFLPTANELLNQ-TDEGYSAPEVSMSGQYSLKSDIYSFGVVMLELLTGRKPFD 618
Query: 477 SS-RPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR 535
SS R R EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR
Sbjct: 619 SSTRSRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR 678
Query: 536 PPMSEVVQALVRLVQRANMSKRTIGNDQGPTTPRGDNQDTQDYM 579
PPMSEVVQALV LVQRANMSKRT+G D P+ G T DYM
Sbjct: 679 PPMSEVVQALVVLVQRANMSKRTVGVD--PSQRAGSADTTSDYM 720
|
|
| TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1717 (609.5 bits), Expect = 8.3e-177, P = 8.3e-177
Identities = 356/573 (62%), Positives = 415/573 (72%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLXXXXXXXXXXXXXXXXXXXXXX 60
M LKYLN+AHNQL+ QL F +L SLS LDLS N
Sbjct: 140 MAPLKYLNLAHNQLK-QLAIDFTKLTSLSILDLSSNAFIGSLPNTCSSLTSAKSIYLQNN 198
Query: 61 XXXGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSXXXXXXXXXXXXXR 120
GTID+LA LPL+NLNIANNRFTGW+P+ LK INLQKDGN +S
Sbjct: 199 QFSGTIDILATLPLENLNIANNRFTGWIPDSLKGINLQKDGNLLNSGPAPPPPPGTPPIS 258
Query: 121 KNNPKHKSDS--NKS--PXXXXXXXXXXXXXXXXXXXXXXXXFVVGGIVAFFLVKRRRSR 176
K++P KS + N+S VV ++AFFL+KR+RS+
Sbjct: 259 KSSPTPKSGNRGNRSNGDSSNSKDSSKSGLGAGGVAGIVISLIVVTAVIAFFLIKRKRSK 318
Query: 177 RSS-TDIEKLDNQPFAPLAASSNEV-QELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHK 234
RSS TDIEK DN P+ +SN+ QE K VQ+ ++TK DT++S+NLRPPP +RHK
Sbjct: 319 RSSSTDIEKTDNNINQPIILASNDFHQENKSVQNPPLVETKKLDTSLSMNLRPPPSERHK 378
Query: 235 SFDEEDFXXXX--XXXXXXXXXPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF 292
SFD++D P+NV +Y+++DLQ+AT SF+V+NLLGEGTFGRVYRAQF
Sbjct: 379 SFDDDDSTMRKPIVAKKAAVVVPSNVNTYTVSDLQVATNSFSVDNLLGEGTFGRVYRAQF 438
Query: 293 ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352
DGKVLAVKKIDSSALP++ DDF E+VS I+ L H N+ +L GYCSE+GQHL+VYEF +
Sbjct: 439 EDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHENVTKLDGYCSEHGQHLVVYEFHR 498
Query: 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412
NGSLHDFLHL++E++KPLIWN RVKIALGTARALEYLHEVCS S+VHKNIKSANILLD+E
Sbjct: 499 NGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYLHEVCSPSIVHKNIKSANILLDSE 558
Query: 413 LNPQLSDCGLASNMPNADEALN-NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTG 471
LNP LSD GLAS +P A+E LN ND GY APE +MSGQY++KSDVYSFGVVMLELLTG
Sbjct: 559 LNPHLSDSGLASFLPTANELLNQND--EGYSAPETSMSGQYSLKSDVYSFGVVMLELLTG 616
Query: 472 RKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPE 531
RKPFDS+R R EQSLVRWATPQLHDIDAL KMVDPALKGLYPVKSLSRFADVIALCVQPE
Sbjct: 617 RKPFDSTRSRSEQSLVRWATPQLHDIDALGKMVDPALKGLYPVKSLSRFADVIALCVQPE 676
Query: 532 PEFRPPMSEVVQALVRLVQRANMSKRTIGNDQG 564
PEFRPPMSEVVQALV LVQRANMSKRT+G G
Sbjct: 677 PEFRPPMSEVVQALVVLVQRANMSKRTVGVGSG 709
|
|
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1084 (386.6 bits), Expect = 2.4e-127, Sum P(2) = 2.4e-127
Identities = 208/324 (64%), Positives = 260/324 (80%)
Query: 255 PTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCD 314
P + Y+++ LQ+AT SF+ EN++GEG+ GRVYRA+F +GK++A+KKID++AL + D
Sbjct: 377 PITASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEED 436
Query: 315 DFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNS 374
+F+E VSN+S+L HPNI+ L GYC+E+GQ LLVYE+ NG+L D LH +D+ + L WN+
Sbjct: 437 NFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNA 496
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434
RVK+ALGTA+ALEYLHEVC S+VH+N KSANILLD ELNP LSD GLA+ PN + ++
Sbjct: 497 RVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVS 556
Query: 435 NDA-GS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492
GS GY APE A+SG Y +KSDVY+FGVVMLELLTGRKP DSSR R EQSLVRWATP
Sbjct: 557 TQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATP 616
Query: 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552
QLHDIDAL+KMVDP+L G+YP KSLSRFAD+IALC+QPEPEFRPPMSEVVQ LVRLVQRA
Sbjct: 617 QLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLVQRA 676
Query: 553 NMSKRTIGNDQGPT--TPRGDNQD 574
++ KR +D G + TP ++ D
Sbjct: 677 SVVKRRSSDDTGFSYRTPEHEHVD 700
|
|
| TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 214/401 (53%), Positives = 269/401 (67%)
Query: 164 IVAFFLVKRRRSRRSSTDIEKLDNQPFAPL---AASSNEVQELKLVQSSSSIDTKTFDTA 220
IV LV +++S S I++ DN P S QEL++ + D K+ D+
Sbjct: 288 IVLIALVSKKKSSLSPHFIDE-DNSHHTPKFKSLTSHGSAQELRVDFGNDYKDGKSGDSG 346
Query: 221 V-------SINLRPPPIDRHKSFDEEDFXXXXXXXXXXXXXPTNVTSYSIADLQMATGSF 273
S L+ R SF + +F + + ++DLQ AT +F
Sbjct: 347 DENIHRIGSKGLKHYVSSRVMSFTDTEFANKLNAKRTTSTR--SAVEFELSDLQSATANF 404
Query: 274 NVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+ NLLGEG+ GRVYRA+++DG+ LAVKKIDS+ S + +V ++S++ H NI E
Sbjct: 405 SPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLFDSGKSEGITPIVMSLSKIRHQNIAE 464
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
LVGYCSE G ++LVYE+ +NGSLH+FLHLSD +KPL WN+RV+IALGTARA+EYLHE C
Sbjct: 465 LVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSKPLTWNTRVRIALGTARAVEYLHEAC 524
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYN 453
S SV+HKNIKS+NILLD +LNP+LSD GL+ + L G GY APE Y
Sbjct: 525 SPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYLRTSQNL----GEGYNAPEARDPSAYT 580
Query: 454 IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513
KSDVYSFGVVMLELLTGR PFD +PR E+SLVRWATPQLHDIDAL+ + DPAL GLYP
Sbjct: 581 PKSDVYSFGVVMLELLTGRVPFDGEKPRPERSLVRWATPQLHDIDALSNIADPALHGLYP 640
Query: 514 VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554
KSLSRFAD+IALCVQ EPEFRPPMSEVV+ALVR+VQR++M
Sbjct: 641 PKSLSRFADIIALCVQVEPEFRPPMSEVVEALVRMVQRSSM 681
|
|
| TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1118 (398.6 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
Identities = 250/564 (44%), Positives = 334/564 (59%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLXXXXXXXXXXXXXXXXXXXXXX 60
M L YLN+ N L G+L+DMF +LP L T+DLS N L
Sbjct: 140 MNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQSFANLTGLKTLHLQEN 199
Query: 61 XXXGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSSXXXXXXXXXXXX 118
G+I+ L +LP +D++N+ANN+FTGW+P +LKNI NL+ GN WSS
Sbjct: 200 QFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNKWSSGRAPSPPPGTRH 259
Query: 119 XRKNNPKHKSDSNKSPXXXXXXXXXXXXXXXXXXXXXXXXFVVGGIVAFFLVKRRRSRRS 178
+N+ S+K+ + G++A L+ RR++
Sbjct: 260 IDRNSSGGGGGSSKA----------LTLGVIIAVSSIGGLILFAGLIA--LISRRKNSND 307
Query: 179 ST---DIEKLDNQ--P-FAPLAA------SSNEVQELKLVQSSSSIDTK-TFDTAVSINL 225
S+ D EK N+ P F P ++ + E + K V S++S++TK + S++
Sbjct: 308 SSHFFDDEKGTNRSKPLFTPQSSQMLQFDNMEEFKNQKTVDSNTSLETKPSVKRTSSVSF 367
Query: 226 RPPPIDRHKSFDEEDFXXXXXXXXXXXXXPTNVTSYSIADLQMATGSFNVENLLGEGTFG 285
+ P + V ++S+ADLQ F+ LLGEGT G
Sbjct: 368 KNSPTFHLIPSTQVAATPDRSSTSQDSPDTRGVKAFSLADLQNTASCFSPNRLLGEGTIG 427
Query: 286 RVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345
RVY+A+F DG+ AVK+IDSS L ++F +VS+IS +HH N+ ELVGYCSE G+++
Sbjct: 428 RVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIVSSISSIHHKNMAELVGYCSEQGRNM 487
Query: 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405
LVYE+ +GSLH FLHLSD+ +KPL WN+R++IALGTA+A+EYLHE CS +VHKNIKS+
Sbjct: 488 LVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIALGTAKAIEYLHETCSPPLVHKNIKSS 547
Query: 406 NILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVM 465
NILLDNELNP+LSD GLA N + + G GY APE Y KSDVYSFGVVM
Sbjct: 548 NILLDNELNPRLSDYGLA----NFHHRTSQNLGVGYNAPECTDPSAYTQKSDVYSFGVVM 603
Query: 466 LELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIA 525
LELLTGRKP+DS RP+ EQSLVRWA PQL D+D L +MVDPAL GLY +S+S FAD+++
Sbjct: 604 LELLTGRKPYDSGRPKAEQSLVRWAKPQLKDMDTLDEMVDPALCGLYAPESVSSFADIVS 663
Query: 526 LCVQPEPEFRPPMSEVVQALVRLV 549
+CV EP RPP+S VV+AL RLV
Sbjct: 664 ICVMTEPGLRPPVSNVVEALKRLV 687
|
|
| TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 1.4e-99, Sum P(2) = 1.4e-99
Identities = 176/299 (58%), Positives = 215/299 (71%)
Query: 256 TNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDD 315
T+V YSIA LQ T SF ENL+G G G VYRA+ +GK+ AVKK+D A + +
Sbjct: 468 TSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHE 527
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
FIE+V+NI + H NI+ELVGYC+E+ Q LLVYE+ NG+L D LH DE K L WN+R
Sbjct: 528 FIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTR 587
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA-LN 434
V +ALG ARALEYLHEVC ++H+N KSAN+LLD++L+ +SDCGLA + + + L+
Sbjct: 588 VSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLS 647
Query: 435 ND--AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492
A GYGAPE SG Y +SDVYSFGVVMLELLTGR +D R R EQ LVRWA P
Sbjct: 648 GQLLAAYGYGAPEFD-SGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIP 706
Query: 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
QLHDIDAL KMVDP+L G YP KSLS FAD+I+ CVQ EPEFRP MSEVVQ L+ +++R
Sbjct: 707 QLHDIDALGKMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRR 765
|
|
| TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 6.8e-98, Sum P(2) = 6.8e-98
Identities = 177/340 (52%), Positives = 226/340 (66%)
Query: 228 PPIDRHKSFDEEDFXXXXXXXXXXXXXP-TNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
PPI R + E P T V +++A LQ T SF+ ENL+G G G
Sbjct: 432 PPIKRVIAKATEPAEASLKRTTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGMLGS 491
Query: 287 VYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346
VYRA+ GK+ AV+K+D + E F+E+V+NI ++ H NI++LVG+CSE+ Q LL
Sbjct: 492 VYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQRLL 551
Query: 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406
++E+ +NG+LHD LH+ D L WN RV+IAL A+ALEYLHE+C +H+N KSAN
Sbjct: 552 IHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKSAN 611
Query: 407 ILLDNELNPQLSDCGLASNMPN-ADEALNND--AGSGYGAPEVAMSGQYNIKSDVYSFGV 463
ILLD+++ +SDCGLA + + A L+ A GYGAPE G Y +K DVYSFGV
Sbjct: 612 ILLDDDIRVHVSDCGLAPLISSGAVSQLSGQLLAAYGYGAPEFEY-GIYTMKCDVYSFGV 670
Query: 464 VMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADV 523
VMLELLTGRK +D R R EQ LVRWA PQLHDIDALAKMVDP+LKG YP KSLS FADV
Sbjct: 671 VMLELLTGRKSYDKKRDRGEQFLVRWAIPQLHDIDALAKMVDPSLKGDYPAKSLSHFADV 730
Query: 524 IALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQ 563
I+ CVQ EPE+RP MSEVVQ L ++QR + + G++Q
Sbjct: 731 ISRCVQSEPEYRPLMSEVVQDLSDMIQREHRRNDSNGDNQ 770
|
|
| TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 786 (281.7 bits), Expect = 7.8e-94, Sum P(3) = 7.8e-94
Identities = 152/294 (51%), Positives = 213/294 (72%)
Query: 256 TNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDD 315
++ T ++IA LQ T +F+ EN++GEG+ G VYRA+ GK LAVKK+ ++ ++ +
Sbjct: 480 SSATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQSDGE 539
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
F+ +VSN+ +L +I+EL+GYC+E+GQ LLVYE+ NGSL D LHL + +K L WN R
Sbjct: 540 FLNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLTWNVR 599
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN 435
+ IALG ++AL++LHEVC VVH+N KS+ +LLD +L+ +++D GLA +P +
Sbjct: 600 INIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLPPRPTSQM- 658
Query: 436 DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495
+GY APEV G Y +SDV+S GVVMLELLTGR+PFD +RPR Q+L +WA P+LH
Sbjct: 659 ---AGYAAPEVEY-GSYTCQSDVFSLGVVMLELLTGRRPFDRTRPRGHQTLAQWAIPRLH 714
Query: 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
DIDAL +MVDP+L G YP+KSLSRFAD+I+ +Q EP FRPP+SE+VQ L ++
Sbjct: 715 DIDALTRMVDPSLHGAYPMKSLSRFADIISRSLQMEPGFRPPISEIVQDLQHMI 768
|
|
| TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 5.7e-84, Sum P(2) = 5.7e-84
Identities = 155/376 (41%), Positives = 219/376 (58%)
Query: 188 QPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEE----DFXX 243
Q A + S+N + V + T D +PPP + + D
Sbjct: 326 QNLAAIHRSNNSIAYSLPVSTGREYPVATEDNPQIKRFQPPPAPQLRHLPSPPVRIDKSA 385
Query: 244 XXXXXXXXXXXPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKI 303
P+ +S A+LQ+AT F+ ENLLGEG G VYRA+ DG+ V+ I
Sbjct: 386 RRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYRAKLPDGQFAVVRNI 445
Query: 304 DSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS 363
S+L + F E++ S+L HPNI+ L+G+C E G+HLLVYE+ + SL++ +H
Sbjct: 446 PMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYEYVGHLSLYNAMH-- 503
Query: 364 DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423
DE KPL W R++IA+G ARAL+YLH + H ++K+ NILLD EL P+++DCGLA
Sbjct: 504 DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILLDEELTPRIADCGLA 563
Query: 424 SNMPNADEALNNDAG------SGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
S P ++ A +GY APE G KSD Y+ GV++LELLTGRK FDS
Sbjct: 564 SLRPLTSNSVKLRASEIAIQNTGYIAPEHGQPGSSGTKSDTYALGVLLLELLTGRKAFDS 623
Query: 478 SRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
SRPR EQ LV+WA+ +LHD +L +M+D + G + + S++AD+I+LC Q E EFRPP
Sbjct: 624 SRPRGEQLLVKWASTRLHDRRSLEQMIDGGIAGTFSSRVASQYADIISLCTQAEKEFRPP 683
Query: 538 MSEVVQALVRLVQRAN 553
+SE+V+AL L+Q+ N
Sbjct: 684 VSEIVEALTALIQKQN 699
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 6.7e-65, P = 6.7e-65
Identities = 144/302 (47%), Positives = 201/302 (66%)
Query: 257 NVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDF 316
+V + S+ +L+ T +F ++L+GEG++GR Y A DGK +AVKK+D++A P E +F
Sbjct: 97 DVPALSLDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEP-ESNVEF 155
Query: 317 IEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH--LSDEDNKP---LI 371
+ VS +S+L H N +EL GYC E +L YEF GSLHD LH + +P L
Sbjct: 156 LTQVSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLD 215
Query: 372 WNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431
W RV+IA+ AR LEYLHE +V+H++I+S+N+LL + +++D L++ P+
Sbjct: 216 WIQRVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAA 275
Query: 432 ALNNDA--GS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488
L++ G+ GY APE AM+GQ KSDVYSFGVV+LELLTGRKP D + PR +QSLV
Sbjct: 276 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 335
Query: 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548
WATP+L + D + + VDP LKG YP K++++ A V ALCVQ E EFRP MS VV+AL L
Sbjct: 336 WATPRLSE-DKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPL 394
Query: 549 VQ 550
++
Sbjct: 395 LR 396
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C8M9 | SRF6_ARATH | No assigned EC number | 0.7152 | 0.9827 | 0.7913 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 579 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.002 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-48
Identities = 83/283 (29%), Positives = 134/283 (47%), Gaps = 47/283 (16%)
Query: 279 LGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG VY+ + + KV AVK + A E ++F+E S + +L HPNI+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEER-EEFLEEASIMKKLSHPNIV 64
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L+G C++ +V E+ G L DFL + + L +++AL A+ +EYL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-----APEVA 447
S + VH+++ + N L+ L ++SD GL+ ++ D G G APE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK--RGGGKLPIKWMAPESL 176
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD- 505
G++ KSDV+SFGV++ E+ T G +P+ P + + + L + D
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELLEDG 220
Query: 506 ---PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
P P +++ C +PE RP SE+V+ L
Sbjct: 221 YRLPR-----PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 277 NLLGEGTFGRVYRAQF---ADGKVL-AVKKIDSSALPSEMCDDFIEMVSNI---SQLHHP 329
LGEG FG VY+ + AVK + A E + + +L HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER----KDFLKEARVMKKLGHP 56
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFL-----HLSDEDNKPLIWNSRVKIALGTAR 384
N++ L+G C+E LV E+ + G L D+L + L + A+ A+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GY 441
+EYL S VH+++ + N L+ +L ++SD GL+ ++ + D G +
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 442 GAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500
APE G + KSDV+SFGV++ E+ T G P+ P L + + L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY----------------PGLSNEEVL 217
Query: 501 AKMVDPALKGLYPVKSL---SRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ KG K +++ C Q +PE RP SE+V+ L
Sbjct: 218 EYL----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LGEG+FG+VY A+ GK++A+K I + + + + + + +L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 332 MELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ L E L LV E+ + G L D L ++ ALEYLH
Sbjct: 60 VRLYDVF-EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLH 114
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
S +VH+++K NILLD + + +L+D GLA + + E L G+ Y APEV +
Sbjct: 115 ---SKGIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFVGTPEYMAPEVLLG 170
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
Y D++S GV++ ELLTG+ PF ++ K+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGD---------------DQLLELFKKIGKPKPP 215
Query: 510 GLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
P +S D+I + +PE R E +Q
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 43/281 (15%)
Query: 279 LGEGTFGRVYRAQFADGKVL-----AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LGEG FG VY+ AVK + A ++ ++F+ + +L HPNI++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNIVK 65
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
L+G C+E ++V E+ G L D+L K L + + AL AR +EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-----APEVAM 448
S + +H+++ + N L+ L ++SD GL+ ++ + D G APE
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRWMAPESLK 177
Query: 449 SGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
G++ KSDV+SFGV++ E+ T G +P+ P + + + L +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPY----------------PGMSNAEVLEYLK--- 218
Query: 508 LKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
KG P ++ C +PE RP SE+V+ L
Sbjct: 219 -KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 78/282 (27%), Positives = 133/282 (47%), Gaps = 46/282 (16%)
Query: 279 LGEGTFGRVYRAQ--FADGKVL---AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LGEG FG VY+ + GK AVK + A ++ ++F+ + +L HPN+++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNVVK 65
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLI-WNSRVKIALGTARALEYLHEV 392
L+G C+E +V E+ + G L +L N+P + + + AL AR +EYL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR----KNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPEVA 447
S + +H+++ + N L+ L ++SD GL+ ++ + D G + APE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESL 175
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
G++ KSDV+SFGV++ E+ T G +P+ P + + + L +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLEYLK-- 217
Query: 507 ALKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
G P D++ C +PE RP SE+V+ L
Sbjct: 218 --NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 69/194 (35%), Positives = 105/194 (54%), Gaps = 11/194 (5%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LGEG FG VY A+ GK +A+K I S + + E + + +L+HPNI++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLRE-IEILKKLNHPNIVKLYGV 59
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ LV E+ + GSL D L E+ L + ++I L LEYLH S +
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH---SNGI 113
Query: 398 VHKNIKSANILLDN-ELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS-GQYNI 454
+H+++K NILLD+ +L+D GL+ + + L G+ Y APEV + G Y+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 455 KSDVYSFGVVMLEL 468
KSD++S GV++ EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 6e-43
Identities = 92/280 (32%), Positives = 135/280 (48%), Gaps = 33/280 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNIS---QLHH 328
+ + LG G+FG VY+A+ GK++AVK + SE I +L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK---KRSEKSKKDQTARREIRILRRLSH 57
Query: 329 PNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
PNI+ L+ E HL LV E+ + G L D+L PL + KIAL R LE
Sbjct: 58 PNIVRLIDAF-EDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLE 112
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
YLH S ++H+++K NILLD +++D GLA + + +L G+ Y APEV
Sbjct: 113 YLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169
Query: 447 AMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
+ G Y K DV+S GV++ ELLTG+ PF + L+R +++
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-------------RILG 216
Query: 506 PALKGLYPVKSL--SRFADVIALCVQPEPEFRPPMSEVVQ 543
P L+ P S D+I C+ +P RP E++Q
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 79/281 (28%), Positives = 140/281 (49%), Gaps = 42/281 (14%)
Query: 275 VENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+ +G+G+FG+VY + +DGK+ +K+ID S + + +D + V + +L+HPNI
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI-- 61
Query: 334 LVGYCS--EYGQHLL-VYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTARAL 386
+ Y E L V E+ G L + ++ KP I + V++ L AL
Sbjct: 62 -IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----AL 116
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-YGAPE 445
+YLH S ++H++IK NI L + +L D G++ + + + G+ Y +PE
Sbjct: 117 KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
+ + YN KSD++S G V+ EL T + PF+ ++ LA +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-----------------NLLELALKI- 215
Query: 506 PALKGLY-PVKSL--SRFADVIALCVQPEPEFRPPMSEVVQ 543
LKG Y P+ S S ++++ +Q +PE RP +++++Q
Sbjct: 216 --LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + +L+G G FG VY+ G +A+K+I + E ++ + + L HPNI
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 332 MELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
++ +G E L ++ E+ +NGSL + + L+ ++ G L YLH
Sbjct: 62 VKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLH 116
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEV-AM 448
E V+H++IK+ANIL + +L+D G+A+ + + + + G+ Y APEV M
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
SG + SD++S G ++ELLTG P+
Sbjct: 174 SG-ASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 28/268 (10%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F + N +G+G+FG V++ + AD +V A+K+ID S + ++ I+ +++L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKP--LIWNSRVKIALGTARALEYL 389
+ + G+ +V E+ +NG LH L + P +W ++I LG L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAM 448
H S ++H++IKS N+ LD N ++ D G+A + + N G+ Y +PE+
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508
YN KSDV++ GVV+ E TG+ PFD++ + +L+ + + V P +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL----------KIIRGVFPPV 221
Query: 509 KGLYPVKSLSRFADVIALCVQPEPEFRP 536
+Y + A +I C+ + RP
Sbjct: 222 SQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 48/277 (17%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F + +G+G FG VY+A+ GK +A+K I + + + I + + + HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK--EKIINEIQILKKCKHPNI 59
Query: 332 MELVGYCSEYGQHL------LVYEFRKNGSLHDFL-HLSDEDNKPLIWNSRVKIALGTAR 384
V Y YG +L +V EF GSL D L + + I + +
Sbjct: 60 ---VKY---YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI----AYVCKELLK 109
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
LEYLH S ++H++IK+ANILL ++ +L D GL++ + + +A N G+ + A
Sbjct: 110 GLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMA 165
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
PEV Y+ K+D++S G+ +EL G+ P+ ++ + +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPY-------------------SELPPMKAL 206
Query: 504 VDPALKGLYPVKSLSR----FADVIALCVQPEPEFRP 536
A G +++ + F D + C+Q PE RP
Sbjct: 207 FKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 277 NLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
LLG G+FG VY A D G+++AVK ++ S E + + +S L HPNI V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI---V 62
Query: 336 GY----CSEYGQHLLVY-EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
Y E L ++ E+ GSL L + +P+I K L YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI----RKYTRQILEGLAYLH 118
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEVA 447
S +VH++IK ANIL+D++ +L+D G A + + + + G + APEV
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+Y +D++S G ++E+ TG+ P+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKK---IDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LLG G+FG VY DG AVK+ D E + ++ +S+L HPNI++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
+G E + E GSL L +P+I +I LG LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH--- 119
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS-GQY 452
+ VH++IK ANIL+D +L+D G+A + A + + APEV G Y
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 453 NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512
+ +D++S G +LE+ TG+ P+ QL + A+ K+ K L
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWS----------------QLEGVAAVFKIGRS--KELP 221
Query: 513 PV-KSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
P+ LS A D I C+Q +P RP +E+++
Sbjct: 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 77/285 (27%), Positives = 128/285 (44%), Gaps = 44/285 (15%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGK-VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + ++G G VY A +A+K+ID + + D+ + V +SQ +HPN+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNV 61
Query: 332 MELVGYCS--EYGQHLLVYEFRKNGSLHDFLHLS------DEDNKPLIWNSRVKIALGTA 383
++ Y S + LV + GSL D + S DE +I +
Sbjct: 62 VKY--YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE---AII----ATVLKEVL 112
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG----LASNMPNADEALNNDAGS 439
+ LEYLH S +H++IK+ NILL + + +++D G LA + G+
Sbjct: 113 KGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 440 G-YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL--VRWATPQLH 495
+ APEV Y+ K+D++SFG+ +EL TG P+ S P ++ + ++ P L
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTLQNDPPSL- 227
Query: 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE 540
+ A K K F +I+LC+Q +P RP E
Sbjct: 228 ETGADYK------------KYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 73/292 (25%), Positives = 133/292 (45%), Gaps = 36/292 (12%)
Query: 277 NLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
LGEG FG+V ++ G+ +AVK ++ S DF + + L H NI
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRTLDHENI 68
Query: 332 MELVGYCSEYGQ--HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALEY 388
++ G C + G L+ E+ +GSL D+L + ++ I R + + + ++Y
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDY 124
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE--ALNNDAGSG--YGAP 444
L S +H+++ + NIL+++E ++SD GLA +P + + S + AP
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
E + +++ SDV+SFGV + EL T P S + L + +++
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA---EFLRMIGIA--QGQMIVTRLL 236
Query: 505 DPALKGLYPVKSLSRFA-------DVIALCVQPEPEFRPPMSEVVQALVRLV 549
+ L + L R D++ LC + EP+ RP ++++ + RL
Sbjct: 237 EL----LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 272 SFNVENLLGEGTFGRVYRA---QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
S+ + LGEG+FG VY A + KVLA K S + I+++++++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLRE-IQILASLN--HP 57
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
PNI++L + + G LV E+ GSL D L PL + + I ALEY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEY 116
Query: 389 LHEVCSLSVVHKNIKSANILLDNELN-PQLSDCGLASNMPNADEALNNDAGS-------G 440
LH ++H++IK NILLD + +L D GLA +P+ + A G
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 441 YGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497
Y APEV + + SD++S G+ + ELLTG PF+ + AT Q I
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-------ATSQTLKI 226
Query: 498 --DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + L P +D++ + +P+ R S +
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 42/219 (19%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCD-DFIEMVSN----ISQLHHPNIM 332
LG+G+FG+V + D GK+ A+K + ++ +E +S+++HP I+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK----KIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 333 ELVGYCS---EYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR---- 384
+L + + E L LV E+ G L L + + + AR
Sbjct: 57 KL--HYAFQTEE--KLYLVLEYAPGGELFSHL------------SKEGRFSEERARFYAA 100
Query: 385 ----ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
ALEYLH SL ++++++K NILLD + + +L+D GLA + + N G+
Sbjct: 101 EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
Y APEV + Y D +S GV++ E+LTG+ PF +
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 275 VENLLGEGTFGRVYRAQ----FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+E ++G G FG V R + +A+K + + + + D F+ S + Q HPN
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPN 66
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L G ++ +++ E+ +NGSL FL +D V + G A ++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLS 123
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPEVA 447
E+ VH+++ + NIL+++ L ++SD GL+ + +++ G + APE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
++ SDV+SFG+VM E+++ G +P+
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 73/275 (26%), Positives = 130/275 (47%), Gaps = 39/275 (14%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG G FG V+ ++ +A+K I A+ SE DDFIE + +L HPN+++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SE--DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
++ +V E+ NG L ++L E L + + A+EYL +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVAMSGQYNI 454
H+++ + N L+ + ++SD GLA + D+ + G+ + PEV +++
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 455 KSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG--L 511
KSDV+SFGV+M E+ + G+ P++ R++ ++ V+ G L
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE-----------RFSNSEV---------VESVSAGYRL 220
Query: 512 Y-PVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
Y P + + ++ C +PE RP +++ L
Sbjct: 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 39/280 (13%)
Query: 272 SFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS---QLH 327
F++ LGEG++G VY+A G+V+A+K + + +D E++ IS Q
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-------PVEEDLQEIIKEISILKQCD 56
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GTAR 384
P I++ G + +V E+ GS+ D + ++ NK L + +IA T +
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTL---TEEEIAAILYQTLK 110
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-A 443
LEYLH S +H++IK+ NILL+ E +L+D G++ + + N G+ + A
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
PEV YN K+D++S G+ +E+ G+ P+ P +R I +
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP------MR-------AIFMIPNK 214
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P L P K F D + C+ +PE RP +++Q
Sbjct: 215 PPPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 63/219 (28%), Positives = 114/219 (52%), Gaps = 26/219 (11%)
Query: 279 LGEGTFGRVYRAQF---ADGK---VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+VY+ + + +A+K + +A P ++ +F + +S L HPNI+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSDLQHPNIV 71
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFL-----------HLSDEDNKPLIWNSR-VKIAL 380
L+G C++ +++E+ +G LH+FL DE K + S + IA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EALNNDA 437
A +EYL S VH+++ + N L+ L ++SD GL+ ++ +AD +
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 438 GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ PE + G++ +SD++SFGVV+ E+ + G +P+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 39/269 (14%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH---HPNIMEL 334
LG G G V + GK++AVK I + +++ + LH P I+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI----QKQILRELDILHKCNSPYIVGF 64
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV--KIALGTARALEYLHEV 392
G G + E+ GSL L E + R+ KIA+ + L YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRI--PERILGKIAVAVLKGLTYLHEK 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-SGYGAPEVAMSGQ 451
++H+++K +NIL+++ +L D G++ + + G S Y APE
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFVGTSSYMAPERIQGND 175
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---PAL 508
Y++KSD++S G+ ++EL TGR P+ P + L +V+ P L
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEPPPRL 224
Query: 509 KGLYPVKSLSR-FADVIALCVQPEPEFRP 536
P S F D + LC+ +P RP
Sbjct: 225 ----PSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 48/273 (17%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKI---DSSALPSEMCDDFIEMVSNISQLH---HPNI 331
LG+G+ G VY+ + GK+ A+KKI ++ + + L P +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRE-------LKTLRSCESPYV 61
Query: 332 MELVG-YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV--KIALGTARALEY 388
++ G + E G+ +V E+ GSL D L K V IA + L+Y
Sbjct: 62 VKCYGAFYKE-GEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDY 114
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVA 447
LH ++H++IK +N+L++++ +++D G++ + N + N G+ Y +PE
Sbjct: 115 LHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR----PRLEQSLVRWATPQLHDIDALAKM 503
Y+ +D++S G+ +LE G+ PF L Q++ P L + +
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE- 231
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
F D I+ C+Q +P+ RP
Sbjct: 232 ----------------FRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 60/291 (20%)
Query: 277 NLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
N +G GTFG+VY A G+++AVK+I + + + + + L HPN LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN---LV 62
Query: 336 GYCSEYG------QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
Y YG + + E+ G+L + L ++ +I RV L L YL
Sbjct: 63 KY---YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RV-YTLQLLEGLAYL 115
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCG----LASNMPNADEALNNDAGS-GYGAP 444
H S +VH++IK ANI LD+ +L D G L +N E + + AG+ Y AP
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 445 EVAMSGQYNIK---SDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA---------TP 492
EV G+ +D++S G V+LE+ TG++P+ L+ + P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW----SELDN---EFQIMFHVGAGHKP 225
Query: 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ D L+ D + C++ +P+ RP SE++Q
Sbjct: 226 PIPDSLQLSPEG----------------KDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 77/294 (26%), Positives = 136/294 (46%), Gaps = 44/294 (14%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCD-----DFIEMVSNI 323
G+F +E +G+G F VY+A DG+V+A+KK+ EM D D ++ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF----EMMDAKARQDCLKEIDLL 56
Query: 324 SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIA 379
QL HPN+++ + E + +V E G L + + + + IW V++
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
ALE++H S ++H++IK AN+ + +L D GL + A ++ G+
Sbjct: 117 ----SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 440 G-YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498
Y +PE YN KSD++S G ++ E+ + PF + L
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------------- 214
Query: 499 ALAKMVDPALKGLYPVKSLSRFA----DVIALCVQPEPEFRPPMSEVVQALVRL 548
+L K ++ K YP ++ D+++ C+ P+PE RP +S V+Q +
Sbjct: 215 SLCKKIE---KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ V +G+G+FG V + + +DGK+L K+ID + + + V+ + +L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 332 MELVGYCSE---------YGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKI 378
V Y Y +V E+ + G L + ++ K + IW ++
Sbjct: 62 ---VRYYDRIIDRSNQTLY----IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 379 ALGTARALEYLH--EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
L AL H +V+H+++K ANI LD N +L D GLA + +
Sbjct: 115 LL----ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 437 AGSG-YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
G+ Y +PE Y+ KSD++S G ++ EL PF
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-24
Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 29/291 (9%)
Query: 260 SYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKV-LAVKKI-DSSALPSEMCDDFI 317
S +I D+ S EN++ G G Y+ + + VK+I D +++PS
Sbjct: 682 SITINDILS---SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE----- 733
Query: 318 EMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK 377
++++ +L HPNI++L+G C L++E+ + +L + L + L W R K
Sbjct: 734 --IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784
Query: 378 IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDA 437
IA+G A+AL +LH CS +VV N+ I++D + P L L + +
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF---I 840
Query: 438 GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497
S Y APE + KSD+Y FG++++ELLTG+ P D+ + S+V WA D
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDC 899
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIAL---CVQPEPEFRPPMSEVVQAL 545
L +DP+++G V + +V+ L C +P RP ++V++ L
Sbjct: 900 H-LDMWIDPSIRGDVSVNQ-NEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 17/220 (7%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG G FG V+ + +AVK + + E F++ + +L H +
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKLRHDKL 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L CSE +V E+ GSL DFL + K L V +A A + YL
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLE- 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVA 447
S + +H+++ + NIL+ L +++D GLA + D+ G+ + APE A
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAA 176
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFD--SSRPRLEQ 484
G++ IKSDV+SFG+++ E++T GR P+ ++R LEQ
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 80/270 (29%), Positives = 124/270 (45%), Gaps = 46/270 (17%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLHHPNIME 333
+GEG G VY+A A GK +A+KK+ + E++ N + HPNI++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR-------LRKQNKELIINEILIMKDCKHPNIVD 79
Query: 334 LVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDED-NKPLIWNSRVKIALGTARALEYLHE 391
G L +V E+ GSL D + + N+P I + + LEYLH
Sbjct: 80 YYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI----AYVCREVLQGLEYLH- 133
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSG 450
S +V+H++IKS NILL + + +L+D G A+ + N+ G+ Y APEV
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---PA 507
Y K D++S G++ +E+ G +P P L + +R AL + P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEG-EP-----PYLREPPLR----------ALFLITTKGIPP 235
Query: 508 LKGLYPVKSLSR-FADVIALCVQPEPEFRP 536
LK + S F D + C+ +PE RP
Sbjct: 236 LKNP---EKWSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 278 LLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G+G FG V + KV AVK + S F+ S ++ L HPN+++L+G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDD---STAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ +V E+ GSL D+L + ++ AL +EYL E +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPEVAMSGQYNI 454
VH+++ + N+L+ +L ++SD GLA + + D+G + APE +++
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 455 KSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV 487
KSDV+SFG+++ E+ + GR P+ PR+ V
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY----PRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
F +E LG G FG V+ + + +A+K + S L + DF + V + +L H +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ--QDFQKEVQALKRLRHKHLI 65
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L CS ++ E + GSL FL + P+ S + +A A + YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV--ASLIDMACQVAEGMAYLEE- 122
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY--GAPEVAMSG 450
+ +H+++ + NIL+ +L +++D GLA + D L++D Y APE A G
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHG 179
Query: 451 QYNIKSDVYSFGVVMLELLT-GRKPF 475
++ KSDV+SFG+++ E+ T G+ P+
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 41/280 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F + +G+G+FG VY+A +V+A+K ID E+ +D + + +SQ P I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSPYI 61
Query: 332 MELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV--KIALGTARALEY 388
+ G G L ++ E+ GS D L KP + I LEY
Sbjct: 62 TKYYG-SFLKGSKLWIIMEYCGGGSCLDLL-------KPGKLDETYIAFILREVLLGLEY 113
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVA 447
LHE +H++IK+ANILL E + +L+D G++ + + N G+ + APEV
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL---AKMV 504
Y+ K+D++S G+ +EL G P LH + L K
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLS----------------DLHPMRVLFLIPKNN 214
Query: 505 DPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
P+L+G S+ F D ++LC+ +P+ RP E+++
Sbjct: 215 PPSLEG----NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 82/289 (28%), Positives = 129/289 (44%), Gaps = 35/289 (12%)
Query: 269 ATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH 327
TG F + ++GEGT+G+VY+A+ G+++A+K +D E + ++ S +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--N 61
Query: 328 HPNIMELVG------YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
HPNI G Q LV E GS+ D + + K L I
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY 441
T R L YLHE V+H++IK NILL +L D G+++ + + N G+ Y
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 442 G-APEVAMSGQ-----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495
APEV + Y+ +SDV+S G+ +EL G+ P +H
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL----------------CDMH 222
Query: 496 DIDALAKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ AL K+ L ++ S+ F D I+ C+ E RP M E+++
Sbjct: 223 PMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 70/274 (25%), Positives = 130/274 (47%), Gaps = 37/274 (13%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
+G G FG V+ + + + +A+K I A+ E DFIE + +L HP +++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
+E LV+EF ++G L D+L + + + L + YL V+
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVAMSGQYNI 454
H+++ + N L+ ++SD G+ + D+ + G+ + +PEV +Y+
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 455 KSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL--KGL 511
KSDV+SFGV+M E+ + G+ P+++ R + + I+A ++ P L + +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYEN----------RSNSEVVETINAGFRLYKPRLASQSV 230
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
Y +++ C + PE RP S ++ L
Sbjct: 231 Y---------ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 68/223 (30%), Positives = 116/223 (52%), Gaps = 28/223 (12%)
Query: 278 LLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNIS-------QLHHP 329
L+G G+FG VY A G+++AVK+++ ++ + D M+ ++ +L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 330 NIMELVGYCSEYGQHLLVY-EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
NI++ +G S HL ++ E+ GS+ L+ + L+ N +I G L Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKG----LNY 121
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNADEALNNDA-----GSGYG 442
LH + ++H++IK ANIL+DN+ ++SD G++ + N+ N A GS +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 443 -APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
APEV Y K+D++S G +++E+LTG+ PF P Q
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 14/223 (6%)
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
++ S + LG G FG V+ + +AVK + + E F+E + +L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKL 58
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
H +++L SE ++ V E+ GSL DFL D + + L + V +A A +
Sbjct: 59 RHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGM 115
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAP 444
Y+ ++ +H++++SANIL+ + L +++D GLA + + + A + AP
Sbjct: 116 AYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFD--SSRPRLEQ 484
E A+ G++ IKSDV+SFG+++ EL+T GR P+ ++R LEQ
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 68/277 (24%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 278 LLGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G F Y+A+ G ++AVK++ ++S+ E+ + + + +++L+HP+I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
++G E L E+ GS+ L + R L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 393 CSLSVVHKNIKSANILLDNE-LNPQLSDCG----LASNMPNADEALNNDAGS-GYGAPEV 446
++H+++K AN+L+D+ +++D G LA+ A E G+ + APEV
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
QY DV+S G V++E+ T + P+++ + +L+ + ++ + + P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATTAPSIPEHLSP 238
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
L+ DV C++ +PE RPP E+++
Sbjct: 239 GLR------------DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 37/292 (12%)
Query: 272 SFNVENL-----LGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVS 321
+F NL LG G FG V+ A+ G+ L + K + +F +
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 322 NISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKI 378
+L H N++ L+G C E H ++ E+ G L FL + DE KP +++ K+
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 379 ALGT--ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
AL T A +++L + VH+++ + N L+ ++ ++S L+ ++ N++ +
Sbjct: 121 ALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 437 AGSG--YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493
A + APE ++ KSDV+SFGV+M E+ T G PF
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF----------------YG 221
Query: 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
L D + L ++ L+ P SR ++ C P+ RP SE+V AL
Sbjct: 222 LSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 76/275 (27%), Positives = 128/275 (46%), Gaps = 33/275 (12%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LG G +G V + + G ++AVK+I ++ E +++ ++ + P + G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
G + E SL F + + + KIA+ +ALEYLH LSV
Sbjct: 69 LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSV 125
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-YGAPE-----VAMSGQ 451
+H+++K +N+L++ +L D G++ + + A DAG Y APE + G
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTIDAGCKPYMAPERINPELNQKG- 183
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ--SLVRWATPQLHDIDALAKMVDPALK 509
Y++KSDV+S G+ M+EL TGR P+DS + +Q +V +PQL
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL--------------- 228
Query: 510 GLYPVKSLS-RFADVIALCVQPEPEFRPPMSEVVQ 543
P + S F D + C++ + RP E++Q
Sbjct: 229 ---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 279 LGEGTFGRVYRAQFADGK------VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V+ + + ++AVK + +A DF ++ H NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREAELLTNFQHENIV 71
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDED----------NKPLIWNSRVKIALGT 382
+ G C+E ++V+E+ ++G L+ FL D L + ++IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-- 440
A + YL S VH+++ + N L+ +L ++ D G++ ++ D G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD--YYRVGGHTML 186
Query: 441 ---YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ PE M ++ +SDV+SFGVV+ E+ T G++P+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F V LG+G++G VY+ + +D + A+K++D ++ + +D + + ++ ++HPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 332 MELVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTAR 384
+ Y + G L +V E+ G L + + K + IW +++ G
Sbjct: 62 ---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG--- 115
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-YGA 443
L+ LHE ++H+++KSANILL ++ D G++ + G+ Y A
Sbjct: 116 -LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK--NMAKTQIGTPHYMA 169
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS-SRPRLEQSLVRWATPQLHDIDALAK 502
PEV Y+ KSD++S G ++ E+ T PF++ S L + R P +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI-------- 221
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P + I +Q +P+ RP +++
Sbjct: 222 ----------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 36/275 (13%)
Query: 279 LGEGTFGRVYRAQFADGKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LG+G FG+VY+AQ + + A K I + E +DF+ + +S+ HPNI+ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ ++ EF G+L + E + L + AL +LH S V
Sbjct: 71 YFYENKLWILIEFCDGGALDS---IMLELERGLTEPQIRYVCRQMLEALNFLH---SHKV 124
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAM-----SGQ 451
+H+++K+ NILL + + +L+D G+++ + + + G+ Y APEV
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---PAL 508
Y+ K+D++S G+ ++EL P +L+ + L K++ P L
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHH----------------ELNPMRVLLKILKSEPPTL 228
Query: 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P K S F D + C+ +P+ RP +E+++
Sbjct: 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 98/303 (32%), Positives = 140/303 (46%), Gaps = 46/303 (15%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVG 336
+G G+FG VY A+ +V+A+KK+ S S E D I+ V + QL HPN +E G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 337 -YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
Y E+ LV E+ GS D L + KPL I G + L YLH S
Sbjct: 83 CYLREH-TAWLVMEYCL-GSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH---SH 134
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEV--AM-SGQ 451
+H++IK+ NILL +L+D G AS + A N+ G+ Y APEV AM GQ
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQ 190
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
Y+ K DV+S G+ +E L RKP P + A L+ I A+ P L
Sbjct: 191 YDGKVDVWSLGITCIE-LAERKP-----PLFNMN----AMSALYHI---AQNDSPTLS-- 235
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRANMSKRTIG 560
F + + C+Q P+ RP E+++ ++ L+QR + R +
Sbjct: 236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELD 294
Query: 561 NDQ 563
N Q
Sbjct: 295 NLQ 297
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 41/286 (14%)
Query: 277 NLLGEGTFGRVYRAQFADGK------VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+LL EGTFGR++ D K V VK + A ++ ++ + L H N
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVF-VKTVKDHASEIQV-TLLLQESCLLYGLSHQN 69
Query: 331 IMELVGYCSE-YGQHLLVYEFRKNGSLHDFLH---LSDEDNKPLIWNSR-VKIALGTARA 385
I+ ++ C E ++Y + G+L FL L + +N + + V +A+ A
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNADEAL--NNDAGSGYG 442
+ YLH V+HK+I + N ++D EL +++D L+ ++ P L N + +
Sbjct: 130 MSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA-- 499
A E ++ +Y+ SDV+SFGV++ EL+T G+ P+ +ID
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV-------------------EIDPFE 227
Query: 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+A + + P+ V+A C +PE RP S++VQ L
Sbjct: 228 MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 34/240 (14%)
Query: 279 LGEGTFGRVYRAQFADGK------VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V +A K +AVK + +A SE+ D E + + Q++HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQVNHPHVI 66
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS--------------------DEDNKPLIW 372
+L G CS+ G LL+ E+ K GSL FL S + D + L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
+ A +R ++YL E + +VH+++ + N+L+ ++SD GL+ ++ D
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 433 LNNDAGS---GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVR 488
+ G + A E Y +SDV+SFGV++ E++T G P+ P +L++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 26/219 (11%)
Query: 279 LGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LGE FG++Y+ +++A+K + P + +F + S +++LHHPNI+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW-GEFQQEASLMAELHHPNIVC 71
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHL----------SDED---NKPLIWNSRVKIAL 380
L+G ++ +++E+ G LH+FL + SDED L + IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE---ALNNDA 437
A +EYL S VHK++ + NIL+ +L+ ++SD GL+ + +AD +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 438 GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ PE M G+++ SD++SFGVV+ E+ + G +P+
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCD-DF--IEMVSNISQLHH 328
+ LGEGT+ VY+A G+++A+KKI +F + + + +L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTARALE 387
PNI+ L+ LV+EF + L +D ++ + +K L T R LE
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEF-----METDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
YLH S ++H+++K N+L+ ++ +L+D GLA + + + + + + Y APE+
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 447 AM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ Y + D++S G + ELL R PF
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-20
Identities = 78/280 (27%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG+G FG V+ + +A+K + + E F++ + +L H +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKL 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L SE ++ V E+ GSL DFL E K L V +A A + Y+
Sbjct: 64 VQLYAVVSEEPIYI-VTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAPEVAMS 449
++ VH+++++ANIL+ L +++D GLA + + + A + APE A+
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 450 GQYNIKSDVYSFGVVMLELLT-GRKPFDS--SRPRLEQSLVRWATPQLHDIDALAKMVDP 506
G++ IKSDV+SFG+++ EL T GR P+ +R L+Q V+
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------------------VER 218
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
+ P + D++ C + EPE RP E +QA +
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 42/277 (15%)
Query: 276 ENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
+G G FG V + G ++AVK+I S+ E +++ + P I++
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 335 VG---------YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
G C E L+ K + +++ + P KIA+ T +A
Sbjct: 69 YGALFREGDCWICME----LMDISLDK---FYKYVYEVLKSVIP--EEILGKIAVATVKA 119
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-SGYGAP 444
L YL E L ++H+++K +NILLD N +L D G++ + ++ A DAG Y AP
Sbjct: 120 LNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAP 176
Query: 445 E-VAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ--SLVRWATPQLHDIDA 499
E + S + Y+++SDV+S G+ + E+ TG+ P+ +Q +V+ P L + +
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE- 235
Query: 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
+ P F + I LC+ + RP
Sbjct: 236 -EREFSP------------SFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDF-IEMVSNIS---QLHHPNIME 333
+GEGT+G+VY+A+ G+++A+KKI + F I + I +L HPNI+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR----MENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 334 LVGYCSEY--GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR------- 384
L + G +V+E+ HD L+ + VK +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMD----HDL--------TGLLDSPEVKFTESQIKCYMKQLL 110
Query: 385 -ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNADEALNNDAGS-GY 441
L+YLH S ++H++IK +NIL++N+ +L+D GLA N + Y
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 442 GAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
PE+ + + +Y + D++S G ++ EL G+ F
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 75/280 (26%), Positives = 134/280 (47%), Gaps = 34/280 (12%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S ++ LG+G FG V+ + +A+K + + E F++ + +L H +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKL 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L SE ++ V EF GSL DFL + D K L V +A A + Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAPEVAMS 449
++ +H+++++ANIL+ + L +++D GLA + + + A + APE A+
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 450 GQYNIKSDVYSFGVVMLELLT-GRKPFDS--SRPRLEQSLVRWATPQLHDIDALAKMVDP 506
G++ IKSDV+SFG+++ EL+T GR P+ +R LEQ V+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-------------------VER 218
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
+ P +++ LC + +P+ RP E +Q+ +
Sbjct: 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTF-EYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 39/274 (14%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCD----DFIEMVSNISQLHHPNIMEL 334
+GEG FG V + ++ KV AVK I CD F+E + +++LHH N++ L
Sbjct: 14 IGEGEFGAVLQGEYTGQKV-AVKNIK--------CDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+G G ++ V E G+L +FL +I ++ +L A +EYL S
Sbjct: 65 LGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE---S 118
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNI 454
+VH+++ + NIL+ + ++SD GLA + N+ + APE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLPVKWTAPEALKHKKFSS 176
Query: 455 KSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513
KSDV+S+GV++ E+ + GR P+ P++ V+ + ++P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKECVEK-------GYRMEPPEGCPAD 225
Query: 514 VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547
V L C + EP+ RP ++ + L +
Sbjct: 226 VYVLMTS------CWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 42/270 (15%)
Query: 279 LGEGTFGRVYRAQF-ADG---KV-LAVKKIDSSALPS---EMCDDFIEMVSNISQLHHPN 330
LG G FG VY+ + +G K+ +A+K + P E+ D+ M S + HP+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS----VDHPH 70
Query: 331 IMELVGYC-SEYGQHLLVYEFRKNGSLHDFLHL-SDEDNKPLIWNSRVKIALGTARALEY 388
++ L+G C S Q L+ + G L D++ D + N V+IA G + Y
Sbjct: 71 VVRLLGICLSS--QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG----MSY 124
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPE 445
L E +VH+++ + N+L+ + +++D GLA + ++ + + G + A E
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV----RWATPQLHDID-- 498
+ Y KSDV+S+GV + EL+T G KP++ L+ R P + ID
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241
Query: 499 -ALAK--MVD----PALKGLYPVKSLSRFA 521
L K M+D P K L + S+ A
Sbjct: 242 MVLVKCWMIDAESRPTFKEL--INEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 67/292 (22%), Positives = 134/292 (45%), Gaps = 33/292 (11%)
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQF-ADGK---VLAVKKIDSSALPSEMCDDFIEMVSN 322
++ + ++G G FG V+R G+ +A+K + + DF+ S
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASI 59
Query: 323 ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT 382
+ Q H NI+ L G +++ +++ E+ +NG+L +L D + V + G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGI 116
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-- 440
A ++YL + ++ VH+++ + NIL+++ L ++SD GL+ + + E +G
Sbjct: 117 AAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 441 --YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDI 497
+ APE ++ SDV+SFG+VM E+++ G +P+ W H++
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY-------------WDMSN-HEV 219
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
K ++ + P+ S ++ C Q + RP ++V L +L+
Sbjct: 220 ---MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 49/280 (17%)
Query: 279 LGEGTFGRV----YRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
LG G FG V +RAQ +A+K I+ A+ SE +DFIE + +L HP +++L
Sbjct: 12 LGSGQFGVVHLGKWRAQIK----VAIKAINEGAM-SE--EDFIEEAKVMMKLSHPKLVQL 64
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
G C++ +V EF +NG L ++L + L + + + +EYL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVAMSG 450
S +H+++ + N L+ + ++SD G+ + D+ + +G+ + PEV
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 451 QYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV----RWATPQLHDIDALAKMVD 505
+Y+ KSDV+SFGV+M E+ T G+ PF+ ++ R P+L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL----------- 225
Query: 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
A +Y +V+ C +PE RP +E+++A+
Sbjct: 226 -ASMTVY---------EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 71/267 (26%), Positives = 121/267 (45%), Gaps = 28/267 (10%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G+G+FG VY+ +V+A+K ID E+ +D + ++ +SQ P I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYITRYYGS 70
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ + ++ E+ GS D L PL I + L+YLH S
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLH---SERK 122
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNIKS 456
+H++IK+AN+LL + + +L+D G+A + + N G+ + APEV Y+ K+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 457 DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516
D++S G+ +EL G P P L+ +P P L+G Y
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQYS--- 226
Query: 517 LSRFADVIALCVQPEPEFRPPMSEVVQ 543
F + + C+ +P FRP E+++
Sbjct: 227 -KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 98/303 (32%), Positives = 141/303 (46%), Gaps = 46/303 (15%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKID-SSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
+G G+FG VY A + +V+AVKK+ S +E D I+ V + QL HPN +E G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 337 -YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
Y E+ LV E+ GS D L + KPL I G + L YLH
Sbjct: 89 CYLKEH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMS---GQ 451
++H++IK+ NILL +L+D G AS A N+ G+ Y APEV ++ GQ
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEGQ 196
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
Y+ K DV+S G+ +E L RKP P + A L+ I A+ P L+
Sbjct: 197 YDGKVDVWSLGITCIE-LAERKP-----PLFNMN----AMSALYHI---AQNDSPTLQSN 243
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVV-----------QALVRLVQRANMSKRTIG 560
S F D C+Q P+ RP +E++ + L+ L+QR + R +
Sbjct: 244 EWTDSFRGFVD---YCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELD 300
Query: 561 NDQ 563
N Q
Sbjct: 301 NLQ 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG G FG V+ + + +AVK + + + DF+ + +L HP +++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
+ +V E K GSL ++L + L + +A A + YL + + +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 399 HKNIKSANILLDNELNPQLSDCGLA----SNMPNADEALNNDAGSGY----GAPEVAMSG 450
H+++ + N+L+ +++D GLA ++ A E G+ + APE A+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE------GAKFPIKWTAPEAALYN 179
Query: 451 QYNIKSDVYSFGVVMLELLT-GRKPF 475
+++IKSDV+SFG+++ E++T GR P+
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 66/277 (23%), Positives = 132/277 (47%), Gaps = 33/277 (11%)
Query: 275 VENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+++ LG G +G VY + +AVK + + ++F++ + + ++ HPN+++
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQ 66
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
L+G C+ ++ EF G+L D+L + + + +A + A+EYL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQISSAMEYLE--- 121
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVAMS 449
+ +H+++ + N L+ +++D GL+ M + AG+ + APE
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAY 179
Query: 450 GQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508
+++IKSDV++FGV++ E+ T G P+ P ++ S V ++ +M P
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQV------YELLEKGYRMERP-- 227
Query: 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+G P + +++ C Q P RP +E+ QA
Sbjct: 228 EGCPP-----KVYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 41/275 (14%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
L+G G +G VYR G+V+A+K I+ P + D V+ +SQL +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 337 YCSEYGQHL------LVYEFRKNGSLHDFLHLS--DEDNKPLIWNSRVKIALGTARALEY 388
Y YG +L ++ E+ + GS+ + E +I AL+Y
Sbjct: 67 Y---YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE-------VLVALKY 116
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVA 447
+H+V V+H++IK+ANIL+ N N +L D G+A+ + + G+ Y APEV
Sbjct: 117 IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 448 MSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
G+ Y+ K+D++S G+ + E+ TG P+ + + K P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD-------------VDAFRAMMLIPKSKPP 220
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEV 541
L+ K L F +A C+ EP+ R E+
Sbjct: 221 RLEDNGYSKLLREF---VAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 24/279 (8%)
Query: 279 LGEGTFGRV--YRAQFAD---GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LGEG FG+V Y A+ G+++AVK + + + + ++ + L+H NI++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVK 70
Query: 334 LVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYLH 390
G CSE G L+ E+ GSL D+L K + +++ + A + YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL----NNDAGSGYGAPEV 446
S +H+++ + N+LLDN+ ++ D GLA +P E + D+ + A E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+++ SDV+SFGV + ELLT S + E+ ++ Q+ + L ++++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVV-RLIELLER 239
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
++ P ++ C + E +FRP ++ L
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNI--SQLHHPNIMELV 335
LG+G FG V Q GK+ A KK+D L + + + ++ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQ-MALNEKKILEKVSSRFIVSL- 58
Query: 336 GYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV-----KIALGTARALEYL 389
Y E L LV G L H+ + +P +R +I G LE+L
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNV-GEPGFPEARAIFYAAQIICG----LEHL 111
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS 449
H+ +V++++K N+LLD+ N ++SD GLA + + GY APEV
Sbjct: 112 HQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
Y+ D ++ G + E++ GR PF + ++E+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 60/213 (28%), Positives = 116/213 (54%), Gaps = 16/213 (7%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + +GEG+FG++Y A+ +D + +K+ID + +P + + + V ++++ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSD----EDNKPLIWNSRVKIALGTARALE 387
+ E G+ +V E+ G L ++ +++ L W V+I+LG L+
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LK 115
Query: 388 YLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMPNADEALNNDAGSGYG-APE 445
++H+ ++H++IKS NI L N + +L D G+A + ++ E G+ Y +PE
Sbjct: 116 HIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
+ + YN K+D++S G V+ EL T + PF+ +
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 62/288 (21%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH---HPNIMEL 334
+G GT+G VY+A+ A G+++A+K I E DDF + IS L HPNI
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-----KLEPGDDFEIIQQEISMLKECRHPNI--- 62
Query: 335 VGYCSEYGQHL------LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GTARA 385
V Y +G +L +V E+ GSL D ++ PL S ++IA T +
Sbjct: 63 VAY---FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PL---SELQIAYVCRETLKG 113
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-AP 444
L YLHE +H++IK ANILL + + +L+D G+++ + + G+ Y AP
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 445 EVA---MSGQYNIKSDVYSFGVVMLELLTGRKP-FDSSRPRLEQSLVRWATPQLHDIDAL 500
EVA G Y+ K D+++ G+ +EL + P FD LH + AL
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD-----------------LHPMRAL 213
Query: 501 AKM-----VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ P LK K F D I C+ +P+ RP ++++Q
Sbjct: 214 FLISKSNFPPPKLKD--KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 46/281 (16%)
Query: 278 LLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G+G FG VY+ +AVK S+ LP ++ F++ + Q HPNI++L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
C + +V E GSL FL L ++++L A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------APEVAMSG 450
+H+++ + N L+ ++SD G M +E G APE G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 451 QYNIKSDVYSFGVVMLELLT-GRKPF-----DSSRPRLEQSLVRWATPQLHDIDALAKMV 504
+Y +SDV+S+G+++ E + G P+ +R R+E S R PQL
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQL--------CP 221
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ + ++ C +PE RP SE+ L
Sbjct: 222 EEIYR-------------LMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 42/275 (15%)
Query: 279 LGEGTFGR--VYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
LG+G FG +YR D ++ K+++ + L + D + + +S L HPNI+
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTARALEYLHEVC 393
+ + L+ E+ G+L+D + + + ++W A+ Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA- 120
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEVAMSG 450
++H++IK+ NI L +L D G++ + E + G Y +PE+
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGV 176
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510
+YN KSD+++ G V+ ELLT ++ FD++ P +V ++G
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNP--------------------LNLVVKIVQG 216
Query: 511 LY-PVKSL--SRFADVIALCVQPEPEFRPPMSEVV 542
Y PV S+ S ++ +Q +PE RP EV+
Sbjct: 217 NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 80/282 (28%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 279 LGEGTFGRVYRAQF-ADGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
LGEG FG V Q D +L AVK + + +DF+ + + HPN+M L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 336 GYCSE------YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR--VKIALGTARALE 387
G C + Y +++ F K+G LH FL S + P ++ VK A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EALNNDAGSGYGAP 444
YL S S +H+++ + N +L+ +N ++D GL+ + N D + + A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
E Y KSDV+SFGV M E+ T G+ P+ P +E S + L + L +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY----PGVENSEI---YDYLRQGNRLKQP 236
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
D L GLY +++ C P+ RP + L
Sbjct: 237 PD-CLDGLY---------SLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 61/212 (28%), Positives = 110/212 (51%), Gaps = 18/212 (8%)
Query: 275 VENLLGEGTFGRVYRAQF-ADGK---VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+E ++G G FG V R + GK +A+K + S + DF+ S + Q HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L G ++ +++ EF +NG+L FL +D + V + G A ++YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYLS 123
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLA------SNMPNADEALNNDAGSGYGAP 444
E ++ VH+++ + NIL+++ L ++SD GL+ ++ P +L + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
E ++ SDV+S+G+VM E+++ G +P+
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 28/267 (10%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G+G+FG V++ KV+A+K ID E+ +D + ++ +SQ P + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGS 70
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ + ++ E+ GS D L + PL I + L+YLH S
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLH---SEKK 122
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNIKS 456
+H++IK+AN+LL +L+D G+A + + N G+ + APEV Y+ K+
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 457 DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516
D++S G+ +EL G P P L+ P P L+G Y K
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYS-KP 228
Query: 517 LSRFADVIALCVQPEPEFRPPMSEVVQ 543
L F + C+ EP FRP E+++
Sbjct: 229 LKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 56/203 (27%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG G FG V ++ +A+K I ++ SE D+FIE + +L H +++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SE--DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
++ +V E+ NG L ++L E K + +++ + YL S +
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVAMSGQYNI 454
H+++ + N L+D++ ++SD GL+ + D+ + GS + PEV + +++
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 455 KSDVYSFGVVMLELLT-GRKPFD 476
KSDV++FGV+M E+ + G+ P++
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 278 LLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCD--DFIEMVSNISQLHHP 329
LGEG FG+V +A+ +AVK + A ++ D +EM+ I + H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HK 76
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH------------LSDEDNKPLIWNSRVK 377
NI+ L+G C++ G +V E+ +G+L DFL + L V
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 378 IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EALN 434
A AR +E+L S +H+++ + N+L+ + +++D GLA ++ + D + N
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 435 NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ APE Y +SDV+SFGV++ E+ T G P+
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 77/274 (28%), Positives = 117/274 (42%), Gaps = 40/274 (14%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LGEG G V + + G + A+K I + P E+ N S P I++ G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKS-CKSPYIVKYYGA 67
Query: 338 CSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRV--KIALGTARALEYLHEVC 393
+ + E+ + GSL D ++ + I +V KIA + L YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRI-GEKVLGKIAESVLKGLSYLH--- 122
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-----SGYGAPEVAM 448
S ++H++IK +NILL + +L D G++ E +N+ AG S Y APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG------ELVNSLAGTFTGTSFYMAPERIQ 176
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR------LEQSLVRWATPQLHDIDALAK 502
Y+I SDV+S G+ +LE+ R PF L +V P+L D
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD------ 230
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
+P +K F D I C++ +P RP
Sbjct: 231 --EPGNG----IKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 20/274 (7%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDS-SALPSEMCDDFIEMVSNISQLHH 328
+F +E +G G F VYRA DG +A+KK+ + ++ D I+ + + QL+H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
PN+++ E + +V E G L + + + + + K + ALE+
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEVA 447
+H S V+H++IK AN+ + +L D GL + A ++ G+ Y +PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
YN KSD++S G ++ E+ + PF + L SL + ++ D P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK----KIEQCDY------PP 227
Query: 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEV 541
L + + L + + +C+ P+PE RP ++ V
Sbjct: 228 LPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 272 SFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDS-SALPSEMCDDFIEMVSNISQLHHP 329
+F +E +G G F VYRA D K +A+KK+ + ++ D ++ + + QL+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTARA 385
N+++ + E + +V E G L + + + + +W V++ A
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAP 444
+E++H S V+H++IK AN+ + +L D GL + A ++ G+ Y +P
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
E YN KSD++S G ++ E+ + PF + L +L + +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---------------SLCQKI 220
Query: 505 DPALKGLYPVKSLS-RFADVIALCVQPEPEFRPPMSEVVQ 543
+ P + S + +++++C+ P+P+ RP + V Q
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 278 LLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LLG+G FG V++ D +AVK LP E+ F+ + Q HPNI++L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
C++ +V E G FL ++ K VK AL A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQLVKFALDAAAGMAYLE---SKNC 114
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-----SGYGAPEVAMSGQY 452
+H+++ + N L+ ++SD G++ D+ + + +G + APE G+Y
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 453 NIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
+ +SDV+S+G+++ E + G P+ P + R + V+ +
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPY----PGMTNQQAR-------------EQVEKGYRMS 214
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
P K V+ C +PE RP SE+ + L
Sbjct: 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 279 LGEGTFGRV----YRAQFADGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G FG V Y + GK + AVK + + + +F+ S ++QL HP I+
Sbjct: 3 LGHGNFGSVVKGVYLMK--SGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIV 59
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYLHE 391
L+G C +LV E G L +L + I S +K A A + YL
Sbjct: 60 RLIGVCKG-EPLMLVMELAPLGPLLKYLK-----KRREIPVSDLKELAHQVAMGMAYLES 113
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNADEALNNDAGS---GYGAPEVA 447
VH+++ + N+LL N ++SD G++ + +D AG + APE
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
G+++ KSDV+S+GV + E + G KP+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 35/271 (12%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG G FG V+ + +A+K + ++ E F+ + + QL HP +
Sbjct: 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRL 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L ++ ++ E+ +NGSL DFL + L N + +A A + ++
Sbjct: 64 VRLYAVVTQE-PIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAPEVAMS 449
+ +H+++++ANIL+ L +++D GLA + + + A + APE
Sbjct: 121 ---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 450 GQYNIKSDVYSFGVVMLELLT-GRKPFDS-SRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
G + IKSDV+SFG+++ E++T GR P+ + P + Q+L R +M P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-----------GYRMPRPD 226
Query: 508 L--KGLYPVKSLSRFADVIALCVQPEPEFRP 536
+ LY +++ LC + +PE RP
Sbjct: 227 NCPEELY---------ELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 39/286 (13%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADG--KVLAVKKIDSSAL-----PSEMCDDFIEMVSNIS 324
+ V LG G FG VY+ + + +LA+K+I+ E ++VS ++
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 325 ----QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRV 376
QL HPNI+ E + +V + + L + + E + IWN V
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
++ L AL YLH+ +VH+++ NI+L + ++D GLA + L +
Sbjct: 121 QMVL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSV 173
Query: 437 AGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495
G+ Y PE+ + Y K+DV++FG ++ ++ T + PF S+ +++ AT
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLAT---K 224
Query: 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEV 541
++A+ +P +G+Y DVI C+ P+ E RP + +V
Sbjct: 225 IVEAV---YEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 60/281 (21%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEM--VSNI------ 323
F + ++G+G FG+V Q D K+ A+K ++ + C +E V N+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK-----QKC---VEKGSVRNVLNERRI 53
Query: 324 -SQLHHPNIMELVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIA 379
+L+HP LV + +++ LV + G L HLS +VK +
Sbjct: 54 LQELNHP---FLVNLWYSFQDEENMYLVVDLLLGGDLR--YHLS----------QKVKFS 98
Query: 380 LGTAR--------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431
+ ALEYLH S ++H++IK NILLD + + ++D +A+ + D
Sbjct: 99 EEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDT 154
Query: 432 ALNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD--SSRPR------- 481
+ +G+ GY APEV Y++ D +S GV E L G++P+ S R
Sbjct: 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ 214
Query: 482 LEQSLVRWATPQLHDIDALAKM--VDPALKGLYPVKSLSRF 520
++ AT IDA+ K+ DP + +K L
Sbjct: 215 ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 278 LLGEGTFGRVYRAQF--ADGKVLAVK-KIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
LG+G+FG V R ++ + GKV+ V K S S++ DDF++ + + L H N++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 335 VGYCSEYG---QH--LLVYEFRKNGSLHDFLHLSDEDNKPL--IWNSRVKIALGTARALE 387
YG H ++V E GSL D L + + + + V+IA G +
Sbjct: 62 ------YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MR 111
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE----ALNNDAGSGYGA 443
YL S +H+++ + NILL ++ ++ D GL +P ++ + + A
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
PE + ++ SDV+ FGV + E+ T G +P+
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 255 PTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYR-AQFADGKVLAVKKIDSSALPSEMC 313
P N + + L T ++ + +G+GT+G+VY+ DG + AVK +D P
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD----PISDV 61
Query: 314 DDFIEMVSNISQL--HHPNIMELVG--YCSEY---GQHLLVYEFRKNGSLHDF----LHL 362
D+ IE NI Q +HPN+++ G Y ++ GQ LV E GS+ + L
Sbjct: 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121
Query: 363 SDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422
++ +I I G L++LH + ++H+++K NILL E +L D G+
Sbjct: 122 GQRLDEAMI----SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 423 ASNMPNADEALNNDAGSGYG-APEVAMSGQ-----YNIKSDVYSFGVVMLELLTGRKPFD 476
++ + + N G+ + APEV Q Y+ + DV+S G+ +EL G P
Sbjct: 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL- 233
Query: 477 SSRPRLEQSLVRWATPQLHDIDALAKMV-DPALKGLYPVKSLSRFADVIALCVQPEPEFR 535
+H + L K+ +P L+P K F I+ C+ + E R
Sbjct: 234 ---------------FDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEAR 278
Query: 536 PPMSEVVQ 543
P ++ +++
Sbjct: 279 PSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 76/283 (26%), Positives = 140/283 (49%), Gaps = 40/283 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG G FG V+ A + +AVK + ++ E F+ + + L H +
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNK---PLIWNSRVKIALGTARALEY 388
++L ++ +++ EF GSL DFL SDE +K P + + +IA G A +
Sbjct: 64 VKLHAVVTKEPIYIIT-EFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMA----F 117
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAPEV 446
+ + + +H+++++ANIL+ L +++D GLA + + + A + APE
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 447 AMSGQYNIKSDVYSFGVVMLELLT-GRKPFDS-SRPRLEQSLVR-WATPQLHDIDALAKM 503
G + IKSDV+SFG++++E++T GR P+ S P + ++L R + P+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------- 224
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
+ + LY +++ C + PE RP E +Q+++
Sbjct: 225 PENCPEELY---------NIMMRCWKNRPEERPTF-EYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-18
Identities = 96/303 (31%), Positives = 141/303 (46%), Gaps = 46/303 (15%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVG 336
+G G+FG VY A+ +V+A+KK+ S S E D I+ V + ++ HPN +E G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 337 -YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
Y E+ LV E+ GS D L + KPL I G + L YLH S
Sbjct: 93 CYLREH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLH---SH 144
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMS---GQ 451
+++H++IK+ NILL +L+D G AS A N+ G+ Y APEV ++ GQ
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAMDEGQ 200
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
Y+ K DV+S G+ +E L RKP P + A L+ I A+ P L+
Sbjct: 201 YDGKVDVWSLGITCIE-LAERKP-----PLFNMN----AMSALYHI---AQNESPTLQSN 247
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRANMSKRTIG 560
F D C+Q P+ RP E+++ L+ L+QR + R +
Sbjct: 248 EWSDYFRNFVDS---CLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELD 304
Query: 561 NDQ 563
N Q
Sbjct: 305 NLQ 307
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 61/225 (27%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 279 LGEGTFGRVYRAQ------FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+G+G FGRV++A+ + ++AVK + A ++M DF + +++ HPNI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIV 71
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLH------------------LSDEDNKPLIWNS 374
+L+G C+ L++E+ G L++FL + PL
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD--EA 432
++ IA A + YL E VH+++ + N L+ + +++D GL+ N+ +AD +A
Sbjct: 132 QLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 433 LNNDA-GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
NDA + PE +Y +SDV+++GVV+ E+ + G +P+
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 48/286 (16%)
Query: 279 LGEGTFGRVYRAQFADGKVLA---VKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
+G G FG+V + G A VK++ +SA P E F++ V +L+HPN+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ-LLFLQEVQPYRELNHPNVLQCL 61
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFL-----HLSDEDNKPLIWNSRVKIALGTARALEYLH 390
G C E +LLV EF G L ++L ++ K ++ ++A G L +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG----LLWLH 117
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPEVA 447
+ +H ++ N L +L+ ++ D GLA D + D + + APE+
Sbjct: 118 Q---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 448 MSGQYNI-------KSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
++ KS+++S GV M EL T +P+ P L D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----------------PDLSDEQV 218
Query: 500 LAKMV-DPALKGLYP---VKSLSRFADVIALCVQPEPEFRPPMSEV 541
L ++V + +K P +K R+ +V+ C +PE RP EV
Sbjct: 219 LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 278 LLGEGTFGRVYRAQFA--DGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+LGEG FG V Q + DG L AVK + ++F+ + + HPN+M+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 334 LVGYC---SEYGQ---HLLVYEFRKNGSLHDFLHLSDEDNKP--LIWNSRVKIALGTARA 385
L+G C S + +++ F K+G LH FL S P L + +K + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYG 442
+EYL + + +H+++ + N +L ++ ++D GL+ + + D +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
A E Y KSDV++FGV M E+ T G+ P+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIE-MVSNISQ-------LHH 328
L+G+GT+GRVY A G+++AVK+++ A + D + MV + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
NI++ +G+ + + E+ GS+ L + L+ ++ G L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAY 123
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA---DEALNNDAGSGYGAPE 445
LH S ++H+++K+ N+L+D + ++SD G++ + D+ ++ + APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 446 VAMSGQ--YNIKSDVYSFGVVMLELLTGRKPF 475
V S Y+ K D++S G V+LE+ GR+P+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 278 LLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG+G FG V ++ G+V+AVKK+ S +E DF + + L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIV 68
Query: 333 ELVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALEYL 389
+ G C G+ LV E+ GSL D+L + ++ + + + + A + +EYL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYL 124
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP-NADEALNNDAGSG---YGAPE 445
S VH+++ + NIL+++E ++ D GL +P + + + G + APE
Sbjct: 125 G---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT 470
++++ SDV+SFGVV+ EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 65/297 (21%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH-- 328
+G GT G+VY+ +F G V+AVK++ + E I M ++ H
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN--KRILMDLDVVLKSHDC 73
Query: 329 PNI----------------MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIW 372
P I MEL+ C + L P+
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLD--------------------KLLKRIQGPIPE 113
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
+ K+ + +AL YL E V+H+++K +NILLD N +L D G++ + + +A
Sbjct: 114 DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKA 170
Query: 433 LNNDAG-SGYGAPE----VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
AG + Y APE + +Y+I++DV+S G+ ++EL TG+ P+ + +
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------- 223
Query: 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ + L K++ L P + S F + LC+ + RP E++Q
Sbjct: 224 --------EFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 72/292 (24%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
F + +LG+G FG V AQ + +AVK + + S ++F+ + + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 329 PNIMELVGYC--SEYGQHL----LVYEFRKNGSLHDFLHLSDEDNKP--LIWNSRVKIAL 380
PN+++L+G S L ++ F K+G LH FL +S +P L + V+ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
A +EYL S + +H+++ + N +L+ + ++D GL+ + + D A
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 440 --GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496
+ A E Y SDV++FGV M E++T G+ P+ +E S
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY----AGVENS----------- 222
Query: 497 IDALAKMVDPALKG---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
++ + +KG P L +++ C PEP+ RP + L
Sbjct: 223 -----EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 53/298 (17%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNIS--------QLHH 328
++GEG +G V + + G+++A+KK S DD E V + QL H
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESE------DD--EDVKKTALREVKVLRQLRH 59
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH-----LSDEDNKPLIWNSRVKIALGTA 383
NI+ L G+ LV+E+ + +L + L L + + IW
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND--AGSGY 441
+A+ Y H S +++H++IK NIL+ +L D G A + + D A Y
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167
Query: 442 GAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF--DSSRPRL------------EQSL 486
APE+ + Y DV++ G +M ELL G F DS +L
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227
Query: 487 VRWATPQLHDIDALAKMVDP-ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + P+ + A + P +L+ YP K S D + C++ +P+ R E++Q
Sbjct: 228 LFSSNPRFAGV-AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 49/239 (20%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQL-HHP 329
F ++GEG+F V A+ K A+K +D L E ++++ + ++L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 330 NIMELVGYCSEYGQHLL--VYEFRKNGSLHDFLH----LSDEDNKPLIWNSRVKIALGTA 383
I++L Y + + L V E+ NG L ++ L ++ A
Sbjct: 63 GIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-----------TRFYAA 109
Query: 384 R---ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
ALEYLH S ++H+++K NILLD +++ +++D G A + +N +
Sbjct: 110 EILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 441 ---------------------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
Y +PE+ SD+++ G ++ ++LTG+ PF S
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 94/303 (31%), Positives = 143/303 (47%), Gaps = 46/303 (15%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVG 336
+G G+FG VY A+ + +V+A+KK+ S S E D I+ V + +L HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 337 -YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
Y E+ LV E+ GS D L + KPL + G + L YLH S
Sbjct: 83 CYLREH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMS---GQ 451
+++H+++K+ NILL +L D G AS M A N G+ Y APEV ++ GQ
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQ 190
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
Y+ K DV+S G+ +E L RKP P + A L+ I A+ PAL+
Sbjct: 191 YDGKVDVWSLGITCIE-LAERKP-----PLFNMN----AMSALYHI---AQNESPALQSG 237
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRANMSKRTIG 560
+ + F D C+Q P+ RP +++ ++ L+QR + R +
Sbjct: 238 HWSEYFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELD 294
Query: 561 NDQ 563
N Q
Sbjct: 295 NLQ 297
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 278 LLGEGTFGRVYRAQFADGKV-LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
+LG+GT+G VY A+ +V +A+K+I S E ++ S L H NI++ +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKIALGTARALEYLHEVC 393
SE G + E GSL L +DN+ I +I G L+YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG----LKYLHD-- 126
Query: 394 SLSVVHKNIKSANILLDNELNP-QLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQ 451
+VH++IK N+L++ ++SD G + + + G+ Y APEV G
Sbjct: 127 -NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 452 --YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
Y +D++S G ++E+ TG+ PF + PQ A M +
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPF-----------IELGEPQ-------AAMFKVGMF 227
Query: 510 GLYP--VKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
++P +SLS A + I C +P+P+ R +++Q
Sbjct: 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 76/245 (31%), Positives = 121/245 (49%), Gaps = 31/245 (12%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVL----AVKKI-DSSALPS--EMCDDFIEMVSNISQLHHP 329
LLG G FG V++ + +G + A+K I D S + E+ D + M S L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS----LDHA 69
Query: 330 NIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKP-LIWNSRVKIALGTARALE 387
I+ L+G C G L LV + GSL D + + P + N V+IA G +
Sbjct: 70 YIVRLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG----MY 123
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA-LNNDAGS--GYGAP 444
YL E +VH+N+ + NILL ++ Q++D G+A + D+ ++ + + A
Sbjct: 124 YLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV----RWATPQLHDIDA 499
E + G+Y +SDV+S+GV + E+++ G +P+ RP L+ R A PQ+ ID
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240
Query: 500 LAKMV 504
MV
Sbjct: 241 YMVMV 245
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 40/254 (15%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEGT+G VY+A+ G+++A+KKI + + + + +L+HPNI++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTARALEYLHEVCSLS 396
G LV+EF D L + + L S +K + L + H S
Sbjct: 67 FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCH---SHG 118
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLA-----SNMPNADEALNNDAGSGYGAPEVAM-SG 450
++H+++K N+L++ E +L+D GLA P Y APE+ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV----VTRWYRAPELLLGDK 174
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD----P 506
Y+ D++S G + ELL+ R F P +ID L K+ P
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLF----------------PGKSEIDQLFKIFRTLGTP 218
Query: 507 ALKGLYPVKSLSRF 520
+ SL+R
Sbjct: 219 DPEVWPKFTSLARN 232
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 49/283 (17%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G G FG V+ + AD +AVK + LP ++ F++ + Q HPNI+ L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
C++ +V E + G DFL + L +++ A +EYL
Sbjct: 62 CTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG--------YGAPEVAMS 449
+H+++ + N L+ + ++SD G++ +E A +G + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 450 GQYNIKSDVYSFGVVMLELLT-GRKPF-----DSSRPRLEQSLVRWATPQLHDIDALAKM 503
G+Y+ +SDV+SFG+++ E + G P+ +R +EQ VR P+L M
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLM 229
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
C + +P RP S V Q L
Sbjct: 230 ER---------------------CWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 39/279 (13%)
Query: 277 NLLGEGTFGRVYRAQF--ADGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
++G+G FG VY +DG+ + AVK + + E + F++ + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 333 ELVGYC-SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
L+G C G L+V + K+G L +F+ E + P + + L A+ +EYL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIR--SETHNPTV-KDLIGFGLQVAKGMEYL-- 114
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EALNNDAGS----GYGAPEV 446
S VH+++ + N +LD +++D GLA ++ + + +++N G+ + A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+ ++ KSDV+SFGV++ EL+T R A P D+D+ +
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT-----------------RGAPP-YPDVDSF-DITVY 214
Query: 507 ALKG---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542
L+G L P +V+ C P+PE RP SE+V
Sbjct: 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 69/267 (25%), Positives = 124/267 (46%), Gaps = 28/267 (10%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G+G+FG V++ +V+A+K ID E+ +D + ++ +SQ P + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYGS 70
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ + ++ E+ GS D L D + + +K L + L+YLH S
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLH---SEKK 122
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNIKS 456
+H++IK+AN+LL + + +L+D G+A + + N G+ + APEV Y+ K+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 457 DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516
D++S G+ +EL G P P + + + K P L G + K
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHP-------------MRVLFLIPKNNPPTLTGEF-SKP 228
Query: 517 LSRFADVIALCVQPEPEFRPPMSEVVQ 543
F D C+ +P FRP E+++
Sbjct: 229 FKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVG 336
LG G FGRV + + A+K + + + I I + +HP I++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 337 YCSEYGQ-HL-LVYEFRKNGSLHDFLH---LSDEDNKPLIWNSRVKIALGTARALEYLHE 391
Y + + ++ ++ E+ G L L L DE + +R IA A EYLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE------YTARFYIA-CVVLAFEYLH- 110
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQ 451
+ ++++++K N+LLD+ +L D G A + + + Y APE+ ++
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSS 478
Y+ D +S G+++ ELLTGR PF
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 28/271 (10%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG+G FG+VY+AQ + VLA K+ + E+ +D++ + ++ HPNI++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL-EDYMVEIDILASCDHPNIVKLLDAF 71
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
++ EF G++ D + L E +PL + T AL YLHE ++
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQ-----Y 452
H+++K+ NIL + + +L+D G+++ + ++ G+ Y APEV M Y
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 453 NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512
+ K+DV+S G+ ++E+ P P + + +AK P L
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNP-------------MRVLLKIAKSEPPTLA--Q 230
Query: 513 PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P + S F D + C++ + R ++++Q
Sbjct: 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 1e-16
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-----VSNISQL 326
+ LGEGT+G VY+A+ G+++A+KKI + ++ I +S + +L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKEL 55
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTARA 385
HPNI++L+ + LV+E+ L +L + + + +K I R
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRG 110
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAP 444
L Y H S ++H+++K NIL++ + +L+D GLA ++ + Y AP
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
Query: 445 EVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
E+ + S Y+ D++S G + E++TG+ F
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/272 (25%), Positives = 132/272 (48%), Gaps = 30/272 (11%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG+G FG+VY+A+ + LA K+ + E+ +D++ + ++ +HP I++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-EDYMVEIEILATCNHPYIVKLLGAF 78
Query: 339 SEYGQHLLVYEFRKNGSLHD-FLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
G+ ++ EF G++ L L +P I +V I AL+YLH S+ +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI---QV-ICRQMLEALQYLH---SMKI 131
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAM-----SGQ 451
+H+++K+ N+LL + + +L+D G+++ + ++ G+ Y APEV M
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
Y+ K+D++S G+ ++E+ P P + + +AK P L
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP-------------MRVLLKIAKSEPPTL--S 236
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P K F D + + PE RP +++++
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 71/284 (25%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 275 VENLLGEGTFGRVYRAQFA-DGK---VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+E ++G G FG V + GK +A+K + + + DF+ S + Q HPN
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPN 66
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L G ++ ++V E+ +NGSL FL D + V + G A ++YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKYLS 123
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG----YGAPEV 446
+ + VH+++ + NIL+++ L ++SD GL+ + + EA G + APE
Sbjct: 124 D---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 447 AMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
++ SDV+S+G+VM E+++ G +P+ W ++ + D + K ++
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W---EMSNQDVI-KAIE 223
Query: 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
+ P+ + ++ C Q + RP ++V L +L+
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDF------IEMVSNISQLHHPN 330
LLG+G FGRVY D G+ LAVK++ E + I+++ N L H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN---LQHER 65
Query: 331 IMELVGYCSEYGQHLLVY-EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
I++ G C + L ++ E+ GS+ D L L K +EYL
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYL 120
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN---ADEALNNDAGSGYG-APE 445
H S +VH++IK ANIL D+ N +L D G + + + + + G+ Y +PE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
V Y K+DV+S G ++E+LT + P+
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG G FG V+ + + +AVK + + + F+E + + L H ++ L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNK---PLIWNSRVKIALGTARALEYLHEVCSL 395
++ ++ E+ GSL DFL SDE K P + + +IA G A Y+
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMA----YIERK--- 122
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAPEVAMSGQYN 453
+ +H+++++AN+L+ L +++D GLA + + + A + APE G +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 454 IKSDVYSFGVVMLELLT-GRKPF 475
IKSDV+SFG+++ E++T G+ P+
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 279 LGEGTFGRVYRA-------QFADGKV-LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
LGEG FG+V RA D V +AVK + +A ++ D EM H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLH------------LSDEDNKPLIWNSRVKI 378
I+ L+G C++ G ++ E+ G+L +FL ++ + L + V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EALNN 435
A AR +EYL S +H+++ + N+L+ + +++D GLA + + D + N
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 436 DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ APE Y +SDV+SFG++M E+ T G P+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 41/274 (14%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLHHPNIME 333
+G+G G VY A A G+ +A+K+++ P + E++ N + + HPNI
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK------ELIINEILVMRENKHPNI-- 78
Query: 334 LVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
V Y Y G L +V E+ GSL D + + D + R + +ALE+LH
Sbjct: 79 -VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLH 132
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMS 449
S V+H++IKS NILL + + +L+D G + + + G+ Y APEV
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
Y K D++S G++ +E++ G P+ + P L + +A P L+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------------LRALYLIATNGTPELQ 236
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P K + F D + C++ + E R E++Q
Sbjct: 237 N--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 71/297 (23%), Positives = 131/297 (44%), Gaps = 48/297 (16%)
Query: 279 LGEGTFGRVYRAQF--------ADGKVLAVKKIDSSALPSEMCD--DFIEMVSNISQLHH 328
LGEG FG+V A+ + +AVK + A ++ D +EM+ I + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH------------LSDEDNKPLIWNSRV 376
NI+ L+G C++ G ++ E+ G+L ++L ++ ++ + + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EAL 433
AR +EYL S +H+++ + N+L+ +++D GLA ++ N D +
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATP 492
N + APE Y +SDV+SFGV+M E+ T G P+ P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----------------P 241
Query: 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
+ ++ L K++ + P + ++ C P RP ++V+ L R++
Sbjct: 242 GI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 279 LGEGTFGRVYR---AQFADGKV---LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG+G+FG VY G+ +A+K ++ +A E + F+ S + + + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72
Query: 333 ELVGYCSEYGQH-LLVYEFRKNGSLHDFL--HLSDEDNKP--------LIWNSRVKIALG 381
L+G S GQ L+V E G L +L + +N P +IA G
Sbjct: 73 RLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
A YL VH+++ + N ++ +L ++ D G+ ++ D G G
Sbjct: 132 MA----YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD--YYRKGGKGL 182
Query: 441 ----YGAPEVAMSGQYNIKSDVYSFGVVMLELLT 470
+ APE G + KSDV+SFGVV+ E+ T
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 32/219 (14%)
Query: 279 LGEGTFGRVY--------------RAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS 324
LGEG FG V+ +F VL K+ + + +DF++ + +S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 325 QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL-------HLSDEDNKPLI-WNSRV 376
+L +PNI+ L+G C ++ E+ +NG L+ FL + +N P + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
+A+ A ++YL SL+ VH+++ + N L+ N +++D G++ N+ + D
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD--YYRI 187
Query: 437 AGSG-----YGAPEVAMSGQYNIKSDVYSFGVVMLELLT 470
G + A E + G++ SDV++FGV + E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 279 LGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V+ A+ D ++AVK + ++ + DF ++ L H +I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQREAELLTVLQHQHIV 70
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNK-----------PLIWNSRVKIALG 381
G C+E L+V+E+ ++G L+ FL D K L + IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
A + YL SL VH+++ + N L+ L ++ D G++ ++ + D G
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--YYRVGGRTM 185
Query: 441 ----YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ PE + ++ +SD++SFGVV+ E+ T G++P+
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 282 GTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVGYCS 339
G +GRV+ A+ + G + A+K I + + + D + +I SQ P +++L Y S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYS 61
Query: 340 EYGQH--LLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
G+ LV E+ G L L DED +R+ IA ALEYLH S
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV------ARIYIA-EIVLALEYLH---S 111
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLAS-------NMPNADEALNND-AGS-GYGAPE 445
++H+++K NIL+D+ + +L+D GL+ N DE + G+ Y APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
V + ++ D +S G ++ E L G PF
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 279 LGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCD--DFIEMVSNISQLHHPNI 331
LGEG FG+V ++ G+ +AVK + + + + D IE++ N L+H NI
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN---LYHENI 68
Query: 332 MELVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLI-WNSRVKIALGTARALEY 388
++ G C+E G + L+ EF +GSL ++L NK I ++K A+ + ++Y
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE--ALNNDAGSG--YGAP 444
L S VH+++ + N+L+++E ++ D GL + E + +D S + AP
Sbjct: 125 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT 470
E + ++ I SDV+SFGV + ELLT
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 68/234 (29%), Positives = 122/234 (52%), Gaps = 30/234 (12%)
Query: 265 DLQMATGSFNVENLLGEGTFGRVYRAQF---ADG---KVLAVKKI-DSSALPSEMCDDFI 317
++ ++T F E LGE FG+VY+ A G + +A+K + D + P + ++F
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFK 56
Query: 318 EMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHL--------SDEDNK- 368
S+L HPNI+ L+G ++ +++ + + LH+FL + S +D+K
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 369 ---PLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425
L V I A +E+L S VVHK++ + N+L+ ++LN ++SD GL
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 426 MPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ AD N+ + +PE M G+++I SD++S+GVV+ E+ + G +P+
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 37/295 (12%)
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSALPSEMCD-DFIEMVS 321
++ S + LG G FG VY + D L V SE + DF+
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 322 NISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKI 378
+S+ +H NI+ L+G E ++ E G L FL + E L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALN 434
A A+ +YL E +H++I + N LL + P ++D G+A ++ A
Sbjct: 122 ARDVAKGCKYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177
Query: 435 NDAGS---GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWA 490
+ PE + G + K+DV+SFGV++ E+ + G P+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY--------------- 222
Query: 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
P + + + + V + P ++ C Q PE RP + +++ +
Sbjct: 223 -PGRTNQEVM-EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 46/291 (15%)
Query: 272 SFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL--HH 328
++ + +G+GT+G+V++ +G AVK +D P D+ IE NI + H
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALSDH 74
Query: 329 PNIMELVGYCSEY----GQHL-LVYEFRKNGSLHD----FLHLSDEDNKPLIWNSRVKIA 379
PN+++ G + G L LV E GS+ D FL + +P+I +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
+G L++LH +H+++K NILL E +L D G+++ + + N G+
Sbjct: 135 MG----LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 187
Query: 440 GYG-APEVAMSGQ-----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493
+ APEV Q Y+ + DV+S G+ +EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL----------------AD 231
Query: 494 LHDIDALAKMV-DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
LH + AL K+ +P P + F D I C+ + E RP +S+++Q
Sbjct: 232 LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSE-------MCDDFIEMVSNISQLHHPN 330
LG+G FG V Q + GK+ A KK+D L + + + +E V++ P
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS------PF 54
Query: 331 IMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
I+ L Y E HL LV G L H+ + + L + + + +L
Sbjct: 55 IVNL-AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS 449
H S+ +V++++K N+LLD++ N +LSD GLA + + +GY APE+
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493
Y+ D ++ G + E++ GR PF + ++ + ++ T +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 279 LGEGTFGRVYRAQF---ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
LG G FG V + + K +AVK + + + D+ + + + QL +P I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
G C E +LV E + G L+ FL + NK + + ++ + ++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET--- 114
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPEVAMSG 450
+ VH+++ + N+LL + ++SD GL+ + ADE G + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 451 QYNIKSDVYSFGVVMLELLT-GRKPF 475
+++ KSDV+SFGV+M E + G+KP+
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 277 NLLGEGTFGRVYRAQFAD------GKV-LAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
N LG G FG VY D G + +AVK + A E + F++ +S +HP
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKP---LIWNSRVKIALGTARAL 386
NI++L+G C ++ E + G L +L + + L + I L A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 387 EYLHEVCSLSVVHKNIKSANILL-----DNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
YL + + +H+++ + N L+ D + ++ D GLA ++ +D G G
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD--YYRKEGEGL 174
Query: 441 ----YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ APE + G++ +SDV+SFGV+M E+LT G++P+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 39/273 (14%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEG+ G V A + G+ +AVKK+D + + V + HPNI+E+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD--LRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 338 CSEYGQHL------LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
Y +L +V EF + G+L D + + N+ I + L +AL +LH
Sbjct: 82 ---YSSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQI----ATVCLAVLKALSFLH- 132
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEVAMSG 450
+ V+H++IKS +ILL ++ +LSD G + + + G+ Y APEV
Sbjct: 133 --AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510
Y + D++S G++++E++ G P+ + P +R P P LK
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-------------PKLK- 236
Query: 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
K R + + +P R +E++
Sbjct: 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 279 LGEGTFGRVYRAQ------FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V+ A+ D ++AVK + L + DF ++ L H +I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFL--HLSDE----DNKPLIWNSR------VKIAL 380
+ G C + ++V+E+ K+G L+ FL H D D +P + IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE---ALNNDA 437
A + YL S VH+++ + N L+ L ++ D G++ ++ + D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 438 GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ PE M ++ +SDV+SFGV++ E+ T G++P+
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 278 LLGEGTFGRVYRAQFADGK----VLAVK--KIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+GEG FG VY+ + + +AVK K +S E F++ + Q HP+I
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK---FLQEAYIMRQFDHPHI 69
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L+G +E +V E G L +L ++ + L S + + + AL YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLA--SLILYSYQLSTALAYLE- 124
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPEV 446
S VH++I + N+L+ + +L D GL+ + ++ A G + APE
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPES 179
Query: 447 AMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
++ SDV+ FGV M E+L G KPF
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 277 NLLGEGTFGRVYRAQFADGKVLAVKKID---SSALPSE-MCDDFIEMVSNISQLHHPNIM 332
+LG+G +G VY G+++AVK+++ S+ L +E + E V + L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+ +G C + + EF GS+ L+ +P+ +I G A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA------DEALNNDAGSGYG-APE 445
C VVH++IK N++L +L D G A + L + G+ Y APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
V Y KSD++S G + E+ TG+ P +S RL
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPL-ASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 29/268 (10%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G+G G V+ A A G+ +A+K+I+ P + + I + + +L +PNI+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILVMKELKNPNIVNFLDS 84
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ +V E+ GSL D + + D + + +ALE+LH + V
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-----AAVCRECLQALEFLH---ANQV 136
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNIKS 456
+H++IKS N+LL + + +L+D G + + + G+ Y APEV Y K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 457 DVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVK 515
D++S G++ +E++ G P+ + P R + TP+L + + L+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI------------ 244
Query: 516 SLSRFADVIALCVQPEPEFRPPMSEVVQ 543
F D + C++ + E R E++Q
Sbjct: 245 ----FRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE------MCDDFIEMVSNISQLHHPNI 331
LG+G FG V Q A GK+ A KK++ L M + I ++++H I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI-----LAKVHSRFI 55
Query: 332 MELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ L Y + L LV G L ++ DE+N LE+LH
Sbjct: 56 VSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
+ ++++++K N+LLDN+ N ++SD GLA + + AG+ G+ APE+
Sbjct: 115 Q---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488
+Y+ D ++ GV + E++ R PF + ++E ++
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEG+FG+ + DGK +K+I+ S + + ++ + V+ +S + HPNI++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLH-----LSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
E G +V ++ + G L+ ++ L ED I + V+I L AL+++H+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ---ILDWFVQICL----ALKHVHD- 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQ 451
++H++IKS NI L + +L D G+A + + E G+ Y +PE+ +
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDS 477
YN KSD+++ G V+ E+ T + F++
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 277 NLLGEGTFGRVYRAQFAD-GKVLAVKKI------DSSALPSEMCDDFIEMVSNISQLHHP 329
N +GEGT+G VYRA+ G+++A+KK+ D + S + ++ + L HP
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS------LREITLLLNLRHP 66
Query: 330 NIMELVGYCSEYGQHL----LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTAR 384
NI+EL G+HL LV E+ + D L D P S+VK + L R
Sbjct: 67 NIVELKEVVV--GKHLDSIFLVMEYCE----QDLASLLDNMPTPFS-ESQVKCLMLQLLR 119
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
L+YLHE ++H+++K +N+LL ++ +++D GLA + + + Y A
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176
Query: 444 PEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
PE+ + Y D+++ G ++ ELL KP
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 68/230 (29%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 269 ATGSFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDF-IEMVSNIS-- 324
+ + LGEGTFG VY+A Q G+V+A+KKI L D F I + I
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKIL 61
Query: 325 -QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK------ 377
+L HPN++ L+ E RK GS++ D D L+ N VK
Sbjct: 62 KKLKHPNVVPLIDMAVERPDK----SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI 117
Query: 378 --IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN 435
L + YLHE ++H++IK+ANIL+DN+ +++D GLA
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 436 DAGSG------------YGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGR 472
G G Y PE+ + +Y D++ G V E+ T R
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY- 337
+G+G FG V + KV AVK I + A F+ S ++QL H N+++L+G
Sbjct: 14 IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVI 68
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
E G +V E+ GSL D+L L + +K +L A+EYL + +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNF 123
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSD 457
VH+++ + N+L+ + ++SD GL + + + APE +++ KSD
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--GKLPVKWTAPEALREKKFSTKSD 181
Query: 458 VYSFGVVMLELLT-GRKPFDSSRPRL 482
V+SFG+++ E+ + GR P+ PR+
Sbjct: 182 VWSFGILLWEIYSFGRVPY----PRI 203
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 67/285 (23%), Positives = 127/285 (44%), Gaps = 47/285 (16%)
Query: 279 LGEGTFGRVYRAQ-FADGKV-----LAVKKIDSSALPSE----MCDDFIEMVSNISQLHH 328
LG G FG+V A + K +AVK + +A SE M + ++++S++ H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSE--LKIMSHLGN--H 98
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
NI+ L+G C+ G L++ E+ G L +FL E L + + A+ + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAF 156
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-------Y 441
L S + +H+++ + N+LL + ++ D GLA ++ N +N G +
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND----SNYVVKGNARLPVKW 209
Query: 442 GAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500
APE + Y +SDV+S+G+++ E+ + G P+ P +
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY----------------PGMPVDSKF 253
Query: 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
K++ + P + + D++ C +P RP ++VQ +
Sbjct: 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 53/250 (21%)
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQ----------------FADGKVL-AVKKIDSSALP 309
+ N LGEG FG V+ + AD VL AVK + A
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-S 59
Query: 310 SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS-DEDN- 367
+DF++ V +S+L PNI L+G C+ ++ E+ +NG L+ FL E +
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 368 -----KPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422
K L +++ + +A A + YL SL+ VH+++ + N L+ +++D G+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 423 ASNMPNADEALNNDAGSGY----GAP---------EVAMSGQYNIKSDVYSFGVVMLELL 469
+ N+ ++D Y G E + G++ KSDV++FGV + E+L
Sbjct: 177 SRNLYSSD----------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
Query: 470 T--GRKPFDS 477
T +P++
Sbjct: 227 TLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 279 LGEGTFGRVYRAQF--------ADGKVLAVKKIDSSALPSEMCD--DFIEMVSNISQLHH 328
LGEG FG+V A+ +AVK + A ++ D +EM+ I + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDED------------NKPLIWNSRV 376
NI+ L+G C++ G ++ E+ G+L ++L + L + V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EAL 433
A AR +EYL S +H+++ + N+L+ + +++D GLA ++ N D +
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
N + APE Y +SDV+SFGV++ E+ T G P+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
++G G FG V+ + AD K++ +K+I + + + L HPNI+E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFLH-----LSDEDNKPLIWNSRVKIALGTARALEYLHE 391
E ++V E+ G+L +++ L DED I + V+I L LH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLA-------LHH 116
Query: 392 VCSLSVVHKNIKSANILLDNELNP-QLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG 450
V + ++H+++K+ NILLD ++ D G++ + + +A Y +PE+
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSS 478
YN KSD+++ G V+ EL + ++ F+++
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 266 LQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNIS 324
L+ G F + L+G GT+G+VY+ + G++ A+K +D + E I M+ S
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 325 QLHHPNIMELVGYCSEYG------QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI 378
HH NI G + Q LV EF GS+ D + + + W + I
Sbjct: 61 --HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--I 116
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
R L +LH+ V+H++IK N+LL +L D G+++ + N G
Sbjct: 117 CREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 173
Query: 439 SGYG-APEVAMSGQ-----YNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
+ Y APEV + Y+ KSD++S G+ +E+ G P P
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 69/266 (25%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LG G G VY+A ++LAVK I E+ + + + + P I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-ELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ + EF GSL + + + ++ +IA+ + L YL SL +
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPE----HVLG----RIAVAVVKGLTYL---WSLKI 116
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSD 457
+H+++K +N+L++ +L D G+++ + N+ A + Y APE QY I SD
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 458 VYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSL 517
V+S G+ +EL GR P+ P+++++ L + L +VD L PV
Sbjct: 176 VWSLGISFMELALGRFPY----PQIQKN-----QGSLMPLQLLQCIVDEDPPVL-PVGQF 225
Query: 518 S-RFADVIALCVQPEPEFRPPMSEVV 542
S +F I C++ +P+ RP ++
Sbjct: 226 SEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 279 LGEGTFGRVYRAQF------ADGKV--LAVKKIDSSALPSEMCD--DFIEMVSNISQLHH 328
LGEG FG+V A+ +V +AVK + S A ++ D +EM+ I + H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--H 83
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS---------DEDNKP---LIWNSRV 376
NI+ L+G C++ G ++ E+ G+L ++L + P L + V
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---EAL 433
A AR +EYL S +H+++ + N+L+ + +++D GLA ++ + D +
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
N + APE Y +SDV+SFGV++ E+ T G P+
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 279 LGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V+ A+ D ++AVK + ++ + DF ++ L H +I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHEHIV 70
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLH-------LSDEDNKP--LIWNSRVKIALGTA 383
+ G C E ++V+E+ K+G L+ FL L E N+P L + + IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE---ALNNDAGSG 440
+ YL S VH+++ + N L+ L ++ D G++ ++ + D +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 441 YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ PE M ++ +SDV+S GVV+ E+ T G++P+
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 51/288 (17%)
Query: 279 LGEGTFGRVYRA---QFADGK-------VLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
LG+GTF +Y+ +D V V K+ S + F E S +SQL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL--AFFETASLMSQLSH 60
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
++++L G C +++V E+ K G L FLH +++N L W ++ +A A AL Y
Sbjct: 61 KHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHY 116
Query: 389 LHEVCSLSVVHKNIKSANILL----DNELNP---QLSDCGLASNMPNADEALNNDAGSGY 441
L + +VH N+ NIL+ NE +LSD G+ + + +E + +
Sbjct: 117 LED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER---IPW 170
Query: 442 GAPEVAMSGQYNIKS--DVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDID 498
APE +GQ ++ D +SFG +LE+ + G +P S+ E+ +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL-STLSSSEK-ERFYQD------- 221
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
+ P+ + A++I C +P RP +++ L
Sbjct: 222 ----------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 39/282 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F + +G GT+G VY+A+ G++ A+K I P E + + + H NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNI 68
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ G + + EF GSL D H++ PL + ++ T + L YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLH- 123
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAM-- 448
S +H++IK ANILL + + +L+D G+++ + + G+ Y APEVA
Sbjct: 124 --SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 449 -SGQYNIKSDVYSFGVVMLELLTGRKP-FDSSRPRLEQSLVRWATPQLHDIDALAKMVD- 505
G YN D+++ G+ +EL + P FD LH + AL M
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFD-----------------LHPMRALFLMTKS 224
Query: 506 ----PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P LK +K + F + + + P+ RP +++Q
Sbjct: 225 NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 20/207 (9%)
Query: 278 LLGEGTFGRVY---RAQFAD-GKVLAVKKIDSSALPSEMCDDFI--EMVSNI-SQLHHPN 330
+LG+G+FG+V+ + D G++ A+K + + L D + +M +I ++++HP
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR---DRVRTKMERDILAEVNHPF 59
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT-ARALEYL 389
I++L G+ L+ +F + G L F LS E + VK L A AL++L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKE---VMFTEEDVKFYLAELALALDHL 114
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H SL ++++++K NILLD E + +L+D GL+ + ++ + G+ Y APEV
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ +D +SFGV+M E+LTG PF
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 39/273 (14%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSE--MCDDFIEMVSNISQLHHPNIMELV 335
+G+G G VY A A G+ +A+++++ P + + ++ + M N +PNI V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN----KNPNI---V 80
Query: 336 GYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
Y Y G L +V E+ GSL D + + D + + +ALE+LH
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALEFLH-- 133
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQ 451
S V+H++IKS NILL + + +L+D G + + + G+ Y APEV
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDIDALAKMVDPALKG 510
Y K D++S G++ +E++ G P+ + P R + TP+L + + L+ +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI------- 245
Query: 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
F D + C+ + E R E++Q
Sbjct: 246 ---------FRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN--ADEALN 434
KIA+ L YL+ V ++H++IK +NIL+++ +L D G++ + N AD +
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164
Query: 435 NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494
S Y +PE G+Y +KSDV+S G+ ++EL G+ PF S + +
Sbjct: 165 T---STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-----DPM 216
Query: 495 HDIDALAKMVD---PAL-KGLYPVKSLSRFADVIALCVQPEPEFRP------PMSEVVQA 544
+D L ++V P L +P + L F D C+ +P RP M +QA
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFP-EDLRDFVD---ACLLKDPTERPTPQQLCAMPPFIQA 272
Query: 545 LVR 547
L
Sbjct: 273 LRA 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 68/292 (23%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 277 NLLGEGTFGRVYRAQFA-DGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIM 332
+++GEG FG+V +A+ DG + A+K++ A + DF + + +L HHPNI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 59
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLH----------LSDEDNKPLIWNSR--VKIAL 380
L+G C G L E+ +G+L DFL + ++ +S+ + A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
AR ++YL + +H+++ + NIL+ +++D GL+ +
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 441 YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF-DSSRPRLEQSLVRWATPQLHDID 498
+ A E Y SDV+S+GV++ E+++ G P+ + L + L PQ + ++
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRLE 231
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
P+ D++ C + +P RP ++++ +L R+++
Sbjct: 232 K-------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEG+ G V A + GK +AVKK+D + + V + HH N++++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ +V EF + G+L D + + + + + + L RAL YLH + V
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGV 139
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNIKS 456
+H++IKS +ILL ++ +LSD G + + + G+ Y APEV Y +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 457 DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516
D++S G++++E++ G P+ + P +R P P +K + V S
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-------------PRVKDSHKVSS 246
Query: 517 LSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ R F D++ + EP R E++Q
Sbjct: 247 VLRGFLDLMLV---REPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 34/281 (12%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIE--MVSN-ISQL--HHPNI 331
+LG+G+FG+V+ A+ + A+K + + + DD +E MV + L HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFL 58
Query: 332 MELVGYCS-EYGQHLL-VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
L YC+ + ++L V E+ G L + + + P +I G L++L
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFL 112
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H S +V++++K NILLD + + +++D G+ D G+ Y APE+ +
Sbjct: 113 H---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDS-SRPRLEQSL-------VRWATPQLHDIDAL 500
+YN D +SFGV++ E+L G+ PF L QS+ RW T + DI
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVK 229
Query: 501 AKMVDP----ALKGLYPVKSLSRFADVIAL-CVQPEPEFRP 536
+ +P +KG R D AL + EP F+P
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 60/242 (24%), Positives = 103/242 (42%), Gaps = 61/242 (25%)
Query: 275 VENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDD--FIEMV----------S 321
LGEGT+G+V +A GK++A+KK+ + +++ D + M
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 322 NISQLHHPNIMELVG-YCSEYGQHLLVYEFRKNGSLHDFLHLSDE----------DNKPL 370
++++ H NIM LV Y DF++L + D K
Sbjct: 73 IMNEIKHENIMGLVDVYVEG-----------------DFINLVMDIMASDLKKVVDRKIR 115
Query: 371 IWNSRVK-IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS---NM 426
+ S+VK I L L LH +H+++ ANI ++++ +++D GLA
Sbjct: 116 LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
Query: 427 PNADEALNNDAGSG------------YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRK 473
P +D ++ Y APE+ M + +Y+ D++S G + ELLTG+
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 474 PF 475
F
Sbjct: 233 LF 234
|
Length = 335 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 278 LLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLHHPNIM 332
+G GTFGRV+ + A+K + A+P + + V N + ++ HP I+
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64
Query: 333 ELVGYCSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR------ 384
L + +E+ Q L + E+ G L +L + + + T
Sbjct: 65 RL--FWTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYASEI 110
Query: 385 --ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG 442
ALEYLH S +V++++K NILLD E + +L+D G A + D Y
Sbjct: 111 VCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWTLCGTPEYL 165
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
APEV S +N D ++ G+++ E+L G PF P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 69/242 (28%), Positives = 122/242 (50%), Gaps = 25/242 (10%)
Query: 278 LLGEGTFGRVYRAQFA-DGKVL----AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+LG G FG VY+ + +G+ + A+K ++ + P + F++ ++ + HP+++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLV 72
Query: 333 ELVGYC-SEYGQHLLVYEFRKNGSLHDFLH-LSDEDNKPLIWNSRVKIALGTARALEYLH 390
L+G C S Q LV + +G L D++H D L+ N V+IA G + YL
Sbjct: 73 RLLGVCLSPTIQ--LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG----MMYLE 126
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPEVA 447
E +VH+++ + N+L+ + + +++D GLA + ++ N D G + A E
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFDS----SRPRLEQSLVRWATPQLHDIDALAK 502
++ +SDV+S+GV + EL+T G KP+D P L + R P + ID
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243
Query: 503 MV 504
MV
Sbjct: 244 MV 245
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 73/293 (24%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 276 ENLLGEGTFGRVYRAQFA-DGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNI 331
E+++GEG FG+V RA DG + A+K + A ++ DF + + +L HHPNI
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNI 65
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS----------DEDNKPLIWNSR--VKIA 379
+ L+G C G + E+ G+L DFL S E S+ ++ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
A ++YL E +H+++ + N+L+ L +++D GL+ +
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF-DSSRPRLEQSLVRWATPQLHDI 497
+ A E Y KSDV+SFGV++ E+++ G P+ + L + L PQ + +
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRM 237
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ P +++ C + P RPP +++ L R+++
Sbjct: 238 EK-------------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 39/273 (14%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSE--MCDDFIEMVSNISQLHHPNIMELV 335
+G+G G VY A A G+ +A+K+++ P + + ++ + M N +PNI V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN----KNPNI---V 79
Query: 336 GYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
Y Y G L +V E+ GSL D + + D + + +AL++LH
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALDFLH-- 132
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQ 451
S V+H++IKS NILL + + +L+D G + + + G+ Y APEV
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDIDALAKMVDPALKG 510
Y K D++S G++ +E++ G P+ + P R + TP+L + + L+ +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV------- 244
Query: 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
F D + C++ + + R E++Q
Sbjct: 245 ---------FRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 80/281 (28%), Positives = 126/281 (44%), Gaps = 51/281 (18%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFI---EMVSNISQLHHPNIMEL 334
+G GT+G VY+A+ G++ AVK I E DDF + + + + H NI+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL-----EPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GTARALEYLHE 391
G + + E+ GSL D H++ PL S ++IA T + L YLH
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTG----PL---SELQIAYVCRETLQGLAYLH- 123
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAM-- 448
S +H++IK ANILL + + +L+D G+A+ + + G+ Y APEVA
Sbjct: 124 --SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 449 -SGQYNIKSDVYSFGVVMLELLTGRKP-FDSSRPRLEQSLVRWATPQLHDIDALAKMVD- 505
+G YN D+++ G+ +EL + P FD LH + AL M
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFD-----------------LHPMRALFLMSKS 224
Query: 506 ----PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542
P LK K S F + + + + P+ RP ++
Sbjct: 225 NFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 7/218 (3%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+F +LG+G FG V Q A GK+ A K+++ + + I + +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 331 IMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ + Y E L LV G L H+ + N + A LE L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS 449
H + V++++K NILLD+ + ++SD GLA +P + GY APEV +
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
+Y + D + G ++ E++ G+ PF + ++++ V
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/269 (24%), Positives = 124/269 (46%), Gaps = 27/269 (10%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI-MELVG 336
+G+G++G V + DGK +KK++ + +SQL HPNI
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS 396
+ E G +V F + G L+ L ++ K L N V+ + A AL+YLHE
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYH--KLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEVAMSGQYNIK 455
++H+++K+ N+ L ++ D G+A + N + + G+ Y +PE+ + YN K
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 456 SDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA-KMVDPALKGLYPV 514
SDV++ G + E+ T + F++ D+++L ++++ L + P
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAK-----------------DMNSLVYRIIEGKLPPM-PK 224
Query: 515 KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
++IA + PE RP + +++
Sbjct: 225 DYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPN 330
F+V++L+G G FG V + A G + A+K + S L ++ F E +I S + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 331 IMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
I +L Y + +L LV E++ G D L L + + L A + +
Sbjct: 63 IPQLQ-YAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFD-EDMAQFYL--AELVLAI 115
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEV 446
H V + VH++IK N+L+D + +L+D G A+ + A++ +N+ G Y APEV
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEV 174
Query: 447 --AMSG----QYNIKSDVYSFGVVMLELLTGRKPF 475
M+G Y ++ D +S GV+ E++ GR PF
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 49/231 (21%)
Query: 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEM--VSNI----- 323
F LG G+FGRV + GK A+K + +++ V ++
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK--------AKIVKLKQVEHVLNEKR 53
Query: 324 --SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
+ HP ++ L G + LV E+ G L F HL +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL--FSHL----------RKSGRFPEP 101
Query: 382 TAR--------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
AR ALEYLH SL +V++++K N+LLD++ +++D G A + L
Sbjct: 102 VARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158
Query: 434 NNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR 481
G Y APE+ +S Y D ++ G+++ E+L G PF P
Sbjct: 159 -----CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN---ISQLHHPNIME 333
LLG+GTFG+V + A G+ A+K + + ++ D+ V+ + HP +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTA 59
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE----DNKPLIWNSRVKIALGTARALEYL 389
L + + V E+ G L F HLS E + + + + + ALEYL
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI------VSALEYL 111
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H S VV+++IK N++LD + + +++D GL + + G+ Y APEV
Sbjct: 112 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y D + GVVM E++ GR PF
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKI----DSSALPSEM----CDDFIEMVSNISQLHH 328
LLG+G FGRVY D G+ LA K++ +S E+ C+ I+++ N L H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECE--IQLLKN---LQH 63
Query: 329 PNIMELVGYCSEYGQHLLV--YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
I++ G + + L E+ GS+ D L + + +I G +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----M 119
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN---ADEALNNDAGSGYG- 442
YLH S +VH++IK ANIL D+ N +L D G + + + + + G+ Y
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+PEV Y K+DV+S G ++E+LT + P+
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 70/295 (23%), Positives = 110/295 (37%), Gaps = 40/295 (13%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
+ + + + ++AVKKI+ + E + + QL HPNI+ V
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TS 67
Query: 339 SEYGQHL-LVYEFRKNGSLHDFL--HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
L +V GS D L H + + I I AL+Y+H S
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF----ILKDVLNALDYIH---SK 120
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG--------APEV- 446
+H+++K+++ILL + LS + +M + +PEV
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 447 --AMSGQYNIKSDVYSFGVVMLELLTGRKPF-DSSRPRLEQSLVRWATPQLHDI----DA 499
+ G YN KSD+YS G+ EL G PF D ++ VR P L D
Sbjct: 181 QQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239
Query: 500 LAKMVDPALKGLYPVKSLSR-----------FADVIALCVQPEPEFRPPMSEVVQ 543
M +P S F + LC+Q +PE RP S+++
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG-TARALEYLHEVCSLSVVHKNIKS 404
L+ ++ G L F HL ++ S V++ + AL++LH+ L +++++IK
Sbjct: 82 LILDYVNGGEL--FTHLYQREHFTE---SEVRVYIAEIVLALDHLHQ---LGIIYRDIKL 133
Query: 405 ANILLDNELNPQLSDCGLASN-MPNADEALNNDAGS-GYGAPEVAMSGQ--YNIKSDVYS 460
NILLD+E + L+D GL+ + +E + G+ Y APEV G ++ D +S
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 461 FGVVMLELLTGRKPFDSSRPRLEQS-----LVRWATPQLHDIDALAK 502
GV+ ELLTG PF + QS +++ P + A A+
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 44/221 (19%)
Query: 277 NLLGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNI 331
+GEG +G VY+A+ G+ +A+KK+ +P + I ++ + HPNI
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPNI 63
Query: 332 MELVGYCSEYGQHL-------LVYEFRKNGSLHDFLH------LSDEDNKPLIWNSRVKI 378
+ L+ C +G LV+E L +L L E K L+
Sbjct: 64 VRLLDVC--HGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQ----- 115
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADEALN 434
R +++LH S +VH+++K NIL+ ++ +++D GLA M AL
Sbjct: 116 ---LLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-----ALT 164
Query: 435 NDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKP 474
+ + Y APEV + Y D++S G + EL R+P
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 61/236 (25%), Positives = 113/236 (47%), Gaps = 17/236 (7%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEG+ G V A + GK++AVKK+D + + V + H N++E+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+ +V EF + G+L D + + + + + + L +AL LH + V
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLH---AQGV 137
Query: 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNIKS 456
+H++IKS +ILL ++ +LSD G + + + G+ Y APE+ Y +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 457 DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR-WATPQLHDIDALAKMVDPALKGL 511
D++S G++++E++ G P+ + P ++R P+L + V P+LKG
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN----LHKVSPSLKGF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKI----DSSALPSEM----CDDFIEMVSNISQLHH 328
LLG+G FGRVY AD G+ LAVK++ +S E+ C+ I+++ N L H
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECE--IQLLKN---LLH 63
Query: 329 PNIMELVGYCSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
I++ G + + L E GS+ D L + L N K +
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGV 119
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN---ADEALNNDAGSGYG- 442
YLH S +VH++IK ANIL D+ N +L D G + + + + + G+ Y
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+PEV Y K+D++S G ++E+LT + P+
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 25/227 (11%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+F +LG+G FG V Q A GK+ A KK++ + + I + +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 331 IMELVGYCSEYGQHL-LVYEFRKNGSLH-DFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
+ + Y E L LV G L H+ + RA+ Y
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-------------GFEEGRAVFY 107
Query: 389 LHEVC-------SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-G 440
E+C +V++++K NILLD+ + ++SD GLA ++P + + G+ G
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVG 166
Query: 441 YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
Y APEV + +Y D ++ G ++ E++ G+ PF + ++++ V
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 72/293 (24%), Positives = 135/293 (46%), Gaps = 40/293 (13%)
Query: 276 ENLLGEGTFGRVYRAQF-ADGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNI 331
++++GEG FG+V +A+ DG + A+K++ A + DF + + +L HHPNI
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNI 70
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSR---------VKIA 379
+ L+G C G L E+ +G+L DFL S + D I NS + A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
AR ++YL + +H+++ + NIL+ +++D GL+ +
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF-DSSRPRLEQSLVRWATPQLHDI 497
+ A E Y SDV+S+GV++ E+++ G P+ + L + L PQ + +
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRL 242
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ P+ D++ C + +P RP ++++ +L R+++
Sbjct: 243 EK-------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 273 FNVENLLGEGTFGRVYRAQFADG-KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+NV ++GEG+FGR Q + + A+K+I S + D E V ++++ HPNI
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNI 60
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKP--LIWNSRVKIALGTARALEYL 389
+ G +V E+ G L + L P I V++ LG ++++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG----VQHI 116
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAP-EVAM 448
HE V+H++IKS NI L +L D G A + + G+ Y P E+
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
+ YN KSD++S G ++ EL T + PF ++
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 75/260 (28%), Positives = 116/260 (44%), Gaps = 57/260 (21%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIE----MVSNISQLHHPNIM 332
++G G FG VY + AD GK+ A+K +D + + + M+S +S P I+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 333 ELVGYCSEYGQHL-----LVYEFRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTAR 384
C Y H + + G LH HLS K + + + +I LG
Sbjct: 61 -----CMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYA-TEIILG--- 109
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM----PNADEALNNDAGSG 440
LE++H + VV++++K ANILLD + ++SD GLA + P+A + G
Sbjct: 110 -LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH-----G 160
Query: 441 YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
Y APEV G Y+ +D +S G ++ +LL G PF + T H+ID
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----------TKDKHEIDR 209
Query: 500 LAKMVD--------PALKGL 511
+ V+ P LK L
Sbjct: 210 MTLTVNVELPDSFSPELKSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 67/282 (23%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+GEGT+G VY+ + G+++A+KKI + +PS I +S + +L HPNI+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA----IREISLLKELQHPNIVC 63
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV- 392
L + + L++EF LS D K + + + YL+++
Sbjct: 64 LQDVLMQESRLYLIFEF-----------LS-MDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 393 -----C-SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPE 445
C S V+H+++K N+L+DN+ +L+D GLA ++ + Y APE
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171
Query: 446 VAMSGQ-YNIKSDVYSFGVVMLELLTGRKPF--DS------------------------S 478
V + Y+ D++S G + E+ T + F DS S
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 479 RPRLEQSLVRWATPQLHD---------IDALAKMV--DPALK 509
P + + +W L +D L KM+ DPA +
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKR 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 74/294 (25%), Positives = 123/294 (41%), Gaps = 36/294 (12%)
Query: 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVS 321
++ L+ G F + ++G GT+G+VY+ + G++ A+K +D + E I M+
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 322 NISQLHHPNIMELVGYCSEYG------QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
S HH NI G + Q LV EF GS+ D + + + W +
Sbjct: 68 KYS--HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN 435
I R L +LH + V+H++IK N+LL +L D G+++ + N
Sbjct: 126 --ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 180
Query: 436 DAGSGYG-APEVAMSGQ-----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489
G+ Y APEV + Y+ +SD++S G+ +E+ G P P L+
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P P LK K +F D I C+ RP ++++
Sbjct: 241 NPP-------------PKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 76/296 (25%), Positives = 134/296 (45%), Gaps = 51/296 (17%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNIS--------QLHH 328
L+GEG++G V + + + G+++A+KK L SE DD +MV I+ QL H
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESE--DD--KMVKKIAMREIRMLKQLRH 59
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH----LSDEDNKPLIWNSRVKIALGTAR 384
N++ L+ + LV+EF + L D L + + ++ R
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ--------ILR 111
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-AGSGYGA 443
+E+ H S +++H++IK NIL+ +L D G A + E + A Y A
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 444 PEVAMSG-QYNIKSDVYSFGVVMLELLTGRK--PFDSSRPRLEQSLVRWAT--PQLHDI- 497
PE+ + +Y D+++ G ++ E+LTG P DS +L + P+ +I
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
Query: 498 ---DALAKMVDPALKGLYPVKSLSRF-------ADVIALCVQPEPEFRPPMSEVVQ 543
A M P +K + P++ RF D+ C++ +P+ RP S+++
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLE--KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 76/284 (26%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+GEGT+G VY+A+ G+++A+KKI + +PS I +S + +L+HPNI+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA----IREISLLKELNHPNIVR 62
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
L+ + LV+EF D D K + +S L YL+++
Sbjct: 63 LLDVVHSENKLYLVFEFL------------DLDLKKYM-DSSPLTGLDPPLIKSYLYQLL 109
Query: 394 -------SLSVVHKNIKSANILLDNELNPQLSDCGLAS--NMP---NADEALNNDAGSGY 441
S V+H+++K N+L+D E +L+D GLA +P E + Y
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT----LWY 165
Query: 442 GAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPF--DS--------------------- 477
APE+ + QY+ D++S G + E++ R F DS
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225
Query: 478 ---SRPRLEQSLVRWATPQLHD---------IDALAKMV--DPA 507
S P + + +WA L +D L+KM+ DPA
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPA 269
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 64/293 (21%)
Query: 279 LGEGTFGRVYRA---------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
LG+GTF ++++ + +VL +K +D S + F E S +SQL H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVL-LKVLDKSH--RNYSESFFEAASMMSQLSHK 59
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+++ G C + ++V E+ K GSL +L +++ + W ++++A A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISW--KLEVAKQLAWALHFL 116
Query: 390 HEVCSLSVVHKNIKSANILLDNEL-----NP---QLSDCGLASNMPNADEALNNDAGSGY 441
+ + H N+ + N+LL E NP +LSD G++ + + L +
Sbjct: 117 EDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP---W 170
Query: 442 GAPE-VAMSGQYNIKSDVYSFGVVMLELLTG-RKPFDSSRPRLEQSLVRWATPQLHDIDA 499
PE + ++ +D +SFG + E+ +G KP + A
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP----------------------LSA 208
Query: 500 LAKMVDPALKGLY-------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
L D K + P + A++I C+ EP+FRP +++ L
Sbjct: 209 L----DSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 49/251 (19%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIE----MVSNISQLHHPNIM 332
++G G FG VY + AD GK+ A+K +D + + + M+S +S P I+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 333 ELVGYCSEYGQHL-----LVYEFRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTAR 384
C Y H + + G LH HLS + + + +I LG
Sbjct: 61 -----CMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRFYA-AEIILG--- 109
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM----PNADEALNNDAGSG 440
LE++H + VV++++K ANILLD + ++SD GLA + P+A + G
Sbjct: 110 -LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH-----G 160
Query: 441 YGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
Y APEV G Y+ +D +S G ++ +LL G PF + T H+ID
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----------TKDKHEIDR 209
Query: 500 LAKMVDPALKG 510
+ + L
Sbjct: 210 MTLTMAVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+GEGT+G VY+A+ G+V+A+KKI ++ +PS I +S + +L+HPNI++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA----IREISLLKELNHPNIVK 63
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTARALEYLHEV 392
L+ + LV+EF + L F+ S PL +K L + L + H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL---PLIKSYLFQLLQGLAFCH-- 117
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQ 451
S V+H+++K N+L++ E +L+D GLA ++ + Y APE+ + +
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 452 -YNIKSDVYSFGVVMLELLTGRK--PFDSSRPRLEQSLVRWATP 492
Y+ D++S G + E++T R P DS +L + TP
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 73/269 (27%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 282 GTFGRVYRAQ-FADGKVLAVKKIDSSALPS--EMCDDFIEMVSNISQLHHPNIMELVGYC 338
G FG VY A+ + G A+K + S + + ++ + E + Q P + +L Y
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-YS 65
Query: 339 SEYGQHL-LVYEFRKNG---SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+ +L LV E+ G SL L ED W ++ IA +E LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPED-----W-AKQYIA-EVVLGVEDLHQ--- 115
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEVAMSGQ 451
++H++IK N+L+D + +L+D GL+ N L N G Y APE +
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVG 169
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRP-----RLEQSLVRW-------ATPQLHD-ID 498
+ SD +S G V+ E L G PF + P + + W +P+ D I+
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 499 ALAKMVDPAL----KGLYPVKSLSRFADV 523
L M DPA G +KS F +
Sbjct: 230 RLLCM-DPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 19/234 (8%)
Query: 252 VKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDS-SALP 309
+KA T + +++ F + LG G+FGRV A+ G+ A+K + L
Sbjct: 1 MKAAYMFTKPDTSSWKLS--DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK 58
Query: 310 SEMCDDFIEMVSNISQLHHPNIMELV-GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNK 368
+ + S + +L HP I+ ++ + E + L+ EF G L F HL
Sbjct: 59 MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL-EFVVGGEL--FTHLRKAGRF 115
Query: 369 PLIWNSRVKI-ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427
P N K A EYLH S ++++++K N+LLDN+ + +++D G A +P
Sbjct: 116 P---NDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169
Query: 428 NADEALNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
+ L G+ Y APEV S + D ++ GV++ E + G PF P
Sbjct: 170 DRTFTL---CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 48/214 (22%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDF--IEMVSNISQL-------HH 328
+GEGTF V +AQ GK A+K M F +E V+N+ ++ H
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKC---------MKKHFKSLEQVNNLREIQALRRLSPH 57
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
PNI+ L ++++ RK G L L D + LI + L R Y
Sbjct: 58 PNILRL---------IEVLFD-RKTGRLALVFELMDMNLYELIKGRKR--PLPEKRVKSY 105
Query: 389 LHEVC-SLSVVHKN------IKSANILLDNELNPQLSD----CGLASNMPNADEALNNDA 437
++++ SL +H+N IK NIL+ +++ +L+D G+ S P + +
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYI----S 160
Query: 438 GSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLT 470
Y APE + G Y K D+++ G V E+L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 36/102 (35%), Positives = 63/102 (61%), Gaps = 5/102 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
MK+LK++ + +N L G++ G L SL+ LDL +N L+G +P S +L +L L+L N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
Query: 61 QFSGTI--DVLANLPLDNLNIANNRFTGWVPE---QLKNINL 97
+ SG I + + L +L++++N +G +PE QL+N+ +
Sbjct: 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
|
Length = 968 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 52/235 (22%)
Query: 273 FNVENLLGEGTFGRVYRAQ---FADGKVLAVKKIDSSALPSEMCDDFIEMVSNI------ 323
+ +E +G GT+GRVY+A+ DGK A+KK + I S
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD--KEQY--TGISQ-SACREIALL 56
Query: 324 SQLHHPNIMELVGYCSEYGQHL--LVYEFRKNGSLHDFLH------------LSDEDNKP 369
+L H N++ LV E+ L++++ + HD + K
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 370 LIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASN 425
L+W +I G + YLH S V+H+++K ANIL+ E + + D GLA
Sbjct: 113 LLW----QILNG----VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
Query: 426 MPNADEALNNDAG----SGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ L + Y APE+ + + Y D+++ G + ELLT F
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+F +LG+G FG V Q A GK+ A KK++ + + I + +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 331 IMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ + Y E L LV G L H+ + N RA+ Y
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNP----------GFDEQRAIFYA 108
Query: 390 HEVC-------SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG 442
E+C +V++++K NILLD+ + ++SD GLA +P + GY
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYM 168
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
APEV + +Y D + G ++ E++ G+ PF + R+++ V
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 35/89 (39%), Positives = 53/89 (59%), Gaps = 3/89 (3%)
Query: 6 YLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT 65
+L+I++N LQG++N +PSL L L+ N G LP SF S L +L L NQFSG
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGA 490
Query: 66 I-DVLANLP-LDNLNIANNRFTGWVPEQL 92
+ L +L L L ++ N+ +G +P++L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSS--ALPSE----MCDDFIEMVSNISQLHHPNIM 332
LG G FG V + + + K+ID + L +E + D+ + + QL +P I+
Sbjct: 3 LGSGNFGCVKKGVYK----MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
++G C E +LV E G L+ FL +D + ++ V++ + ++YL
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL-SGKKDEITV--SNVVELMHQVSMGMKYLEGK 114
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPEVA 447
+ VH+++ + N+LL N+ ++SD GL+ + AD++ +G + APE
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECI 170
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+++ +SDV+S+G+ M E + G+KP+
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEG G V++A+ G+ +A+KK+ L + + + + + HP +++L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 338 CSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS 396
+G LV E+ L + L DE+ PL + + Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLR--DEER-PLPEAQVKSYMRMLLKGVAYMHA---NG 119
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND--AGSGYGAPEVAMSGQ-YN 453
++H+++K AN+L+ + +++D GLA + L + A Y APE+ + Y+
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 454 IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
D+++ G + ELL G P +EQ
Sbjct: 180 PGVDLWAVGCIFAELLNGS-PLFPGENDIEQ 209
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 50/290 (17%)
Query: 278 LLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPS---EMCDDFIEMVSNISQLHHP 329
+LG G FG VY+ + DG+ +A+K + + P E+ D+ M S P
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS----P 69
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS-DEDNKPLIWNSRVKIALGTARALEY 388
+ L+G C L V + G L D++ + D + N V+IA G + Y
Sbjct: 70 YVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKG----MSY 124
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPE 445
L EV +VH+++ + N+L+ + + +++D GLA + + + D G + A E
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSR----PRLEQSLVRWATPQLHDIDAL 500
+ ++ +SDV+S+GV + EL+T G KP+D P L + R P + ID
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241
Query: 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
MV C + E RP E+V R+ +
Sbjct: 242 MIMVK---------------------CWMIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 278 LLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNI--SQLHHPNIMEL 334
++G+G+FG+V A+ DGK AVK + + + I N+ + HP ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYLHEVC 393
+ V +F G L F HL E + P R + A A AL YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLH--- 113
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASN-MPNADEALNNDAGSGYGAPEVAMSGQY 452
S+++V++++K NILLD++ + L+D GL + +D Y APEV Y
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 453 NIKSDVYSFGVVMLELLTGRKPF 475
+ D + G V+ E+L G PF
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 35/287 (12%)
Query: 272 SFNVENLLGEGTFGRVYRA--QFADGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQLH 327
S +E +LG G FG + R + + L A+ + + + F+ + Q
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFD 64
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
H NI+ L G + ++V E+ NG+L FL + L+ + + G A ++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMK 121
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG----YGA 443
YL E + VHK + + +L++++L ++S G + EA+ + A
Sbjct: 122 YLSE---MGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PE ++ SDV+SFG+VM E+++ G +P+ W + D + K
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-------------W---DMSGQDVI-K 219
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
V+ + P + ++ C Q E RP S++ L ++V
Sbjct: 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 43/228 (18%)
Query: 279 LGEGTFGRVYRAQFADGKVL-----------------AVKKIDSSALPSEMCDDFIEMVS 321
LGEG FG V+ + + + L AVK + A + +DF++ V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLKEVK 71
Query: 322 NISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL---HLSDEDNK---------- 368
+S+L PNI+ L+G C + ++ E+ +NG L+ FL HL D++
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 369 -PLI-WNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426
P I ++S + +AL A ++YL SL+ VH+++ + N L+ L +++D G++ N+
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 427 PNADEALNNDAGSG-----YGAPEVAMSGQYNIKSDVYSFGVVMLELL 469
D G + A E + G++ SDV++FGV + E+L
Sbjct: 189 YAGD--YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 66/288 (22%), Positives = 124/288 (43%), Gaps = 43/288 (14%)
Query: 279 LGEGTFGRVYRAQFADGKVLA---VKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
+G G FG+V ++ +A VK++ ++A E ++F++ L HPNI++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCL 61
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV----KIALGTARALEYLHE 391
G C E +LLV+E+ + G L +L + NS++ ++A A + ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRR----NSQLLLLQRMACEIAAGVTHMHK 117
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND---AGSGYGAPEVA- 447
+ +H ++ N L ++L ++ D G+ + D D + APE+
Sbjct: 118 ---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 448 ------MSGQYNIKSDVYSFGVVMLELL-TGRKPFD--SSRPRLEQSLVRWATPQLHDID 498
++ + S+V++ GV + EL +P+ S R L + D
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----------D 224
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
K+ P L+ Y R+ +V+ C PE R EV + L
Sbjct: 225 QQVKLFKPQLELPYS----ERWYEVLQFCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 279 LGEGTFGRVYRAQFADG-KVLAVKKIDSSAL--PSEMCDDFIEMVSNISQLHHPNIMELV 335
+G+G+FG+V + + D ++ A+K I + + SE+ E + ++Q++ P I+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAER-TVLAQVNCPFIVPLK 59
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
+ LV F G L F HL E + + +R A ALE LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL--FHHLQRE-GRFDLSRARFYTA-ELLCALENLHK---F 112
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLAS-NMPNADEALNNDAGSGYGAPEVAMSGQYNI 454
+V+++++K NILLD + + L D GL NM + D+ Y APE+ + Y
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 455 KSDVYSFGVVMLELLTGRKPF 475
D ++ GV++ E+LTG PF
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 70/252 (27%), Positives = 121/252 (48%), Gaps = 33/252 (13%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADG---------KVLAVKKIDSSALPSEMCDDFIEMVSN 322
+F + +LG G +G+V+ + G KVL I A +E +++ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 323 ISQLHHPNIMEL-VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
I Q P ++ L + ++ HL++ ++ G L F HLS + V+I G
Sbjct: 61 IRQ--SPFLVTLHYAFQTDTKLHLIL-DYINGGEL--FTHLSQRER---FKEQEVQIYSG 112
Query: 382 -TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
ALE+LH+ L +++++IK NILLD+ + L+D GL+ + DE + G
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCG 168
Query: 441 ---YGAPEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPF-----DSSRPRLEQSLVRWA 490
Y AP++ G ++ D +S GV+M ELLTG PF +S+ + + +++
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
Query: 491 TPQLHDIDALAK 502
P ++ ALAK
Sbjct: 229 PPYPQEMSALAK 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 71/238 (29%), Positives = 116/238 (48%), Gaps = 46/238 (19%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNIS---QLHH 328
F++ +GEGT+G+VY+A+ D G+++A+KK+ L +E I + I QL+H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNH 65
Query: 329 PNIMEL----------VGYCSEYGQHLLVYEFRKNGSLHDFL--------HLSDEDNKPL 370
NI+ L + + + G LV+E+ HD + H S++ K
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIK-- 119
Query: 371 IWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430
S +K L L Y H+ L H++IK +NILL+N+ +L+D GLA + N++
Sbjct: 120 ---SFMKQLL---EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLA-RLYNSE 169
Query: 431 EA---LNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
E+ N Y PE+ + + Y DV+S G ++ EL T +KP + L Q
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 279 LGEGTFGRVYRAQ------FADGK-----------VLAVKKIDSSALPSEMCDDFIEMVS 321
LGEG FG V+ + F D ++AVK + A + +DF++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLKEIK 71
Query: 322 NISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL-------HLSDEDNKPLIWNS 374
+S+L PNI+ L+ C ++ E+ +NG L+ FL D + +++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434
+ +A A ++YL SL+ VH+++ + N L+ +++D G++ N+ + D
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD--YY 186
Query: 435 NDAGSG-----YGAPEVAMSGQYNIKSDVYSFGVVMLELLT 470
G + + E + G++ SDV++FGV + E+LT
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 12/219 (5%)
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQFADGKV--LAVKKIDSSAL-PSEMCDDFIEMVSNI 323
+M FN LG G+FGRV A + + +A+K+ + S + + D +
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 324 SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
+ ++HP + L G + LV EF G FL NK + A
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIV 141
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
EYL SL++V++++K N+LLD + +++D G A + L Y A
Sbjct: 142 LIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--GTPEYIA 196
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
PE+ ++ + +D ++ G+ + E+L G PF ++ P L
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL 235
|
Length = 340 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 59/289 (20%)
Query: 219 TAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENL 278
TA+ + P + ++K+ D +F + +KA + I L+M F+V +
Sbjct: 4 TALVYDCDIPALRKNKNID--NFLSR---YEKAAE--------KITKLRMKAEDFDVIKV 50
Query: 279 LGEGTFGRVYRAQFADG-KVLAVK--------KIDSSALPSEMCDDFIEMVSN---ISQL 326
+G G FG V + +V A+K K SA E D I +N I QL
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD--IMAHANSEWIVQL 108
Query: 327 HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
H Y + ++L +V E+ G D ++L + P W TA
Sbjct: 109 H---------YAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKW-----ARFYTAEV 151
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YG 442
+ L + S+ +H+++K N+LLD + +L+D G M +A+ + D G Y
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYI 210
Query: 443 APEVAMS----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
+PEV S G Y + D +S GV + E+L G PF SLV
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF------YADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSN--ISQLHHPNIMELV 335
+G+G+FG+V A+ ADGK AVK + A+ + I N + + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 336 GYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYLHEVC 393
Y + L V ++ G L F HL E + P R + A A AL YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLH--- 113
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQY 452
SL+++++++K NILLD++ + L+D GL + + G+ Y APEV Y
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 453 NIKSDVYSFGVVMLELLTGRKPFDS 477
+ D + G V+ E+L G PF S
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIE--MVSN---ISQLHHPNI 331
+LG+G+FG+V A+ + A+K + + + DD +E MV HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV---LEDDDVECTMVERRVLALAWEHPFL 58
Query: 332 MELVGYCS-EYGQHLL-VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
L +C+ + +HL V E+ G L H+ ARA Y
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDL--MFHIQS------------SGRFDEARARFYA 102
Query: 390 HE-VCSLSVVHKN------IKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GY 441
E +C L +HK +K N+LLD + + +++D G+ N + + G+ Y
Sbjct: 103 AEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDY 162
Query: 442 GAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
APE+ +YN D +SFGV++ E+L G+ PF
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN---ISQLHHPNIME 333
LLG+GTFG+V + A GK A+K + + ++ D+ ++ + HP +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK--DEVAHTLTESRVLKNTRHPFLTS 59
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE----DNKPLIWNSRVKIALGTARALEYL 389
L + V E+ G L F HLS E +++ + + + AL+YL
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEI------VSALDYL 111
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H S +V++++K N++LD + + +++D GL + G+ Y APEV
Sbjct: 112 H---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y D + GVVM E++ GR PF
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 36/270 (13%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LG+G +G VY+ G +A+K+I S+ F +++ + LH +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK----FNQIIMELDILHKAVSPYIVDF 64
Query: 338 CSEYGQHLLVY---EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+ VY E+ GSL D L+ + + + +I + L++L E
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG---- 450
+++H+++K N+L++ +L D G++ N+ A A N Y APE SG
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 451 --QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD--IDALAKMVDP 506
Y ++SDV+S G+ +LE+ GR P+ P+ + L+ +VD
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPY---------------PPETYANIFAQLSAIVDG 225
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
L S D +A C+ P RP
Sbjct: 226 DPPTLPSGYS-DDAQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGK----VLAVKKIDSSALP---SEMCDDFIEMVSNIS 324
F +LG G FG VY+ + +G+ +A+K++ + P E+ D+ M S
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS--- 65
Query: 325 QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIW--NSRVKIALGT 382
+ +P++ L+G C L + + G L D++ +DN + N V+IA G
Sbjct: 66 -VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKG- 121
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE-ALNNDAGS-- 439
+ YL E +VH+++ + N+L+ + +++D GLA + ADE + + G
Sbjct: 122 ---MNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLA-KLLGADEKEYHAEGGKVP 174
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFD 476
+ A E + Y +SDV+S+GV + EL+T G KP+D
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 2/96 (2%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
K L+ L+++ NQ G + G L L L LS N LSG +P SS L SL L +NQ
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 62 FSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI 95
SG I + +P L L+++ N+ +G +P+ L N+
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
|
Length = 968 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LG+GTFG VY A+ G+++A+KK+ E C + E+ S HPNI++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTARALEYLHEVCSLS 396
E + V+E+ G+L+ + D KP S ++ I + L ++H
Sbjct: 67 FRENDELYFVFEY-MEGNLYQL--MKDRKGKPFS-ESVIRSIIYQILQGLAHIH---KHG 119
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADEALNNDAGSG--YGAPEVAM-S 449
H+++K N+L+ +++D GLA S P D S Y APE+ + S
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV------STRWYRAPEILLRS 173
Query: 450 GQYNIKSDVYSFGVVMLELLTGR 472
Y+ D+++ G +M EL T R
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKI----DSSALPSEM----CDDFIEMVSNISQLHH 328
LLG G FG VY AD G+ LAVK++ DS E+ C+ I+++ N L H
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECE--IQLLKN---LRH 63
Query: 329 PNIMELVGYCSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
I++ G + + L E+ GS+ D L + L N + + +
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGV 119
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN---ADEALNNDAGSGYG- 442
YLH S +VH++IK ANIL D+ N +L D G + + + + + G+ Y
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+PEV Y K+DV+S ++E+LT + P+
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 278 LLGEGTFGRVYRAQFADG----KVLAVKKIDSSALPSEMCDD-FIEMVSNISQ-LHHPNI 331
+LG+G +G+V++ + G K+ A+K + + + D + NI + + HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE----DNKPLIWNSRVKIALGTARALE 387
++L+ G+ L+ E+ G L F+HL E ++ + S + +AL E
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLAL------E 114
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
+LH ++++++K NILLD + + +L+D GL + + G+ Y APE+
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
M + D +S G +M ++LTG PF
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG------YG 442
+H V S ++H++IKSANILL + +L D G S M A +++D G Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF-SKMYAA--TVSDDVGRTFCGTPYYV 212
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI--DAL 500
APE+ Y+ K+D++S GV++ ELLT ++PFD + ++ L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------------NMEEVMHKTL 258
Query: 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
A DP + P +++ + +P+ RP
Sbjct: 259 AGRYDPLPPSISP-----EMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN---ISQLHHPNIME 333
LLG+GTFG+V + A G+ A+K + + ++ D+ ++ + HP +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHTLTENRVLQNSRHPFLTA 59
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE----DNKPLIWNSRVKIALGTARALEYL 389
L + + V E+ G L F HLS E +++ + + + AL+YL
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI------VSALDYL 111
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H +VV++++K N++LD + + +++D GL + G+ Y APEV
Sbjct: 112 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y D + GVVM E++ GR PF
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNI--SQLHHPNIMEL 334
++G+G+FG+V A+ +DG AVK + + + + I N+ L HP ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 335 VGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYLHEV 392
Y + + L V ++ G L F HL E R + A A A+ YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGEL--FFHLQRER---CFLEPRARFYAAEVASAIGYLH-- 113
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQ 451
SL+++++++K NILLD++ + L+D GL +E + G+ Y APEV
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDS 477
Y+ D + G V+ E+L G PF S
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
F E S + Q+ H +I+ L G C ++++V EF + G L F+H + L +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWK 107
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILL-----DNELNP--QLSDCGLASNMPN 428
K+A A AL YL + +VH N+ + NILL D E P +LSD G+ + +
Sbjct: 108 FKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 429 ADEALNNDAGSGYGAPE-VAMSGQYNIKSDVYSFGVVMLEL-LTGRKPFD----SSRPRL 482
E + + APE V S +I +D +SFG + E+ G P + + R
Sbjct: 165 RQECVERIP---WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF 221
Query: 483 EQSLVRWATPQLHDIDALAKMV 504
+ TP LA ++
Sbjct: 222 YEGQCMLVTP---SCKELADLM 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 29/229 (12%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL---- 326
+F +LG+G FG V Q A GK+ A KK++ + + M N Q+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE---AMALNEKQILEKV 57
Query: 327 HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
+ ++ L Y E L LV G L H+ + N RA
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYNMGNP----------GFDEERA 104
Query: 386 LEYLHEVC-------SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
+ Y E+ +V++++K NILLD+ + ++SD GLA +P +
Sbjct: 105 VFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164
Query: 439 SGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
GY APEV + +Y D + G ++ E++ G+ PF + ++++ V
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDF----IEM--VSNISQLHHPNI 331
+GEG++G V++ + + G+++A+KK + SE DD I + + + QL HPN+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESE--DDPVIKKIALREIRMLKQLKHPNL 62
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L+ + LV+E+ H L+ +++ + + + KI T +A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNADEALNNDAGSGYGAPEVAMSG 450
+ +H+++K NIL+ + +L D G A + D+ + A Y APE+ +
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 451 -QYNIKSDVYSFGVVMLELLTG 471
QY DV++ G V ELLTG
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG G G V + Q ++ +K+ + + + I + + + + P I+ G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
G+ + E GSL L + + ++ K+++ R L YL E ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG----KVSIAVLRGLAYLRE--KHQIM 126
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYNIKSD 457
H+++K +NIL+++ +L D G++ + D N+ G+ Y +PE Y+++SD
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 458 VYSFGVVMLELLTGRKP 474
++S G+ ++EL GR P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNI--SQLHHPNIMEL 334
++G+G+FG+V A+ A+ K AVK + A+ + + I N+ + HP ++ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYLHEVC 393
+ V ++ G L F HL E R + A A AL YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRER---CFLEPRARFYAAEIASALGYLH--- 113
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQY 452
SL++V++++K NILLD++ + L+D GL + + G+ Y APEV Y
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 453 NIKSDVYSFGVVMLELLTGRKPFDS 477
+ D + G V+ E+L G PF S
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 278 LLGEGTFGRVYRAQFADGK----VLAVKK---IDSSALPSEMCDDFI-EMVSNISQLHHP 329
+LG+G+FG+V A+ V +KK + + M + + + HP
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK-----HP 56
Query: 330 NIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
+ +L C + L V E+ G L + S ++P +I LG L++
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQF 111
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGSGYGAPEVA 447
LHE ++++++K N+LLD+E + +++D G+ + Y APE+
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
Y D ++ GV++ E+L G+ PF+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 56/273 (20%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
F V ++G G FG V+ + G+V A+K + S + + + I V ++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM---IKRNQIAHVRAERDILADAD 59
Query: 328 HPNIMELVGYCS-EYGQHL-LVYEFRKNGSLHDFL-HLSDEDNKPLIWNSRVKIALGTAR 384
P I++L Y S + +HL LV E+ G D + L +D P +R IA
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEET-ARFYIAELVL- 112
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE------ALNNDA- 437
AL+ +H L +H++IK NIL+D + + +L+D GL M A + +N
Sbjct: 113 ALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 438 ----------------------GS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKP 474
G+ Y APEV Y ++ D +S GV++ E+L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 475 FDSSRPRLEQS-LVRWAT----PQLHDIDALAK 502
F S + + ++ W P + A
Sbjct: 230 FYSDTLQETYNKIINWKESLRFPPDPPVSPEAI 262
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-10
Identities = 25/59 (42%), Positives = 35/59 (59%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
LK L++++N+L + F LP+L LDLS N L+ P++FS L SL SL L N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 42/202 (20%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 286 RVYRAQFADGKVLAVK-----KIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340
+Y+ F + K + ++ L ++ ++ I+ + I NI+++ G+ +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVL-IDITENEIKNLRRIDSN---NILKIYGFIID 89
Query: 341 YGQHL----LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS 396
L L+ E+ G L + L + K L + +++ +A+ + L L++ +
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYK--YTN 143
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS--GQYNI 454
+KN+ S + L+ ++ GL + + N Y + ++ +Y I
Sbjct: 144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTI 201
Query: 455 KSDVYSFGVVMLELLTGRKPFD 476
K D+YS GVV+ E+ TG+ PF+
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVK--KIDSSALPSEMCDDFIEMVSNISQ-LHHPNIME 333
LLG+GTFG+V + A GK A+K K + E+ E S + Q HP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTE--SRVLQNTRHPFLTA 59
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE----DNKPLIWNSRVKIALGTARALEYL 389
L + + V E+ G L F HLS E +++ + + + AL YL
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI------VSALGYL 111
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H S VV++++K N++LD + + +++D GL + + G+ Y APEV
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y D + GVVM E++ GR PF
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQ 325
F + +G+G +G+V+ A+ D G+++A+K++ S L + + V ++
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL---NEVRHVLTERDILTT 57
Query: 326 LHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLH----LSDEDNKPLIWNSRVKIAL 380
+++L+ Y + ++L L E+ G L+ LS++ ++R +A
Sbjct: 58 TKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-------HARFYMAE 109
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
A++ LHE L +H+++K N L+D + +L+D GL+ N+ GS
Sbjct: 110 MFE-AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSP 162
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
Y APEV Y+ D +S G ++ E L G PF S P
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 59/244 (24%), Positives = 114/244 (46%), Gaps = 46/244 (18%)
Query: 279 LGEGTFGRVYRAQFADG---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
+G GT+G VY+A+ DG + A+K+I+ + + C + ++ + +L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 336 GYCSEYGQH--LLVYEFRKNGSLHDFLHL------SDEDNKPLIWNSRVKIALGTARALE 387
+ L++++ + HD H+ S + KP V++ G ++L
Sbjct: 65 KVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKP------VQLPRGMVKSLL 114
Query: 388 Y-----LHEVCSLSVVHKNIKSANILLDNELNPQ-----LSDCGLASNMPNADEALNN-- 435
Y +H + + V+H+++K ANIL+ E P+ ++D G A + + L +
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 436 --DAGSGYGAPEVAMSGQYNIKS-DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492
Y APE+ + ++ K+ D+++ G + ELLT F Q ++ + P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNP 228
Query: 493 QLHD 496
HD
Sbjct: 229 YHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 67/237 (28%), Positives = 111/237 (46%), Gaps = 29/237 (12%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIE--MVSN-ISQLHHPNIME 333
+LG+G+FG+V A+ G+ AVK + + + DD +E MV + L N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVV---LIDDDVECTMVEKRVLALAWENPFL 58
Query: 334 LVGYCS-EYGQHLL-VYEFRKNGSLHDFLHLSDEDNKPLIWNS--RVKIALGTARALEYL 389
YC+ + +HL V EF G L H+ D+ L + +I G L++L
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCG----LQFL 112
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H S ++++++K N++LD + + +++D G+ D + G+ Y APE+
Sbjct: 113 H---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF--DSSRPRLEQSLV------RWATPQLHDI 497
+Y D +SFGV++ E+L G+ PF D E V RW T + DI
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 46/303 (15%)
Query: 277 NLLGEGTFGRVYRAQF-ADGKVLAVKKI---DSSALPSEMCDDFIEMVSNISQLHHPNIM 332
N +G G G VY+ G++ A+K I + ++C + IE++ +++ HPN++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE-IEILRDVN---HPNVV 135
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+ G+ ++ EF GSL + H++DE + + +I G A YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADE---QFLADVARQILSGIA----YLH-- 185
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS-- 449
+VH++IK +N+L+++ N +++D G++ + + N+ G+ Y +PE +
Sbjct: 186 -RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 450 --GQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
G Y+ D++S GV +LE GR PF R WA+ + M P
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWAS-----LMCAICMSQP 293
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQGPT 566
P + F I+ C+Q EP R + ++L+Q + + G QG
Sbjct: 294 PEA---PATASREFRHFISCCLQREPAKRW-------SAMQLLQHPFILRAQPGQGQGGP 343
Query: 567 TPR 569
Sbjct: 344 NLH 346
|
Length = 353 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 50/287 (17%)
Query: 279 LGEGTFGRVYRAQFADGKVLA---VKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
+G G FG+V + G A VK++ SA E F+E L H N+++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQCL 61
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV--KIALGTARALEYLHEVC 393
G C+E +LLV EF G L +L S + + + ++A A L +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND---AGSGYGAPEVAMSG 450
+ +H ++ N LL +L ++ D GL+ N D + D + APE+
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 451 QYNI-------KSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA- 501
N+ +S+V+S GV + EL G +P+ L D L
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPY----------------RHLSDEQVLTY 221
Query: 502 -------KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEV 541
K+ P LK + R+ +V+ C PE RP EV
Sbjct: 222 TVREQQLKLPKPRLK----LPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 38/92 (41%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+L+YLN+++N G + G +P+L TLDLS N LSG +P S SSL L L N
Sbjct: 119 SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176
Query: 63 SGTIDV-LANLP-LDNLNIANNRFTGWVPEQL 92
G I L NL L+ L +A+N+ G +P +L
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 60/284 (21%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 279 LGEGTFGRVYRAQFADGKV-------LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
LG+G+FG VY A G V +A+K ++ +A E + F+ S + + + ++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 71
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLH--LSDEDNKPLI----WNSRVKIALGTARA 385
+ L+G S+ L++ E G L +L + +N P+ +++A A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG---SGYG 442
+ YL+ + VH+++ + N ++ + ++ D G+ ++ D G +
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501
+PE G + SDV+SFGVV+ E+ T +P+ + ++R+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFVME--------G 237
Query: 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
++D P +++ +C Q P+ RP E++ ++
Sbjct: 238 GLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-----HHPNI 331
+LG+G+FG+V A+ G++ AVK + + + DD +E ++ +HP +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI---LQDDDVECTMTEKRILSLARNHPFL 58
Query: 332 MELVGYCSEYGQHLL-VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTARALEYL 389
+L C + L V EF G L + S ++ R + A AL +L
Sbjct: 59 TQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEITSALMFL 112
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H+ ++++++K N+LLD+E + +L+D G+ + + G+ Y APE+
Sbjct: 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y D ++ GV++ E+L G PF++
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 36/91 (39%), Positives = 54/91 (59%), Gaps = 3/91 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M +L+ L++A N+ G L D FG L LDLS N SG +P+ SLS L L L N
Sbjct: 451 MPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVP 89
+ SG I D L++ L +L++++N+ +G +P
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/100 (40%), Positives = 61/100 (61%), Gaps = 3/100 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K L+YL + N+L G + L L +LDLS N+LSG +P+ L +L L+L +N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 61 QFSGTIDV-LANLP-LDNLNIANNRFTGWVPEQL-KNINL 97
F+G I V L +LP L L + +N+F+G +P+ L K+ NL
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358
|
Length = 968 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 46/207 (22%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL--HHPNIMEL 334
++G G++ +V + ++ A+K + + + D+++ ++ + +HP ++ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKP----LIWNSRVKIALGTARALEYLH 390
+ V E+ G L H+ + P +++ + +AL YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLAL------NYLH 113
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
E ++++++K N+LLD+E + +L+D G+ + + G+ Y APE+
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFD 476
Y D ++ GV+M E++ GR PFD
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 43/239 (17%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADG----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLH 327
+F + +LG G +G+V+ + G K+ A+K + +AL V +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-----------VQKAKTVE 49
Query: 328 HP----NIMELV-----------GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIW 372
H N++E V + +E HL++ ++ G + F HL DN
Sbjct: 50 HTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL-DYVSGGEM--FTHLYQRDN---FS 103
Query: 373 NSRVKIALG-TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN-MPNAD 430
V+ G ALE+LH+ L +V+++IK NILLD+E + L+D GL+ +
Sbjct: 104 EDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160
Query: 431 EALNNDAGS-GYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
E + G+ Y APE+ G + D +S G+++ ELLTG PF R QS V
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSAL--PSEMCDDFIE--MVSNISQLHHPNIME 333
+G+GTFG+VY+ + D ++ A+K + + E+ E ++ P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT-ARALEYLHEV 392
L LV ++ G L F HL E R K + ALE+LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFS---EDRAKFYIAELVLALEHLHK- 114
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-YGAPEVAMSGQ 451
+V++++K NILLD + L D GL+ ++ N G+ Y APEV + +
Sbjct: 115 --YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 452 -YNIKSDVYSFGVVMLELLTGRKPF 475
Y D +S GV++ E+ G PF
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 62/240 (25%), Positives = 118/240 (49%), Gaps = 38/240 (15%)
Query: 279 LGEGTFGRVYRAQFADG---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
+G GT+G VY+A+ DG K A+K+I+ + + C + ++ + +L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 336 G-YCSEYGQHL-LVYEFRKNGSLHDFLHL------SDEDNKPL-IWNSRVKIALGTARAL 386
+ S + + L++++ + HD H+ S + KP+ + S VK L + L
Sbjct: 65 KVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLL--YQIL 118
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQ-----LSDCGLASNMPNADEALNN----DA 437
+ +H + + V+H+++K ANIL+ E P+ ++D G A + + L +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 438 GSGYGAPEVAMSGQYNIKS-DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496
Y APE+ + ++ K+ D+++ G + ELLT F Q ++ + P HD
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPFHHD 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 28/87 (32%), Positives = 53/87 (60%), Gaps = 1/87 (1%)
Query: 7 LNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQFSGT 65
++++ + G+++ +LP + T++LS N LSG +P F++ SSL L L NN F+G+
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 66 IDVLANLPLDNLNIANNRFTGWVPEQL 92
I + L+ L+++NN +G +P +
Sbjct: 134 IPRGSIPNLETLDLSNNMLSGEIPNDI 160
|
Length = 968 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 279 LGEGTFGRVYRAQFAD---GKV---LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG+G+FG VY D G+ +AVK ++ SA E + F+ S + +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 72
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHL--SDEDNKP----LIWNSRVKIALGTARAL 386
L+G S+ L+V E +G L +L + +N P +++A A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG---SGYGA 443
YL+ + VH+++ + N ++ ++ ++ D G+ ++ D G + A
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PE G + SD++SFGVV+ E+ + +P+ EQ L K
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVL---------------K 232
Query: 503 MVDPALKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
V + G Y P R D++ +C Q P+ RP E+V L
Sbjct: 233 FV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 277 NLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDF----IEMVSNISQLHHPNI 331
N + EGT+G VYRA+ G+++A+KK+ + E + F + ++ + +L HPNI
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEK-EGFPITSLREINILLKLQHPNI 66
Query: 332 MEL----VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTARAL 386
+ + VG S + +V E+ + HD L + +P + S VK + L +
Sbjct: 67 VTVKEVVVG--SNLDKIYMVMEYVE----HDLKSLMETMKQPFL-QSEVKCLMLQLLSGV 119
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP-NADEALNNDAGSGYGAPE 445
+LH+ ++H+++K++N+LL+N ++ D GLA Y APE
Sbjct: 120 AHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 446 VAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
+ + +Y+ D++S G + ELLT + F
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 37/272 (13%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+GEG+ G V A + G+ +AVK +D + + V + H N++E+ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEM--Y 84
Query: 338 CSEY-GQHLLV-YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
S G+ L V EF + G+L D + + + + + + +AL YLH S
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLH---SQ 136
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAMSGQYNI 454
V+H++IKS +ILL + +LSD G + + + G+ Y APEV Y
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 455 KSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---PALKGL 511
+ D++S G++++E++ G P+ S P + A+ ++ D P LK
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSP----------------VQAMKRLRDSPPPKLKNA 240
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + + R D + + EP+ R E++
Sbjct: 241 HKISPVLR--DFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 70/262 (26%)
Query: 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNI------- 323
F ++G G FG V Q D G + A+KK+ S EM + E V+++
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----EMLEK--EQVAHVRAERDIL 55
Query: 324 SQLHHPNIMELVGYCS--EYGQHLLVYEFRKNGSLHDFLHLSD---EDNKPLIWNSRVKI 378
++ +P +++L Y S + L+ E+ G + L D E+ +R I
Sbjct: 56 AEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE------TRFYI 107
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-----SNMPNADEAL 433
A T A++ +H L +H++IK N+LLD + + +LSD GL S+ L
Sbjct: 108 A-ETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 434 NNDAGSG----------------------------------YGAPEVAMSGQYNIKSDVY 459
++ S Y APEV + YN + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223
Query: 460 SFGVVMLELLTGRKPFDSSRPR 481
S GV+M E+L G PF S P+
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQ 245
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSA---LPSEMCDDFIEMVSNISQLHHPNIMEL 334
LGEGT+ VY+ + G+++A+K+I A PS I +S + +L H NI+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA----IREISLMKELKHENIVRL 63
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+ +LV+E+ L ++ + L N+ + + + HE
Sbjct: 64 HDVIHTENKLMLVFEYMDK-DLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SGQY 452
V+H+++K N+L++ +L+D GLA +N+ + Y AP+V + S Y
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 453 NIKSDVYSFGVVMLELLTGRKPF 475
+ D++S G +M E++TGR F
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 263 IADLQMATGSFNVENLLGEGTFGRV--YRAQFADGKVLAVKKIDSSALPSEMCDDFIEMV 320
I DL+M + V ++G G FG V R + KV A+K + + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 321 SNISQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIA 379
+I + + + Y + ++L +V E+ G D ++L + P W
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWAR----- 145
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
TA + L + S+ +H+++K N+LLD + +L+D G M N + + D
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAV 204
Query: 440 G---YGAPEVAMS----GQYNIKSDVYSFGVVMLELLTGRKPF 475
G Y +PEV S G Y + D +S GV + E+L G PF
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGK-VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F V ++GEG +G V + + + K ++A+KK S E+ + + + + L NI
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+EL G+ LV+E+ + + L L +E + +A+ + H+
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEK----NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND--AGSGYGAPEVAMS 449
+VH++IK N+L+ + +L D G A N+ A + A Y +PE+ +
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPF 475
Y D++S G ++ EL G+ F
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
R L+Y+H S ++H+++K +N+ ++ + ++ D GLA + DE A Y A
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRA 185
Query: 444 PEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPF 475
PE+ ++ YN D++S G +M ELLTGR F
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 263 IADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVS 321
I LQM ++V ++G G FG V + + KV A+K + + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 322 NISQL-HHPNIMELVGYCS-EYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI 378
+I + P +++L +C+ + ++L +V E+ G D ++L + P W
Sbjct: 95 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAK---- 145
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
TA + L + S+ ++H+++K N+LLD + +L+D G M + + D
Sbjct: 146 -FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTA 203
Query: 439 SG---YGAPEVAMS----GQYNIKSDVYSFGVVMLELLTGRKPF 475
G Y +PEV S G Y + D +S GV + E+L G PF
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKK------IDSSALPSEMCDDFIEMVSNISQ 325
F +LG G FG+V A++ G++ A+K I + S MC+ I +N +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 326 LHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI-ALGTA 383
HP ++ L C + H+ V E+ G L +H+ + + R A
Sbjct: 61 --HPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTD----VFSEPRAVFYAACVV 111
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG- 442
L+YLHE +V++++K N+LLD E +++D GL G G+G
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE------------GMGFGD 156
Query: 443 ------------APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
APEV Y D + GV++ E+L G PF
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 20/228 (8%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKI--DSSALPSEMCDDFIEMVSNISQLHHPN 330
+ V L G+ GRV+ A V KI + L M ++ N++ HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM------LLQNVN---HPS 118
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
++ + +V + L+ +L +PL + + I L YLH
Sbjct: 119 VIRMKDTLVSGAITCMVLP-HYSSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLH 174
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
+ ++H+++K+ NI +++ + D G A+ P A AG+ APEV
Sbjct: 175 ---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLAR 230
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497
+YN K+D++S G+V+ E+L P + V+ L I
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
KI++ R L YL E ++H+++K +NIL+++ +L D G++ + D N+
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF 158
Query: 437 AGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKP 474
G+ Y +PE Y ++SD++S G+ ++E+ GR P
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 26/65 (40%), Positives = 42/65 (64%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
K L L+++HNQL GQ+ F ++P LS LDLS N LSG +P++ ++ SL + + +N
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582
Query: 62 FSGTI 66
G++
Sbjct: 583 LHGSL 587
|
Length = 968 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 279 LGEGTFGRVY--RAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
LGEGT+ VY R++ D ++A+K+I C I VS + L H NI+ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTARALEYLHEVCSL 395
LV+E+ + L +L +D I VK+ L R L Y H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL----DDCGNSINMHNVKLFLFQLLRGLNYCHR---R 123
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SGQYN 453
V+H+++K N+L++ +L+D GLA + +N+ + Y P++ + S Y+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 454 IKSDVYSFGVVMLELLTGRKPFDSS 478
+ D++ G + E+ TGR F S
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 23/187 (12%)
Query: 368 KPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM- 426
K L + + A+ +E+L S +H+++ + NILL ++ D GLA ++
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 427 PNADEALNNDA--GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLE 483
+ D DA + APE Y I+SDV+SFGV++ E+ + G P+
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------- 282
Query: 484 QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P + + + + + P + + C EP RP SE+V+
Sbjct: 283 --------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
Query: 544 ALVRLVQ 550
L L+Q
Sbjct: 335 HLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 279 LGEGTFGRVYRAQFAD--GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH---HPNIME 333
+GEG +G+V++A+ G+ +A+K++ M I V+ + L HPN++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 334 LVGYCS-----EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGTARALE 387
L C+ + LV+E D D+ +P + +K + R L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA 447
+LH S VVH+++K NIL+ + +L+D GLA + Y APEV
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ Y D++S G + E+ RKP
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 37/218 (16%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKI----DSSALPSEMCDDFIEMVSNI---SQLHHPN 330
+G+GTFG V++A+ +++A+KK+ + P I + I L H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-------ITALREIKILQLLKHEN 72
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA----- 385
++ L+ C R GS + + D L+ N VK L +
Sbjct: 73 VVNLIEICRTKATP----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 386 ---LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-----SNMPNADEALNNDA 437
L Y+H ++H+++K+ANIL+ + +L+D GLA S + N
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 438 GSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKP 474
Y PE+ + Y D++ G +M E+ T R P
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 63/260 (24%), Positives = 119/260 (45%), Gaps = 30/260 (11%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIE--MVSN--ISQL 326
FN +LG+G+FG+V A+ ++ A+K + + + DD +E MV ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV---IQDDDVECTMVEKRVLALQ 57
Query: 327 HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
P + + C + L V E+ G L + + +P +I++G
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG---- 113
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGSGYGAP 444
L +LH ++++++K N++LD+E + +++D G+ +M + Y AP
Sbjct: 114 LFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAP 170
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD-SSRPRLEQSLVRWATPQLHDID---AL 500
E+ Y D +++GV++ E+L G+ PFD L QS++ H++ +L
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME------HNVSYPKSL 224
Query: 501 AKMVDPALKGL---YPVKSL 517
+K KGL +P K L
Sbjct: 225 SKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 66/277 (23%), Positives = 106/277 (38%), Gaps = 62/277 (22%)
Query: 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQL 326
F LLG+G GRV+ + GK+ A+K +D + + + ++ V ++ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM---IKRNKVKRVLTEQEILATL 58
Query: 327 HHPNIMELVGYCS-EYGQHL-LVYEFRKNGSLHDFLH------LSDEDNKPLIWNSRVKI 378
HP + L Y S + +L LV ++ G L L LS+E +R
Sbjct: 59 DHPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV-------ARFYA 109
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
A ALEYLH L +V++++K NILL + LSD L+ ++
Sbjct: 110 AEVLL-ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 439 SG------------------------------YGAPEVAMSGQYNIKSDVYSFGVVMLEL 468
G Y APEV + D ++ G+++ E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 469 LTGRKPFDSSRPR--LEQSLVRWAT-PQLHDIDALAK 502
L G PF S L + T P + + A+
Sbjct: 226 LYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSAR 262
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGSGYGA 443
AL +LHE ++++++K N+LLD E + +L+D G+ + D Y A
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
PE+ Y D ++ GV+M E++ GR PFD
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 6/111 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ +L++L +A NQL GQ+ GQ+ SL + L +N LSG +P L+SL+ L L N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 61 QFSGTIDV-LANLP-LDNLNIANNRFTGWVPEQL----KNINLQKDGNSWS 105
+G I L NL L L + N+ +G +P + K I+L NS S
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
|
Length = 968 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
AL +LHE ++++++K N+LLD + + +L+D G+ + + G+ Y A
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
PE+ +Y D ++ GV+M E++ GR PFD
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+GEGT+G VY+A+ + +A+KKI + +PS I +S + ++ H NI+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA----IREISLLKEMQHGNIVR 65
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIAL-GTARALEYLHE 391
L + LV+E+ + L + S + K N R +K L R + Y H
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAK----NPRLIKTYLYQILRGIAYCH- 119
Query: 392 VCSLSVVHKNIKSANILLDNELNP-QLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM- 448
S V+H+++K N+L+D N +L+D GLA ++ + Y APE+ +
Sbjct: 120 --SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPF 475
S Y+ D++S G + E++ + F
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 1/95 (1%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
++L+ + + N G+L F +LP + LD+S N L G + + SL L L N+
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 62 FSGTI-DVLANLPLDNLNIANNRFTGWVPEQLKNI 95
F G + D + L+NL+++ N+F+G VP +L ++
Sbjct: 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
|
Length = 968 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 44/197 (22%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338
LG G G V++ ++ +K+ + + + I + + + + P I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
G+ + E GSL L + + ++ K+++ + L YL E ++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG----KVSIAVIKGLTYLRE--KHKIM 126
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYNIKSD 457
H+++K +NIL+++ +L D G++ + D N+ G+ Y +PE Y+++SD
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 458 VYSFGVVMLELLTGRKP 474
++S G+ ++E+ GR P
Sbjct: 185 IWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L+ +N++ N ++G + G + SL LDLS+N+ +G++P+S L+SL L L N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 61 QFSGTI-DVLANLPLD--NLNIANN 82
SG + L L + N +N
Sbjct: 501 SLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 44/220 (20%)
Query: 279 LGEGTFGRVYRAQFAD---GKVLAVKKI-DSSALPSEMCDDFIEMVSNISQL-HHPNIME 333
LG+G +G V++A D +V+A+KKI D+ ++ F E + + +L HPNI++
Sbjct: 15 LGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTFRE-IMFLQELGDHPNIVK 71
Query: 334 LVG-YCSEYGQHL-LVYEF---------RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT 382
L+ +E + + LV+E+ R N + ++ +K I +K
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRAN--------ILEDVHKRYIMYQLLK----- 118
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND------ 436
AL+Y+H S +V+H+++K +NILL+++ +L+D GLA ++ +E N
Sbjct: 119 --ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 437 AGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
A Y APE+ + S +Y D++S G ++ E+L G+ F
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 13/213 (6%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
LGEGT+ V++ + ++A+K+I C I VS + L H NI+ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTARALEYLHEVCSLS 396
LV+E+ + D D L+ VKI + R L Y H+
Sbjct: 72 IHTERCLTLVFEYLDS----DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHK---RK 123
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SGQYNI 454
++H+++K N+L++ + +L+D GLA + +N+ + Y P+V + S +Y+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 455 KSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
D++ G ++ E+ TGR F S + E L+
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 2/88 (2%)
Query: 7 LNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI 66
L + + L+G + + +L L +++LS N++ GN+P S S++SL L L N F+G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 67 -DVLANL-PLDNLNIANNRFTGWVPEQL 92
+ L L L LN+ N +G VP L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 273 FNVENLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-- 327
+ + LG+G +G V A+ A + + +A+KKI + + + + L
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR---ELKLLRHF 58
Query: 328 --HPNI-----MELVGYCSEYGQHLLVYEFRKNGSLHDFLH----LSDEDNKPLIWNSRV 376
H NI M++V + +L YE LH + L+D + I+
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYL--YEELMEADLHQIIRSGQPLTDAHFQSFIYQ--- 113
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNADEA--- 432
L+Y+H S +V+H+++K N+L++ + ++ D GLA N E
Sbjct: 114 -----ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 433 -LNNDAGSGYGAPEVAMSGQYNIKS-DVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
A Y APE+ +S Q K+ DV+S G ++ ELL GRKP + ++Q
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 295 GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353
G+ + V++I+ A +EM F++ ++S+L +HPNI+ + +V F
Sbjct: 25 GEYVTVRRINLEACTNEMVT-FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 354 GSLHDFL--HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN 411
GS D + H D ++ I I G +AL+Y+H + VH+++K+++IL+
Sbjct: 84 GSAKDLICTHFMDGMSELAI----AYILQGVLKALDYIHH---MGYVHRSVKASHILISV 136
Query: 412 ELNPQLSDCGLASNMPNADEALNNDAGSGYG----------APEVAMSG--QYNIKSDVY 459
+ LS GL SN+ + + +PEV Y+ KSD+Y
Sbjct: 137 DGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194
Query: 460 SFGVVMLELLTGRKPF 475
S G+ EL G PF
Sbjct: 195 SVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 279 LGEGTFGRVY--RAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
LGEGT+ V+ R++ + ++A+K+I C I VS + L H NI+ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTARALEYLHEVCSL 395
LV+E+ L L +D ++ VKI L R L Y H
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---R 123
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SGQYN 453
V+H+++K N+L++ +L+D GLA + +N+ + Y P+V + S +Y+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 454 IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487
+ D++ G + E+ +GR F S E L+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+G G +G VY+A+ G +A+K + + LP + + ++ + HPNI+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66
Query: 334 LVGYCS-----EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT-ARALE 387
L+ C+ + LV+E + L +L P +K + R L+
Sbjct: 67 LMDVCATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPA---ETIKDLMRQFLRGLD 122
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
+LH C +VH+++K NIL+ + +L+D GLA + + AL + Y APEV
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALTPVVVTLWYRAPEV 178
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ Y D++S G + E+ RKP
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDA---GSG 440
R L+YLH S ++H++IK N+L+++ ++ D GLA + DE+ +
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA-RVEEPDESKHMTQEVVTQY 169
Query: 441 YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
Y APE+ M S Y D++S G + ELL R F + P
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+G G FG V A+ G+ +A+KKI + L + E+ + L H NI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT---YREL-KLLKHLRHENIIS 73
Query: 334 LVG-YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L + S V E LH L ++PL R L+Y+H
Sbjct: 74 LSDIFISPLEDIYFVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVH-- 125
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQ- 451
S VVH+++K +NIL++ + ++ D GLA + + Y APE+ ++ Q
Sbjct: 126 -SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 452 YNIKSDVYSFGVVMLELLTGRKPF 475
Y+++ D++S G + E+L G+ F
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 76/320 (23%), Positives = 139/320 (43%), Gaps = 46/320 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIE--MVSN--ISQLH 327
FN +LG+G+FG+V A+ ++ A+K + + + DD +E MV ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV---IQDDDVECTMVEKRVLALSG 58
Query: 328 HPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
P + + C + L V E+ G L + +P +IA+G L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----L 114
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGSGYGAPE 445
+LH S ++++++K N++LD+E + +++D G+ NM + Y APE
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFD-SSRPRLEQSLVRWATPQLHDIDALAKMV 504
+ Y D ++FGV++ E+L G+ PF+ L QS++ H++ M
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------HNVAYPKSMS 225
Query: 505 DPAL---KGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRT 558
A+ KGL +P K L C PE + E A R + + ++
Sbjct: 226 KEAVAICKGLMTKHPGKRLG--------C---GPEGERDIKE--HAFFRYIDWEKLERKE 272
Query: 559 IGNDQGPTTPRGDNQDTQDY 578
+ Q P P+ +D +++
Sbjct: 273 V---QPPYKPKACGRDAENF 289
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 65/249 (26%), Positives = 101/249 (40%), Gaps = 49/249 (19%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F ++G G FG V Q D G V A+K + + + + I +I L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI--LVEADS 60
Query: 332 MELVGYCSEYGQHL---LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
+ +V + L L+ EF G + L D + ++ IA T A++
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIA-ETVLAIDS 116
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA-----LNNDAGSG--- 440
+H+ L +H++IK N+LLD++ + +LSD GL + + A LN+ S
Sbjct: 117 IHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 441 ----------------------------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
Y APEV M YN D +S GV+M E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 473 KPFDSSRPR 481
PF S P+
Sbjct: 234 PPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 11/106 (10%)
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG------YG 442
L EV S ++H+++KSANI L +L D G + ++++ D S Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY---SDSVSLDVASSFCGTPYYL 238
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD--SSRPRLEQSL 486
APE+ +Y+ K+D++S GV++ ELLT +PF S R ++Q L
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 51/206 (24%)
Query: 363 SDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422
+ +PL + + AR +E+L S +H+++ + NILL ++ D GL
Sbjct: 163 DELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL 219
Query: 423 ASNM-PNADEALNNDA--GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF--- 475
A ++ + D DA + APE Y +SDV+SFGV++ E+ + G P+
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
Query: 476 -----------DSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVI 524
+ +R R + +ATP+++ I M+D
Sbjct: 280 QIDEEFCRRLKEGTRMRAPE----YATPEIYSI-----MLD------------------- 311
Query: 525 ALCVQPEPEFRPPMSEVVQALVRLVQ 550
C PE RP SE+V+ L L+Q
Sbjct: 312 --CWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 67/258 (25%), Positives = 107/258 (41%), Gaps = 67/258 (25%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F ++G G FG V Q D G + A+K + + + + E V++I + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK------EQVAHI-RAERDIL 55
Query: 332 MELVG-------YCSEYGQHL-LVYEFRKNGSLHDFLH----LSDEDNKPLIWNSRVKIA 379
+E G Y + ++L L+ EF G + L LS+E + I
Sbjct: 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE------ 109
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM------------- 426
T A++ +H+ L +H++IK N+LLD + + +LSD GL + +
Sbjct: 110 --TVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 427 --PNADEALNN--------------------DAGS-GYGAPEVAMSGQYNIKSDVYSFGV 463
P +D + N G+ Y APEV M YN D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 464 VMLELLTGRKPFDSSRPR 481
+M E+L G PF S P+
Sbjct: 225 IMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 61/261 (23%), Positives = 96/261 (36%), Gaps = 58/261 (22%)
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL--HLSDEDNKPLIWNSRVKIALGTARA 385
HPNIM + ++ F GS + L + + ++ LI N I G R
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRG 113
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPE 445
L YLH+ +H+NIK+++IL+ + LS ++ + A Y P+
Sbjct: 114 LNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----AKVVYDFPQ 166
Query: 446 VAMSGQ--------------YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491
+ S YN+KSD+YS G+ EL TGR PF R + L +
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF-QDMLRTQMLLQKLKG 225
Query: 492 PQLHDIDALA------------------------------KMVDPALKGLYPVKSLSRFA 521
P +D M L+ F
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 522 DVIALCVQPEPEFRPPMSEVV 542
+++ LC+Q +PE RP S ++
Sbjct: 286 NLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 51/227 (22%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFI-------EMVSNIS 324
+ + +G G +G V A G+ +A+KKI S + DD I E+ +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKL-LR 54
Query: 325 QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDF---LHLSDEDNKPLIWNSRVKIALG 381
L H NI+ L L + +D L + D +I + L
Sbjct: 55 HLRHENIIGL----------LDILRPPSPEDFNDVYIVTELMETDLHKVI---KSPQPLT 101
Query: 382 TA----------RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431
R L+YLH S +V+H+++K +NIL+++ + ++ D GLA + + DE
Sbjct: 102 DDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV-DPDE 157
Query: 432 ALNNDAGSG-----YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGR 472
Y APE+ +S Y D++S G + ELLT +
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 279 LGEGTFGRVY----RAQFADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIME 333
LG+G+FG VY + A+ ++ +K+I L P+E E +S+L HP I++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-AQLLSKLDHPAIVK 66
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
E ++ E+ + L L K L N + + + Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASN-MPNADEALNNDAGSGYGAPEVAMSGQY 452
++H+++K+ NI L N L ++ D G++ M + D A Y +PE Y
Sbjct: 125 -RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 453 NIKSDVYSFGVVMLEL 468
+ KSD++S G ++ E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKI----DSSALPS----EMCDDFIEMVSNISQLHHP 329
+GEGT+G V++A+ + +++A+K++ D +PS E+C + +L H
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC--------LLKELKHK 59
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA------ 383
NI+ L + LV+E+ D+D K + I
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEY------------CDQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 384 --RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-G 440
+ L + H S +V+H+++K N+L++ +L+D GLA + + +
Sbjct: 108 LLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW 164
Query: 441 YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKP 474
Y P+V + Y+ D++S G + EL +P
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 278 LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-----HHPNI 331
+LG+G+FG+V A+ +V A+K + + + DD ++ ++ HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI---LQDDDVDCTMTEKRILALAAKHPFL 58
Query: 332 MELVGYCSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
L +C + L V E+ G L + S + ++P SR A T AL +L
Sbjct: 59 TAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRFYAAEVTL-ALMFL 112
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H V+++++K NILLD E + +L+D G+ G+ Y APE+
Sbjct: 113 HR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
+Y D ++ GV+M E++ G+ PF++
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 324 SQLHHPNIMELV--GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
++L+HPNI+ L+ G G V+E+ +L + L + L ++ L
Sbjct: 33 ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL----AADGALPAGETGRLMLQ 87
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDA- 437
AL H +VH+++K NI++ + ++ D G+ + +P +A
Sbjct: 88 VLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 438 ------GS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
G+ Y APE SD+Y++G++ LE LTG+
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 42/269 (15%)
Query: 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
S+ + N++G G+FG VY A D + +A+KK+ P + + M L+H N
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIM----KNLNHIN 120
Query: 331 IMELVGYCSEYGQHLLVYEFRKN--------------GSLHDFLHLSDEDNKPLIWNSRV 376
I+ L Y F+KN ++H ++ +N L
Sbjct: 121 IIFLKDY-------YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMPNADEALNN 435
+ RAL Y+H S + H+++K N+L+D N +L D G A N+ +++
Sbjct: 174 LYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 436 DAGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494
Y APE+ + + Y D++S G ++ E++ G P S + ++Q LVR
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQSSVDQ-LVRI----- 283
Query: 495 HDIDALAKMVDPALKGLYPVKSLSRFADV 523
I L + LK + P + +F DV
Sbjct: 284 --IQVLGTPTEDQLKEMNPNYADIKFPDV 310
|
Length = 440 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
R L+Y+H S ++H+++K +NI ++ + ++ D GLA DE A Y A
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 183
Query: 444 PEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
PE+ ++ YN D++S G +M ELLTG+ F
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPE 445
+H + L VH++IK N+LLD + +L+D G M N D + + G Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM-NQDGTVQSSVAVGTPDYISPE 173
Query: 446 V--AMS---GQYNIKSDVYSFGVVMLELLTGRKPF 475
+ AM G+Y + D +S GV M E+L G PF
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
F E S +SQ+ H ++ + G C ++++V EF ++G L D ++ P+ W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILL------DNELNP--QLSDCGLASNMP 427
+ +A A AL YL + ++VH N+ + NILL + P +LSD G++
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS-PFIKLSDPGVSFTAL 175
Query: 428 NADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL 486
+ +E + + APE G + +D +SFG +LE+ FD P E
Sbjct: 176 SREERVERIP---WIAPECVPGGNSLSTAADKWSFGTTLLEIC-----FDGEVPLKE--- 224
Query: 487 VRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
R + + + ++ +P+ K L A +I+ C+ EP RP +++ L
Sbjct: 225 -RTPSEKERFYEKKHRLPEPSCKEL---------ATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 51/212 (24%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKK----IDSSALPSEMCDD--FIEMVSN----ISQLH 327
+GEGT+G+VY+A+ GK++A+KK +D +P + ++M+S + L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDN-KPLIWNSRVKIALGTARAL 386
++ E G S Y LV+E+ + L F+ + +PL + + +
Sbjct: 69 VEHVEEKNGKPSLY----LVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNP-QLSDCGLASNMPNADEALNNDAGS-GYGAP 444
+ H V+H+++K N+L+D + +++D GL ++ ++ + Y AP
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 445 EVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
EV + S Y+ D++S G + E+ + F
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 369 PLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428
PL + I AL YLH ++H+++K+ NI LD N L D G A +
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 429 ADEALNNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ SG +PE+ Y K+D++S G+V+ E+
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIE--MVSN--ISQLH 327
FN +LG+G+FG+V A + ++ A+K + + + DD +E MV ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI---IQDDDVECTMVEKRVLALPG 58
Query: 328 HPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
P + + C + L V E+ G L + + +P +IA+G L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----L 114
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPE 445
+LH S ++++++K N++LD E + +++D G+ + G+ Y APE
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPE 171
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
+ Y D ++FGV++ E+L G+ PFD
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 12 NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLA- 70
N L+G++ G SL + L N+ SG LP F+ L + L + NN G I+
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449
Query: 71 NLP-LDNLNIANNRFTGWVP-----EQLKNINLQKD 100
++P L L++A N+F G +P ++L+N++L ++
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRN 485
|
Length = 968 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 48/229 (20%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ------ 325
+ ++ ++G+G++G V A G+ +A+KKI+ D E VS+ ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN----------DVFEHVSDATRILREIK 51
Query: 326 ----LHHPNIME-----LVGYCSEYGQHLLVYEFRKNGSLHDFLH----LSDEDNKPLIW 372
L HP+I+E L E+ +V+E ++ LH + L+ E ++ ++
Sbjct: 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLY 110
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPN 428
RAL+Y+H + +V H+++K NIL + + ++ D GLA ++ P
Sbjct: 111 Q--------LLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159
Query: 429 ADEALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPF 475
A + A Y APE+ S +Y D++S G + E+LTG+ F
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 20/103 (19%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG--- 440
R L+Y+H S +V+H+++K +N+LL+ + ++ D GLA A +G
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI------ADPEHDHTGFLT 167
Query: 441 -------YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y APE+ + S Y D++S G ++ E+L+ R F
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
R L+Y+H S ++H+++K +N+ ++ + ++ D GLA DE A Y A
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRA 183
Query: 444 PEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPF 475
PE+ ++ YN D++S G +M ELL G+ F
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 65/310 (20%), Positives = 129/310 (41%), Gaps = 52/310 (16%)
Query: 195 ASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDR-------HKSFDEEDFSKKSIV 247
A+S + K + +++ T ++ + PPP + ++S +E F +V
Sbjct: 63 ATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFY---VV 119
Query: 248 VKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGK----VLAVKKI 303
+ + D+ ++T F + +LLGEGTFG+V A K V V+ +
Sbjct: 120 LGE--------------DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV 165
Query: 304 DSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS 363
+++ F+E V +M++ Y H+ + + L D++
Sbjct: 166 PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIM-- 223
Query: 364 DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNP----- 415
+ P +I T AL+Y H L ++H ++K NIL+ D ++P
Sbjct: 224 --KHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRA 279
Query: 416 --------QLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLE 467
++ D G + ++ A+ + Y +PEV + + +D++S G ++ E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVST--RHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337
Query: 468 LLTGRKPFDS 477
L TG+ +D+
Sbjct: 338 LYTGKLLYDT 347
|
Length = 467 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---Y 441
A++ +H+ L VH++IK N+LLD + +L+D G + AD + ++ G Y
Sbjct: 114 AIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL-LADGTVQSNVAVGTPDY 169
Query: 442 GAPEV--AM---SGQYNIKSDVYSFGVVMLELLTGRKPF 475
+PE+ AM G+Y + D +S GV M E+L G PF
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 18/222 (8%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDF--IEMVSNISQLHHPNIMELV 335
LGEG++ VY+ + +GK++A+K I L E F I S + L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
LV+E+ D D+ L + R L Y+H+
Sbjct: 70 DIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---R 122
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SGQYN 453
++H+++K N+L+ + +L+D GLA +N+ + Y P+V + S +Y+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 454 IKSDVYSFGVVMLELLTGRKPFDSSR---PRLEQSLVRWATP 492
D++ G + +E++ G F + +LE+ + TP
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP 224
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 360 LHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419
LS++ + L++ L+Y+H S ++H+++K N+ ++ + ++ D
Sbjct: 112 HPLSEDKVQYLVYQ--------MLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILD 160
Query: 420 CGLASNMPNAD-EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPF 475
GLA + AD E Y APEV ++ YN D++S G +M E+LTG+ F
Sbjct: 161 FGLARH---ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 369 PLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-- 426
PL + + AR +E+L S +H+++ + NILL ++ D GLA ++
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 427 -PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484
P+ + + APE Y +SDV+SFGV++ E+ + G P+
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY--------- 277
Query: 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544
P + + + + + P + ++ C Q +P+ RP S +V+
Sbjct: 278 -------PGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEI 330
Query: 545 LVRLVQ 550
L L+Q
Sbjct: 331 LGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 25/185 (13%)
Query: 364 DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423
+ED L + + A+ + +L S + +H+++ + NILL + ++ D GLA
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 424 SNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSR 479
++ N + N + APE + Y +SDV+S+G+++ E+ + G P+
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY---- 317
Query: 480 PRLEQSLVRWATPQLHDIDA-LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538
P + +D+ KM+ + L P + S D++ C +P RP
Sbjct: 318 PGMP-------------VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364
Query: 539 SEVVQ 543
++VQ
Sbjct: 365 KQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+LK L++ N L G++ + L SL L L+ N L G +P+ + SL +YL N
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 63 SGTI--DVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQ 98
SG I ++ L++L++ N TG +P L N+ NLQ
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263
|
Length = 968 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 12/150 (8%)
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
++HP+I++L G + Y + + R L + +L+ + N + + I RA
Sbjct: 140 INHPSIIQLKGTFT-YNKFTCLILPRYKTDL--YCYLAAKRNIAIC--DILAIERSVLRA 194
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP---NADEALNNDAGSGYG 442
++YLHE ++H++IK+ NI +++ + L D G A+ P NA++
Sbjct: 195 IQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATN 250
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
APE+ Y D++S G+V+ E+ T
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 36/236 (15%)
Query: 269 ATGSFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDF--IEMVSNISQ 325
AT N+E L GEG++ VY+ +G+++A+K I ++ +E F I S +
Sbjct: 4 ATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKG 59
Query: 326 LHHPNIM---------ELVGYCSEYGQ-HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
L H NI+ E + + EY L Y + G LH + N R
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-------------NVR 106
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN 435
+ R L Y+H ++H+++K N+L+ +L+D GLA + ++
Sbjct: 107 L-FMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162
Query: 436 DAGS-GYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489
+ + Y P+V + + Y+ D++ G + +E+L G+ F EQ W
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-05
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 27 SLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSG-TIDVLANLP-LDNLNIANNRF 84
+L +LDLS N L+ +F L +L L L N + + + + LP L +L+++ N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 40/199 (20%)
Query: 362 LSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421
LSD+ ++ L + AR +E+L S + VH+++ + N+LL ++ D G
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFG 282
Query: 422 LASNMPNADEALNNDAGSGY-----GAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
LA ++ + ++ GS + APE Y SDV+S+G+++ E+ + G P+
Sbjct: 283 LARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340
Query: 476 -----DSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQP 530
DS+ +S R A P D A + +Y D++ C
Sbjct: 341 PGMIVDSTFYNKIKSGYRMAKP------------DHATQEVY---------DIMVKCWNS 379
Query: 531 EPEFRPP---MSEVVQALV 546
EPE RP +S++V++L+
Sbjct: 380 EPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
+ L+Y+H + ++H+++K N+ ++ + ++ D GLA + E Y A
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRA 183
Query: 444 PEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSS 478
PEV ++ Y D++S G +M E+LTG+ F
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 26/177 (14%)
Query: 266 LQMATG-SFNVENLLGEGTFGRVYRAQFADGK------VLAVKKIDSSALPSE------M 312
L TG + ++ L+G G FG VY Q A V ++ +++ + E +
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 313 CD-DFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF----RKNGSLHDFLHLSDEDN 367
D D I + NI + H I + G C + + + Y F + + + N
Sbjct: 66 YDIDKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN 124
Query: 368 KPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424
K LI N I LEY+HE + H +IK NI++D + D G+AS
Sbjct: 125 KKLIKN----IMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 39/165 (23%), Positives = 76/165 (46%), Gaps = 35/165 (21%)
Query: 323 ISQLHHPNIMELVGYCSEYGQHLLVYEF-------RKNGSLHDFLHLSDED--NKPLIWN 373
+ +L+H NI+++ + +L E + + L+ F++ D ++PL+
Sbjct: 217 LGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
+R I A+EY+H ++H++IK NI L+ + L D G A EA
Sbjct: 269 TR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 434 NNDAGSGYG--------APEVAMSGQYNIKSDVYSFGVVMLELLT 470
+ YG +PE+ Y +D++S G+++L++L+
Sbjct: 325 D------YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 31/84 (36%), Positives = 50/84 (59%), Gaps = 5/84 (5%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
LK L+++ N+++ L LP+L LDLSFN LS +LP+ S+LS+L++L L N+
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197
Query: 62 FSGTIDVLANLP--LDNLNIANNR 83
S + L L+ L+++NN
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNS 220
|
Length = 394 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 34/136 (25%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ------------------- 44
L+ L + N+ G++ G+ +L+ LDLS N L+G +P+
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 45 -----SFSSLSSLSSLYLQNNQFSGTIDV-LANLPLDN-LNIANNRFTG------WVPEQ 91
S + SL + LQ+N FSG + LPL L+I+NN G W
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 92 LKNINLQKDGNSWSSG 107
L+ ++L + N + G
Sbjct: 454 LQMLSLAR--NKFFGG 467
|
Length = 968 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGSGYG 442
R L+Y+H S +V+H+++K +N+LL+ + ++ D GLA + D Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 443 APEVAMS-GQYNIKSDVYSFGVVMLELLTGRKP 474
APE+ ++ +Y DV+S G + ELL GRKP
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 33/230 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKV-LAVKKIDSS--ALPSEMCDDFIEMVSNISQLHHP 329
F L+ G +G VY + + + A+KKI+ L +++ F+E ++ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-DILTFAENP 61
Query: 330 NIMELVGYCS-EYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPL-IWNSRVKIALGTARAL 386
++ + +CS E +HL +V E+ + G L ++ L + +R+ A T AL
Sbjct: 62 FVVSM--FCSFETKRHLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLAL 114
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-----SNMPNADEA-LNNDA--- 437
EYLH + +VH+++K N+L+ + + +L+D GL+ S N E + D
Sbjct: 115 EYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 438 ------GS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
G+ Y APEV + Y D ++ G+++ E L G PF P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 42/192 (21%), Positives = 86/192 (44%), Gaps = 23/192 (11%)
Query: 362 LSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421
ED+ PL + ++ + A+ +++L S + +H+++ + N+LL + ++ D G
Sbjct: 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFG 257
Query: 422 LASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDS 477
LA ++ N + N + APE Y ++SDV+S+G+++ E+ + G+ P+
Sbjct: 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-- 315
Query: 478 SRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
P + KMV + P + ++ +C EP RP
Sbjct: 316 --------------PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361
Query: 538 MSEVVQALVRLV 549
S++ Q + R +
Sbjct: 362 FSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDF--IEMVSNISQLHHPNIMELV 335
LGEG++ VY+ + G+++A+K+I L E F I S + L H NI+ L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTARALEYLHEVCS 394
LV+E+ L L +D + V++ L R L Y H
Sbjct: 70 DIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---Q 121
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SGQY 452
V+H+++K N+L+ +L+D GLA + +N+ + Y P+V + S +Y
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 453 NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
+ D++ G + E+ TGR F S +Q
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 36/152 (23%), Positives = 63/152 (41%), Gaps = 48/152 (31%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS-------------------- 424
A+E +H++ +H++IK NIL+D + + +L+D GL +
Sbjct: 113 AIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 425 NMPNADEALNND-----------------------AGSG-YGAPEVAMSGQYNIKSDVYS 460
+M ++E D G+ Y APEV + Y D +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 461 FGVVMLELLTGRKPFDSSRP-RLEQSLVRWAT 491
GV++ E+L G+ PF + P + ++ W T
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---Y 441
A++ +H+ L VH++IK NIL+D + +L+D G + D + + G Y
Sbjct: 114 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDY 169
Query: 442 GAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPF 475
+PE+ + G+Y + D +S GV M E+L G PF
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 36/167 (21%), Positives = 56/167 (33%), Gaps = 22/167 (13%)
Query: 389 LHEVC-SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA 447
+ +L +H+ KS NILL + +L G + + + APEV
Sbjct: 23 CLQCLGALRELHRQAKSGNILLTWDGLLKLD--GSVAFKTPE----QSRPDPYFMAPEVI 76
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD-IDALAKMVDP 506
Y K+D+YS G+ + E L P E+ L L ++ +
Sbjct: 77 QGQSYTEKADIYSLGITLYEALDYELP-----YNEERELS----AILEILLNGMPADDPR 127
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553
L V + F D + LC P+ R RA
Sbjct: 128 DRSNLEGVSAARSFEDFMRLCASRLPQRREA-----ANHYLAHCRAL 169
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSL----HDFLHLSDEDNKPLIWNSRVKIALGTAR 384
PN++ L Y LV + + G L FL++ +E K W + + +AL
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR--WAAEMVVAL---- 98
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-YGA 443
+ LH +V +++ NILLD+ + QL+ S + +++ + +A Y A
Sbjct: 99 --DALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV---EDSCDGEAVENMYCA 150
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
PEV + D +S G ++ ELLTG+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L L+++ N++ L L +L LDLS N++ L S S+L +LS L L NN+
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243
Query: 62 FSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
+ + NL L+ L+++NN+ + NL++
Sbjct: 244 LEDLPESIGNLSNLETLDLSNNQISSI-SSLGSLTNLRE 281
|
Length = 394 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 281 EGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIE-MVSNISQLHHPNIMELVGYC 338
+G FG+V + K+ K I + + IE MV + + +PN ++L
Sbjct: 26 DGKFGKVSVLKHKPTQKLFVQKIIKAKNF------NAIEPMVHQLMK-DNPNFIKLYYSV 78
Query: 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398
+ H+L+ ++ K+G L D L + ++ + KI AL LH +++
Sbjct: 79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV----KKIIRQLVEALNDLH---KHNII 131
Query: 399 HKNIKSANILLD-NELNPQLSDCGLASNM--PNADEALNNDAGSGYGAPEVAMSGQYNIK 455
H +IK N+L D + L D GL + P+ D Y +PE Y++
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDVS 186
Query: 456 SDVYSFGVVMLELLTGRKPFDSS 478
D ++ GV+ ELLTG+ PF
Sbjct: 187 FDWWAVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 279 LGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G FG+V +A + A + +AVK + A SE E+ I HH N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 333 ELVGYCSEYGQHLLV-YEFRKNGSLHDFL 360
L+G C++ G L+V E+ K G+L ++L
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 8e-04
Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN 36
+ LK L+++ N L + F LPSL +LDLS N
Sbjct: 23 LPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 67/274 (24%), Positives = 100/274 (36%), Gaps = 89/274 (32%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH--- 328
F+ ++G+G FG V Q GK+ A+K + L SEM QL H
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMK----TLLKSEMFKK--------DQLAHVKA 50
Query: 329 ----------PNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFL---HLSDEDNKPLIWNS 374
P ++ L Y + Q+L L+ EF G L L ED +
Sbjct: 51 ERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV------T 103
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS---------- 424
R +A A+E +H+ L +H++IK NIL+D + +LSD GL++
Sbjct: 104 RFYMA-ECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 425 ---------------------------NMPNADE-----------ALNNDAGSGYGAPEV 446
M + D+ A + Y APE+
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
+ Y + D +S G +M E L G PF S
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 279 LGEGTFGRVYRAQ-FADGK-----VLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNI 331
LG G FG+V A F GK +AVK + +SA E + + + +S L H NI
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER-EALMSELKILSHLGQHKNI 104
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL 360
+ L+G C+ G L++ E+ G L +FL
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 54/168 (32%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL--------------ASNMPNAD 430
A+E +H+ + +H++IK NIL+D + + +L+D GL + + D
Sbjct: 113 AVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 431 EA-LNNDAGS---------------------------------GYGAPEVAMSGQYNIKS 456
+N+ G Y APEV + Y
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229
Query: 457 DVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDIDALAKM 503
D +S GV++ E+L G+ PF + P + ++ W T LH I AK+
Sbjct: 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT-SLH-IPPQAKL 275
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 31/226 (13%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDD-FIEMVSNISQLHHPNIMELV 335
L+G+G G VY A + +A+KKI + + F+ + L HP I+ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 336 GYCSEYGQHLLVYEFRKNGSLHDFLH---LSDEDNKPLIWNSRVK----IALGTARALEY 388
CS+ + + +L L + +K L + V I +EY
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGSG------- 440
+H S V+H+++K NILL + D G A ++ L+ D
Sbjct: 129 VH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 441 -----------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y APE + + +D+Y+ GV++ ++LT P+
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 279 LGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G FG+V A + A + +AVK + A SE E+ I HH N++
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 333 ELVGYCSEYGQHLLV-YEFRKNGSLHDFL 360
L+G C++ G L+V EF K G+L ++L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKI-DSSALPSEMCDDFIEMVSNISQLHHPNIM---E 333
+G G +G V A GK +A+KKI + +P+ E + + H NI+ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE-LKILRHFKHDNIIAIRD 71
Query: 334 LVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA-RALEYLHE 391
++ + + +V + ++ LH +H ++PL ++ L R L+Y+H
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIH----SDQPLT-EEHIRYFLYQLLRGLKYIH- 124
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-----AGSGYGAPEV 446
S +V+H+++K +N+L++ + ++ D G+A + ++ A Y APE+
Sbjct: 125 --SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 447 AMS-GQYNIKSDVYSFGVVMLELLTGRKP 474
+S +Y D++S G + E+L GR+
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 33/122 (27%), Positives = 61/122 (50%), Gaps = 11/122 (9%)
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLA----SNMPNADEALNNDAG 438
R L+Y+H S +V+H+++K AN+ ++ E L ++ D GLA + +
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 439 SGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHD 496
Y +P + +S Y D+++ G + E+LTG+ F + LEQ L+ + P + +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILESVPVVRE 240
Query: 497 ID 498
D
Sbjct: 241 ED 242
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 29/122 (23%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAP 444
+++LH S ++H+++K +NI++ ++ ++ D GLA Y AP
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR--PRLEQSLVRWATPQLHDIDALAK 502
EV + Y D++S G +M EL+ G F + + + + + TP ++ L
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 503 MV 504
V
Sbjct: 252 TV 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 279 LGEGTFGRVYRAQFADG--------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HP 329
LG G FGRV A A G KV AVK + S+A SE + + +S L H
Sbjct: 45 LGSGAFGRVVEAT-AHGLSHSQSTMKV-AVKMLKSTARSSEK-QALMSELKIMSHLGPHL 101
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH 361
NI+ L+G C++ G ++ E+ + G L D+LH
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 26/229 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGK-VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ V +G G FG V+ + + K I L + V+ + +L H NI
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 332 MELVG-YCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ + + ++ Q L ++ EF G L + + + ++ V I AL Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 390 HEV----CSLSVVHKNIKSANILLD-------------NELN----PQLSDCGLASNMPN 428
H + V+H+++K NI L N LN ++ D GL+ N+
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 429 ADEALNNDAGSGYGAPEVAM--SGQYNIKSDVYSFGVVMLELLTGRKPF 475
A + Y +PE+ + + Y+ KSD+++ G ++ EL +G+ PF
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 40/190 (21%), Positives = 81/190 (42%), Gaps = 27/190 (14%)
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425
++ L + V + A +E+L S + VH+++ + N+L+ ++ D GLA +
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 426 MPNADEALNNDAGSGY-----GAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSR 479
+ ++ GS + APE + Y SDV+SFG+++ E+ T G P+
Sbjct: 289 IMRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY---- 342
Query: 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539
P+L + + + P + +++ C + + E RP S
Sbjct: 343 ------------PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS 390
Query: 540 EVVQALVRLV 549
++V + L+
Sbjct: 391 QLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 10/86 (11%)
Query: 28 LSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIANNRFT 85
+ L L L G +P S L L S+ L N G I L ++ L+ L+++ N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 86 GWVPE------QLKNINLQKDGNSWS 105
G +PE L+ +NL +GNS S
Sbjct: 480 GSIPESLGQLTSLRILNL--NGNSLS 503
|
Length = 623 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 579 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.02 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.98 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.66 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.61 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.55 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.48 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.33 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.28 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.26 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.24 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.22 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.97 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.95 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.94 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.93 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.93 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=503.82 Aligned_cols=467 Identities=28% Similarity=0.451 Sum_probs=311.5
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|++++.+|..|.++++|+.|+|++|+++|.+|..+.+|++|+.|+|++|.|+|.+|. +..++ |+.|+|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 4678888888888888888888888999999999999888888888889999999999999888764 66665 889999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcch
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSSGPAPPPP---PGTPPARKNNPKHKSDSNKSPSESEGGSKKSGIGGGGIA 152 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~ 152 (579)
++|+++|.+|..+..+ .+...+|.+.+. .|... ........+++..+..........+....+. ...++++
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~-~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~-~~~~~~~ 632 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGS-LPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT-PSWWFYI 632 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceee-CCCcchhcccChhhhcCCccccCCccccCCCCCcccccc-ceeeeeh
Confidence 9999988888877655 334455554432 21110 1111122233322211100000000001111 1112222
Q ss_pred hHHHHHHHHHHHHH-HHHHHhhhcCCCCccccccCCCCCcccccchhhHHhhhhhccCCcccccccccccccCCCCCCCC
Q 008055 153 GILISLFVVGGIVA-FFLVKRRRSRRSSTDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPID 231 (579)
Q Consensus 153 g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 231 (579)
++++++++++++++ ++++++++++......+..+.
T Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------- 668 (968)
T PLN00113 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG-------------------------------------------- 668 (968)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhhhcccccccccccc--------------------------------------------
Confidence 22222222222222 222333222111110000000
Q ss_pred CCCCCCcccccccchhhhccccCCCCccccCHHHHHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCc
Q 008055 232 RHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS 310 (579)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~ 310 (579)
.+....+.. .....+...++ ...|...+.||+|+||.||+|.. .++..||||++.....
T Consensus 669 ---~~~~~~~~~------------~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-- 728 (968)
T PLN00113 669 ---TWELQFFDS------------KVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-- 728 (968)
T ss_pred ---ccccccccc------------ccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--
Confidence 000000000 00012233333 23567788999999999999986 5789999999864332
Q ss_pred hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 008055 311 EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390 (579)
Q Consensus 311 ~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 390 (579)
...+|++.+++++|||||+++++|.+.+..++||||+++|+|.++++ .++|.++..|+.|+|+||+|||
T Consensus 729 ----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH 797 (968)
T PLN00113 729 ----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLH 797 (968)
T ss_pred ----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhc
Confidence 11245778899999999999999999999999999999999999985 2789999999999999999999
Q ss_pred hcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh
Q 008055 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT 470 (579)
Q Consensus 391 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt 470 (579)
..++++|+||||||+||+++.++..++. ||....... .....++..|+|||++.+..++.++|||||||++|||+|
T Consensus 798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t 873 (968)
T PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873 (968)
T ss_pred cCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHh
Confidence 7667799999999999999999888875 665433221 122356789999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC--CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 471 GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL--YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 471 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
|+.||+.... ....+.+|+...... .....++++.+... .+.....++.+++.+||+.||++||||.|+++.|+++
T Consensus 874 g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 874 GKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999964322 223445554422222 22334455555332 3445667889999999999999999999999999988
Q ss_pred HHH
Q 008055 549 VQR 551 (579)
Q Consensus 549 ~~~ 551 (579)
.+.
T Consensus 952 ~~~ 954 (968)
T PLN00113 952 SRS 954 (968)
T ss_pred hcc
Confidence 763
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-54 Score=436.71 Aligned_cols=289 Identities=48% Similarity=0.818 Sum_probs=253.6
Q ss_pred CccccCHHHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceee
Q 008055 257 NVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336 (579)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 336 (579)
....|++.++..+|++|...+.||+|+||.||+|...+|..||||++....... ..+|..|+.++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999999999999887654332 456999999999999999999999
Q ss_pred EEeeCC-eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 337 YCSEYG-QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 337 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
||.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.+.||||||||+|||+|+++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999988 599999999999999999854332 89999999999999999999999877789999999999999999999
Q ss_pred EEecccccccCCC-CCccccc-CCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 416 QLSDCGLASNMPN-ADEALNN-DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 416 kl~Dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
||+|||+++.... ....... .+|.+|+|||++..+..+.|+|||||||+++||+||+.|.+...+.....+.+|..+.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999976654 3333333 7888999999999999999999999999999999999999876655556688998766
Q ss_pred ccChhHHhhhcCcccc-CCCCh-hhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 494 LHDIDALAKMVDPALK-GLYPV-KSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
+.+. .+.+++|+.+. ..++. .....+..++.+|++.+|..||+|.+|+++|+.+..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 6554 78899999987 66664 678889999999999999999999999999965553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=401.04 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=223.9
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-eEEEEEEecCCC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-QHLLVYEFRKNG 354 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g 354 (579)
.+.||+|+||+||+|.++....||||++..........+.|.+|+.++.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4559999999999999986666999999887766555789999999999999999999999999877 799999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcCCCCCCEEEcCCC-ceEEecccccccCCCC-Cc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS-VVHKNIKSANILLDNEL-NPQLSDCGLASNMPNA-DE 431 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~-~~ 431 (579)
+|.++++.. ....+++..++.|+.|||+||+|||.+ + ||||||||+|||++.++ ++||+|||+++..... ..
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 999999743 467899999999999999999999976 6 99999999999999997 9999999999876554 23
Q ss_pred ccccCCCCCccCccccc--cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 432 ALNNDAGSGYGAPEVAM--SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 432 ~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.....||..|||||++. ...|+.|+||||||+++|||+||+.||..... ......++....+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASAVVVGGLR 264 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhcCCC
Confidence 33367888999999999 56899999999999999999999999976543 2233444455666
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
...+..++..+..++.+||+.||++||++.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 677777899999999999999999999999999999999875554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=383.29 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=212.3
Q ss_pred cccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-eEEEEEEec
Q 008055 274 NVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-QHLLVYEFR 351 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 351 (579)
+..+.||+|..|+||++.++ +++.+|+|.+. ...+....+++.+|+++++.++||+||.++|.|...+ ...++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 33578999999999999886 68899999994 3445677889999999999999999999999999998 599999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
++|+|++++.. .+.+++....+|+.+|++||.|||+. ++||||||||+|||++..|++||||||.++.+.+. .
T Consensus 161 DgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 161 DGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-I 233 (364)
T ss_pred CCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-h
Confidence 99999999863 36689999999999999999999962 49999999999999999999999999999988765 5
Q ss_pred ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 432 ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 432 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
..+..||..|||||.+.+..|+.++||||||++++||.+|+.||....+. ...-.+.+..+++.. .+.
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-----------~~~~~~Ll~~Iv~~p-pP~ 301 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-----------YLDIFELLCAIVDEP-PPR 301 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-----------CCCHHHHHHHHhcCC-CCC
Confidence 56788999999999999999999999999999999999999999764110 111122333333322 223
Q ss_pred CChh-hHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 512 YPVK-SLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 512 ~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.|.. ++.+|..++..||++||.+|||+.|+++.
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3443 78899999999999999999999999853
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=373.01 Aligned_cols=204 Identities=29% Similarity=0.521 Sum_probs=187.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|.+.+.||+|+||+||+|+++ ++..||||.+.+........+....|+.+|+.++|||||++++++.+++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888888999999999999875 6899999999988777777888899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC------CceEEecccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE------LNPQLSDCGL 422 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~------~~~kl~Dfg~ 422 (579)
|||.||||.+|++. ...+++..+..++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999973 34789999999999999999999976 99999999999999865 4579999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
|+.+.+.....+.+|++-|||||+++.++|+.|+|+||+|+++|+|++|+.||+....
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9999888777888999999999999999999999999999999999999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=386.37 Aligned_cols=254 Identities=25% Similarity=0.473 Sum_probs=220.8
Q ss_pred ccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+...+.||+|.||.||.|.+.....||+|.++..... .+.|.+|+++|+.++|+|||+++|+|..++.++||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3445779999999999999998889999999875433 5788899999999999999999999999889999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
.|+|.+||+. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...+....
T Consensus 285 ~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999999974 3566788999999999999999999965 9999999999999999999999999999944333322
Q ss_pred cccCC--CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 433 LNNDA--GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 433 ~~~~~--~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
....+ ...|.|||.+..++|+.|+|||||||+||||+| |+.||.... ...+.+.++.+.+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyR 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYR 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCc
Confidence 22222 337999999999999999999999999999999 999997643 2345566777888
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
-..|..|+.++.++|..||+.+|++|||+..+...|+.+...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 888999999999999999999999999999999999887743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=387.70 Aligned_cols=249 Identities=27% Similarity=0.465 Sum_probs=216.7
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.+|...+.||+|||+.||.++. ..|+.||+|++.+..+ .....+...+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4788999999999999999977 7899999999987654 3456778899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|+|.+++|.++++ ...++++.+++.+++||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999986 467899999999999999999999976 999999999999999999999999999998875
Q ss_pred C-CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 A-DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
. ....+.+||+.|+|||++....++..+||||+||++|-|++|++||+...-.+ ....+...
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----------------ty~~Ik~~- 233 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----------------TYNKIKLN- 233 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----------------HHHHHHhc-
Confidence 4 66778899999999999999999999999999999999999999997642211 11111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+|.....+..+||.++|+.||.+|||+++|+..
T Consensus 234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 123455666788999999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=356.97 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=216.8
Q ss_pred CccccceeccCCceEEEEE-EeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceee-EEeeCCe-EEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG-YCSEYGQ-HLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ 348 (579)
+|++.+.||+|.||.||++ ...+|..+|.|.++-...+....+....|+.+|++++|||||++++ .+.++.+ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 5778899999999999999 4578999999999977778888899999999999999999999998 4444444 89999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS--VVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||..|+|...++..+...+.+++..+++++.|++.||.++|..- .. |+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999988888889999999999999999999999631 24 899999999999999999999999999988
Q ss_pred CCCCcc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 427 PNADEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...... .+.+||+.||+||.+...+|+.|+||||+||++|||+.-++||.+..- ..+.+-+.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----------------~~L~~KI~ 241 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----------------LSLCKKIE 241 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----------------HHHHHHHH
Confidence 665443 457899999999999999999999999999999999999999976421 11111111
Q ss_pred ccccCCCC-hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 506 PALKGLYP-VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 506 ~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
..--...| ...+..+.+||..|+.+||+.||+...+++.+..
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111123 5667899999999999999999997666665544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=364.32 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=206.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.++||+|+||.||.++.+ +++.||+|++++..+.. ...+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 346899999999999999999665 68999999998876543 3567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC-
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM- 426 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~- 426 (579)
+||+.||.|+.+|. ....+++..+..++..|+.||.|||+. +||||||||+|||+|.+|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999996 456688999999999999999999976 9999999999999999999999999999844
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.......+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...... .....+...
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~~I~~~ 240 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYDKILKG 240 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHHHHhcC
Confidence 4445566679999999999999999999999999999999999999999764321 111111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCC
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRP 536 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 536 (579)
. ....+.-...+..+++.+.|..||++|.
T Consensus 241 k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 K-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred c-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1 1223333567889999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=367.72 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=205.7
Q ss_pred hCCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCc-----hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPS-----EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.+.|.+.+.||+|+||.|-+|. .++|+.||||++++..... .......+|+++|++++|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4467888999999999999995 4589999999998765432 122335699999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Df 420 (579)
.||||||++||+|.+++- ....+.+.....++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999985 345566677788999999999999965 99999999999999766 77899999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCC---CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccCh
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQY---NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 497 (579)
|+|+.........+.+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.......
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--------------- 388 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--------------- 388 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---------------
Confidence 99999988888889999999999999986653 347899999999999999999997543211
Q ss_pred hHHhhhcCccc--cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 498 DALAKMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 498 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....++....+ .+....+..++..++|.+||..||++|||+.|+++
T Consensus 389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 00111111111 01122445678999999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=345.27 Aligned_cols=273 Identities=21% Similarity=0.333 Sum_probs=212.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.|+....+|+|+||+||+++++ +|+.||||++..+..+....+-.++|+++|++++|||+|.++..|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999887 59999999998777666666777899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC-C
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP-N 428 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-~ 428 (579)
||+..-|+++- .....++.+...+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+|+.+. +
T Consensus 82 ~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99875555543 3456788899999999999999999976 99999999999999999999999999999887 5
Q ss_pred CCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChhHHh-----
Q 008055 429 ADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDIDALA----- 501 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~----- 501 (579)
++....++.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+..+-+.. .+.....+..+....+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 555555778899999999987 78999999999999999999999998664332211 12222221111111110
Q ss_pred --hhcCccc------cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH--HHHHHHHHH
Q 008055 502 --KMVDPAL------KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV--QALVRLVQR 551 (579)
Q Consensus 502 --~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl--~~L~~i~~~ 551 (579)
.+.-|.. ...+| ....-+.+++..||+.||++|++.++++ ..+..++++
T Consensus 235 F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred eeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 0000111 11112 2334788999999999999999999998 344444443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=385.13 Aligned_cols=262 Identities=27% Similarity=0.486 Sum_probs=219.0
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+....+.||+|+||.||+|+.. +...||||.++... ..+..++|.+|+++++.++|||||+|+|.|.+++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34445678999999999999643 45689999998655 344689999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDED----------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
+||+|||..|||++||+..... ..+++..+.+.||.|||.|++||-.+ .+|||||..+|+||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 9999999999999999643211 22388899999999999999999965 9999999999999999999
Q ss_pred eEEecccccccCCCCCcccccCC---CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhc
Q 008055 415 PQLSDCGLASNMPNADEALNNDA---GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWA 490 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 490 (579)
|||+|||+++.....+....... ...|||||.++.++||+++|||||||+|||+++ |+.||.+..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS----------- 710 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS----------- 710 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----------
Confidence 99999999998766554433222 348999999999999999999999999999999 999997532
Q ss_pred cccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
+.+.+..+-...+ -..|+.||.++++||..||+.+|.+||+++||-..|+...+...
T Consensus 711 -----n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 711 -----NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -----hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 2222333323333 56789999999999999999999999999999999988775544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.92 Aligned_cols=272 Identities=25% Similarity=0.427 Sum_probs=221.1
Q ss_pred cccCHHHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEE
Q 008055 259 TSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338 (579)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 338 (579)
.+.+..++++..+.+.+.+.||+|.||+||+|+|.. .||||++.......+..+.|.+|+.+++.-+|.||+-++|||
T Consensus 380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred CCccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 344557777778888889999999999999998863 589999999888888999999999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
...+. .+|+.+|+|.+|+.++|. ...++.......|+.|||+|+.|||.+ +|||||||..||++.++++|||+
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred cCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence 98777 999999999999999984 346788899999999999999999976 99999999999999999999999
Q ss_pred cccccccCCCC---CcccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccc
Q 008055 419 DCGLASNMPNA---DEALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492 (579)
Q Consensus 419 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 492 (579)
|||++..-..- .......+...|||||++.. .+|++.+||||||+++|||+||..||..... ++.+- -+..
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIif-mVGr 607 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIF-MVGR 607 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEE-Eecc
Confidence 99998643221 11222334567999999974 4689999999999999999999999973221 11110 0000
Q ss_pred cccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.+ +.+. .......++.++.+|+..||..++++||.+.+|+..|++++.+.
T Consensus 608 G~---------l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 608 GY---------LMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cc---------cCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 00 0000 01123467789999999999999999999999999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=325.01 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=214.6
Q ss_pred CCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|...+.||+|.||.||+|+ .++|+.||||+++.............+|++.|+.++|+||+.+++.|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367778999999999999995 4689999999998877666667788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||+. +|+..++ .....++..++..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+++.....
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9964 9999996 4566889999999999999999999976 9999999999999999999999999999988765
Q ss_pred Ccccc-cCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh---hhhhhcccc---------cc
Q 008055 430 DEALN-NDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ---SLVRWATPQ---------LH 495 (579)
Q Consensus 430 ~~~~~-~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~---~~~~~~~~~---------~~ 495 (579)
..... .+.|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+..+ .++ .+.-...|. ++
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCccccccc
Confidence 55443 3678899999999865 599999999999999999988877755432 222 111222222 22
Q ss_pred ChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+...+...-.+.+...++ .+.....+|+..|+..||.+|+|++|+++.
T Consensus 234 dY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 333333222233333333 345566999999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.97 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=209.9
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCch-hHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE-MCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 345 (579)
...+|...+.||+|+|++|++|+. +.++.||||++.+..+-++ ..+-...|-..|.+| .||.|++|+..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 345788899999999999999954 5789999999987665432 334456778888888 9999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|+||+++|+|.++|+. -..+++..+..++.+|+.||+|||.+ |||||||||+|||+|+++++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999973 35688899999999999999999965 999999999999999999999999999987
Q ss_pred CCCCCcc--------------cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcc
Q 008055 426 MPNADEA--------------LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 426 ~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 491 (579)
+.+.... .+.+||..|.+||++.....+..+|+|+||||+|+|+.|.+||....+-
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---------- 293 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---------- 293 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----------
Confidence 6543221 3467888999999999999999999999999999999999999765431
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
-...++++ +.-.+++..++.+.+|+.+.|..||.+|+|.++|.+
T Consensus 294 ------liFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 ------LIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ------HHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11222221 233466777789999999999999999999988875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.60 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=211.5
Q ss_pred CCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 347 (579)
..|+..++||+|.||.||+|+ ..+|+.||+|++.......+......+||.+|++++||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 357777899999999999995 56899999999988777777788899999999999999999999998776 799999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
+|||+. ||.-++. .....+++.++..+++|++.||+|||.+ ||+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus 197 FeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999976 7877775 4456899999999999999999999966 99999999999999999999999999999765
Q ss_pred CCC--cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhhhccccccChhHHhh
Q 008055 428 NAD--EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 428 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 502 (579)
... .....+.|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+..+-+. ..+.-+..|.-.. +...+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~-W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY-WPVSK 348 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc-ccccc
Confidence 544 34556778999999999865 599999999999999999999999987654321 1222222222222 22222
Q ss_pred hcC-ccccCC--C-------ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVD-PALKGL--Y-------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~-~~~~~~--~-------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+-. ..++.. + ....+....+|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 001111 1 1233457789999999999999999999884
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=331.83 Aligned_cols=237 Identities=25% Similarity=0.402 Sum_probs=206.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+|+..+.||.|+||.|.+++.+ +|..+|+|++++..+ .-.+.+...+|..+|+.+.||+++++++.|.+.+.++||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 5777899999999999999775 688999999987654 33456677899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++||.|+++++ ..+++++.+++.++.||+.||+|||.+ +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 125 yv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 125 YVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred ccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999997 456789999999999999999999965 999999999999999999999999999998754
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
...+.+||+.|+|||++....|..++|+|||||++|||+.|.+||....+ .....+++...+
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~~~~v- 258 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQIYEKILEGKV- 258 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHHhCcc-
Confidence 36778999999999999999999999999999999999999999976432 122333433333
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCC
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFR 535 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~R 535 (579)
.+|......+.+|+.+.|+.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3667777889999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=354.99 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=213.3
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCC-eEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYG-QHLL 346 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 346 (579)
.++|.+.+.||.|.||.||+|+. .+|..||||+++++...-+ .-.-.+|++.|++++ |||||++.+.+.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45788999999999999999964 5799999999987765533 233468999999998 999999999998887 9999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||||+ .+|+++++ .....+++..+..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+..
T Consensus 88 VfE~Md-~NLYqLmK---~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMK---DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHh---hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999995 59999997 3477899999999999999999999987 9999999999999998889999999999998
Q ss_pred CCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh-hhh-hccccccCh---hHH
Q 008055 427 PNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS-LVR-WATPQLHDI---DAL 500 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~-~~~-~~~~~~~~~---~~~ 500 (579)
........++.|.+|.|||++.. +-|+.+.|+||+|||++|+.+-++.|.+..+-+.-. +.+ ...|....+ ..+
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 88777777888999999999875 568999999999999999999999997755422111 111 112221111 112
Q ss_pred hhhcCcc--------ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 501 AKMVDPA--------LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 501 ~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+.-. +....+. +..+..+++.+|+.+||++|||+.++++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 2111111 1112223 67889999999999999999999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=360.99 Aligned_cols=263 Identities=25% Similarity=0.452 Sum_probs=206.6
Q ss_pred HhCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 341 (579)
..++|++.+.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..+ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 456789999999999999999964 235689999997543 233456788999999999 899999999988764
Q ss_pred -CeEEEEEEecCCCChhhhhcccCCC------------------------------------------------------
Q 008055 342 -GQHLLVYEFRKNGSLHDFLHLSDED------------------------------------------------------ 366 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 366 (579)
+..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4688999999999999998642210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCC
Q 008055 367 ----NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGS 439 (579)
Q Consensus 367 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~ 439 (579)
...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23478889999999999999999976 9999999999999999999999999999765332211 1123346
Q ss_pred CccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHH
Q 008055 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLS 518 (579)
Q Consensus 440 ~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (579)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+...+........+...+.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 304 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----------------EFCQRLKDGTRMRAPENATP 304 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------HHHHHHhcCCCCCCCCCCCH
Confidence 7999999999999999999999999999997 999997533211 00000101111122344567
Q ss_pred HHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 519 RFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 519 ~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+.+++.+||+.||++|||+.++++.|+.++++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=357.88 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=209.9
Q ss_pred CCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
..|+....||+|+.|.||.+. ..+++.||||++...... ..+-+.+|+.+|+..+|+|||.+++.|...+++|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 357777899999999999994 567899999999766543 34667899999999999999999999988899999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||+||+|.+.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999885 34589999999999999999999976 9999999999999999999999999999877655
Q ss_pred C-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 D-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. ...+.+||++|||||+.....|++|+||||||++++||+.|.+||-...+ +.....+...-.+.+
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------------lrAlyLIa~ng~P~l 489 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------------LRALYLIATNGTPKL 489 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------------HHHHHHHhhcCCCCc
Confidence 4 55667899999999999999999999999999999999999999964322 111122222212222
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...+..|.+++.+||..||++|+++.|+|+
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 235566789999999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.69 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=202.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC--eEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG--QHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 348 (579)
++...+.||+|+||+||++... +|...|||.+..... ...+.+.+|+.+|.+++|||||+.+|...... .+++.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4556789999999999999765 489999999876532 22677899999999999999999999855444 688999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccccCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGLASNMP 427 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 427 (579)
||+++|+|.+++... +..+++..+..++.||++||+|||.+ ||+||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999732 22799999999999999999999965 9999999999999999 7999999999988665
Q ss_pred C----CCcccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 428 N----ADEALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 428 ~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
. ........+|+.|||||++..+. ...++|||||||++.||+||++||...... ...+..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---------------~~~~~~ 234 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---------------AEALLL 234 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---------------HHHHHH
Confidence 3 22234567889999999998633 345999999999999999999999652100 011111
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
+......+..|...+.+..+++.+|+..+|++|||+.++++--.
T Consensus 235 ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 235 IGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11122223456667788999999999999999999999987643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=340.55 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=207.7
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.+.|++.+.||.|..++||+|+. ..++.||||++.-...... .+.+.+|+..++.++||||+.++..|..+..+|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35789999999999999999964 5689999999987766544 788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
.||.+|++.+.++..... .+.+..+..|++++++||.|||++ |.||||+|+.||||+.+|.|||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999765443 488999999999999999999987 999999999999999999999999998765544
Q ss_pred CCc-c----cccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhh-hhhccccccChhHH
Q 008055 429 ADE-A----LNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL-VRWATPQLHDIDAL 500 (579)
Q Consensus 429 ~~~-~----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 500 (579)
.+. . .+..++++|||||+++. ..|+.|+||||||++..||.+|+.||....+-....+ .....|... .
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t--- 254 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-T--- 254 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-c---
Confidence 332 1 34477899999999764 4699999999999999999999999976543211100 000111000 0
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...........|.+++..||+.||++|||++++++
T Consensus 255 -----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 -----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00001111223458999999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=354.46 Aligned_cols=239 Identities=26% Similarity=0.465 Sum_probs=207.3
Q ss_pred ccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.++.||.|+.|.||+|+++ ++.||||+++.- -..+|+.|+.|+||||+.+.|+|....-+++|||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3578999999999999986 678999988432 235688999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 434 (579)
-|.+.|+ .+..+.....+.+.++||.|+.|||.+ +|||||||.-||||..+..|||+|||.++......+...
T Consensus 198 qL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 198 QLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh
Confidence 9999996 466788888999999999999999976 999999999999999999999999999998877777778
Q ss_pred cCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCCh
Q 008055 435 NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPV 514 (579)
Q Consensus 435 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (579)
+.||..|||||++...+.++|+|||||||+||||+||..||...+.. -.-| .+-...+.-..|.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIw------------GVGsNsL~LpvPs 334 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIW------------GVGSNSLHLPVPS 334 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEE------------eccCCcccccCcc
Confidence 88999999999999999999999999999999999999999653321 1111 1112234445688
Q ss_pred hhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 515 KSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 515 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.|+.-|.-|+++||+..|..||++++++.-|.
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 89999999999999999999999999998774
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=379.23 Aligned_cols=263 Identities=27% Similarity=0.497 Sum_probs=219.8
Q ss_pred hCCccccceeccCCceEEEEEEeCC--Cc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD--GK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
....+..+.||+|+||.||.|...+ |. .||||.+.... +.+...+|.+|..+|+.++|||||+++|+|.+.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 4456667899999999999997653 43 48899886543 45667899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDED---NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.++++|||++|+|..||+..+.. ...++....+.++.|||+|++||+++ ++|||||..+|+|++....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999854322 45688999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCcccccCC---CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccC
Q 008055 421 GLASNMPNADEALNNDA---GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
|+|+.+...+....... ...|||||.+..+.|+.|+|||||||++||++| |..||.....
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---------------- 910 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---------------- 910 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----------------
Confidence 99996654433322222 237999999999999999999999999999999 9999965332
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.+.+..++... +-..|..|+..++++|..||+.+|++||++..|++.+..+++...
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 22333333334 556788999999999999999999999999999999999987443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.57 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=209.6
Q ss_pred HHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC---chhHHHHHHHHHHHhhcC-CCCccceeeEEeeCC
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP---SEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYG 342 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 342 (579)
...+.|.+.+.||+|+||+|+.|.+ .++..||+|++...... ....+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999965 47899999987665222 133455668999999998 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEeccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCG 421 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg 421 (579)
..++||||+.||+|++++. ...++.+..+..++.|++.|++|||.+ ||+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999996 256788899999999999999999966 99999999999999999 999999999
Q ss_pred ccccC-CCCCcccccCCCCCccCccccccCC-CC-ccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChh
Q 008055 422 LASNM-PNADEALNNDAGSGYGAPEVAMSGQ-YN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498 (579)
Q Consensus 422 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 498 (579)
++... .......+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---------------- 230 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---------------- 230 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----------------
Confidence 99988 4666777889999999999999877 86 78999999999999999999998632210
Q ss_pred HHhhhcCccccCCCChhh-HHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 499 ALAKMVDPALKGLYPVKS-LSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
....+... .-.+|... ..++..++.+|+..||.+|+|+.+++
T Consensus 231 l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 231 LYRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 01111111 11234444 67899999999999999999999999
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=357.29 Aligned_cols=267 Identities=29% Similarity=0.489 Sum_probs=221.4
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEeCC--C--cE-EEEEEeCC-CCCCchhHHHHHHHHHHHhhcCCCCccceeeEE
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQFAD--G--KV-LAVKKIDS-SALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 338 (579)
.+++..++..+.+.||+|+||.||+|.++. + .. ||||..+. .........+|+.|.++++.++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344555666677999999999999997653 2 23 89999886 346678889999999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
.....+++|||+|.||+|.++|+. ....++..++..++.++|.||+|||.+ ++|||||..+|+|++.++.+||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999973 333689999999999999999999976 99999999999999999999999
Q ss_pred cccccccCCCCCccc-ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccC
Q 008055 419 DCGLASNMPNADEAL-NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
|||+++......... .......|+|||.+....|+.++|||||||++||+++ |..||.+....
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------------- 369 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------------- 369 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------------
Confidence 999987654222111 1223458999999999999999999999999999999 89999765432
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
....+++....+...+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 370 -~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 370 -EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11222223444555666788899999999999999999999999999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.20 Aligned_cols=245 Identities=21% Similarity=0.352 Sum_probs=209.9
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
....+|.+.++||+|.||+|+++..+ +++.+|||++++..+ ..+..+..+.|-+++... +||.++.++..|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44567999999999999999999876 678999999998764 456677778888877665 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+.||++..+.+ ...+++..+..++..|+.||+|||++ +|||||||.+|||+|.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999665543 56789999999999999999999987 99999999999999999999999999998
Q ss_pred cCC-CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 425 NMP-NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 425 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
... .+....+.+||+.|||||++.+..|+.++|+|||||+||||+.|..||.+.++++ ....+
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----------------~FdsI 580 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----------------VFDSI 580 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Confidence 655 5667778899999999999999999999999999999999999999998755421 11111
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
+.. ...||...+.+..++++++|..+|++|..+
T Consensus 581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 224677788899999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=354.44 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=215.8
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCC-CCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSS-ALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+-|++.+.||+|+.|.|..|++ .+|+.+|||++.+. .........+.+|+.+|+.+.|||++++++.+++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578889999999999999976 47999999999776 444555677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|.|++++- ...++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999995 467799999999999999999999976 999999999999999999999999999998888
Q ss_pred CCcccccCCCCCccCccccccCCCC-ccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
+.-..+.+|++.|.|||++++.+|+ .++||||.|||||.|+||+.||+...- ..++..-
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------------------r~LLlKV 224 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------------------RVLLLKV 224 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------------------HHHHHHH
Confidence 7777888999999999999999985 789999999999999999999985322 1111122
Q ss_pred ccC--CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKG--LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.++ ..|...+.+.++|+.+|+..||++|.|++||++-
T Consensus 225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 222 2356677899999999999999999999999764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=363.11 Aligned_cols=274 Identities=24% Similarity=0.461 Sum_probs=232.7
Q ss_pred hCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.....+.++||.|.||.||+|+++ ....||||.++.... ..+..+|+.|..+|.+++||||++|.|........+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345678899999999999999875 346899999987664 456789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|.|||++|+|+.||+. ...++.+.+...++++||.|++||-+. ++|||||..+|||++.+..+|++|||+++.
T Consensus 707 IiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999984 345689999999999999999999965 999999999999999999999999999997
Q ss_pred CCCCC-cccccCCC---CCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNAD-EALNNDAG---SGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~-~~~~~~~~---~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
+.+.. ..++..|+ ..|.|||.+...++|.++|||||||+|||.++ |..||-... +..+
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQdV 843 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDV 843 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hHHH
Confidence 75544 22233332 47999999999999999999999999999999 999985432 1233
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccccccCCCCCCCCC
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQGPTT 567 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~~~~~~~~~~~~ 567 (579)
.+.++...+-.-|.+|+..+.+|+..||++|=.+||.+.+|+..|..++++-.--+......+.+++
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~ 910 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQ 910 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcc
Confidence 4455667777778999999999999999999999999999999999999876655555555555554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.87 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=203.7
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
..++|+++..||+|+||.||+|+-+ +|..+|+|++++... ...+.+....|-.+|...++|+||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4567999999999999999999655 699999999988764 35567778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||++||++..+|. ....|++..+..++.+++.|++.||+. |+|||||||+|+|||..|++||+|||++..+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999995 456799999999999999999999987 9999999999999999999999999998322
Q ss_pred CC----------------------CCc--------------------------ccccCCCCCccCccccccCCCCccchH
Q 008055 427 PN----------------------ADE--------------------------ALNNDAGSGYGAPEVAMSGQYNIKSDV 458 (579)
Q Consensus 427 ~~----------------------~~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv 458 (579)
.. .+. ....+||+.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 000 112357888999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCch-hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC
Q 008055 459 YSFGVVMLELLTGRKPFDSSRPR-LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537 (579)
Q Consensus 459 wslGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 537 (579)
||||||+||||.|.+||....+. ..+.+..|..- +..........+..+||.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999876553 33444444321 1111112233678899999999 9999976
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.26 Aligned_cols=249 Identities=19% Similarity=0.339 Sum_probs=202.8
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEee----CCeEEEEEEe
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSE----YGQHLLVYEF 350 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 350 (579)
...||+|++|.||+|.+ +|+.||||+++...... ...+.+.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 68899999997654332 334678899999999999999999999876 4578999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++.. ...+++.....++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence 999999999963 34688999999999999999999963 37889999999999999999999999998765332
Q ss_pred cccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 431 EALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----------------~~~~i~~~~~ 239 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----------------IYDLIINKNN 239 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhcCC
Confidence 223456778999999976 689999999999999999999999997643211 0111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
+...+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 22234456778999999999999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=343.05 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=213.5
Q ss_pred HHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.......+.+.||+|-||.|..+....+..||||+++.... .....+|.+|+++|.+++||||++++|.|..++..++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 44556778899999999999999998889999999986654 45578999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
+|||++|+|.+|+...... .+.-.....|+.|||.|++||... ++|||||.++|+|++.++++||+|||+++.+.
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999743222 234455678999999999999965 99999999999999999999999999999776
Q ss_pred CCCccccc---CCCCCccCccccccCCCCccchHHhHHHHHHHHHh--CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 428 NADEALNN---DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT--GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 428 ~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
.++..... .-...|||||.+..++++.++|||+||+++||+++ ...||.....+ ..++ ....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vve----------n~~~ 755 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVE----------NAGE 755 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHH----------hhhh
Confidence 55443221 22458999999999999999999999999999987 67898654322 1111 1111
Q ss_pred hcCc---cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 503 MVDP---ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 503 ~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
+.+. ......|..|+..+++++.+||..+-++||+++++...|++.
T Consensus 756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111 112234677889999999999999999999999999888754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.52 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=211.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+........+.+.+|++++++++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888899999999999999655 68899999999888777778889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+.| +|+.++. ....++++.+..|+.+++.||.|||++ +|+|||+||.|||++..+.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9976 9999995 567899999999999999999999965 9999999999999999999999999999987664
Q ss_pred Cccc-ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEAL-NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.... ...||+-|||||++.++.|+..+|.||+||++|||++|++||.... +.+++....
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------------------i~~Lv~~I~ 213 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------------------ITQLVKSIL 213 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------------------HHHHHHHHh
Confidence 4333 3467899999999999999999999999999999999999995421 111111111
Q ss_pred c--CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 K--GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ...|......+.+++...|.+||.+|.|-.+++.
T Consensus 214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 1234567789999999999999999999998873
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.09 Aligned_cols=259 Identities=25% Similarity=0.446 Sum_probs=204.9
Q ss_pred hCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||.||+|.+ .++..||||+++.... ....+.+.+|+.++..+ +||||++++++|.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34688889999999999999963 2456899999975432 23456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC---------------------------------------------------------
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE--------------------------------------------------------- 365 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 365 (579)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999864221
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 366 --------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 366 --------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112578889999999999999999976 999999999999999999999999999876543322
Q ss_pred cc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 432 AL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 432 ~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ....+..|+|||++.+..++.++|||||||++|||++ |..||....... .+.+.+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----------------~~~~~~~~~ 333 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----------------KFYKMIKEG 333 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----------------HHHHHHHhC
Confidence 11 1223457999999999999999999999999999998 899996532210 111111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.....+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 12222333456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=331.99 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=205.7
Q ss_pred hCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
..+|++.+.||+|+||.||+|.++ .+..||+|.++.... ......+.+|+..+++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 346888999999999999999753 356899999976532 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.++++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999863 234688999999999999999999976 999999999999999999999999998765
Q ss_pred CCCCCccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
........ ...++..|+|||.+.+..++.++|||||||++||+++ |..||....... +.+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----------------~~~ 219 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----------------VIK 219 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHH
Confidence 42221111 1223457999999999999999999999999999876 999996543211 011
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.+........+..++..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111112223455677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=335.98 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=203.7
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|+..+.||+|+||.||++.. .+++.||+|.+...... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999975 57899999998755432 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999887532 234688999999999999999999976 9999999999999999999999999999876544
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+ ....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-------------~~~~~~~-~~~~ 221 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-------------EEVDRRV-KEDQ 221 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-------------HHHHHHh-hccc
Confidence 3334456788999999999999999999999999999999999999764321110 0111111 0111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
..++...+..+.+|+.+||+.||++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1234445678999999999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.62 Aligned_cols=260 Identities=26% Similarity=0.465 Sum_probs=205.8
Q ss_pred hCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||.||+|... ++..||+|+++.... ......+.+|+.+++.+ +|+||++++++|...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 346888999999999999998642 345799999976543 23456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC---------------------------------------------------------
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE--------------------------------------------------------- 365 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 365 (579)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998853211
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc---
Q 008055 366 ---------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL--- 433 (579)
Q Consensus 366 ---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 433 (579)
...++++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 113478889999999999999999976 99999999999999999999999999987654322111
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
...++..|+|||++....++.++|||||||++|||++ |+.||....... .+............
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQMSR 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccCccC
Confidence 1123457999999998899999999999999999997 999996532211 11111111112222
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
+...+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3334578999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.19 Aligned_cols=247 Identities=29% Similarity=0.450 Sum_probs=205.6
Q ss_pred CccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.|+..+.||+|.||.||+|. .+.++.||+|++..... .....++..|+..+..++++||.++++.+..+..++++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 46667899999999999995 45789999999976554 34467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
|.||++.+.++ .+..+.+.....|++++..||.|||.+ +.+|||||+.|||+..+|.+|++|||++..+....
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999996 233446777788999999999999966 99999999999999999999999999997765544
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. .+..||+.|||||++....|+.|+||||||++.+||++|.+|+....+-... -.+.+-..|.+
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------------flIpk~~PP~L- 231 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------------FLIPKSAPPRL- 231 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------------EeccCCCCCcc-
Confidence 33 5678999999999999889999999999999999999999999765431000 01111111222
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+.+++..||..||+.||++.++++
T Consensus 232 ---~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 ---DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2345568999999999999999999999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=337.56 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=202.4
Q ss_pred CCccccceeccCCceEEEEEEeCC-----------------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccc
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-----------------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 333 (579)
++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .......|.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 478889999999999999997532 3469999987543 2344677899999999999999999
Q ss_pred eeeEEeeCCeEEEEEEecCCCChhhhhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008055 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE---------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398 (579)
Q Consensus 334 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 398 (579)
+++++.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998854211 123578889999999999999999976 999
Q ss_pred EcCCCCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh--CCC
Q 008055 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT--GRK 473 (579)
Q Consensus 399 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~ 473 (579)
||||||+|||++.++.+||+|||+++........ ....++..|+|||++....++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999998765433221 11233568999999988899999999999999999987 567
Q ss_pred CCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 474 PFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 474 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
||....... ...... ..............+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ---VIENAG-------EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH---HHHHHH-------HHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776533211 100000 000000000111123456678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=320.08 Aligned_cols=265 Identities=21% Similarity=0.317 Sum_probs=206.6
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe--eCCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS--EYGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~ 348 (579)
.|+.++.|++|.||.||+|+. ++++.||+|+++...-.....-.-.+|+.+|.+++|||||.+..+.. +-+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 366678899999999999976 47899999999877655555566789999999999999999988875 346799999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||+. +|..+++ ...+++...++..+..|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+..
T Consensus 157 e~~Eh-DLksl~d---~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYVEH-DLKSLME---TMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHh-hHHHHHH---hccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99976 9999997 3457899999999999999999999976 999999999999999999999999999998876
Q ss_pred CCc-ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh--hhhhhhhccc------cccChh
Q 008055 429 ADE-ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL--EQSLVRWATP------QLHDID 498 (579)
Q Consensus 429 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~------~~~~~~ 498 (579)
.-. ....+.|.+|.|||.+.+. .|++..|+||+|||+.||+++++.|.+..+-. ...+.....| .+....
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 543 3345678899999999865 59999999999999999999999997643311 1111111111 111110
Q ss_pred H-----HhhhcCccccCCCChh-hHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 499 A-----LAKMVDPALKGLYPVK-SLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 499 ~-----~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ..+.....++..|+.. ..+.-.+|+..+|..||.+|.|+.|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 0111111223333333 4567889999999999999999999885
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.78 Aligned_cols=266 Identities=20% Similarity=0.299 Sum_probs=203.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+++.+ +++.||+|++............+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999875 67899999997665445556778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++++.+..+.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999887765543 234688999999999999999999976 9999999999999999999999999999765432
Q ss_pred Cc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChhH-------
Q 008055 430 DE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDIDA------- 499 (579)
Q Consensus 430 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~------- 499 (579)
.. .....++..|+|||++.+..++.++|||||||++|||++|+.||......... .+.....+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 12235677899999999889999999999999999999999999764322111 111111100000000
Q ss_pred HhhhcCcccc------CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALK------GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+... ..+....+..+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0111224567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.09 Aligned_cols=266 Identities=22% Similarity=0.434 Sum_probs=231.1
Q ss_pred HHHHHHhCCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 264 ADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
++++....+..+.++||-|.||.||.|.|+. .-.||||.++..... ..+|+.|..+|+.++|||+|+|+|.|....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 5666667778888999999999999998864 668999999866543 789999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
.+|+|+|||..|+|.+||+.. +...++.-..+.++.||+.|++||..+ ++|||||..+|+|+.++..+||+|||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 999999999999999999843 334566677889999999999999976 899999999999999999999999999
Q ss_pred cccCCCCCccccc--CCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 423 ASNMPNADEALNN--DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 423 ~~~~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
++.+......... ....-|.|||.+.-..++.|+|||+|||+|||+.| |-.||.+.+ ...
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSq 474 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQ 474 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHH
Confidence 9987653322211 12347999999999999999999999999999999 999996532 346
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
+..+++...+-..|+.|+..+++||..||+++|.+||++.|+-+.++.++....+
T Consensus 475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 6677788888888999999999999999999999999999999999999886665
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.13 Aligned_cols=266 Identities=26% Similarity=0.366 Sum_probs=213.8
Q ss_pred HHHhCCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC----
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY---- 341 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 341 (579)
.+..++|.+.+.||+|||+-||.+. ..++..||+|++.... .+..+..++|++..++++|||+++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 3456789999999999999999996 5678999999997665 35567889999999999999999999987433
Q ss_pred -CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 342 -GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+.|++++|+..|+|.+.+...+..+..+++.+.+.|+.+|++||++||+. .++++||||||.|||+++.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 458999999999999999987777777899999999999999999999987 446999999999999999999999999
Q ss_pred cccccCCCC----------CcccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 008055 421 GLASNMPNA----------DEALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 421 g~~~~~~~~----------~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~ 487 (579)
|.++...-. ........|..|.|||.+. +...++++|||||||++|+|+.|..||+...+ .+.++.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE
Confidence 998654321 1123345688999999986 44578999999999999999999999975322 111111
Q ss_pred hhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
-. +....+.-......++.+.+++.+|++.||.+||++.+++..+..++
T Consensus 253 LA-------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LA-------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred Ee-------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00 11111111112235678999999999999999999999999887664
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.12 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=219.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe-EEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ-HLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 348 (579)
++|...+.+|+|+||.++.++++ +++.+++|.+..........+....|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888999999999999999765 67899999998877777767788999999999999999999999999888 99999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
+||+||+|.+.+...+ +.-++++++..++.|++.|++|||++ .|+|||||+.||+++.++.|||+|||+|+.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997544 56789999999999999999999966 999999999999999999999999999999887
Q ss_pred CC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 AD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ...+..||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.. .-+.+++ +.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----------------~Li~ki~-~~ 221 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----------------ELILKIN-RG 221 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH----------------HHHHHHh-hc
Confidence 76 555678899999999999999999999999999999999999999765421 1111111 12
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.....|.....++..++..|+..+|+.||++.+++..
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2334566777899999999999999999999999976
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.51 Aligned_cols=249 Identities=26% Similarity=0.459 Sum_probs=201.8
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||.||++.++++..+|+|.+...... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 357788999999999999999988889999998654432 45788899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999998632 23588999999999999999999976 99999999999999999999999999987654322
Q ss_pred cccc--cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EALN--NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.... ..++..|+|||++....++.++||||||+++|||++ |+.||....... . +..+.. .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~-------------~~~i~~-~ 217 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V-------------VEMISR-G 217 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H-------------HHHHHC-C
Confidence 2211 123447999999988889999999999999999999 999996543211 0 000100 0
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11112233446789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.43 Aligned_cols=257 Identities=20% Similarity=0.415 Sum_probs=206.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.+|++.+.||+|+||.||+|.+. ++. .||+|.++... .....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46889999999999999999754 333 38999986432 234467788999999999999999999999764 578
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999863 234578899999999999999999976 999999999999999999999999999986
Q ss_pred CCCCCcccc---cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEALN---NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
......... ...+..|+|||++....++.++|||||||++|||++ |..||....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----------------~~ 221 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 221 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HH
Confidence 654332221 122457999999999999999999999999999998 999997543211 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
..+........+..++..+.+++.+||..+|++||++.+++..|..+.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111112222223445678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=326.96 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=203.2
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc------------hhHHHHHHHHHHHhhcCCCCccce
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS------------EMCDDFIEMVSNISQLHHPNIMEL 334 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l 334 (579)
+..++|++.+.||+|.||.|-+|+.. +++.||||++.+..... ...+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34568999999999999999999754 79999999997643221 122567899999999999999999
Q ss_pred eeEEee--CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 335 VGYCSE--YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 335 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
+.+..+ .+.+|||+|||..|.+...- .....+++.++++|+.+++.||+|||.+ |||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 999876 46899999999998876432 2233399999999999999999999966 99999999999999999
Q ss_pred CceEEecccccccCCC------CCcccccCCCCCccCccccccCC----CCccchHHhHHHHHHHHHhCCCCCCCCCchh
Q 008055 413 LNPQLSDCGLASNMPN------ADEALNNDAGSGYGAPEVAMSGQ----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~p~~~~~~~~ 482 (579)
|++||+|||.+..... .+......||+.|+|||...++. .+.+.||||+||+||-|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 9999999999875522 22233467899999999998743 24678999999999999999999965432
Q ss_pred hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.....+++...+......+..+.+.+||.++|.+||++|.+..+|..-.
T Consensus 325 --------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 --------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1223334444443322334567899999999999999999999987554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=324.07 Aligned_cols=254 Identities=24% Similarity=0.431 Sum_probs=207.5
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||.||+|...+++.||+|.++.... ..+.+.+|+..+++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3457889999999999999999888888999999875442 2567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999998632 245689999999999999999999976 999999999999999999999999999876653
Q ss_pred CCcccc--cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEALN--NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...... ......|+|||++....++.++||||||+++|||++ |+.||....... +...+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~~~~~~ 218 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----------------VLQQVD 218 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHH
Confidence 221111 111247999999998899999999999999999999 999996543211 001111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.......+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111112234456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.70 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=202.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999765 689999999865432 2234566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999862 34688899999999999999999976 999999999999999999999999999876543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 154 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----------------~~~i~~~-- 213 (291)
T cd05612 154 R--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI----------------YEKILAG-- 213 (291)
T ss_pred C--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC--
Confidence 2 2234578899999999988899999999999999999999999976432110 0111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQA 544 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 544 (579)
...++......+.+++.+||+.||.+||+ +.++++.
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11223344568899999999999999995 7777744
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.53 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=209.8
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG- 342 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 342 (579)
+.....++|.+.+.||+|+||.||+|.. .+++.||||++............+.+|+..+..++|+|++++...+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344567999999999999999999965 47899999999776665666677889999999999999999987764332
Q ss_pred -------eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 343 -------QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 343 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 36799999999999999975544556789999999999999999999975 99999999999999999999
Q ss_pred EEecccccccCCCCC---cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccc
Q 008055 416 QLSDCGLASNMPNAD---EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 492 (579)
||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---------- 252 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------- 252 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------
Confidence 999999987654321 1233457889999999999999999999999999999999999997543210
Q ss_pred cccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+...... .....+...+.++.+++.+||+.||++||++.++++
T Consensus 253 ------~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 253 ------VMHKTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ------HHHHHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 01111111 111234455678999999999999999999999975
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=323.40 Aligned_cols=260 Identities=24% Similarity=0.420 Sum_probs=209.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||||.+.... ........+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46889999999999999999764 78999999886533 23444567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.........+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864444455688899999999999999999976 999999999999999999999999999876543
Q ss_pred CCcc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc-
Q 008055 429 ADEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP- 506 (579)
Q Consensus 429 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 506 (579)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ .+...+..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------------~~~~~~~~~ 223 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---------------SLCQKIEQC 223 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---------------HHHHHHhcC
Confidence 3221 123456789999999988899999999999999999999999864322110 01111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
......+...+..+.+++.+||..+|++||++.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111111234557899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=328.80 Aligned_cols=248 Identities=35% Similarity=0.616 Sum_probs=196.6
Q ss_pred ccceeccCCceEEEEEEeC-----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 275 VENLLGEGTFGRVYRAQFA-----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.+.||.|.||.||+|.+. .+..|+||.++.. ......+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 3578999999653 334457899999999999999999999999998888999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.++++.. ....+++..+..|+.||+.||.|||++ +++|+||+++||++++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999743 346789999999999999999999976 8999999999999999999999999999876332
Q ss_pred Ccc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 DEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
... ........|+|||.+....++.++||||||+++|||++ |+.||...... .....+ .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~----------------~~~~~~-~ 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE----------------EIIEKL-K 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----------------HHHHHH-H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------cccccc-c
Confidence 222 12223457999999999899999999999999999999 78998654221 111222 2
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
...+...+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2223334556778899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=319.29 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=209.9
Q ss_pred CCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..|++.+.||+|.-|+||+++.++ +..+|+|++.+.... .....+...|-++|+.++||.+..|++.|+.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356677899999999999998875 589999999876544 445667788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||+||+|+.+++. .....+++..+..++..|+.||+|||.. |||+|||||+||||.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999998874 4566799999999999999999999965 999999999999999999999999998732210
Q ss_pred ---------------------------------C-C-----------------------cccccCCCCCccCccccccCC
Q 008055 429 ---------------------------------A-D-----------------------EALNNDAGSGYGAPEVAMSGQ 451 (579)
Q Consensus 429 ---------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~~ 451 (579)
. . .....+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 011234566799999999999
Q ss_pred CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCC
Q 008055 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPE 531 (579)
Q Consensus 452 ~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 531 (579)
++.++|+|+|||++|||+.|..||.+... ...+..++-..+.-......+..+.+||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999987542 24455555555544334466788999999999999
Q ss_pred CCCCCC----hHHHHH
Q 008055 532 PEFRPP----MSEVVQ 543 (579)
Q Consensus 532 P~~Rps----~~evl~ 543 (579)
|.+|.. +.||.+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999988 777763
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.98 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=197.6
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
+.||+|+||.||++... +|+.||+|+++.... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999975432 2334566788999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC-Cccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA-DEAL 433 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 433 (579)
+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999886 245688999999999999999999976 9999999999999999999999999998753222 2223
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ...++
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~--~~~~p 215 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILME--EIRFP 215 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH----------------HHHHHcC--CCCCC
Confidence 34578899999999999999999999999999999999999965432110 0001100 11234
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
...+.++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 45567899999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=328.46 Aligned_cols=263 Identities=26% Similarity=0.437 Sum_probs=207.6
Q ss_pred CCccccceeccCCceEEEEEEeCC-Cc--EEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GK--VLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||.||+|..++ +. .+++|.++... .....+.+..|+.++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 468889999999999999997753 33 46888876422 234456788999999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 347 VYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
+|||+++|+|.++++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999964321 123588899999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+||+|||++..............+..|+|||++....++.++|||||||++|||++ |..||.......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----------- 226 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----------- 226 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----------
Confidence 99999999864322111111222346999999988889999999999999999998 999996543211
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
+............+..++..+.+++.+||+.+|.+|||+.++++.|+.+.+....
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 227 ------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred ------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111111122223344567899999999999999999999999999999976644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=327.68 Aligned_cols=255 Identities=26% Similarity=0.486 Sum_probs=206.1
Q ss_pred CccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|+..+.+++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 57788999999999999997643 2579999986543 2344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 008055 346 LVYEFRKNGSLHDFLHLSDED------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 413 (579)
++|||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998643211 14578899999999999999999976 999999999999999999
Q ss_pred ceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 008055 414 NPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 489 (579)
.++|+|||++........ .....++..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999876533221 112234567999999998899999999999999999998 99999754321
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.+...+........+..++.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 234 ---------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ---------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111122223355677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.94 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=201.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.+|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888999999999999999775 688999999875432 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999862 34678888999999999999999976 999999999999999999999999999976543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....+++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~~~- 231 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------IYEKILAGR- 231 (329)
T ss_pred C--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------HHHHHhcCC-
Confidence 2 233467889999999999999999999999999999999999996543210 111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVV 542 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl 542 (579)
..++...+..+.+++.+||+.||++||+ +.+++
T Consensus 232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1223334567899999999999999997 57766
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=333.10 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=206.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 457999999999999999999765 68889999987543 2344577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999863 34588899999999999999999964 2699999999999999999999999999876533
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhc------------ccc---
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA------------TPQ--- 493 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~------------~~~--- 493 (579)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||............... .+.
T Consensus 157 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred c-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 2 223345778999999999889999999999999999999999999654332111110000 000
Q ss_pred ---------------ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 494 ---------------LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 494 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.........+.............+.++.+|+.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000111111111112345689999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=323.71 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=215.0
Q ss_pred hCCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
..+|++.+.||+|.||.|-+|. +..|+.||||.+++..+. .+..-.+.+|+++|..++||||+.++..|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3478888999999999999995 578999999999887664 34456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||..+|.|++|+. ....+++.++..+++||+.|+.|+|++ +++|||||.+|||+|.++++||+|||++-.+.
T Consensus 132 MEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999995 466799999999999999999999987 99999999999999999999999999998888
Q ss_pred CCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
......+.+|++-|.+||++.+.+| .+.+|-|||||+||-|+.|..||++.+-. .-+.++-..
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------------~lvrQIs~G 268 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------------RLVRQISRG 268 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------------HHHHHhhcc
Confidence 7777788999999999999999998 57899999999999999999999875321 111111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.. +....+....-||++||..+|++|.|+.+|..-+.
T Consensus 269 aY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 269 AY---REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred cc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11 12233456678999999999999999999987654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=303.85 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=211.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|-||.||.|+.+ ++-.||+|++.+..+. .....++.+|+++.+.++||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 46888999999999999999764 6788999998765432 344577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||..+|+|...|+.. ...++++.....++.|+|.||.|+|.. +|+||||||+|+|++.++.+||+|||.+-..+
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999998632 345688888999999999999999965 99999999999999999999999999886554
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.....+.++|..|.+||+..+..++..+|+|++|++.||++.|.+||...... +...++.. .
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~k--~ 237 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIRK--V 237 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHHH--c
Confidence 45566788899999999999999999999999999999999999999764321 11111111 1
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+|...+....++|.+|+..+|.+|.+..|++.-
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 223456667789999999999999999999998754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.36 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=207.0
Q ss_pred hCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 342 (579)
.++|.+.+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.+++++. ||||++++++|.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 567888999999999999999753 23479999996543 2344567899999999996 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC---------------------------------------------------------
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE--------------------------------------------------------- 365 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 365 (579)
..++|||||++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864211
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 008055 366 -----------------------------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD 410 (579)
Q Consensus 366 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~ 410 (579)
....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 113478888999999999999999975 999999999999999
Q ss_pred CCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhh
Q 008055 411 NELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSL 486 (579)
Q Consensus 411 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~ 486 (579)
.++.+||+|||+++........ ....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 9999999999998765432221 12234567999999998899999999999999999997 999996532210
Q ss_pred hhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 487 VRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
.+...+........+...+..+.+++.+||+.+|++||++.+|.+.|+++++
T Consensus 348 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 ------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0001111111222334556789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=322.55 Aligned_cols=253 Identities=23% Similarity=0.441 Sum_probs=207.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|.+.+.||+|+||.||+|... .++.||+|++.... .....+.+|++.+++++||||+++++++...+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 35778899999999999999765 58899999986543 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999998632 234688999999999999999999976 9999999999999999999999999998766443
Q ss_pred Ccccc--cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEALN--NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..... ...+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~~ 220 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEK 220 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHC
Confidence 22111 122457999999998899999999999999999998 99998653321 11111112
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
......+...+.++.+++.+||..+|++|||+.++++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 222334455667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=321.52 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=203.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC---e--EE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG---Q--HL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---~--~~ 345 (579)
.|...+++|.|+||.||+|... +++.||||++-....- -.+|+++|+.++|||||++.-+|.... + ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4666799999999999999764 5799999998544321 136888899999999999998885432 2 24
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLAS 424 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 424 (579)
+|||||+. +|.++++.....+..++...+.-+..||.+||.|||.. +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999976 99999986656677888888899999999999999965 99999999999999976 899999999999
Q ss_pred cCCCCCcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhh-hccccccChhHHh
Q 008055 425 NMPNADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVR-WATPQLHDIDALA 501 (579)
Q Consensus 425 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~ 501 (579)
.+.......++.++..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+...... ..+.+ ...|...+...+.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 99988888889999999999999875 599999999999999999999999977443211 11111 1222221111110
Q ss_pred ----hhcCcccc-----CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 ----KMVDPALK-----GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ----~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+.++ ..+....+.+..+|+.+++..+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00011111 1234556788999999999999999999999983
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=329.15 Aligned_cols=264 Identities=25% Similarity=0.447 Sum_probs=206.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCc--EEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGK--VLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||.||+|.++ ++. .+|+|.++... .......+.+|+.++.++ +||||+++++++...+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46888899999999999999764 444 45777765432 234456788899999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 347 VYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
||||+++|+|.++++.... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999964321 123688999999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+||+|||++..............+..|+|||++....++.++|||||||++|||+| |..||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------- 231 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------- 231 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----------
Confidence 99999999864322111111223457999999988889999999999999999998 999996533211
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
..+..........+...+..+.+++.+||+.+|++||++.++++.|+++++.....
T Consensus 232 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 232 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred ------HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 00111111111123334567899999999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=337.98 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=204.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||+|++...... ......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999876 5889999999754322 234567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999852 34688899999999999999999976 999999999999999999999999999876543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
......++..|+|||++.+..++.++|||||||++|||++|..||....... ...+..|.. .....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------~~~~~ 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-----------TLQRP 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-----------cccCC
Confidence 2234567889999999999999999999999999999999999997644321 111111111 00000
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.........+.++.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001345688999999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=335.38 Aligned_cols=262 Identities=25% Similarity=0.460 Sum_probs=205.4
Q ss_pred hCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee-C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE-Y 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~ 341 (579)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+..|+.++.++ +|+||++++++|.. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 457889999999999999999542 357899999875432 33456778899999999 89999999998865 4
Q ss_pred CeEEEEEEecCCCChhhhhcccCCC-------------------------------------------------------
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDED------------------------------------------------------- 366 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 366 (579)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999998532210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc---ccCCCCCc
Q 008055 367 --NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL---NNDAGSGY 441 (579)
Q Consensus 367 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y 441 (579)
...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.++|+|||++..+....... ...++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13688999999999999999999976 99999999999999999999999999997654322211 12234579
Q ss_pred cCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHH
Q 008055 442 GAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRF 520 (579)
Q Consensus 442 ~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 520 (579)
+|||++.+..++.++|||||||++|||++ |..||....... . +...+........+.....++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E--------------FCRRLKEGTRMRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H--------------HHHHHhccCCCCCCccCCHHH
Confidence 99999999999999999999999999998 999996532210 0 001111111112233445689
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 521 ADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 521 ~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+++.+||+.+|++||++.++++.|+++++.
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=322.87 Aligned_cols=253 Identities=22% Similarity=0.418 Sum_probs=205.7
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 356889999999999999999988888999999865432 35678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.++++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999998632 345678889999999999999999976 9999999999999999999999999999765432
Q ss_pred Cccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.... ...++..|+|||++....++.++|||||||++|+|++ |+.||....... .... +. .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----------~~----~ 219 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA----------LQ----R 219 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH----------HH----c
Confidence 2111 1223457999999988889999999999999999999 999996543211 0000 00 0
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
..........+.++.+++.+||..+|++||+++++.+.|++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111223345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.67 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=196.6
Q ss_pred CccccceeccCCceEEEEEEeC--CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh---cCCCCccceeeEEe-----eC
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA--DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ---LHHPNIMELVGYCS-----EY 341 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~-----~~ 341 (579)
+|++.+.||+|+||.||+|... +++.||+|++............+.+|+..++. ++||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6889999999999999999763 46889999987654433334455566666655 47999999999885 34
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
...++||||+. ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 56899999996 6999988632 234588999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCch-hhhhhhhhcccccc-ChhH
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR-LEQSLVRWATPQLH-DIDA 499 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~ 499 (579)
++.............++..|+|||++....++.++|||||||++|||++|++||...... ....+.+....... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 997665443333455678999999998889999999999999999999999999765432 11122221110000 0000
Q ss_pred Hhh----hcCccccC---CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAK----MVDPALKG---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~----~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ........ ......+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 001224567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.38 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=205.8
Q ss_pred CCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||.||+|.++. ...||+|.+.... .......|.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 468889999999999999998742 4579999986543 33445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999863 234789999999999999999999975 9999999999999999999999999999876
Q ss_pred CCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 427 PNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 427 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
....... ....+..|+|||.+....++.++||||||+++|||++ |..||....... +..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-----------------~~~ 219 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-----------------VIK 219 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-----------------HHH
Confidence 4222111 1223457999999998899999999999999999998 999996432211 001
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.+........+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111122344567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=318.62 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=206.4
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-----CCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-----YGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 343 (579)
...|...+.||+|+||.|+.+.. .+|+.||||++.......-..++-.+|++.++.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34566678999999999999965 478999999998666556678889999999999999999999998854 467
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.|+|+|+| +.+|+..++ .++.++..++..++.|+++||.|+|+. +|+||||||.|+|++.+..+||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 89999999 569999996 345599999999999999999999955 9999999999999999999999999999
Q ss_pred ccCCC---CCcccccCCCCCccCccccc-cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPN---ADEALNNDAGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~---~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
+.... .........|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+.-..-.+.....+.. ..+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e~ 251 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEED 251 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHHH
Confidence 98754 33334567788999999986 4679999999999999999999999997765322211111111111 1111
Q ss_pred Hhhhc--------C-------ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMV--------D-------PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~--------~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+..+- . ..+...++ .......+|+.+||..||.+|+|++|.++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111 0 00011122 44567889999999999999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=349.42 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=202.5
Q ss_pred CccccceeccCCceEEEEEEeC-C-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-D-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|.+.+.||+|+||.||+|... + +..||+|.+.... ......+..|+.+++.++||||+++++++...+..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888999999999999999654 3 5778888764432 3344567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.++++.......++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999998864444455788999999999999999999976 9999999999999999999999999999865433
Q ss_pred Cc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.. .....+++.|+|||++.+..++.++|||||||++|||++|+.||....... .+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----------------~~~~~~~~ 286 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----------------IMQQVLYG 286 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC
Confidence 21 223457889999999999999999999999999999999999996543211 11111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ...+...+..+.+++.+||+.||++||++.+++.
T Consensus 287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11 1123345568999999999999999999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=323.71 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=209.0
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
..+|++.+.||.|+||.||+|...++..+|+|.+.... ......+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44688889999999999999998889999999987554 2235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.++++.. ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999742 345689999999999999999999976 9999999999999999999999999998765432
Q ss_pred Cccc-ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 430 DEAL-NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 430 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.... ....+..|+|||.+....++.++||||||+++|+|++ |+.||....... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----------------~~~-~~~~~ 220 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----------------VYD-QITAG 220 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----------------HHH-HHHhC
Confidence 2211 1223457999999988889999999999999999998 899996543211 111 11112
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.....+..++..+.+++.+||..||++|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2223345566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=321.17 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=200.9
Q ss_pred ccccceeccCCceEEEEEEeCCC-c--EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------Ce
Q 008055 273 FNVENLLGEGTFGRVYRAQFADG-K--VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------GQ 343 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 343 (579)
|.+.+.||+|+||.||+|...+. . .+|+|.++...........+..|+..++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678899999999999987543 2 589999877655556677889999999999999999999987432 24
Q ss_pred EEEEEEecCCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSD--EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 2234588999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccCh
Q 008055 422 LASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDI 497 (579)
Q Consensus 422 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 497 (579)
++......... .....+..|+|||++....++.++|||||||++|||++ |+.||....... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----------- 223 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----------- 223 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-----------
Confidence 98765433211 11223457999999998899999999999999999999 889996533211 0
Q ss_pred hHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.+.+...-....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 ---YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000001111112334557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.63 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=204.4
Q ss_pred ccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe-----
Q 008055 273 FNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ----- 343 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 343 (579)
|.+.+.||+|+||.||+|.... +..||+|+++...........+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997642 3689999998665555556788999999999999999999998866544
Q ss_pred -EEEEEEecCCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 344 -HLLVYEFRKNGSLHDFLHLSD--EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 344 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+++|||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885432 2234688999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccC
Q 008055 421 GLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 421 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
|+++......... ....+..|+|||++....++.++|||||||++|||++ |..||....... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~---------- 224 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I---------- 224 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----------
Confidence 9987654432211 1223457999999988889999999999999999999 889986533210 1
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
. +.+........+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 225 ---~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 ---Y-DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---H-HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11111111223445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.45 Aligned_cols=246 Identities=26% Similarity=0.451 Sum_probs=200.0
Q ss_pred eeccCCceEEEEEEe---CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 278 LLGEGTFGRVYRAQF---ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.||+|+||.||+|.+ .++..+|+|+++.........+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 35789999998766555556778999999999999999999999885 45678999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc-
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL- 433 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 433 (579)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999852 34688999999999999999999976 99999999999999999999999999987654332211
Q ss_pred ---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 434 ---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 434 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
....+..|+|||.+....++.++|||||||++|||++ |..||....... +.+.+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~~~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----------------VTQMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHCCCC
Confidence 1122458999999988889999999999999999998 999997543211 1111122222
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
...+..++.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 234455677899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=318.39 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=211.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999776 789999999875332 2344678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.........+++..+..++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865444456789999999999999999999976 999999999999999999999999999875543
Q ss_pred CCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+.....
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~ 223 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------------SLCKKIEKC 223 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---------------HHHhhhhcC
Confidence 222 2223456789999999988899999999999999999999999964321100 000111111
Q ss_pred ccCCCCh-hhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 508 LKGLYPV-KSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 508 ~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.....+. ..+..+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111222 45568999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.10 Aligned_cols=259 Identities=27% Similarity=0.504 Sum_probs=207.2
Q ss_pred CccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+|++.+.||+|+||.||+|... ....+++|.+..... ......+..|+..++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3677899999999999999753 235788888865432 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 008055 346 LVYEFRKNGSLHDFLHLSDE--------------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~ 405 (579)
++|||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 99999999999999864211 123578999999999999999999976 9999999999
Q ss_pred CEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCch
Q 008055 406 NILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPR 481 (579)
Q Consensus 406 Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~ 481 (579)
|||+++++.+||+|||+++........ ....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998765332221 11223457999999988889999999999999999999 99999654321
Q ss_pred hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 482 LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+.+..........+...+.++.+++.+||+.+|++||++.++++.|++++.+
T Consensus 237 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 -----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11111122222223445567899999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.62 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=201.1
Q ss_pred CCccccceeccCCceEEEEEEeCC--CcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD--GKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
++|++.+.||+|+||.||+|.... +..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 368889999999999999997543 36899999864332 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999862 34688999999999999999999976 99999999999999999999999999997654
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. .....+++.|+|||++.+..++.++|||||||++|||++|..||....... ....+....
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----------------~~~~i~~~~ 244 (340)
T PTZ00426 183 TR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----------------IYQKILEGI 244 (340)
T ss_pred CC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----------------HHHHHhcCC
Confidence 32 234567889999999998889999999999999999999999997543211 011111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
..++...+..+.+++.+||+.||++|+ +++++++
T Consensus 245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 113344556789999999999999995 7888765
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=327.43 Aligned_cols=262 Identities=26% Similarity=0.476 Sum_probs=210.2
Q ss_pred HHHhCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEe
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCS 339 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 339 (579)
.+..++|++.+.||+|+||.||++...+ ...+|+|.+..... ......+.+|+.++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445678889999999999999997642 36899999875433 33456788999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 008055 340 EYGQHLLVYEFRKNGSLHDFLHLSD------------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANI 407 (579)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Ni 407 (579)
..+..+++|||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999986432 2345688999999999999999999976 999999999999
Q ss_pred EEcCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhh
Q 008055 408 LLDNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLE 483 (579)
Q Consensus 408 ll~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~ 483 (579)
++++++.+||+|||+++......... ....+..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 99999999999999998664432211 1122457999999988899999999999999999998 99998653321
Q ss_pred hhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 484 QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.+.+..........+..++..+.+++.+||..||++|||+.++++.|+.++
T Consensus 242 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ---------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111112222234455678999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=332.80 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=196.6
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
+.||+|+||.||++... +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999975432 2334566788999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-ccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EAL 433 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 433 (579)
+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 99988852 34688999999999999999999976 99999999999999999999999999987532222 223
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ......... ..++
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~~~~~~--~~~p 215 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILMEE--IRFP 215 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcCC--CCCC
Confidence 3457889999999999999999999999999999999999996543211 001111111 1133
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
...+.++.+++.+||..||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 44567889999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.01 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=205.3
Q ss_pred CCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+|.+.+.||+|+||.||+|...+ +..||+|.++.... .+....+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457888999999999999997643 47899999875432 33467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 345 LLVYEFRKNGSLHDFLHLSD----------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
++||||+++|+|.++++... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996432 1234578899999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhc
Q 008055 415 PQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWA 490 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 490 (579)
+||+|||++......... .....+..|+|||++....++.++|||||||++|||++ |..||....... .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~---- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---V---- 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H----
Confidence 999999998754332211 12223567999999999999999999999999999999 999986543211 0
Q ss_pred cccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
... .........+...+..+.+++.+||..||++||++.||++.|+
T Consensus 234 ---------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 ---------IEC-ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---------HHH-HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 011 1111111223445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.37 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=210.3
Q ss_pred HhCCccccceeccCCceEEEEEEeCC-----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-CC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFAD-----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-YG 342 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 342 (579)
..++|++.+.||+|+||.||+|.+.+ +..|++|++.... .......+.+|+..+++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 45678899999999999999998765 6889999886432 34456778899999999999999999998765 57
Q ss_pred eEEEEEEecCCCChhhhhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDED----NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
..++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998654322 15689999999999999999999976 99999999999999999999999
Q ss_pred cccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccc
Q 008055 419 DCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 419 Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|||+++.+...... ....++..|+|||++....++.++|||||||++||+++ |+.||....... +..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~------ 230 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA------ 230 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH------
Confidence 99999765433221 11233457999999988889999999999999999999 999997543211 111
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..........+..++.++.+++.+||..||++|||+.++++.|+.+.++
T Consensus 231 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 --------YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1111111112334567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.46 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=211.2
Q ss_pred HhCCccccceeccCCceEEEEEEeCCC-cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeE-Ee---e--
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADG-KVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGY-CS---E-- 340 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~---~-- 340 (579)
...++++.+.|.+|||+.||.|....+ ..||+|++-.. +....+...+|+.+|+.|. |+|||.+++. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 344678899999999999999987665 99999998665 4667788999999999996 9999999993 21 1
Q ss_pred -CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 008055 341 -YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419 (579)
Q Consensus 341 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 419 (579)
.-+++|.||||.||.|-+++.... ...|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 236789999999999999997433 33499999999999999999999987 78899999999999999999999999
Q ss_pred ccccccCCCCC----------cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhh
Q 008055 420 CGLASNMPNAD----------EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL 486 (579)
Q Consensus 420 fg~~~~~~~~~----------~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~ 486 (579)
||.+....... .......|+.|.|||++. +...++|+|||||||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99886432221 112345678999999984 66789999999999999999999999976421
Q ss_pred hhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 487 VRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
..+++..+.-.-.......|.+||..||+.||++||++-+|+..+.++.+...
T Consensus 264 --------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred --------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 11222222212224667889999999999999999999999999999887443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=323.50 Aligned_cols=266 Identities=26% Similarity=0.421 Sum_probs=206.8
Q ss_pred ccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEE
Q 008055 273 FNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHL 345 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 345 (579)
|.+.+.||+|+||+||++.. .++..||+|.+..... ......+.+|++.++.++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37889999999999988643 3578999999875432 23456788999999999999999999988653 4688
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999999862 3589999999999999999999976 999999999999999999999999999876
Q ss_pred CCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
....... ....++..|+|||.+....++.++||||||+++|||++|..||......... ...+..... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQM-TVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhccccccc-chhhhh
Confidence 6443221 1122345699999998888999999999999999999999998654322111 111111111 111222
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
+.++.......+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 223333333345566789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.42 Aligned_cols=250 Identities=22% Similarity=0.427 Sum_probs=201.9
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||.||++...++..+|+|.+...... ...+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 357788999999999999998887778999998754432 46788999999999999999999999988899999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+.+|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999998632 23689999999999999999999976 99999999999999999999999999987654322
Q ss_pred ccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... ...++..|+|||++....++.++|||||||++|||++ |..||....... ..... ...
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~-~~~ 217 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----------------TVEKV-SQG 217 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHH-hcC
Confidence 111 1223457999999988889999999999999999999 999996543211 00011 111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111122334578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=324.55 Aligned_cols=250 Identities=25% Similarity=0.440 Sum_probs=221.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.+-|++.+.||+|.|++|-+|++- .|..||||++.+...+......+..|++.|+.++|||||++|........+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345888899999999999999654 7999999999998888777788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCceEEecccccccCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMP 427 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 427 (579)
|+=++|+|++||- .....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|.+||.|||++-.+.
T Consensus 97 ELGD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999996 3455788999999999999999999987 899999999998775 56899999999999888
Q ss_pred CCCcccccCCCCCccCccccccCCCC-ccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
++....+.+|+..|.|||++.+..|+ +++||||||||||.|++|++||.... +.+.+..++|.
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImDC 234 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMDC 234 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhcc
Confidence 88888889999999999999999997 67899999999999999999997543 33455555553
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+...|.....++.+||..||..||.+|.+.++|+.
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 34567888899999999999999999999988874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.02 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=204.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|.+.+.||+|+||.||+|... +++.||+|++...... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999765 7899999999754322 244667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999863 25688999999999999999999975 999999999999999999999999999876544
Q ss_pred CC------------------------------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCC
Q 008055 429 AD------------------------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478 (579)
Q Consensus 429 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~ 478 (579)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 122345678999999999999999999999999999999999999764
Q ss_pred Cchh-hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC-hHHHHHH
Q 008055 479 RPRL-EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVVQA 544 (579)
Q Consensus 479 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 544 (579)
.... ...+..|. ..+........+..+.+++.+|+. ||.+||+ +.++++.
T Consensus 234 ~~~~~~~~i~~~~---------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK---------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC---------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4211 11111111 011111111246789999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.33 Aligned_cols=258 Identities=21% Similarity=0.393 Sum_probs=203.8
Q ss_pred HHhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY 341 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 341 (579)
+.+++|++.+.||+|+||.||+|... .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34567999999999999999998653 356799999864332 23456788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDED------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
...++||||+++|+|.++++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999998642211 23467888999999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcc
Q 008055 416 QLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 491 (579)
+|+|||++.......... ...++..|+|||++....++.++|||||||++|||++ |..||....... .
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~----- 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---V----- 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-----
Confidence 999999987554322211 1223457999999998889999999999999999999 788986543211 0
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
........ ....+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 231 --------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 --------LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00111111 11223445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.21 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=193.4
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3455688999999999999765 68999999986543 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 245677888999999999999976 99999999999999999999999999987654322
Q ss_pred -cccccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 431 -EALNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
......++..|+|||++.. ...+.++|||||||++|||++|+.||........... ....
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--------------~~~~ 288 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--------------MCAI 288 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--------------HHHH
Confidence 1233467889999998743 2235689999999999999999999974322111110 0000
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
........+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112234456789999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=331.84 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=193.0
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||+|+||.||++... +++.||+|++.... ........+..|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999765 57899999986532 2234456788899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-ccccc
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EALNN 435 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 435 (579)
.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 999862 34688999999999999999999976 99999999999999999999999999987543222 22334
Q ss_pred CCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChh
Q 008055 436 DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVK 515 (579)
Q Consensus 436 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (579)
.++..|+|||++.+..++.++|||||||++|||++|+.||....... ........ ...++..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----------------~~~~~~~~--~~~~~~~ 215 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----------------MYRKILQE--PLRFPDG 215 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----------------HHHHHHcC--CCCCCCc
Confidence 57889999999999999999999999999999999999996532210 00111111 1123445
Q ss_pred hHHHHHHHHHhcCCCCCCCCCChHHH
Q 008055 516 SLSRFADVIALCVQPEPEFRPPMSEV 541 (579)
Q Consensus 516 ~~~~l~~li~~cl~~dP~~Rps~~ev 541 (579)
.+..+.+++.+||+.||++||++..+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 56788999999999999999865333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.28 Aligned_cols=246 Identities=24% Similarity=0.456 Sum_probs=198.9
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGS 355 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (579)
+.||+|+||.||+|... +++.+|+|.+.... ..+....+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999764 78999999886433 34456778999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc-
Q 008055 356 LHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN- 434 (579)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 434 (579)
|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 80 L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999862 234688999999999999999999976 999999999999999999999999999875443211111
Q ss_pred --cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 435 --NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 435 --~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
...+..|+|||.+....++.++|||||||++|||++ |..||....... ............
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~ 216 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQGVRLP 216 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCCCC
Confidence 111346999999998889999999999999999998 889986533211 111111122223
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34455678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.93 Aligned_cols=265 Identities=21% Similarity=0.307 Sum_probs=199.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|.+.+.||+|+||.||+|..+ ++..||+|+++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999765 688999999865432 2234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 997 499988852 234578889999999999999999975 9999999999999999999999999998754332
Q ss_pred C-cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhcc-------ccccChhH
Q 008055 430 D-EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWAT-------PQLHDIDA 499 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~-------~~~~~~~~ 499 (579)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+..... +.......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 2 2223456778999999865 56899999999999999999999999765432211 1111110 00111111
Q ss_pred HhhhcCccccCC----CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKGL----YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+..... .....+.++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111111000 01123467889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.65 Aligned_cols=248 Identities=26% Similarity=0.435 Sum_probs=201.8
Q ss_pred CccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
+|++.+.||+|+||.||++.++++..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 47778899999999999998887888999998654432 356888999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998632 33688999999999999999999976 999999999999999999999999999876543221
Q ss_pred ccc--cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 432 ALN--NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 432 ~~~--~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
... ...+..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----------------~~~~~~~~ 218 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-----------------VESVSAGY 218 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-----------------HHHHHcCC
Confidence 111 112346999999998899999999999999999999 8999965432110 01111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
....+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2223344667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.22 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=200.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.+|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46778899999999999999764 444 47777775332 23344677788888999999999999998764 5678
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 99999999999999963 234689999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
........ ...++..|+|||.+....++.++|||||||++|||++ |..||....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~~ 221 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----------------VP 221 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HH
Confidence 54332211 1223457999999998899999999999999999998 999997643221 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
+.+........+..++..+.+++.+||..+|++|||+.|+++.|..+.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111111112223345678899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=322.27 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=206.6
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46788899999999999999642 34568999886543 34466789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 345 LLVYEFRKNGSLHDFLHLSD---------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 1223589999999999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcc
Q 008055 416 QLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 491 (579)
||+|||++......... ....++..|+|||++....++.++|||||||++|||++ |..||....... .
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----- 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----- 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H-----
Confidence 99999998765432211 11223457999999998889999999999999999999 999996543211 0
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
...+.... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 232 --------~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 --------IECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --------HHHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 01111100 0111223456799999999999999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.94 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=209.5
Q ss_pred CCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY 341 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 341 (579)
++|.+.+.||+|+||.||++... +...+|+|.++... .......+.+|+.++..+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 46889999999999999999653 23579999997543 233456788899999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL 409 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill 409 (579)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975322 123588999999999999999999976 99999999999999
Q ss_pred cCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 008055 410 DNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQS 485 (579)
Q Consensus 410 ~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~ 485 (579)
+.++.+||+|||++.......... ....+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987654322111 1122357999999988889999999999999999998 88998653321
Q ss_pred hhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 486 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.+.+.+........+...+.++.+++.+||+.+|++|||+.++++.|++++....
T Consensus 250 -------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 -------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred -------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111111111222344556789999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.98 Aligned_cols=243 Identities=22% Similarity=0.315 Sum_probs=197.5
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
+.||+|+||.||++... +++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 689999999975432 2344567888999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC-Cccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA-DEAL 433 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 433 (579)
+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9998885 234688999999999999999999976 9999999999999999999999999998753222 2223
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...++..|+|||++.+..++.++|||||||++|||++|+.||........ ....... ...++
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----------------~~~~~~~--~~~~p 215 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------FELILME--DIKFP 215 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----------------HHHhccC--CccCC
Confidence 34578899999999988999999999999999999999999965332110 0000000 11234
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRP-----PMSEVVQA 544 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 544 (579)
...+.++.+++.+||..||++|+ ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 44567889999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.50 Aligned_cols=260 Identities=25% Similarity=0.418 Sum_probs=206.6
Q ss_pred hCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 342 (579)
.++|.+.+.||+|+||.||+|.+. .++.||+|+++.... ....+.+..|+.++.++. ||||++++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 345777899999999999999764 346899999976432 333457889999999997 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC---------------------------------------------------------
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE--------------------------------------------------------- 365 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 365 (579)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999964321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 366 -------------------------------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 366 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 112467788899999999999999965 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
+++++.+||+|||+++....... .....++..|+|||.+....++.++|||||||++|||++ |..||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999876432221 112234567999999998889999999999999999998 899986532211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.....+....+...+..++..+.+++.+||..+|++||++++|++.|+.++
T Consensus 350 --------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111122222234455678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=318.86 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=210.6
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++.. .+++.+|||.+..... .......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677889999999999999975 5789999998865432 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999864434455789999999999999999999976 999999999999999999999999999876543
Q ss_pred CCcc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.... ....++..|+|||++.+..++.++||||||+++|+|++|..||........... .......
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------------~~~~~~~ 224 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC--------------KKIEQCD 224 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh--------------hhhhcCC
Confidence 3222 223466789999999888899999999999999999999999965332111100 0000111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.....+...+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111112345678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.47 Aligned_cols=266 Identities=21% Similarity=0.336 Sum_probs=203.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|+++++.++||||++++++|.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 467999999999999999999776 68889999886543 2344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999862 34578888999999999999999963 3799999999999999999999999999875533
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhh----hcc-------------
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR----WAT------------- 491 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~----~~~------------- 491 (579)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||............. +..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2 1223456779999999998889999999999999999999999997543221111100 000
Q ss_pred -------ccc-c--ChhHHhhhcCccccCCCC-hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 492 -------PQL-H--DIDALAKMVDPALKGLYP-VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 492 -------~~~-~--~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.. . ....+...+........+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 0 000000000000011111 123467899999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=321.89 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=206.6
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+|.+.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+..+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 35778899999999999999642 35678899886443 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 345 LLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999964321 123588999999999999999999976 99999999999999999
Q ss_pred CceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 008055 413 LNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 488 (579)
+.++|+|||++......... ....++..|+|||++....++.++|||||||++|||+| |+.||....... ..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~- 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI- 235 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-
Confidence 99999999998755432211 12233567999999998899999999999999999999 999986543211 00
Q ss_pred hccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..+ ........+...+..+.+++.+||+.+|++|||+.+|+++|+++...
T Consensus 236 ------------~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ------------ECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ------------HHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 001 11111112333456899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.10 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=196.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----CeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 345 (579)
+|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999764 689999999875443334456788999999999999999999987533 3579
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+. ++|.+++. ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998885 234689999999999999999999976 999999999999999999999999999875
Q ss_pred CCCCCc----ccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccC--
Q 008055 426 MPNADE----ALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHD-- 496 (579)
Q Consensus 426 ~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~-- 496 (579)
...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+........
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 123456789999999875 6789999999999999999999999976432111 1111111000000
Q ss_pred -------hhHHhhhcCccccCCC---ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 497 -------IDALAKMVDPALKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 497 -------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.......+.......+ ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 01234578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=316.64 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=204.2
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|...++..||+|++..... ....+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 356899999999999999999887777899999975443 24578899999999999999999998754 56899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999632 234578999999999999999999976 9999999999999999999999999998765433
Q ss_pred Cccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.... ...++..|+|||+.....++.++||||||+++|||++ |..||........ ... ...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----------------~~~-~~~ 218 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQ-VER 218 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----------------HHH-Hhc
Confidence 2211 1223457999999988899999999999999999999 8889865432110 000 011
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
......+...+..+.+++.+||+.+|++||++.++++.|++..
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1111223445678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=318.21 Aligned_cols=252 Identities=26% Similarity=0.457 Sum_probs=197.5
Q ss_pred ceeccCCceEEEEEEeCC-Cc--EEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecC
Q 008055 277 NLLGEGTFGRVYRAQFAD-GK--VLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+.||+|+||.||+|...+ +. .+++|.++... .......+..|+..+.++ +||||+++++++...+..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998753 43 46888876432 234456788999999999 89999999999999999999999999
Q ss_pred CCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 353 NGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 353 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
+|+|.++++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999864321 123578999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
|++..............+..|+|||++....++.++|||||||++|||++ |..||.......
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----------------- 219 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------------- 219 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----------------
Confidence 99853322111111223457999999988889999999999999999997 999996532210
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
..+.+........+...+.++.+++.+||+.+|.+|||+.++++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00111111111223345568899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.68 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=203.0
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|++.+.||+|+||.||++... +++.||+|++...... ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999764 6899999999754432 2223557789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888532 234689999999999999999999976 9999999999999999999999999998766443
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~~~ 221 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERRVK-EDQ 221 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHHhh-hcc
Confidence 3333456778999999999888999999999999999999999999753321100 01111111 111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
..++...+..+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 223444567889999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.17 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=195.6
Q ss_pred ceeccCCceEEEEEEe----CCCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 277 NLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+.||+|+||.||+++. .+++.||+|+++.... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578999999875432 122345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999852 34577888899999999999999976 99999999999999999999999999987543222
Q ss_pred c-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 E-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||....... .+..+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------------~~~~~~~~~-- 216 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------------TIDKILKGK-- 216 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCC--
Confidence 2 223457889999999998889999999999999999999999997543211 111111111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
...+...+..+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 123444567889999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.09 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=194.2
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHH---HhhcCCCCccceeeEEeeCCeEEEE
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSN---ISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
|++.+.||+|+||.||+|... +++.||||+++.... .....+.+..|+++ ++.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999765 689999999975432 22234455555554 4567899999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|..+++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998875 24689999999999999999999976 99999999999999999999999999986533
Q ss_pred CC-CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NA-DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.. .......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~----------------~~~i~~~ 216 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV----------------FDSIVND 216 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC
Confidence 22 222334578899999999999999999999999999999999999976432110 0111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
...++...+..+.+++.+||+.||++||+ +.++++
T Consensus 217 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 --EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11234445678899999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.47 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=197.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 357999999999999999999775 6889999998754422 22346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+. ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 83 EYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred ECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9995 688887752 335688899999999999999999976 999999999999999999999999999865432
Q ss_pred CC-cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh--hhh-hhccccccChhHHh--
Q 008055 429 AD-EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ--SLV-RWATPQLHDIDALA-- 501 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~-- 501 (579)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|..||......... .+. ....+.........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 22 2233456778999999865 45889999999999999999999999764321111 000 00111000000000
Q ss_pred -hhcCccccCCCC---------hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 -KMVDPALKGLYP---------VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 -~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+ ......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 012346789999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=310.69 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=205.6
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC-ccceeeEEeeCC------e
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN-IMELVGYCSEYG------Q 343 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~ 343 (579)
.|+..++||+|+||+||+|+. .+|+.||+|++......+.......+|+.+++.++|+| |+++++++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 456677899999999999965 47899999999765543344556689999999999999 999999998776 8
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++|+||++ -+|..++.........++...+..++.|++.||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 899999995 499999975443324567788999999999999999976 9999999999999999999999999999
Q ss_pred ccCC-CCCcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh--hhhhhccccccChhH
Q 008055 424 SNMP-NADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ--SLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 499 (579)
+... +........+|.+|.|||++.+. .|+...||||+|||++||++++.-|.+..+.... -..-...|....+..
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8766 33345566778899999999977 6899999999999999999999999776542111 111112222222222
Q ss_pred HhhhcCccc--cCCC-C-------hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 500 LAKMVDPAL--KGLY-P-------VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 500 ~~~~~~~~~--~~~~-~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+..+.+-.. .... + ........+++.+|++.+|.+|.|++..++.
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222111110 0000 0 1111478899999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.65 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=199.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||||++..... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999765 689999999975432 2334566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999862 34689999999999999999999976 999999999999999999999999999865422
Q ss_pred CCc---------------------------------------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHH
Q 008055 429 ADE---------------------------------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELL 469 (579)
Q Consensus 429 ~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell 469 (579)
... .....+|+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 01234788999999999999999999999999999999
Q ss_pred hCCCCCCCCCchh-hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC---hHHHHH
Q 008055 470 TGRKPFDSSRPRL-EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP---MSEVVQ 543 (579)
Q Consensus 470 tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~ 543 (579)
+|..||....... ...+..|.. .+........+..+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE---------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999997644321 111111110 00000011234678899999996 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.09 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=201.5
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
...++|++.+.||+|+||.||++... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567999999999999999999765 688999999965322 2233456778999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999862 3477888999999999999999976 999999999999999999999999999876
Q ss_pred CCCCCc--ccccCCCCCccCccccccC----CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 426 MPNADE--ALNNDAGSGYGAPEVAMSG----QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 426 ~~~~~~--~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
...... .....+++.|+|||++... .++.++|||||||++|||++|+.||...... ..
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~ 255 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GT 255 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----------------HH
Confidence 543221 2234578899999998653 3789999999999999999999999754321 01
Q ss_pred HhhhcCccccCCCCh--hhHHHHHHHHHhcCCCCCCC--CCChHHHHHH
Q 008055 500 LAKMVDPALKGLYPV--KSLSRFADVIALCVQPEPEF--RPPMSEVVQA 544 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 544 (579)
...+........++. ..+.++.+++.+||..+|.+ |+|+.++++.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111111111111222 34578899999999999998 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=333.55 Aligned_cols=239 Identities=24% Similarity=0.337 Sum_probs=195.0
Q ss_pred ceeccCCceEEEEEEe----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 277 NLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+.||+|+||.||+++. .+|+.||+|++............+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 367899999997654333345567789999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-c
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-E 431 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 431 (579)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999852 34689999999999999999999976 99999999999999999999999999987654332 2
Q ss_pred ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 432 ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 432 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
.....++..|+|||++....++.++|||||||++|||++|+.||....... ....+... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----------------~~~~i~~~--~~~ 216 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----------------TMTMILKA--KLG 216 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----------------HHHHHHcC--CCC
Confidence 233456789999999998889999999999999999999999997543210 11111111 112
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCChHH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRPPMSE 540 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rps~~e 540 (579)
.+...+..+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 33445678899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=319.47 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=203.4
Q ss_pred CCccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.+|++.+.||+|+||.||+|.. .++..+|+|.+..... ......+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 3577889999999999999974 3567899999975432 344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 346 LVYEFRKNGSLHDFLHLSDE-------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
+||||+++|+|.+++..... ....+++.++..++.|++.||+|||++ +|+||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853211 123578889999999999999999976 99999999999999999
Q ss_pred CceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 008055 413 LNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 488 (579)
+.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------- 233 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------- 233 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 9999999999976543221 112223457999999988889999999999999999999 99999653321
Q ss_pred hccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.+.+.+........+..++..+.+++.+||+.||++||++.+|++.|.
T Consensus 234 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 234 ----------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 111111111111233445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=320.15 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=196.1
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||+|+||.||++..+ +|+.||+|.+....... .....+..|++++++++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 68999999997544322 2234556799999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccC
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 436 (579)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 9888532 334588899999999999999999976 99999999999999999999999999987665443333456
Q ss_pred CCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhh
Q 008055 437 AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516 (579)
Q Consensus 437 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (579)
++..|+|||++.+..++.++|||||||++|||++|+.||.......... ............ ......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~~-~~~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE------------ELKRRTLEDEVK-FEHQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH------------HHHHHhhccccc-cccccC
Confidence 7789999999998889999999999999999999999996532211100 000111111111 011234
Q ss_pred HHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 517 LSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 517 ~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
+.++.+++.+||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 56789999999999999999998876444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=316.78 Aligned_cols=253 Identities=24% Similarity=0.461 Sum_probs=205.0
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||.||+|..++++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+..+++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 34578899999999999999999889999999998755432 467889999999999999999999874 46789999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999998632 345688999999999999999999965 999999999999999999999999999876542
Q ss_pred CCccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
..... ...++..|+|||++....++.++||||||+++|||++ |+.||....... +.+.+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~ 217 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----------------VIQNLE 217 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----------------HHHHHH
Confidence 22111 1223457999999988889999999999999999999 999996543211 111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.......+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111122234455789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=316.05 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=203.9
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|...++..+|+|.+...... .+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3468888999999999999999888889999999765432 457889999999999999999999885 456899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999998632 234588999999999999999999976 9999999999999999999999999998765432
Q ss_pred Cccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.... ...++..|+|||++....++.++||||||+++|||++ |..||....... . . .....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~-------------~-~~~~~ 218 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---V-------------L-EQVER 218 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H-------------H-HHHHc
Confidence 2111 1223457999999988889999999999999999999 899996533211 0 0 11111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
......+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11222344556789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.87 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=198.0
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------- 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 341 (579)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 457999999999999999999764 68899999885432 2334689999999999999999876432
Q ss_pred -CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEec
Q 008055 342 -GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSD 419 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~D 419 (579)
...++||||++ ++|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 24678999997 478777764444566789999999999999999999976 999999999999999665 699999
Q ss_pred ccccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhh-hccccccC
Q 008055 420 CGLASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVR-WATPQLHD 496 (579)
Q Consensus 420 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~-~~~~~~~~ 496 (579)
||+++............+++.|+|||++.+ ..++.++|||||||++|||++|.+||....... ...+.. ...|....
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 999987655544455667889999999875 468999999999999999999999997643211 111111 11111000
Q ss_pred hhHH---------hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 IDAL---------AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+ .......+...++...+.++.+|+.+||..||.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 0000111122234445678999999999999999999999983
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=320.96 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=197.0
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||+|+||+||++... +++.||+|.+...... ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999764 6889999998654322 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc-ccc
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA-LNN 435 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 435 (579)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988754444456789999999999999999999976 9999999999999999999999999998765443322 233
Q ss_pred CCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChh
Q 008055 436 DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVK 515 (579)
Q Consensus 436 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (579)
.++..|+|||++.+..++.++|||||||++|||++|+.||......... .......... ...++..
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~--~~~~~~~ 223 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRILND--SVTYPDK 223 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH------------HHHHHhhccc--CCCCccc
Confidence 5677999999999999999999999999999999999999653321100 0000011111 1123344
Q ss_pred hHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 516 SLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 516 ~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
.+..+.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 567899999999999999999 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=322.18 Aligned_cols=261 Identities=25% Similarity=0.460 Sum_probs=208.4
Q ss_pred hCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
..+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+..++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 446788899999999999999641 34579999886543 234457788999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999964321 123578889999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||+++......... ...++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 9999999999999997664432221 1223457999999988889999999999999999998 888886543211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+.+.+........+..++..+.+++.+||+.+|++|||+.++++.|++++.-
T Consensus 248 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ---------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111223445667899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=318.86 Aligned_cols=269 Identities=26% Similarity=0.389 Sum_probs=204.0
Q ss_pred CCccccceeccCCceEEEEEEeC-----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 343 (579)
.+|++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46888899999999999999743 57899999986543 3445778899999999999999999998753 356
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 8899999999999999862 234588999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
.......... ....+..|+|||++.+..++.++|||||||++|||++|..|+................ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ-GQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc-cccchHH
Confidence 8664432211 1112335999999988889999999999999999999887764332111110000000 0000111
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
+.+.+........+...+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2222222222223445667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=333.80 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=214.0
Q ss_pred ccccceeccCCceEEEEEEeC--CCc--EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 273 FNVENLLGEGTFGRVYRAQFA--DGK--VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..+.++||+|.||+|++|.|. +|+ .||||.+....... ...+|++|+.+|.+|+|||+++|||...+ ....|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 344688999999999999775 344 68999998766543 68899999999999999999999999887 7789999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|+++.|+|.+.|+. .....|.......++.|||.||.||..+ ++|||||..+|+|+-....|||+|||+.+.+..
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999984 3455677888899999999999999965 999999999999999999999999999998877
Q ss_pred CCcccccCC----CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 429 ADEALNNDA----GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 429 ~~~~~~~~~----~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
.+..+.... ...|+|||.+...+|+.++|||+|||+||||+| |..||-+... ..+.+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHh
Confidence 666554332 347999999999999999999999999999999 8999976432 344555
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
+|...+-..|..|++.+++++..||..+|++|||+..|.+.+-
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 6666666678999999999999999999999999999985543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=328.09 Aligned_cols=259 Identities=26% Similarity=0.470 Sum_probs=217.0
Q ss_pred HHhCCccccceeccCCceEEEEEEeCC---C--cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFAD---G--KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
+.++.....++||.|.||.||+|.+.+ | -.||||.-+.... .+..+.|+.|..+++.++||||++++|+|.+ .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 344455667899999999999997543 3 3578888776443 3447899999999999999999999999986 5
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..|+|||.++-|.|..||+ .+...++......++.||+.||.|||.. .+|||||..+|||+.....+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 7899999999999999997 3456788888999999999999999965 999999999999999999999999999
Q ss_pred cccCCCCCcccccCC--CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 423 ASNMPNADEALNNDA--GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
++.+..........+ ..-|||||.+.-.+++.++|||.|||.+||++. |..||.+-.. ..
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sD 600 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SD 600 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cc
Confidence 998766554443333 236999999999999999999999999999998 9999975321 12
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+...++.+-+...|+.|+..++.|+.+||..+|.+||++.++...|.++++.
T Consensus 601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 2223344555667899999999999999999999999999999999999883
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=313.30 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=206.5
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||+|... +++.|++|.+............+..|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999765 689999999876655556678889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.++++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999742 245688999999999999999999976 99999999999999999999999999987654432
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. ....++..|+|||+..+..++.++|||||||++|||++|+.||....... ....... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~~ 218 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----------------LILKIIR-GVF 218 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc-CCC
Confidence 22 22345678999999998889999999999999999999999997543211 0111111 111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+.++.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12233456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.55 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=196.9
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|++.+.||+|+||.||+|.. .+++.||+|++..... .......+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999965 4688999999976432 33456678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999863 34578888999999999999999976 9999999999999999999999999987532100
Q ss_pred C------------------------------------------------cccccCCCCCccCccccccCCCCccchHHhH
Q 008055 430 D------------------------------------------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSF 461 (579)
Q Consensus 430 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 461 (579)
. ......+|..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 0012357789999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHh--cCCCCCCCCCCh
Q 008055 462 GVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIAL--CVQPEPEFRPPM 538 (579)
Q Consensus 462 Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~ 538 (579)
||++|||++|..||........ ..+..|.. ..........+.++.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976433211 11111110 00101111234678889988 556666679999
Q ss_pred HHHHH
Q 008055 539 SEVVQ 543 (579)
Q Consensus 539 ~evl~ 543 (579)
.+++.
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=320.66 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=202.9
Q ss_pred CccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+|.+.+.||+|+||.||+|... .+..||+|++.... .......+.+|+.++..++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3666788999999999999753 35789999997543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 008055 346 LVYEFRKNGSLHDFLHLSD------------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 413 (579)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985221 1123578888999999999999999976 999999999999999999
Q ss_pred ceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 008055 414 NPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 489 (579)
.+||+|||+++........ .....+..|+|||.+....++.++|||||||++|||++ |..||.......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 9999999998765433221 12223558999999988889999999999999999998 888986543211
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
....+.+. .....+..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ---------~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 ---------VIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 1122345677889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=313.56 Aligned_cols=250 Identities=25% Similarity=0.471 Sum_probs=205.7
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 346788899999999999999875 78899999975542 46788999999999999999999999998999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999998632 223689999999999999999999976 9999999999999999999999999998766332
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.. ....+..|+|||++....++.++||||||+++|||++ |..||....... +...+....
T Consensus 156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~ 216 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPHVEKGY 216 (256)
T ss_pred cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHhcCC
Confidence 21 2233457999999988889999999999999999998 999996543211 111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
....+...+..+.+++.+||..+|++|||+.+++++|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 222334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.88 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=201.6
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
++....++|++.+.||+|+||.||++... +++.+|+|++.+... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 578999999865322 2233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999852 3478889999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCc--ccccCCCCCccCccccccCC----CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC
Q 008055 423 ASNMPNADE--ALNNDAGSGYGAPEVAMSGQ----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 423 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
+........ .....++..|+|||++.... ++.++|||||||++|||++|+.||......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------------- 253 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------------- 253 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---------------
Confidence 976543222 22445788999999997543 788999999999999999999999754321
Q ss_pred hhHHhhhcCccccCCCC--hhhHHHHHHHHHhcCCCCCCC--CCChHHHHHH
Q 008055 497 IDALAKMVDPALKGLYP--VKSLSRFADVIALCVQPEPEF--RPPMSEVVQA 544 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 544 (579)
.....+.+......++ ...+..+.+++.+|+..++.+ |+++.++++.
T Consensus 254 -~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 -GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111122111111122 234567889999999865554 8899998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=317.85 Aligned_cols=258 Identities=22% Similarity=0.426 Sum_probs=204.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
..+|++.+.||+|+||.||+|.+. ++. .||+|.+.... .......+.+|+..++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 356888999999999999999753 444 48999986543 23445678899999999999999999999875 457
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
+++|||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 899999999999999863 234688999999999999999999976 99999999999999999999999999987
Q ss_pred cCCCCCcccc---cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNADEALN---NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
.......... ...+..|+|||...+..++.++|||||||++|||++ |..||....... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~ 220 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----------------I 220 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence 6643322211 223457999999998899999999999999999998 999996543211 1
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
...+........+..++..+.+++.+||..||++||++.++++.|+++.++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1111111111223345568899999999999999999999999998776443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=317.13 Aligned_cols=256 Identities=25% Similarity=0.472 Sum_probs=204.8
Q ss_pred hCCccccceeccCCceEEEEEEeC-CC---cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DG---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
..+|+..+.||+|+||.||+|... ++ ..+|+|.+..... ....+.+..|++++++++|||++++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 346778899999999999999765 33 3789999865432 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999862 235688999999999999999999976 999999999999999999999999999876
Q ss_pred CCCCCcccc----cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNADEALN----NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
......... ...+..|+|||++....++.++|||||||++|||++ |+.||....... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----------------~ 219 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----------------V 219 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----------------H
Confidence 543221111 112346999999988889999999999999999998 999996533210 1
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
...+........+..++..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 220 ~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 220 MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1111111122223345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.91 Aligned_cols=245 Identities=22% Similarity=0.405 Sum_probs=196.9
Q ss_pred eccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCC
Q 008055 279 LGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGS 355 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (579)
||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 899999999999764 35579999986543 2344567889999999999999999999886 457899999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc-
Q 008055 356 LHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN- 434 (579)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 434 (579)
|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999862 244689999999999999999999976 999999999999999999999999999875543322111
Q ss_pred ---cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 435 ---NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 435 ---~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
...+..|+|||++....++.++|||||||++|||++ |..||....... +...+......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----------------VMSFIEQGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHHHHHCCCCC
Confidence 112357999999988889999999999999999997 999997543211 11111122222
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.02 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=206.9
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++.|++.+.||+|.|+.||++.+ .+|+.+|+|++..........+++.+|+.+.+.++|||||++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 34677888999999999999954 57999999999877776677888999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~ 425 (579)
|+|.|++|..-+-. ...+++..+-..+.||+.||.|+|.+ +|||||+||+|+++-. ..-+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999765531 24567788889999999999999976 9999999999999953 34579999999998
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc-hhhhhhhhhccccccChhHHhhhc
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
+..+.......|+++|||||++...+|+..+|||+.||+||-|+.|.+||.+... ...+.+...
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------------- 227 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------------- 227 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------
Confidence 8866666678899999999999999999999999999999999999999976332 211111100
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
+-...+.+-....++..+|+.+||..||.+|.|+.|.+
T Consensus 228 ~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 228 AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 00111111233456788999999999999999999876
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.87 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=200.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++... +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999764 689999999976433 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998632 34689999999999999999999976 999999999999999999999999999976644
Q ss_pred CCcc--cccCCCCCccCccccc------cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 429 ADEA--LNNDAGSGYGAPEVAM------SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~------~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
.... ....++..|+|||++. ...++.++|||||||++|||++|+.||....... ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------------~~ 218 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------------TY 218 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----------------HH
Confidence 3322 2235678999999986 4567899999999999999999999997543211 01
Q ss_pred hhhcCccccCCCC--hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYP--VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+........++ ...+..+.+++.+|+. +|++|||+.+++.
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 219 NNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111100001111 2345678999999998 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.74 Aligned_cols=246 Identities=27% Similarity=0.468 Sum_probs=199.4
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
++||+|+||.||+|...++..+|+|.+.... .......+.+|+..++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999998889999999986543 334455788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc--c
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL--N 434 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 434 (579)
.+++.. ....+.+..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 998863 234578999999999999999999976 99999999999999999999999999986543322111 1
Q ss_pred cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 435 NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 435 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...+..|+|||++....++.++||||||+++|+|++ |..||........ ............+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-----------------REQVEKGYRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-----------------HHHHHcCCCCCCC
Confidence 122457999999998889999999999999999999 9999965432110 0011111122234
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
...+..+.+++.+||..+|++||++.+++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=315.84 Aligned_cols=254 Identities=25% Similarity=0.461 Sum_probs=204.0
Q ss_pred CCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
.+|++.+.||+|+||.||+|... .+..+|+|.++.... ......+.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999763 234799999865432 3446788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999963 234688999999999999999999976 9999999999999999999999999998766
Q ss_pred CCCCcccc----cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 427 PNADEALN----NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 427 ~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
........ ...+..|+|||++....++.++||||||+++||+++ |..||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~------------- 220 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK------------- 220 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH-------------
Confidence 44322111 112347999999998899999999999999999887 999996543211 000
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.+. .......+...+..+.+++.+||+.+|++||++.++++.|.++
T Consensus 221 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AIE-EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHh-CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 1111122334567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=332.17 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=195.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++... +++.||+|++..... .......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36889999999999999999765 688999999975432 2334466788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999862 35688999999999999999999975 999999999999999999999999999875432
Q ss_pred CCc------------------------------------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCC
Q 008055 429 ADE------------------------------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472 (579)
Q Consensus 429 ~~~------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~ 472 (579)
... .....+|..|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 11235788999999999999999999999999999999999
Q ss_pred CCCCCCCchh-hhhhhhhccccccChhHHhhhcCccccCCCC--hhhHHHHHHHHHhcCC--CCCCCCCChHHHHHH
Q 008055 473 KPFDSSRPRL-EQSLVRWATPQLHDIDALAKMVDPALKGLYP--VKSLSRFADVIALCVQ--PEPEFRPPMSEVVQA 544 (579)
Q Consensus 473 ~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~--~dP~~Rps~~evl~~ 544 (579)
.||....... ...+..|.. .+ .++ .....++.+++.+++. .++..||++.||++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~---------------~~--~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKE---------------TL--IFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcC---------------cc--cCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9997643221 111111110 00 011 1133567788877553 233356899999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=316.02 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=203.3
Q ss_pred CccccceeccCCceEEEEEEeCC-C---cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFAD-G---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.|++.+.||+|+||.||+|.... + ..||+|.+.... .......|..|+..++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 57788999999999999997653 3 369999986543 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999863 234688999999999999999999976 99999999999999999999999999987554
Q ss_pred CCCccccc---CC---CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 428 NADEALNN---DA---GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 428 ~~~~~~~~---~~---~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
........ .+ +..|+|||++....++.++|||||||++|||++ |..||...... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---------- 224 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---------- 224 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----------
Confidence 32221111 11 236999999998899999999999999999987 99999654321 111111
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
........+..++..+.+++.+||..+|++||++.+++..|+.+
T Consensus 225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ----EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111122344567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.20 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=196.1
Q ss_pred ceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 277 NLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
+.||+|+||.||++.. .+++.||+|++..... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 4789999999975432 2234566788999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC-CCccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN-ADEAL 433 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~ 433 (579)
+|..++. ....+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9998885 234688999999999999999999951 3999999999999999999999999999875332 22223
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...++..|+|||++.+..++.++|||||||++|||++|+.||......... ...... ...++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~----------------~~i~~~--~~~~p 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------------ELILME--EIRFP 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH----------------HHHhcC--CCCCC
Confidence 345788999999999999999999999999999999999999654321110 000000 11123
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
...+.++.+++.+||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 44556889999999999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.45 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=196.8
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|.+.+.||+|+||.||++.. .+++.||||++..... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999965 4789999999865322 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999862 34678889999999999999999976 999999999999999999999999999863221
Q ss_pred CCc------------------------------------------------ccccCCCCCccCccccccCCCCccchHHh
Q 008055 429 ADE------------------------------------------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYS 460 (579)
Q Consensus 429 ~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 460 (579)
... .....++..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 00134678899999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccChhHHhhhcCccccCCCC--hhhHHHHHHHHHhcCCCCCCCC--
Q 008055 461 FGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDIDALAKMVDPALKGLYP--VKSLSRFADVIALCVQPEPEFR-- 535 (579)
Q Consensus 461 lGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~R-- 535 (579)
|||++|||++|..||....... ...+..|.. ...++ ...+.++.+++.+|+. +|.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE-----------------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC-----------------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 9999999999999997543211 111111110 00111 1234678899999997 67665
Q ss_pred -CChHHHHHH
Q 008055 536 -PPMSEVVQA 544 (579)
Q Consensus 536 -ps~~evl~~ 544 (579)
+++.++++.
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 599888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.93 Aligned_cols=256 Identities=24% Similarity=0.428 Sum_probs=204.7
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 343 (579)
++|.+.+.||+|+||.||++... .+..+|+|.++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 46888999999999999999642 345799999875432 34456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.++++.. ....+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999998632 223489999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
......... ....++..|+|||++....++.++|||||||++|||++ |..||....... .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----------------~ 252 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----------------K 252 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----------------H
Confidence 765433211 11223457999999998899999999999999999998 999996543211 1
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.............+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111111122233456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=318.83 Aligned_cols=256 Identities=23% Similarity=0.402 Sum_probs=205.0
Q ss_pred hCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|.+.+.||+|+||.||+|.... +..||+|.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4578889999999999999997642 46899999865432 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDED------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQL 417 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 417 (579)
.++||||+++|+|.+++...... ...+.+..++.++.|++.||.|||+. +++||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999998643221 23478899999999999999999965 9999999999999999999999
Q ss_pred ecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 418 SDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 418 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+|||+++....... .....++..|+|||.+....++.++|||||||++|||++ |..||.......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----------- 229 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----------- 229 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----------
Confidence 99999876543321 112234568999999988889999999999999999998 999996533211
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
..+..........+..++..+.+++.+||..+|++|||+.++++.|+
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 ------VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111111112234455778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.71 Aligned_cols=251 Identities=27% Similarity=0.495 Sum_probs=202.0
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|.+.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 46888899999999999999888777899998865432 2467888999999999999999999875 4568899999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.++++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999632 234578999999999999999999976 99999999999999999999999999987654322
Q ss_pred ccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... ...++..|+|||......++.++||||||+++|||++ |..||....... . ...+ ...
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~-------------~~~~-~~~ 219 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V-------------LEQV-ERG 219 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHH-HcC
Confidence 111 1223457999999988889999999999999999999 999997543211 0 0011 011
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.....+...+..+.+++.+||..||++||+++++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.33 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=197.3
Q ss_pred CccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
+|++.+.||+|+||.||+++.. +++.||+|++.+... .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998653 578999999865322 123345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999852 34688999999999999999999976 99999999999999999999999999987
Q ss_pred cCCCCCc--ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 425 NMPNADE--ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 425 ~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
....... .....++..|+|||++.+. .++.++|||||||++|||++|+.||......... ..+.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------~~~~ 220 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-------------SEVS 220 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-------------HHHH
Confidence 6433222 2234578899999999765 4788999999999999999999999643221100 0000
Q ss_pred -hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 502 -KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 502 -~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
.+.. ....++...+..+.+++.+||+.||++|| +++++++
T Consensus 221 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 RRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0110 11123344567889999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=326.32 Aligned_cols=237 Identities=22% Similarity=0.351 Sum_probs=190.9
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|..+ +++.||+|++..... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 588999999875432 223455677788888765 799999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC-CCcc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN-ADEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 432 (579)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999998862 34688999999999999999999976 999999999999999999999999999875322 2222
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------------~~~i~~~--~~~~ 215 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----------------FEAILND--EVVY 215 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------------HHHHhcC--CCCC
Confidence 334578899999999988999999999999999999999999976432110 0111110 0112
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
+...+.++.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 33455688999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=319.53 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=204.7
Q ss_pred HHhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY 341 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 341 (579)
+..++|++.+.||+|+||.||+|..+ .+..||+|.+..... ......+.+|+..+++++||||+++++++.+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34668999999999999999999653 245899998865432 23345678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDE------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
+..++||||+++|+|.++++.... ....+.+..+..++.|++.||.|||++ +|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999964321 123456778899999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcc
Q 008055 416 QLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 491 (579)
+|+|||+++......... ...++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~----- 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V----- 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-----
Confidence 999999987553322111 1123457999999998899999999999999999999 788986533211 1
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.....+.. ....+..++..+.+++.+||+.||++|||+.++++.|+..+
T Consensus 231 --------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 --------LKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --------HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 01111111 11123344578999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=327.22 Aligned_cols=262 Identities=25% Similarity=0.455 Sum_probs=203.4
Q ss_pred hCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC-
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY- 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 341 (579)
.++|++.+.||+|+||.||+|.. .+++.||||+++.... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 45789999999999999999963 3578999999975432 33456788999999999 789999999988654
Q ss_pred CeEEEEEEecCCCChhhhhcccCCC-------------------------------------------------------
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDED------------------------------------------------------- 366 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 366 (579)
...+++|||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999998642110
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc---cc
Q 008055 367 --------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL---NN 435 (579)
Q Consensus 367 --------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~ 435 (579)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12467888899999999999999976 99999999999999999999999999987653222111 12
Q ss_pred CCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCCh
Q 008055 436 DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPV 514 (579)
Q Consensus 436 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (579)
.++..|+|||.+....++.++||||||+++|||++ |..||....... .+...+........+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKEGTRMRAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----------------HHHHHHhccCCCCCCC
Confidence 23457999999988899999999999999999997 999996532110 0001111111111222
Q ss_pred hhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 515 KSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 515 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..+.++.+++.+||+.+|++|||+.+|++.|+.+++.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3446789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.68 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=207.5
Q ss_pred hCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
.++|.+.+.||+|+||.||++... ....+|+|.++.... ......+..|+..++.+ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 346888999999999999999642 245789999875432 34466788899999999 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 9999999999999999999964321 124588999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
+++++.+||+|||+++......... ....+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999997654322111 1122346999999998889999999999999999999 899986543211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
+............+..++.++.+++.+||..+|++|||+.++++.|.++....
T Consensus 245 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 ---------------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 01111111111233455678999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=312.55 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=203.7
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC---chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP---SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
+.|++.+.||+|++|.||++.. .+++.+|+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999975 46899999998654322 2234678889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998863 34578889999999999999999976 9999999999999999999999999998765
Q ss_pred CCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 427 PNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 427 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~ 218 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------------AAIFK 218 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----------------HHHHH
Confidence 432211 1234556899999999988999999999999999999999999653221 11111
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
..........+...+..+.+++.+||..+|++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122223445566789999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.89 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=207.4
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|.+.+.||+|+||.||+|..+++..+|+|.+...... ...+.+|+..+++++|+||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999888889999998765432 467889999999999999999999999889999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999632 234689999999999999999999976 999999999999999999999999999876543
Q ss_pred CCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||....... .+..+ .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------------~~~~~-~ 218 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----------------VLEQV-E 218 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH-H
Confidence 2111 11223457999999998889999999999999999999 999996533210 01111 1
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.......+...+..+.+++.+||..+|++||++.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111122233446789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=326.12 Aligned_cols=242 Identities=20% Similarity=0.301 Sum_probs=194.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCC-CccceeeEEeeCCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHP-NIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 348 (579)
+|++.+.||+|+||.||+|... +++.||+|++..... .......+..|.+++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999765 578999999975432 233456778888999888765 5888899999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998852 34578899999999999999999976 999999999999999999999999999864322
Q ss_pred -CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 -ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
........++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~~-- 215 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQSIME-- 215 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc--
Confidence 222233457889999999999999999999999999999999999997643211 0111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
....++...+.++.+++.+||..||++|++.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122344456788999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.14 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=203.3
Q ss_pred hCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .......|..|+..++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4568889999999999999997753 5678899876433 23345678899999999999999999999999899
Q ss_pred EEEEEEecCCCChhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEE
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---NPQL 417 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl 417 (579)
.++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999864321 123588999999999999999999976 999999999999998764 5899
Q ss_pred ecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 418 SDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 418 ~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+|||+++......... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----------- 229 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------- 229 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------
Confidence 9999987663322111 1112347999999998899999999999999999997 999997543211
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
+.+.+....+...+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 ------VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111222334455678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=326.64 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=195.0
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||++... +++.||+|+++..... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 6889999999764332 23345677888988888 799999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC-CCCcc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP-NADEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-~~~~~ 432 (579)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++... .....
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 999988852 35689999999999999999999976 99999999999999999999999999986432 22223
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh--hhhhhhhccccccChhHHhhhcCccccC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL--EQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||+...... .....++ ....+.... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~~~--~ 222 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY---------LFQVILEKQ--I 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH---------HHHHHHcCC--C
Confidence 34567889999999999999999999999999999999999996422110 0000000 011111111 1
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCC------hHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPP------MSEVV 542 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl 542 (579)
..|...+..+.+++.+||+.||++|++ +.+++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 234445678899999999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=325.94 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=191.6
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||++... +++.||+|++++.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999999765322 23445677788887766 899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC-CCcc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN-ADEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 432 (579)
|+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99998875 234688999999999999999999976 999999999999999999999999999875322 2222
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh-hcCccccCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK-MVDPALKGL 511 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 511 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||......... .......+.+ .... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~i~~~--~~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVILEK--QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc--------ccccHHHHHHHHhcC--CCC
Confidence 3345788999999999999999999999999999999999999632111000 0000001111 1111 112
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
+|...+..+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 445566788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=325.68 Aligned_cols=242 Identities=20% Similarity=0.295 Sum_probs=194.4
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+|++.+.||+|+||.||+|... +++.||+|++.+... .......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999765 578999999875432 223344566677777766 6899999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998852 34588899999999999999999976 999999999999999999999999999875432
Q ss_pred CC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 AD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ......+++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----------------~~~~i~~~- 216 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------LFQSIMEH- 216 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC-
Confidence 22 2233457889999999999999999999999999999999999997643211 11111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
...++...+.++.+++.+||+.||++|++.
T Consensus 217 -~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 112344556788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.89 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=200.7
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe-eCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS-EYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 349 (579)
.+|++.+.||+|+||.||++... |..+|+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888899999999999999765 7789999986432 3567889999999999999999999764 5567899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.++++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999998632 233578999999999999999999976 9999999999999999999999999998754332
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....+..|+|||++....++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~ 216 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGY 216 (256)
T ss_pred C--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHhcCC
Confidence 2 12233457999999988889999999999999999998 99998643221 1111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 2223345567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=325.88 Aligned_cols=242 Identities=22% Similarity=0.329 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +++.||+|++..... .......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999765 578999999875432 233445677788888765 899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-cc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 432 (579)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999988852 34688899999999999999999976 99999999999999999999999999987543222 22
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----------------~~~~i~~~~--~~~ 215 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----------------LFESILHDD--VLY 215 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCC--CCC
Confidence 23456789999999999899999999999999999999999997643211 011111111 112
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCC-------ChHHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRP-------PMSEVVQ 543 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~ 543 (579)
+...+.++.+++.+||+.||++|| ++.++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 333456889999999999999999 6777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.10 Aligned_cols=246 Identities=25% Similarity=0.430 Sum_probs=197.3
Q ss_pred ceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 277 NLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999996532 268999999766543 44677899999999999999999999876 456899999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
+|+|.+++.. ...+++..++.++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999963 23688999999999999999999976 9999999999999999999999999998765443322
Q ss_pred ccc----CCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 433 LNN----DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 433 ~~~----~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... .++..|+|||.+....++.++|||||||++|||++ |..||...... .+..+ ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~--------------~~~~ 214 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAM--------------LESG 214 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH--------------HHcC
Confidence 111 11346999999998899999999999999999998 99999754321 11111 1111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.....+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11123344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.26 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=208.5
Q ss_pred hCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
..+|++.+.||+|+||.||++... .+..||+|.++... .......+.+|+.+++++ +||||++++++|..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 346889999999999999999642 12368999886433 234467888999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..+++|||+++|+|.+++..... ....+.+..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 9999999999999999999864321 223578899999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCcccc---cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEALN---NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||+++.......... ...+..|+|||++....++.++|||||||++|||++ |..||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 244 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 244 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 99999999999999876543322111 122346999999999999999999999999999999 889986543211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
....+........+..++.++.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus 245 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 ---------------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ---------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 111111111222334456789999999999999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.93 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=202.1
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|++.+.||+|+||.||++... +++.||+|.+....... .....+..|+.++++++|+|++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999664 68899999987654332 2345577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988532 234588999999999999999999965 99999999999999999999999999987654433
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
......++..|+|||++.+..++.++|||||||++|+|++|+.||......... ........ ....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-------------~~~~~~~~-~~~~ 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERLVK-EVQE 222 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------HHHHhhhh-hhhh
Confidence 333456778999999999989999999999999999999999999754321100 00111100 0111
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
.++...+..+.+++.+||+.||++||| +.|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 223344567899999999999999999 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=352.34 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=204.5
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQH 344 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 344 (579)
....+|.+.+.||+|+||.||++... ++..+|+|.+............+..|+.+++.++|||||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44568999999999999999999765 57789999997766656667789999999999999999999998854 4578
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEcCCCCCCEEEcC---------
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC----SLSVVHKNIKSANILLDN--------- 411 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~iiH~Dlkp~Nill~~--------- 411 (579)
|+||||+++|+|.++|.........+++..++.|+.||+.||+|||... ..+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999754444567999999999999999999999742 135999999999999964
Q ss_pred --------CCceEEecccccccCCCCCcccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCch
Q 008055 412 --------ELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR 481 (579)
Q Consensus 412 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~ 481 (579)
.+.+||+|||++.............+++.|+|||++.. ..++.++|||||||++|||++|..||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 24589999999986654433344567889999999864 45889999999999999999999999653321
Q ss_pred hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 482 LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. . +...+.... .......+..+.+||..||..+|.+||++.+++.
T Consensus 250 ~-q---------------li~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 S-Q---------------LISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred H-H---------------HHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 0 0 000000000 0001123467999999999999999999999984
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.16 Aligned_cols=262 Identities=21% Similarity=0.359 Sum_probs=200.9
Q ss_pred CCccccceeccCCceEEEEEEeCC---------------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCcccee
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD---------------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 335 (579)
.+|++.+.||+|+||.||++..++ ...||+|.+.... .......+.+|++.+++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 478899999999999999986542 2358999987543 344566789999999999999999999
Q ss_pred eEEeeCCeEEEEEEecCCCChhhhhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 008055 336 GYCSEYGQHLLVYEFRKNGSLHDFLHLSDE--------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANI 407 (579)
Q Consensus 336 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Ni 407 (579)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999853211 112468889999999999999999976 999999999999
Q ss_pred EEcCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh--CCCCCCCCCchh
Q 008055 408 LLDNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT--GRKPFDSSRPRL 482 (579)
Q Consensus 408 ll~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~p~~~~~~~~ 482 (579)
++++++.+||+|||++.......... ...++..|+|||++....++.++|||||||++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999987654322111 1223457999999998899999999999999999998 667886533211
Q ss_pred hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
. +.... ..............+...+..+.+++.+||+.||++|||+.+|++.|+
T Consensus 241 ~--~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V--IENTG--------EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H--HHHHH--------HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0 00000 000000000011122334578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.84 Aligned_cols=241 Identities=20% Similarity=0.342 Sum_probs=190.4
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhh-cCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQ-LHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +++.||+|.++.... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999765 578999999975432 12233445556666654 5899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-cc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 432 (579)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 999998852 34688999999999999999999976 99999999999999999999999999987543322 22
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----------------~~~i~~--~~~~~ 215 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----------------FDSILN--DRPHF 215 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHc--CCCCC
Confidence 234578899999999988999999999999999999999999975432110 001100 11223
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChH-HHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMS-EVV 542 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 542 (579)
+...+.++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 444556789999999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.92 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=206.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999765 5899999999754322 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 349 EFRKNGSLHDFLHLSDE-------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
||++||+|.+++..... ....+++..++.++.||++||+|||+. +|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123456778899999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCC-------------------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh
Q 008055 422 LASNMPNAD-------------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482 (579)
Q Consensus 422 ~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~ 482 (579)
++....... ......+++.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 987652110 0011346789999999999999999999999999999999999996532211
Q ss_pred hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCC-CChHHHHHHHHHHHHHc
Q 008055 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR-PPMSEVVQALVRLVQRA 552 (579)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~L~~i~~~~ 552 (579)
.. .. .....+... ......+..+.+++.+||+.||++| ++++++++.|+..++..
T Consensus 239 i~-~~-------------~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 IS-YR-------------DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hh-hh-------------hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 00 000000000 0012345678899999999999999 56788888888887643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=324.06 Aligned_cols=242 Identities=20% Similarity=0.316 Sum_probs=194.3
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +++.||+|++++... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999775 578999999975432 223355677788888777 799999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC-Ccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA-DEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 432 (579)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 999988852 34689999999999999999999976 9999999999999999999999999998653222 222
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|+|++|+.||........ ...+... ...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----------------~~~i~~~--~~~~ 215 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----------------FQSILED--EVRY 215 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----------------HHHHHcC--CCCC
Confidence 234567899999999999999999999999999999999999975432110 0011111 1123
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCCh-----HHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPM-----SEVVQ 543 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 543 (579)
+...+..+.+++.+||+.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 34456789999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.87 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=199.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------G 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 342 (579)
.++|++.+.||+|+||.||++... +|..||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999764 689999999976554455567788999999999999999999988644 3
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++ +|.+.++ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999965 6666653 2377888999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhh-hccccccChh--
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVR-WATPQLHDID-- 498 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~-~~~~~~~~~~-- 498 (579)
++............++..|+|||++.+..++.++|||||||++|+|++|+.||........ ..+.. ...+......
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 8765433333345667899999999999999999999999999999999999976532110 00000 0000000000
Q ss_pred --HHhhhcC--cccc----------------CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 499 --ALAKMVD--PALK----------------GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 499 --~~~~~~~--~~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....... +... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000 00111234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.79 Aligned_cols=262 Identities=21% Similarity=0.384 Sum_probs=201.5
Q ss_pred CCccccceeccCCceEEEEEEeC-----------------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccc
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-----------------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 333 (579)
++|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|+..++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 46889999999999999998533 23468999987543 2344678899999999999999999
Q ss_pred eeeEEeeCCeEEEEEEecCCCChhhhhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 008055 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDED-------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406 (579)
Q Consensus 334 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N 406 (579)
+++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998643211 23477889999999999999999976 99999999999
Q ss_pred EEEcCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh--CCCCCCCCCch
Q 008055 407 ILLDNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT--GRKPFDSSRPR 481 (579)
Q Consensus 407 ill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~p~~~~~~~ 481 (579)
||++.++.++|+|||++.......... ....+..|+|||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987654322111 1222457999999888889999999999999999998 77888643221
Q ss_pred hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 482 LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.. + ... ...............+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~--~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV--I-ENT-------GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH--H-HHH-------HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 10 0 000 0000000000011123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=325.84 Aligned_cols=238 Identities=23% Similarity=0.321 Sum_probs=188.6
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHH-HHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVS-NISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999775 689999999865432 1222344445544 56789999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-cc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 432 (579)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 999998852 34688899999999999999999976 99999999999999999999999999987543222 22
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|..||....... ....+..... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~~~--~~ 215 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNILNKPL--RL 215 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHcCCC--CC
Confidence 33457889999999999999999999999999999999999997543211 0011111111 12
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
+...+..+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 233456889999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.38 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=208.5
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 348 (579)
+|++.+.||.|+||.||++.. .++..+|+|.+..........+.+..|+..++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999965 468899999998766666667788999999999999999999998753 45689999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC--SLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||+++++|.+++.........+++..++.++.|++.||.|||..+ +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999755445667899999999999999999999332 349999999999999999999999999998876
Q ss_pred CCCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 427 PNADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
..... .....++..|+|||++....++.++||||||+++|+|++|+.||...... . +.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~--------------~~~~~~ 223 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q--------------LASKIK 223 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H--------------HHHHHh
Confidence 54433 22345677899999999888999999999999999999999999764321 1 111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.......+...+..+.+++.+||+.+|++||++.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11122334455678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=330.28 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=201.6
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
+.++....++|++.+.||+|+||.||++..+ +++.+|+|++..... .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455566789999999999999999999775 678999999865322 22334567889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+..++||||+++|+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999852 3478888999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCc--ccccCCCCCccCccccccCC----CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPNADE--ALNNDAGSGYGAPEVAMSGQ----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|++........ .....+|+.|+|||++.... ++.++|||||||++|||++|..||.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------------ 254 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------ 254 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------------
Confidence 99976643222 22345788999999987543 7899999999999999999999997543210
Q ss_pred cChhHHhhhcCcc--ccCCCChhhHHHHHHHHHhcCCCCCCC--CCChHHHHHH
Q 008055 495 HDIDALAKMVDPA--LKGLYPVKSLSRFADVIALCVQPEPEF--RPPMSEVVQA 544 (579)
Q Consensus 495 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 544 (579)
....+.... +........+..+.+++.+|+..++.+ |+++.++++.
T Consensus 255 ----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 255 ----TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ----HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111110 111112235568899999999844433 6788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.44 Aligned_cols=256 Identities=26% Similarity=0.459 Sum_probs=203.6
Q ss_pred hCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|++.+.||+|+||.||++... ++..||+|.+.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 457888999999999999999753 46789999987543 23445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 008055 344 HLLVYEFRKNGSLHDFLHLSD------------------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~ 405 (579)
.++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999986321 1123578889999999999999999976 9999999999
Q ss_pred CEEEcCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCch
Q 008055 406 NILLDNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPR 481 (579)
Q Consensus 406 Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~ 481 (579)
||++++++.++|+|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875433221 111223457999999988899999999999999999998 88888643221
Q ss_pred hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 482 LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
. ....+.+... ...+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~----------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 E----------------VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H----------------HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 0111111111 1123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.55 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=203.9
Q ss_pred hCCccccceeccCCceEEEEEEeCC-----------------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCcc
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD-----------------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 332 (579)
..+|++.+.||+|+||.||++...+ +..||+|.+..... ......+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578899999999999999986542 24689999875543 34567889999999999999999
Q ss_pred ceeeEEeeCCeEEEEEEecCCCChhhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 008055 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE-------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 333 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~ 405 (579)
++++++...+..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999864331 123689999999999999999999976 9999999999
Q ss_pred CEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh--CCCCCCCCCc
Q 008055 406 NILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT--GRKPFDSSRP 480 (579)
Q Consensus 406 Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~p~~~~~~ 480 (579)
||+++.++.++|+|||++......... ....++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999998765433211 12233557999999988889999999999999999998 6788865332
Q ss_pred hh-hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 481 RL-EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 481 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.. ......+.. . .........+..++.++.+++.+||+.||++|||+.+|++.|+
T Consensus 240 ~~~~~~~~~~~~----~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVIENAGHFFR----D-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhccc----c-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 010000000 0 0000011123344578999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=332.41 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=194.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999764 688999999975432 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999863 34578888999999999999999976 9999999999999999999999999997532100
Q ss_pred C------------------------------------------------cccccCCCCCccCccccccCCCCccchHHhH
Q 008055 430 D------------------------------------------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSF 461 (579)
Q Consensus 430 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 461 (579)
. ......+|..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0012346788999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC---
Q 008055 462 GVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP--- 537 (579)
Q Consensus 462 Gv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps--- 537 (579)
||++|||++|+.||........ ..+..|.. ............++.+++.+|+ .+|++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 9999999999999976433211 11111111 0110111223457788888876 59999997
Q ss_pred hHHHHH
Q 008055 538 MSEVVQ 543 (579)
Q Consensus 538 ~~evl~ 543 (579)
+.++++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777663
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.29 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=200.7
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|+..+.||+|+||.||++... +++.+|+|.+....... .....+.+|+.+++.++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999764 68999999987654332 2345577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888532 234689999999999999999999965 99999999999999999999999999987654433
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
......++..|+|||++.+..++.++|||||||++|||++|..||........... +...+. ....
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-------------~~~~~~-~~~~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-------------VDRRVL-ETEE 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHHhhh-cccc
Confidence 33345677899999999988999999999999999999999999975432211100 000000 0011
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
.++...+..+.+|+.+||+.||++||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 233445567899999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.76 Aligned_cols=241 Identities=23% Similarity=0.354 Sum_probs=191.1
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhh-cCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQ-LHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +++.||+|+++.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999775 578999999975432 12234455667777765 5999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-cc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 432 (579)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 999999862 34678899999999999999999976 99999999999999999999999999987532222 22
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|..||........... +. .. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~-------------i~-~~----~~~~ 215 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-------------IR-MD----NPCY 215 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HH-hC----CCCC
Confidence 334578899999999988999999999999999999999999975432110000 00 00 1112
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChH-HHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMS-EVV 542 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 542 (579)
+.....++.+++.+||+.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 333456789999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.92 Aligned_cols=249 Identities=25% Similarity=0.497 Sum_probs=201.3
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.+|++.+.||+|+||.||++.+.++..+|+|.+...... ...+.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 357788999999999999998877889999998755432 45688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999862 234578899999999999999999976 99999999999999999999999999987553322
Q ss_pred cc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. .....+..|+|||++.+..++.++||||||+++|||++ |..||....... +.+.....
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~ 217 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----------------VVETINAG 217 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----------------HHHHHhCC
Confidence 11 11223457999999998889999999999999999998 999996533211 00000111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.+...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11112233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.23 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=201.9
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|++.++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45777899999999999999532 35688999876433 34467889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 008055 345 LLVYEFRKNGSLHDFLHLSDED-----------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 413 (579)
+++|||+++|+|.++++..... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 9999999999999998643211 13578999999999999999999976 999999999999999999
Q ss_pred ceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 008055 414 NPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 489 (579)
.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------ 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------
Confidence 9999999998755332211 11223457999999998999999999999999999998 9999865332111
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
..... .......+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 234 ----------~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ----------IECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------HHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111 11111223345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.63 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=194.3
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh---cCCCCccceeeEEee-----CC
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ---LHHPNIMELVGYCSE-----YG 342 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~-----~~ 342 (579)
+|++.+.||+|+||.||+|... +++.||+|.+............+.+|+..++. ++||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999765 68899999987654333333445556665554 479999999998854 34
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 5898888632 234589999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccChh-HH
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDID-AL 500 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~-~~ 500 (579)
+.............++..|+|||++.+..++.++|||||||++|||++|++||....... ...+..+......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 876654333334456778999999998899999999999999999999999996543321 1111111100000000 00
Q ss_pred ----hhhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 ----AKMVDPALK---GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+... .......+..+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=333.28 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=197.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+.|++.+.||+|+||.||+++.. +++.||+|++..... .......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999764 689999999865332 2233566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999863 34578888899999999999999976 999999999999999999999999999753210
Q ss_pred CC--------------------------------------------cccccCCCCCccCccccccCCCCccchHHhHHHH
Q 008055 429 AD--------------------------------------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVV 464 (579)
Q Consensus 429 ~~--------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~ 464 (579)
.. ......++..|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0012357789999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC---ChHH
Q 008055 465 MLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP---PMSE 540 (579)
Q Consensus 465 l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~e 540 (579)
+|||++|+.||........ ..+..|.. ..........+..+.+++.+|+ .+|++|+ ++.+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 9999999999976543211 11111111 0000111234457788888876 5999999 8888
Q ss_pred HHHH
Q 008055 541 VVQA 544 (579)
Q Consensus 541 vl~~ 544 (579)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.77 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=207.9
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC------CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL------PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG 342 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 342 (579)
..|.-.++||.|..++|.++.+ ++|..+|+|++..... ..+..+.-..|+.+|+++ .||+|+.+.++++...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4567778999999999999865 4788999999854322 123334456788999876 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
.+++|+|.|+.|.|+++|. ....++++....|++|+..|++|||.. .||||||||+|||++++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999995 466799999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccc------cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAM------SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
+..+.++......+||++|+|||.+. ...|+..+|+||+|||+|.|+.|.+||-...+-..
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------------- 236 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------------- 236 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-------------
Confidence 99999998888899999999999985 34578899999999999999999999954322110
Q ss_pred hhHHhhhcCcccc--CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH--HHHHHHH
Q 008055 497 IDALAKMVDPALK--GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ--ALVRLVQ 550 (579)
Q Consensus 497 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~i~~ 550 (579)
+..++..... ...-.+......+||.+||+.||.+|.|++|+++ .+.++.+
T Consensus 237 ---LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 237 ---LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ---HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 0111111111 1111344567889999999999999999999984 3444443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=325.04 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=189.4
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHH-HHHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEM-VSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +++.||+|++...... ......+..| ..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999765 5788999998654321 1222334444 3456788999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC-Ccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA-DEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 432 (579)
|+|.+++.. ...+.+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 999998862 34577888889999999999999976 9999999999999999999999999998754322 222
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------~~~i~~~~--~~~ 215 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----------------YDNILNKP--LQL 215 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----------------HHHHHhCC--cCC
Confidence 334578899999999999999999999999999999999999975432110 00111110 112
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+...+..+.+++.+||+.||.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2344568899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.05 Aligned_cols=249 Identities=29% Similarity=0.504 Sum_probs=203.9
Q ss_pred ceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 277 NLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+.||+|+||.||+|.... +..+++|.+....... ..+.+.+|++.+..++|+|++++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999997654 7899999997655433 46788999999999999999999999999999999999999
Q ss_pred CCChhhhhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 353 NGSLHDFLHLSDED-----NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 353 ~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
+++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999743221 46789999999999999999999975 99999999999999999999999999998765
Q ss_pred CCC---cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 428 NAD---EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 428 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
... ......++..|+|||.+....++.++||||||+++|||++ |..||....... +.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~ 219 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----------------VLEY 219 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHH
Confidence 432 1223345668999999988889999999999999999999 699997643211 1111
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
+........+...+.++.+++.+||..+|++|||+.++++.|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111122334455678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=312.19 Aligned_cols=256 Identities=21% Similarity=0.422 Sum_probs=205.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.+|++.+.||+|+||.||+|... +|. .+|+|.+..... ......+.+|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 46788899999999999999764 233 589998865543 3445778899999999999999999999987 7899
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999863 234589999999999999999999975 999999999999999999999999999976
Q ss_pred CCCCCcccccC---CCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEALNND---AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
........... .+..|+|||.+....++.++||||||+++||+++ |+.||....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~ 221 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----------------IP 221 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HH
Confidence 64333222111 2347999999988889999999999999999999 999997643211 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+.+........+..++..+.+++.+||..+|..||++.++++.|.++.+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111111222334556889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.10 Aligned_cols=241 Identities=21% Similarity=0.330 Sum_probs=190.7
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhh-cCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQ-LHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|..+ +|+.||+|.++.... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999775 688999999975432 12234455667777765 4899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-cc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 432 (579)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 999998852 34688899999999999999999976 99999999999999999999999999986432222 22
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... + ...+.. ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~-------------~~~~~~--~~~~~ 215 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L-------------FESIRV--DTPHY 215 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHHh--CCCCC
Confidence 33457889999999999999999999999999999999999997543211 0 000000 01122
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChH-HHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMS-EVV 542 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 542 (579)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 333456889999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=309.18 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=193.2
Q ss_pred ceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe-eCCeEEEEEEec
Q 008055 277 NLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS-EYGQHLLVYEFR 351 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 351 (579)
+.||+|+||.||+|.+. +...+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 24579999885432 2344678889999999999999999999875 456689999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
.+|+|.+++.. ....+.+..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999863 233467778889999999999999976 999999999999999999999999999875432211
Q ss_pred -----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhC-CCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 432 -----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTG-RKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 432 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.....++..|+|||.+....++.++|||||||++|||++| .+||....... +.. .+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~--------------~~~ 216 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV--------------YLL 216 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--------------HHh
Confidence 1112234579999999888999999999999999999995 56665432211 111 111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
.......+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111111223345689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.36 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=193.0
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||++... +++.||+|++...... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999999765332 23456678888888887 699999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC-CCcc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN-ADEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 432 (579)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 999988752 34689999999999999999999976 999999999999999999999999999875322 2233
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh-hcCccccCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK-MVDPALKGL 511 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 511 (579)
....++..|+|||++.+..++.++|||||||++|||++|..||.......... ....+.+ +... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~--~~~ 221 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN----------TEDYLFQVILEK--PIR 221 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc----------cHHHHHHHHHhC--CCC
Confidence 34567889999999999999999999999999999999999996432111000 0011111 1111 112
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
.+...+..+.+++.+||..||++|+++.
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 3444567889999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.05 Aligned_cols=253 Identities=23% Similarity=0.443 Sum_probs=204.1
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.++++++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 456889999999999999999988888889999886532 235678899999999999999999999887 7889999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999998632 244678889999999999999999976 999999999999999999999999999876543
Q ss_pred CCccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
..... ...++..|+|||++....++.++|||||||++|+|++ |+.||....... . .....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~--------------~~~~~ 217 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V--------------IRALE 217 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H--------------HHHHh
Confidence 22111 1223456999999988889999999999999999999 999996543211 0 00011
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.......+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111111223445689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.90 Aligned_cols=266 Identities=19% Similarity=0.235 Sum_probs=200.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------ 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 341 (579)
..++|++.+.||+|+||.||++... .++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999754 688999999976655555567788999999999999999999988543
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
...++||||+++ +|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 6766663 2478888999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hh-hhhhccccccCh--
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QS-LVRWATPQLHDI-- 497 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~-~~~~~~~~~~~~-- 497 (579)
+++............++..|+|||++.+..++.++|||||||++|||++|+.||........ .. +.....+.....
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 99866544333445678899999999998999999999999999999999999976432111 00 000000000000
Q ss_pred --hHHhhhcCc---------------cc---cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 498 --DALAKMVDP---------------AL---KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 498 --~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.......+. .. ....+......+.+++.+||..||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00 000112234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=313.81 Aligned_cols=269 Identities=25% Similarity=0.418 Sum_probs=208.7
Q ss_pred CCccccceeccCCceEEEEEEeC-----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 343 (579)
..|++.+.||+|+||.||++.+. .+..+|+|.+...... .....+.+|++.++.+.||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35677889999999999999754 3689999999765433 456789999999999999999999999877 567
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.+++|||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 8999999999999999963 233589999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
.......... ....+..|+|||.+....++.++||||||+++|||++|..|+............. . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHHH
Confidence 8765322211 1123346999999988899999999999999999999999986532211100000 0 00011122
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
+...+........+..++.++.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222222333333445667899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=311.06 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=204.6
Q ss_pred hCCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
..+|.+.+.||+|+||.||+|...+ ...||+|...... .....+.+.+|+..+++++||||+++++++.+ +..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 3457888999999999999997643 2468999886543 23456788999999999999999999999875 5678
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ....+++..++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999999963 234589999999999999999999975 999999999999999999999999999876
Q ss_pred CCCCCcccc--cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADEALN--NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
......... ...+..|+|||.+....++.++||||||+++|||++ |+.||......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~----------------~~ 220 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----------------GR 220 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HH
Confidence 544322111 122347999999988889999999999999999997 99999754321110 00
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+ ........+..++..+.+++.+|+..+|++|||+.++++.|.++.++
T Consensus 221 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 I-ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred H-HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00111123445667899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=313.21 Aligned_cols=268 Identities=23% Similarity=0.393 Sum_probs=203.3
Q ss_pred CccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 344 (579)
.|++.+.||+|+||.||++.. .++..||+|.++... .......+.+|+.+++.++|||++++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467889999999999999974 357889999986543 234456789999999999999999999998765 568
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999852 234589999999999999999999976 99999999999999999999999999987
Q ss_pred cCCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
........ ....++..|+|||++.+..++.++|||||||++|||+++..|+.............. .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~ 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQM-TVTRL 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-cccc-cHHHH
Confidence 65433221 122334579999999888899999999999999999998776533211100000000 0000 00111
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
............+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111112222344667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=308.50 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=198.7
Q ss_pred ceeccCCceEEEEEEeCC--C--cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 277 NLLGEGTFGRVYRAQFAD--G--KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+.||+|++|.||+|.+.+ + ..+|+|.+...... ...+.+..|+..+++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999997643 3 36899999776543 567789999999999999999999999988 88999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
+|+|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999874321 5689999999999999999999976 9999999999999999999999999998766442221
Q ss_pred c----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 433 L----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 433 ~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
. ...++..|+|||++....++.++|||||||++|||++ |+.||........ . .......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~--------------~~~~~~~ 217 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--L--------------KKIDKEG 217 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--H--------------HHHHhcC
Confidence 1 1234568999999998899999999999999999999 9999965432110 0 0000000
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111123345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.90 Aligned_cols=259 Identities=18% Similarity=0.275 Sum_probs=195.5
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
...+|.+.+.||+|+||.||++.. .+++.||+|... ...+.+|+.++++++||||+++++++......++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 346799999999999999999965 468899999753 23467899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||++. ++|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 162 ~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 162 LPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 99994 788888752 34688999999999999999999976 99999999999999999999999999986532
Q ss_pred CCC--cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCch-----hhh---hhhhhc--cc-cc
Q 008055 428 NAD--EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR-----LEQ---SLVRWA--TP-QL 494 (579)
Q Consensus 428 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~-----~~~---~~~~~~--~~-~~ 494 (579)
... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ... .+.... .| ..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 221 222346788999999999989999999999999999999999887432210 000 010000 00 00
Q ss_pred c--ChhHHhhhc----C-----ccccCCC--ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 H--DIDALAKMV----D-----PALKGLY--PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~--~~~~~~~~~----~-----~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ....+.... . +..+... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000011000 0 0000000 0124567899999999999999999999985
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=306.40 Aligned_cols=246 Identities=25% Similarity=0.462 Sum_probs=200.2
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
+.||+|+||.||++...+++.||+|.+...... .....+..|+++++.++|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999998877999999998765443 4567889999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc---
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL--- 433 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 433 (579)
.+++.. ....+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999863 234678899999999999999999976 99999999999999999999999999987554221111
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....+..|+|||.+.+..++.++|||||||++|||++ |..||........ ............
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-----------------~~~~~~~~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-----------------RERIESGYRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-----------------HHHHhcCCCCCC
Confidence 1122346999999988889999999999999999999 8899865432111 111111112223
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
+...+..+.+++.+||..+|++|||+.|+++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.01 Aligned_cols=265 Identities=20% Similarity=0.327 Sum_probs=199.5
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-----eEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-----QHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 345 (579)
+|++.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999976 47899999998755433445577889999999999999999999998766 789
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888774 345689999999999999999999976 999999999999999999999999999876
Q ss_pred CCCCCc--ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-ccccChh--
Q 008055 426 MPNADE--ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-PQLHDID-- 498 (579)
Q Consensus 426 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~-- 498 (579)
...... .....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..+.+... +......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 533221 1223457789999998764 478999999999999999999999976543211 11111110 0000000
Q ss_pred --HHhhhcCc-cc-c------CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 499 --ALAKMVDP-AL-K------GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 499 --~~~~~~~~-~~-~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.....+.. .. . .......+.++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 00 0 01122335678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=310.43 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=203.8
Q ss_pred CccccceeccCCceEEEEEEeCC--CcEEEEEEeCCCC--------CCchhHHHHHHHHHHHhh-cCCCCccceeeEEee
Q 008055 272 SFNVENLLGEGTFGRVYRAQFAD--GKVLAVKKIDSSA--------LPSEMCDDFIEMVSNISQ-LHHPNIMELVGYCSE 340 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 340 (579)
.|++.+.||+|+||.||+|..+. ++.+|+|.+.... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788899999999999998765 6889999875332 122334567778887764 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998864434456789999999999999999999952 38999999999999999999999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
|++.............++..|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----------------~ 222 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----------------A 222 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----------------H
Confidence 999766544333344567789999999988899999999999999999999999965432110 0
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
....+...........+..+.+++.+||+.||++||++.|+.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111111234568999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=308.23 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=202.5
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||++... +++.+|+|.+..... ....+.+.+|+.+++.++|+||+++++.+.+.+..+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999765 688999999865432 23456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++|+|||.+.......
T Consensus 80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999999988532 244578899999999999999999976 99999999999999999999999999987654332
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. ....++..|+|||++.+..++.++||||||+++|+|++|..||........ ..... ....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----------------~~~~~-~~~~ 217 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----------------ILKVC-QGSY 217 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----------------HHHHh-cCCC
Confidence 22 234466789999999888899999999999999999999999975432110 00110 1111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+..+.+++.+||+.||++|||+.+++..
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 12233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=306.94 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=206.2
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|+..+.||.|+||.||.++. .+++.+++|.+............+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999965 4688999999876665556677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999986322 45688999999999999999999975 99999999999999999999999999987654433
Q ss_pred -cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 -EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
......++..|+|||++.+..++.++||||||+++|||++|..||....... ..........
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~~~~~- 218 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------------LVVKIVQGNY- 218 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHcCCC-
Confidence 2223456778999999988889999999999999999999999996533211 1111111111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+..+.+++.+||..+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223445689999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.02 Aligned_cols=250 Identities=27% Similarity=0.329 Sum_probs=211.5
Q ss_pred hCCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 346 (579)
...|++.+.||+|.||.||++..+. |+.+|+|.+.+.... ........+|+.+|+++. |||||.+.+.|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4468888999999999999998764 999999999876543 234568889999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC----CceEEecccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE----LNPQLSDCGL 422 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~ 422 (579)
|||++.||.|++.+... .+++..+..++.|++.++.|||.. ||+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998643 389999999999999999999965 99999999999999643 4799999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
+.............||+.|+|||++....|+..+||||+||++|.|++|.+||......... ..
T Consensus 186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~----------------~~ 249 (382)
T KOG0032|consen 186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF----------------LA 249 (382)
T ss_pred ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH----------------HH
Confidence 99888766677788999999999999999999999999999999999999999764422111 01
Q ss_pred hcCc--cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVDP--ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+... .+.............+++..|+..||.+|+|+.++++
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111 1222233445678899999999999999999999998
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.90 Aligned_cols=251 Identities=33% Similarity=0.542 Sum_probs=201.5
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|++.+.||+|+||+||++... +++.+|+|++..............+|+..+++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999776 4668999999877654444445566999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC-CCCC
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNAD 430 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~-~~~~ 430 (579)
++++|.+++. ....+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999996 345689999999999999999999986 9999999999999999999999999998753 2223
Q ss_pred cccccCCCCCccCccccc-cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EALNNDAGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
......++..|+|||++. ...++.++||||+|+++|+|++|..||............ .+.......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~-------------~~~~~~~~~ 220 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII-------------EKILKRPLP 220 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH-------------HHHHHTHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh-------------hhccccccc
Confidence 334456677899999998 788999999999999999999999999865211111110 000000000
Q ss_pred --CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 --GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..........+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001112378999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.52 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=197.6
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 577889999999999999975 478899999986543 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999997542 357788899999999999999976 9999999999999999999999999998765332
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
......++..|+|||++.+..++.++|||||||++|+|++|+.||.......... ..........+.....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MPLQLLQCIVDEDPPV 219 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------chHHHHHHHhccCCCC
Confidence 2223456779999999998899999999999999999999999996532211000 0000011111111111
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......+.++.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1112234678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=312.79 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=195.6
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHH-HHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVS-NISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+|++.+.||+|+||.||++... +|+.||+|+++....... ...+..|+. .++..+||||+++++++...+..+++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 6888999999999999999765 689999999976543333 334444555 4666799999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++ |+|.+++.........+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 688888765444456789999999999999999999963 28999999999999999999999999998765433
Q ss_pred CcccccCCCCCccCcccccc----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 DEALNNDAGSGYGAPEVAMS----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... ..+.....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~~~ 222 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---------------QQLKQVVE 222 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---------------HHHHHHHh
Confidence 22223456778999998864 456889999999999999999999996432111 11111111
Q ss_pred ccccCCCC-hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYP-VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ....+ ...+.++.+++.+||..+|++||++.++++
T Consensus 223 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 EP-SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 01111 224568999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=315.10 Aligned_cols=259 Identities=22% Similarity=0.418 Sum_probs=203.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
..+|+..+.||+|+||.||+|.+. ++. .+|+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 346778899999999999999753 444 478888865432 33345788999999999999999999998754 56
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++++||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 799999999999999862 234688899999999999999999976 99999999999999999999999999997
Q ss_pred cCCCCCcccc---cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNADEALN---NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
.......... ...+..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---------------- 221 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---------------- 221 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------
Confidence 6543322211 223458999999988889999999999999999998 99999654321111
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
+.+........+..++..+.+++.+||..+|++||++.++++.|+++.+...
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 222 -DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 1111111111223345688999999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.42 Aligned_cols=238 Identities=22% Similarity=0.324 Sum_probs=187.9
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHH-HHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMV-SNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|+.. +++.||+|++..... .......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 688999999865432 122234444454 457889999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC-Ccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA-DEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 432 (579)
|+|..++. ....+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99998875 234678888999999999999999976 9999999999999999999999999998753222 222
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|..||....... ....+... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~--~~~~ 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----------------MYDNILHK--PLQL 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHhcC--CCCC
Confidence 33456789999999998899999999999999999999999997543211 00111111 1122
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
+......+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 334556889999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.14 Aligned_cols=265 Identities=18% Similarity=0.234 Sum_probs=199.7
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------G 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 342 (579)
.++|.+.+.||+|+||.||++... .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999754 688999999976554455567788999999999999999999987543 3
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999964 7777664 2477888999999999999999975 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccC-hhH-
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHD-IDA- 499 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~-~~~- 499 (579)
++............++..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..-....... ...
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 9766443333445678899999999999999999999999999999999999976543211 1110000000000 000
Q ss_pred ---HhhhcC--ccc----------------cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 500 ---LAKMVD--PAL----------------KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 500 ---~~~~~~--~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+...+. +.. ...........+.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 000111223578899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=310.36 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=198.3
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 4688899999999999999976 468899999986543 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999998862 34678999999999999999999976 9999999999999999999999999998765432
Q ss_pred Cc-ccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 DE-ALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.. .....++..|+|||.+. ...++.++|||||||++|||++|+.||......... ..+... ....
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~~~---------~~~~ 228 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMSKS---------NFQP 228 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeeecC---------CCCC
Confidence 21 22334567899999884 345788999999999999999999998643321100 000000 0000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+.. ......+..+.+++.+||..+|++|||++++++.
T Consensus 229 ~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 PKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000 0112345688999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.31 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=193.0
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
....+|++.+.||+|+||.||+|... ++..||+|+..... ...|+.++++++||||+++++++...+..++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 44567999999999999999999765 56789999754322 2458889999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||++. ++|.+++.. ....+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 135 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 999994 688888752 345689999999999999999999976 9999999999999999999999999998754
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCC-CCCCCCCchhh-------hhhhhhcc-----c-
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR-KPFDSSRPRLE-------QSLVRWAT-----P- 492 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~-~p~~~~~~~~~-------~~~~~~~~-----~- 492 (579)
..........++..|+|||++.+..++.++|||||||++|||+++. .+|........ ..+.+... +
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 4333333455788999999999999999999999999999999954 44443221100 00110000 0
Q ss_pred ccc---ChhHHhhhcCc--cccCCC-------ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 493 QLH---DIDALAKMVDP--ALKGLY-------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 493 ~~~---~~~~~~~~~~~--~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+. .......+.+. ..+..+ ....+..+.++|.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000 00000111000 000000 0122345677999999999999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=330.73 Aligned_cols=250 Identities=23% Similarity=0.433 Sum_probs=217.0
Q ss_pred cceeccCCceEEEEEEe-CCC----cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 276 ENLLGEGTFGRVYRAQF-ADG----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.++||.|+||+||+|.+ .+| -+||||++..... .....++.+|+.+|.+++|||+++++|+|.... ..||++|
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 57899999999999954 444 4789998865543 344688999999999999999999999998655 8899999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
|+.|+|.++++. ....+-.+..+.|..|||+||.|||++ +++||||..+|||+.+-..+||.|||+++.+....
T Consensus 779 mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999984 456688889999999999999999976 99999999999999999999999999999888777
Q ss_pred cccccCC---CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 431 EALNNDA---GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 431 ~~~~~~~---~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..+...+ .+.|||=|.+....|+.++|||||||++||++| |..||++... +.+.+.++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~ 915 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEK 915 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhc
Confidence 6665444 347999999999999999999999999999999 9999987543 345556666
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
..+-..|+.++.+++-++.+||..|+..||+++++...+.++.+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 66667789999999999999999999999999999999988775
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=313.30 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=200.9
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++|+||+++++++......++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4788889999999999999975 46889999998765432 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ...+++.++..++.|++.||.|||.. +|+||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999985 23478899999999999999999976 9999999999999999999999999998765432
Q ss_pred Ccc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+. .....
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~-------------~~~~~ 234 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA-------------TNGTP 234 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh-------------cCCCC
Confidence 221 223566789999999888899999999999999999999999965432110 00000 00000
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+...+..+.+++.+||..+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 01122334567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.20 Aligned_cols=265 Identities=22% Similarity=0.352 Sum_probs=202.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 6888999999999999999765 67889999886543 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.++++. ...+++..+..++.|++.||.|||+. .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999963 35678899999999999999999962 389999999999999999999999999986553321
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC--------------
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD-------------- 496 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 496 (579)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....................
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 22345677999999998888999999999999999999999999654322111111000000000
Q ss_pred ------hhHHhhhcCccccCCCC-hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 497 ------IDALAKMVDPALKGLYP-VKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 497 ------~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
......... ......+ ...+.++.+++.+||..+|++|||+.++++.-
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 234 PRPMAIFELLDYIVN-EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cchhhHHHHHHHHhc-CCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 0011111 12456799999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.39 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=190.5
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHH-HHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVS-NISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999764 689999999965432 2223344555544 46779999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC-CCcc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN-ADEA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 432 (579)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99998885 345688999999999999999999976 999999999999999999999999999875322 2222
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|..||....... .......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~~~~~~~--~~ 215 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----------------MYDNILHKPL--VL 215 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----------------HHHHHHcCCc--cC
Confidence 33457889999999999999999999999999999999999997543211 0111111111 11
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+...+..+.+++.+|++.+|.+||++++.++.
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 22345678899999999999999998744433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=307.26 Aligned_cols=248 Identities=28% Similarity=0.475 Sum_probs=202.3
Q ss_pred CCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|...+ ++.+++|.+.... ..+.+.+|++.+++++||||+++++++.+....++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 468888999999999999998764 7899999986542 16788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999862 345789999999999999999999976 9999999999999999999999999998766543
Q ss_pred Cc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.. .....++..|+|||++.+..++.++||||||+++|+|++|+.||........... ... ....
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~--~~~~ 217 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPN--KPPP 217 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hcc--CCCC
Confidence 32 2223456789999999988999999999999999999999999975432111000 000 0000
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+......+.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01122334567899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=319.79 Aligned_cols=243 Identities=19% Similarity=0.303 Sum_probs=194.3
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 348 (579)
+|+..+.||+|+||.||+|... +++.||+|++..... .......+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999765 688999999875432 2233456777888888775 577888999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999885 234688999999999999999999976 999999999999999999999999999875432
Q ss_pred CC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 AD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~~~~i~~~- 216 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----------------LFQSIMEH- 216 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC-
Confidence 22 2223457889999999998899999999999999999999999997643211 01111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
...++...+.++.+++.+||+.+|.+|++..
T Consensus 217 -~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 -NVSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1123444556889999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=320.78 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=195.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++... +++.||+|++.+.. ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36889999999999999999765 68999999986432 22234566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999862 244688899999999999999999976 999999999999999999999999999876543
Q ss_pred CCcc--cccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 429 ADEA--LNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
.... ....++..|+|||++.. ..++.++|||||||++|||++|+.||........ . .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~--------------~ 218 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--Y--------------G 218 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--H--------------H
Confidence 3222 12357889999999863 4578899999999999999999999965332110 0 0
Q ss_pred hhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCC--CCChHHHHHH
Q 008055 502 KMVDPALK---GLYPVKSLSRFADVIALCVQPEPEF--RPPMSEVVQA 544 (579)
Q Consensus 502 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 544 (579)
.+...... .......+..+.+++.+|+..++++ |+++.++++.
T Consensus 219 ~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00000000 0011224567889999988654443 7899888855
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.08 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=204.8
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|+..+.||+|+||.||++.. .+++.+|+|.+............+.+|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999966 4688999999977665556678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 429 (579)
+++++|.+++... ....+++..+..++.+++.||+|||++ +++|+||+|+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999632 234588999999999999999999976 99999999999999865 45799999999876554
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.......++..|+|||.+....++.++||||||+++|+|++|+.||........ ...... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----------------~~~~~~-~~~ 218 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----------------VLKIMS-GTF 218 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----------------HHHHHh-cCC
Confidence 433345567789999999988899999999999999999999999965432110 001111 111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1223345668999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=315.34 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=198.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|.+.+.||+|+||.||+|..+ +++.||+|.++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 46888999999999999999765 678899999875432 2234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9975 88887752 234578889999999999999999976 9999999999999999999999999998754332
Q ss_pred Cc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh-hhh-hcccc------ccChhH
Q 008055 430 DE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS-LVR-WATPQ------LHDIDA 499 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~-~~~-~~~~~------~~~~~~ 499 (579)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.. ...+. ......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 22 223455778999999865 468999999999999999999999997654322111 111 11100 000000
Q ss_pred HhhhcCccccC----CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKG----LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....-.+.... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 001124567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.39 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=195.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++... +++.||+|++..... .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 689999999965332 2344567788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999862 34688999999999999999999976 999999999999999999999999999864422
Q ss_pred CCc------------------------------------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCC
Q 008055 429 ADE------------------------------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472 (579)
Q Consensus 429 ~~~------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~ 472 (579)
... .....+|..|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 11235778999999999999999999999999999999999
Q ss_pred CCCCCCCchhh-hhhhhhccccccChhHHhhhcCccccCCCCh--hhHHHHHHHHHhcCCCCCCCCCC---hHHHHH
Q 008055 473 KPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKGLYPV--KSLSRFADVIALCVQPEPEFRPP---MSEVVQ 543 (579)
Q Consensus 473 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps---~~evl~ 543 (579)
.||........ ..+..|.. ...++. ..+.++.+++.+|+. ||.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKE-----------------TLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCC-----------------ceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99976443211 11111100 001111 234578889988774 9999986 555553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=309.82 Aligned_cols=249 Identities=26% Similarity=0.459 Sum_probs=197.8
Q ss_pred ceeccCCceEEEEEEeCC-------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 277 NLLGEGTFGRVYRAQFAD-------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+..++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997643 25789998865432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-----ceEEeccc
Q 008055 350 FRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-----NPQLSDCG 421 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfg 421 (579)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999964322 224578899999999999999999965 999999999999999887 89999999
Q ss_pred ccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccCh
Q 008055 422 LASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDI 497 (579)
Q Consensus 422 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 497 (579)
++......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------------- 221 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------------- 221 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---------------
Confidence 98765432211 12233568999999999999999999999999999998 999996533211
Q ss_pred hHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
....+........+...+..+.+++.+||..+|++||++.+|++.|+
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 222 --VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111112233455678999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.77 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=200.5
Q ss_pred CccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC----chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP----SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
+|.+.+.||+|+||.||+|...+++.+|+|.+...... ......+.+|+..+++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998888999999998654321 23346688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999862 24578899999999999999999976 89999999999999999999999999986542
Q ss_pred CCC-------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 428 NAD-------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 428 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------------- 217 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---------------- 217 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----------------
Confidence 211 111234567899999999888999999999999999999999999653321100
Q ss_pred hhhcCc-cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDP-ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...... ......+...+..+.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 1111223345678899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.02 Aligned_cols=267 Identities=21% Similarity=0.291 Sum_probs=200.2
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|++|.||+|... ++..||+|++............+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999765 689999999876544444456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
++ ++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68988886322 235689999999999999999999976 99999999999999999999999999987543322
Q ss_pred c-ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhhhcccc------ccChhHH
Q 008055 431 E-ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVRWATPQ------LHDIDAL 500 (579)
Q Consensus 431 ~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~------~~~~~~~ 500 (579)
. .....++..|+|||++.+. .++.++|||||||++|+|+||+.||........ ..+..+..+. .......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 1 1223456789999988654 578999999999999999999999976433211 1111111100 0000000
Q ss_pred hhhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALK---GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......... .......+.++.+++.+||..||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0011224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=309.59 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=196.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC-----
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY----- 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----- 341 (579)
+++.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4567888899999999999999765 68899999986543 2245678888999888 799999999998653
Q ss_pred -CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 342 -GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
...+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 4689999999999999998632 234688999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCC-cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPNAD-EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|++....... ......++..|+|||++. ...++.++|||||||++|||++|..||...........
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-------- 227 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------- 227 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--------
Confidence 9987653322 222344677899999986 34578899999999999999999999965432111100
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..........+...+..+.+++.+||..+|.+|||+.++++
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 --------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000111112234567899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.60 Aligned_cols=198 Identities=26% Similarity=0.403 Sum_probs=171.7
Q ss_pred CccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-C-----CCccceeeEEeeCCeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-H-----PNIMELVGYCSEYGQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~ 344 (579)
+|++.+.||+|+||.|-+|. .++++.||||+++... ....+...|+.+|..++ | -|+|+++++|...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 89999999999999999995 4579999999998754 34566778888888886 3 3899999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC--CceEEecccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE--LNPQLSDCGL 422 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfg~ 422 (579)
|||+|.+ .-+|+++++... ...++...+..|+.||+.||..||+. +|||+||||+||||.+. ..+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999 459999998543 44588999999999999999999976 99999999999999754 4799999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
+..... ...++..+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+..+
T Consensus 338 Sc~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 338 SCFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 976543 33366778899999999999999999999999999999999888876543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=304.51 Aligned_cols=246 Identities=27% Similarity=0.453 Sum_probs=205.9
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|++++.||+|+||+||++.++ .|..+|||.+... ...++++.|+.++++++.|++|++||.+.....+|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 667889999999999999664 7999999998643 34788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC-C
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA-D 430 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 430 (579)
..|++.+.++ ...+++++.++..|++..++||+|||.. .-||||||..|||++.+|.+||+|||.+..+... .
T Consensus 111 GAGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 111 GAGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred CCCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999997 4567899999999999999999999976 7899999999999999999999999999766432 2
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
...+..+|+.|||||++..-.|+.++||||||++..||..|++||....+-..- ++.|.. +..-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----FMIPT~-----------PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----FMIPTK-----------PPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----EeccCC-----------CCCCC
Confidence 234556889999999999999999999999999999999999999754331100 011100 00011
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.-|+..+.+|.+++++||..+|++|.|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 225666789999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=301.12 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=199.3
Q ss_pred cccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHh--hcCCCCccceeeEEeeCC----eEEEE
Q 008055 274 NVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS--QLHHPNIMELVGYCSEYG----QHLLV 347 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv 347 (579)
+..++||+|.||.||||.+. ++.||||++.. +..+.|..|-.+++ .++|+||++++++-.... +.+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34577999999999999886 59999999964 34677888877776 469999999999876544 88999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV------CSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
+||.+.|+|.+||. ...++|....+|+.-+++||+|||+. ..++|+|||||++|||+..|+++.|+|||
T Consensus 287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999996 45689999999999999999999975 25689999999999999999999999999
Q ss_pred ccccCCCCCc---ccccCCCCCccCccccccCC-CC-----ccchHHhHHHHHHHHHhCCCCCCC-CCchhhhhhhhhcc
Q 008055 422 LASNMPNADE---ALNNDAGSGYGAPEVAMSGQ-YN-----IKSDVYSFGVVMLELLTGRKPFDS-SRPRLEQSLVRWAT 491 (579)
Q Consensus 422 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslGv~l~elltg~~p~~~-~~~~~~~~~~~~~~ 491 (579)
+|..+..... ....+||..|||||++.+.- +. .+.||||+|.++|||++...-++. ..+...-.+...+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 9987754432 33467889999999996532 22 368999999999999986554431 11111111110111
Q ss_pred ccccChhHHhh-hcCccccCCCCh-----hhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 492 PQLHDIDALAK-MVDPALKGLYPV-----KSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 492 ~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
.-+..+.+.. ++....++.++. .....+.+.+..||+.||+.|.|+.=+-+.+.++..
T Consensus 442 -~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 -NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred -CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111122222 222333444432 345679999999999999999999999888887764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=318.43 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=196.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++..+ +++.+|+|++.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999775 578899999864321 2233455788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999963 234688899999999999999999976 999999999999999999999999999875533
Q ss_pred CCcc--cccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 429 ADEA--LNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
.... ....++..|+|||++. ...++.++|||||||++|||++|+.||....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~----------------~~~ 218 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TYG 218 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH----------------HHH
Confidence 2221 2245788999999986 3468899999999999999999999997543211 111
Q ss_pred hhcCccccCCC---ChhhHHHHHHHHHhcCCCCCCC--CCChHHHHHH
Q 008055 502 KMVDPALKGLY---PVKSLSRFADVIALCVQPEPEF--RPPMSEVVQA 544 (579)
Q Consensus 502 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 544 (579)
.+.....+..+ ....+..+.+++.+|+..++.+ |+++.++++.
T Consensus 219 ~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111111111 1234678899999988665554 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.97 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=203.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|+++...........+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999775 58899999987655555556788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++++.+..+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776653 234588999999999999999999976 9999999999999999999999999998766544
Q ss_pred Cc--ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChh-------
Q 008055 430 DE--ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDID------- 498 (579)
Q Consensus 430 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~------- 498 (579)
.. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .......+......
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 32 2234456789999999887 7899999999999999999999999754321110 11110000000000
Q ss_pred HHh--hhcCcc----ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 499 ALA--KMVDPA----LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 499 ~~~--~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ...+.. ....++...+.++.+++.+||..+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000000 001123334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=308.00 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=201.2
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||.|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 6788899999999999999765 68899999986543 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999862 2789999999999999999999975 99999999999999999999999999997765432
Q ss_pred -cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 -EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
......++..|+|||++.+..++.++|||||||++|+|++|+.||......... ..+. ....
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------------~~~~----~~~~ 215 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------------FLIP----KNNP 215 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------------HHhh----hcCC
Confidence 222344566899999999888999999999999999999999999654321100 0000 0111
Q ss_pred CCCChh-hHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GLYPVK-SLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+.. .+..+.+++.+||..+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 4567899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.76 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=201.5
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-CCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-YGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 349 (579)
+|++.+.||+|++|.||++..+ +++.+|+|++..........+.+.+|++.+++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999764 57899999997655555556778899999999999999999988764 456899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++... ....+++.++..++.+++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998632 234689999999999999999999976 9999999999999999999999999998765432
Q ss_pred Cc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.. .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ ...... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~-~~ 218 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----------------VYRIIE-GK 218 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHHh-cC
Confidence 22 2233456789999999998999999999999999999999999975432110 000000 11
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+...+..+.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11223345578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=320.08 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=196.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999765 67899999986532 22233456788899999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999963 234688899999999999999999976 999999999999999999999999999876543
Q ss_pred CCcc--cccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 429 ADEA--LNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~ 218 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TYG 218 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----------------HHH
Confidence 3222 12457889999999875 467899999999999999999999997543211 111
Q ss_pred hhcCccccCCCC---hhhHHHHHHHHHhcCCCCCCC--CCChHHHHH
Q 008055 502 KMVDPALKGLYP---VKSLSRFADVIALCVQPEPEF--RPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 543 (579)
.+.....+..++ ...+.++.+++.+|+..++.+ |+++.++++
T Consensus 219 ~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 219 KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111111111111 224568899999999876654 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=312.51 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=212.8
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+..+.|..-++||+|+||.||-+..+ +|+.||.|.+.++.+.. ......++|-.+|.++..+.||.+-..|+..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567899999999999999999654 79999999997765543 33455678999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|+..|.||+|+-+|. ......++++.+..++.+|+.||++||+. +||+|||||+|||+|+.|+++|+|.|+|..
T Consensus 262 lVLtlMNGGDLkfHiy--n~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIY--NHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEee--ccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999988775 34456899999999999999999999976 999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
+..........||.+|||||++..+.|+...|+|||||+||||+.|+.||....+.... +.+.+.+.
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdrr~~ 403 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDRRTL 403 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHHHHh
Confidence 98888888889999999999999999999999999999999999999999765433211 11222111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
.-...++...+++..++....|+.||++|...+
T Consensus 404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 112235666778889999999999999997554
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.20 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=199.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-------hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-------EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
+|.+...||+|+||.||+|... +++.+|+|.+....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999764 68899999886543321 233567889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999963 34578889999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCc-------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC
Q 008055 424 SNMPNADE-------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 424 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------- 218 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------------- 218 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---------------
Confidence 76642111 11223566899999999888999999999999999999999999754221
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+..... ......+...+..+.+++.+||+.||.+||++.++++
T Consensus 219 -~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 -QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111111 1112233445678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.15 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=201.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+.+++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999876 68999999987554333345667899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|..++. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998888764 234589999999999999999999975 9999999999999999999999999999866543
Q ss_pred Cc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChhHH------
Q 008055 430 DE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDIDAL------ 500 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~------ 500 (579)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+..............
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 32 222345668999999875 45789999999999999999999999764432111 1111000000000000
Q ss_pred -hhhcCccccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 -AKMVDPALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 -~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+...... ....+..+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 0123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=305.89 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=190.1
Q ss_pred eeccCCceEEEEEEeCC---CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 278 LLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+..+++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997643 45789998865543 233457888999999999999999999999999999999999999
Q ss_pred ChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 355 SLHDFLHLSDE-DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 355 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
+|.++++.... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999964332 223566778889999999999999976 99999999999999999999999999986543322111
Q ss_pred ---ccCCCCCccCccccccC-------CCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 434 ---NNDAGSGYGAPEVAMSG-------QYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 434 ---~~~~~~~y~aPE~~~~~-------~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
...++..|+|||++... .++.++||||||+++|||++ |..||............ +.. ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~-------~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VRE-------QQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hhc-------ccCC
Confidence 12345679999998632 35789999999999999997 99999654322111000 000 0000
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
..++ ......+..+.+++..|| .+|++|||+.+|+..|+
T Consensus 230 ~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 111233457889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=305.12 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=187.1
Q ss_pred ceeccCCceEEEEEEeCC-------------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 277 NLLGEGTFGRVYRAQFAD-------------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
+.||+|+||.||+|.+.+ ...+++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 358999999999997532 2358888876543 3345678889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-------eE
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN-------PQ 416 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-------~k 416 (579)
.++||||+++|+|..++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. ++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999988852 234688999999999999999999965 9999999999999987654 89
Q ss_pred EecccccccCCCCCcccccCCCCCccCccccc-cCCCCccchHHhHHHHHHHHH-hCCCCCCCCCchhhhhhhhhccccc
Q 008055 417 LSDCGLASNMPNADEALNNDAGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELL-TGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 417 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
++|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|..||.........
T Consensus 153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---------- 219 (262)
T cd05077 153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---------- 219 (262)
T ss_pred eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----------
Confidence 9999998654322 2234567899999887 466899999999999999998 488888643211100
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
........ .......++.+++.+||+.||++||++.+|++.|
T Consensus 220 -------~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 -------RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000010 1112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.91 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=198.6
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+.++..+.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344556666778999999999999754 67889999886543 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPL--IWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGL 422 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~ 422 (579)
+||||+++++|.+++... ...+ .+..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999998632 2234 7788889999999999999976 9999999999999976 67899999999
Q ss_pred cccCCCCCc-ccccCCCCCccCccccccCC--CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 423 ASNMPNADE-ALNNDAGSGYGAPEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 423 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
+........ .....++..|+|||++.... ++.++||||||+++|+|++|+.||......... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~---------- 222 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MF---------- 222 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hh----------
Confidence 876543222 22234577899999986543 788999999999999999999999643211000 00
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+.....++.+++.+||+.+|++|||+.++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 --KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000001112234455678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.13 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=201.2
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEe-
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCS- 339 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 339 (579)
++.+....++|++.+.||+|+||.||++... +++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3445556788999999999999999999764 67899999876432 2235677888999888 7999999999874
Q ss_pred ----eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 340 ----EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 340 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
..+..++||||+++++|.++++........+++..+..++.|++.||.|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34578999999999999998864333455788899999999999999999975 99999999999999999999
Q ss_pred EEecccccccCCCCC-cccccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhh
Q 008055 416 QLSDCGLASNMPNAD-EALNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~ 489 (579)
+|+|||++....... ......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFKI 241 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhhc
Confidence 999999987654322 1223356778999999853 457889999999999999999999996543211 00000
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
. ....+ ....+......+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~-----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 P-----------RNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-----------ccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 00000 001122234579999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.18 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=194.8
Q ss_pred ccceeccC--CceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 275 VENLLGEG--TFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 275 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
+.++||+| +|++||++.. .+|+.||+|++............+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999966 47899999999766554555667788999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998532 233588999999999999999999976 999999999999999999999999986543321111
Q ss_pred --------ccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHH
Q 008055 432 --------ALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDAL 500 (579)
Q Consensus 432 --------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 500 (579)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ........+...+...+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 111234557999999976 4589999999999999999999999975322110 00000000000000000
Q ss_pred --hhh--------cC-----------------ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 --AKM--------VD-----------------PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 --~~~--------~~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... .+ ...........+..+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 00 00000112234568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.26 Aligned_cols=256 Identities=25% Similarity=0.476 Sum_probs=200.5
Q ss_pred ccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC------
Q 008055 273 FNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG------ 342 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 342 (579)
|.+.+.||+|+||.||+|.+. .++.||+|++..........+.+.+|++.+++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 3688999999776555556778889999999999999999999885432
Q ss_pred eEEEEEEecCCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSD--EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
..++++||+.+|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875332 1223578899999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccC
Q 008055 421 GLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 421 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
|+++....... ......+..|++||.+....++.++|||||||++|||++ |+.||....... ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI----- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH-----
Confidence 99876543221 112223457999999988889999999999999999999 889986543211 111000
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.. .....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 --------~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 --------KG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------cC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00111233456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=306.65 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=203.0
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.|+..+.||.|+||.||+|... ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4677788999999999999765 588999999875432 34467888999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++. ..++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999885 23578889999999999999999975 99999999999999999999999999987654433
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. ....++..|+|||++.+..++.++|||||||++|||++|..||........ .........
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------------~~~~~~~~~ 218 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----------------LFLIPKNNP 218 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------------hhhhhcCCC
Confidence 22 123456689999999888899999999999999999999999965432110 011111112
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23345567789999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=303.68 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=202.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.+++|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 47888999999999999999764 578899999875542 246788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ....+++..+..++.|++.||.|||++ +|+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999998863 235688999999999999999999976 9999999999999999999999999998765433
Q ss_pred C-cccccCCCCCccCccccccC---CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 D-EALNNDAGSGYGAPEVAMSG---QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ......++..|+|||.+... .++.++||||||+++|||++|+.||............ .. .. ..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~---------~~-~~ 222 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SK---------SN-FP 222 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh---------cc-CC
Confidence 2 12223456689999999776 7899999999999999999999999754322111000 00 00 00
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+...+.++.+++.+||..+|.+|||+.+|+.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 -PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001122344568999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.50 Aligned_cols=244 Identities=30% Similarity=0.422 Sum_probs=200.4
Q ss_pred eeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
+||+|.||+||.|+..+ ...+|||.+.... .+..+-+.+|+.+-++++|.|||+++|.+.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999997664 4578999986544 45567789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccccCCCCCc-c
Q 008055 357 HDFLHLSDEDNKPL--IWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGLASNMPNADE-A 432 (579)
Q Consensus 357 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~-~ 432 (579)
.++++. .-.++ .+.....+.+||++||.|||++ .|||||||-+|||++. .|.+||+|||.++.+..-.. .
T Consensus 660 SsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 660 SSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 999973 33445 6778888999999999999976 9999999999999974 58899999999987765443 3
Q ss_pred cccCCCCCccCccccccC--CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 433 LNNDAGSGYGAPEVAMSG--QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
.+..||..|||||++..+ .|..++|||||||++.||.||++||....... ..+.++--=...+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------AAMFkVGmyKvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------AAMFKVGMYKVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------HhhhhhcceecCC
Confidence 456788899999999765 48899999999999999999999996432110 0111111111234
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
..|.+...+...+|.+|+.+||.+||+++++++.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 4577888899999999999999999999999864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.28 Aligned_cols=238 Identities=26% Similarity=0.390 Sum_probs=186.0
Q ss_pred eeccCCceEEEEEEeCC-------------------------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCcc
Q 008055 278 LLGEGTFGRVYRAQFAD-------------------------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 332 (579)
.||+|+||.||+|.+.. ...|++|++.... ......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999996421 1358888886433 23456788899999999999999
Q ss_pred ceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 333 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
++++++.+....++||||+++|+|..++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++..
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999998862 345688999999999999999999965 99999999999999764
Q ss_pred C-------ceEEecccccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHH-hCCCCCCCCCchhh
Q 008055 413 L-------NPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELL-TGRKPFDSSRPRLE 483 (579)
Q Consensus 413 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell-tg~~p~~~~~~~~~ 483 (579)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3 3799999987543221 12345678999998865 56899999999999999995 69999965432111
Q ss_pred hhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 484 QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
... .... ...+......+.+++.+||+.+|++|||+.++++.|
T Consensus 231 ~~~-----------------~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERF-----------------YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH-----------------HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 100 0000 011122234789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=303.18 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=202.3
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC---CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL---PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
+|+..+.||+|+||.||+|... ++..|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999776 789999999865332 234567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999862 34578899999999999999999976 99999999999999999999999999987654
Q ss_pred CCCcccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.........++..|+|||.+.... ++.++|+|||||++|+|++|+.||........ .......
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~----------------~~~~~~~ 217 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA----------------VFKIGRS 217 (258)
T ss_pred ccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH----------------HHHHHhc
Confidence 443233445677899999987766 89999999999999999999999965432110 0010010
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+......+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112233445678899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=303.72 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=203.9
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||++.. .+++.||+|.+............+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999965 4689999999876544445567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988632 234578899999999999999999976 99999999999999999999999999987654432
Q ss_pred ccc-ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EAL-NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
... ...++..|+|||++.+..++.++|||||||++|+|++|+.||....... ........ ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~~~-~~ 218 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------------LVLKIIRG-SY 218 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----------------HHHHHhcC-CC
Confidence 221 2345668999999998889999999999999999999999996532211 11111111 11
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+.++.+++.+||+.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1223445678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.52 Aligned_cols=246 Identities=26% Similarity=0.455 Sum_probs=198.2
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.+|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|||++++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 3578889999999999999975 57889999986432 246788999999999999999999998754 47999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 80 MSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999998632 234578899999999999999999976 9999999999999999999999999998754321
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
......+..|+|||++.+..++.++|||||||++|||++ |+.||........ .........
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~~ 215 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-----------------KECVEKGYR 215 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-----------------HHHHhCCCC
Confidence 112233457999999988899999999999999999998 9999965432111 111111112
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
...+...+..+.+++.+||+.+|+.||++.++++.|+
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 2223345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.67 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=202.7
Q ss_pred cCHHHHHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEE
Q 008055 261 YSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYC 338 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 338 (579)
+...++..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 33445555678899999999999999999976 468899999986532 2245667888888888 899999999998
Q ss_pred eeC-----CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 008055 339 SEY-----GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413 (579)
Q Consensus 339 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 413 (579)
... +..++||||+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 653 468999999999999998865444456789999999999999999999976 999999999999999999
Q ss_pred ceEEecccccccCCCCCc-ccccCCCCCccCccccccC-----CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 008055 414 NPQLSDCGLASNMPNADE-ALNNDAGSGYGAPEVAMSG-----QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~ 487 (579)
.+||+|||++........ .....++..|+|||++... .++.++|||||||++|||++|+.||....... .+.
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~ 243 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF 243 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH
Confidence 999999999876543222 1223456789999998643 36889999999999999999999996543211 111
Q ss_pred hhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
++... ..+. ...+......+.+++.+||+.+|++||++.++++
T Consensus 244 ~~~~~-----------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRN-----------PPPT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcC-----------CCCC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11000 0000 0112234457899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=307.91 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=201.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||++... ++..||+|.+.... .......+.+|+..+++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5788899999999999999775 78999999986542 334457788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|..++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999886321 234689999999999999999999962 38999999999999999999999999998765332
Q ss_pred cccccCCCCCccCccccccC------CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 431 EALNNDAGSGYGAPEVAMSG------QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||......... ..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~~~~~~ 223 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQLSAIV 223 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HHHHHHh
Confidence 22233456789999998544 3588999999999999999999999653221100 1111111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.. .....+...+.++.+++.+||+.+|++||++.+++..
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 1122344466789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.68 Aligned_cols=247 Identities=25% Similarity=0.413 Sum_probs=200.1
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.|+..+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3566788999999999999754 578999999875443 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++. ...+.+..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999885 24578899999999999999999965 99999999999999999999999999987654332
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||........ .........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------------~~~~~~~~~ 218 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----------------LFLIPKNSP 218 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----------------HhhhhcCCC
Confidence 21 123456689999999988899999999999999999999999864332110 000111111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233455688999999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.09 Aligned_cols=265 Identities=20% Similarity=0.279 Sum_probs=197.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||+|... +|+.+|+|++............+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999765 689999999976544444456678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
++ ++|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 588887752 235689999999999999999999976 99999999999999999999999999987554322
Q ss_pred c-ccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhhhcc-ccccChhHHhhhcC
Q 008055 431 E-ALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVRWAT-PQLHDIDALAKMVD 505 (579)
Q Consensus 431 ~-~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~ 505 (579)
. .....++..|+|||++.+.. ++.++|||||||++|||+||..||........ ..+..... +.......+....+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 2 22234567899999987644 78999999999999999999888643322111 11111000 00000001111111
Q ss_pred ccccC---------CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKG---------LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..... ......+.++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=306.41 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=196.7
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|++.+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++|||++++++++...+..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 567788999999999999765 57788999886443 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD- 430 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 430 (579)
++|+|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 85 AGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999988752 235689999999999999999999976 99999999999999999999999999986543322
Q ss_pred cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 431 EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
......++..|+|||++. ...++.++|||||||++|||++|+.||....... ...... ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~-----------~~~~ 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIA-----------KSEP 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHh-----------hcCC
Confidence 122345677899999984 3457889999999999999999999996533210 000000 0000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+ ....+...+.++.+++.+||+.||++||++.++++.
T Consensus 226 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 P--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011233345689999999999999999999988743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=307.29 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=198.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.|++.+.||.|+||.||+|... ++..+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 46888999999999999999775 58899999986543 3456778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|..++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999888752 234688999999999999999999965 9999999999999999999999999988654322
Q ss_pred C-cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 430 D-EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
. ......++..|+|||++. ...++.++|||||||++|||++|..||...... .....+.. .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-----------~ 230 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAK-----------S 230 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHhc-----------C
Confidence 1 122334567899999985 344788999999999999999999999653221 00111000 0
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+ ....+...+.++.+++.+||+.+|++||++.++++
T Consensus 231 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00112344567899999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=301.94 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=201.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||+|... +++.|++|.++.........+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999764 789999999977665445678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++.. ...+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999862 34578889999999999999999976 99999999999999999999999999987664433
Q ss_pred ccc-----ccCCCCCccCccccccCC---CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 431 EAL-----NNDAGSGYGAPEVAMSGQ---YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 431 ~~~-----~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
... ...++..|+|||++.... ++.++||||||+++|+|++|+.||........... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~---------------~ 218 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF---------------H 218 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH---------------H
Confidence 221 234566899999998766 88999999999999999999999965422110000 0
Q ss_pred hcCccccCCCCh--hhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVDPALKGLYPV--KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .......+. ..+..+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VG-AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred Hh-cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 011111222 23567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.42 Aligned_cols=267 Identities=21% Similarity=0.312 Sum_probs=191.3
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC------CCCccceeeE
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH------HPNIMELVGY 337 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~ 337 (579)
++...+++|++.+.||+|+||.||+|... .++.||||+++... .....+..|+.++..++ |.++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 44456789999999999999999999764 57899999996432 12334445666665554 4568888888
Q ss_pred EeeC-CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---
Q 008055 338 CSEY-GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL--- 413 (579)
Q Consensus 338 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~--- 413 (579)
+... +..++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||.. .+|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccc
Confidence 8754 5788999988 7789888852 34688999999999999999999952 3999999999999998765
Q ss_pred -------------ceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 414 -------------NPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 414 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
.+||+|||.+..... ......+|..|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998754322 22345678899999999999999999999999999999999999976543
Q ss_pred hhhhhhhhhccccccCh-------hHHhhhcCc--cccC---------------CCChhhHHHHHHHHHhcCCCCCCCCC
Q 008055 481 RLEQSLVRWATPQLHDI-------DALAKMVDP--ALKG---------------LYPVKSLSRFADVIALCVQPEPEFRP 536 (579)
Q Consensus 481 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~--~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~Rp 536 (579)
.............+... .....+.+. .+.. .........+.+||.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 22111111000000000 000000000 0000 00011235688999999999999999
Q ss_pred ChHHHHH
Q 008055 537 PMSEVVQ 543 (579)
Q Consensus 537 s~~evl~ 543 (579)
|+.|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999985
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.41 Aligned_cols=264 Identities=19% Similarity=0.272 Sum_probs=197.4
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------ 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 341 (579)
..++|.+.+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 356899999999999999999975 4688999999976543334456778899999999999999999887532
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
...++++|++ +++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 4578999988 789988874 34589999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccC---
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHD--- 496 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~--- 496 (579)
++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ...+..........
T Consensus 164 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 164 LARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred cceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99765432 233456789999999876 568999999999999999999999996543211 01111111000000
Q ss_pred ---hhHHhhhcCccccCC-------CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 497 ---IDALAKMVDPALKGL-------YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 497 ---~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......... .+... ........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000 001123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=302.99 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=195.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC---chhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP---SEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 345 (579)
+|+..+.||+|+||.||+|... ++..||+|++...... ......+.+|+.+++.++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6888899999999999999764 6889999998654322 2345678889999999999999999998865 36788
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
++|||+++++|.+++.. ...+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 83 l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999999862 33578899999999999999999965 999999999999999999999999999875
Q ss_pred CCCCCc----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADE----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----------------~~~~ 219 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----------------AAIF 219 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----------------HHHH
Confidence 532111 11233566899999999888999999999999999999999999653221 1111
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..........++......+.+++ +||..+|++||++.||++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 220 KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111112233444456677787 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=311.07 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=200.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+|++.+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|++.++.++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888899999999999999775 48999999997655432 355678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+.+++|.+++... ....+++..+..++.|++.||+|||.. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998632 345689999999999999999999976 9999999999999999999999999998654322
Q ss_pred Ccc------------------------------cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCC
Q 008055 430 DEA------------------------------LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR 479 (579)
Q Consensus 430 ~~~------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~ 479 (579)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 11235667999999998889999999999999999999999997543
Q ss_pred chhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC----hHHHHH
Q 008055 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP----MSEVVQ 543 (579)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~ 543 (579)
.. ...................+..+.+++.+||+.||++||| +.+++.
T Consensus 237 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 1111111111111111124678999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=309.82 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=201.0
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|++.+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 5788999999999999999975 5799999999865443 234667889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999985 23578889999999999999999976 9999999999999999999999999998765433
Q ss_pred Ccc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
... ....++..|+|||.+.+..++.++|||||||++|+|++|..||......... ...+. ....
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-~~~~~--------------~~~~ 233 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIAT--------------NGTP 233 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-eeecc--------------CCCC
Confidence 222 2234567899999999888999999999999999999999999654321100 00000 0000
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+...+..+.+++.+||..+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123344567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=305.42 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=202.4
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
++|++...||+|+||.||+|..+ +.+.+++|.+..... ......+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46888899999999999999764 346789998865432 23467889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDN-----KPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 419 (579)
++||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999996433211 2689999999999999999999976 999999999999999999999999
Q ss_pred ccccccCCCCCc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccC
Q 008055 420 CGLASNMPNADE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 420 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~---------- 227 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V---------- 227 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H----------
Confidence 999864432211 112233456999999988889999999999999999999 888986432211 0
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
+............+...+..+.+++.+||+.+|++|||+.+++..|.
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 ---LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111111111123345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=301.04 Aligned_cols=250 Identities=29% Similarity=0.525 Sum_probs=200.7
Q ss_pred ccccceeccCCceEEEEEEeCC-----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 273 FNVENLLGEGTFGRVYRAQFAD-----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
|++.+.||.|+||.||++...+ +..+|+|.+..... ....+.+..|+..+..++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999997753 48899999965432 22567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999986321 12289999999999999999999976 99999999999999999999999999987665
Q ss_pred CCCcccc--cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 428 NADEALN--NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 428 ~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
....... ..++..|+|||.+....++.++||||||+++|+|++ |..||...... .+.+.+
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----------------~~~~~~ 217 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----------------EVLEYL 217 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHH
Confidence 4422221 224568999999988889999999999999999999 88888653221 111111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
........+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111222334567899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=299.66 Aligned_cols=268 Identities=23% Similarity=0.365 Sum_probs=201.4
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh--cCCCCccceeeEEeeC----Ce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ--LHHPNIMELVGYCSEY----GQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~ 343 (579)
..+..+.+.||+|.||.||+|+|+ |+.||||++...+ ...+.+|.++++. ++|+||+.+++.-..+ .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 456788899999999999999997 8899999997544 5677777777764 5999999999876432 36
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV-----CSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
+|||++|.+.|+|++||. ...++....++++..+|.||+|||.. ..+.|.|||||+.|||+..++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 899999999999999996 35688899999999999999999963 36789999999999999999999999
Q ss_pred cccccccCCCCC-----cccccCCCCCccCccccccCC----C-C-ccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 008055 419 DCGLASNMPNAD-----EALNNDAGSGYGAPEVAMSGQ----Y-N-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 419 Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~----~-~-~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~ 487 (579)
|+|+|-...... .....+||-.|||||++...- + + ..+||||||.++||+.....- .+..++..-.+.
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~-ggi~eey~~Pyy 437 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES-GGIVEEYQLPYY 437 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc-CCEehhhcCCcc
Confidence 999996554432 233467888999999996432 2 1 358999999999999853211 000000011112
Q ss_pred hhccccccChhHHhh-hcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 488 RWATPQLHDIDALAK-MVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
+|+.+. +..+.+.+ ++...+++..| ..+...+.++|+.||..+|..|.|+=.+.+.|.++.+
T Consensus 438 d~Vp~D-Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSD-PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCC-CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222221 22222222 33344444443 4567789999999999999999999999999988875
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=308.42 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|++.+.||.|+||.||+|.. .+++.|++|.+..... ...+.+.+|+..++.++|||++++++++...+..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3588999999999999999965 5789999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999885 23588999999999999999999976 9999999999999999999999999998765433
Q ss_pred Ccc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||........... .. . ....
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~--~~-----------~--~~~~ 233 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA-----------T--NGTP 233 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HH-----------h--cCCc
Confidence 222 223466789999999988899999999999999999999999976443211100 00 0 0000
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+...+..+.+++.+||..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01123344567899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.46 Aligned_cols=245 Identities=32% Similarity=0.452 Sum_probs=201.6
Q ss_pred ccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|.-.+.||.|+||.||.|+. ++.+.||||++..... ..+.+.+++.|+..|++++|||+|.+.|+|-.....||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44467799999999999965 5788999999975543 356688999999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
| -|+-.+++. ...+++-+.++..|+.+.+.||+|||.+ +.||||||..|||+++.|.|||+|||.+....+
T Consensus 108 C-lGSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 108 C-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred H-hccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9 457777775 3456788889999999999999999965 999999999999999999999999999987654
Q ss_pred cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
..+++||+.|||||++. .+.|+-|+||||||++..||...++|+.....- .....+.+.-.|.
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------------SALYHIAQNesPt 244 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------SALYHIAQNESPT 244 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------------HHHHHHHhcCCCC
Confidence 34678999999999986 577999999999999999999999997543211 1111111111122
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+ ...+.+..|.+++..||+.-|.+|||..+++.
T Consensus 245 L---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 L---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2 24456778999999999999999999998873
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=307.61 Aligned_cols=240 Identities=25% Similarity=0.434 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEeCC--------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 277 NLLGEGTFGRVYRAQFAD--------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+.||+|+||.||+|.... ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999997642 2347888775432 344567889999999999999999999999989999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--------eEEecc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN--------PQLSDC 420 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~kl~Df 420 (579)
||+++|+|.++++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999963 233688999999999999999999976 9999999999999987765 699999
Q ss_pred cccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCC-CCCCCCCchhhhhhhhhccccccChh
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGR-KPFDSSRPRLEQSLVRWATPQLHDID 498 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 498 (579)
|++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||...........
T Consensus 153 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~------------ 217 (258)
T cd05078 153 GISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------------ 217 (258)
T ss_pred ccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH------------
Confidence 988654332 22345678999999986 45799999999999999999984 66644322111100
Q ss_pred HHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
... ....+.....++.+++.+||+.||++|||++++++.|+
T Consensus 218 -----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 -----YED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----HHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 11223334467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=311.71 Aligned_cols=195 Identities=23% Similarity=0.383 Sum_probs=158.6
Q ss_pred cceeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeEEEEEEe
Q 008055 276 ENLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQHLLVYEF 350 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 350 (579)
.+.||+|+||.||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 467999999999999765 467899999865432 3456789999999999999999998854 4568899999
Q ss_pred cCCCChhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCceEEeccc
Q 008055 351 RKNGSLHDFLHLSD-----EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCG 421 (579)
Q Consensus 351 ~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg 421 (579)
+. ++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 58888775321 1223588999999999999999999976 99999999999999 456789999999
Q ss_pred ccccCCCCC----cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCC
Q 008055 422 LASNMPNAD----EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSS 478 (579)
Q Consensus 422 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~ 478 (579)
+++...... ......++..|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 997654322 1223456778999999876 45899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=320.27 Aligned_cols=237 Identities=21% Similarity=0.273 Sum_probs=183.1
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc---CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL---HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
||+|+||.||+|+.. +++.||+|++...... ......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 6899999998653321 22234455566666554 799999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-cc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EA 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 432 (579)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999885 245688999999999999999999976 99999999999999999999999999987543222 22
Q ss_pred cccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 433 LNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+...... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~-~ 216 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----------------YRNIAFGKVR-F 216 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----------------HHHHHcCCCC-C
Confidence 344578899999998754 489999999999999999999999965432110 0000000000 0
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
.....+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 0112346788999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=320.82 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=201.3
Q ss_pred ccccceeccCCceEEEEEEeCCCc-EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFADGK-VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|++...||.|+||.||+|..++.. ..|.|++.... .+...+|+-|+++|+.++||+||++++.|.-.+.+++..|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 455677999999999999877544 44667775443 456788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC-CCCC
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM-PNAD 430 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~-~~~~ 430 (579)
.||-+...+- .-+..+.+.++..+++|++.||.|||.+ +|||||||..|||++-+|.++|+|||.+... ....
T Consensus 112 ~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred CCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999988775 4577899999999999999999999965 9999999999999999999999999987533 2233
Q ss_pred cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 431 EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...++.||++|||||+.+ ..+|++++||||||++|.||..+.+|-....+ ...+.++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----------------MRVllKiaK 249 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLLKIAK 249 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------------HHHHHHHhh
Confidence 445678999999999985 46799999999999999999999999754322 112222221
Q ss_pred ccccC-CCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 506 PALKG-LYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 506 ~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
..... ..|......|.+++.+||..||..||++.+++
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 11111 23556677899999999999999999999998
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.58 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=202.3
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|+..+.||+|+||.||++..+ +++.+|+|.+..... ......+.+|++.+++++||||+++++++...+..++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999776 689999999876543 34567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++... ...+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998632 2578889999999999999999996 1499999999999999999999999999986553322
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
.. ...++..|+|||++.+..++.++||||||+++|+|++|+.||......... . ...+........ .
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~----------~~~~~~~~~~~~-~ 222 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-I----------FELLQYIVNEPP-P 222 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-H----------HHHHHHHhcCCC-C
Confidence 21 255667899999999889999999999999999999999999654211000 0 011111111111 1
Q ss_pred CCChh-hHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 511 LYPVK-SLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 511 ~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+.. .+..+.+++.+||..+|++|||+.+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11222 5667999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.58 Aligned_cols=237 Identities=27% Similarity=0.451 Sum_probs=187.6
Q ss_pred ceeccCCceEEEEEEeCCCc-----------EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 277 NLLGEGTFGRVYRAQFADGK-----------VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+.||+|+||.||+|...+.. .+++|.+..... ....+.+|+.+++.++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999876433 467777654332 15788899999999999999999999988 7889
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-------ceEEe
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-------NPQLS 418 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~ 418 (579)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999998632 22688999999999999999999965 999999999999999887 79999
Q ss_pred cccccccCCCCCcccccCCCCCccCccccccC--CCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccccc
Q 008055 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMSG--QYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLH 495 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 495 (579)
|||++..... .....++..|+|||++... .++.++|||||||++|||++ |..||........... +.
T Consensus 151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--~~----- 220 (259)
T cd05037 151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--YQ----- 220 (259)
T ss_pred CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--Hh-----
Confidence 9999876543 1223445689999999876 78999999999999999999 5788865432111000 00
Q ss_pred ChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
... ..+......+.+++.+||..+|++|||+.++++.|
T Consensus 221 ---------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 01111126889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=308.41 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=198.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+..++.++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46888999999999999999765 678999999865432 2234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 996 589888853 244678899999999999999999965 9999999999999999999999999998754332
Q ss_pred Cc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcccccc-ChhHH-----
Q 008055 430 DE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLH-DIDAL----- 500 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~~----- 500 (579)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+......... .+..+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 22 222345678999999865 4578899999999999999999999976543211 111111110000 00000
Q ss_pred -hhhcCccccC----CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 -AKMVDPALKG----LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 -~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+.... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 011234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.59 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=197.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC---CchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL---PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 344 (579)
.+|++.+.||+|+||.||++... ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999764 589999998854321 123456788899999999999999999988663 567
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999862 23478888999999999999999976 99999999999999999999999999987
Q ss_pred cCCCCC----cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNAD----EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~ 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------------AAI 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------------HHH
Confidence 543211 112234567899999998888999999999999999999999999643211 111
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+..........+......+.+++.+|+. +|++||+++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11111111223345556788899999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=307.26 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|++.+.||+|+||+||++... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46778899999999999999765 68899999886543 23446788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998863 34688999999999999999999963 38999999999999999999999999998654322
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
......++..|+|||++.+..++.++|||||||++|+|++|..||........... ..... .............
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~ 231 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD---DPMGI--LDLLQQIVQEPPP 231 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh---hhhHH--HHHHHHHhhccCC
Confidence 12234567799999999888899999999999999999999999975432110000 00000 0011111111111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.......+..+.+++.+||+.||++|||+.|+++..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111122556899999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=303.42 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=187.4
Q ss_pred eeccCCceEEEEEEeCCCc---EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 278 LLGEGTFGRVYRAQFADGK---VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.||+|+||.||++...++. .+++|.+..... ....+.+.+|+..++.++||||+++++.|.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999754433 456666654332 234578899999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC---c
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD---E 431 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 431 (579)
+|.++++........+.+.....++.|++.||+|||+. +++||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975433344567777889999999999999976 99999999999999999999999999875432211 1
Q ss_pred ccccCCCCCccCcccccc-------CCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 432 ALNNDAGSGYGAPEVAMS-------GQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 432 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....... .+..... ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~------~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIK------DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh------hccccc
Confidence 122345678999998753 245789999999999999997 577886533211 0000000 000011
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.++.+ +......+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 2234467889999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=307.40 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=201.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999875 58999999987655444455678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988764 233589999999999999999999976 9999999999999999999999999998765433
Q ss_pred Ccc-cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChh-------H
Q 008055 430 DEA-LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDID-------A 499 (579)
Q Consensus 430 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~-------~ 499 (579)
... ....++..|+|||++.+ ..++.++|||||||++|||++|++||........ ..+..+......... .
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 222 22345668999999875 4478899999999999999999999965432111 111111110000000 0
Q ss_pred HhhhcCccccC-----CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKG-----LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+..+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000 001234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=301.05 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=203.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||.|+||.||+|... ++..+|+|++....... ..+.+.+|++.++.++|+|++++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 36888999999999999999754 67899999987554433 56788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
++++++|.++++.... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999863221 24688999999999999999999965 9999999999999999999999999998765443
Q ss_pred Ccc-----cccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 430 DEA-----LNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 430 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
... ....++..|+|||++... .++.++|||||||++|||++|+.||...... ....+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~----------- 222 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN----------- 222 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC-----------
Confidence 322 223456789999998876 7899999999999999999999999754321 011111100
Q ss_pred cCccccCCC-ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 VDPALKGLY-PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...... ....+..+.+++.+||..||++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001111100 1234578899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=303.66 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=196.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 36777889999999999999754 68899999986543 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999998852 34688999999999999999999976 9999999999999999999999999998655332
Q ss_pred C-cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 D-EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ......++..|+|||++. ...++.++|||||||++|+|++|..||....+.......... ....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-----------~~~~ 228 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-----------NFQP 228 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-----------CCCC
Confidence 2 122345677899999974 455889999999999999999999998543321111000000 0000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.... ....+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 1123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=306.28 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=199.3
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
..++....+.|++.+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 344445667899999999999999999976 468899999985432 2345677888888888 79999999999853
Q ss_pred ------CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 341 ------YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 341 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
....+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 46789999999999999998632 234578888999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCC-cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 008055 415 PQLSDCGLASNMPNAD-EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 488 (579)
++|+|||++....... ......++..|+|||.+. ...++.++|||||||++|||++|..||.........
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---- 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---- 235 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----
Confidence 9999999987543221 122344677899999986 346788999999999999999999999653321111
Q ss_pred hccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
................+..+.+++.+||+.||.+||++.|+++
T Consensus 236 ------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0011111111112235568999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=305.66 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=199.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||.|+||.||++... ++..+|+|.+.... ......+..|++++++++||||+++++++......++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 46888899999999999999764 68899999986442 3445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999862 234689999999999999999999976 9999999999999999999999999987654332
Q ss_pred Cc-ccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 430 DE-ALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
.. .....++..|+|||++. ...++.++||||||+++|||++|+.||...... ..+..+. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-----------~~ 223 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKIL-----------KS 223 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHh-----------cC
Confidence 21 22234677899999975 344678999999999999999999999754321 1111100 00
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
..+ ....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 011233455688999999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=303.21 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=204.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+|++.+.||.|+||.||++... +++.||+|.+...... ....+.+.+|++.+++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999775 6899999999765432 2456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ...+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999862 25788999999999999999999976 9999999999999999999999999998766554
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.......++..|+|||++....++.++|+||||+++|+|++|..||..........+ ...... ..
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------~~~~~~-~~ 218 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI--------------RAKQET-AD 218 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH--------------HHHhcc-cc
Confidence 333445566789999999988899999999999999999999999976442111111 111110 12
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCCh--HHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPM--SEVV 542 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl 542 (579)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 23344556889999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=301.82 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=187.7
Q ss_pred eeccCCceEEEEEEeCC---CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 278 LLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 3467888775433 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc-
Q 008055 355 SLHDFLHLSDED-NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA- 432 (579)
Q Consensus 355 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 432 (579)
+|.+++...... .....+.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999654322 23356778899999999999999976 9999999999999999999999999998654332211
Q ss_pred --cccCCCCCccCcccccc-------CCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 433 --LNNDAGSGYGAPEVAMS-------GQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 433 --~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
....++..|+|||++.. ..++.++|||||||++|||++ |..||........ +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~----------- 224 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVR----------- 224 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhh-----------
Confidence 11223457999998743 356789999999999999999 7888865432110 000000
Q ss_pred hcCccc-cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 503 MVDPAL-KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 503 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.....+ ....+...+..+.+++..|| .||++|||+++|++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 225 EQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 000000 11123345567888999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=282.76 Aligned_cols=244 Identities=25% Similarity=0.466 Sum_probs=196.0
Q ss_pred cceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 276 ENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
...||.|..|.|++++++ .|..+|||.+...... +..+++...+.++... ++|+||+.+|||..+...++.||.|.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 456999999999999776 5899999999876643 4456666666666555 58999999999999999999999984
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
.-+..+++ ....++++..+-++...+++||.||.++ ++|+|||+||+|||+|+.|++|+||||++..+.......
T Consensus 175 ~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 175 TCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 34555554 3455688888889999999999999986 599999999999999999999999999998887766666
Q ss_pred ccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC---cc
Q 008055 434 NNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---PA 507 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 507 (579)
...|-+.|||||.+.- .+|+.++||||||++++||.||+.||...+.+. +.+.++++ |.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---------------e~ltkvln~ePP~ 314 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---------------EVLTKVLNEEPPL 314 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---------------HHHHHHHhcCCCC
Confidence 6667789999999963 468999999999999999999999998755432 22222222 11
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.+ ....+..|++++..||..|+.+||...++++
T Consensus 315 L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111 1225678999999999999999999998874
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=305.05 Aligned_cols=265 Identities=21% Similarity=0.344 Sum_probs=202.5
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999764 689999999987665455567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+ +++|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998632 35689999999999999999999976 99999999999999999999999999987664432
Q ss_pred c--ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhh-ccc------cccChhH
Q 008055 431 E--ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRW-ATP------QLHDIDA 499 (579)
Q Consensus 431 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~-~~~------~~~~~~~ 499 (579)
. .....++..|+|||++.+. .++.++|||||||++|||++|.+||........ ...... ..+ .......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1 2234567789999998754 468999999999999999999888865432111 011110 000 0000000
Q ss_pred HhhhcCcccc----CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALK----GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+... .......+..+.+++.+||..+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0011233478999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=300.35 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=207.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|+||.||++... +++.+|+|.+............+.+|++.++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999654 788999999976655555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999865444456789999999999999999999965 9999999999999999999999999998766543
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... +..........
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~ 219 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----------------LRYKVQRGKYP 219 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHhcCCCC
Confidence 2223456678999999998889999999999999999999999997643211 11111111112
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 233455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.09 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=205.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|++|.||+|... +++.|++|++...... .....+..|+..+.+++|+|++++++++...+..++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5788899999999999999776 5899999998765432 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE-VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
+++++|.+++.. ...+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999863 2668999999999999999999996 5 9999999999999999999999999998766443
Q ss_pred Cccc-ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEAL-NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.... ...++..|+|||.+....++.++||||||+++|+|++|+.||.......... ....+.....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-------------~~~~~~~~~~ 220 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-------------LMQAICDGPP 220 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH-------------HHHHHhcCCC
Confidence 3322 3345678999999998889999999999999999999999997653211111 1111111111
Q ss_pred cCCCChh-hHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 509 KGLYPVK-SLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 509 ~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112233 56789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.21 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=197.0
Q ss_pred hCCccccceeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|+++++.++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999653 3578999988543 234579999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
+||++. ++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 68888883 345689999999999999999999976 9999999999999999999999999998765
Q ss_pred CCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hh---hhhhhccc---cccC
Q 008055 427 PNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQ---SLVRWATP---QLHD 496 (579)
Q Consensus 427 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~---~~~~~~~~---~~~~ 496 (579)
..... .....++..|+|||++....++.++|||||||++|||++|+.||....... .. .+...... .+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 43322 123457889999999999999999999999999999999999996543211 01 11110000 0000
Q ss_pred --hhHH---hhhcCccccCCCC-------hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 497 --IDAL---AKMVDPALKGLYP-------VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 497 --~~~~---~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+ ........+..+. ...+.++.+++.+||..||++|||+.+++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0001111111111 1234578899999999999999999999864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.00 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=200.9
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC----chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP----SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
+|+..+.||+|+||.||++.. .+++.||+|.+...... ....+.+..|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999965 57899999998654321 1245678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASN 425 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 425 (579)
||||+++++|.+++.. ..++++..+..++.|++.||+|||++ +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999863 34678899999999999999999976 999999999999998776 589999999876
Q ss_pred CCCCCcc-----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNADEA-----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
....... ....++..|+|||++.+..++.++||||+|+++|+|++|..||........ ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------------~~~~ 220 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-------------LALI 220 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-------------HHHH
Confidence 5432111 122456689999999888899999999999999999999999964321100 0111
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+..........+...+.++.+++.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1111111122344556678999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.29 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 347 (579)
++|+..+.||.|++|.||++... +++.+|+|.+..... ......+.+|++++++++||||++++++|.+ .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36788899999999999999874 688999999875433 2446778999999999999999999998864 3478999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999998764444456688899999999999999999976 99999999999999999999999999986553
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCch--hhhhhhhhccccccChhHHhhhcC
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... ....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+... ...
T Consensus 157 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~ 225 (287)
T cd06621 157 NSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----------MPN 225 (287)
T ss_pred cccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----------CCc
Confidence 3221 2234566899999999889999999999999999999999999754220 00111111110 000
Q ss_pred ccccCCCC--hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYP--VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.+..... ...+..+.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00100001 123568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.67 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=199.6
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC---chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP---SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
+|++.+.||+|+||.||+|... +++.||+|.+...... ......+..|+..+++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999764 6899999999765543 33445677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+ +|+|.+++... ...+++..+..++.|+++||.|||++ +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999998632 23689999999999999999999976 99999999999999999999999999997665
Q ss_pred CCCcc-cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhcc-ccccChhHHh--
Q 008055 428 NADEA-LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWAT-PQLHDIDALA-- 501 (579)
Q Consensus 428 ~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~-- 501 (579)
..... .....+..|+|||.+.+ ..++.++|||||||++|||++|.+||....... ......... +.........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 43222 22334668999998864 457899999999999999999988886543211 111111110 0000000000
Q ss_pred -hhcCccccC-----CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 -KMVDPALKG-----LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 -~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......... ......+.++.+++.+||+.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000 011234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.08 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=200.9
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
-|++.+.||+|+||.||+|.. .++..+|+|.+..... ......+.+|+..+++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366788999999999999976 4688999999865433 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999985 24578999999999999999999975 99999999999999999999999999987654322
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. ....++..|+|||.+....++.++|||||||++|+|++|..||........ .........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~~ 218 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-----------------LFLIPKNNP 218 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-----------------HHHHhcCCC
Confidence 11 123456689999999888899999999999999999999999965332110 000111111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12233455788999999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=320.83 Aligned_cols=261 Identities=19% Similarity=0.235 Sum_probs=194.0
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
....|.+.+.||+|+||.||++.+. .++.||||... ...+.+|++++++++|+||+++++++...+..++|
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3557999999999999999999775 57889999642 23456899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||++ .++|.+++.. ....+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 239 ~e~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 239 LPKY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEcc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 9999 4789888752 234689999999999999999999976 99999999999999999999999999987653
Q ss_pred CCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCch--------hhhhhhhhcc---cc
Q 008055 428 NADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--------LEQSLVRWAT---PQ 493 (579)
Q Consensus 428 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~--------~~~~~~~~~~---~~ 493 (579)
.... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... ....+..... +.
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 3221 12235788999999999999999999999999999999987654321110 0011111111 00
Q ss_pred cc---ChhHHhhhc---CccccCCCC-------hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 494 LH---DIDALAKMV---DPALKGLYP-------VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 494 ~~---~~~~~~~~~---~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.. .......+. .......+. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000000 000000000 0123468899999999999999999999863
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.14 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=207.7
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
....|++.+.||+||.+.||++...+.+.||+|++.....+......|..|+..|.++ .|.+||++++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456889999999999999999998899999999887777788889999999999998 699999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||= ..+|..+|+.... ....| .+..+..|++.|+.++|++ ||||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9975 5699999974322 12223 6888999999999999987 9999999999999975 589999999998776
Q ss_pred CCCcc---cccCCCCCccCccccccCC-----------CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 428 NADEA---LNNDAGSGYGAPEVAMSGQ-----------YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 428 ~~~~~---~~~~~~~~y~aPE~~~~~~-----------~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
..... ....||..||+||.+.... .++++||||+|||||+|+-|+.||....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------------- 576 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------------- 576 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------------
Confidence 65432 3457889999999986432 4578999999999999999999996422
Q ss_pred ccChhHHhhhcCccccCCCChhhHH-HHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLS-RFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+..+.+++-.-.||.-... ++.++++.||..||.+|||..++|+
T Consensus 577 -n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 -NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 123455666677555455543322 3999999999999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.81 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=208.5
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|.+.+.||+|+||.||++... +++.+++|++............+.+|++.++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999765 689999999987665556677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999975444457799999999999999999999976 99999999999999999999999999987654433
Q ss_pred -cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 -EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
......++..|+|||......++.++||||+|+++|+|++|+.||....... ....... ...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~~ 220 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----------------LALKILK-GQY 220 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----------------HHHHHhc-CCC
Confidence 1222345668999999988889999999999999999999999996543210 0011111 111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2233355678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=306.01 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=200.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 347 (579)
++|++.+.||.|+||.||+|... +++.+|+|.++...........+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 36788899999999999999775 688999999976554444455677899999999999999999998877 899999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+. ++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 5999888632 23689999999999999999999976 99999999999999999999999999987665
Q ss_pred CCC-cccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhh-hccccccChhHH---
Q 008055 428 NAD-EALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVR-WATPQLHDIDAL--- 500 (579)
Q Consensus 428 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~--- 500 (579)
... ......++..|+|||.+.+.. ++.++||||||+++|||++|..||....... ...+.. +..+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 432 222334567899999987544 6899999999999999999999997543211 111111 111100000000
Q ss_pred --------hhhcCccccCCCChh-hHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 --------AKMVDPALKGLYPVK-SLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 --------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.......+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000011112222322 4677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.59 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=201.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++... +++.+|+|.+..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999765 689999999865432 2344577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999863 35688999999999999999999976 999999999999999999999999999876644
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....++..|+|||.+....++.++||||||+++|+|++|+.||....... ........
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~-- 213 (290)
T cd05580 154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----------------IYEKILEG-- 213 (290)
T ss_pred C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcC--
Confidence 3 233456778999999988888999999999999999999999996543210 01111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVV 542 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl 542 (579)
...++...+..+.+++.+||..||.+|+ +++|++
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1122334457889999999999999998 666766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=306.74 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=196.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 349 (579)
+|...+.||+|+||.||++... +++.+|+|.+...... .....+..|+..+.++. |+||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3455678999999999999764 6899999998755433 44567888999999986 9999999999999999999999
Q ss_pred ecCCCChhhhhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 350 FRKNGSLHDFLHL-SDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 350 ~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|+. ++|.++... .......+++..+..++.+++.||+|||+. .+++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 466554321 112235689999999999999999999962 3899999999999999999999999999876544
Q ss_pred CCcccccCCCCCccCccccccC---CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEALNNDAGSGYGAPEVAMSG---QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
........++..|+|||++... .++.++|||||||++|||++|+.||...... ...+.... ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~-----------~~~~ 228 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQLTQVV-----------KGDP 228 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHHhhhc-----------CCCC
Confidence 3333344567789999998766 6899999999999999999999999653211 00000000 0001
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+.+....+...+.++.+++.+||+.+|++|||+.+|+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112223456789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.39 Aligned_cols=253 Identities=24% Similarity=0.420 Sum_probs=196.2
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC--------chhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP--------SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
+|.+.+.||.|+||.||+|... +++.+|+|.+...... ....+.+..|+..++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999654 6899999988542211 112356778999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++|+|.++++. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999863 24688899999999999999999975 999999999999999999999999999
Q ss_pred cccCCCCCc---ccccCCCCCccCccccccCC--CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccCh
Q 008055 423 ASNMPNADE---ALNNDAGSGYGAPEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497 (579)
Q Consensus 423 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 497 (579)
+........ .....++..|+|||++.... ++.++||||||+++|||++|..||...... ..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~------ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGN------ 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhc------
Confidence 875432211 11234566899999987654 789999999999999999999999643221 00000000
Q ss_pred hHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...............+..+.+++.+||..+|++|||+.++++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 ----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000001111111234578999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.64 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=199.2
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC----
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG---- 342 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---- 342 (579)
.+++|++.+.||+|+||.||+|..+ +++.+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3578999999999999999999875 678999999865432 346788999999998 7999999999996544
Q ss_pred --eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 343 --QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 343 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999865443356789999999999999999999965 9999999999999999999999999
Q ss_pred cccccCCCCCc-ccccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPNADE-ALNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|++........ .....++..|+|||++.. ..++.++|||||||++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------------ 225 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------------ 225 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------------
Confidence 99875543222 223345678999998753 346789999999999999999999996432211
Q ss_pred cChhHHhhhcCccc-cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPAL-KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.++..... ....+...+..+.+++.+||..||++|||+.++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ----ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011110000 01112234568899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=292.38 Aligned_cols=270 Identities=26% Similarity=0.429 Sum_probs=224.2
Q ss_pred cCHHHHHHHhCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccce
Q 008055 261 YSIADLQMATGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 334 (579)
....++.+...+++...++-+|.||.||+|.|.+ .+.|-+|.++.... .-+...+..|.-++..+.|||+..+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccce
Confidence 3467888888999999999999999999996653 34566777765442 3446778888888888999999999
Q ss_pred eeEEe-eCCeEEEEEEecCCCChhhhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 008055 335 VGYCS-EYGQHLLVYEFRKNGSLHDFLHLSD----EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL 409 (579)
Q Consensus 335 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill 409 (579)
.+.+. +....+++|.++.-|+|+.|+..-+ ...+.++-.+...++.|++.|++|||++ +|||.||..+|++|
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 99885 4567889999999999999997322 2234577788899999999999999976 99999999999999
Q ss_pred cCCCceEEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhh
Q 008055 410 DNELNPQLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQS 485 (579)
Q Consensus 410 ~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~ 485 (579)
|+..++||+|=.+++.+.+.+... .......||+||.+....|+.++|||||||++|||+| |+.||...++.
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---- 505 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---- 505 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----
Confidence 999999999999999888766543 2334557999999999999999999999999999999 99999765542
Q ss_pred hhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 486 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+..++..+.+-..|-+|+.++..++..||..+|++||+++|++..|.++..+
T Consensus 506 -------------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 506 -------------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -------------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 33344444555566889999999999999999999999999999999988754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=294.74 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=207.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 348 (579)
+|.+.+.||+|++|.||+|... +++.+++|++..........+.+.+|+..+++++||||+++++.+.+. ...+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999876 789999999976655455678899999999999999999999999988 8999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999863 22789999999999999999999976 999999999999999999999999999877655
Q ss_pred CCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
... .....++..|+|||.+....++.++||||||+++|+|++|..||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---------------AALYKIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------------HHHHhccc
Confidence 442 334456678999999988889999999999999999999999997643110 01111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.......+...+..+.+++.+|+..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11222334455678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=305.15 Aligned_cols=194 Identities=23% Similarity=0.386 Sum_probs=157.5
Q ss_pred ceeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe--eCCeEEEEEEec
Q 008055 277 NLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS--EYGQHLLVYEFR 351 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~ 351 (579)
..||+|+||.||+|... ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .....++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 57999999999999865 357899999865432 345778999999999999999999885 356789999998
Q ss_pred CCCChhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCceEEecccc
Q 008055 352 KNGSLHDFLHLSD-----EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCGL 422 (579)
Q Consensus 352 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg~ 422 (579)
. ++|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 6 57877764221 1223588899999999999999999965 99999999999999 5667899999999
Q ss_pred cccCCCCCc----ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCC
Q 008055 423 ASNMPNADE----ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSS 478 (579)
Q Consensus 423 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~ 478 (579)
++....... .....++..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 976543221 122345778999999876 45799999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.17 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=199.2
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||.|+||.||+|... +++.||||++............+.+|++.+++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999765 689999999876554444556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6898888632 245688999999999999999999976 99999999999999999999999999987554322
Q ss_pred cc-cccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccC----hhHHhh-
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHD----IDALAK- 502 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~- 502 (579)
.. ....++..|+|||++.+.. ++.++|||||||++|||+||+.||....... ......+....... ...+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 22 2233466899999887654 5889999999999999999999996543211 11111111110000 000000
Q ss_pred ------hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 ------MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
........ .......++.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 01123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.01 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=195.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999765 6899999998654322 223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 499998863 234688999999999999999999976 9999999999999999999999999998654322
Q ss_pred Cc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh--hhhhc-cccccChhHHhh--
Q 008055 430 DE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS--LVRWA-TPQLHDIDALAK-- 502 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~-- 502 (579)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... +.+.. .+..........
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11 122234668999999875 458899999999999999999999996543211110 00000 000000000000
Q ss_pred -hcC--------ccccCCCC-hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 -MVD--------PALKGLYP-VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 -~~~--------~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ..+....+ ......+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00000000 011257789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.76 Aligned_cols=248 Identities=31% Similarity=0.422 Sum_probs=197.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 35788899999999999999765 68999999986443 23344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 577777642 234689999999999999999999965 999999999999999999999999999875533
Q ss_pred CCcccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||......... .....
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~----------------~~~~~ 228 (307)
T cd06607 168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------YHIAQ 228 (307)
T ss_pred C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH----------------HHHhc
Confidence 2 2234567899999884 456889999999999999999999999654321110 00000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.......+...+..+.+++.+||+.+|++||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001111123345689999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=297.34 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=199.3
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||.|+||.||++... +++.+|+|.+..... .....+.+.+|+.+++.++||||+++++++.+....+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999775 489999999976543 234567789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccC
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 436 (579)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 999963 34588899999999999999999975 99999999999999999999999999998765543333345
Q ss_pred CCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhh
Q 008055 437 AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516 (579)
Q Consensus 437 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (579)
++..|+|||.+....++.++|+||||+++|+|++|..||....... ...............++...
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGNGKLEFPNYI 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccCCCCCCCccc
Confidence 6778999999988889999999999999999999999997643211 11111222212233344455
Q ss_pred HHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 517 LSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 517 ~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
+.++.+++.+||+.+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678999999999999999999 566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.14 Aligned_cols=250 Identities=23% Similarity=0.405 Sum_probs=200.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|.+.+.||+|+||.||++... +|..+|+|.+..........+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999765 588999999876544444566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-eEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN-PQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~ 429 (579)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998632 234578999999999999999999976 9999999999999998864 699999998765443
Q ss_pred Ccc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
... ....++..|+|||++....++.++||||||+++|||++|..||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~ 219 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----------------LVLKICQGYF 219 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHhcccC
Confidence 222 12345678999999988889999999999999999999999996533211 0111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+..+.+++.+||..+|++|||+.++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112234568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=317.03 Aligned_cols=245 Identities=22% Similarity=0.370 Sum_probs=195.2
Q ss_pred ccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe--EEEEEE
Q 008055 275 VENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ--HLLVYE 349 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 349 (579)
...+||+|+|-+||+|.. .+|..||.-.++.... ..+..++|..|+.+|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346799999999999965 4677787544433322 34456899999999999999999999999977554 779999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecccccccCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLASNMPN 428 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 428 (579)
.|..|+|..|++. .+.+.......|++||++||.|||.+ .++|||||||.+||+|+.+ |.|||+|.|+|+....
T Consensus 124 L~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999863 44577788999999999999999998 7899999999999999765 8999999999987754
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.. .....||+.|||||+.. ..|++.+||||||+.++||+|+..||..... ...+.+-+-.+.
T Consensus 199 s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----------------~AQIYKKV~SGi 260 (632)
T KOG0584|consen 199 SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----------------PAQIYKKVTSGI 260 (632)
T ss_pred cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----------------HHHHHHHHHcCC
Confidence 33 33368999999999885 8899999999999999999999999965332 122222222222
Q ss_pred cC-CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KG-LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
++ .+..-...++.++|.+|+.. .++|||+.|+|.
T Consensus 261 KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 21 11112235788999999999 999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.36 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=198.6
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+|++.+.||+|+||.||++... .++.|++|.+..... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888999999999999999765 578999999875532 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999852 34688899999999999999999976 9999999999999999999999999987632110
Q ss_pred C----------------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 430 D----------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 430 ~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
. ......++..|+|||.+....++.++|||||||++|||++|..||....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~------- 225 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LF------- 225 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-------
Confidence 0 0001234568999999988889999999999999999999999996533211 00
Q ss_pred ccChhHHhhhcCcccc-CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 494 LHDIDALAKMVDPALK-GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
......... .......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 -------GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -------HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000000 00111345678999999999999999997766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.99 Aligned_cols=266 Identities=18% Similarity=0.240 Sum_probs=200.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------ 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 341 (579)
..++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3568999999999999999999764 789999999876544445556778899999999999999999988543
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588887742 278889999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccC----
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHD---- 496 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~---- 496 (579)
++.............++..|+|||++.+..++.++|||||||++|+|++|+.||...+... ...+.........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9986654333333456778999999999999999999999999999999999997543211 01111000000000
Q ss_pred ----------------hhHHhhhcCccc----cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 497 ----------------IDALAKMVDPAL----KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 497 ----------------~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.....+...... ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 000122345678999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.36 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=196.3
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|.....||+|+||.||++... ++..||||.+.... ....+.+.+|+..++.++|+||+++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 333467999999999999764 68899999986533 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 102 ~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 102 EGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999885 23578899999999999999999976 999999999999999999999999999865433221
Q ss_pred -ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 432 -ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 432 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
.....++..|+|||++....++.++||||||+++|||++|+.||........ + ..+.....+...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-----------~~~~~~~~~~~~- 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M-----------RRIRDNLPPRVK- 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----------HHHHhcCCCccc-
Confidence 1223467789999999888899999999999999999999999965332110 0 011111111111
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.....+..+.+++.+||..||++|||+.++++.
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112234578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=310.76 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=213.7
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
...+.|.+...||+|.|+.|..+.+. ++..||||.+++........+.+.+|++++..++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567889999999999999999764 68999999999888777777779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+.+|.+++++.. .....+..+..++.|+..|++|||++ .|+|||||++|||++.+.++||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence 9999999999999963 33345577888999999999999976 9999999999999999999999999999998
Q ss_pred CCCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.......+.++++.|.|||++.+.+| ++.+|+||+|+++|-|+.|..||++..-.. .-+
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------------------Lr~ 265 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------------------LRP 265 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------------------ccc
Confidence 87777888899999999999998887 578999999999999999999998643211 111
Q ss_pred ccccCC--CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 506 PALKGL--YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 506 ~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
+.+++. .+.....++.+++.+++..+|.+|++++++.+.-
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111111 1223345778999999999999999999987543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=301.55 Aligned_cols=269 Identities=20% Similarity=0.292 Sum_probs=197.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCe-----
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQ----- 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 343 (579)
++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999765 6899999998765443444567888999999994 6999999999877665
Q ss_pred EEEEEEecCCCChhhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEeccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDED-NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCG 421 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 421 (579)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+. +|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888643322 45689999999999999999999976 9999999999999998 8899999999
Q ss_pred ccccCCCCCc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc-cccccCh
Q 008055 422 LASNMPNADE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA-TPQLHDI 497 (579)
Q Consensus 422 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~-~~~~~~~ 497 (579)
++........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ..+.... .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9875533221 222345678999998865 4578999999999999999999999975432111 1111110 0000000
Q ss_pred ---hHHhhhcC-cccc----CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 498 ---DALAKMVD-PALK----GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 498 ---~~~~~~~~-~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
........ +... .......+.++.+++.+||..||++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 0000 0001234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=296.97 Aligned_cols=259 Identities=21% Similarity=0.309 Sum_probs=193.4
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeC--CeEEEEE
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEY--GQHLLVY 348 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 348 (579)
|++.+.||+|+||.||+|... +++.||+|+++....... ......|+..+.++. |+|++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 567889999999999999754 689999999876543322 234456788888884 99999999999887 8999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||++ |+|.+++.. ....+++..+..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9996 588887752 234689999999999999999999976 9999999999999999 9999999999976654
Q ss_pred CCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHhhhcCc
Q 008055 429 ADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
........++..|+|||++.. ..++.++|||||||++|||++|..||........ .............. .+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV---LKKFRK 228 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH---HHhhcc
Confidence 433333456778999997654 5578899999999999999999999976443211 11111111000000 000000
Q ss_pred c--ccCCC-----------ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 A--LKGLY-----------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~--~~~~~-----------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ....+ ....+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 00000 1234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=298.74 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=198.9
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|++.+.||.|++|.||+|... +|..||+|++............+.+|+..++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999764 7999999999765544445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
+ ++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999886322 24689999999999999999999975 999999999999999999999999999875533221
Q ss_pred c-cccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccCh----hHHhhhc
Q 008055 432 A-LNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDI----DALAKMV 504 (579)
Q Consensus 432 ~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~ 504 (579)
. ....++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ..+.++........ ..+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1 223346789999988654 578999999999999999999999975433111 11111111000000 0000000
Q ss_pred C---c---cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 D---P---ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~---~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. . ..........+..+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0 0000111233467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=296.63 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=197.2
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC---CCCccceeeEEeeCCeEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH---HPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 347 (579)
.|++.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++ |||++++++++.+....++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 367788999999999999976 5789999999865432 334567788999988886 99999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999998852 2688999999999999999999976 99999999999999999999999999987665
Q ss_pred CCCc-ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 428 NADE-ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 428 ~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... .....++..|+|||.+.++ .++.++|||||||++|+|++|..||......... .+ +.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~----------~~~~~~ 219 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---ML----------IPKSKP 219 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hc----------cccCCC
Confidence 4332 2223466789999998754 4689999999999999999999999754321100 00 000000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+.+. ....+.++.+++.+||..||++||++.+++..
T Consensus 220 ~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 PRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 11245689999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=302.84 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=197.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHLL 346 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 346 (579)
..+|++.+.||+|+||.||+|... +|+.||+|.+............+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 347889999999999999999764 689999999875543333344567899999999999999999998654 56899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+. ++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 588888763 235689999999999999999999976 9999999999999999999999999998766
Q ss_pred CCCCcc-cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccCh----hH
Q 008055 427 PNADEA-LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDI----DA 499 (579)
Q Consensus 427 ~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~----~~ 499 (579)
...... .....+..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+..+........ ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 543222 22234667999999865 4578999999999999999999999976443211 11111111000000 00
Q ss_pred HhhhcCccccCC-C------ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKGL-Y------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
........+... . .......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000 0 0113567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=298.85 Aligned_cols=266 Identities=20% Similarity=0.275 Sum_probs=196.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+.+|.+.+.||+|+||.||+|... ++..||+|++..... ......+.+|+..++.++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467999999999999999999754 688999999865442 223446678999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+. ++|.+++.. ....+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 678777642 234577888899999999999999976 999999999999999999999999999875433
Q ss_pred CC-cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhc---cccccChhHH---
Q 008055 429 AD-EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA---TPQLHDIDAL--- 500 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~--- 500 (579)
.. ......++..|+|||++.+. .++.++|||||||++|||++|..||.......+.....|. .|.......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 22 12223456789999998754 5788999999999999999999999765432221111111 0100000000
Q ss_pred hhhcCccccCCC---------ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLY---------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
............ .......+.+++.+|+..||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0012457889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=298.14 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=192.5
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||+|+||+||++... +|+.||+|.+...... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999654 6899999998754322 23345667899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccC
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 436 (579)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.............
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 99986322 24688999999999999999999976 99999999999999999999999999987654433333345
Q ss_pred CCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhh
Q 008055 437 AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKS 516 (579)
Q Consensus 437 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (579)
++..|+|||++.+..++.++|||||||++|+|++|+.||......... ..+..... ......+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------EELKRRTL-EMAVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------------HHHHhccc-cccccCCccC
Confidence 567899999998888999999999999999999999999654321100 01111100 0111233445
Q ss_pred HHHHHHHHHhcCCCCCCCCCChHH
Q 008055 517 LSRFADVIALCVQPEPEFRPPMSE 540 (579)
Q Consensus 517 ~~~l~~li~~cl~~dP~~Rps~~e 540 (579)
+..+.+++.+||+.+|++||++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 678999999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=298.48 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=187.8
Q ss_pred eeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchh-HHHHHHHHHH---HhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 278 LLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEM-CDDFIEMVSN---ISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+||+|+||.||++... +++.+|+|.+......... ...+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 6889999998765433222 2233344333 334579999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
+|+|.+++.. ...+++..+..++.|++.||+|||.. +|+||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~ 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-P 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-c
Confidence 9999998852 34689999999999999999999975 99999999999999999999999999986553322 2
Q ss_pred cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 433 LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
....++..|+|||.+.. ..++.++|||||||++|||++|..||..........+ .... ......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--------------~~~~-~~~~~~ 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------------DRMT-LTVNVE 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH--------------HHHh-hcCCcC
Confidence 23456789999999864 5589999999999999999999999965432111111 0000 011112
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHHH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQA 544 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 544 (579)
.+...+.++.+++.+||..||++|| |++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 3444567899999999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=304.37 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=194.0
Q ss_pred ceeccC--CceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEG--TFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
..||+| +||+||++... +|+.||+|++..........+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999764 799999999976655555567888999999999999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc-
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA- 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 432 (579)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986432 34588899999999999999999975 9999999999999999999999999865332211110
Q ss_pred -------cccCCCCCccCccccccC--CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhc--ccc----ccC
Q 008055 433 -------LNNDAGSGYGAPEVAMSG--QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWA--TPQ----LHD 496 (579)
Q Consensus 433 -------~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~--~~~----~~~ 496 (579)
....++..|+|||++.+. .++.++|||||||++|||++|+.||......... ...... .+. ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 011234569999999763 4789999999999999999999999764321110 000000 000 000
Q ss_pred hh--------HH--------------hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 ID--------AL--------------AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ~~--------~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .. ..+.+..+....+..+...+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 00 0001111122223446678999999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.39 Aligned_cols=251 Identities=28% Similarity=0.390 Sum_probs=208.3
Q ss_pred hCCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+-++.-...||.|.||.||.|. ..+|...|+|.++-+...........+|+.++..++|||+|+.+|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4456667889999999999995 457899999999877766777788899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||++|+|.+.+. .+.-.++.....+..|++.|+.|||++ |||||||||.||+++.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999986 334455666677889999999999976 999999999999999999999999999976654
Q ss_pred CC-----cccccCCCCCccCccccccCC---CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 429 AD-----EALNNDAGSGYGAPEVAMSGQ---YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 429 ~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
.. ......||+.|||||++.+.. ...++||||+||++.||+||+.||...+ .++.+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----------------ne~aI 1450 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----------------NEWAI 1450 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----------------chhHH
Confidence 32 223467899999999997543 5678999999999999999999996433 22222
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
---+-..-.+.+|.....+-.+++.+||..||+.|+++.|+++
T Consensus 1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2222334455667778888999999999999999999887764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.99 Aligned_cols=265 Identities=27% Similarity=0.475 Sum_probs=218.6
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeE
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGY 337 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 337 (579)
++..++..+.+.||+|.||.|++|... ....||||.++..... ...+.+..|+++++.+ +|+||+.++|+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 334444556679999999999999643 1457999999876655 6678899999999888 69999999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhcccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 008055 338 CSEYGQHLLVYEFRKNGSLHDFLHLSD---ED-------N--KPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~ 405 (579)
|...+..++|+||+..|+|.++++..+ .. . ..+.....+.++.|||.|++||++. +++||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999997554 00 1 2388899999999999999999965 8999999999
Q ss_pred CEEEcCCCceEEecccccccCCCCCccccc--CC--CCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCc
Q 008055 406 NILLDNELNPQLSDCGLASNMPNADEALNN--DA--GSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP 480 (579)
Q Consensus 406 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~~--~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~ 480 (579)
|||+.++..+||+|||+++........... .+ ...|||||.+....|+.++|||||||++|||+| |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999876554433211 11 235999999999999999999999999999999 9999965221
Q ss_pred hhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 481 RLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
...+.+.+....+...|..|..+++++|..||+.+|++||++.++++.+...+..
T Consensus 528 ----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 ----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred ----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1222334555666677888999999999999999999999999999999997654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=297.25 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=201.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
+..|+..+.||+|+||.||+|... ++..+++|.+..... ....+.+|++.++.++|+|++++++++...+..++|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 456777889999999999999776 688999999975443 4567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999732 24789999999999999999999975 999999999999999999999999998765433
Q ss_pred CCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... .....++..|+|||++.+..++.++|||||||++|+|++|+.||......... . ......
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~--------------~~~~~~ 232 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F--------------LITTKG 232 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H--------------HHHhcC
Confidence 221 12233566899999998888999999999999999999999999654322110 0 000000
Q ss_pred ccC-CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKG-LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 100 112224568999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.16 Aligned_cols=249 Identities=30% Similarity=0.498 Sum_probs=202.3
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|++|.||++... +++.+++|++..... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4777899999999999999875 688999999976543 3567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++... ...+++..+..++.|++.||.|||.. +++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999998632 25789999999999999999999975 99999999999999999999999999987765543
Q ss_pred cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 431 EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
......++..|+|||.+....++.++||||||+++|+|++|+.||........... ......+..
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~~~-- 217 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------------IATNGPPGL-- 217 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------------HHhcCCCCc--
Confidence 23344566789999999888899999999999999999999999975422110000 000000000
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011112568999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=299.76 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|++.+.||.|+||.||++.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 4788899999999999999975 468899999986433 2235678889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999985 23578889999999999999999976 9999999999999999999999999988655433
Q ss_pred Ccc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
... ....++..|+|||.+....++.++|||||||++|+|++|+.||.......... .... ....
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~~~~-------------~~~~ 233 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIAT-------------NGTP 233 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--ehhc-------------CCCC
Confidence 222 22345668999999988889999999999999999999999997543211100 0000 0000
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+...+..+.+++.+||..+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122344678899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.87 Aligned_cols=268 Identities=23% Similarity=0.363 Sum_probs=195.8
Q ss_pred CccccceeccCCceEEEEEEeC---CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 345 (579)
+|++.+.||+|+||.||+|... ++..||+|.+.... ........+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999765 47899999997643 1223346678899999999999999999999887 8899
Q ss_pred EEEEecCCCChhhhhcccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC----CCceEEecc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDN-KPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN----ELNPQLSDC 420 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Df 420 (579)
+||||+++ +|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 7777765333333 3788999999999999999999966 9999999999999999 899999999
Q ss_pred cccccCCCCCc----ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-------hhhhh
Q 008055 421 GLASNMPNADE----ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-------QSLVR 488 (579)
Q Consensus 421 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-------~~~~~ 488 (579)
|++........ .....++..|+|||++.+. .++.++|||||||++|+|++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876543222 1123456789999988764 578999999999999999999999975433210 00000
Q ss_pred h----ccccccChhH------HhhhcCccccCCCC---------h--hhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 489 W----ATPQLHDIDA------LAKMVDPALKGLYP---------V--KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 489 ~----~~~~~~~~~~------~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ..+....... .....+......++ . .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000000000 00000000001111 0 33457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=288.75 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=204.5
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
..++|+.+++||+|.||.|-+++- ..++.||+|++++..+ .++....-..|-++|+..+||.+..+-..|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 345788889999999999999965 4799999999988754 44556667789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc-
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN- 425 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~- 425 (579)
||||..||.|+-+|. ..+.+++.....+-..|+.||.|||.+ +||+||||.+|.|+|.+|++||.|||+++.
T Consensus 246 VMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999998875 355688888899999999999999965 999999999999999999999999999974
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc-
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV- 504 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 504 (579)
...+....+.+||+.|+|||++....|+.++|+|.+||++|||++|+.||...+ .+.+..++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------------h~kLFeLIl 381 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------------HEKLFELIL 381 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------------hhHHHHHHH
Confidence 344566778899999999999999999999999999999999999999995422 12222211
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCC
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 536 (579)
-..+ .||.....+...|+...|..||.+|.
T Consensus 382 ~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 MEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1111 35666677889999999999999995
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=301.32 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=195.5
Q ss_pred ccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 275 VENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
....||+|+||.||++... +++.||+|.+..... ...+.+.+|+..+..++||||+++++++...+..++||||+++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 3457999999999999764 689999999865432 2346688899999999999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc-c
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE-A 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 432 (579)
++|.+++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 103 GALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 99999874 24578999999999999999999965 999999999999999999999999999865433221 2
Q ss_pred cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCC
Q 008055 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLY 512 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (579)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... .+..... .... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~-----------~~~~--~~~~ 239 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRD-----------SPPP--KLKN 239 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc-----------cCCC--Cccc
Confidence 23446778999999998889999999999999999999999996533211 1100000 0000 0011
Q ss_pred ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 513 PVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 513 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+..+.+++.+||+.+|++||++.++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12334578999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=299.37 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=194.7
Q ss_pred CCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|...+ ++.||||.++..... .....+..|+..+.+. .||||+++++++.+....+++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 467888999999999999998764 899999999765432 2345566677666666 5999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+. ++|.+++.. ....+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 577777642 234788999999999999999999962 3899999999999999999999999999876644
Q ss_pred CCcccccCCCCCccCccccccCC----CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQ----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
........++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... +.+ ....
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~--------------~~~~ 232 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVL--------------TKIL 232 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHH--------------HHHh
Confidence 33333344567899999987554 7899999999999999999999996532211 111 1111
Q ss_pred CccccC-CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 505 DPALKG-LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 505 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...... ......+.++.+++.+||+.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111100 0111245689999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=313.25 Aligned_cols=273 Identities=23% Similarity=0.344 Sum_probs=208.5
Q ss_pred ccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------CeEE
Q 008055 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------GQHL 345 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 345 (579)
+...+.||+|+||.||+|++ +.|+.||||.+..... ....+...+|++++++++|+|||++++.-++. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 44567899999999999985 5799999999976542 34478899999999999999999999876543 3568
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCc--eEEeccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD--NELN--PQLSDCG 421 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~--~kl~Dfg 421 (579)
+|||||.+|||...+... ++...+++.+.+.++.+++.||.|||++ +|+||||||.||++- .+|+ .||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999743 4556899999999999999999999987 999999999999984 3343 4999999
Q ss_pred ccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
.|+.+.......+..||..|.+||++.. ..|+..+|.|||||++|+++||..||..........-.-|..- ......+
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~-tkkp~~v 248 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII-TKKPSGV 248 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh-ccCCCce
Confidence 9999988888888899999999999984 7889999999999999999999999965332110000011000 0000000
Q ss_pred hhhcCccccC------CC------ChhhHHHHHHHHHhcCCCCCCCCC--ChHHHHHHHHHHHHH
Q 008055 501 AKMVDPALKG------LY------PVKSLSRFADVIALCVQPEPEFRP--PMSEVVQALVRLVQR 551 (579)
Q Consensus 501 ~~~~~~~~~~------~~------~~~~~~~l~~li~~cl~~dP~~Rp--s~~evl~~L~~i~~~ 551 (579)
.-...+..++ .+ .......+..++..+|..+|++|. .+.+....+..|++.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0111111111 11 122334677888999999999999 888888888777763
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.71 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=195.4
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc---CCCCccceeeEEeeCCe-----
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL---HHPNIMELVGYCSEYGQ----- 343 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 343 (579)
|++.+.||+|+||.||+|..+ +++.||+|++............+..|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999876 489999999975544333344566676666554 69999999999987776
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.+++|||+. ++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 5899888632 223589999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc---------ccc
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA---------TPQ 493 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~---------~~~ 493 (579)
.............++..|+|||++.+..++.++|||||||++|||++|++||........ ..+.+.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 776544333334456789999999988999999999999999999999999975432211 1111100 000
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
............... ..........+.+++.+||+.||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000000 0011233567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=287.91 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=195.3
Q ss_pred cceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHH-hhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 276 ENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+..||.|+||+|+|..++ .|+.+|||++...... ...+++..|.+.. +.-+.||||+++|.+..++.+|+.||.|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 466999999999999765 7999999999876653 3355666666655 45589999999999999999999999995
Q ss_pred CChhhhhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 354 GSLHDFLHL-SDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 354 gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
.+|..+.+. +......+++.-.-+|+...+.||.||.+. ..|||||+||+|||++..|.+||||||++..+...-..
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk 224 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK 224 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence 577665532 223455688888889999999999999974 69999999999999999999999999999877654444
Q ss_pred cccCCCCCccCccccc--cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 433 LNNDAGSGYGAPEVAM--SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
....|-.+|||||.+. ...|+.++||||||++|||+.||..||.......++ +.+++......
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq---------------l~~Vv~gdpp~ 289 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ---------------LCQVVIGDPPI 289 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH---------------HHHHHcCCCCe
Confidence 4455667899999986 335999999999999999999999999876542221 22222111100
Q ss_pred -CCC---hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 511 -LYP---VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 511 -~~~---~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.++ -.....+..++.-|+.+|-+.||.+.++++.
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 011 2245689999999999999999999999864
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.52 Aligned_cols=248 Identities=31% Similarity=0.441 Sum_probs=196.8
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|+..+.||+|+||.||++... ++..+|+|++..... ..+....+..|+..++.++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999764 688999999865432 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+. |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 96 578777642 245689999999999999999999976 999999999999999999999999998865432
Q ss_pred cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||....... .........
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----------------~~~~~~~~~ 240 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIAQNE 240 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHHhcc
Confidence 22335667899999974 4568899999999999999999999986532211 111111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.........+..+.+++.+||+.+|.+||++.++++.+.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 111112334567899999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=298.16 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=198.8
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEEEEEE
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHLLVYE 349 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 349 (579)
|++.+.||.|+||.||+|... +++.+|+|++............+.+|+.+++.++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999776 588999999987653344556788999999999999999999999887 89999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++ ++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 489888852 225789999999999999999999976 9999999999999999999999999998766443
Q ss_pred Cc--ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-ccccChhHHhhh-
Q 008055 430 DE--ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-PQLHDIDALAKM- 503 (579)
Q Consensus 430 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~- 503 (579)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..+.+... +.........++
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 31 222344668999998764 4578999999999999999999999976543211 11111110 000000000000
Q ss_pred ----c------CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 ----V------DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ----~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ...+...+...++..+.+++.+||..+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000001111113568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.49 Aligned_cols=266 Identities=22% Similarity=0.343 Sum_probs=194.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-------
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG------- 342 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 342 (579)
++|++.+.||+|+||.||+|... +++.||+|.+............+.+|+.++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999765 6899999998655433344456678999999999999999999986544
Q ss_pred -eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 343 -QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 343 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
..++||||+. ++|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999996 588887752 234689999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcc-----cccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhc-----
Q 008055 422 LASNMPNADEA-----LNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA----- 490 (579)
Q Consensus 422 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~----- 490 (579)
++......... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98755332211 1223456899999886643 788999999999999999999999765432111111110
Q ss_pred ---cccccChhHHhhhcCc-cccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 491 ---TPQLHDIDALAKMVDP-ALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 491 ---~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.............+ ...... +......+.+++.+||..||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0011000000000000 000000 0112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=290.69 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=199.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC---CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA---LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 344 (579)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ........+.+|+.++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999764 68999999875322 2234456788999999999999999999998654 568
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999852 23578888999999999999999976 99999999999999999999999999987
Q ss_pred cCCCCC----cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNAD----EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAI 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHH
Confidence 653211 111234567899999999888999999999999999999999999653211 112
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+..........+......+.+++.+||. +|..||++.+++.
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 22222222334456666789999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.91 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=204.6
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||+|++|.||++... +++.|++|.+............+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999765 678999999987765545677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999863 25689999999999999999999965 99999999999999999999999999987665433
Q ss_pred cc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 EA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ...... ....
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~-~~~~ 216 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----------------ALFRIV-QDDH 216 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHh-ccCC
Confidence 32 22345668999999988888999999999999999999999996533110 000000 0111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+..+.+++.+||..+|++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1233445678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.44 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=196.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|++|.||+|... +++.||+|.+............+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999765 68899999987654444445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccccCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGLASNMPN 428 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 428 (579)
|++ ++|.+++... ....+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5888877522 233467888889999999999999976 9999999999999985 45789999999875533
Q ss_pred CCc-ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhh-hccccccC---hhHHh
Q 008055 429 ADE-ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVR-WATPQLHD---IDALA 501 (579)
Q Consensus 429 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~-~~~~~~~~---~~~~~ 501 (579)
... .....++..|+|||++.+. .++.++|||||||++|+|+||+.||......... .... +..+.... ...+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 221 1223456789999988654 5789999999999999999999999754321110 1101 01110000 00000
Q ss_pred hhc--CccccC----CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 KMV--DPALKG----LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... .+.... ......+.++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 011233467899999999999999999999985
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=327.98 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=189.5
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------ 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 341 (579)
-..+|+..++||+||||.||+++.+ ||+.||||++.... .......+.+|+..+++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3457888899999999999999887 89999999998776 566678889999999999999999987432100
Q ss_pred --------------------------------------------------------------------------------
Q 008055 342 -------------------------------------------------------------------------------- 341 (579)
Q Consensus 342 -------------------------------------------------------------------------------- 341 (579)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 008055 342 ---------------------------------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388 (579)
Q Consensus 342 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~ 388 (579)
-.+|+-||||+..+|.++++...... .....+.++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 01467899998888888776322111 356788999999999999
Q ss_pred HHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC-------------------CCCcccccCCCCCccCcccccc
Q 008055 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP-------------------NADEALNNDAGSGYGAPEVAMS 449 (579)
Q Consensus 389 LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~ 449 (579)
+|+. |||||||||.||+++++..|||+|||+++... +........||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9976 99999999999999999999999999997621 0112234456778999999976
Q ss_pred CC---CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC--CChhhHHHHHHHH
Q 008055 450 GQ---YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL--YPVKSLSRFADVI 524 (579)
Q Consensus 450 ~~---~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 524 (579)
.. |+.|+|+|||||+++||+. ||....++ ...+..+-+..+... +.......=..+|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER---------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER---------------ASILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHH---------------HHHHHhcccCCCCCCcccccccchHHHHHH
Confidence 54 9999999999999999984 67553322 122222222222211 2222333456899
Q ss_pred HhcCCCCCCCCCChHHHHH
Q 008055 525 ALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 525 ~~cl~~dP~~Rps~~evl~ 543 (579)
.+|++.||++|||+.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999984
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=294.59 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=196.5
Q ss_pred ccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|...+.||+|++|.||++.. .+++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457899999999999975 478899999986433 233566889999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
++++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999999862 4578899999999999999999976 999999999999999999999999998765433221
Q ss_pred -ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 432 -ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 432 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||.......... .+.....+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-------------~~~~~~~~~~-- 235 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-------------RIRDNLPPKL-- 235 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-------------HHHhcCCCCC--
Confidence 122346778999999988889999999999999999999999996533211100 0000000000
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 012224568999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.84 Aligned_cols=271 Identities=17% Similarity=0.237 Sum_probs=188.9
Q ss_pred HhCCccccceeccCCceEEEEEEeCC--CcEEEEEEeC---------------CCCCCchhHHHHHHHHHHHhhcCCCCc
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFAD--GKVLAVKKID---------------SSALPSEMCDDFIEMVSNISQLHHPNI 331 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~---------------~~~~~~~~~~~~~~e~~~l~~l~h~ni 331 (579)
..++|++.+.||+|+||.||++..+. +..+++|.+. ...........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999986542 2222222111 011112334567899999999999999
Q ss_pred cceeeEEeeCCeEEEEEEecCCCChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 008055 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE-DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD 410 (579)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~ 410 (579)
+++++++...+..++|+|++. ++|.+++..... .........+..|+.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999994 577777642211 122334567788999999999999976 999999999999999
Q ss_pred CCCceEEecccccccCCCCCc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCC-CCCCCCchhhhhhh
Q 008055 411 NELNPQLSDCGLASNMPNADE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRK-PFDSSRPRLEQSLV 487 (579)
Q Consensus 411 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~-p~~~~~~~~~~~~~ 487 (579)
.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||++|.. ||..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999976644322 223457889999999999999999999999999999999875 55433221111111
Q ss_pred hhc------ccccc-ChhHHhhhcCcccc----CCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 488 RWA------TPQLH-DIDALAKMVDPALK----GLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 488 ~~~------~~~~~-~~~~~~~~~~~~~~----~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ...+. ....+.+.++.... ... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 100 00000 00111111111000 000 0112356788999999999999999999985
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.58 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=198.0
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC----
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG---- 342 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 342 (579)
...++|++.+.||+|+||.||+|..+ +++.||+|+++...........+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567899999999999999999875 5889999999765443444567788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceE
Q 008055 343 ------QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ 416 (579)
Q Consensus 343 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 416 (579)
..++|+||+++ ++..++.. ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 77776642 234689999999999999999999976 999999999999999999999
Q ss_pred EecccccccCCCCCcc--cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccc
Q 008055 417 LSDCGLASNMPNADEA--LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATP 492 (579)
Q Consensus 417 l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~ 492 (579)
|+|||++......... .....+..|+|||.+.+ ..++.++|||||||++|||++|++||........ ..+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998765433211 11234567999998864 4578999999999999999999999975432111 111111100
Q ss_pred ccc----ChhHHhhh--cCc------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 493 QLH----DIDALAKM--VDP------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 493 ~~~----~~~~~~~~--~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ........ .+. .... .....+..+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000000 000 0000 01123568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=293.45 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=197.2
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|.+.+.||+|+||.||+|... +++.|++|++...... .......+|+..+++++ |||++++++++.+.+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567789999999999999875 5788999998755432 22334456888999998 99999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 889999886322 35689999999999999999999976 99999999999999999999999999987665443
Q ss_pred cccccCCCCCccCccccc-cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccC----hhHHhhhc
Q 008055 431 EALNNDAGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHD----IDALAKMV 504 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~ 504 (579)
......++..|+|||++. ...++.++||||||+++|||++|+.||....... ......+..+.... ...+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 333445677899999875 4457899999999999999999999996543221 11111111111000 00000000
Q ss_pred Ccccc-------CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALK-------GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.... .......+..+.+++.+||+.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 0001112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.45 Aligned_cols=270 Identities=19% Similarity=0.296 Sum_probs=201.2
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----Ce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 343 (579)
..+|.+.+.||+|+||.||++.. .+++.||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34789999999999999999975 4689999999876543444456778899999999999999999987643 35
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68988885 235689999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCC-cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccC----
Q 008055 424 SNMPNAD-EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHD---- 496 (579)
Q Consensus 424 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~---- 496 (579)
....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||........ ..+.....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7654432 2223345678999998865 4688999999999999999999999975432111 1111111100000
Q ss_pred --hhHHhhhcC-------ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH--HHHH
Q 008055 497 --IDALAKMVD-------PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA--LVRL 548 (579)
Q Consensus 497 --~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i 548 (579)
.......+. +.... .....+..+.+++.+||+.+|++|||+.++++. +..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 00000 112355678999999999999999999999866 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.25 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=198.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|++.+.||.|++|.||+|... +|..||+|.+..... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788899999999999999875 688999999876543 22345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 80 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 975 8888875322 234689999999999999999999965 99999999999999999999999999987543322
Q ss_pred c-ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhh-hhccccccChhHHhhhcCc
Q 008055 431 E-ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLV-RWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 431 ~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 506 (579)
. .....++..|++||++.+. .++.++|||||||++|+|++|+.||....... ...+. .+..+.......+... +
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 232 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--P 232 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--c
Confidence 1 1223456789999998654 57889999999999999999999997543221 11111 1111111111111100 0
Q ss_pred cccCC-----------CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGL-----------YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+... .....+..+.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01011 11223567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=291.83 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=187.7
Q ss_pred eeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-hhHHHHHHH---HHHHhhcCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 278 LLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-EMCDDFIEM---VSNISQLHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
.||+|+||.||++... +++.||+|.+....... .....+..| ...++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 58899999987654322 112223333 334455689999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 152 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CC
Confidence 999999885 234689999999999999999999975 9999999999999999999999999998755332 22
Q ss_pred cccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 433 LNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
....++..|+|||++.++ .++.++|||||||++|||++|+.||.......... ..... ......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~~-~~~~~~ 217 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRMT-LTMAVE 217 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--------------HHHHh-hccCCC
Confidence 334567899999998754 68999999999999999999999997542211100 00000 001112
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
.+...+.++.+++.+|+..+|++|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2334467899999999999999999 8889874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=299.72 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=197.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC--CeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY--GQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~ 345 (579)
.++|++.+.||+|+||.||+|... +++.+|+|++............+..|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888899999999999999765 688999999865443334456677899999999 999999999998643 4689
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||++ ++|.+++.. ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999996 599988852 2678889999999999999999976 999999999999999999999999999876
Q ss_pred CCCCCc------ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccc-cC
Q 008055 426 MPNADE------ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQL-HD 496 (579)
Q Consensus 426 ~~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~-~~ 496 (579)
...... .....++..|+|||++.. ..++.++||||||+++|+|++|+.||........ ..+..+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543321 112345678999998765 4578899999999999999999999975433211 11111110000 00
Q ss_pred hhH-----HhhhcC----cccc--CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 497 IDA-----LAKMVD----PALK--GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 497 ~~~-----~~~~~~----~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
... ...+++ .... .......+.++.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 000000 0000 00111245789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=290.19 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHH-HhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSN-ISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|... +++.||+|.+...... ......+..|... ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999764 6899999998754422 2222334444443 4556899999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc---cc
Confidence 999999862 34578899999999999999999976 999999999999999999999999999875433 12
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...++..|+|||.+.+..++.++||||||+++|||++|..||........ ...... ..........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~------------~~~~~~~~~~ 217 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDNILS------------RRINWPEEVK 217 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHh------------cccCCCCccc
Confidence 23456789999999888889999999999999999999999965432110 000000 0000111112
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
..++..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23567899999999999999999887665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=297.00 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=192.7
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGS 355 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (579)
.+.+|.|+++.||++.. +++.||+|++..........+.+.+|+..+++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666544 68999999998765555667889999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc----
Q 008055 356 LHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE---- 431 (579)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 431 (579)
|.+++... ....+++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99998733 234578889999999999999999976 999999999999999999999999998865432221
Q ss_pred ----ccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhhhccccccChh-----
Q 008055 432 ----ALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVRWATPQLHDID----- 498 (579)
Q Consensus 432 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~----- 498 (579)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..........+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 112234557999999875 3588999999999999999999999975432110 000000000000000
Q ss_pred -HHhh----hcCcc----ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 499 -ALAK----MVDPA----LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 499 -~~~~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.... ..++. ...........++.+++.+||..||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0111223345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=293.07 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=200.4
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|++.+.||.|++|.||++... +++.+++|.+............+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999764 7899999998766554455678889999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD- 430 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 430 (579)
++ +|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 88888753 235789999999999999999999976 99999999999999999999999999987665443
Q ss_pred cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhh-ccccccChhHHhh-----
Q 008055 431 EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRW-ATPQLHDIDALAK----- 502 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~----- 502 (579)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......... ..... ..+..........
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12223455689999998776 7899999999999999999999999654421110 01010 0000000000000
Q ss_pred ---hcCccc--cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 ---MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ---~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+... ........+.++.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 00111235678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.98 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=194.2
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||.|+||.||++... +++.+++|.+..... .......+.+|++.+++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999976543 234567788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc-----
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE----- 431 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 431 (579)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998632 3689999999999999999999976 999999999999999999999999999875433211
Q ss_pred ----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 432 ----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 432 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.....++..|+|||......++.++||||||+++|+|++|..||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------~~~~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----------------FQNILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhcCC
Confidence 1123456689999999888899999999999999999999999975432110 00111100
Q ss_pred ccCCCChh--hHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 508 LKGLYPVK--SLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 508 ~~~~~~~~--~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
. ..+.. .+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 11122 257889999999999999999996665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.29 Aligned_cols=266 Identities=22% Similarity=0.369 Sum_probs=198.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe----eCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS----EYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~ 345 (579)
.+|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57889999999999999999754 6899999999765444445677888999999999999999998875 335689
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+. |+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 68998885 234589999999999999999999976 999999999999999999999999999875
Q ss_pred CCCCCcc-----cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhh--cccccc--
Q 008055 426 MPNADEA-----LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW--ATPQLH-- 495 (579)
Q Consensus 426 ~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~--~~~~~~-- 495 (579)
....... ....++..|+|||++.. ..++.++|||||||++|||++|+.||.............. ..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5332211 12345678999999865 4588999999999999999999999965432111000000 000000
Q ss_pred ---ChhHHhhhcCc-cccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 496 ---DIDALAKMVDP-ALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 496 ---~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+....+. ...... ....+.++.+++.+||+.+|++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 000011 12345789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.11 Aligned_cols=263 Identities=20% Similarity=0.320 Sum_probs=194.7
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----Ce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 343 (579)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 35799999999999999999975 478999999986432 233456788899999999999999999887543 35
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+. ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 58887764 34689999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCcc----cccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccCh
Q 008055 424 SNMPNADEA----LNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDI 497 (579)
Q Consensus 424 ~~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 497 (579)
......... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...+.+..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~--~~ 231 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP--SQ 231 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC--CH
Confidence 765332211 12345678999998754 568999999999999999999999996543211 00111111100 00
Q ss_pred hHHhhhcCcc---------ccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 498 DALAKMVDPA---------LKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 498 ~~~~~~~~~~---------~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.....+.+.. ..... ....+.++.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0010000000 00000 01234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=287.92 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=190.5
Q ss_pred HHHHHHhCCcccccee--ccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHh-hcCCCCccceeeEEe
Q 008055 264 ADLQMATGSFNVENLL--GEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNIS-QLHHPNIMELVGYCS 339 (579)
Q Consensus 264 ~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~ 339 (579)
.+.....+.|++.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.... ..+||||+++++.+.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEe
Confidence 3334445567777776 99999999999764 688899999865432211 111111 127999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEe
Q 008055 340 EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLS 418 (579)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~ 418 (579)
..+..++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999863 23789999999999999999999976 999999999999999998 99999
Q ss_pred cccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChh
Q 008055 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 498 (579)
|||++...... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... ....
T Consensus 153 dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~----------- 217 (267)
T PHA03390 153 DYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLE----------- 217 (267)
T ss_pred cCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHH-----------
Confidence 99998765322 23356778999999998889999999999999999999999997543211 0001
Q ss_pred HHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC-hHHHHH
Q 008055 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVVQ 543 (579)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~ 543 (579)
.+...... ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus 218 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11111110 11122345678999999999999999996 588873
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=283.34 Aligned_cols=270 Identities=22% Similarity=0.319 Sum_probs=201.3
Q ss_pred CCccccceeccCCceEEEEEEeCC-----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-CCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-YGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 344 (579)
..|+....||+|.||.||+|.-++ .+.+|+|+++.............+|+.+++.++|||++.+...+-. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 358889999999999999995432 3479999998775555556778899999999999999999998866 7889
Q ss_pred EEEEEecCCCChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC----CceEEec
Q 008055 345 LLVYEFRKNGSLHDFLHLSDE-DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE----LNPQLSD 419 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~D 419 (579)
++++||.+. +|...++..+. ....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 88888864332 335788899999999999999999976 89999999999999877 9999999
Q ss_pred ccccccCCCCCc----ccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhh----------
Q 008055 420 CGLASNMPNADE----ALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ---------- 484 (579)
Q Consensus 420 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~---------- 484 (579)
+|+++.+...-. ....+.|.+|.|||.+.+.+ ||.+.||||.|||+.||+|-.+.|.+...+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999987654322 22345688999999998765 899999999999999999999988654322111
Q ss_pred -hhhhhccccccChhHHhhhcCc-----ccc-CCC-C----------hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 485 -SLVRWATPQLHDIDALAKMVDP-----ALK-GLY-P----------VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 485 -~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~-~----------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.+.-...|...++..+.++-+- .++ ..+ + ...+..-.+|+.++|..||-+|.|+.+.++-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111122222222222221110 000 000 0 0012237899999999999999999998754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=293.78 Aligned_cols=258 Identities=19% Similarity=0.200 Sum_probs=183.0
Q ss_pred HhCCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchh---------HHHHHHHHHHHhhcCCCCcccee
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEM---------CDDFIEMVSNISQLHHPNIMELV 335 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~ 335 (579)
..++|.+.+.||+|+||.||+|...+ +..+|+|+.......... ......+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34679999999999999999998654 345666654322211000 01122334455677999999999
Q ss_pred eEEeeCC----eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC
Q 008055 336 GYCSEYG----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN 411 (579)
Q Consensus 336 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 411 (579)
+++.... ..++++|++. .++.+.+.. ....++..+..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765433 3467788764 466666542 22356778899999999999999976 9999999999999999
Q ss_pred CCceEEecccccccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc-hh
Q 008055 412 ELNPQLSDCGLASNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP-RL 482 (579)
Q Consensus 412 ~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~-~~ 482 (579)
++.++|+|||+++....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999876532211 1123577899999999999999999999999999999999999975421 11
Q ss_pred hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
...... .+-+..+..... ....++..+.+++..|+..+|++||++.++++.|
T Consensus 242 ~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAK--------CDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhH--------HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000000 000111111111 1223467899999999999999999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=289.14 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=197.2
Q ss_pred CccccceeccCCceEEEEEEeCC-CcEEEEEEeCC---CCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDS---SALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
+|.+.+.||+|+||.||++.... +..+++|.++. ..........+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997653 44455665543 222233345667789999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875444556799999999999999999999976 9999999999999975 569999999987654
Q ss_pred CCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.... .....++..|+|||......++.++|+||||+++|+|++|..||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------------~~~~~~~~- 219 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----------------SVVLRIVE- 219 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHHc-
Confidence 3322 22344567899999998888899999999999999999999999643211 01111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+...+.++.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112234456678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.53 Aligned_cols=265 Identities=21% Similarity=0.289 Sum_probs=202.2
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-----eEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-----QHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 345 (579)
+|++.+.||.|+||.||+|... +++.+|+|++..........+.+.+|+..++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999865 5899999999765544455678899999999999999999999987765 789
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
++|||++ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 589888852 33789999999999999999999976 999999999999999999999999999986
Q ss_pred CCCCC----cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccCh--
Q 008055 426 MPNAD----EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDI-- 497 (579)
Q Consensus 426 ~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~-- 497 (579)
..... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ...+.........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65432 12233456789999999877 78999999999999999999999997654321 111111111000000
Q ss_pred ----hHHhhhcC---ccc---cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 498 ----DALAKMVD---PAL---KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 498 ----~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......+. ... ........+..+.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 000 000112245678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=293.55 Aligned_cols=248 Identities=29% Similarity=0.422 Sum_probs=194.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|+..+.||+|+||.||+|... ++..+|+|.+.... ........+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999765 67889999986432 223445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 688777642 234578899999999999999999976 9999999999999999999999999998765332
Q ss_pred CcccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
....++..|+|||.+. ...++.++|||||||++|+|++|..||........ .......
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------------~~~~~~~ 229 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIAQN 229 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH----------------HHHHhhc
Confidence 2334567899999974 35678899999999999999999999865322110 0011111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
......+...+..+.+++.+||..+|++||++.+++..-
T Consensus 230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111111223456789999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.02 Aligned_cols=246 Identities=31% Similarity=0.443 Sum_probs=193.1
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|...+.||+|+||.||+|... +++.|++|++..... .......+.+|+..++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999764 688999999865432 234456788899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 578777752 245688999999999999999999976 999999999999999999999999998864322
Q ss_pred cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.....++..|+|||++. ...++.++|||||||++|||++|..||......... .......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----------------~~~~~~~ 236 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------YHIAQND 236 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----------------HHHHhcC
Confidence 22345677899999984 456888999999999999999999998654321110 0000000
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.........+..+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111112234578999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.70 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=199.6
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-CCeE
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-YGQH 344 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 344 (579)
...+++|++.+.||.|+||.||++... +++.||+|++..........+.+..|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446778999999999999999999754 78999999986544434456778899999999999999999998865 5678
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
+++|||+ +++|.++++ ...+++..+..++.|+++||.|||+. +|+||||+|+||++++++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 568988875 23577888889999999999999976 99999999999999999999999999987
Q ss_pred cCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccc-------c
Q 008055 425 NMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQL-------H 495 (579)
Q Consensus 425 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~-------~ 495 (579)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+.+...... .
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 54321 223345678999998765 5689999999999999999999999965432111 11111111000 0
Q ss_pred ChhHHhhhcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 496 DIDALAKMVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......-...-......+ ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000011111 1245689999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=291.08 Aligned_cols=243 Identities=24% Similarity=0.367 Sum_probs=194.2
Q ss_pred cceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 276 ENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
...||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++|+|++++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35699999999999976 478999999985433 234567889999999999999999999999999999999999999
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc-cc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE-AL 433 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 433 (579)
+|.+++. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........ ..
T Consensus 103 ~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 103 ALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred cHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999874 23578899999999999999999976 999999999999999999999999998865533221 22
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
...++..|+|||.+.+..++.++||||||+++|+|++|..||........... +.....+.+. ..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~~~~--~~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLPPKLK--NL 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhhCCcccC--Cc
Confidence 23456789999999888899999999999999999999999965332111100 0000111111 11
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 514 VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 223457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=294.74 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=193.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------- 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 341 (579)
.++|++.+.||+|+||.||+|... +++.+|+|++............+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999765 689999999865543333345677899999999999999999887543
Q ss_pred -CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 342 -GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
...++||||+.+ +|...+.. ....+++..+..++.|+++||+|||.. +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999964 67776652 345689999999999999999999965 9999999999999999999999999
Q ss_pred cccccCCCCCccc------------ccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhh
Q 008055 421 GLASNMPNADEAL------------NNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSL 486 (579)
Q Consensus 421 g~~~~~~~~~~~~------------~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~ 486 (579)
|++.......... ...++..|+|||.+.+. .++.++|||||||++|||++|++||........ ..+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9987553322111 11335679999988654 578999999999999999999999975443211 111
Q ss_pred hh-hcccc---ccChhHHhhhcCccccCCCC-------hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 487 VR-WATPQ---LHDIDALAKMVDPALKGLYP-------VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 487 ~~-~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. +..+. ......+....+.......+ ......+.+++.+||..||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11 11100 00011111100000000001 112257889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.59 Aligned_cols=272 Identities=19% Similarity=0.271 Sum_probs=201.8
Q ss_pred CHHHHHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee
Q 008055 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
...++...+++|.+.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667789999999999999999999965 578999999997654333445678889999999999999999998754
Q ss_pred C------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 341 Y------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 341 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
. ...+++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888887 789988875 23588999999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhcc-
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWAT- 491 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~- 491 (579)
+||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...+.+...
T Consensus 159 ~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 159 LKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999875432 2223456778999998866 568899999999999999999999996543211 111111111
Q ss_pred ------ccccCh--hHHhhhcCccccC---CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 492 ------PQLHDI--DALAKMVDPALKG---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 492 ------~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+.+... ......+...... ......+.++.+++.+|++.||.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 0000000000000 0011234578999999999999999999998855
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=299.02 Aligned_cols=268 Identities=18% Similarity=0.305 Sum_probs=196.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------G 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 342 (579)
..+|.+.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999764 689999999876544344456788999999999999999999988654 3
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++|+||+. .+|..++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 5689999996 4777654 23578899999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccC----
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHD---- 496 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~---- 496 (579)
+...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+..........
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8754321 222345678999999876 46889999999999999999999999764321110 000000000000
Q ss_pred -----hhHHhhhcCccccCCC---ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH--HHHHH
Q 008055 497 -----IDALAKMVDPALKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQA--LVRLV 549 (579)
Q Consensus 497 -----~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 549 (579)
............+... .......+.+++.+||+.||++||++.+++.. ++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000000000000 01234578899999999999999999999943 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=291.41 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=198.1
Q ss_pred CccccceeccCCceEEEEEEe----CCCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
+|++.+.||+|+||.||++.. .+++.||||.++.... .....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377889999999999999864 3578899999865332 123346678899999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998852 34588899999999999999999975 99999999999999999999999999987
Q ss_pred cCCCCCcc--cccCCCCCccCccccccCC--CCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccChhH
Q 008055 425 NMPNADEA--LNNDAGSGYGAPEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDIDA 499 (579)
Q Consensus 425 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 499 (579)
........ ....++..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------- 220 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI------------- 220 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH-------------
Confidence 65433221 1234567899999987655 7889999999999999999999995322110 0000
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
....... ....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 221 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 SRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0011100 112233445678999999999999999999888776643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=296.60 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=193.0
Q ss_pred CccccceeccCCceEEEEEEeC-C--CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee----CCe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-D--GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE----YGQ 343 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 343 (579)
+|++.+.||+|+||.||++... . +..||+|++..........+.+..|+.+++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999765 3 77899999875433334456788899999998 59999999987543 245
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++++||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 68998885 345688999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCc-----ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCch-hhhhhhhhccccccC
Q 008055 424 SNMPNADE-----ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR-LEQSLVRWATPQLHD 496 (579)
Q Consensus 424 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~ 496 (579)
........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ....+....... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~ 230 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP--D 230 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC--C
Confidence 76543221 122346778999998765 46899999999999999999999999754321 111111111000 0
Q ss_pred hhHHhhh-----------cCccccC---CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 497 IDALAKM-----------VDPALKG---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 497 ~~~~~~~-----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......+ ....... .........+.+++.+||+.||++|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000 0011235679999999999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.64 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=194.7
Q ss_pred CccccceeccCCceEEEEEEe----CCCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
.|++.+.||+|+||.||++.. .+|..||+|++..... .....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999975 3689999999865432 123346678899999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999863 34578889999999999999999975 99999999999999999999999999987
Q ss_pred cCCCCCc--ccccCCCCCccCccccccC--CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNADE--ALNNDAGSGYGAPEVAMSG--QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
....... .....++..|+|||.+... .++.++||||||+++|+|++|..||........ ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------------~~~~ 220 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------------QAEI 220 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------------HHHH
Confidence 6543221 1233467789999998753 467899999999999999999999964221100 0011
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
.+.+... ...++...+..+.+++.+||+.||++|| ++.+++.
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 SRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111000 1123344557889999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=289.58 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=200.5
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 347 (579)
++|.+.+.||+|+||.||++... +++.||+|++..... .......+.+|..++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999765 789999999876433 2334567888999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999863 33689999999999999999999976 99999999999999999999999999987554
Q ss_pred CCCc---------------------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhh
Q 008055 428 NADE---------------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL 486 (579)
Q Consensus 428 ~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~ 486 (579)
.... .....++..|+|||.+....++.++||||||++++++++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 3221 111234568999999988889999999999999999999999997543210
Q ss_pred hhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh----HHHH
Q 008055 487 VRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM----SEVV 542 (579)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl 542 (579)
...... .....++...+..+.+++.+||+.+|++||++ .+++
T Consensus 230 ------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 230 ------------TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred ------------HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 011111 11112334446789999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.39 Aligned_cols=264 Identities=19% Similarity=0.292 Sum_probs=197.4
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-----
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG----- 342 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 342 (579)
..++|++.+.||+|+||.||++.. .++..||||++............+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 466899999999999999999965 47899999998654433444567889999999999999999999886543
Q ss_pred -eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 343 -QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 343 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 779988875 24688999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcccc------
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQ------ 493 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~------ 493 (579)
++...... .....++..|+|||++.. ..++.++|||||||++|+|++|+.||........ ..+.......
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98765332 223345778999999875 4588999999999999999999999975432110 1111100000
Q ss_pred -cc--ChhHHhhhcCccccC---CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 -LH--DIDALAKMVDPALKG---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 -~~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+. ........+...... .........+.+++.+|++.||++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000000000000 011234457889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.47 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=199.1
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|+..+.||+|+||.||+|... +++.+|+|.+..........+.+..|+..+++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999775 5899999999876544445577888999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
+ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5999999632 24689999999999999999999976 999999999999999999999999999876544332
Q ss_pred -ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccC-hhHHhhh--cC
Q 008055 432 -ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHD-IDALAKM--VD 505 (579)
Q Consensus 432 -~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~--~~ 505 (579)
......+..|+|||.+.+. .++.++|||||||++|||++|+.||........ ..+.+........ ...+... .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2223345679999998776 789999999999999999999999966432110 1111110000000 0000000 00
Q ss_pred cc--------ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PA--------LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ....+ ...+..+.+++.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 00011 112567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=272.20 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=193.3
Q ss_pred hCCcccc-ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHH-hhcCCCCccceeeEEee----CC
Q 008055 270 TGSFNVE-NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVGYCSE----YG 342 (579)
Q Consensus 270 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~ 342 (579)
+++|.+. ++||-|-.|.|-.+.++ +++.+|+|++.... ...+|+++- ..-.|||||.+++.|.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3455543 67999999999999765 68899999985432 334555543 33479999999998753 35
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEec
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSD 419 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~D 419 (579)
.+.+|||.|+||.|++.+.. .....+++.++..|+.||+.|+.|||.. +|.||||||+|+|+.. +..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 66799999999999999863 3456799999999999999999999965 9999999999999964 45689999
Q ss_pred ccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 420 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
||+|+.........+.+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||...... .+...
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispg---------- 274 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPG---------- 274 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChh----------
Confidence 99999877666677778899999999999999999999999999999999999999764421 11000
Q ss_pred HhhhcCccccCCCC----hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKGLYP----VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+...+... ...|| ...++...++|+.+|..+|++|.|+.++..
T Consensus 275 Mk~rI~~g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 275 MKRRIRTG-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHhHhhcc-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 00000000 11233 334567889999999999999999998864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.29 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=193.8
Q ss_pred CCcc-ccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCch------------hHHHHHHHHHHHhhcCCCCccceee
Q 008055 271 GSFN-VENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSE------------MCDDFIEMVSNISQLHHPNIMELVG 336 (579)
Q Consensus 271 ~~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~ 336 (579)
++|. +.+.||.|+||.||+|... +++.||+|++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999764 689999999865432210 1125678999999999999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceE
Q 008055 337 YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ 416 (579)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 416 (579)
++...+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +|+|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 69999885 234588999999999999999999976 999999999999999999999
Q ss_pred EecccccccCCCC---------------CcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 417 LSDCGLASNMPNA---------------DEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 417 l~Dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
|+|||++...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998755411 011122345689999998764 468999999999999999999999976543
Q ss_pred hh-hhhhhhhcc-ccc---cChhHHh------hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 481 RL-EQSLVRWAT-PQL---HDIDALA------KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 481 ~~-~~~~~~~~~-~~~---~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ...+..... +.. .....+. ........ ......+.++.+++.+||+.+|++|||+.+++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 21 111111110 000 0000000 00000000 001223567899999999999999999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=319.50 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=208.6
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
+.++....++|++.++||+|+||.|..++++ .++.||+|++.+-.. .......|.+|-.+|.-.+.+-|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566777889999999999999999999875 688999999976332 23445778999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
..++|+|||||+||+|-.++.. ...+++..+..++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999962 22799999999999999999999965 9999999999999999999999999
Q ss_pred cccccCCCCCc--ccccCCCCCccCccccc----c-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 421 GLASNMPNADE--ALNNDAGSGYGAPEVAM----S-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 421 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
|.+-.+...+. ....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.... ++
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lv------ 287 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LV------ 287 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HH------
Confidence 98876654443 34567899999999996 2 568999999999999999999999995421 11
Q ss_pred ccChhHHhhhcCccccCCCC--hhhHHHHHHHHHhcCCCCCCCCCC---hHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYP--VKSLSRFADVIALCVQPEPEFRPP---MSEVV 542 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps---~~evl 542 (579)
+...++++-.-.-.|| ...+.+..+||.+.+ -+|+.|.. +.++.
T Consensus 288 ----eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 288 ----ETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred ----HHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence 2223333332222344 446678889999887 45788877 77765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=279.44 Aligned_cols=237 Identities=26% Similarity=0.374 Sum_probs=194.3
Q ss_pred eccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCCh
Q 008055 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSL 356 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 356 (579)
||.|+||.||++... +++.+|+|.+...... ......+..|+.+++.++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 5899999998765432 23566788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-ccccc
Q 008055 357 HDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-EALNN 435 (579)
Q Consensus 357 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 435 (579)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 999863 33688999999999999999999976 99999999999999999999999999987654432 22334
Q ss_pred CCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChh
Q 008055 436 DAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVK 515 (579)
Q Consensus 436 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (579)
.++..|+|||...+...+.++|+||||+++|+|++|..||....... ....... ....++..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~--~~~~~~~~ 215 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----------------IYEKILK--DPLRFPEF 215 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHhc--CCCCCCCC
Confidence 55678999999988888999999999999999999999996543210 0111111 11223444
Q ss_pred hHHHHHHHHHhcCCCCCCCCCChHH
Q 008055 516 SLSRFADVIALCVQPEPEFRPPMSE 540 (579)
Q Consensus 516 ~~~~l~~li~~cl~~dP~~Rps~~e 540 (579)
.+..+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 4678899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.61 Aligned_cols=264 Identities=19% Similarity=0.317 Sum_probs=198.0
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe----
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ---- 343 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 343 (579)
..++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999775 67899999987654334455677889999999999999999988765554
Q ss_pred --EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 344 --HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 344 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 679999885 24689999999999999999999975 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccC---
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHD--- 496 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~--- 496 (579)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+..........
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 98765432 223345678999999865 3678999999999999999999999965432111 1111110000000
Q ss_pred ---hhHHhhhcC---ccccCCC---ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 ---IDALAKMVD---PALKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ---~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......++. ...+..+ ....+.++.+++.+||..+|++|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 0000000 1123568999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=271.71 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=202.8
Q ss_pred cccCHHHHHHHhCCccccceeccCCceEEEEE-EeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceee
Q 008055 259 TSYSIADLQMATGSFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVG 336 (579)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 336 (579)
..-.+.|+-..++ ++||+|+|+.|-.+ ...+|.+||||++.+. ......+..+|++++..+ .|+||+++++
T Consensus 71 ~~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLie 143 (463)
T KOG0607|consen 71 LSGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIE 143 (463)
T ss_pred ccchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence 3445677766664 78999999999998 4678999999999876 355677888999999887 7999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--
Q 008055 337 YCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN-- 414 (579)
Q Consensus 337 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-- 414 (579)
+|+++...|||||-|.||.|-.+|+ ....+++.++..+.++|+.||.+||++ ||.||||||+|||-.+...
T Consensus 144 fFEdd~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 144 FFEDDTRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred HhcccceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcC
Confidence 9999999999999999999999997 345688999999999999999999977 9999999999999976544
Q ss_pred -eEEecccccccCCCCCc--------ccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 415 -PQLSDCGLASNMPNADE--------ALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 415 -~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
+|||||.++........ ..+.+|+..|||||+.. ...|+.++|.||||||+|-|+.|.+||.+.-.
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 69999998754322111 12334555799999874 23588999999999999999999999965322
Q ss_pred hhhhhhhhhccccccChhHHhhhcCccc--cCCCChh----hHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 481 RLEQSLVRWATPQLHDIDALAKMVDPAL--KGLYPVK----SLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. -..|..-.... ..-..+++... +..||+. .+.+..++++..+..|+.+|.++.+++.
T Consensus 297 ~----dCGWdrGe~Cr-~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 297 A----DCGWDRGEVCR-VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred C----cCCccCCCccH-HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 12222211111 01111111111 2234543 3456789999999999999999999886
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.45 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=191.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--------
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-------- 341 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 341 (579)
.+|.+.+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 57899999999999999999764 688999999865543 3456788899999999999999999776543
Q ss_pred ------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCc
Q 008055 342 ------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELN 414 (579)
Q Consensus 342 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~ 414 (579)
...++||||++ ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999996 58988874 23588999999999999999999976 9999999999999974 567
Q ss_pred eEEecccccccCCCCCc----ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhh
Q 008055 415 PQLSDCGLASNMPNADE----ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~ 489 (579)
+||+|||++........ .....++..|+|||++.. ..++.++|||||||++|+|++|+.||..............
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 89999999876532211 112345668999998754 5578899999999999999999999976543211111111
Q ss_pred ccccccC--hh----HHhhhcC-ccccCC-----CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 490 ATPQLHD--ID----ALAKMVD-PALKGL-----YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 490 ~~~~~~~--~~----~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+.... .. ....... ...... .......++.+++.+||..||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0010000 00 0000000 000000 01124467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.31 Aligned_cols=240 Identities=25% Similarity=0.311 Sum_probs=192.2
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHh-hcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS-QLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 347 (579)
+..|+....+|.|+|++|-++.+ .+++..++|++.+... +-.+|+.++. .-+||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 55677788899999999999965 4688999999976621 2234454443 34899999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE-cCCCceEEecccccccC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL-DNELNPQLSDCGLASNM 426 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~ 426 (579)
||++.|+-|.+.+.. .. .....+..|+.+|+.|+.|||.+ |++||||||+|||+ ++.++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~----~~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS----KP-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHh----cc-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999988877752 12 22267788999999999999975 99999999999999 68999999999999877
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
... ..+...|..|.|||++....|++++||||||++||+|++|+.||.....+ ..+.. .
T Consensus 467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------~ei~~---~ 525 (612)
T KOG0603|consen 467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------IEIHT---R 525 (612)
T ss_pred chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------HHHHH---h
Confidence 554 33445577899999999999999999999999999999999999764332 01111 1
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+.+....+.+..+|+.+||+.||.+||+|.++...
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12233335566789999999999999999999998754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.72 Aligned_cols=147 Identities=26% Similarity=0.404 Sum_probs=130.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|.+.+.||+|+||.||+|... +++.||||++..... .......+..|+..++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999775 689999999975433 3344567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
||+.+++|.++++. ...+.+..++.|+.||+.||+|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999863 23578889999999999999999976 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=248.73 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=205.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.|+..+.||+|.||+||+|+.+ .++.||+|++.....+........+|+-+++.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555688999999999999765 578999999987776666667888999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
|. .+|..+.. .-...++.+.+..++.|+++||.++|.+ ++.||||||.|.||+.+|.+|++|||+++...-.-
T Consensus 83 cd-qdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 95 58887775 3456788899999999999999999965 99999999999999999999999999998776544
Q ss_pred ccc-ccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHh-CCCCCCCCCchhh--hhhhhhccccccChhHHhhhcC
Q 008055 431 EAL-NNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLE--QSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 431 ~~~-~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
..+ ....|.+|.+|.++.+.+ |++..|+||.|||+.|+.. |++.|.+.+.... ..+.....|.-..+..+.++-|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 333 456788999999999866 8999999999999999998 7777766543221 1111222233233333333333
Q ss_pred ccccCCCCh---------hhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPV---------KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
-...+.+|. .....-.+++++.+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222233332 11223468889999999999999988765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=280.26 Aligned_cols=245 Identities=20% Similarity=0.301 Sum_probs=200.1
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
+...+|..+.+||+|+||.|-++..+ +.+.||||++++..+- .+..+--+.|-++|+.. +-|.++++...|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33457889999999999999999665 4678999999887543 23334445666677655 678999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
|+||||+.||+|--.+++ -..+.+..+..+|..||-||-+||++ |||+||||.+|||+|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999877763 34566778899999999999999965 99999999999999999999999999997
Q ss_pred cC-CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 425 NM-PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 425 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
.- .......+.++|+.|+|||++..++|+..+|+|||||+||||+.|++||++.++.+ ....+
T Consensus 499 Eni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI 562 (683)
T KOG0696|consen 499 ENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAI 562 (683)
T ss_pred ccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Confidence 54 34445667889999999999999999999999999999999999999998865421 11122
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 537 (579)
.+. +-.||...+.+...+....+...|.+|..
T Consensus 563 ~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 221 23467777788899999999999999953
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.43 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=206.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCc-EEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGK-VLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
-.+++....||-|+||.|-++..+... .+|+|++++..+ +..+.+....|-.+|..++.|.||++|..|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345566678999999999999766443 489999977543 445566778899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||-|-||.|...++ ....+....+..++..+++|++|||.+ +||+|||||+|.|++.+|-+||.|||+|+.+.
T Consensus 499 mEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999996 456678888889999999999999976 99999999999999999999999999999999
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.+....+.+||+.|.|||++....++.++|.||||+++|||++|.+||.+.++-... ..+.+-+|
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-------------n~ILkGid-- 636 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-------------NLILKGID-- 636 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-------------HHHHhhhh--
Confidence 999999999999999999999999999999999999999999999999876542111 11111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCC
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPP 537 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 537 (579)
.-.+|........++|.+.+..+|.+|..
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 12345556667889999999999999976
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=254.40 Aligned_cols=202 Identities=26% Similarity=0.400 Sum_probs=170.2
Q ss_pred ccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh-cCCCCccceeeEEeeCCeEEEEEEecC
Q 008055 275 VENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ-LHHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
....||+|++|.|-+.++ .+|...|+|++..... .+..++...|+.+..+ ..+|.+|.++|.+.+.+..++.||.|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 346699999999998876 4899999999976654 3445666777777655 489999999999999999999999995
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 432 (579)
.+|..+.+.....+..+++...-+|+..+..||.|||++ ..++|||+||+|||++.+|++|+||||++..+.+.-..
T Consensus 129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 588888776666788899999999999999999999985 68999999999999999999999999999876554333
Q ss_pred cccCCCCCccCcccccc----CCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 433 LNNDAGSGYGAPEVAMS----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 433 ~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
....|-..|||||.+.. ..|+.|+||||||+++.||.+++.||+....
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 33445668999999853 4699999999999999999999999987654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=272.19 Aligned_cols=222 Identities=20% Similarity=0.217 Sum_probs=176.2
Q ss_pred CCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCChhhhh
Q 008055 282 GTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL 360 (579)
Q Consensus 282 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 360 (579)
|.+|.||++.. .+++.||+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999976 478999999986542 2233444455567999999999999999999999999999999998
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCC
Q 008055 361 HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440 (579)
Q Consensus 361 ~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 440 (579)
.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... ......+..
T Consensus 77 ~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~ 147 (237)
T cd05576 77 SK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENM 147 (237)
T ss_pred HH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCcc
Confidence 63 23588999999999999999999976 9999999999999999999999999987654332 222344567
Q ss_pred ccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHH
Q 008055 441 YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRF 520 (579)
Q Consensus 441 y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 520 (579)
|+|||......++.++||||+|+++|||++|+.|+....... .. ......+...+..+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~----~~~~~~~~~~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NT----HTTLNIPEWVSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------cc----ccccCCcccCCHHH
Confidence 999999988889999999999999999999998875422100 00 00001223345678
Q ss_pred HHHHHhcCCCCCCCCCChHHH
Q 008055 521 ADVIALCVQPEPEFRPPMSEV 541 (579)
Q Consensus 521 ~~li~~cl~~dP~~Rps~~ev 541 (579)
.+++.+||+.||++||++.+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHccCCHHHhcCCCcc
Confidence 999999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.98 Aligned_cols=263 Identities=21% Similarity=0.365 Sum_probs=198.6
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--------CCe
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--------YGQ 343 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~ 343 (579)
|+...+||+|.||.||+|+.+ .|+.||+|++-...-....-....+|+++|..++|+|++.++..|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 445678999999999999765 57788988765433333445667899999999999999999988843 346
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
+|+||.+|+. +|..++. .....++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 8999999976 8888885 3446789999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc-----ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh--------hhhhh
Q 008055 424 SNMPNADE-----ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ--------SLVRW 489 (579)
Q Consensus 424 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~--------~~~~~ 489 (579)
+.+..... ....+.|.+|.+||.+.+. .|+++.|||+.||++.||+||.+.+.+..+.... .+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76543322 2334568899999998864 5899999999999999999999999776542111 12233
Q ss_pred ccccccChhHHhhhcCccc-cCCC--------ChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 490 ATPQLHDIDALAKMVDPAL-KGLY--------PVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
+.|...+..-...+-.+.+ .+.+ |-.-..+..+|+.+++..||.+|+.+.+++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 4444444333322211111 1111 111124678999999999999999998887
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.49 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=204.9
Q ss_pred HHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEe-----e
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCS-----E 340 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~ 340 (579)
..+..|++.+.||+|.+|.||+++. ++++.+|+|++.... +..+++..|.++++.. +|||++.++|++. .
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3456788999999999999999965 578899999986544 2345666778888765 7999999999984 3
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
++.+|||||||.+|+.-++++... +..+.|..+..|++.++.||.+||++ .++|||+|-.|||++.++.|||+||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 578999999999999999998655 77899999999999999999999976 8999999999999999999999999
Q ss_pred cccccCCC-CCcccccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPN-ADEALNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|++..+.. .....+..+|+.|||||++.- ..|+.++|+||||++..||..|.+|+....+-
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------------- 234 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------------- 234 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------------
Confidence 99876643 334456778999999999863 34778999999999999999999999765431
Q ss_pred cChhHHhhh-cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 495 HDIDALAKM-VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 495 ~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
..+..+ -.|..+...+..-..+|.++|..||..|-++||++.+++
T Consensus 235 ---raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 235 ---RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred ---hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 111111 012222234566778999999999999999999999887
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=283.03 Aligned_cols=245 Identities=26% Similarity=0.353 Sum_probs=201.4
Q ss_pred cceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 276 ENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.+.||.|.||+||-|.+ ++|+.||||++.+-.........+.+|+.+|+.++||.||.+...|+..+..++|||-+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999976 47999999999998888888899999999999999999999999999999999999999 55
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CceEEecccccccCCCCCc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~ 431 (579)
++-+.+-. .+...+++.....++.||+.||.|||.+ +|+|+||||+|||+.+. .++||||||+|+...+...
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 66666542 3456788888888999999999999976 99999999999999654 5799999999999988777
Q ss_pred ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC
Q 008055 432 ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511 (579)
Q Consensus 432 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (579)
..+..||+.|+|||++....|...-|+||.|||+|--++|..||....+-.++ + ++ ..-+..+.-
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ-I--------QN---AaFMyPp~P--- 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ-I--------QN---AAFMYPPNP--- 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH-h--------hc---cccccCCCc---
Confidence 77888999999999999999999999999999999999999999653221111 0 00 000111111
Q ss_pred CChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 512 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
-.+......+||...|+..=++|-|....+
T Consensus 788 -W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 123345678889999988888998887654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=263.84 Aligned_cols=237 Identities=30% Similarity=0.447 Sum_probs=193.0
Q ss_pred CceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCChhhhhc
Q 008055 283 TFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH 361 (579)
Q Consensus 283 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 361 (579)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999876 489999999976543322 6788999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCCc
Q 008055 362 LSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY 441 (579)
Q Consensus 362 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y 441 (579)
.. ..+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus 80 ~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 80 KR----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred hc----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCC
Confidence 32 2288899999999999999999976 9999999999999999999999999999876654444445567789
Q ss_pred cCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChh--hHHH
Q 008055 442 GAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVK--SLSR 519 (579)
Q Consensus 442 ~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 519 (579)
++||.+....++.++||||||+++|+|++|..||...... ..+.+............. .+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~ 216 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----------------LELFKKIGKPKPPFPPPEWKISPE 216 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccCCCCccccccCCHH
Confidence 9999999888999999999999999999999999653211 111111111111110111 5578
Q ss_pred HHHHHHhcCCCCCCCCCChHHHHH
Q 008055 520 FADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 520 l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.86 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=196.1
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CC-----CccceeeEEeeC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HP-----NIMELVGYCSEY 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~ 341 (579)
.+++|.+...+|+|.||.|-.+.. +.+..||+|+++.-. ...+..+-|+++++++. +. -+|.+.+||+-.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 367899999999999999999954 457899999996533 22445566888888883 22 367788889999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC----------
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---------- 411 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---------- 411 (579)
++.++|+|.+ |-++++++.. ....+++..++..|+.|+++++++||+. +++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999998 6699999973 3456788899999999999999999976 9999999999999842
Q ss_pred ----------CCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCch
Q 008055 412 ----------ELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR 481 (579)
Q Consensus 412 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~ 481 (579)
+..++|+|||.|+..... ....+.|..|.|||++.+-.++.++||||+||||+|+.||...|......
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 345899999998765433 24456678999999999999999999999999999999999999765432
Q ss_pred hhhhh-hhhcccccc---ChhHHhhhcC-------------------ccccC-----CCChhhHHHHHHHHHhcCCCCCC
Q 008055 482 LEQSL-VRWATPQLH---DIDALAKMVD-------------------PALKG-----LYPVKSLSRFADVIALCVQPEPE 533 (579)
Q Consensus 482 ~~~~~-~~~~~~~~~---~~~~~~~~~~-------------------~~~~~-----~~~~~~~~~l~~li~~cl~~dP~ 533 (579)
+.-.+ .+...|.-. ......+... ...+. ........++.+|+.+||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 21111 111111000 0000000000 00000 11234556799999999999999
Q ss_pred CCCChHHHHH
Q 008055 534 FRPPMSEVVQ 543 (579)
Q Consensus 534 ~Rps~~evl~ 543 (579)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=274.01 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=197.2
Q ss_pred hCCccccceeccCCceEEEEE-EeCCCcEEEEEEeCCCCCC-----chhHHHHHHHHHHHhhcCCCCccceeeEEe-eCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALP-----SEMCDDFIEMVSNISQLHHPNIMELVGYCS-EYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~ 342 (579)
.++|-++++||+|||+.||+| .+...+.||||+-...... ....+...+|.++-+.++||.||++++||. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456788899999999999999 4567889999986543322 223345678999999999999999999995 567
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CceEEec
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSD 419 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~D 419 (579)
.++-|+|||+|.+|.-||+ ..+.+++.++..|+.||+.||.||.+. +.+|||-||||.|||+.+. |.+||.|
T Consensus 542 sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 8899999999999999986 345688999999999999999999988 7899999999999999643 7899999
Q ss_pred ccccccCCCCCcc--------cccCCCCCccCccccccC----CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 008055 420 CGLASNMPNADEA--------LNNDAGSGYGAPEVAMSG----QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 420 fg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~ 487 (579)
||+++.+...... ....||.+|++||.+.-+ +.+.|+||||.|||+|+++-|+.||...... +.+.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH
Confidence 9999887543321 123457799999998643 4789999999999999999999999754321 1111
Q ss_pred hhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
. ...+.+..+-.+ ..-+....+...+|++||+.--++|....++.
T Consensus 695 q--------eNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 Q--------ENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h--------hhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 111111111111 11133456788999999999999999888876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=281.55 Aligned_cols=267 Identities=17% Similarity=0.231 Sum_probs=180.3
Q ss_pred HhCCccccceeccCCceEEEEEEe-----------------CCCcEEEEEEeCCCCCC------------chhHHHHHHH
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-----------------ADGKVLAVKKIDSSALP------------SEMCDDFIEM 319 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~------------~~~~~~~~~e 319 (579)
..++|++.++||+|+||.||+|.. .+++.||||++...... ....+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999953 23568999998643211 0111223446
Q ss_pred HHHHhhcCCCCc-----cceeeEEee--------CCeEEEEEEecCCCChhhhhcccCC--------------------C
Q 008055 320 VSNISQLHHPNI-----MELVGYCSE--------YGQHLLVYEFRKNGSLHDFLHLSDE--------------------D 366 (579)
Q Consensus 320 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 366 (579)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 667777743 3578999999999999999864211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc--cCCCCCccCc
Q 008055 367 NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN--NDAGSGYGAP 444 (579)
Q Consensus 367 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~y~aP 444 (579)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........... ...++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999976 999999999999999999999999999876543222222 2236789999
Q ss_pred cccccCCC----------------------CccchHHhHHHHHHHHHhCCC-CCCCCCchhhhhhhhhccccccChhHHh
Q 008055 445 EVAMSGQY----------------------NIKSDVYSFGVVMLELLTGRK-PFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 445 E~~~~~~~----------------------~~~~DvwslGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
|.+..... ..+.||||+||++|+|++|.. ||...... ...+..+. .+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f-~~~~~~~~----~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF-NTELRQYD----NDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh-hhHHhhcc----chHHHHH
Confidence 99864321 124799999999999999875 77532110 00000000 0000000
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCC---CCCCChHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEP---EFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~ 543 (579)
........-...........+++.+||..+| .+|+|++|+++
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000111111123345678899999999766 68999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=292.92 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=168.1
Q ss_pred HhCCccccceeccCCceEEEEEEeC-C----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeE------
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-D----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY------ 337 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------ 337 (579)
..++|.+.+.||+|+||.||+|.+. + +..||+|++..... .+.+..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4568999999999999999999875 4 68999998864321 1111111 1222222233322221
Q ss_pred EeeCCeEEEEEEecCCCChhhhhcccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcC
Q 008055 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDED----------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKN 401 (579)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D 401 (579)
+......++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 24567899999999999999988632110 00112334567999999999999976 999999
Q ss_pred CCCCCEEEcC-CCceEEecccccccCCCCCc--ccccCCCCCccCccccccC----------------------CCCccc
Q 008055 402 IKSANILLDN-ELNPQLSDCGLASNMPNADE--ALNNDAGSGYGAPEVAMSG----------------------QYNIKS 456 (579)
Q Consensus 402 lkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~----------------------~~~~~~ 456 (579)
|||+|||++. ++.+||+|||+++.+..... .....+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 57899999999976533221 2234567899999965422 234567
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC----CC--ChhhHHHHHHHHHhcCCC
Q 008055 457 DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG----LY--PVKSLSRFADVIALCVQP 530 (579)
Q Consensus 457 DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~l~~li~~cl~~ 530 (579)
|||||||++|||+++..|++.........+... . .+.........+.... .+ .........+|+.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN---D-YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhc---C-CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999998777643211111111000 0 0001111111111000 00 011123456899999999
Q ss_pred CCCCCCChHHHHH
Q 008055 531 EPEFRPPMSEVVQ 543 (579)
Q Consensus 531 dP~~Rps~~evl~ 543 (579)
||++|||+.++++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=274.81 Aligned_cols=202 Identities=22% Similarity=0.318 Sum_probs=170.6
Q ss_pred ccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
|..++.||-|+||.|.+++. .+...||+|.+.+.+ +.+........|..+|+.-+.+-||+|+..|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 77788899999999999954 456789999997654 3455667778899999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC--
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN-- 428 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-- 428 (579)
++||++-.+|-. -.-+.+..+..++..+..|+++.|+. |+|||||||+|||||.+|++||.|||+++-+..
T Consensus 711 IPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998852 33467778888999999999999965 999999999999999999999999999843211
Q ss_pred -------CCc----------------------------------ccccCCCCCccCccccccCCCCccchHHhHHHHHHH
Q 008055 429 -------ADE----------------------------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLE 467 (579)
Q Consensus 429 -------~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~e 467 (579)
++. ....+||..|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000 012246778999999999999999999999999999
Q ss_pred HHhCCCCCCCCCch
Q 008055 468 LLTGRKPFDSSRPR 481 (579)
Q Consensus 468 lltg~~p~~~~~~~ 481 (579)
|+.|+.||....+.
T Consensus 864 m~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPG 877 (1034)
T ss_pred HhhCCCCccCCCCC
Confidence 99999999765543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=256.87 Aligned_cols=250 Identities=20% Similarity=0.362 Sum_probs=194.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchh-HHHHHHHHHHH-hhcCCCCccceeeEEeeCCeEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEM-CDDFIEMVSNI-SQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~ 345 (579)
...+|++.++||+|+|+.|..++++ +.+.||+|++++.....+. .+-...|-.+. +.-+||.+|.+..+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467999999999999999999775 5788999999876544322 22223333333 3348999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|.||++||+|--+++ ..++++++++..+...|..||.|||+. |||+||||.+|||+|..|++||.|+|+++.
T Consensus 328 fvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999977765 356799999999999999999999976 999999999999999999999999999874
Q ss_pred -CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh-
Q 008055 426 -MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM- 503 (579)
Q Consensus 426 -~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 503 (579)
+.+++...+.++|+.|.|||++.+..|...+|+|++||+++||+.|+.||+.-... .|....++-+.++
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~---------n~d~ntedylfqvi 471 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD---------NPDMNTEDYLFQVI 471 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC---------CcccchhHHHHHHH
Confidence 45666777889999999999999999999999999999999999999999742110 0011111111111
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCC
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 536 (579)
++..++ .|...+.....+++.-|.+||.+|.
T Consensus 472 lekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 LEKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 111111 2333344566788899999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=285.15 Aligned_cols=241 Identities=26% Similarity=0.436 Sum_probs=183.7
Q ss_pred ccceeccCCce-EEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEecC
Q 008055 275 VENLLGEGTFG-RVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 275 ~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
-.+++|.|+.| .||+|.++ |+.||||++-. +..+...+|+..++.- +|||||++++.-.+....|+..|.|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34679999987 56999885 78999999843 3345667899999877 7999999999999999999999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---C--CceEEecccccccCC
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---E--LNPQLSDCGLASNMP 427 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~--~~~kl~Dfg~~~~~~ 427 (579)
..+|.+++...............+.++.|+++||++||.. +||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5699999975311111112144578899999999999965 9999999999999976 3 468999999998886
Q ss_pred CCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 428 NADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 428 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
.+.... ...||.+|+|||++....-+.++||||+||++|+.++ |.+||...-......+ .....+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------TGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------cCccceee
Confidence 654433 2356779999999998888889999999999999999 5999976432211100 00001100
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
..+... .+..+||.+|++++|..||++.+|+
T Consensus 735 --------L~~~~d-~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 --------LEPLPD-CEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred --------eccCch-HHHHHHHHHhcCCCcccCCCHHHHh
Confidence 011111 1778999999999999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=247.17 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=195.3
Q ss_pred cceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----CeEEEEEE
Q 008055 276 ENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQHLLVYE 349 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 349 (579)
.+.||-|+||.||.+.. ++|+.||.|++..-...-...+.+.+|++++.-++|.|++..+++..-. .+.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 47899999999999854 5899999999865443344568889999999999999999998876432 35788999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
.| ..+|+..+- ..+.++...+.-++.||++||+|||.. +|.||||||.|.|++.+..+||||||+++.....
T Consensus 138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 98 458887773 567888899999999999999999965 9999999999999999999999999999865443
Q ss_pred Ccc--cccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhh-ccccccChhHHh---
Q 008055 430 DEA--LNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRW-ATPQLHDIDALA--- 501 (579)
Q Consensus 430 ~~~--~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~--- 501 (579)
+.. .....|..|.|||++++. .|+.+.||||.|||+.||+..+..|....+-. .+.+.+. ..|.+.+.+...
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 322 234567899999999975 48999999999999999998888886544322 1222222 223322211111
Q ss_pred --hhcCccccC-CC--------ChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 502 --KMVDPALKG-LY--------PVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 502 --~~~~~~~~~-~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.++....+. .+ +.....+-..+..+++..||++|.+..+.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111111 11 112234567888999999999999999888654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.75 Aligned_cols=255 Identities=17% Similarity=0.338 Sum_probs=195.3
Q ss_pred hCCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeC--CeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEY--GQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~ 345 (579)
.++|++.+.+|+|-++.||.|. ..+.+.++||+++.-. .+.+.+|+++|..+. ||||+++++...+. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3578889999999999999995 4577889999997543 577889999999996 99999999998764 4667
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLAS 424 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 424 (579)
||+||+.+.+...+. ..++...+..++.++++||.|+|+ +||.|||+||.|+|||.. ..++|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHh
Confidence 999999998877654 346777888999999999999994 599999999999999865 578999999999
Q ss_pred cCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhh---------------hh
Q 008055 425 NMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL---------------VR 488 (579)
Q Consensus 425 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~---------------~~ 488 (579)
...++....-...+..|..||.+.. ..|+..-|+|||||++..|+..+.||-......++.. ..
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 8887776666777889999999875 4589999999999999999999999855433222111 01
Q ss_pred hcc---ccccC------hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 489 WAT---PQLHD------IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 489 ~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.. |.+.+ ......++.+.-+. -...+..+++.+.|..|-.+|+|++|...
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhc
Confidence 110 00000 00111111111111 12357889999999999999999999873
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=247.55 Aligned_cols=133 Identities=22% Similarity=0.396 Sum_probs=112.3
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC--------CCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH--------HPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~~ 340 (579)
.++|.+.++||-|.|++||++.. .+.+.||+|+.+... ...+..+.||++|++++ -.+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 47899999999999999999954 578899999997643 34566778999988763 2479999999964
Q ss_pred ----CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 008055 341 ----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD 410 (579)
Q Consensus 341 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~ 410 (579)
+.+++||+|++ |-+|-.+|... ..+.++...+.+|+.||+.||.|||+.| ||||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45899999999 77999998743 4566888999999999999999999976 999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=240.80 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=193.2
Q ss_pred CccccceeccCCceEEEEE-EeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee------CCeE
Q 008055 272 SFNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE------YGQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~ 344 (579)
+|.-...+|.|.- .|..+ ..-.++.||+|++..........++..+|...+..+.|+||++++.+|.- ..+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5666778898888 55555 33468999999987766556667888899999999999999999998843 2467
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
|+|||+| ..+|...++ -.++......|..|++.|++|||.. +|+||||||+||++..+..+||.|||+++
T Consensus 97 y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 9999999 569988875 3467788899999999999999965 99999999999999999999999999998
Q ss_pred cCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh--hhh-hcc----------
Q 008055 425 NMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS--LVR-WAT---------- 491 (579)
Q Consensus 425 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~--~~~-~~~---------- 491 (579)
.....-.......+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+- .++. +.+ ...
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-IDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-HHHHHHHHHHhcCCCHHHHHHhh
Confidence 66554344456678899999999998899999999999999999999988864321 1110 000 000
Q ss_pred ----------ccccChhHHhh-hcCccccCC--CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 492 ----------PQLHDIDALAK-MVDPALKGL--YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 492 ----------~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
|+... ....+ +-|...... .+........+++.+||..||++|-+++++++
T Consensus 246 ~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00000 00000 001111110 11123356789999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=230.55 Aligned_cols=210 Identities=34% Similarity=0.560 Sum_probs=181.2
Q ss_pred eccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCChh
Q 008055 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLH 357 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 357 (579)
||+|.+|.||++...+ ++.+++|++....... ....+.+|+..++.+.|++++++++++......+++||++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998764 8999999997654322 3577899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccccCCCCC-ccccc
Q 008055 358 DFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGLASNMPNAD-EALNN 435 (579)
Q Consensus 358 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~-~~~~~ 435 (579)
+++... ...+++..+..++.+++++|+|||+. +++|+||+|.||+++. ++.++|+|||.+....... .....
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 80 DLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 998632 14688999999999999999999976 9999999999999999 8999999999987654432 12234
Q ss_pred CCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCCh
Q 008055 436 DAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPV 514 (579)
Q Consensus 436 ~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (579)
.....|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 456689999999877 788999999999999999
Q ss_pred hhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 515 KSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 515 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=260.23 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=199.2
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|+....+|.|.||.|||++. ..++..|+|+++... .........|+-+++.++||||+.++|.+-..+..+++||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4788899999999999999965 478999999997654 2335666788999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC-
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN- 428 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~- 428 (579)
||.+|+|.+..+ -..++++-++..+++..++||+|||. ++=+|||||-.|||+++.|.+|+.|||.+..+..
T Consensus 93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999876 46689999999999999999999995 4889999999999999999999999999865532
Q ss_pred CCcccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
-.......||+.|||||+.. .+.|..++|||++|++..|+-.-++|.....+-..-.+- .... .-.
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~---------~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSG---------FQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccC---------CCC
Confidence 23445678999999999985 566899999999999999998888775332211000000 0000 000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.++ -...-.+.|.++++.|+..+|.+||++..+++
T Consensus 235 p~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 12233457889999999999999999998874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.77 Aligned_cols=204 Identities=25% Similarity=0.308 Sum_probs=169.4
Q ss_pred HHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC------CCCccceeeEE
Q 008055 266 LQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH------HPNIMELVGYC 338 (579)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~ 338 (579)
.++...+|.+....|+|-|++|.+|.. ..|..||||+|....+- .+.=..|+++|.+|+ --|+++++..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 345677899999999999999999964 45889999999765432 333456788888774 34789999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEE
Q 008055 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQL 417 (579)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl 417 (579)
...+++|||+|-+ .-+|.++|+.+. ....|....+..++.|+..||..|.++ +|+|.||||.|||+++.. .+||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 9999999999988 459999997553 345678888999999999999999987 999999999999999765 4699
Q ss_pred ecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCC
Q 008055 418 SDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478 (579)
Q Consensus 418 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~ 478 (579)
||||.|...... ....+.++..|.|||++.+-.|+...|+||.||+||||.||+..|.+.
T Consensus 579 CDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 579 CDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 999998766543 233345566899999999999999999999999999999999988654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.44 Aligned_cols=198 Identities=21% Similarity=0.316 Sum_probs=168.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhH------HHHHHHHHHHhhcC---CCCccceeeEEee
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMC------DDFIEMVSNISQLH---HPNIMELVGYCSE 340 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~---h~niv~l~~~~~~ 340 (579)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+..+-.+.+ ...-.|+.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999776 45678899887765322111 22345899999997 9999999999999
Q ss_pred CCeEEEEEEec-CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 008055 341 YGQHLLVYEFR-KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419 (579)
Q Consensus 341 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 419 (579)
++..|++||-. ++-+|++++. ....+++.++..|++||+.|+++||+. +|||||||-+||.++.+|.+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 4569999995 566789999999999999999999965 999999999999999999999999
Q ss_pred ccccccCCCCCcccccCCCCCccCccccccCCCC-ccchHHhHHHHHHHHHhCCCCCC
Q 008055 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 420 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~p~~ 476 (579)
||.+..... +......||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998875543 455567889999999999999884 56799999999999998888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=230.45 Aligned_cols=198 Identities=32% Similarity=0.491 Sum_probs=170.5
Q ss_pred ccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
|.+.+.||.|++|.||++...+ ++.+|+|.+...... ...+.+..|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999998765 889999999765432 24678889999999999999999999999999999999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD- 430 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 430 (579)
++++|.+++.... ..+++.....++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 80 EGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999986322 1178899999999999999999976 99999999999999999999999999987765442
Q ss_pred -cccccCCCCCccCcccc-ccCCCCccchHHhHHHHHHHHHhCCCCCCC
Q 008055 431 -EALNNDAGSGYGAPEVA-MSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~elltg~~p~~~ 477 (579)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334456689999998 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=227.45 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=184.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeE-EeeCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGY-CSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 347 (579)
+.|++.+.||+|.||.+-+++++ +.+.+++|.+..... ..++|.+|...--.+ .|.||+..++. |+..+..+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 36888999999999999999887 567889999876653 367888887654444 68999988764 5677788899
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCceEEeccccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD--NELNPQLSDCGLASN 425 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfg~~~~ 425 (579)
+||++.|+|.+-+. ...+.+.....++.|++.|+.|||++ ++||||||.+||||- +...+||||||+.+.
T Consensus 101 qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999998764 35677888899999999999999965 999999999999994 335799999999865
Q ss_pred CCCCCcccccCCCCCccCccccccC-----CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSG-----QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
... .......+..|.+||..... ...+.+|||.||+++|.++||..||.... ..+..+.+|.. .
T Consensus 173 ~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~--------w 241 (378)
T KOG1345|consen 173 VGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQ--------W 241 (378)
T ss_pred cCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHH--------H
Confidence 432 11122335579999987532 24678999999999999999999997422 12233333322 1
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
.+...+.+... .....+..+++.++-+.++|++|=-..++.++.
T Consensus 242 ~~rk~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 242 LKRKNPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hcccCccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11111111111 122346788999999999999995555555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=228.85 Aligned_cols=263 Identities=23% Similarity=0.390 Sum_probs=192.3
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY 341 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 341 (579)
....+.|.++++||+|.|++||++... ..+.||+|.+..... ..+...|+++|.++ .+.||+++.+++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 344567889999999999999999543 467899999865543 45688999999888 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDC 420 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Df 420 (579)
+...+|+||++.....+++. .++...+..++..+..||+++|.+ |||||||||.|+|++.. +.-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 99999999999988888774 356788899999999999999976 99999999999999865 56689999
Q ss_pred cccccC-----------------CC-C---------------------------CcccccCCCCCccCcccccc-CCCCc
Q 008055 421 GLASNM-----------------PN-A---------------------------DEALNNDAGSGYGAPEVAMS-GQYNI 454 (579)
Q Consensus 421 g~~~~~-----------------~~-~---------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~ 454 (579)
|++... .. . .......||+||.|||++.. ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 998511 00 0 00112346889999999975 45789
Q ss_pred cchHHhHHHHHHHHHhCCCCCCCCCchhhh--hhh-------------------hhccccccChhHH----hhh-cCccc
Q 008055 455 KSDVYSFGVVMLELLTGRKPFDSSRPRLEQ--SLV-------------------RWATPQLHDIDAL----AKM-VDPAL 508 (579)
Q Consensus 455 ~~DvwslGv~l~elltg~~p~~~~~~~~~~--~~~-------------------~~~~~~~~~~~~~----~~~-~~~~~ 508 (579)
++||||.|||++-+++++.||-....+.+. .++ -|........... ..+ .....
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999999554322110 000 1111110000000 000 00000
Q ss_pred c--------CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 K--------GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+ ....+..+..+++++.+|+..||.+|.|+++.|+
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 0111223457899999999999999999999883
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=267.73 Aligned_cols=193 Identities=19% Similarity=0.280 Sum_probs=137.0
Q ss_pred hcCC-CCccceeeEE-------eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 008055 325 QLHH-PNIMELVGYC-------SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS 396 (579)
Q Consensus 325 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 396 (579)
.++| +||++++++| .....+++++||+ +++|.+++.. ....+++.+++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 5788888877 2234567788987 6699999962 245689999999999999999999965 9
Q ss_pred eEEcCCCCCCEEEcC-------------------CCceEEecccccccCCCCC-----------------cccccCCCCC
Q 008055 397 VVHKNIKSANILLDN-------------------ELNPQLSDCGLASNMPNAD-----------------EALNNDAGSG 440 (579)
Q Consensus 397 iiH~Dlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~-----------------~~~~~~~~~~ 440 (579)
|+||||||+||||+. ++.+|++|||+++...... ......+|+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999964 3455666666665321100 0011235678
Q ss_pred ccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHH
Q 008055 441 YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRF 520 (579)
Q Consensus 441 y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 520 (579)
|||||++.+..++.++|||||||++|||++|.+|+...... +.... .....+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~----------~~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLR----------HRVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHH----------HhhcChhh-----hhcCHHH
Confidence 99999999999999999999999999999998887532110 00000 00000000 0112345
Q ss_pred HHHHHhcCCCCCCCCCChHHHHH
Q 008055 521 ADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 521 ~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+++.+||+.+|.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=209.65 Aligned_cols=169 Identities=26% Similarity=0.324 Sum_probs=126.0
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
|+|.++++. .+..+++.+++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 789999862 345699999999999999999999976 4 999999999999999 99987654322
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+.. .... .++... ..+
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~-------~~~~-~~~~~~-~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLN-------GMPA-DDPRDR-SNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHH-------Hhcc-CCcccc-ccH
Confidence 25678999999999999999999999999999999999999653221 011111000 0000 000000 011
Q ss_pred hhhHH--HHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 514 VKSLS--RFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 514 ~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
..... ++.+++.+||..+|++||++.++++.+..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 22222 68999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=214.12 Aligned_cols=248 Identities=21% Similarity=0.416 Sum_probs=199.7
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGS 355 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (579)
..+|.+...|..|+|+++ |..+++|++..........++|.+|.-.++-+.||||+.++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345889999999999997 4456778887777777778899999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe--cccccccCCCCCccc
Q 008055 356 LHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS--DCGLASNMPNADEAL 433 (579)
Q Consensus 356 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~ 433 (579)
|+..++.. .....+..++.+++.++|+|++|||.. .+-|.---|.+..|++|++.+++|+ |--++... .
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe------~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------V 344 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec------c
Confidence 99999842 334567789999999999999999987 3334444689999999999888764 33332211 1
Q ss_pred ccCCCCCccCccccccCCCC---ccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccC
Q 008055 434 NNDAGSGYGAPEVAMSGQYN---IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~---~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
.....+.||+||.+...+.+ .++|+|||++++|||.|...||....+ .+.--++.-..++.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp----------------mecgmkialeglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP----------------MECGMKIALEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc----------------hhhhhhhhhccccc
Confidence 22346789999999876644 578999999999999999999975332 12222344456677
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
..|+.....+.+|+.-|+..||.+||.+..|+-.|+.++
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 788888899999999999999999999999999988764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=212.94 Aligned_cols=166 Identities=19% Similarity=0.165 Sum_probs=127.2
Q ss_pred HHhCCccccceeccCCceEEEEEEeC--CCcEEEEEEeCCCCC---CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA--DGKVLAVKKIDSSAL---PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
...++|.+.+.||+|+||+||+|.+. +++.+|||++..... .......+.+|++++++++|+|++..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567999999999999999999764 577889998753311 22345678999999999999999963322 25
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCEEEcCCCceEEeccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI-KSANILLDNELNPQLSDCG 421 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg 421 (579)
..++||||++|++|... . ... ...++.++++||.|||+. ||+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---ccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 68999999999999732 1 101 145788999999999976 9999999 9999999999999999999
Q ss_pred ccccCCCCCccc---------ccCCCCCccCccccccC
Q 008055 422 LASNMPNADEAL---------NNDAGSGYGAPEVAMSG 450 (579)
Q Consensus 422 ~~~~~~~~~~~~---------~~~~~~~y~aPE~~~~~ 450 (579)
+++......... ...++..|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998665433211 22345579999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=205.54 Aligned_cols=262 Identities=19% Similarity=0.220 Sum_probs=195.9
Q ss_pred CccccceeccCCceEEEEEEeCCC--cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC----CCCccceeeEE-eeCCeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADG--KVLAVKKIDSSALPSEMCDDFIEMVSNISQLH----HPNIMELVGYC-SEYGQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~ 344 (579)
+|.+.+.||+|+||.||.+..... ..+|+|.......... . .+..|..++..+. -+++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-c-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999976543 4788888755432211 1 5566777776665 25888898888 577889
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-----CceEEec
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-----LNPQLSD 419 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~D 419 (579)
++||+.+ |.+|.++..... ...++....+.|+.|++.+|++||+. |++||||||.|++++.. ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999988 889999875332 57899999999999999999999976 99999999999999865 4689999
Q ss_pred ccccc--cCCCCCc---------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 008055 420 CGLAS--NMPNADE---------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 420 fg~~~--~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 488 (579)
||+++ ....... .....+|..|.++....+...+.+.|+||++-++.|++.|..||.........
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---- 246 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---- 246 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH----
Confidence 99998 3221111 11234788999999999999999999999999999999999999654321110
Q ss_pred hccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
..+.+..............+.++.++...+-..+...+|....+...|++.......
T Consensus 247 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 247 ---------SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred ---------HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 011110000000002233456777777777779999999999999999888877643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-24 Score=229.32 Aligned_cols=253 Identities=21% Similarity=0.262 Sum_probs=184.5
Q ss_pred cccceeccCCceEEEEEEe-CCCcEEEEEEeC----CCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 274 NVENLLGEGTFGRVYRAQF-ADGKVLAVKKID----SSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
...+++|.|++|.|+.... ...+.++.|... ...........+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998887743 334444554433 22222222233566777778899999999888887777777779
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||++ +|+.++. ....+....+..+++|+..|++|||.. ||.|||+|++|++++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999985 234678888999999999999999965 999999999999999999999999999865543
Q ss_pred CCc-----ccccCCCCCccCccccccCCCCcc-chHHhHHHHHHHHHhCCCCCCCCCchhhhhhh-hhccccccChhHHh
Q 008055 429 ADE-----ALNNDAGSGYGAPEVAMSGQYNIK-SDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV-RWATPQLHDIDALA 501 (579)
Q Consensus 429 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 501 (579)
... .....++.+|+|||++...+|++. .||||.|+++..|.+|+.||........+... .... ........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~-~~~~~~~~- 550 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD-QRNIFEGP- 550 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc-ccccccCh-
Confidence 332 233456779999999999999865 79999999999999999999765433221100 0000 00000000
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.......+.+-..++.+||+++|.+|.|+.+|++.
T Consensus 551 --------~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 --------NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --------HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00112345677899999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-22 Score=200.60 Aligned_cols=255 Identities=30% Similarity=0.480 Sum_probs=196.9
Q ss_pred ccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCch-hHHHHHHHHHHHhhcCCC-CccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSE-MCDDFIEMVSNISQLHHP-NIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 350 (579)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999876 8889999987665443 578899999999999988 799999999877788999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 429 (579)
+.++++.+++...... ..+.......++.|++.+++|+|.. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776522111 3688889999999999999999976 899999999999999988 7999999998755443
Q ss_pred C-------cccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCch--hhhhhhhhccccccCh
Q 008055 430 D-------EALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQLHDI 497 (579)
Q Consensus 430 ~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 497 (579)
. ......++..|+|||.+.. ..++...|+||+|++++++++|..||...... .....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~----------- 224 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----------- 224 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH-----------
Confidence 3 2245567889999999987 57889999999999999999999997654321 00000
Q ss_pred hHHhhhcCccccCCCC----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 498 DALAKMVDPALKGLYP----VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
..+.....+....... ......+.+++..|+..+|..|.+..+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000000011 1223578899999999999999999887765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-22 Score=187.23 Aligned_cols=260 Identities=16% Similarity=0.227 Sum_probs=200.7
Q ss_pred CCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 348 (579)
-.|.+.++||+|.||.++.|. +-+++.||||.-..... +-++..|.+.++.| ..+.|..++-+-.++.+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 368899999999999999995 45799999997654432 23455667777666 5688988888878888889999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-----CceEEeccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-----LNPQLSDCGLA 423 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~Dfg~~ 423 (579)
|.+ |-+|+++.. ..++.++.+.++.||+|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|
T Consensus 104 dLL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 779988875 3567899999999999999999999976 89999999999999743 45899999999
Q ss_pred ccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccccc
Q 008055 424 SNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495 (579)
Q Consensus 424 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 495 (579)
+.+.+..+ ..+..||..||+--...+.+.+.+-|.=|+|-++++.+.|..||.+.......
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK----------- 245 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK----------- 245 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----------
Confidence 87754432 33456788999999999999999999999999999999999999876532111
Q ss_pred ChhHHhhhcCccccCC---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 496 DIDALAKMVDPALKGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 496 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
....++-+...... .....+.++..-+.-.-..+-.+-|...-+-.-+..++.+.+.
T Consensus 246 --~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 246 --EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred --HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11111111111110 1123456777777777788888999998888888888876554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=178.84 Aligned_cols=262 Identities=19% Similarity=0.262 Sum_probs=194.5
Q ss_pred HHhCCccccceeccCCceEEEEEE-eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC-CCccceeeEEeeCCeEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH-PNIMELVGYCSEYGQHL 345 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~ 345 (579)
+..+.|.+++.||.|+||.+|.|. ..+|..||||.-...... -.+..|.++...+++ ..|..+..|..+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 345689999999999999999994 578999999987654432 234566777777755 56667777788888999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CceEEecccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSDCGL 422 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~ 422 (579)
+|||.. |-+|.++.. .-...++...++-++-|++.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+
T Consensus 88 lVMdLL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeecc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 999998 789999886 3345688899999999999999999976 99999999999999744 4689999999
Q ss_pred cccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 423 ASNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 423 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
++.+.+..+ .....+|..|.+--...+-..+.+-|+-|+|-++.++-.|..||.+.......
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---------- 230 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---------- 230 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH----------
Confidence 987644322 22334666788777766677788999999999999999999999876543211
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
+..+.+.+..-...........|.+|.-.+..|-..--++-|...-+-+.+.-+.+
T Consensus 231 QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 231 QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11222222111111111223456788888889988888888888777766665554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=182.28 Aligned_cols=141 Identities=19% Similarity=0.192 Sum_probs=108.2
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchh------------------------HHHHHHHHHHHhhcCCCCc
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEM------------------------CDDFIEMVSNISQLHHPNI 331 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 331 (579)
.+.||+|+||.||+|...+|+.||||+++........ ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998888999999999754321111 0122348899999988776
Q ss_pred cceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCCEEEc
Q 008055 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL-HEVCSLSVVHKNIKSANILLD 410 (579)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~Dlkp~Nill~ 410 (579)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 23489999999887765432 134678899999999999999999 555 999999999999998
Q ss_pred CCCceEEecccccccC
Q 008055 411 NELNPQLSDCGLASNM 426 (579)
Q Consensus 411 ~~~~~kl~Dfg~~~~~ 426 (579)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=183.99 Aligned_cols=174 Identities=10% Similarity=0.156 Sum_probs=135.5
Q ss_pred HHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc-hhHHH------HHHHHHHHhhcCCCCccceeeEEee
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS-EMCDD------FIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~------~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
...++|.+.+++|.|+||.||.+.. ++..+|+|.+....... ..... +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 57789999997554322 22222 5789999999999999999988654
Q ss_pred C--------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 341 Y--------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 341 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
. +..+++|||++|.+|.++.. ++. ....+++.+|..||+. |++|||++|+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999988742 222 2456899999999976 99999999999999998
Q ss_pred CceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHH
Q 008055 413 LNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELL 469 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell 469 (579)
+ ++|+|||........... ..++....++.++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999987654221111 11444556778999999999988765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-22 Score=214.36 Aligned_cols=245 Identities=24% Similarity=0.288 Sum_probs=178.0
Q ss_pred CccccceeccCCceEEEEEEeCCCcEEEEEEeCCCC--CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSA--LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++...+.||.+.|=+|.+|++++|. |+||++-+.. ..-....+-+++++ ...++|||.+++...-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566788999999999999998887 8899986544 22222333344455 566799999999887777777888989
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC--C
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM--P 427 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~--~ 427 (579)
|... +|++.+. ....+...+..-|+.|++.||..+|+. ||+|||||.+||||+.-.-+.|+||..-+.. +
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9855 8999884 344567778888999999999999976 9999999999999999999999999864322 1
Q ss_pred CCC---ccccc---CCCCCccCccccccCC-----------CCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 008055 428 NAD---EALNN---DAGSGYGAPEVAMSGQ-----------YNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 428 ~~~---~~~~~---~~~~~y~aPE~~~~~~-----------~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 489 (579)
... ..... ..-.+|+|||.+.... .+++.||||+||++.||++ |++||..+. +..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhH
Confidence 111 11111 1123799999985421 4678999999999999999 899996421 1111
Q ss_pred ccccccC-hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 490 ATPQLHD-IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 490 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....-.+ ..-+.++-| ..+++++..|++.||++|.++++.++.
T Consensus 248 r~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 111222222 257899999999999999999999976
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-22 Score=207.26 Aligned_cols=226 Identities=23% Similarity=0.308 Sum_probs=183.3
Q ss_pred eccCCceEEEEEE----eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEEecCC
Q 008055 279 LGEGTFGRVYRAQ----FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 279 lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+|+|+||.|+.++ ...|..+|+|..++.............|..++...+ ||.+|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999863 335788999998776544333335566778888886 99999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
|+|...+. ....+.+.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++........
T Consensus 82 g~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99998775 344566667777888899999999976 9999999999999999999999999999876544333
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (579)
+++..|||||++. .+...+|.||||++++||+||..||... .+..+. ......|
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il--~~~~~~p 207 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRIL--KAELEMP 207 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHh--hhccCCc
Confidence 7888999999997 6788999999999999999999999650 111111 1123456
Q ss_pred hhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 514 VKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 514 ~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
.+......+++..++..+|..|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 7777888999999999999999765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=174.71 Aligned_cols=142 Identities=21% Similarity=0.240 Sum_probs=111.1
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchh------------------------HHHHHHHHHHHhhcCCCCc
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEM------------------------CDDFIEMVSNISQLHHPNI 331 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 331 (579)
.+.||+|+||.||+|...+|+.||||++......... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998878999999998765321100 1223578899999999987
Q ss_pred cceeeEEeeCCeEEEEEEecCCCChhhh-hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEE
Q 008055 332 MELVGYCSEYGQHLLVYEFRKNGSLHDF-LHLSDEDNKPLIWNSRVKIALGTARALEYLHE-VCSLSVVHKNIKSANILL 409 (579)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~Nill 409 (579)
.....+... ..++||||++++++... +. ...++......++.|++.++.+||+ . ||+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655444333 24899999998855432 32 2356778899999999999999997 5 99999999999999
Q ss_pred cCCCceEEecccccccCCC
Q 008055 410 DNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 410 ~~~~~~kl~Dfg~~~~~~~ 428 (579)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=172.24 Aligned_cols=186 Identities=16% Similarity=0.125 Sum_probs=139.6
Q ss_pred cccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc--hhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEEe
Q 008055 274 NVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS--EMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.+...|++|+||+||.+.. .+..++.+.+....... -....+.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997765 67788878776554321 12235789999999995 5889999886 457999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCEEEcCCCceEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI-KSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
+.|.+|...+. . ....++.|++.+|+++|++ ||+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~-----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP-----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh-----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99999875432 0 1135778999999999976 9999999 799999999999999999999755433
Q ss_pred Ccc--------------cccCCCCCccCccccccC-CCC-ccchHHhHHHHHHHHHhCCCCCCCC
Q 008055 430 DEA--------------LNNDAGSGYGAPEVAMSG-QYN-IKSDVYSFGVVMLELLTGRKPFDSS 478 (579)
Q Consensus 430 ~~~--------------~~~~~~~~y~aPE~~~~~-~~~-~~~DvwslGv~l~elltg~~p~~~~ 478 (579)
... .....++.|++|+...-. ..+ ...++++-|.-+|.++|+..+.-..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 311 112246677888765322 333 5679999999999999998886543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=181.79 Aligned_cols=235 Identities=21% Similarity=0.343 Sum_probs=150.6
Q ss_pred ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCC----------CCccceeeEE--
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHH----------PNIMELVGYC-- 338 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~-- 338 (579)
+...+.||.|+++.||.+.+. +++.+|+|++.... ......+.+.+|......+.+ -.++--++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999765 58999999975433 223456777777666555322 1222222221
Q ss_pred -------eeC---C-----eEEEEEEecCCCChhhhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 008055 339 -------SEY---G-----QHLLVYEFRKNGSLHDFLHL---SDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHK 400 (579)
Q Consensus 339 -------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 400 (579)
... . ..+++|+-+ -+||.+++.. .......+....++.+..|+++.+++||.. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 1 225678877 5688877542 112223355566678889999999999976 99999
Q ss_pred CCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCCccCccccccC--------CCCccchHHhHHHHHHHHHhCC
Q 008055 401 NIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG--------QYNIKSDVYSFGVVMLELLTGR 472 (579)
Q Consensus 401 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwslGv~l~elltg~ 472 (579)
||+|+|++++.+|.++|+||+........... ...+..|.+||..... .++.+.|.|++|+++|.|++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999987655432221 3445789999987542 4788999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCC
Q 008055 473 KPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR 535 (579)
Q Consensus 473 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 535 (579)
.||+......... | .+ .... +.++.+..||..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~---~-----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE---W-----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG---G-----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc---c-----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998654321110 0 01 1122 567889999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=181.65 Aligned_cols=199 Identities=19% Similarity=0.247 Sum_probs=140.8
Q ss_pred CCCCccceeeEEee---------------------------CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHH
Q 008055 327 HHPNIMELVGYCSE---------------------------YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIA 379 (579)
Q Consensus 327 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 379 (579)
+|||||++.++|.+ ...+|+||..++ .+|.+++. ....+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh-----cCCCchHHHHHHH
Confidence 59999999987633 235689998885 48999885 2334555677789
Q ss_pred HHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCC--ceEEecccccccCCCCC-------cccccCCCCCccCccccc
Q 008055 380 LGTARALEYLHEVCSLSVVHKNIKSANILLD--NEL--NPQLSDCGLASNMPNAD-------EALNNDAGSGYGAPEVAM 448 (579)
Q Consensus 380 ~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~--~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~ 448 (579)
.|+++|+.|||++ ||.|||+|++|||+. +|+ .+.|+|||.+-.....+ ......+....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999987 999999999999994 443 46899999864322211 112223344689999986
Q ss_pred cCC--C----CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHH
Q 008055 449 SGQ--Y----NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFAD 522 (579)
Q Consensus 449 ~~~--~----~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 522 (579)
..+ . -.|+|.|+.|-+.||+++...||.... +...+...+ .+...+..|..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y---------------qe~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY---------------QESQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh---------------hhhhCCCCcccCChHHHH
Confidence 432 1 258999999999999999999996521 111111111 111223346677788999
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 523 VIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 523 li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
++...|+.||++|++..-....|+--+.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 9999999999999998776666654444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=187.91 Aligned_cols=213 Identities=24% Similarity=0.380 Sum_probs=160.0
Q ss_pred HhhcCCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 008055 323 ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI 402 (579)
Q Consensus 323 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl 402 (579)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+. .....+++.....++++++.||+|||. ++-..|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeee
Confidence 356789999999999999999999999999999999996 356678999999999999999999996 334499999
Q ss_pred CCCCEEEcCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCC-------CCccchHHhHHHHHHHHHhCC
Q 008055 403 KSANILLDNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQ-------YNIKSDVYSFGVVMLELLTGR 472 (579)
Q Consensus 403 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslGv~l~elltg~ 472 (579)
++.|+++|..+.+||+|||+......... ........-|.|||.+.... .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876543110 11111223599999997632 466799999999999999999
Q ss_pred CCCCCCCchhh-hhhhhhccccccChhHHhhhcCccccCCCC-h-hhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 473 KPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKGLYP-V-KSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 473 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.||+....... ..+...+. +.-.+.+++... . +....+..++..||..+|+.||++.++-..++.+.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~----------~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVK----------KGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCChHHHHHHHH----------hcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99976332211 11111110 101111121111 1 33447899999999999999999999998887666
Q ss_pred H
Q 008055 550 Q 550 (579)
Q Consensus 550 ~ 550 (579)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=194.95 Aligned_cols=253 Identities=20% Similarity=0.318 Sum_probs=181.3
Q ss_pred HHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc-hhHHHHHHHHHHHhhcC---CCCccceeeEEe
Q 008055 264 ADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLH---HPNIMELVGYCS 339 (579)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 339 (579)
.+.++....|.|.+.||+|+||+||+|...+|+.||+|+=+...... -...+ ++.||+ -+.|..+...+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHc
Confidence 45566677899999999999999999998889999999876544221 11122 222333 234555555556
Q ss_pred eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-------C
Q 008055 340 EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-------E 412 (579)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-------~ 412 (579)
-.+..++|+||.+.|+|.+++. ..+.++|.-.+.++.|++..+++||.. +|||+||||+|.||.. .
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred cCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcc
Confidence 6778899999999999999996 456688888999999999999999976 9999999999999952 3
Q ss_pred CceEEecccccccC---CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhh
Q 008055 413 LNPQLSDCGLASNM---PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~ 489 (579)
.-++|+|||.+-.+ .+.........|..+-.+|+..+..+++.+|.|.|+-+++-|+.|+.-- .... ..|
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g------~~~ 910 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNG------SSW 910 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCC------cce
Confidence 45899999998654 3333444556677999999999999999999999999999999987532 0000 001
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
. ++..++.- -....+.+++..+|..|-..=|...++...|++++.+.
T Consensus 911 ~-------------~~~~~~Ry---~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 911 M-------------VKTNFPRY---WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred e-------------ccccchhh---hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 1 11111000 01123556677777733333477777777777777643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=162.67 Aligned_cols=135 Identities=17% Similarity=0.186 Sum_probs=103.3
Q ss_pred ccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-----CCCCccceeeEEeeCC---eEE-
Q 008055 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-----HHPNIMELVGYCSEYG---QHL- 345 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 345 (579)
-.+.||+|+||.||. +......+||++..... ...+.+.+|+..++.+ .||||++++|++.++. ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 357899999999996 44333347998865432 2356789999999999 6799999999998763 434
Q ss_pred EEEEe--cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEcCCCCCCEEEcC----CCceEEe
Q 008055 346 LVYEF--RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL-EYLHEVCSLSVVHKNIKSANILLDN----ELNPQLS 418 (579)
Q Consensus 346 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~ 418 (579)
+|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999963 124444 35677888777 999976 9999999999999974 3479999
Q ss_pred ccccc
Q 008055 419 DCGLA 423 (579)
Q Consensus 419 Dfg~~ 423 (579)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-17 Score=159.18 Aligned_cols=136 Identities=17% Similarity=0.243 Sum_probs=113.0
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCch------hHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSE------MCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+.||+|++|.||+|.+ .|..+++|+......... ....+..|+..+..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677889998764432211 124577899999999999998888887778889999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
++|++|.+++... .. .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988521 11 7788999999999999976 999999999999999 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=163.35 Aligned_cols=144 Identities=17% Similarity=0.147 Sum_probs=110.4
Q ss_pred CccccceeccCCceEEEEEE--eCCCcEEEEEEeCCCCCCc----------------------hhHHHHHHHHHHHhhcC
Q 008055 272 SFNVENLLGEGTFGRVYRAQ--FADGKVLAVKKIDSSALPS----------------------EMCDDFIEMVSNISQLH 327 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 327 (579)
-|.+.+.||+|+||.||+|. ..+|+.||+|++....... .....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 5689999999987543110 01123567999999987
Q ss_pred CCC--ccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcCCCC
Q 008055 328 HPN--IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS-VVHKNIKS 404 (579)
Q Consensus 328 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~Dlkp 404 (579)
+.. +.+++++ ...++||||+++++|..+.. ....+.......++.|++.+|++||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 532 3334432 23589999999988876542 123455566788999999999999976 8 99999999
Q ss_pred CCEEEcCCCceEEecccccccCC
Q 008055 405 ANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 405 ~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=155.76 Aligned_cols=141 Identities=16% Similarity=0.129 Sum_probs=108.9
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc--------------------hhHHHHHHHHHHHhhcCCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS--------------------EMCDDFIEMVSNISQLHHP 329 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~ 329 (579)
...|.+.+.||+|+||.||++..++|+.||||++....... ........|+..+..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 33477889999999999999988889999999875432100 0112356788888888777
Q ss_pred C--ccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 008055 330 N--IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANI 407 (579)
Q Consensus 330 n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Ni 407 (579)
+ +...++ ....++||||+++++|..+... .....++.+++.++.++|+. +|+||||||+||
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni 156 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI 156 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence 4 444443 2456899999999998765420 23467889999999999975 999999999999
Q ss_pred EEcCCCceEEecccccccCC
Q 008055 408 LLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 408 ll~~~~~~kl~Dfg~~~~~~ 427 (579)
++++++.++|+|||++....
T Consensus 157 ll~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcCCCcEEEEECCccccCC
Confidence 99999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-18 Score=184.13 Aligned_cols=205 Identities=22% Similarity=0.333 Sum_probs=140.1
Q ss_pred CCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.+|+.++.|..|+||.||.++++. .+.+|+|+=+...+-+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRn----------ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRN----------ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccchhhhc----------cccccCCccee-----------------
Confidence 468889999999999999998864 56788843322221100 22333344443
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+-...++ ...+++.. ++.+++|||. .+|+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 136 ----gDc~tllk----~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLK----NIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcc----cCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 44444443 22233332 2678999995 49999999999999999999999999997532111
Q ss_pred C----------------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccc
Q 008055 430 D----------------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATP 492 (579)
Q Consensus 430 ~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~ 492 (579)
. .....++|+.|.|||++....|...+|+|++|+|+||.+.|..||.+..+++. ..++...
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 0 01123578899999999999999999999999999999999999987644321 1111000
Q ss_pred cccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC
Q 008055 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 537 (579)
....+-....+.+.++++.+.|+.+|..|--
T Consensus 275 --------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 275 --------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred --------------ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 0001112234467899999999999999953
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=175.31 Aligned_cols=171 Identities=21% Similarity=0.350 Sum_probs=127.7
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
...|+.|++|...+|.+||... ......++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999633 334556788889999999999999 3 89999999999999999999999999
Q ss_pred ccccCCCCC-------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 422 LASNMPNAD-------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 422 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+........ ......+|..||+||.+.+..|+.|+||||||++|+|++. =..+|.... ....+.+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--t~~d~r~----- 474 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--TLTDIRD----- 474 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH--hhhhhhc-----
Confidence 987665544 3445567889999999999999999999999999999997 233332110 0000000
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
..+++.....+| .=..|+.+++++.|.+||++.
T Consensus 475 --------g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 475 --------GIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --------CCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 011111112222 224799999999999999433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=152.58 Aligned_cols=132 Identities=18% Similarity=0.263 Sum_probs=106.4
Q ss_pred eeccCCceEEEEEEeCCCcEEEEEEeCCCCCCch------hHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEec
Q 008055 278 LLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSE------MCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFR 351 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 351 (579)
.||+|+||.||+|.+ ++..+++|.......... ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 577899998654332111 1355678999999999887766666666677789999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|++|.+++... . ..++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----N-------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987521 0 07899999999999976 999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-17 Score=175.96 Aligned_cols=139 Identities=14% Similarity=0.229 Sum_probs=111.4
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc-----hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS-----EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
..|...+.||+|+||.||++.+.+...++.+++.+..... .....+.+|++++..++|++++....++.+....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3456678999999999999987654433333332221111 12356789999999999999998888887777889
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999874 3567899999999999976 99999999999999 577999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=143.99 Aligned_cols=139 Identities=20% Similarity=0.247 Sum_probs=97.2
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHH----------------------HHHHHHHhhcCCCC--c
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDF----------------------IEMVSNISQLHHPN--I 331 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--i 331 (579)
.+.||+|+||.||+|...+++.||||++............+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999986543221111111 24555555554332 3
Q ss_pred cceeeEEeeCCeEEEEEEecCCCChhh-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 008055 332 MELVGYCSEYGQHLLVYEFRKNGSLHD-FLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD 410 (579)
Q Consensus 332 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~ 410 (579)
.+.+++ ...++||||++++++.. .+... ... ..+..++.+++.++.++|. +.+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 334432 24689999999854421 11100 001 5678899999999999997 14999999999999999
Q ss_pred CCCceEEecccccccCC
Q 008055 411 NELNPQLSDCGLASNMP 427 (579)
Q Consensus 411 ~~~~~kl~Dfg~~~~~~ 427 (579)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.3e-15 Score=133.51 Aligned_cols=135 Identities=22% Similarity=0.205 Sum_probs=112.5
Q ss_pred ccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC--CCccceeeEEeeCCeEEEEEEecC
Q 008055 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH--PNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++++....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35679999999999998754 7889999865432 4578888999988876 588999998888889999999998
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
++.+..+ +......++.+++++|.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777543 4456677899999999999975335799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.2e-17 Score=173.84 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=187.3
Q ss_pred CccccceeccCCceEEEEEEeCC--CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFAD--GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 348 (579)
.|.+.+.||+|+|+.|-...... ...+|+|.+...............|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46667779999999998886533 445666666554433344455555777666675 999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEcCCCCCCEEEcCCC-ceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH-EVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~ 426 (579)
+|..+|++++.+. .......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..++.|||+|..+
T Consensus 101 ~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Ccccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998873 122224556667788999999999999 65 999999999999999999 9999999999876
Q ss_pred CC-CCc---ccccCC-CCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 427 PN-ADE---ALNNDA-GSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 427 ~~-~~~---~~~~~~-~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
.. .+. .....+ +..|+|||...+.. .....|+||.|+++.-+++|..||+...... .....|......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~----- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKGR----- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccccc-----
Confidence 55 222 223456 78999999998854 4678899999999999999999997654332 222222221000
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..............+++.+++..+|+.|.+.+++..
T Consensus 250 -------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000111222345678899999999999999988864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.9e-15 Score=140.83 Aligned_cols=136 Identities=17% Similarity=0.163 Sum_probs=104.0
Q ss_pred ceec-cCCceEEEEEEeCCCcEEEEEEeCCCCC-----------CchhHHHHHHHHHHHhhcCCCCc--cceeeEEeeC-
Q 008055 277 NLLG-EGTFGRVYRAQFADGKVLAVKKIDSSAL-----------PSEMCDDFIEMVSNISQLHHPNI--MELVGYCSEY- 341 (579)
Q Consensus 277 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~- 341 (579)
..|| .|+.|+||++... +..+++|++..... .......+.+|+.++..++|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5688 8999999999775 67789998854221 11223567889999999998875 6677765432
Q ss_pred C---eEEEEEEecCC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 008055 342 G---QHLLVYEFRKN-GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQL 417 (579)
Q Consensus 342 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 417 (579)
+ ..++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 699988752 234433 357899999999976 9999999999999999889999
Q ss_pred eccccccc
Q 008055 418 SDCGLASN 425 (579)
Q Consensus 418 ~Dfg~~~~ 425 (579)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.9e-15 Score=141.92 Aligned_cols=201 Identities=23% Similarity=0.399 Sum_probs=145.9
Q ss_pred HHHHHHhhcCCCCccceeeEEeeC-----CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 008055 318 EMVSNISQLHHPNIMELVGYCSEY-----GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392 (579)
Q Consensus 318 ~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 392 (579)
.-+..+-.+.|-|||+++.|+.+. .+..++.|||..|+|..+|+..+.....+......+++.||..||.|||..
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 345556667899999999998654 457899999999999999998888888888888899999999999999986
Q ss_pred CCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-----cccccCCCCCccCccccccCCCCccchHHhHHHHHHH
Q 008055 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-----EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLE 467 (579)
Q Consensus 393 ~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~e 467 (579)
.+.|+|+++..+-|++..+|-+||.---......... ......+-++|.|||+-.....+.++|||+||....|
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 8899999999999999999988875422211111100 1112234568999998877778889999999999999
Q ss_pred HHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh---cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 468 LLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM---VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 468 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
|..|..--..+.... .....+... +...+ =..++.+|++..|..||+|++++
T Consensus 275 mailEiq~tnseS~~------------~~ee~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 275 MAILEIQSTNSESKV------------EVEENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHheeccCCCccee------------ehhhhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 998764322111110 000111111 01111 12568899999999999999987
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.1e-15 Score=159.91 Aligned_cols=104 Identities=32% Similarity=0.501 Sum_probs=92.6
Q ss_pred CcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEccc
Q 008055 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIAN 81 (579)
Q Consensus 4 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~ 81 (579)
++.|+|++|.|+|.+|..|+.|++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|. +..++ |+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 67899999999999999999999999999999999999999999999999999999999998875 77776 99999999
Q ss_pred CcCCCCCccccccC-----eeeccCCCCCCC
Q 008055 82 NRFTGWVPEQLKNI-----NLQKDGNSWSSG 107 (579)
Q Consensus 82 N~l~~~~p~~l~~~-----~~~~~~n~~~~~ 107 (579)
|.|+|.+|..+..+ .+.+.+|...|+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccC
Confidence 99999999887653 345566664443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.4e-13 Score=141.14 Aligned_cols=143 Identities=22% Similarity=0.273 Sum_probs=98.8
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc----------------------------hh----------HHHHH
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS----------------------------EM----------CDDFI 317 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~~----------~~~~~ 317 (579)
.+.||.|++|.||+|++++|+.||||+.+...... .. .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986532100 00 01234
Q ss_pred HHHHHHhhc----CCCCccceeeEE-eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 008055 318 EMVSNISQL----HHPNIMELVGYC-SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR-ALEYLHE 391 (579)
Q Consensus 318 ~e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 391 (579)
.|...+.++ +|.+-+.+-..+ ......++||||++|++|.++..... ... .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 455555544 233333333333 23456799999999999988764211 112 23456666555 4677886
Q ss_pred cCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 392 ~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 5 99999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-12 Score=137.21 Aligned_cols=146 Identities=18% Similarity=0.256 Sum_probs=93.2
Q ss_pred CCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCC----------------------------c----hhHHH--
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALP----------------------------S----EMCDD-- 315 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~~~-- 315 (579)
..|+. +.||.|++|.||+|++++ |+.||||+....... . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999987 999999999754210 0 11111
Q ss_pred ----HHHHHHHHhhcC----CCCccceeeEEee-CCeEEEEEEecCCCChhhhhcccCC--CCCCCCHHHHHHHHHHHHH
Q 008055 316 ----FIEMVSNISQLH----HPNIMELVGYCSE-YGQHLLVYEFRKNGSLHDFLHLSDE--DNKPLIWNSRVKIALGTAR 384 (579)
Q Consensus 316 ----~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~ 384 (579)
+..|...+.+++ +.+.+.+-..+.+ ....++||||++|+.+.++-..... ....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 233444444332 3333333333332 4567899999999999875321111 11123222233333333
Q ss_pred HHHHHHhcCCCCeEEcCCCCCCEEEcCCC----ceEEecccccccCC
Q 008055 385 ALEYLHEVCSLSVVHKNIKSANILLDNEL----NPQLSDCGLASNMP 427 (579)
Q Consensus 385 ~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~~~~~~ 427 (579)
+. .|++|+|++|.||+++.++ .++++|||+...+.
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 22 3999999999999999888 99999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-13 Score=140.38 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=175.7
Q ss_pred Cccccceecc--CCceEEEEEEe---CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEE
Q 008055 272 SFNVENLLGE--GTFGRVYRAQF---ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 345 (579)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+...........=.+|+.....+ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999965 4688899998554433223233334555555555 5999999888999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR----ALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDC 420 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Df 420 (579)
+-+|++ +.+|.++.+.. ...++....+.+..+..+ ||.++|.. +++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 999999 47888877622 223556667777777777 99999954 99999999999999999 78899999
Q ss_pred cccccCCCCCcccc------cCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPNADEALN------NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|+...+........ ..+..-|++||.. .+-++...|+|++|.++.+-.++..+....... .|
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W----- 335 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW----- 335 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc-----
Confidence 99887766542221 1455679999987 456788999999999999999987766432110 01
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
..+.... +...+......++...+..|++.+|-.|++.+.+.
T Consensus 336 ---~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 ---SQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---ccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111111 11112222234566699999999999999977665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.1e-12 Score=148.25 Aligned_cols=107 Identities=37% Similarity=0.532 Sum_probs=92.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|+.|+|++|++.+.+|+.|+.+++|+.|+|++|.++|.+|..|.++++|+.|+|++|+++|.+|. +..+. |+.|+
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 46899999999999999999999999999999999999999999999999999999999999998875 67775 99999
Q ss_pred cccCcCCCCCcccc--ccC-eeeccCCCCCCC
Q 008055 79 IANNRFTGWVPEQL--KNI-NLQKDGNSWSSG 107 (579)
Q Consensus 79 l~~N~l~~~~p~~l--~~~-~~~~~~n~~~~~ 107 (579)
+++|+++|.+|..- ..+ ...+.+|...|+
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCG 609 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence 99999999999642 222 234566764444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4e-11 Score=124.97 Aligned_cols=167 Identities=22% Similarity=0.273 Sum_probs=125.3
Q ss_pred EeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCC
Q 008055 291 QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL 370 (579)
Q Consensus 291 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l 370 (579)
+..++.+|.|...+.... .......+-++.++.++||||++++..++..+..|+|+|.+. -|..++.. +
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------h
Confidence 445788888888765542 345566778889999999999999999999999999999985 45555542 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc-cCCCCCccCcccccc
Q 008055 371 IWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN-NDAGSGYGAPEVAMS 449 (579)
Q Consensus 371 ~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~y~aPE~~~~ 449 (579)
........+.||+.||.+||+.| +++|++|.-..|+++..|..||++|.++........... ..--..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 24556667899999999999754 899999999999999999999999998754433221111 111124666765432
Q ss_pred CCCCccchHHhHHHHHHHHHhCC
Q 008055 450 GQYNIKSDVYSFGVVMLELLTGR 472 (579)
Q Consensus 450 ~~~~~~~DvwslGv~l~elltg~ 472 (579)
.. -..|.|-|||+++|++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 22 3469999999999999983
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-11 Score=113.00 Aligned_cols=130 Identities=22% Similarity=0.163 Sum_probs=93.5
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCcc-ceeeEEeeCCeEEEEEEecCCC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM-ELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.+.|+.|.++.||++... +..+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356899999999999875 77899998754431 123456778888877655554 444433 33458999999998
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC--SLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++.... . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 775420 0 11345678999999999761 12359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.4e-11 Score=109.47 Aligned_cols=139 Identities=15% Similarity=0.134 Sum_probs=97.1
Q ss_pred cceeccCCceEEEEEEeCC-------CcEEEEEEeCCCCC-----------C---------chhHHHHH----HHHHHHh
Q 008055 276 ENLLGEGTFGRVYRAQFAD-------GKVLAVKKIDSSAL-----------P---------SEMCDDFI----EMVSNIS 324 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~ 324 (579)
...||.|--+.||.|...+ +..+|||+.+.... + ......+. .|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 47999998743210 0 11122233 7888888
Q ss_pred hcCC--CCccceeeEEeeCCeEEEEEEecCCCChhh-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEc
Q 008055 325 QLHH--PNIMELVGYCSEYGQHLLVYEFRKNGSLHD-FLHLSDEDNKPLIWNSRVKIALGTARALEYL-HEVCSLSVVHK 400 (579)
Q Consensus 325 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~ 400 (579)
++.. -++...+++ ...++||||+.++.+.. .++ ...++......+..+++.+|.+| |+. +|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8743 355555654 56789999997654422 221 12244456677889999999999 755 99999
Q ss_pred CCCCCCEEEcCCCceEEecccccccCC
Q 008055 401 NIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 401 Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||++.|||+++ +.+.|+|||.+-...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-12 Score=132.22 Aligned_cols=250 Identities=18% Similarity=0.150 Sum_probs=174.1
Q ss_pred HHhCCccccceeccCCceEEEEEEe--CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQF--ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
.-..+|..+..||.|.|+.|++... .++..|++|.+............-..|+.+...+ -|.++++.+..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788999999999999999854 4688999999876554322222223455555544 688899988888877888
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEeccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLA 423 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~ 423 (579)
|+--|||+++++...+. ....+....++.+..|++.++.++|. +.++|+|+||+||++..+ +..+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccc
Confidence 89999999998876652 23345666788899999999999995 499999999999999886 77899999998
Q ss_pred ccCCCCCcccccCCCCCcc--CccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 424 SNMPNADEALNNDAGSGYG--APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
..+.- ... ......++. +++......+..+.|+||||..+.|.++|..--..... | ..+.
T Consensus 415 t~~~~-~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~--------~~i~ 476 (524)
T KOG0601|consen 415 TRLAF-SSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S--------LTIR 476 (524)
T ss_pred cccce-ecc-cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c--------eeee
Confidence 65211 111 111222344 45555566788999999999999999987643221110 0 0000
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
. ..-...+. ....++.+...+...++..||.+.++....+.
T Consensus 477 ~----~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 S----GDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred c----ccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 00000111 22577888999999999999999888765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-10 Score=108.49 Aligned_cols=142 Identities=22% Similarity=0.239 Sum_probs=109.3
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC--CCccceeeEEeeC---CeEEEEEEec
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH--PNIMELVGYCSEY---GQHLLVYEFR 351 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~ 351 (579)
+.|+.|.++.||++...+|+.+++|........ .....+..|...++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998877789999997654321 134567888888888865 3456777777654 3668999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC-------------------------------------- 393 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 393 (579)
+|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888775531 34677778888889999999998531
Q ss_pred ---------------CCCeEEcCCCCCCEEEcC--CCceEEecccccc
Q 008055 394 ---------------SLSVVHKNIKSANILLDN--ELNPQLSDCGLAS 424 (579)
Q Consensus 394 ---------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~ 424 (579)
...++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 5668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.1e-10 Score=99.97 Aligned_cols=133 Identities=20% Similarity=0.278 Sum_probs=99.4
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEE-eCCCCCCchh-----HHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKK-IDSSALPSEM-----CDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
..+++|+-+.+|.+.+.+.. +++|. +.+....++. ..+-.+|.+++.+++---|..-+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999776444 55554 4443332221 23456788888887655555555567778888999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
++|-.|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888522 245667777778889976 999999999999998775 99999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.9e-11 Score=132.60 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=161.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..|.+.+.+-+|.++.++.+.-. .|...++|...... +.....+....+-..+-..+||.++...--+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34556667788888888876432 23333444332211 11111222222222222335576666555555667889999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
+|..+++|...++... ..+.......+..+.++++|||.. .+.|+|++|.|+++..++..++.|||.......
T Consensus 884 ~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999987432 344445556677788899999953 689999999999999999999999984321100
Q ss_pred ---------------------C-----------CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCC
Q 008055 429 ---------------------A-----------DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 429 ---------------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~ 476 (579)
. .......+++.|.+||...+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00122345778999999999999999999999999999999999997
Q ss_pred CCCch-hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChH
Q 008055 477 SSRPR-LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 539 (579)
Q Consensus 477 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 539 (579)
..... ..+.+.....+ ....+.....+..+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~f~ni~~~~~~----------------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIP----------------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CcchhhhhhccccCCCC----------------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 64331 11111111100 1122334455677888888899999997766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-08 Score=101.18 Aligned_cols=262 Identities=16% Similarity=0.154 Sum_probs=161.8
Q ss_pred ccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHH-hhcCCCCccceeeEE------ee-CCeEEE
Q 008055 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVGYC------SE-YGQHLL 346 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~------~~-~~~~~l 346 (579)
....||+|+.+.+|..-.-.+ .+.|+......... .+ .+..| +.-.||-+-.-+.+= -+ .....+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~--aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ--AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecchhhc--hhheeecCCCchHH--HH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 356799999999997532112 24577765442211 11 12222 333566443312111 12 223668
Q ss_pred EEEecCCC-Chhhhhcc--cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 347 VYEFRKNG-SLHDFLHL--SDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 347 v~e~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.|..+++. -...++.- .+.......|...+.+++.+|.+.+.||+. |.+-+|+.++|+|+++++.+.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 88887764 22333321 112233568999999999999999999976 9999999999999999999999986543
Q ss_pred ccCCCCCcccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhC-CCCCCCCCchh------hhhhhhhcc
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTG-RKPFDSSRPRL------EQSLVRWAT 491 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg-~~p~~~~~~~~------~~~~~~~~~ 491 (579)
....++....-.++...|.+||.-. +...+...|.|.|||++++++.| ++||.+..... +..+...-.
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 3333333334455677899999764 33456789999999999999995 99997643211 111111100
Q ss_pred ccccChhHHhhhcCccccC----CCChhhHHHHHHHHHhcCCCC--CCCCCChHHHHHHHHHHHHHcc
Q 008055 492 PQLHDIDALAKMVDPALKG----LYPVKSLSRFADVIALCVQPE--PEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~L~~i~~~~~ 553 (579)
..... ..+.++. .--...+..+..+..+|+... +.-|||++.++..|.++-++..
T Consensus 245 ---~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 245 ---AYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ---eechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00000 0011111 111334567889999999654 5689999999998877766443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.9e-09 Score=94.07 Aligned_cols=145 Identities=19% Similarity=0.212 Sum_probs=104.5
Q ss_pred ccceeccCCceEEEEEEeCCCcEEEEEEe-CCCCCC-----chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 275 VENLLGEGTFGRVYRAQFADGKVLAVKKI-DSSALP-----SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
...+|-+|+-+.|+++.+. |+.+.||.- .+...- .-...+...|++.+.+++--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999885 666666653 332211 122355678899988876555555555677777888999
Q ss_pred EecCC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEEecccccc
Q 008055 349 EFRKN-GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---NPQLSDCGLAS 424 (579)
Q Consensus 349 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~ 424 (579)
||++| .++.+++...-. ..........++..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 488888763322 2222233367888899999999976 999999999999996554 45899999975
Q ss_pred c
Q 008055 425 N 425 (579)
Q Consensus 425 ~ 425 (579)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.7e-10 Score=123.85 Aligned_cols=89 Identities=30% Similarity=0.560 Sum_probs=80.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCC--CCCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANL--PLDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~--~L~~l 77 (579)
|++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|. +..+ .+..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 57899999999999999999999999999999999999999999999999999999999999999875 5443 47889
Q ss_pred EcccCcCCCCCc
Q 008055 78 NIANNRFTGWVP 89 (579)
Q Consensus 78 ~l~~N~l~~~~p 89 (579)
++++|...+..|
T Consensus 521 ~~~~N~~lc~~p 532 (623)
T PLN03150 521 NFTDNAGLCGIP 532 (623)
T ss_pred EecCCccccCCC
Confidence 999998765444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.9e-10 Score=85.38 Aligned_cols=61 Identities=41% Similarity=0.591 Sum_probs=54.7
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 62 (579)
++|++|+|++|+|+...++.|.++++|+.|+|++|+|+...|..|.++++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999966668899999999999999999977778899999999999999976
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=9.6e-09 Score=104.12 Aligned_cols=170 Identities=19% Similarity=0.260 Sum_probs=126.2
Q ss_pred CceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe----eCCeEEEEEEecCC-CCh
Q 008055 283 TFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS----EYGQHLLVYEFRKN-GSL 356 (579)
Q Consensus 283 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL 356 (579)
-..+.|++.. .||..|++|+++...... .......+++++++.|+|+|++...+. .+..+++||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3467899954 589999999994433211 122345577889999999999998875 34578899999986 577
Q ss_pred hhhhcccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 357 HDFLHLSD-----------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 357 ~~~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
.++.-... ..+...++...|.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+.+|+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 76542211 1234567889999999999999999965 999999999999999999999999998765
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRK 473 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~ 473 (579)
...... |-+. --.+-|.=.||.+++.|.||..
T Consensus 443 l~~d~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT-------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC-------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 543320 0111 1235799999999999999864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.1e-11 Score=103.71 Aligned_cols=82 Identities=28% Similarity=0.428 Sum_probs=49.8
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEccc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIAN 81 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~~ 81 (579)
+++.|.||+|.++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.|+.|+.|+++-|+|.-.+..|+.++ |+.|||++
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhccc
Confidence 4455566666666 45555666666666666666666 566666666666666666666665555555555 66666666
Q ss_pred CcCCC
Q 008055 82 NRFTG 86 (579)
Q Consensus 82 N~l~~ 86 (579)
|+++.
T Consensus 112 nnl~e 116 (264)
T KOG0617|consen 112 NNLNE 116 (264)
T ss_pred ccccc
Confidence 66643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-10 Score=101.01 Aligned_cols=92 Identities=28% Similarity=0.513 Sum_probs=75.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc-c-ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI-D-VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~-~~~~~~-L~~l 77 (579)
|.+|+.|++++|+|. .+|..++.|++|+.|+++-|+|. .+|..|+.++.|+.|||.+|+|+... | .|..+. |..|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 467888999999998 78888999999999999999988 88999999999999999999888643 3 355554 8888
Q ss_pred EcccCcCCCCCccccccC
Q 008055 78 NIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~ 95 (579)
+|++|.|. .+|...+.+
T Consensus 133 yl~dndfe-~lp~dvg~l 149 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKL 149 (264)
T ss_pred HhcCCCcc-cCChhhhhh
Confidence 99999987 666655555
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.3e-08 Score=96.32 Aligned_cols=143 Identities=17% Similarity=0.106 Sum_probs=98.0
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc---------hhHHHHHHHHHHHhhcCCC--CccceeeEEee-----
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS---------EMCDDFIEMVSNISQLHHP--NIMELVGYCSE----- 340 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~----- 340 (579)
+.+-.-....|++..+ +|+.|.||......... .-...+.+|...+.++..- ....++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777765 57789999774333110 0011366777777766322 23345555543
Q ss_pred CCeEEEEEEecCCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-------C
Q 008055 341 YGQHLLVYEFRKNG-SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-------E 412 (579)
Q Consensus 341 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-------~ 412 (579)
....++|||++++. +|.+++.... ..+.....+..++.+++..+.-||+. ||+|+||++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999876 8998875221 23345567788999999999999976 9999999999999975 4
Q ss_pred CceEEeccccccc
Q 008055 413 LNPQLSDCGLASN 425 (579)
Q Consensus 413 ~~~kl~Dfg~~~~ 425 (579)
+.+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6889999998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.6e-10 Score=116.96 Aligned_cols=148 Identities=20% Similarity=0.262 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc----------cCCCCCccCcccccc
Q 008055 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN----------NDAGSGYGAPEVAMS 449 (579)
Q Consensus 380 ~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~----------~~~~~~y~aPE~~~~ 449 (579)
.+++.||.|+|. +.++||++|.|++|.++..+..||+.|+++........... ......|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999997 56999999999999999999999999998755443211110 112336999999999
Q ss_pred CCCCccchHHhHHHHHHHHH-hCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcC
Q 008055 450 GQYNIKSDVYSFGVVMLELL-TGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCV 528 (579)
Q Consensus 450 ~~~~~~~DvwslGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 528 (579)
...+.++|+||+||++|-+. .|+..+......... ......+..-...+....+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHh
Confidence 88899999999999999999 466666543221111 111111111122344667788999999999
Q ss_pred CCCCCCCCChHHHHH
Q 008055 529 QPEPEFRPPMSEVVQ 543 (579)
Q Consensus 529 ~~dP~~Rps~~evl~ 543 (579)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-08 Score=93.87 Aligned_cols=128 Identities=20% Similarity=0.241 Sum_probs=81.4
Q ss_pred EEEEEEeCCCcEEEEEEeCCCCCC------------------------chhHHHHHHHHHHHhhcCCC--CccceeeEEe
Q 008055 286 RVYRAQFADGKVLAVKKIDSSALP------------------------SEMCDDFIEMVSNISQLHHP--NIMELVGYCS 339 (579)
Q Consensus 286 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 339 (579)
.||.|...+|..+|+|+....... ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999987432110 01113346799999988765 455555442
Q ss_pred eCCeEEEEEEecC--CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCCEEEcCCCceE
Q 008055 340 EYGQHLLVYEFRK--NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL-HEVCSLSVVHKNIKSANILLDNELNPQ 416 (579)
Q Consensus 340 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~Dlkp~Nill~~~~~~k 416 (579)
..++||||++ |..+..+... .+.......++.+++..+..+ |.. ||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4579999998 5555444321 111233466777777766664 544 99999999999999988 999
Q ss_pred EecccccccCC
Q 008055 417 LSDCGLASNMP 427 (579)
Q Consensus 417 l~Dfg~~~~~~ 427 (579)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.4e-07 Score=89.02 Aligned_cols=137 Identities=17% Similarity=0.123 Sum_probs=93.7
Q ss_pred ccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC--------------------chhHHHHHHHHHHHhhcCCC--C
Q 008055 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP--------------------SEMCDDFIEMVSNISQLHHP--N 330 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h~--n 330 (579)
..+.+.||.|--+.||.|...+|.++|||.=...... ........+|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567889999999999999999999999953211100 01123346788888887544 5
Q ss_pred ccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc
Q 008055 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD 410 (579)
Q Consensus 331 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~ 410 (579)
+.+.++ .+...+||||++|--|...- +.......|+..|++-+..+-.. ||||+|+++-||+++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 555554 35678999999986655421 11222333444444444444443 999999999999999
Q ss_pred CCCceEEeccccccc
Q 008055 411 NELNPQLSDCGLASN 425 (579)
Q Consensus 411 ~~~~~kl~Dfg~~~~ 425 (579)
++|.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999986643
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.6e-09 Score=92.76 Aligned_cols=99 Identities=34% Similarity=0.520 Sum_probs=34.2
Q ss_pred CCcEEeccCCcCCCCchhhhC-CCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccccc-CCCC-CCeEEc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFG-QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVL-ANLP-LDNLNI 79 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~-L~~l~l 79 (579)
+++.|+|++|+|+ .|. .++ .+.+|+.|||++|.|+ .++ .+..|++|+.|+|++|+|+...+.+ ..++ |+.|+|
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 5789999999998 453 466 5889999999999999 455 5888999999999999999865544 2344 999999
Q ss_pred ccCcCCCCCc-ccc---ccC-eeeccCCCCC
Q 008055 80 ANNRFTGWVP-EQL---KNI-NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p-~~l---~~~-~~~~~~n~~~ 105 (579)
++|+|...-- ..+ ..+ .+...+|+.+
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 9999975321 122 222 4455667655
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=1e-08 Score=76.04 Aligned_cols=59 Identities=42% Similarity=0.638 Sum_probs=52.7
Q ss_pred CCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcccCcC
Q 008055 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIANNRF 84 (579)
Q Consensus 26 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~N~l 84 (579)
|+|+.|+|++|+|+...+..|.++++|+.|+|++|+|+...+. +..++ |+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999966667899999999999999999988764 77776 99999999985
|
... |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.8e-09 Score=110.22 Aligned_cols=89 Identities=26% Similarity=0.338 Sum_probs=50.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|+.|+.|+||+|.|..+-++.+.-.++|++|+|++|+|+...+.+|..|..|+.|+|++|+|+..-+. |..++ |+.||
T Consensus 292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld 371 (873)
T KOG4194|consen 292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD 371 (873)
T ss_pred cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence 34555566666666555555555556666666666666654455555555555555555555544432 44443 66666
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|.|++.|.
T Consensus 372 Lr~N~ls~~IE 382 (873)
T KOG4194|consen 372 LRSNELSWCIE 382 (873)
T ss_pred CcCCeEEEEEe
Confidence 66666665544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.3e-09 Score=109.00 Aligned_cols=103 Identities=25% Similarity=0.385 Sum_probs=70.5
Q ss_pred CCCCcEEeccCCcCCC-CchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l 77 (579)
|+.|+++++..|+|.. -||+.+-.|..|+.||||+|+|. ..|..+-.-.++-.|+||+|+|..+|.. +-++. |-.|
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFL 155 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhh
Confidence 4566677777777632 36677777888888888888887 7777777777788888888888776643 45554 7788
Q ss_pred EcccCcCCCCCccccccC----eeeccCCCCC
Q 008055 78 NIANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|||+|+|. .+|..+.++ .+...+|++.
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 88888887 455444444 3444555544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.6e-07 Score=85.39 Aligned_cols=106 Identities=22% Similarity=0.209 Sum_probs=79.7
Q ss_pred HHHHHHHHHHhhcCC--CCccceeeEEeeC----CeEEEEEEecCCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 008055 314 DDFIEMVSNISQLHH--PNIMELVGYCSEY----GQHLLVYEFRKNG-SLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386 (579)
Q Consensus 314 ~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L 386 (579)
....+|...+.++.. =.+...+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 355667776666532 2345566665542 2458999999884 8999886321 155566788999999999
Q ss_pred HHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEEecccccccC
Q 008055 387 EYLHEVCSLSVVHKNIKSANILLDNEL---NPQLSDCGLASNM 426 (579)
Q Consensus 387 ~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~ 426 (579)
.-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999977 999999999999999887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.6e-08 Score=89.97 Aligned_cols=83 Identities=35% Similarity=0.570 Sum_probs=39.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccc-cCCCCCCeeEeecccccCcc--cccCCCC-CCe
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSF-SSLSSLSSLYLQNNQFSGTI--DVLANLP-LDN 76 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~~~~--~~~~~~~-L~~ 76 (579)
|.+|+.|+|++|+|+ .++ .+..|++|+.|+|++|.|+ .+...+ ..+++|+.|+|++|+|...- ..+..++ |+.
T Consensus 41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 467899999999998 454 4888999999999999999 565555 46899999999999998754 3355565 999
Q ss_pred EEcccCcCCC
Q 008055 77 LNIANNRFTG 86 (579)
Q Consensus 77 l~l~~N~l~~ 86 (579)
|+|.+|+++.
T Consensus 118 L~L~~NPv~~ 127 (175)
T PF14580_consen 118 LSLEGNPVCE 127 (175)
T ss_dssp EE-TT-GGGG
T ss_pred eeccCCcccc
Confidence 9999999974
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.3e-09 Score=106.16 Aligned_cols=104 Identities=33% Similarity=0.561 Sum_probs=87.5
Q ss_pred CcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccCc
Q 008055 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNR 83 (579)
Q Consensus 4 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~ 83 (579)
|+.|.+++|+++ .+|+.++.++.|..||.+.|.+. .+|+.++.|.+|+.|++..|++...++.+..++|..||+|+|+
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNk 222 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNK 222 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCc
Confidence 677788888887 78888888888888888888888 7888999999999999999999999988889999999999999
Q ss_pred CCCCCccccccC----eeeccCCCCCCCCCC
Q 008055 84 FTGWVPEQLKNI----NLQKDGNSWSSGPAP 110 (579)
Q Consensus 84 l~~~~p~~l~~~----~~~~~~n~~~~~~~~ 110 (579)
++ .+|-+|..+ .+....|++.+.|..
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 98 899888877 455666777665544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.8e-06 Score=79.77 Aligned_cols=140 Identities=19% Similarity=0.137 Sum_probs=100.1
Q ss_pred eccCCceEEEEEEeCCCcEEEEEEeCCCCC---C-chhHHHHHHHHHHHhhcCC--CCccceeeEEe-e----CCeEEEE
Q 008055 279 LGEGTFGRVYRAQFADGKVLAVKKIDSSAL---P-SEMCDDFIEMVSNISQLHH--PNIMELVGYCS-E----YGQHLLV 347 (579)
Q Consensus 279 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~-~----~~~~~lv 347 (579)
-|+||-+.|++..+. |+.+-+|+-..... - ......|.+|+..+.++.. -.+.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477999999998775 44688887642111 0 2245678888888887743 2244444 332 1 1245799
Q ss_pred EEecCC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--eEEecccccc
Q 008055 348 YEFRKN-GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN--PQLSDCGLAS 424 (579)
Q Consensus 348 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~~~ 424 (579)
+|-++| -+|.+++... .-.+.+...+..++.++++.+.-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998754 5888887522 223557777889999999999999976 9999999999999986667 9999998664
Q ss_pred c
Q 008055 425 N 425 (579)
Q Consensus 425 ~ 425 (579)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.1e-09 Score=105.20 Aligned_cols=94 Identities=29% Similarity=0.460 Sum_probs=81.3
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc----ccCCCC-CC
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID----VLANLP-LD 75 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~-L~ 75 (579)
..+|++|+||+|+|+..-++.|..|.+|+.|+|++|.++..-...|..+++|+.|||++|.|++.++ .+..++ |+
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 3689999999999998889999999999999999999997777789999999999999999999983 255565 99
Q ss_pred eEEcccCcCCCCCc-cccccC
Q 008055 76 NLNIANNRFTGWVP-EQLKNI 95 (579)
Q Consensus 76 ~l~l~~N~l~~~~p-~~l~~~ 95 (579)
.|+|.+|+|. .|| ..|.++
T Consensus 396 kL~l~gNqlk-~I~krAfsgl 415 (873)
T KOG4194|consen 396 KLRLTGNQLK-SIPKRAFSGL 415 (873)
T ss_pred heeecCceee-ecchhhhccC
Confidence 9999999998 555 455554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.3e-09 Score=102.96 Aligned_cols=92 Identities=34% Similarity=0.415 Sum_probs=57.5
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCC---------------------CCCcccc-CCCCCCeeEeec
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG---------------------NLPQSFS-SLSSLSSLYLQN 59 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g---------------------~~p~~~~-~l~~L~~L~l~~ 59 (579)
+.|+.||...|-+. .+|+.++++.+|..|+|.+|+|.- .+|++++ +|++|..|||..
T Consensus 183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRd 261 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRD 261 (565)
T ss_pred HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccc
Confidence 34566666666665 566666666666666666666651 3444444 566666677777
Q ss_pred ccccCcccccCCCC-CCeEEcccCcCCCCCccccccC
Q 008055 60 NQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 60 N~l~~~~~~~~~~~-L~~l~l~~N~l~~~~p~~l~~~ 95 (579)
|+|+..|+.+..+. |.+||+|+|.|+ .+|..++++
T Consensus 262 Nklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 262 NKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred cccccCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 77776666665554 777777777776 455556655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.2e-07 Score=94.72 Aligned_cols=144 Identities=18% Similarity=0.248 Sum_probs=90.2
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC----------------------------chhHH----------HHHH
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP----------------------------SEMCD----------DFIE 318 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~----------~~~~ 318 (579)
+.|+.++-|.||+|++++|+.||||+....... ....+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999998532210 00111 1223
Q ss_pred HHHHHhhc----C-CCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 008055 319 MVSNISQL----H-HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393 (579)
Q Consensus 319 e~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 393 (579)
|...+.++ + .+++.--.=|++-.+...|+|||++|-.+.+..... ...++.........++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhc-
Confidence 44444333 1 233222222233356788999999998888774321 12333222222222211 1222222
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 394 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|+.|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.2e-08 Score=97.05 Aligned_cols=101 Identities=35% Similarity=0.590 Sum_probs=53.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|..|+|++|-+. .+|.+++.+..|+.||||+|.|. .+|..+-.+..|+.+-.++|++....+. +..+. |.+|||
T Consensus 435 ~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 435 QKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred hcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence 34444555555444 44555555555555555555544 3444333333333333334444444443 55554 778888
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
.+|.+. .+|+.++++ .+...||++.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCccC
Confidence 888877 677777666 3445566554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.8e-08 Score=102.29 Aligned_cols=84 Identities=29% Similarity=0.451 Sum_probs=75.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCC-ccccCCCCCCeeEeecccccCcccccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP-QSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~ 78 (579)
|..|+.||||.|+|. ..|..+-.-.++-.|+||+|+|. +|| +-|-+|+.|-.||||+|+|...||.+..+. |++|.
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLK 179 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhh
Confidence 467899999999999 78999999999999999999999 566 557789999999999999999999988886 99999
Q ss_pred cccCcCCC
Q 008055 79 IANNRFTG 86 (579)
Q Consensus 79 l~~N~l~~ 86 (579)
|++|+|..
T Consensus 180 Ls~NPL~h 187 (1255)
T KOG0444|consen 180 LSNNPLNH 187 (1255)
T ss_pred cCCChhhH
Confidence 99998754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.9e-06 Score=78.70 Aligned_cols=154 Identities=19% Similarity=0.228 Sum_probs=96.7
Q ss_pred CHHHHHHHhCCccccc---eeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhH-----------------HH-----H
Q 008055 262 SIADLQMATGSFNVEN---LLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMC-----------------DD-----F 316 (579)
Q Consensus 262 ~~~~~~~~~~~~~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-----------------~~-----~ 316 (579)
+...+.....+..+.+ .|..|--+.||+|...++..+|||+++......... .. .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3344444444444444 455777889999988889999999986433211110 00 1
Q ss_pred HHHHHHHhhcC--CCCccceeeEEeeCCeEEEEEEecCCCC-hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 008055 317 IEMVSNISQLH--HPNIMELVGYCSEYGQHLLVYEFRKNGS-LHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393 (579)
Q Consensus 317 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 393 (579)
..|+..|.++. +-.+.+-+++. ...|||||+.... -.-.| ...++.......+..++++.+.-|-..
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~- 185 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE- 185 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh-
Confidence 24566665552 22333334332 3579999995431 11111 112233335667778888888888763
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 394 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
.++||+||+.-|||+. ++.+.|+|||.+....
T Consensus 186 -a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 -AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 3999999999999999 7899999999886543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.1e-06 Score=79.34 Aligned_cols=139 Identities=15% Similarity=0.165 Sum_probs=82.9
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC--ccceeeEEeeCCeEEEEEEecCCC
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN--IMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
..||+|..+.||+. .+..+++|...... ......+|.+.++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999984 25567788876433 2344577888887775333 456777777777888999999886
Q ss_pred C-hhhhh---------------------cccCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhc-CCCCeEEc
Q 008055 355 S-LHDFL---------------------HLSDEDNKPLIWNSRVKIAL----------GTAR-ALEYLHEV-CSLSVVHK 400 (579)
Q Consensus 355 s-L~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------~ia~-~L~~LH~~-~~~~iiH~ 400 (579)
+ +...+ |.-......+... ...+.. .+.. ...+|... ....++|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 3 21111 1110011111100 000000 0001 12222211 13357899
Q ss_pred CCCCCCEEEcCCCceEEecccccc
Q 008055 401 NIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 401 Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4e-07 Score=89.34 Aligned_cols=86 Identities=28% Similarity=0.345 Sum_probs=59.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|+.|+|++|.|+++-+..|.++..|+.|.|..|+|.-.--..|.+|..|+.|+|.+|+|+..-|. |..+. |..|+
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 56677777777777777777777777777777777777655555667777777777777777766554 44443 77777
Q ss_pred cccCcCCC
Q 008055 79 IANNRFTG 86 (579)
Q Consensus 79 l~~N~l~~ 86 (579)
|-.|+|..
T Consensus 353 l~~Np~~C 360 (498)
T KOG4237|consen 353 LLSNPFNC 360 (498)
T ss_pred hccCcccC
Confidence 77777654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-07 Score=98.01 Aligned_cols=183 Identities=15% Similarity=0.106 Sum_probs=133.0
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC-ccceeeEEeeCCeEEEEEEecCCC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN-IMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.+-.++|+++++||.+-...+....+.+... ....-++++|.+++||| .+..++-++.+...+++|+++.++
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 3457899999999986443333334443221 34456788999999999 666666666677888999999877
Q ss_pred -ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 355 -SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 355 -sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
+...... .....+...+...+...-+++++|||.. .=+|+| ||+..+ +..+..||+....+.......
T Consensus 320 rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 320 RSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred ccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccccc
Confidence 2222111 1222344455566777788899999953 348898 777665 578999999988776655555
Q ss_pred ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCC
Q 008055 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 434 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~ 476 (579)
...+++.|+|||+.....+....|+|++|+-..+|.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 6677889999999999999999999999998888888877754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-05 Score=75.10 Aligned_cols=140 Identities=14% Similarity=0.187 Sum_probs=90.4
Q ss_pred HHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC-chhHHHH------HHHHHHHhhcCC---CCccceeeE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP-SEMCDDF------IEMVSNISQLHH---PNIMELVGY 337 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~------~~e~~~l~~l~h---~niv~l~~~ 337 (579)
+..++|.+.+++-......|.+... +|+.+++|........ ......| .+++..+.+++. -....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888888888887766 4688889987654321 1111111 233333333322 222232222
Q ss_pred Ee-----eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 338 CS-----EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 338 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
.. -....+++|||++|..|.++.. +.. .++..+++++.-||+. |++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 21 2235568999999988876542 221 2445677789999976 99999999999999965
Q ss_pred CceEEecccccc
Q 008055 413 LNPQLSDCGLAS 424 (579)
Q Consensus 413 ~~~kl~Dfg~~~ 424 (579)
.++++||+.-+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.1e-07 Score=61.04 Aligned_cols=36 Identities=39% Similarity=0.606 Sum_probs=19.3
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCC
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS 39 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~ 39 (579)
+|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 34445555555555555555555
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=59.84 Aligned_cols=40 Identities=40% Similarity=0.578 Sum_probs=34.7
Q ss_pred CCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc
Q 008055 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI 66 (579)
Q Consensus 26 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 66 (579)
++|+.|+|++|+|+ .+|+.|.+|++|+.|+|++|+|+...
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCCc
Confidence 57999999999999 78888999999999999999999643
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.3e-07 Score=87.75 Aligned_cols=80 Identities=24% Similarity=0.366 Sum_probs=65.4
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCC-CCCeEEccc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANL-PLDNLNIAN 81 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~l~l~~ 81 (579)
-|+.||||.|.|+ .+-++..-+|+++.|+||+|.|. .+- ++..|++|+.||||+|.|+....+-..+ +++.|+|++
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhh
Confidence 4789999999998 78888888999999999999998 444 4899999999999999998765543334 367777777
Q ss_pred CcCC
Q 008055 82 NRFT 85 (579)
Q Consensus 82 N~l~ 85 (579)
|.|.
T Consensus 362 N~iE 365 (490)
T KOG1259|consen 362 NKIE 365 (490)
T ss_pred hhHh
Confidence 7764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.6e-07 Score=101.18 Aligned_cols=82 Identities=32% Similarity=0.451 Sum_probs=65.9
Q ss_pred CCCcEEeccCCcCCCCch-hhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCC-CCCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANL-PLDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~l~l 79 (579)
.+|+.|+|++|+|. .+| ..+.+|..|+.|+||+|+|+ .+|..+.++..|++|...+|+|...| .+..+ +|+.+||
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEec
Confidence 57889999999998 455 46778899999999999998 78888888888888888888888766 55455 4888888
Q ss_pred ccCcCCC
Q 008055 80 ANNRFTG 86 (579)
Q Consensus 80 ~~N~l~~ 86 (579)
|.|+|+.
T Consensus 460 S~N~L~~ 466 (1081)
T KOG0618|consen 460 SCNNLSE 466 (1081)
T ss_pred ccchhhh
Confidence 8888864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.9e-07 Score=98.14 Aligned_cols=97 Identities=28% Similarity=0.356 Sum_probs=62.8
Q ss_pred CCCcEEeccCCcCCCCchhhhCC-----------------CCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccC
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQ-----------------LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSG 64 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~-----------------l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~ 64 (579)
.+|++|+|++|+|++ +|....+ ..+|+.|+|++|+|+ .+|..+ ++|+.|+|++|+|++
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss 416 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS 416 (788)
T ss_pred cccceEecCCCccCC-CCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC
Confidence 356777777777763 3322221 236788888888888 466433 578888888888887
Q ss_pred cccccCCCCCCeEEcccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 65 TIDVLANLPLDNLNIANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 65 ~~~~~~~~~L~~l~l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
.+... ..|+.|+|++|+|+ .+|..+..+ .+...+|++.+
T Consensus 417 IP~l~--~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 417 LPMLP--SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred CCcch--hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 54321 13778888888887 677766554 34556666654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.4e-05 Score=74.03 Aligned_cols=144 Identities=19% Similarity=0.195 Sum_probs=82.6
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCC--CccceeeEEe---eCCeEEEEEEe
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP--NIMELVGYCS---EYGQHLLVYEF 350 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~---~~~~~~lv~e~ 350 (579)
++.|+.|..+.||+....+ ..+++|..... .....+..|...++.+... .+.+++.+.. .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 3578999999999999877 58899997543 2345666777777666432 3456665442 33457899999
Q ss_pred cCCCChhh----------------hh---cccCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHH
Q 008055 351 RKNGSLHD----------------FL---HLSDEDNKPLIWNS---------RVKI------------ALGTAR-ALEYL 389 (579)
Q Consensus 351 ~~~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~L~~L 389 (579)
++|..+.. .+ +............. .... ...+.. .++.+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99987766 11 11111111111110 0000 111222 33334
Q ss_pred Hhc----CCCCeEEcCCCCCCEEEc-CCCceEEecccccc
Q 008055 390 HEV----CSLSVVHKNIKSANILLD-NELNPQLSDCGLAS 424 (579)
Q Consensus 390 H~~----~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~ 424 (579)
++. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 321 245799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.5e-06 Score=94.24 Aligned_cols=100 Identities=28% Similarity=0.353 Sum_probs=63.6
Q ss_pred CCCcEEeccCCcCCCC--chhhhCC-------------C-CCCCEEeccCCcCCCCCCccccCC----------------
Q 008055 2 KTLKYLNIAHNQLQGQ--LNDMFGQ-------------L-PSLSTLDLSFNTLSGNLPQSFSSL---------------- 49 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~--~p~~~~~-------------l-~~L~~L~l~~N~l~g~~p~~~~~l---------------- 49 (579)
++|+.|+|++|+|++. +|..+.. + .+|+.|+|++|+|++ +|....+|
T Consensus 302 ~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l 380 (788)
T PRK15387 302 PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPAL 380 (788)
T ss_pred cccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccCC-CCCCCcccceehhhccccccCccc
Confidence 6788888888888852 2222211 1 489999999999994 55432221
Q ss_pred -CCCCeeEeecccccCcccccCCCCCCeEEcccCcCCCCCccccccC-eeeccCCCCC
Q 008055 50 -SSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWS 105 (579)
Q Consensus 50 -~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~l~~~-~~~~~~n~~~ 105 (579)
.+|+.|+|++|+|++.+... ..|+.|++++|.|++ +|..+..+ .+...+|.+.
T Consensus 381 ~~~L~~LdLs~N~Lt~LP~l~--s~L~~LdLS~N~Lss-IP~l~~~L~~L~Ls~NqLt 435 (788)
T PRK15387 381 PSGLKELIVSGNRLTSLPVLP--SELKELMVSGNRLTS-LPMLPSGLLSLSVYRNQLT 435 (788)
T ss_pred ccccceEEecCCcccCCCCcc--cCCCEEEccCCcCCC-CCcchhhhhhhhhccCccc
Confidence 25677777788777654322 238899999999985 67554444 2333445444
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=84.29 Aligned_cols=145 Identities=17% Similarity=0.222 Sum_probs=89.9
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc-----------------------------hhH------HHHHHHH
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS-----------------------------EMC------DDFIEMV 320 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------~~~------~~~~~e~ 320 (579)
.+.||.-+.|.||+|++++|+.||||+-+...... +.. -+|..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999875432110 000 1233344
Q ss_pred HHHhh----cCCCCccc---eeeEE-eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 008055 321 SNISQ----LHHPNIME---LVGYC-SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392 (579)
Q Consensus 321 ~~l~~----l~h~niv~---l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 392 (579)
+...+ +.|-+... +=.++ .-.....|+||||+|.-+.+.-.. ....++...+..-+.++..-+-+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~--- 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFK--- 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHh---
Confidence 43332 23444111 11222 234578999999999877665321 233455544444443332222222
Q ss_pred CCCCeEEcCCCCCCEEEcC----CCceEEecccccccCCC
Q 008055 393 CSLSVVHKNIKSANILLDN----ELNPQLSDCGLASNMPN 428 (579)
Q Consensus 393 ~~~~iiH~Dlkp~Nill~~----~~~~kl~Dfg~~~~~~~ 428 (579)
.|++|+|=.|.||+++. ++.+.+.|||+......
T Consensus 320 --~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 --TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 39999999999999984 67899999999765543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.3e-06 Score=92.13 Aligned_cols=76 Identities=20% Similarity=0.372 Sum_probs=38.6
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccC
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANN 82 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N 82 (579)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+..+..+. -.|+.|+|++|
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~LP~~l~-s~L~~L~Ls~N 272 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRITELPERLP-SALQSLDLFHN 272 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccCcCChhHh-CCCCEEECcCC
Confidence 4666777777776 4454433 35666666666666 4454432 245555555555543332221 12444444444
Q ss_pred cCC
Q 008055 83 RFT 85 (579)
Q Consensus 83 ~l~ 85 (579)
+|+
T Consensus 273 ~L~ 275 (754)
T PRK15370 273 KIS 275 (754)
T ss_pred ccC
Confidence 444
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.2e-05 Score=85.39 Aligned_cols=79 Identities=14% Similarity=0.288 Sum_probs=56.8
Q ss_pred cceeccCCceEEEEEEeCCC---cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCc--cceeeEEeeC---CeEEE
Q 008055 276 ENLLGEGTFGRVYRAQFADG---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNI--MELVGYCSEY---GQHLL 346 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~l 346 (579)
.+.++.|.+..+|+....++ ..+++|+....... .....+.+|+++++.+. |.++ .+++.+|.+. +..++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 46789999999999877654 46777876543321 12346778999998885 6654 7778887664 56789
Q ss_pred EEEecCCCC
Q 008055 347 VYEFRKNGS 355 (579)
Q Consensus 347 v~e~~~~gs 355 (579)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00011 Score=68.21 Aligned_cols=132 Identities=20% Similarity=0.281 Sum_probs=92.2
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCC--------------CCchhHHHHHHHHHHHhhcC------CCCcccee
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSA--------------LPSEMCDDFIEMVSNISQLH------HPNIMELV 335 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~l~ 335 (579)
...||+|+.-.||. +.+....+||++.... ......++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999996 5566777899887655 11122455666666665555 88999999
Q ss_pred eEEeeCCeEEEEEEecCC--C----ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 008055 336 GYCSEYGQHLLVYEFRKN--G----SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL 409 (579)
Q Consensus 336 ~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill 409 (579)
|+.+.+....+|+|.+.+ | +|.+++. ...++. ...+. +-+-.+||-++ .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999999999998754 2 6777774 223443 33333 33445666654 89999999999999
Q ss_pred cCCC----ceEEec-cc
Q 008055 410 DNEL----NPQLSD-CG 421 (579)
Q Consensus 410 ~~~~----~~kl~D-fg 421 (579)
.... .+.|+| ||
T Consensus 152 ~~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLG 168 (199)
T ss_pred EecCCCceEEEEEeCCC
Confidence 6432 467777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.4e-07 Score=89.86 Aligned_cols=93 Identities=27% Similarity=0.351 Sum_probs=81.0
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeec-ccccCccc-ccCCCC-CCeEEc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN-NQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~~-~~~~~~-L~~l~l 79 (579)
....|+|..|+|+.+.|++|+.+++|+.||||+|+|+-+-|..|.+|.+|..|-|-+ |+|+..+. .|..+. |+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 457899999999988889999999999999999999999999999999997776655 99999884 588886 999999
Q ss_pred ccCcCCCCCccccccC
Q 008055 80 ANNRFTGWVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~ 95 (579)
.-|++.....+.|..+
T Consensus 148 Nan~i~Cir~~al~dL 163 (498)
T KOG4237|consen 148 NANHINCIRQDALRDL 163 (498)
T ss_pred ChhhhcchhHHHHHHh
Confidence 9999997777766665
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.4e-05 Score=72.93 Aligned_cols=141 Identities=19% Similarity=0.162 Sum_probs=81.9
Q ss_pred eeccCCc-eEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEEecCCCC
Q 008055 278 LLGEGTF-GRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYEFRKNGS 355 (579)
Q Consensus 278 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 355 (579)
.|-.|.+ ..||+.... +..+.+|+..... ......|++++..+. +--+.+++++....+..++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 789999764 4678888875432 224456777766652 3335567777776677899999999877
Q ss_pred hhhhh-------------------cccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhc--
Q 008055 356 LHDFL-------------------HLSDEDNKPLIWN--SRVKIAL--------------------GTARALEYLHEV-- 392 (579)
Q Consensus 356 L~~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~ia~~L~~LH~~-- 392 (579)
|.... |.......++... ....... .+...+..|-..
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 65431 1111101111100 0000000 011112222111
Q ss_pred --CCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 393 --CSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 393 --~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13458999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.2e-05 Score=89.20 Aligned_cols=78 Identities=27% Similarity=0.381 Sum_probs=49.5
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEccc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIAN 81 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~ 81 (579)
.+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+..++.+. ..|+.|+|++
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~-~sL~~L~Ls~ 292 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENLP-EELRYLSVYD 292 (754)
T ss_pred cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCccccccC-CCCcEEECCC
Confidence 35677777777776 4555443 36777777777776 5666554 467777777777775543332 2477777777
Q ss_pred CcCCC
Q 008055 82 NRFTG 86 (579)
Q Consensus 82 N~l~~ 86 (579)
|+|++
T Consensus 293 N~Lt~ 297 (754)
T PRK15370 293 NSIRT 297 (754)
T ss_pred Ccccc
Confidence 77764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.4e-05 Score=71.19 Aligned_cols=104 Identities=20% Similarity=0.160 Sum_probs=80.4
Q ss_pred HHHHHHHhhcCC-CCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 008055 317 IEMVSNISQLHH-PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395 (579)
Q Consensus 317 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 395 (579)
..|..+++.+.+ +++.+++|+|- .+++.||...+++..... .-..-...+|..+.+||.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357778888866 69999999995 378999998776643200 001122468999999999999999999975444
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 396 SVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 396 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
.+.-.|++++|+-+++++++|++|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 577799999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.1e-07 Score=94.94 Aligned_cols=103 Identities=31% Similarity=0.464 Sum_probs=70.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCc-cccCCCCCCeeEeecccccCcccccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~ 78 (579)
|+.|+.|||+.|+++..- .+..|++|++|||+.|.|. .+|. ....+. |+.|+|+||.++.... +.++. |..||
T Consensus 186 l~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL~g-ie~LksL~~LD 260 (1096)
T KOG1859|consen 186 LPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTLRG-IENLKSLYGLD 260 (1096)
T ss_pred HHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhhhh-HHhhhhhhccc
Confidence 356889999999998433 7888999999999999998 5663 334444 8888888888876443 33443 88888
Q ss_pred cccCcCCCCCc----cccccC-eeeccCCCCCCCC
Q 008055 79 IANNRFTGWVP----EQLKNI-NLQKDGNSWSSGP 108 (579)
Q Consensus 79 l~~N~l~~~~p----~~l~~~-~~~~~~n~~~~~~ 108 (579)
|++|-|++.-- ..|..+ .+-..||++||.|
T Consensus 261 lsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 261 LSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 88888875321 111111 2344677777754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2e-06 Score=81.52 Aligned_cols=81 Identities=27% Similarity=0.385 Sum_probs=63.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCC-CCCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANL-PLDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~l~l 79 (579)
++.++.|+||+|+|. .+ +.+..|++|+.||||+|.|+ .+...-..|-+++.|.|+.|.|...- .+..+ +|..||+
T Consensus 306 ~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~LS-GL~KLYSLvnLDl 381 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETLS-GLRKLYSLVNLDL 381 (490)
T ss_pred ccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhhh-hhHhhhhheeccc
Confidence 467899999999998 34 34889999999999999998 56666666778888999998876532 22333 4888899
Q ss_pred ccCcCC
Q 008055 80 ANNRFT 85 (579)
Q Consensus 80 ~~N~l~ 85 (579)
++|+|.
T Consensus 382 ~~N~Ie 387 (490)
T KOG1259|consen 382 SSNQIE 387 (490)
T ss_pred cccchh
Confidence 988885
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1e-06 Score=74.00 Aligned_cols=80 Identities=28% Similarity=0.474 Sum_probs=50.7
Q ss_pred CcEEeccCCcCCCCchhhhCC-CCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCC-CCCeEEccc
Q 008055 4 LKYLNIAHNQLQGQLNDMFGQ-LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANL-PLDNLNIAN 81 (579)
Q Consensus 4 L~~L~l~~n~l~~~~p~~~~~-l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~l~l~~ 81 (579)
|+.++|++|.|. ..|+.|.. ++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|...+..+..+ +|..|+..+
T Consensus 55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~~ 132 (177)
T KOG4579|consen 55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSPE 132 (177)
T ss_pred EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCCC
Confidence 445677777776 45555544 346677777777776 56666777777777777777777666554444 366666666
Q ss_pred CcCC
Q 008055 82 NRFT 85 (579)
Q Consensus 82 N~l~ 85 (579)
|.+.
T Consensus 133 na~~ 136 (177)
T KOG4579|consen 133 NARA 136 (177)
T ss_pred Cccc
Confidence 6654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.8e-07 Score=91.25 Aligned_cols=86 Identities=30% Similarity=0.483 Sum_probs=56.3
Q ss_pred cEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccCcC
Q 008055 5 KYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRF 84 (579)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l 84 (579)
...||+.|++. .+|..+..+-.|+.|.|.+|.|. .||..+.+|..|+.|||+.|+++-.++.++.++|+.|-+++|++
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNNkl 155 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNNKL 155 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecCcc
Confidence 34566777776 66666666666666666666666 66666666666667777767666666666666666666666666
Q ss_pred CCCCccccc
Q 008055 85 TGWVPEQLK 93 (579)
Q Consensus 85 ~~~~p~~l~ 93 (579)
+ .+|+.++
T Consensus 156 ~-~lp~~ig 163 (722)
T KOG0532|consen 156 T-SLPEEIG 163 (722)
T ss_pred c-cCCcccc
Confidence 5 4444443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.7e-06 Score=93.61 Aligned_cols=90 Identities=28% Similarity=0.420 Sum_probs=79.7
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEccc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIAN 81 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~~ 81 (579)
.|+.|+|++|+++ ..|-.+..+.+|+.|+++.|.|. ..|.+.+++.+|++|+|.+|++...|..+..++ |+.|++|+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhcCchhHHhhhcccccccch
Confidence 4889999999998 78888999999999999999999 789999999999999999999999988888875 99999999
Q ss_pred CcCCCCCccccccC
Q 008055 82 NRFTGWVPEQLKNI 95 (579)
Q Consensus 82 N~l~~~~p~~l~~~ 95 (579)
|.|. .+|..+..+
T Consensus 124 N~f~-~~Pl~i~~l 136 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVL 136 (1081)
T ss_pred hccC-CCchhHHhh
Confidence 9997 677655443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0004 Score=63.92 Aligned_cols=127 Identities=20% Similarity=0.353 Sum_probs=87.7
Q ss_pred CCccccceeccCCc-eEEEEEEeCCCcEEEEEEeCC---CC-------CCc---------hhHHHHHHHHHHHhhcC---
Q 008055 271 GSFNVENLLGEGTF-GRVYRAQFADGKVLAVKKIDS---SA-------LPS---------EMCDDFIEMVSNISQLH--- 327 (579)
Q Consensus 271 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~-------~~~---------~~~~~~~~e~~~l~~l~--- 327 (579)
.+++..+.||.|.- |.||+++.. |+.||+|.+.. .. ... .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56778899999999 999999885 77999999421 00 000 22345788888887774
Q ss_pred CCCc--cceeeEEeeC------------------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 008055 328 HPNI--MELVGYCSEY------------------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387 (579)
Q Consensus 328 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 387 (579)
+..+ |+.+||..-. ....+|.||++... .+... -+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHH
Confidence 4455 8889987322 12357777775422 22222 3445566678
Q ss_pred HHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 388 ~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89976 9999999999986 3489999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00031 Score=67.68 Aligned_cols=73 Identities=12% Similarity=0.140 Sum_probs=43.7
Q ss_pred ceeccCCce-EEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCC---CccceeeEEeeC---CeEEEEEE
Q 008055 277 NLLGEGTFG-RVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP---NIMELVGYCSEY---GQHLLVYE 349 (579)
Q Consensus 277 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e 349 (579)
+.|+.|+.. .||+. +..+++|...... ....+..|.+.+..+... .+.++++..... +..+++|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 457777776 58975 2356777654321 234677888888776421 233344433322 24588999
Q ss_pred ecCCCChh
Q 008055 350 FRKNGSLH 357 (579)
Q Consensus 350 ~~~~gsL~ 357 (579)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00092 Score=66.75 Aligned_cols=76 Identities=13% Similarity=0.079 Sum_probs=54.5
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC---CCccceeeEEee---CCeEEEEEE
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH---PNIMELVGYCSE---YGQHLLVYE 349 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e 349 (579)
.+.||.|..+.||+....+++ +.+|..+. .. ....+..|...++.+.- -.+.++++++.. .+..++|||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 467999999999998766664 56666432 11 13567788888877742 357778887754 467899999
Q ss_pred ecCCCCh
Q 008055 350 FRKNGSL 356 (579)
Q Consensus 350 ~~~~gsL 356 (579)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00034 Score=62.25 Aligned_cols=128 Identities=17% Similarity=0.220 Sum_probs=83.9
Q ss_pred cccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccc-eeeEEeeCCeEEEEEEecC
Q 008055 274 NVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME-LVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~ 352 (579)
.+.+.|++|++|.||++.+..+ .+|+|+-.... ....+..|.+++..+.-.++.+ ++.|- ...+.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 3457799999999999998744 77888765433 2466778888888776666554 33332 2345599999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC--CCEEEcCCCceEEeccccccc
Q 008055 353 NGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKS--ANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 353 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp--~Nill~~~~~~kl~Dfg~~~~ 425 (579)
|-.|.++-... ..++ +..+++. +|.-+ ..||-|+.|.- .||++.+. .+.|+||.-|+.
T Consensus 96 G~~L~~~~~~~-------~rk~----l~~vlE~-a~~LD--~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG-------DRKH----LLRVLEK-AYKLD--RLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc-------cHHH----HHHHHHH-HHHHH--HhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 87887654310 1222 2334444 33333 24899999874 45655554 899999998873
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 579 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-118
Identities = 109/294 (37%), Positives = 166/294 (56%), Gaps = 8/294 (2%)
Query: 257 NVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP-SEMCDD 315
+ +S+ +LQ+A+ +F+ +N+LG G FG+VY+ + ADG ++AVK++ E+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL--Q 73
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR 375
F V IS H N++ L G+C + LLVY + NGS+ L E PL W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN 435
+IALG+AR L YLH+ C ++H+++K+ANILLD E + D GLA M D +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 436 D-AGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS--LVRWAT 491
G+ G+ APE +G+ + K+DV+ +GV++LEL+TG++ FD +R + L+ W
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
L L +VD L+G Y + + + V LC Q P RP MSEVV+ L
Sbjct: 254 G-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-112
Identities = 97/294 (32%), Positives = 155/294 (52%), Gaps = 9/294 (3%)
Query: 255 PTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCD 314
P + DL+ AT +F+ + L+G G FG+VY+ DG +A+K+ + +
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--E 80
Query: 315 DFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNS 374
+F + +S HP+++ L+G+C E + +L+Y++ +NG+L L+ SD + W
Sbjct: 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA-- 432
R++I +G AR L YLH ++H+++KS NILLD P+++D G++ D+
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 433 LNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491
G+ GY PE + G+ KSDVYSFGVV+ E+L R S PR +L WA
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
H+ L ++VDP L +SL +F D C+ E RP M +V+ L
Sbjct: 258 E-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-111
Identities = 94/307 (30%), Positives = 148/307 (48%), Gaps = 20/307 (6%)
Query: 254 APTNVTSYSIADLQMATGSFNVE------NLLGEGTFGRVYRAQFADGKVLAVKKIDSSA 307
+ T S+S +L+ T +F+ N +GEG FG VY+ + +AVKK+ +
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66
Query: 308 LPSEM--CDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE 365
+ F + + +++ H N++EL+G+ S+ LVY + NGSL D L +
Sbjct: 67 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-CLD 125
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425
PL W+ R KIA G A + +LHE +H++IKSANILLD ++SD GLA
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 426 MPNADEALNND--AGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
+ + G+ Y APE A+ G+ KSD+YSFGVV+LE++TG D R
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE-- 239
Query: 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542
Q L+ + + +D + S+ V + C+ + RP + +V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 543 QALVRLV 549
Q L +
Sbjct: 299 QLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 9e-74
Identities = 74/317 (23%), Positives = 120/317 (37%), Gaps = 33/317 (10%)
Query: 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVS 321
+L + + + G FG V++AQ + +AVK S V
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ---NEYEVY 70
Query: 322 NISQLHHPNIMELVGYCSE----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK 377
++ + H NI++ +G L+ F + GSL DFL + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 378 IALGTARALEYLHE-------VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430
IA AR L YLHE ++ H++IKS N+LL N L ++D GLA
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 431 EALNNDAGSG---YGAPEVAMSG-----QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
A + G Y APEV ++ D+Y+ G+V+ EL + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 483 EQSL--VRWATPQLHDIDALA--KMVDPALKGLY-PVKSLSRFADVIALCVQPEPEFRPP 537
P L D+ + K P L+ + ++ + I C + E R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 538 MSEVVQALVRLVQRANM 554
V + + ++ + N+
Sbjct: 306 AGCVGERITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-62
Identities = 75/280 (26%), Positives = 134/280 (47%), Gaps = 26/280 (9%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
++ +G G+FG V+RA++ G +AVK + +E ++F+ V+ + +L HPNI+
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+G ++ +V E+ GSL+ LH + L R+ +A A+ + YLH +
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RN 157
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYN 453
+VH+N+KS N+L+D + ++ D GL+ + + + AG+ + APEV N
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 454 IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYP 513
KSDVYSFGV++ EL T ++P+ +++ + K
Sbjct: 218 EKSDVYSFGVILWELATLQQPWG-------------------NLNPAQVVAAVGFKCKRL 258
Query: 514 V---KSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ A +I C EP RP + ++ L L++
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 82/312 (26%), Positives = 146/312 (46%), Gaps = 36/312 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
VE ++G G FG V +A++ K +A+K+I+S FI + +S+++HPNI+
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+L G C LV E+ + GSL++ LH E + L ++ + YLH +
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 393 CSLSVVHKNIKSANILLDNELN-PQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSG 450
+++H+++K N+LL ++ D G A ++ + N+ GS + APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVFEGS 178
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA-LK 509
Y+ K DV+S+G+++ E++T RKPFD +I A + A
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD-------------------EIGGPAFRIMWAVHN 219
Query: 510 GLYPV--KSL-SRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQGPT 566
G P K+L ++ C +P RP M E+V+ + L++ + + +
Sbjct: 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
Query: 567 TPRGDNQDTQDY 578
P G++ + Y
Sbjct: 280 LPPGEDGRVEPY 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-58
Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 41/285 (14%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKI--DSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+E ++G G FG+VYRA + G +AVK D S+ ++ + + L HPNI+
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L G C + LV EF + G L+ L K + + V A+ AR + YLH+
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 393 CSLSVVHKNIKSANILLDNELNPQ--------LSDCGLASNMPNADEALNNDAGS-GYGA 443
+ ++H+++KS+NIL+ ++ ++D GLA + AG+ + A
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYAWMA 182
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
PEV + ++ SDV+S+GV++ ELLTG PF ID LA
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-------------------GIDGLAVA 223
Query: 504 VDPALKGLYPVKSLS---RFADVIALCVQPEPEFRPPMSEVVQAL 545
A+ L + FA ++ C P+P RP + ++ L
Sbjct: 224 YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-56
Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
+ L+G+G FG+VY ++ G+V A++ ID + F V Q H N++
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+G C ++ K +L+ + + L N +IA + + YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---A 148
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLAS-----NMPNADEALNNDAGS-GYGAPEV-- 446
++HK++KS N+ DN ++D GL S ++ L G + APE+
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 447 -------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
++ SDV++ G + EL PF + +A
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----------------EA 250
Query: 500 LAKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQALVRL 548
+ + +K + + +D++ C E E RP ++++ L +L
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-56
Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 274 NVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
N L E G +++ ++ G + VK + + DF E + HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 334 LVGYCSE-YGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++G C H L+ + GSL++ LH + N + + VK AL AR + +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSG 450
+ + S ++++D ++ ++S + + + + + APE
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKK 183
Query: 451 QYNI---KSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
+ +D++SF V++ EL+T PF D+ + + A
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFA-------------------DLSNMEIGMKVA 224
Query: 508 LKGLYPV--KSLS-RFADVIALCVQPEPEFRPPMSEVVQAL 545
L+GL P +S + ++ +C+ +P RP +V L
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 27/282 (9%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
V +G G+FG VY+ ++ G V AVK ++ +A + F V + + H NI+
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
+GY + Q +V ++ + SL+ LH + IA TAR ++YLH +
Sbjct: 86 MGYSTA-PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 395 LSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEVAM--- 448
S++H+++KS NI L + ++ D GLA+ + + SG + APEV
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508
S Y+ +SDVY+FG+V+ EL+TG+ P+ + +Q I+ + +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQI-----------IEMVGRGSLSPD 246
Query: 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
R ++A C++ + + RP ++ + L +
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-55
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKI-----DSSALPSEMCDDFIEMVSNISQL 326
E +G+G FG V++ + D V+A+K + + E +F V +S L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
+HPNI++L G +V EF G L+ L + P+ W+ ++++ L A +
Sbjct: 81 NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGI 135
Query: 387 EYLHEVCSLSVVHKNIKSANILLDN-----ELNPQLSDCGLASNMPNADEALNNDAGS-G 440
EY+ + +VH++++S NI L + + +++D GL+ ++ ++ G+
Sbjct: 136 EYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQ 191
Query: 441 YGAPEV--AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498
+ APE A Y K+D YSF +++ +LTG PFD +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-----------------YSYG 234
Query: 499 ALAKMVDPALKGLYPV---KSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ + +GL P R +VI LC +P+ RP S +V+ L
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-54
Identities = 64/339 (18%), Positives = 117/339 (34%), Gaps = 48/339 (14%)
Query: 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIE--M 319
+ ++ + + + L+G G +G VY+ D + +AVK +FI
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV-----FSFANRQNFINEKN 57
Query: 320 VSNISQLHHPNIMELVGYCSEYG-----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNS 374
+ + + H NI + ++LLV E+ NGSL +L W S
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 375 RVKIALGTARALEYLHE------VCSLSVVHKNIKSANILLDNELNPQLSDCGLA----- 423
++A R L YLH ++ H+++ S N+L+ N+ +SD GL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 424 ---SNMPNADEALNNDAGS-GYGAPEVAMS-------GQYNIKSDVYSFGVVMLELLTGR 472
D A ++ G+ Y APEV + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 473 KPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVD-----PALKGLYPVKS--LSRFADVI 524
E Q + + + +V P + S + + I
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 525 ALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGNDQ 563
C + E R + + L+ +K
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 39/287 (13%)
Query: 275 VENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+LG+G FG+ + G+V+ +K++ E F++ V + L HPN+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC 393
+G + + + E+ K G+L + + W+ RV A A + YLH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG----------- 442
S++++H+++ S N L+ N ++D GLA M +
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 443 ----APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498
APE+ Y+ K DV+SFG+V+ E++ PR + ++
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVR 237
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
P P F + C +PE RP ++ L
Sbjct: 238 GFLDRYCP--PNCPP-----SFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 72/310 (23%), Positives = 129/310 (41%), Gaps = 45/310 (14%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIE-MVSNISQLHHPNIME 333
++ +G+G FG V+R ++ +V AVK S E F E + L H NI+
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEV-AVKIFSSR----EERSWFREAEIYQTVMLRHENILG 100
Query: 334 LVGYCSEYG----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ ++ Q LV ++ ++GSL D+L+ + +K+AL TA L +L
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHL 155
Query: 390 HE-----VCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADEALNNDAGS- 439
H ++ H+++KS NIL+ ++D GLA S D A N+ G+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 440 GYGAPEV------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATP 492
Y APEV + ++D+Y+ G+V E+ +L + + P
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 493 QLHDIDALAKMVDPALKGLYPV--------KSLSRFADVIALCVQPEPEFRPPMSEVVQA 544
+ ++ K+V + L P ++L A ++ C R + +
Sbjct: 276 SVEEM---RKVV--CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 545 LVRLVQRANM 554
L +L Q+ +
Sbjct: 331 LSQLSQQEGI 340
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-51
Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 35/304 (11%)
Query: 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIE-MVSNISQLHHPNIMEL 334
+G+G +G V+ ++ KV AVK ++ E F E + + H NI+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEKV-AVKVFFTT----EEASWFRETEIYQTVLMRHENILGF 96
Query: 335 VGYC----SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ + Q L+ ++ +NGSL+D+L + L S +K+A + L +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 391 E-----VCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADEALNNDAGS-G 440
++ H+++KS NIL+ ++D GLA S+ D N G+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 441 YGAPEV------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQ 493
Y PEV Q I +D+YSFG+++ E+ +L + + P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 494 LHDIDALA--KMVDPALKGLYPVKS-LSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
D+ + K + P+ + L + ++ C P R V + L ++ +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 551 RANM 554
++
Sbjct: 332 SQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-50
Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 47/304 (15%)
Query: 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIE-MVSNISQLHHPNIMEL 334
+G+G +G V+R + V AVK S + F E + N L H NI+
Sbjct: 13 LECVGKGRYGEVWRGSWQGENV-AVKIFSSR----DEKSWFRETELYNTVMLRHENILGF 67
Query: 335 VGYC----SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ Q L+ + + GSL+D+L L S ++I L A L +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 391 E-----VCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADEALNNDAGS-G 440
++ H+++KS NIL+ ++D GLA + D N G+
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 441 YGAPEV------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVRWATP 492
Y APEV + D+++FG+V+ E+ +V P
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV----P 238
Query: 493 QLHDIDALAKMVDPALKGLYPV--------KSLSRFADVIALCVQPEPEFRPPMSEVVQA 544
+ + K+V + P +L+ A ++ C P R + +
Sbjct: 239 NDPSFEDMRKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 545 LVRL 548
L ++
Sbjct: 297 LTKI 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 52/275 (18%), Positives = 105/275 (38%), Gaps = 40/275 (14%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
+G G+F VY+ +A ++ L F E + L HPNI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 337 YC---SEYGQHLLVY-EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+ + +++ E +G+L +L + K + + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 393 CSLSVVHKNIKSANILLDNEL-NPQLSDCGLASNMPNADEALNNDAGSGYG-----APEV 446
+ ++H+++K NI + + ++ D GLA+ + A + G APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFMAPEM 201
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+Y+ DVY+FG+ MLE+ T P+ + + + + V
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSEYPY----------------SECQNAAQIYRRVTS 244
Query: 507 ALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSE 540
+K K ++I C++ + R + +
Sbjct: 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 37/284 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ V +G G++GR + + +DGK+L K++D ++ + V+ + +L HPNI
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 332 MELVG-YCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTARA 385
+ L +V E+ + G L + ++ + L + ++ L A
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL----A 123
Query: 386 LEYLHE--VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYG 442
L+ H +V+H+++K AN+ LD + N +L D GLA + + G+ Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
+PE YN KSD++S G ++ EL PF + LA
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----------------SQKELAG 226
Query: 503 MVDPALKGLYPV--KSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ +G + S ++I + + RP + E+++
Sbjct: 227 KI---REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHHPN 330
F +E +G G F VYRA DG +A+KK+ L + + QL+HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTARAL 386
+++ E + +V E G L + + + + +W V++ AL
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----AL 149
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPE 445
E++H S V+H++IK AN+ + +L D GL + A ++ G+ Y +PE
Sbjct: 150 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
YN KSD++S G ++ E+ + PF ++ +L K +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG---------------DKMNLYSLCKKI- 250
Query: 506 PALKGLY---PVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ Y P S ++ +C+ P+PE RP ++ V
Sbjct: 251 --EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 74/345 (21%), Positives = 124/345 (35%), Gaps = 54/345 (15%)
Query: 207 QSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADL 266
SS +D T + + P R SF + S ++ P+ S+
Sbjct: 6 HHSSGVDLGTENLYFQSMHQLQP--RRVSFR----GEASETLQSPGYDPSRPESFFQQS- 58
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ 325
F + LG G++G V++ + DG++ AVK+ S + + V + +
Sbjct: 59 ------FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 326 L-HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIAL 380
+ HP + L E G L E SL L +W
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE---AWGASLPEAQVWG----YLR 164
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
T AL +LH S +VH ++K ANI L +L D GL + A G
Sbjct: 165 DTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG-EVQEGDP 220
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
Y APE+ + G Y +DV+S G+ +LE+ + H +
Sbjct: 221 RYMAPEL-LQGSYGTAADVFSLGLTILEVACNMELP-------------------HGGEG 260
Query: 500 LAKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
++ L + LS V+ + ++P+P+ R ++
Sbjct: 261 WQQLRQGYLPPEFT-AGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 37/289 (12%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+ +G G FG V+ + L AVK + P ++ F++ + Q HPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPN 173
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L+G C++ +V E + G FL + L + +++ A +EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-----GAPE 445
S +H+++ + N L+ + ++SD G++ D G APE
Sbjct: 231 ---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA--DGVYAASGGLRQVPVKWTAPE 285
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
G+Y+ +SDV+SFG+++ E + G P+ P L ++ ++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPY----PNLSNQQT------REFVEKGGRLP 335
Query: 505 DPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
P L ++ ++ C EP RP S + Q L + +R
Sbjct: 336 CPELCPDAVF---------RLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 63/280 (22%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +GEG+FG+ + DG+ +K+I+ S + S+ ++ V+ ++ + HPNI
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTARALE 387
++ E G +V ++ + G L ++ + I + V+I L AL+
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFK--RINAQKGVLFQEDQILDWFVQICL----ALK 139
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
++H ++H++IKS NI L + QL D G+A + + E G+ Y +PE+
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+ YN KSD+++ G V+ EL T + F++ + L +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----------------SMKNLVLKI-- 237
Query: 507 ALKGLYPV--KSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ G +P S +++ + P RP ++ +++
Sbjct: 238 -ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 57/300 (19%), Positives = 110/300 (36%), Gaps = 62/300 (20%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPN 330
F+ +G G FG V++ DG + A+K+ S + + V + L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 331 IMELVGY--CSEYGQHLLVY-EFRKNGSLHDFLHLSDEDNKPL----IWNSRVKIALGTA 383
+ V Y H+L+ E+ GSL D + + + + + L
Sbjct: 73 V---VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----LLLQVG 125
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG--- 440
R L Y+H S+S+VH +IK +NI + P + + +++ + G
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 441 -------------YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL 486
+ A EV + K+D+++ + ++
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---------- 232
Query: 487 VRWATPQLHDIDALAKMVDPALKGLYPV--KSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
Q H+I +G P + LS+ F +++ + + P+PE RP +V+
Sbjct: 233 ---NGDQWHEI----------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 63/321 (19%), Positives = 117/321 (36%), Gaps = 54/321 (16%)
Query: 249 KKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSA 307
+ + + + + LGEG F V + DG A+K+I
Sbjct: 7 HHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE 66
Query: 308 LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH----LLVYEFRKNGSLHDFLHLS 363
+ ++ +HPNI+ LV YC L+ F K G+L + +
Sbjct: 67 Q--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL 124
Query: 364 DEDNKPL----IWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419
+ L I + LG R LE +H + H+++K NILL +E P L D
Sbjct: 125 KDKGNFLTEDQIL----WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD 177
Query: 420 CGLAS----NMPNADEALNNDAGSG------YGAPEVAMSGQY---NIKSDVYSFGVVML 466
G + ++ + +AL + Y APE+ + + ++DV+S G V+
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 467 ELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSR----FAD 522
++ G P+D + + S+ A++ + R
Sbjct: 238 AMMFGEGPYDMVFQKGD-SVAL------------------AVQNQLSIPQSPRHSSALWQ 278
Query: 523 VIALCVQPEPEFRPPMSEVVQ 543
++ + +P RP + ++
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLS 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 49/291 (16%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +G+G FG V + KV AVK I + A F+ S ++QL H N+
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNL 248
Query: 332 MELVGYCS-EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
++L+G E G +V E+ GSL D+L L + +K +L A+EYL
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------A 443
+ VH+++ + N+L+ + ++SD GL + + G A
Sbjct: 307 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWTA 354
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PE +++ KSDV+SFG+++ E+ + GR P+ PR+ V + ++ K
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLKDV------VPRVEKGYK 404
Query: 503 MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
M P +Y DV+ C + RP ++ + L +
Sbjct: 405 MDAPDGCPPAVY---------DVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 51/291 (17%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +G+G FG V + KV AVK I + A F+ S ++QL H N+
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNL 76
Query: 332 MELVGYCS-EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
++L+G E G +V E+ GSL D+L L + +K +L A+EYL
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------- 442
+ VH+++ + N+L+ + ++SD GL +
Sbjct: 135 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWT 181
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501
APE +++ KSDV+SFG+++ E+ + GR P+ PR+ V + ++
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLKDV------VPRVEKGY 231
Query: 502 KMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
KM P +Y +V+ C + RP ++ + L +
Sbjct: 232 KMDAPDGCPPAVY---------EVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 68/281 (24%), Positives = 128/281 (45%), Gaps = 37/281 (13%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVL---AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ LG G FG V + + KV+ AVK + + A + D+ + + + QL +P I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ ++G C +LV E + G L+ +L N+ + + +++ + ++YL E
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYL-E 134
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVA 447
+ VH+++ + N+LL + ++SD GL+ + + + APE
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+++ KSDV+SFGV+M E + G+KP+ ++ S V ++ +M P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY----RGMKGSEV------TAMLEKGERMGCP 242
Query: 507 AL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
A + +Y D++ LC + E RP + V L
Sbjct: 243 AGCPREMY---------DLMNLCWTYDVENRPGFAAVELRL 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 62/321 (19%), Positives = 116/321 (36%), Gaps = 68/321 (21%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F LG G FG V+ A+ D A+K+I + + V +++L HP I
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGI 65
Query: 332 MELVGY------------CSEYGQHLLVY---EFRKNGSLHDFLH---LSDEDNKPLIWN 373
V Y + +Y + + +L D+++ +E + + +
Sbjct: 66 ---VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
I L A A+E+LH S ++H+++K +NI + ++ D GL + M +E
Sbjct: 123 ----IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 434 NNDAGSG-------------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD--SS 478
Y +PE Y+ K D++S G+++ ELL PF
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232
Query: 479 RPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538
R R + P L + ++ + P P RP
Sbjct: 233 RVRTLTDVRNLKFPPL------------------FTQKYPCEYVMVQDMLSPSPMERPEA 274
Query: 539 SEVVQALVRLVQRANMSKRTI 559
+++ + + + +T+
Sbjct: 275 INIIE--NAVFEDLDFPGKTV 293
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 69/295 (23%), Positives = 139/295 (47%), Gaps = 41/295 (13%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+++ LG G +G VY + + AVK + + E +F++ + + ++ HPN
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPN 70
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+++L+G C+ ++ EF G+L D+L + + + + + +A + A+EYL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG------YGAP 444
+ +H+++ + N L+ +++D GL+ M D A +G + AP
Sbjct: 129 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT---YTAHAGAKFPIKWTAP 181
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
E +++IKSDV++FGV++ E+ T G P+ P ++ S V ++ +M
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQV------YELLEKDYRM 231
Query: 504 VDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSK 556
P + +Y +++ C Q P RP +E+ QA + Q +++S
Sbjct: 232 ERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 69/289 (23%), Positives = 126/289 (43%), Gaps = 43/289 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVK--KIDSSALPSEMCDDFIEMVSNISQLHHP 329
+G G FG V+ + + +A+K + + + +DFIE + +L HP
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-----EDFIEEAEVMMKLSHP 63
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALEY 388
+++L G C E LV EF ++G L D+L + L + + L + Y
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAY 119
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAP 444
L V+H+++ + N L+ ++SD G+ + D+ + G+ + +P
Sbjct: 120 L---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASP 174
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
EV +Y+ KSDV+SFGV+M E+ + G+ P+ S V + DI ++
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEV------VEDISTGFRL 224
Query: 504 VDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
P L +Y ++ C + PE RP S +++ L + +
Sbjct: 225 YKPRLASTHVY---------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 54/288 (18%), Positives = 114/288 (39%), Gaps = 42/288 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN-- 330
+++ +G G +V++ ++ A+K ++ ++ D + ++ +++L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L Y +V E N L+ +L K + R A+ +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN--ADEALNNDAGS-GYGAPEV- 446
+VH ++K AN L+ + +L D G+A+ M ++ G+ Y PE
Sbjct: 145 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 447 ----------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496
+ + KSDV+S G ++ + G+ PF +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------NQ 245
Query: 497 IDALAKMVDPALKGLYPVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
I L ++DP + +P + DV+ C++ +P+ R + E++
Sbjct: 246 ISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 61/272 (22%), Positives = 99/272 (36%), Gaps = 45/272 (16%)
Query: 277 NLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV 335
+G G+FG V+R + G AVKK+ E E+ + L P I+ L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------EL-VACAGLSSPRIVPLY 116
Query: 336 GYCSEYGQHLLVY-EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCS 394
G G + ++ E + GSL + + + G LEYLH +
Sbjct: 117 G-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEG----LEYLH---T 168
Query: 395 LSVVHKNIKSANILLDNELNP-QLSDCGLA-----SNMPNADEALNNDAGSGYG-APEVA 447
++H ++K+ N+LL ++ + L D G A + + + G+ APEV
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL---AKMV 504
M + K D++S +ML +L G P+ Q A
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPW----------------TQYFRGPLCLKIASEP 272
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
P + P A I ++ EP R
Sbjct: 273 PPIREI--PPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 78/279 (27%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHH 328
F V NLLG+G+F VYRA+ G +A+K ID A+ ++ V QL H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLI-WNSRVKIALGTARALE 387
P+I+EL Y + LV E NG ++ +L KP +R + +
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMH-QIITGML 126
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
YLH S ++H+++ +N+LL +N +++D GLA+ + E G+ Y +PE+
Sbjct: 127 YLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
A + ++SDV+S G + LL GR PFD+ + V
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD-----------------TVKNTLNKV-- 224
Query: 507 ALKGLYPV-KSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ Y + LS A D+I ++ P R +S V+
Sbjct: 225 -VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 58/300 (19%), Positives = 118/300 (39%), Gaps = 66/300 (22%)
Query: 276 ENLLGEGTFGRVYRAQFADG------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+LG G FG VY+ + V A+K++ + P + ++ ++ + +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKAN-KEILDEAYVMASVDNP 77
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
++ L+G C L+ + G L D++ ++ + + + A+ + YL
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG------- 442
+ +VH+++ + N+L+ + +++D GLA + ++ G G
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY---HAEG-GKVPIKWM 186
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP-----------RLEQSLVRWA 490
A E + Y +SDV+S+GV + EL+T G KP+D RL Q +
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI--C 244
Query: 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
T ++ I M C + + RP E++ ++ +
Sbjct: 245 TIDVYMI-----MRK---------------------CWMIDADSRPKFRELIIEFSKMAR 278
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 72/322 (22%), Positives = 119/322 (36%), Gaps = 59/322 (18%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADG------KVLAVKKIDSSALPSEMCDDFIEMVSNISQ 325
+LG G FG V++ + V +K I+ + + + I
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQSF-QAVTDHMLAIGS 71
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
L H +I+ L+G C LV ++ GSL D + P + + A+
Sbjct: 72 LDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKG 127
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYG 442
+ YL E +VH+N+ + N+LL + Q++D G+A +P D+ L +
Sbjct: 128 MYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP-----------RLEQSLVRWA 490
A E G+Y +SDV+S+GV + EL+T G +P+ R RL Q +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP--QIC 242
Query: 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
T ++ + MV C + RP E+ R+
Sbjct: 243 TIDVYMV-----MVK---------------------CWMIDENIRPTFKELANEFTRMA- 275
Query: 551 RANMSKRTIGNDQGPTTPRGDN 572
R I + GP G
Sbjct: 276 RDPPRYLVIKRESGPGIAPGPE 297
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 54/292 (18%), Positives = 115/292 (39%), Gaps = 58/292 (19%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F L+G G FG+V++A+ DGK +K++ +E + ++ +++L H NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKA---LAKLDHVNI 66
Query: 332 MELVGYCSEYGQHL----------------LVYEFRKNGSLHDFLHLSDED--NKPLIWN 373
+ G + + EF G+L ++ + +K L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
++ + ++Y+H S ++++++K +NI L + ++ D GL +++ D
Sbjct: 126 ---ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKR 178
Query: 434 NNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492
G+ Y +PE S Y + D+Y+ G+++ ELL
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----------------- 221
Query: 493 QLHDIDALAKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+ + G+ + ++ + +PE RP SE+++
Sbjct: 222 --FETSKFFTDL---RDGIIS-DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 54/288 (18%), Positives = 115/288 (39%), Gaps = 42/288 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN-- 330
+++ +G G +V++ ++ A+K ++ ++ D + ++ +++L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L Y +V E N L+ +L K + R A+ +H
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN--ADEALNNDAGS-GYGAPEV- 446
+ +VH ++K AN L+ + +L D G+A+ M ++ G+ Y PE
Sbjct: 126 Q---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 447 ----------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496
+ + KSDV+S G ++ + G+ PF +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------NQ 226
Query: 497 IDALAKMVDPALKGLYPVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
I L ++DP + +P + DV+ C++ +P+ R + E++
Sbjct: 227 ISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 69/314 (21%), Positives = 135/314 (42%), Gaps = 37/314 (11%)
Query: 272 SFNVENLLGEGTFGRVYRAQF---ADGKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLH 327
+ +++ ++G G FG V + + ++ A+K + + DF+ S + Q
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFD 104
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
HPNI+ L G ++ ++V E+ +NGSL FL + + V + G A ++
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMK 161
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GA 443
YL + VH+++ + NIL+++ L ++SD GL + + EA G +
Sbjct: 162 YLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PE ++ SDV+S+G+V+ E+++ G +P+ + V + +D +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----WEMSNQDV------IKAVDEGYR 268
Query: 503 MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIG 560
+ P LY ++ C Q + RP ++V L +L++ K
Sbjct: 269 LPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITS 319
Query: 561 NDQGPTTPRGDNQD 574
P+ D +
Sbjct: 320 AAARPSNLLLDQSN 333
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 64/291 (21%), Positives = 126/291 (43%), Gaps = 45/291 (15%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ LG G FG V ++ +AVK I ++ + +F + + +L HP +
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKL 65
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++ G CS+ +V E+ NG L ++L K L + +++ + +L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLE- 121
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG--------A 443
S +H+++ + N L+D +L ++SD G+ + L++ S G A
Sbjct: 122 --SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV------LDDQYVSSVGTKFPVKWSA 173
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PEV +Y+ KSDV++FG++M E+ + G+ P+ S V + + +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----DLYTNSEV------VLKVSQGHR 223
Query: 503 MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
+ P L +Y ++ C PE RP +++ ++ L ++
Sbjct: 224 LYRPHLASDTIY---------QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 48/286 (16%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHH 328
+ LG+G F + + +V A K + S L + + M +S L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR---- 384
+++ G+ + +V E + SL + R + AR
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELH------------KRRKALTEPEARYYLR 122
Query: 385 ----ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
+YLH V+H+++K N+ L+ +L ++ D GLA+ + E G+
Sbjct: 123 QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
Y APEV ++ + DV+S G +M LL G+ PF++S +
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----------------CLKE 222
Query: 500 LAKMVDPALKGLYPV-KSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ K Y + K ++ A +I +Q +P RP ++E++
Sbjct: 223 TYLRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 67/296 (22%), Positives = 135/296 (45%), Gaps = 43/296 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+++ LG G +G VY + + AVK + + E +F++ + + ++ HPN
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPN 277
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+++L+G C+ ++ EF G+L D+L + + + + + +A + A+EYL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------A 443
+ +H+N+ + N L+ +++D GL+ M + A
Sbjct: 336 ---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTA 387
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PE +++IKSDV++FGV++ E+ T G P+ P ++ S V ++ +
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQV------YELLEKDYR 437
Query: 503 MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSK 556
M P + +Y +++ C Q P RP +E+ QA + Q +++S
Sbjct: 438 MERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 43/301 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQF---ADGKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLH 327
++E ++G G G V + V A+K + + + DF+ S + Q
Sbjct: 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFD 108
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
HPNI+ L G + ++V E+ +NGSL FL + V + G +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMR 165
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG----- 442
YL L VH+++ + N+L+D+ L ++SD GL+ + + +A G G
Sbjct: 166 YLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG---GKIPIR 219
Query: 443 --APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
APE ++ SDV+SFGVVM E+L G +P+ + V + ++
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY----WNMTNRDV------ISSVEE 269
Query: 500 LAKMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKR 557
++ P L+ ++ C + RP S++V L L++ +
Sbjct: 270 GYRLPAPMGCPHALH---------QLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320
Query: 558 T 558
T
Sbjct: 321 T 321
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 40/353 (11%), Positives = 81/353 (22%), Gaps = 53/353 (15%)
Query: 226 RPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFG 285
I + ++ + V V T+ + L + L G
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRS 76
Query: 286 RVYRA-QFADGKVLAVKKIDSSALPSE-MCDDFIEMVSNISQLHHPNIMELVGYC----- 338
V+ + A+K A S + E ++L + E
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 339 ---------------------SEYGQHLLVYEFRKNGSLHDFLHLSD---EDNKPLIWNS 374
+LL+ L D +
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILA 195
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434
+ R L S +VH + N+ + + L D
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK---VGTRGP 249
Query: 435 NDAGSGYGAPEVAMSGQ---YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491
+ AP ++ + + + G+ + + PF P ++ S R
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR--- 306
Query: 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
++ L F +I + + R E ++
Sbjct: 307 -------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 39/295 (13%)
Query: 276 ENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+ LG+G FG V ++ G ++AVK++ S + DF + + LH
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDF 85
Query: 331 IMELVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALE 387
I++ G G+ LV E+ +G L DFL ++ + SR + + + +E
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ----RHRARLDASRLLLYSSQICKGME 141
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YG 442
YL S VH+++ + NIL+++E + +++D GLA +P + Y
Sbjct: 142 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY- 197
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD-IDAL 500
APE ++ +SDV+SFGVV+ EL T K S L P L ++ L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 501 AK---MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ + P ++ +++ LC P P+ RP S + L L
Sbjct: 258 EEGQRLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQLDMLWS 303
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 67/274 (24%), Positives = 121/274 (44%), Gaps = 33/274 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
LG G +G V + + G+++AVK+I ++ E +++ ++ + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ G G + E + SL F + + + + KIA+ +ALE+LH
Sbjct: 69 VTFYGALFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-SGYGAPEV---- 446
LSV+H+++K +N+L++ ++ D G++ + + A + DAG Y APE
Sbjct: 128 K--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPE 184
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD- 505
Y++KSD++S G+ M+EL R P+DS L ++V+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---------------TPFQQLKQVVEE 229
Query: 506 --PALKGLYPVKSLSR-FADVIALCVQPEPEFRP 536
P L P S F D + C++ + RP
Sbjct: 230 PSPQL----PADKFSAEFVDFTSQCLKKNSKERP 259
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 63/291 (21%), Positives = 126/291 (43%), Gaps = 41/291 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVK--KIDSSALPSEMCDDFIEMVSNISQLHHP 329
LG G FG V ++ +A+K K S + D+FIE + L H
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHE 79
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+++L G C++ ++ E+ NG L ++L E +++ A+EYL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPE 445
S +H+++ + N L++++ ++SD GL+ + D+ + GS + PE
Sbjct: 137 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSPPE 191
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
V M +++ KSD+++FGV+M E+ + G+ P+ R S I ++
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY----ERFTNSET------AEHIAQGLRLY 241
Query: 505 DPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553
P L + +Y ++ C + + RP ++ ++ ++ +
Sbjct: 242 RPHLASEKVY---------TIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 60/336 (17%), Positives = 126/336 (37%), Gaps = 43/336 (12%)
Query: 226 RPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGS-FNVENLLGEGTF 284
P K F ++ + + S S + G +++ +G G
Sbjct: 10 LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69
Query: 285 GRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN--IMELVGYCSEYG 342
+V++ ++ A+K ++ ++ D + ++ +++L + I+ L Y
Sbjct: 70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129
Query: 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI 402
+V E N L+ +L K + R A+ +H+ +VH ++
Sbjct: 130 YIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDL 181
Query: 403 KSANILLDNELNPQLSDCGLASNMPN--ADEALNNDAGS-GYGAPEV-----------AM 448
K AN L+ + +L D G+A+ M ++ G+ Y PE
Sbjct: 182 KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508
+ + KSDV+S G ++ + G+ PF + I L ++DP
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------NQISKLHAIIDPNH 285
Query: 509 KGLYPVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ +P + DV+ C++ +P+ R + E++
Sbjct: 286 EIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 43/300 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG+G FG V+ + +A+K + + E F++ + +L H +
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKL 241
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L SE +V E+ GSL DFL E K L V +A A + Y+
Sbjct: 242 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------AP 444
++ VH+++++ANIL+ L +++D GLA + + N AP
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-----NEYTARQGAKFPIKWTAP 350
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
E A+ G++ IKSDV+SFG+++ EL T GR P+ P + V L ++ +M
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREV------LDQVERGYRM 400
Query: 504 VDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGN 561
P + L+ D++ C + EPE RP + L + N
Sbjct: 401 PCPPECPESLH---------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 71/319 (22%), Positives = 130/319 (40%), Gaps = 56/319 (17%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVL-----AVKKIDSSALPSEMCDDFIEMVSNISQL 326
+ ++G G FG VY+ A+K + + + DF+ + Q
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQF 103
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
H NI+ L G S+Y +++ E+ +NG+L FL E + V + G A +
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 160
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----G 442
+YL +++ VH+++ + NIL+++ L ++SD GL+ + + EA +G
Sbjct: 161 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFD-----------SSRPRLEQSLVRWA 490
APE ++ SDV+SFG+VM E++T G +P+ + RL
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP--MDC 275
Query: 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
++ + M+ C Q E RP +++V L +L++
Sbjct: 276 PSAIYQL-----MMQ---------------------CWQQERARRPKFADIVSILDKLIR 309
Query: 551 RANMSKRTIGNDQGPTTPR 569
+ K D +
Sbjct: 310 APDSLKTLADFDPRVSIRL 328
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 69/330 (20%), Positives = 125/330 (37%), Gaps = 53/330 (16%)
Query: 227 PPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
P P D K+ + + A P + D + + LG+G F +
Sbjct: 2 PAPADPGKAGVPGVAAPGA----PAAAPPAKEIPEVLVD-PRSRRRYVRGRFLGKGGFAK 56
Query: 287 VYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHHPNIMELVGYCSEYGQH 344
+ +V A K + S L + + M +S L H +++ G+ +
Sbjct: 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116
Query: 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR--------ALEYLHEVCSLS 396
+V E + SL + R + AR +YLH
Sbjct: 117 FVVLELCRRRSLLELH------------KRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYNIK 455
V+H+++K N+ L+ +L ++ D GLA+ + E G+ Y APEV ++ +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 456 SDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPV- 514
DV+S G +M LL G+ PF++S + + K Y +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETS-----------------CLKETYLRI---KKNEYSIP 261
Query: 515 KSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
K ++ A +I +Q +P RP ++E++
Sbjct: 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 68/294 (23%), Positives = 125/294 (42%), Gaps = 36/294 (12%)
Query: 276 ENLLGEGTFGRVYRAQFA-----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
LGEG FG+V ++ G+ +AVK + + + + D + + + L+H N
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHEN 84
Query: 331 IMELVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALE 387
I++ G C+E G + L+ EF +GSL ++L NK I + +K A+ + ++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMD 140
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GA 443
YL S VH+++ + N+L+++E ++ D GL + E A
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV-RWATPQLHDIDALA 501
PE M ++ I SDV+SFGV + ELLT L+ ++ L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 502 K---MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ + P +Y ++ C + +P R +++ L++
Sbjct: 258 EGKRLPCPPNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 66/273 (24%), Positives = 112/273 (41%), Gaps = 44/273 (16%)
Query: 278 LLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG 336
+LG+GT+G VY + +A+K+I S E ++ L H NI V
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNI---VQ 83
Query: 337 Y--CSEYGQHLLVY-EFRKNGSLHDFLHLSD---EDNKPLIWNSRVKIALGTARALEYLH 390
Y + ++ E GSL L +DN+ I +I G L+YLH
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLH 139
Query: 391 EVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASNMPNADEALNNDAGSGYG-APEVAM 448
+ +VH++IK N+L++ ++SD G + + + G+ APE+
Sbjct: 140 DNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 449 SGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL-HDIDALAKMVD 505
G Y +D++S G ++E+ TG+ PF +L A+ K+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPF----------------YELGEPQAAMFKV-- 238
Query: 506 PALKGLYPV-KSLSR-FADVIALCVQPEPEFRP 536
K + +S+S I C +P+P+ R
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 62/311 (19%), Positives = 124/311 (39%), Gaps = 59/311 (18%)
Query: 279 LGEGTFGRVYRAQFADG------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G FG VY+ + V A+K++ + P + ++ ++ + +P++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKAN-KEILDEAYVMASVDNPHVC 80
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L+G C L+ + G L D++ ++ + + + A+ + YL +
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 135
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS---GYGAPEVAMS 449
+VH+++ + N+L+ + +++D GLA + ++ + + G + A E +
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 450 GQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP-----------RLEQSLVRWATPQLHDI 497
Y +SDV+S+GV + EL+T G KP+D RL Q + T ++ I
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI--CTIDVYMI 251
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKR 557
MV C + + RP E++ ++ R
Sbjct: 252 -----MVK---------------------CWMIDADSRPKFRELIIEFSKMA-RDPQRYL 284
Query: 558 TIGNDQGPTTP 568
I D+ P
Sbjct: 285 VIQGDERMHLP 295
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 38/295 (12%)
Query: 276 ENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
LG+G FG V ++ G+V+AVKK+ S + DF + + L H N
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDN 72
Query: 331 IMELVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALE 387
I++ G C G+ L+ E+ GSL D+L +K I + + ++ + +E
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGME 128
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GA 443
YL + +H+++ + NIL++NE ++ D GL +P E A
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK- 502
PE ++++ SDV+SFGVV+ EL T + S + + Q+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 503 -----MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ P +Y ++ C RP ++ + ++
Sbjct: 246 KNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 38/296 (12%)
Query: 276 ENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
LG+G FG V ++ G+V+AVKK+ S + DF + + L H N
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDN 103
Query: 331 IMELVGYCSEYGQH--LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARALE 387
I++ G C G+ L+ E+ GSL D+L +K I + + ++ + +E
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGME 159
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GA 443
YL + +H+++ + NIL++NE ++ D GL +P E A
Sbjct: 160 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK- 502
PE ++++ SDV+SFGVV+ EL T + S + + Q+ +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 503 -----MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
+ P +Y ++ C RP ++ + ++ +
Sbjct: 277 KNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 79/313 (25%), Positives = 129/313 (41%), Gaps = 56/313 (17%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F +G+G+FG V++ KV+A+K ID E+ +D + ++ +SQ P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYV 82
Query: 332 MELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GTARALE 387
+ G L ++ E+ GS D L PL +IA + L+
Sbjct: 83 TKYYG-SYLKDTKLWIIMEYLGGGSALDLLE-----PGPL---DETQIATILREILKGLD 133
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEV 446
YLH S +H++IK+AN+LL +L+D G+A + + N G+ + APEV
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL---AKM 503
Y+ K+D++S G+ +EL G P +LH + L K
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHS----------------ELHPMKVLFLIPKN 234
Query: 504 VDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEV------------VQALVRLVQ 550
P L+G + S+ + + C+ EP FRP E+ L L+
Sbjct: 235 NPPTLEG-----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELID 289
Query: 551 RANMSKRTIGNDQ 563
R K +D
Sbjct: 290 RYKRWKAEQSHDD 302
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 47/298 (15%), Positives = 94/298 (31%), Gaps = 48/298 (16%)
Query: 227 PPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
P+ + + E +I K + Q+ + V +LLGEG F +
Sbjct: 35 SKPVSSYPNTFEWQCKLPAIKPKT--------------EFQLGSKLVYVHHLLGEGAFAQ 80
Query: 287 VYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIE--MVSNISQLHHPNIMELVGYC 338
VY A D + +K P+ + +I ++ + M+
Sbjct: 81 VYEATQGDLNDAKNKQKFVLKVQK----PANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136
Query: 339 SEYGQHLLVYEFRKNGSLHDFL-HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSV 397
+LV E G+L + + + K + + A+ +E +H +
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEI 193
Query: 398 VHKNIKSANILLDNELNP-----------QLSDCGLASNMPN--ADEALNNDAGS-GYGA 443
+H +IK N +L N L D G + +M + G+
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF---DSSRPRLEQSLVR-WATPQLHDI 497
E+ + +N + D + + +L G + + E R ++
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEF 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 65/281 (23%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 275 VENLLGEGTFGRVYRAQF-ADGKVL--AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ LG G FG V + + K + A+K + ++ ++ + + QL +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYI 72
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L+G C +LV E G LH FL E+ + ++ ++ + ++YL
Sbjct: 73 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVA 447
+ VH+++ + N+LL N ++SD GL+ + D + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+++ +SDV+S+GV M E L+ G+KP+ +++ V + I+ +M P
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPY----KKMKGPEV------MAFIEQGKRMECP 235
Query: 507 AL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
LY +++ C + E RP V Q +
Sbjct: 236 PECPPELY---------ALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 55/298 (18%)
Query: 272 SFNVENLLGEGTFGRVYRAQF--ADGKVL--AVKKI-DSSALPSEMCDDFIEMVSNISQL 326
+ LG+G+FG V R ++ GK + AVK + E DDFI V+ + L
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARA 385
H N++ L G +V E GSL D L ++ + A+ A
Sbjct: 79 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEG 133
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY---- 441
+ YL S +H+++ + N+LL ++ D GL +P D+
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 442 GAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPR-----LEQSLVRWATPQ-- 493
APE + ++ SD + FGV + E+ T G++P+ +++ R P+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 494 ---LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548
++++ MV C +PE RP + L+
Sbjct: 251 PQDIYNV-----MVQ---------------------CWAHKPEDRPTFVALRDFLLEA 282
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 69/292 (23%), Positives = 123/292 (42%), Gaps = 49/292 (16%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG G FG V+ A + +AVK + ++ E F+ + + L H +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 245
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L ++ ++ EF GSL DFL ++ + + A + ++
Sbjct: 246 VKLHAVVTKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIE- 301
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------AP 444
+ +H+++++ANIL+ L +++D GLA + + N AP
Sbjct: 302 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-----NEYTAREGAKFPIKWTAP 354
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK- 502
E G + IKSDV+SFG++++E++T GR P+ P + V I AL +
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----PGMSNPEV---------IRALERG 401
Query: 503 --MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
M P + LY +++ C + PE RP + L
Sbjct: 402 YRMPRPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVLDDFYT 444
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 38/292 (13%)
Query: 279 LGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LGEG FG+V + G+++AVK + + A P + + + + L+H +I++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHIIK 97
Query: 334 LVGYCSEYGQ--HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
G C + G LV E+ GSL D+L L+ A + YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL-----LFAQQICEGMAYLH- 151
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPEV 446
+ +H+++ + N+LLDN+ ++ D GLA +P E Y APE
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 208
Query: 447 AMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV-RWATPQLHDIDALAK-- 502
++ SDV+SFGV + ELLT LE + + L + L +
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 503 -MVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
+ P +Y ++ C + E FRP ++ L + ++
Sbjct: 269 RLPRPDKCPAEVY---------HLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 36/315 (11%)
Query: 279 LGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G G +G V + G+++AVK+I S+ E +++ + P I++ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRV-KIALGTARALEYLHEVCSLS 396
G + E + S F +I + KI L T +AL +L E L
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-SGYGAPEV----AMSGQ 451
++H++IK +NILLD N +L D G++ + ++ A DAG Y APE A
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---PAL 508
Y+++SDV+S G+ + EL TGR P+ D L ++V P L
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNS---------------VFDQLTQVVKGDPPQL 250
Query: 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSE------VVQALVRLVQRANMSKRTIGN- 561
+ F + + LC+ + RP E ++ R V+ A + +
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQM 310
Query: 562 DQGPTTPRGDNQDTQ 576
P++P +
Sbjct: 311 PATPSSPMYVDHHHH 325
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNI------ 323
F + LG+G FG VY A+ +LA+K + + L + +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA------GVEHQLRREVEI 62
Query: 324 -SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKI 378
S L HPNI+ L GY + + L+ E+ G+++ L ++
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TY 114
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
A AL Y H S V+H++IK N+LL + +++D G + + P + G
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLCG 169
Query: 439 S-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
+ Y PE+ ++ K D++S GV+ E L G+ PF+++
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 57/319 (17%)
Query: 279 LGEGTFGRVYRAQFADG-------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
LG G FG VY Q + +V AVK + + DF+ IS+ +H NI
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDE-LDFLMEALIISKFNHQNI 95
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKIALGTARALEY 388
+ +G + ++ E G L FL + L + +A A +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQL----SDCGLASNMPNADEALNNDAGSGYG-- 442
L +H++I + N LL P D G+A ++ A G
Sbjct: 156 LE---ENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAML 207
Query: 443 -----APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHD 496
PE M G + K+D +SFGV++ E+ + G P+ P +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSKSN 251
Query: 497 IDALAKMVD----PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552
+ L + P ++ C Q +PE RP + +++ + Q
Sbjct: 252 QEVLEFVTSGGRMDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
Query: 553 NMSKRTIGNDQGPTTPRGD 571
++ + + GP +
Sbjct: 307 DVINTALPIEYGPLVEEEE 325
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 64/316 (20%), Positives = 114/316 (36%), Gaps = 54/316 (17%)
Query: 270 TGSFNVENLLGEG--TFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
G + + ++G+G V A++ G+ + V++I+ A +EM +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 327 HHPNIMELVGYCS-EYGQHL-LVYEFRKNGSLHDFLHLSDED--NKPLIWNSRVKIALGT 382
+HPNI+ + L +V F GS D + D N+ I I G
Sbjct: 84 NHPNIVPY--RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI----AYILQGV 137
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG 442
+AL+Y+H + VH+++K+++IL+ + LS +M + +
Sbjct: 138 LKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 443 --------APEVA--MSGQYNIKSDVYSFGVVMLELLTGRKPF-------------DSSR 479
+PEV Y+ KSD+YS G+ EL G PF + +
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 480 PRLE--------------QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSR-FADVI 524
P L V + + + + ++ S F +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 525 ALCVQPEPEFRPPMSE 540
C+Q P+ RP S
Sbjct: 315 EQCLQRNPDARPSAST 330
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 43/300 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG+G FG V+ + +A+K + + E F++ + +L H +
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKL 324
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L SE +V E+ GSL DFL E K L V +A A + Y+
Sbjct: 325 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE- 380
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------AP 444
++ VH+++++ANIL+ L +++D GLA + + N AP
Sbjct: 381 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-----NEYTARQGAKFPIKWTAP 433
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
E A+ G++ IKSDV+SFG+++ EL T GR P+ P + V L ++ +M
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREV------LDQVERGYRM 483
Query: 504 VDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGN 561
P + L+ D++ C + EPE RP + L + N
Sbjct: 484 PCPPECPESLH---------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 60/286 (20%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
SF +++LG G G + D + +AVK+I D ++++ + HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDE--HPNV 80
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ + + E +L +++ D + L + + T L +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHLH- 135
Query: 392 VCSLSVVHKNIKSANILLDN-----ELNPQLSDCGLASNMPN---ADEALNNDAGS-GYG 442
SL++VH+++K NIL+ ++ +SD GL + + + G+ G+
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 443 APEV---AMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDID 498
APE+ D++S G V +++ G PF S R
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----------------Q 237
Query: 499 ALAKMVDPALKGLYPVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
A + +L L+P K A ++I + +P+ RP V++
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 65/306 (21%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F +LG+G FG+V +A+ D + A+KKI + E + V ++ L+H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYV 64
Query: 332 MEL------------VGYCSEYGQHL-LVYEFRKNGSLHDFLH----LSDEDNKPLIWNS 374
+ + L + E+ +NG+L+D +H D W
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRL 121
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434
+I AL Y+H S ++H+++K NI +D N ++ D GLA N+ + + L
Sbjct: 122 FRQILE----ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 435 NDAGSG---------------YGAPEV-AMSGQYNIKSDVYSFGVVMLELLTGRKPF-DS 477
D+ + Y A EV +G YN K D+YS G++ E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGM 232
Query: 478 SRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
R + + L + V + + +I L + +P RP
Sbjct: 233 ERVNILKKL---------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 538 MSEVVQ 543
++
Sbjct: 278 ARTLLN 283
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 68/289 (23%), Positives = 127/289 (43%), Gaps = 43/289 (14%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG G FG V+ + +AVK + ++ + F+ + + QL H +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRL 70
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L ++ ++ E+ +NGSL DFL L N + +A A + ++
Sbjct: 71 VRLYAVVTQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG-------AP 444
+ +H+++++ANIL+ + L+ +++D GLA + + N AP
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-----NEYTAREGAKFPIKWTAP 179
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
E G + IKSDV+SFG+++ E++T GR P+ P + V + +++ +M
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEV------IQNLERGYRM 229
Query: 504 VDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
V P + LY ++ LC + PE RP + L
Sbjct: 230 VRPDNCPEELY---------QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 276 ENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+ ++G+G FG VY ++ D + A+K + ++ + F+ + L+HPN
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQV-EAFLREGLLMRGLNHPN 83
Query: 331 IMELVGYCS-EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
++ L+G G ++ + +G L F+ + + L AR +EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAP 444
VH+++ + N +LD +++D GLA ++ + + + A
Sbjct: 141 A---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 445 EVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
E + ++ KSDV+SFGV++ ELLT G P+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 72/301 (23%), Positives = 136/301 (45%), Gaps = 61/301 (20%)
Query: 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMV 320
S AD Q G++ + +G+G F +V A+ G+ +A+K ID + L V
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 321 SNISQLHHPNIMELVGY-CSEYGQHL-LVYEFRKNGSLHDFL----HLSDEDNKPLIWNS 374
+ L+HPNI++L + E + L L+ E+ G + D+L + +++
Sbjct: 66 RIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-------- 115
Query: 375 RVKIALGTAR--------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426
AR A++Y H +VH+++K+ N+LLD ++N +++D G SN
Sbjct: 116 --------ARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF-SNE 163
Query: 427 PNADEALNNDAGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484
L+ G+ Y APE+ +Y+ + DV+S GV++ L++G PFD
Sbjct: 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------ 217
Query: 485 SLVRWATPQLHDIDALAKMVDPALKGLYPV-KSLSRFA-DVIALCVQPEPEFRPPMSEVV 542
++ L + V L+G Y + +S +++ + P R + +++
Sbjct: 218 -----------NLKELRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263
Query: 543 Q 543
+
Sbjct: 264 K 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 79/312 (25%), Positives = 140/312 (44%), Gaps = 52/312 (16%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F+V LGEG++G VY+A G+++A+K++ + S++ + I+ +S + Q P++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDL-QEIIKEISIMQQCDSPHV 86
Query: 332 MELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GTARALE 387
++ G L +V E+ GS+ D + L NK L + +IA T + LE
Sbjct: 87 VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTL---TEDEIATILQSTLKGLE 139
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEV 446
YLH + +H++IK+ NILL+ E + +L+D G+A + + N G+ + APEV
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL---AKM 503
YN +D++S G+ +E+ G+ P+ +H + A+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYA----------------DIHPMRAIFMIPTN 240
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRA 552
P + P F D + C+ PE R ++++Q L L+ A
Sbjct: 241 PPPTFRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEA 298
Query: 553 NMSKRTIGNDQG 564
K Q
Sbjct: 299 MDVKLKRQESQQ 310
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 65/318 (20%), Positives = 112/318 (35%), Gaps = 55/318 (17%)
Query: 279 LGEGTFGRVYRAQFADGK------VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G FG VY Q + +AVK + + DF+ IS+ +H NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQNIV 137
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKIALGTARALEYL 389
+G + ++ E G L FL + L + +A A +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQL----SDCGLASNMPNADEALNNDAGSGYG--- 442
+H++I + N LL P D G+A ++ A G
Sbjct: 198 E---ENHFIHRDIAARNCLL-TCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249
Query: 443 ----APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDI 497
PE M G + K+D +SFGV++ E+ + G P+ P +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSKSNQ 293
Query: 498 DALAKMVD----PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553
+ L + P ++ C Q +PE RP + +++ + Q +
Sbjct: 294 EVLEFVTSGGRMDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348
Query: 554 MSKRTIGNDQGPTTPRGD 571
+ + + GP +
Sbjct: 349 VINTALPIEYGPLVEEEE 366
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 275 VENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+ +LG+G FG V AQ KV AVK + + + S ++F+ + + + HP
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 330 NIMELVGYCSE------YGQHLLVYEFRKNGSLHDFL--HLSDEDNKPLIWNSRVKIALG 381
++ +LVG +++ F K+G LH FL E+ L + V+ +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY 441
A +EYL S + +H+++ + N +L ++ ++D GL+ + + D
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG----CA 198
Query: 442 G-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
A E Y + SDV++FGV M E++T G+ P+
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 61/270 (22%), Positives = 117/270 (43%), Gaps = 38/270 (14%)
Query: 279 LGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337
+G GT G+V++ +F G V+AVK++ S E +++ + P I++ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC--F 90
Query: 338 CSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSL 395
+ + E + + + ++ K+ + +AL YL E
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL----GKMTVAIVKALYYLKE--KH 144
Query: 396 SVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-SGYGAPEV-----AMS 449
V+H+++K +NILLD +L D G++ + + +A + AG + Y APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD---P 506
Y+I++DV+S G+ ++EL TG+ P+ + + D + L K++ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKT---------------DFEVLTKVLQEEPP 248
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
L G + F + C+ + RP
Sbjct: 249 LLPG--HMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 57/299 (19%)
Query: 274 NVENLLGEGTFGRVYRAQFADGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+ ++G G FG VY D AVK ++ E+ F+ + HP
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHP 86
Query: 330 NIMELVGYCSEY-GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
N++ L+G C G L+V + K+G L +F+ + + L A+ ++Y
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKY 143
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGA 443
L S VH+++ + N +LD + +++D GLA +M + + ++ + A
Sbjct: 144 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDS-----------SRPRLEQSLVRWAT 491
E + ++ KSDV+SFGV++ EL+T G P+ RL Q +
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCP 258
Query: 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
L+++ M+ C P+ E RP SE+V + +
Sbjct: 259 DPLYEV-----MLK---------------------CWHPKAEMRPSFSELVSRISAIFS 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ ++ ++G G V A A + +A+K+I+ + M D+ ++ + +SQ HHPNI
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPNI 75
Query: 332 MELVGYCS-EYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWN-SRVKIAL---GTARA 385
+ Y S L LV + GS+ D + + IA
Sbjct: 76 VSY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-----AGSG 440
LEYLH +H+++K+ NILL + + Q++D G+++ + + N G+
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 441 Y-GAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDI 497
APEV + Y+ K+D++SFG+ +EL TG P+ P ++ ++ P L
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 498 DALAKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRP 536
+M +K + F +I+LC+Q +PE RP
Sbjct: 251 VQDKEM----------LKKYGKSFRKMISLCLQKDPEKRP 280
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHH 328
F++ LG+G FG VY A+ ++A+K + S L + + S L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTAR 384
PNI+ + Y + + L+ EF G L+ L ++ S + A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------SATFMEE-LAD 125
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
AL Y H V+H++IK N+L+ + +++D G + + P G+ Y
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMCGTLDYLP 180
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSS 478
PE+ ++ K D++ GV+ E L G PFDS
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 40/335 (11%), Positives = 86/335 (25%), Gaps = 69/335 (20%)
Query: 278 LLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIE------------------ 318
+LG+ A G+ V + P ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 319 -----MVSNISQLHHPNIMELVGYCSEYGQHLLVYEF----RKNGSLHDF---LHLSDED 366
+ + P +++ + ++ F R +L F L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 367 NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426
+K L+ ++R+++ L R L LH +VH ++ +I+LD L+
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 427 PNADEALNNDAGSGYGAPEV----------AMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
+ + G G+ PE D ++ G+ + + P
Sbjct: 262 ---GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 477 SSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
W +I + ++ ++ E R
Sbjct: 319 DDAAL---GGSEWIFRSCKNIPQPVR-------------------ALLEGFLRYPKEDRL 356
Query: 537 PMSEVVQALVRLVQRANMSKRTIGNDQGPTTPRGD 571
+ ++ R +S R
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREG 391
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 74/304 (24%), Positives = 131/304 (43%), Gaps = 50/304 (16%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +G+G G VY A A G+ +A+++++ P + + I + + + +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNI 79
Query: 332 MELVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
V Y Y G L +V E+ GSL D + + + +ALE+
Sbjct: 80 ---VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEVA 447
LH S V+H++IKS NILL + + +L+D G + + + G+ Y APEV
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL---AKMV 504
Y K D++S G++ +E++ G P+ + + + AL A
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN----------------ENPLRALYLIATNG 232
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRAN 553
P L+ P K + F D + C++ + E R E++Q +L L+ A
Sbjct: 233 TPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290
Query: 554 MSKR 557
+ +
Sbjct: 291 EATK 294
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 275 VENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+ +LGEG FG V KV AVK + ++F+ + + HP
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 330 NIMELVGYCSE-----YGQHLLVYEFRKNGSLHDFL--HLSDEDNKPLIWNSRVKIALGT 382
N++ L+G C E + +++ F K G LH +L + K + + +K +
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG 442
A +EYL + + +H+++ + N +L +++ ++D GL+ + + D G
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---QGRI-A 209
Query: 443 -------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
A E Y KSDV++FGV M E+ T G P+
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/309 (16%), Positives = 107/309 (34%), Gaps = 29/309 (9%)
Query: 259 TSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSAL--------PS 310
+ + + + + L +G F ++ + D K A+KK + S L +
Sbjct: 19 LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSN 77
Query: 311 EMCDDFIEMVSNI-------SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL--- 360
+ + + + + G + Y + ++YE+ +N S+ F
Sbjct: 78 NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 361 -HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419
L + I + Y+H ++ H+++K +NIL+D +LSD
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 420 CGLASNMPNADEALNNDAGS-GYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFD 476
G + M D+ + G+ + PE + K D++S G+ + + PF
Sbjct: 196 FGESEYMV--DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 477 SSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFA-DVIALCVQPEPEF 534
+E + +R + K LS D + L ++ P
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 535 RPPMSEVVQ 543
R + ++
Sbjct: 314 RITSEDALK 322
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 64/312 (20%), Positives = 122/312 (39%), Gaps = 62/312 (19%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVL--------AVKKIDSSALPSEMCDDFIEMVSNI 323
LG+GTF ++++ + +K +D + + F E S +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMM 66
Query: 324 SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
S+L H +++ G C +++LV EF K GSL +L ++ + ++++A A
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLA 123
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQ--------LSDCGLASNMPNADEALNN 435
A+ +L E +++H N+ + NILL E + + LSD G++ + D
Sbjct: 124 AAMHFL-E--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 436 DAGSGYG-------APEVAM-SGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSL 486
PE N+ +D +SFG + E+ + G KP L+
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL----SALDSQR 226
Query: 487 VRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546
L + ++ P L ++I C+ EP+ RP +++ L
Sbjct: 227 K------LQFYEDRHQLPAPKAAELA---------NLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 547 RLVQRANMSKRT 558
L + + +
Sbjct: 272 SLFTPDLVPRGS 283
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 49/218 (22%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 279 LGEGTFGRVYRAQFADG-------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
LG+G+FG VY +V A+K ++ +A E +F+ S + + + ++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRER-IEFLNEASVMKEFNCHHV 90
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL------HLSDEDNKPLIWNSRVKIALGTARA 385
+ L+G S+ L++ E G L +L ++ P + +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG--- 442
+ YL+ + VH+++ + N ++ + ++ D G+ ++ D G G
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG----GKGLLP 203
Query: 443 ----APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+PE G + SDV+SFGVV+ E+ T +P+
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 66/281 (23%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVL---AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ LG G FG V + + K A+K + ++ ++ + + QL +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYI 398
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L+G C +LV E G LH FL E+ + ++ ++ + ++YL
Sbjct: 399 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 452
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY----GAPEVA 447
+ VH+N+ + N+LL N ++SD GL+ + D + + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 448 MSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+++ +SDV+S+GV M E L+ G+KP+ +++ V + I+ +M P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPY----KKMKGPEV------MAFIEQGKRMECP 561
Query: 507 AL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
LY +++ C + E RP V Q +
Sbjct: 562 PECPPELY---------ALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 65/311 (20%), Positives = 127/311 (40%), Gaps = 49/311 (15%)
Query: 275 VENLLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDD------FIEMVSNISQ 325
+ + LG G VY A+ D +A+K A+ + F V N SQ
Sbjct: 15 IVDKLGGGGMSTVYLAE--DTILNIKVAIK-----AIFIPPREKEETLKRFEREVHNSSQ 67
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
L H NI+ ++ E + LV E+ + +L +++ + PL ++ +
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDG 123
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA-----SNMPNADEALNNDAGS- 439
+++ H+ + +VH++IK NIL+D+ ++ D G+A +++ + L G+
Sbjct: 124 IKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL----GTV 176
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH-DID 498
Y +PE A + +D+YS G+V+ E+L G PF+ V A + +
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVP 230
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVVQALVRLVQRANMSKR 557
+ V + P ++VI + + R + E+ L ++ ++
Sbjct: 231 NVTTDVRKDI----PQS----LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282
Query: 558 TIGNDQGPTTP 568
D+ T
Sbjct: 283 VYELDKMKTIA 293
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 276 ENLLGEGTFGRVYRAQFADGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
++G G FG VY D AVK ++ E+ F+ + HPN+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 332 MELVGYCSEY-GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ L+G C G L+V + K+G L +F+ + + L A+ +++L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLA 209
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPE 445
S VH+++ + N +LD + +++D GLA +M + + ++ + A E
Sbjct: 210 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP-----------RLEQSLVRWATPQ 493
+ ++ KSDV+SFGV++ EL+T G P+ RL Q +
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCPDP 324
Query: 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
L+++ M+ C P+ E RP SE+V + +
Sbjct: 325 LYEV-----MLK---------------------CWHPKAEMRPSFSELVSRISAIFS 355
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 50/297 (16%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVL----AVKKIDSSALPSEMCDDFIEMVSNISQLH 327
+ +LGEG FG VY + + K AVK + F+ + L
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLD 71
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR-VKIALGTARAL 386
HP+I++L+G E ++ E G L +L NK + V +L +A+
Sbjct: 72 HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICKAM 126
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG---- 442
YL S++ VH++I NIL+ + +L D GL+ + + D
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI------EDEDYYKASVTRLP 177
Query: 443 ----APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDI 497
+PE ++ SDV+ F V M E+L+ G++PF LE V + +
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF----FWLENKDV------IGVL 227
Query: 498 DALAKMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552
+ ++ P L LY ++ C +P RP +E+V +L + Q
Sbjct: 228 EKGDRLPKPDLCPPVLY---------TLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 68/310 (21%), Positives = 132/310 (42%), Gaps = 55/310 (17%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG+G FG+VY+A+ G + A K I++ + +D+I + ++ HP I
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEILATCDHPYI 78
Query: 332 MELVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GTARA 385
V Y L ++ EF G++ + E ++ L + +I + A
Sbjct: 79 ---VKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGL---TEPQIQVVCRQMLEA 129
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAP 444
L +LH S ++H+++K+ N+L+ E + +L+D G+++ + ++ G+ Y AP
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 445 EVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDID 498
EV M Y+ K+D++S G+ ++E+ P P R+ + + P L
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 246
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVR 547
+ F D + + + PE RP +++++ AL
Sbjct: 247 KWSV----------------EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
Query: 548 LVQRANMSKR 557
LV A
Sbjct: 291 LVAEAKAEVM 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
+ +GEG FG V++ + V A+K + S + F++ + Q
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVR-EKFLQEALTMRQF 73
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
HP+I++L+G +E ++ E G L FL + S + A + AL
Sbjct: 74 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL---ASLILYAYQLSTAL 129
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG---- 442
YL S VH++I + N+L+ + +L D GL+ M ++ S G
Sbjct: 130 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASK-GKLPI 181
Query: 443 ---APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
APE ++ SDV+ FGV M E+L G KPF
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 92/332 (27%), Positives = 148/332 (44%), Gaps = 68/332 (20%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNI---SQLHH 328
F+ +G G+FG VY A+ + +V+A+KK+ S S + + +++ + +L H
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRH 113
Query: 329 PNIMELVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL---GT 382
PN + Y Y LV E+ GS D L + KPL V+IA G
Sbjct: 114 PNT---IQYRGCYLREHTAWLVMEY-CLGSASDLLEVH---KKPL---QEVEIAAVTHGA 163
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG 442
+ L YLH S +++H+++K+ NILL +L D G AS M A N+ G+ Y
Sbjct: 164 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYW 216
Query: 443 -APEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498
APEV ++ GQY+ K DV+S G+ +EL KP P ++ +
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KP-----PLFN----------MNAMS 260
Query: 499 AL---AKMVDPALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ----------- 543
AL A+ PAL+ S F + + C+Q P+ RP +++
Sbjct: 261 ALYHIAQNESPALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316
Query: 544 ALVRLVQRANMSKRTIGNDQGPTTPRGDNQDT 575
++ L+QR + R + N Q + Q+
Sbjct: 317 VIMDLIQRTKDAVRELDNLQYRKMKKILFQEA 348
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 73/306 (23%), Positives = 131/306 (42%), Gaps = 68/306 (22%)
Query: 279 LGEGTFGRVYRAQFAD-----GKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V+ A+ + K+L AVK + L + DF ++ L H +I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHIV 80
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFL------------HLSDEDNKPLIWNSRVKIAL 380
+ G C + ++V+E+ K+G L+ FL + L + + IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
A + YL S VH+++ + N L+ L ++ D G++ ++ + D G
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193
Query: 441 YG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATP 492
+ PE M ++ +SDV+SFGV++ E+ T G++P+
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW----------------F 237
Query: 493 QLHDIDALAKMVD------PAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544
QL + + + + P + K +Y DV+ C Q EP+ R + E+ +
Sbjct: 238 QLSNTEVIECITQGRVLERPRVCPKEVY---------DVMLGCWQREPQQRLNIKEIYKI 288
Query: 545 LVRLVQ 550
L L +
Sbjct: 289 LHALGK 294
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 276 ENLLGEGTFGRVYRAQFADG-------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
LGE FG+VY+ V A+K + A ++F ++L H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLR-EEFRHEAMLRARLQH 71
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR------------V 376
PN++ L+G ++ +++ + +G LH+FL + + + V
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
+ A +EYL S VVHK++ + N+L+ ++LN ++SD GL + AD
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---- 184
Query: 437 AGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
G APE M G+++I SD++S+GVV+ E+ + G +P+
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 52/295 (17%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-H 327
G F + L+G GT+G+VY+ + G++ A+K +D + + ++ + ++ + + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSH 79
Query: 328 HPNIME-----LVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL- 380
H NI + L LV EF GS+ D + L IA
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTL---KEEWIAYI 134
Query: 381 --GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
R L +LH V+H++IK N+LL +L D G+++ + N G
Sbjct: 135 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 439 SGY-GAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492
+ Y APEV Y+ KSD++S G+ +E+ G P
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---------------- 235
Query: 493 QLHDIDALAKMVD---PALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
+H + AL + P LK K S+ F I C+ RP ++++
Sbjct: 236 DMHPMRALFLIPRNPAPRLKS----KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 50/305 (16%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +GEG+ G V A+ G+ +AVK +D + V + H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNV 104
Query: 332 MELVGYCSEY--GQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
V Y G+ L ++ EF + G+L D + L + +AL Y
Sbjct: 105 ---VEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAY 156
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY-GAPEVA 447
LH + V+H++IKS +ILL + +LSD G + + + G+ Y APEV
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL---AKMV 504
Y + D++S G++++E++ G P+ S + A+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFS----------------DSPVQAMKRLRDSP 257
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRAN 553
P LK K D + + +P+ R E++ LV L+Q
Sbjct: 258 PPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYR 315
Query: 554 MSKRT 558
T
Sbjct: 316 KQTST 320
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 67/305 (21%)
Query: 279 LGEGTFGRVYRAQFAD-----GKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LGEG FG+V+ A+ + K+L AVK + A S DF ++ L H +I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR-QDFQREAELLTMLQHQHIV 106
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFL-----------HLSDEDNKPLIWNSRVKIALG 381
G C+E L+V+E+ ++G L+ FL D PL + +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGY 441
A + YL L VH+++ + N L+ L ++ D G++ ++ + D G
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGGR 219
Query: 442 G-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493
PE + ++ +SDV+SFGVV+ E+ T G++P+ Q
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----------------YQ 263
Query: 494 LHDIDALAKMVD------PAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
L + +A+ + P +Y ++ C Q EP+ R + +V L
Sbjct: 264 LSNTEAIDCITQGRELERPRACPPEVY---------AIMRGCWQREPQQRHSIKDVHARL 314
Query: 546 VRLVQ 550
L Q
Sbjct: 315 QALAQ 319
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 73/372 (19%), Positives = 142/372 (38%), Gaps = 54/372 (14%)
Query: 234 KSFDEEDFSKKSIV-VKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF 292
K +E + ++ ++ + V D + + LG G G V++
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFE-------KISELGAGNGGVVFKVSH 54
Query: 293 -ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVG-YCSEYGQHLLVYEF 350
G V+A K I P+ E+ + + + P I+ G + S+ G+ + E
Sbjct: 55 KPSGLVMARKLIHLEIKPAIRNQIIREL-QVLHECNSPYIVGFYGAFYSD-GEISICMEH 112
Query: 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD 410
GSL L + + ++ K+++ + L YL E ++H+++K +NIL++
Sbjct: 113 MDGGSLDQVLKKAGRIPEQIL----GKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVN 166
Query: 411 NELNPQLSDCGLASNMPNADEALNNDAG-SGYGAPEVAMSGQYNIKSDVYSFGVVMLELL 469
+ +L D G++ + D N+ G Y +PE Y+++SD++S G+ ++E+
Sbjct: 167 SRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 470 TGRKPF--------------------------DSSRPRLEQSLVRWATPQLHDIDALAKM 503
GR P + R + P + + L +
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE------VVQALVRLVQRANMSKR 557
V+ L F D + C+ P R + + + ++ V A
Sbjct: 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS 344
Query: 558 TIGNDQGPTTPR 569
TIG +Q P+TP
Sbjct: 345 TIGLNQ-PSTPT 355
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 70/323 (21%), Positives = 127/323 (39%), Gaps = 57/323 (17%)
Query: 266 LQMATGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS 324
+++ V +L EG F VY AQ G+ A+K++ S+ E I+ V +
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMK 80
Query: 325 QL-HHPNIMELVGYCSEYGQH-------LLVYEFRKNGSLHDFLHLSDEDNKPL----IW 372
+L HPNI++ S + L+ G L +FL E PL +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVL 139
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
KI T RA++++H ++H+++K N+LL N+ +L D G A+ + + +
Sbjct: 140 ----KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 433 LNNDAGSG-------------YGAPEV--AMSGQ-YNIKSDVYSFGVVMLELLTGRKPFD 476
+ Y PE+ S K D+++ G ++ L + PF+
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
Query: 477 SSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
+ +V K P + + + F +I +Q PE R
Sbjct: 255 DG---AKLRIVN------------GKYSIPP----HDTQY-TVFHSLIRAMLQVNPEERL 294
Query: 537 PMSEVVQALVRLVQRANMSKRTI 559
++EVV L + N++ ++
Sbjct: 295 SIAEVVHQLQEIAAARNVNPKSP 317
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 60/253 (23%), Positives = 106/253 (41%), Gaps = 26/253 (10%)
Query: 232 RHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQ 291
H P + L + + LG G +G V +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQAT-PGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCR 57
Query: 292 F-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350
A+K I +++ + +E V+ + L HPNIM+L + + + LV E
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 351 RKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406
K G L D + ++ D +I ++ + YLH ++VH+++K N
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVII----KQV----LSGVTYLH---KHNIVHRDLKPEN 166
Query: 407 ILLDN---ELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYNIKSDVYSFG 462
+LL++ + ++ D GL++ N + + G+ Y APEV + +Y+ K DV+S G
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFEN-QKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIG 224
Query: 463 VVMLELLTGRKPF 475
V++ LL G PF
Sbjct: 225 VILFILLAGYPPF 237
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 44/362 (12%), Positives = 94/362 (25%), Gaps = 76/362 (20%)
Query: 226 RPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFG 285
R P + + + + S+V S + T +LG+
Sbjct: 30 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRT--LVRGTVLGQEDPY 87
Query: 286 RVYRAQ-FADGKVLAVKKIDSSALPSEMCDD--------------------------FIE 318
A G+ V + P FI
Sbjct: 88 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147
Query: 319 MVSNISQLHHPNIMELVGYCSEYGQ---HLLVYEFRKN-GSLHDFLHLSDEDNKPLIWNS 374
+ ++ + + L + N + + L +K L+ ++
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207
Query: 375 RVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434
R+++ L R L LH +VH ++ +I+LD L+ D A
Sbjct: 208 RLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARV 260
Query: 435 NDAGS-GYGAPEVAMS-----------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
+ S G+ PE+ D ++ G+V+ + P
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320
Query: 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFA-DVIALCVQPEPEFRPPMSEV 541
+ K++ + ++ ++ E R +
Sbjct: 321 GSEWI-----------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
Query: 542 VQ 543
++
Sbjct: 358 ME 359
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 77/314 (24%)
Query: 276 ENLLGEGTFGRVYRAQFADG--------KVLAVKKIDSSALPSEMCDDFIEMVSNISQL- 326
LG G FG+V A A G KV AVK + S+A E + + + +S L
Sbjct: 51 GKTLGAGAFGKVVEAT-AFGLGKEDAVLKV-AVKMLKSTAHADEK-EALMSELKIMSHLG 107
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----------HLSDEDNKPLIWNSRV 376
H NI+ L+G C+ G L++ E+ G L +FL N +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
+ A+ + +L S + +H+++ + N+LL N ++ D GLA ++ N +
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--- 221
Query: 437 AGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP-------- 480
G APE Y ++SDV+S+G+++ E+ + G P+
Sbjct: 222 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280
Query: 481 ----RLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
++ Q +A ++ I M C EP RP
Sbjct: 281 KDGYQMAQP--AFAPKNIYSI-----MQA---------------------CWALEPTHRP 312
Query: 537 PMSEVVQALVRLVQ 550
++ L Q
Sbjct: 313 TFQQICSFLQEQAQ 326
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+N+ +LG+G+FG V + + + AVK I+ ++ ++ + V + +L HPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
M+L + +V E G L D + S+ D +I ++ +
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----KQV----FSGIT 135
Query: 388 YLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
Y+H ++VH+++K NILL++ + + ++ D GL++ + + + G+ Y A
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIGTAYYIA 191
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
PEV + G Y+ K DV+S GV++ LL+G PF
Sbjct: 192 PEV-LRGTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 70/316 (22%), Positives = 128/316 (40%), Gaps = 75/316 (23%)
Query: 279 LGEGTFGRVYRAQFAD-----GKVL-AVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+GEG FGRV++A+ + AVK + A DF + +++ +PNI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIV 113
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFL--------------------HLSDEDNKPLIW 372
+L+G C+ L++E+ G L++FL +S PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
++ IA A + YL VH+++ + N L+ + +++D GL+ N+ +AD
Sbjct: 174 AEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 433 LNNDAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484
+ G PE +Y +SDV+++GVV+ E+ + G +P+
Sbjct: 231 KAD----GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--------- 277
Query: 485 SLVRWATPQLHDIDALAKMVD------PAL--KGLYPVKSLSRFADVIALCVQPEPEFRP 536
+ + + + D P LY +++ LC P RP
Sbjct: 278 -------YGMAHEEVIYYVRDGNILACPENCPLELY---------NLMRLCWSKLPADRP 321
Query: 537 PMSEVVQALVRLVQRA 552
+ + L R+ +RA
Sbjct: 322 SFCSIHRILQRMCERA 337
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPN 330
+ + +LG+G+FG V + G+ AVK I + + + V + QL HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARAL 386
IM+L + + G LV E G L D + S+ D +I + L +
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII-----RQVLS---GI 139
Query: 387 EYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASNMPNADEALNNDAGS-GYG 442
Y+H +VH+++K N+LL++ + N ++ D GL+++ + + + G+ Y
Sbjct: 140 TYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYI 195
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
APEV + G Y+ K DV+S GV++ LL+G PF+
Sbjct: 196 APEV-LHGTYDEKCDVWSTGVILYILLSGCPPFN 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 276 ENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
+GEG FG V++ + V A+K + S + F++ + Q HP+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVR-EKFLQEALTMRQFDHPH 452
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I++L+G +E ++ E G L FL + L S + A + AL YL
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLE 508
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YGAPE 445
S VH++I + N+L+ + +L D GL+ M ++ A G + APE
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPE 562
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
++ SDV+ FGV M E+L G KPF
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 74/260 (28%), Positives = 116/260 (44%), Gaps = 44/260 (16%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHH 328
G + + + LG GTFG+V + G +AVK ++ + S I+ + N+ H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 329 PNIMELVGY-CSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR-- 384
P+I++L Y +V E+ G L D++ + RV+ AR
Sbjct: 71 PHIIKL--YQVISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEM--EARRL 116
Query: 385 ------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
A++Y H VVH+++K N+LLD +N +++D GL SNM + E L G
Sbjct: 117 FQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRTSCG 172
Query: 439 S-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFD-SSRPRLEQSLVR------- 488
S Y APEV Y + D++S GV++ LL G PFD P L + +
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE 232
Query: 489 WATPQLHDIDALAKM--VDP 506
+ + + L M VDP
Sbjct: 233 YLNRSVATL--LMHMLQVDP 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 279 LGEGTFGRVYRAQFADGKVL--------AVKKIDSSALPSEMCDDF---IEMVSNISQLH 327
LGEG FG+V A+ AVK + A ++ D +EM+ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGK-- 99
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL------------HLSDEDNKPLIWNSR 375
H NI+ L+G C++ G ++ E+ G+L ++L ++ + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN 435
V AR +EYL S +H+++ + N+L+ +++D GLA ++ N D
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 436 DAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKP 474
G APE Y +SDV+SFGV+M E+ T G P
Sbjct: 217 ----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 279 LGEGTFGRVYRAQ------FADGKVLAVKKIDSSALPSEMCDDF---IEMVSNISQLHHP 329
LG G FG+V A A + +AVK + A SE ++++ +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGH--HL 91
Query: 330 NIMELVGYCSEYGQHLLV-YEFRKNGSLHDFL------------HLSDEDNKPLIWNSRV 376
N++ L+G C++ G L+V EF K G+L +L D L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
+ A+ +E+L S +H+++ + NILL + ++ D GLA ++ + +
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK- 207
Query: 437 AGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
G APE Y I+SDV+SFGV++ E+ + G P+
Sbjct: 208 ---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + ++LG+G V+R + G + A+K ++ + + D + + +L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNI 69
Query: 332 MEL--VGYCSEYGQHLLVYEFRKNGSLHDFLH-------LSDEDNKPLIWNSRVKIALGT 382
++L + + +L+ EF GSL+ L L + + ++ +
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD--------V 121
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCGLASNMPNADEALNNDAG 438
+ +L +VH+NIK NI+ D + +L+D G A + + DE + G
Sbjct: 122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYG 177
Query: 439 S-GYGAPEV--------AMSGQYNIKSDVYSFGVVMLELLTGRKPF-DSSRPRLEQSL 486
+ Y P++ +Y D++S GV TG PF PR + +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 71/313 (22%), Positives = 121/313 (38%), Gaps = 76/313 (24%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSN-ISQL----H 327
E +LG G+ G V G+ +AVK++ DF ++ I L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---------DFCDIALMEIKLLTESDD 67
Query: 328 HPNIMELVGYCSEY-GQHL-LVYEFRKNGSLHDFL---HLSDEDNKPLIWNSRVKIALGT 382
HPN++ YCSE + L + E N +L D + ++SDE+ K + + +
Sbjct: 68 HPNVIRY--YCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ-------------LSDCGLASNMPNA 429
A + +LH SL ++H+++K NIL+ +SD GL + +
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 430 DEA----LNNDAGS-GYGAPEV-------AMSGQYNIKSDVYSFGVVMLELLT-GRKPFD 476
+ LNN +G+ G+ APE+ + D++S G V +L+ G+ PF
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 477 SSRPRLEQ------SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQP 530
R SL + A A D+I+ +
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT-------------------DLISQMIDH 282
Query: 531 EPEFRPPMSEVVQ 543
+P RP +V++
Sbjct: 283 DPLKRPTAMKVLR 295
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 44/232 (18%)
Query: 279 LGEGTFGRVYRAQFADG-------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
LGEG FG+V +A V AVK + +A PSE+ D + + + Q++HP++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSEL-RDLLSEFNVLKQVNHPHV 88
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL--------------------HLSDEDNKPLI 371
++L G CS+ G LL+ E+ K GSL FL L D + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 372 WNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431
+ A ++ ++YL + +VH+++ + NIL+ ++SD GL+ ++ D
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 432 ALNNDAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
+ G A E Y +SDV+SFGV++ E++T G P+
Sbjct: 206 YVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+N+ +LG+G+FG V + + + AVK I+ ++ ++ + V + +L HPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
M+L + +V E G L D + S+ D +I K +
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-----KQVFS---GIT 135
Query: 388 YLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
Y+H ++VH+++K NILL + + + ++ D GL++ + + + G+ Y A
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIGTAYYIA 191
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
PEV + G Y+ K DV+S GV++ LL+G PF
Sbjct: 192 PEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
++V+ LG+G F V R G A K I++ L + +L HPNI
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
+ L E H LV++ G L + + S+ D I ++
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------ILESIA 119
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQ---LSDCGLASNMPNADEALNNDAGS-GYGA 443
Y H S +VH+N+K N+LL ++ L+D GLA + + EA + AG+ GY +
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLS 175
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
PEV Y+ D+++ GV++ LL G PF
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 276 ENLLGEGTFGRVYRAQFADGKVL---AVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNI 331
++++GEG FG+V +A+ + A+K++ A + DF + + +L HHPNI
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNI 88
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL------------HLSDEDNKPLIWNSRVKIA 379
+ L+G C G L E+ +G+L DFL +++ L + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
AR ++YL +H+++ + NIL+ +++D GL+ + +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KK 198
Query: 440 GYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKP 474
G A E Y SDV+S+GV++ E+++ G P
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 45/229 (19%)
Query: 279 LGEGTFGRVYRAQFADG--------KVLAVKKIDSSALPSEMCDDF---IEMVSNISQLH 327
LG G FG+V A A G V AVK + SA +E + ++++S +
Sbjct: 31 LGAGAFGKVVEAT-AYGLIKSDAAMTV-AVKMLKPSAHLTER-EALMSELKVLSYLGN-- 85
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL--------------HLSDEDNKPLIWN 373
H NI+ L+G C+ G L++ E+ G L +FL + ++D L
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
+ + A+ + +L S + +H+++ + NILL + ++ D GLA ++ N +
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 434 NNDAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKP 474
G APE + Y +SDV+S+G+ + EL + G P
Sbjct: 203 V----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS---QLHH 328
+ + ++G+G F V R G+ AVK +D + S ++ S L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSL--------HDFLHLSDEDNKPLIWNSRVKIAL 380
P+I+EL+ S G +V+EF L S+ + + L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM-----RQIL 140
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ---LSDCGLASNMPNADEALNNDA 437
AL Y H +++H+++K +LL ++ N L G+A + +
Sbjct: 141 E---ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 438 GS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482
G+ + APEV Y DV+ GV++ LL+G PF ++ RL
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 45/230 (19%)
Query: 279 LGEGTFGRVYRAQFADG----------KVLAVKKIDSSALPSEMCDDF---IEMVSNISQ 325
LGEG FG+V A+ A G V AVK + A ++ D +EM+ I +
Sbjct: 89 LGEGCFGQVVMAE-AVGIDKDKPKEAVTV-AVKMLKDDATEKDL-SDLVSEMEMMKMIGK 145
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL------------HLSDEDNKPLIWN 373
H NI+ L+G C++ G ++ E+ G+L ++L ++ + + +
Sbjct: 146 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
V AR +EYL S +H+++ + N+L+ +++D GLA ++ N D
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 434 NNDAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475
G APE Y +SDV+SFGV+M E+ T G P+
Sbjct: 261 KT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 66/223 (29%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-------EMCDDFIEMVSN-- 322
+ LG G +G V + A+K I S + + F E + N
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 323 --ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRV 376
+ L HPNI++L + LV EF + G L + + + D ++
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM----K 153
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASNMPNADEAL 433
+I + YLH ++VH++IK NILL+N LN ++ D GL+S D L
Sbjct: 154 QIL----SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKL 205
Query: 434 NNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ G+ Y APEV + +YN K DV+S GV+M LL G PF
Sbjct: 206 RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 79/308 (25%), Positives = 131/308 (42%), Gaps = 66/308 (21%)
Query: 279 LGEGTFGRVYRAQFADG----------KVLAVKKIDSSALPSEMCDDF---IEMVSNISQ 325
LGEG FG+V A+ A G KV AVK + S A ++ D +EM+ I +
Sbjct: 77 LGEGAFGQVVLAE-AIGLDKDKPNRVTKV-AVKMLKSDATEKDL-SDLISEMEMMKMIGK 133
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL------------HLSDEDNKPLIWN 373
H NI+ L+G C++ G ++ E+ G+L ++L + S + L
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
V A AR +EYL S +H+++ + N+L+ + +++D GLA ++ + D
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 434 NNDAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQS 485
G APE Y +SDV+SFGV++ E+ T G P+ P +
Sbjct: 249 KT----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY----PGVPVE 300
Query: 486 LVRWATPQLHDIDALAKMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + +M P+ LY ++ C P RP ++V+
Sbjct: 301 EL------FKLLKEGHRMDKPSNCTNELY---------MMMRDCWHAVPSQRPTFKQLVE 345
Query: 544 ALVRLVQR 551
L R+V
Sbjct: 346 DLDRIVAL 353
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 68/316 (21%), Positives = 124/316 (39%), Gaps = 54/316 (17%)
Query: 275 VENLLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDD------FIEMVSNISQ 325
+ +LG G V+ A+ D + +AVK L +++ D F N +
Sbjct: 16 LGEILGFGGMSEVHLAR--DLRDHRDVAVK-----VLRADLARDPSFYLRFRREAQNAAA 68
Query: 326 LHHPNIMELVGYCSEYGQ----HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
L+HP I+ + +V E+ +L D +H P+ +++
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIAD 124
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDA---G 438
+AL + H+ ++H+++K ANI++ ++ D G+A + ++ ++ A G
Sbjct: 125 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 439 S-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD- 496
+ Y +PE A + +SDVYS G V+ E+LTG PF P V A + +
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRED 235
Query: 497 ---IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVVQALVRLVQRA 552
A + + L V+ + PE R +E+ LVR+
Sbjct: 236 PIPPSARHEGLSADL------------DAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283
Query: 553 NMSKRTIGNDQGPTTP 568
+ D T+
Sbjct: 284 PPEAPKVLTDAERTSL 299
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 71/325 (21%), Positives = 125/325 (38%), Gaps = 90/325 (27%)
Query: 279 LGEGTFGRVYRAQFADG--------KVLAVKKIDSSALPSEMCDDF---IEMVSNISQLH 327
LG G FG+V A A G +V AVK + A SE + ++M++ +
Sbjct: 53 LGSGAFGKVMNAT-AYGISKTGVSIQV-AVKMLKEKADSSER-EALMSELKMMTQLGS-- 107
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL-------------------HLSDEDNK 368
H NI+ L+G C+ G L++E+ G L ++L +ED
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 369 PLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428
L + + A A+ +E+L S VH+++ + N+L+ + ++ D GLA ++ +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 429 ADEALNNDAGSGYG-------APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP 480
+ G APE G Y IKSDV+S+G+++ E+ + G P+
Sbjct: 225 DSNYVVR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 481 ------------RLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCV 528
+++Q +AT +++ I M C
Sbjct: 281 DANFYKLIQNGFKMDQP--FYATEEIYII-----MQS---------------------CW 312
Query: 529 QPEPEFRPPMSEVVQALVRLVQRAN 553
+ RP + L + A
Sbjct: 313 AFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
+ + LG G F V + Q GK A K I L S E + + ++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTA 383
HPNI+ L +L+ E G L DFL L++++ + K L
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL-----KQILD-- 119
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALNNDAGS 439
+ YLH S + H ++K NI+L ++ P L D G+A + A N G+
Sbjct: 120 -GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGT 174
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ APE+ +++D++S GV+ LL+G PF
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/259 (19%), Positives = 102/259 (39%), Gaps = 40/259 (15%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM------VSNI 323
++ + LG G FG V+ A K + VK I + + + ++ ++ +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 324 SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGS-LHDFLHLSDEDNKPLIWNSRVKIALGT 382
S++ H NI++++ G LV E +G L F+ + ++
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI------------DRHPRLDEPL 131
Query: 383 AR--------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434
A A+ YL ++H++IK NI++ + +L D G + +
Sbjct: 132 ASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS-AAYLERGKLFY 187
Query: 435 NDAGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV--RWA 490
G+ Y APEV M Y + +++S GV + L+ PF +E ++
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 491 TPQLHDIDALAKM--VDPA 507
+ +L + ++ + P
Sbjct: 248 SKELMSL--VSGLLQPVPE 264
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 26/217 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
+++ LG G F V + + + G A K I + E + + Q+
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTA 383
H N++ L +L+ E G L DFL LS+E+ I K L
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-----KQILD-- 126
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALNNDAGS 439
+ YLH + + H ++K NI+L ++ P L D GLA + N G+
Sbjct: 127 -GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGT 181
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ APE+ +++D++S GV+ LL+G PF
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 64/291 (21%), Positives = 103/291 (35%), Gaps = 45/291 (15%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDD------FIEMVS 321
G + + L+G G G VY A+ D +++A+K + + D
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAE--DTVRERIVALK-----LMSETLSSDPVFRTRMQREAR 86
Query: 322 NISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
+L P+++ + + GQ + L L PL V I
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQ 142
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL---NNDAG 438
AL+ H H+++K NIL+ + L D G+AS DE L N G
Sbjct: 143 IGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVG 197
Query: 439 S-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497
+ Y APE ++D+Y+ V+ E LTG P+ + + ++
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQA 250
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVVQALVR 547
V P + PV F VIA + PE R ++ A
Sbjct: 251 IPRPSTVRPGI----PVA----FDAVIARGMAKNPEDRYVTCGDLSAAAHA 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ----LH 327
+ + +LG G V R K AVK ID + S ++ E+ + L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 328 ----HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIA 379
HPNI++L LV++ K G L D+L LS+++ + ++ +
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM-----RAL 133
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
L + LH L++VH+++K NILLD+++N +L+D G + + + E L G+
Sbjct: 134 LE---VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGT 186
Query: 440 -GYGAPEV------AMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
Y APE+ Y + D++S GV+M LL G PF
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
+++ LG G F V + + + G A K I + E + + Q+
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTA 383
HPNI+ L +L+ E G L DFL LS+E+ I K L
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-----KQILD-- 126
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALNNDAGS 439
+ YLH + + H ++K NI+L ++ P L D GLA + N G+
Sbjct: 127 -GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGT 181
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ APE+ +++D++S GV+ LL+G PF
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 63/265 (23%), Positives = 110/265 (41%), Gaps = 44/265 (16%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPS-EMCDDFIEM-VSNISQLH 327
G + + +LLGEG++G+V AVK + L + ++ + + +L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 328 HPNIMELVG-YCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR- 384
H N+++LV +E Q + +V E+ G + ++ + + A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPVCQAHG 113
Query: 385 -------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA--DEALNN 435
LEYLH S +VHK+IK N+LL ++S G+A + D+
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 436 DAGS-GYGAPEVAMSGQ-YN-IKSDVYSFGVVMLELLTGRKPF-DSSRPRL-------EQ 484
GS + PE+A ++ K D++S GV + + TG PF + +L
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
Query: 485 SLVRWATPQLHDIDALAKM--VDPA 507
++ P L D+ L M +PA
Sbjct: 231 AIPGDCGPPLSDL--LKGMLEYEPA 253
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
++V+ LG+G F V R G A K I++ L + +L HPNI
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
+ L E H LV++ G L + + S+ D I ++
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------ILESIA 142
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQ---LSDCGLASNMPNADEALNNDAGS-GYGA 443
Y H S +VH+N+K N+LL ++ L+D GLA + + EA + AG+ GY +
Sbjct: 143 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLS 198
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
PEV Y+ D+++ GV++ LL G PF
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG+G F V R G+ A I++ L + L HPNI
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
+ L SE G H L+++ G L + + + S+ D I + L A+
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-----QQILE---AVL 124
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNP---QLSDCGLASNMPNADEALNNDAGS-GYGA 443
+ H + VVH+N+K N+LL ++L +L+D GLA + +A AG+ GY +
Sbjct: 125 HCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
PEV Y D+++ GV++ LL G PF
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 7e-25
Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + ++LG+G V+R + G + A+K ++ + + E + +L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FEVLKKLNHKNI 69
Query: 332 MEL--VGYCSEYGQHLLVYEFRKNGSLHDFLH-------LSDEDNKPLIWNSRVKIALGT 382
++L + + +L+ EF GSL+ L L + + ++ +
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD--------V 121
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCGLASNMPNADEALNNDAG 438
+ +L +VH+NIK NI+ D + +L+D G A + + DE + G
Sbjct: 122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYG 177
Query: 439 S-GYGAPEV--------AMSGQYNIKSDVYSFGVVMLELLTGRKPF-DSSRPRLEQSL 486
+ Y P++ +Y D++S GV TG PF PR + +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-25
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 17/219 (7%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
G + ++ LG G FG V R G+ +A+K+ P +E + + +L+H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE-IQIMKKLNH 71
Query: 329 PNIMELV------GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT 382
PN++ + LL E+ + G L +L+ E+ L +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDI 130
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLD---NELNPQLSDCGLASNMPNADEALNNDAGS 439
+ AL YLHE ++H+++K NI+L L ++ D G A + E G+
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFVGT 186
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y APE+ +Y + D +SFG + E +TG +PF
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 45/269 (16%)
Query: 263 IADLQMATGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-V 320
+A + G + + LGEG+FG+V A + + +A+K I L +E +
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 321 SNISQLHHPNIMELVGY-CSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI 378
S + L HP+I++L Y + +V E+ G L D++ + R+
Sbjct: 61 SYLKLLRHPHIIKL--YDVITTPTDIVMVIEY-AGGELFDYI----------VEKKRMTE 107
Query: 379 ALGTAR--------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430
R A+EY H +VH+++K N+LLD+ LN +++D GL SN+
Sbjct: 108 D--EGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGL-SNIMTDG 161
Query: 431 EALNNDAGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFD-SSRPRLEQSLV 487
L GS Y APEV Y + DV+S G+V+ +L GR PFD P L + +
Sbjct: 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN 221
Query: 488 R-------WATPQLHDIDALAKM--VDPA 507
+ +P + + +M DP
Sbjct: 222 SCVYVMPDFLSPGAQSL--IRRMIVADPM 248
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 35/275 (12%)
Query: 225 LRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFN----VENLLG 280
LR P E + ++ A F ++++G
Sbjct: 44 LRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIG 103
Query: 281 EGTFGRVYRAQF-ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSN-ISQLH----HPNIM 332
G V R A G AVK ++ +A E ++ E L HP+I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALEY 388
L+ LV++ + G L D+L LS+++ + ++ + L A+ +
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-----RSLLE---AVSF 215
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV- 446
LH + ++VH+++K NILLD+ + +LSD G + ++ E L G+ GY APE+
Sbjct: 216 LH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEIL 271
Query: 447 -----AMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
Y + D+++ GV++ LL G PF
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F + LG G FG V+ + + G +K I+ M + + + L HPNI
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM-EQIEAEIEVLKSLDHPNI 82
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL--------HLSDEDNKPLIWNSRVKIALGTA 383
+++ +Y +V E + G L + + LS+ L+ K +
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM-----KQMMN-- 135
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASNMPNADEALNNDAGS- 439
AL Y H S VVHK++K NIL + ++ D GLA + DE N AG+
Sbjct: 136 -ALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGTA 190
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
Y APEV K D++S GVVM LLTG PF
Sbjct: 191 LYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 268 MAT---GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNI 323
MA +++ LGEG +G V A + +AVK +D + ++ + +
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICIN 59
Query: 324 SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
L+H N+++ G+ E L E+ G L D + + + A
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDA 107
Query: 384 R--------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP---NADEA 432
+ + YLH + + H++IK N+LLD N ++SD GL + + N +
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERL 163
Query: 433 LNNDAGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFD 476
LN G+ Y APE+ +++ DV+S G+V+ +L G P+D
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
++ LG G F V + + + G A K I S E + + ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTA 383
HPN++ L +L+ E G L DFL L++E+ + K L
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-----KQILN-- 125
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALNNDAGS 439
+ YLH SL + H ++K NI+L + P+ + D GLA + + N G+
Sbjct: 126 -GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGT 180
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ APE+ +++D++S GV+ LL+G PF
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +EN +G G++G V A A KKI + D F + + + L HPNI
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSLDHPNI 68
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
+ L + LV E G L + + + D ++ K L A+
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM-----KDVLS---AVA 120
Query: 388 YLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
Y H L+V H+++K N L + +L D GLA+ + + G+ Y +
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTKVGTPYYVS 176
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
P+V + G Y + D +S GV+M LL G PF +
Sbjct: 177 PQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHH 328
G + + + LG GTFG+V + G +AVK ++ + S I + N+ H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR---- 384
P+I++L S +V E+ G L D++ N R+ +R
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEK--ESRRLFQ 123
Query: 385 ----ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
++Y H VVH+++K N+LLD +N +++D GL SNM + E L GS
Sbjct: 124 QILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRTSCGSP 179
Query: 440 GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFD 476
Y APEV Y + D++S GV++ LL G PFD
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 50/247 (20%), Positives = 99/247 (40%), Gaps = 59/247 (23%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSAL-----------------PSEM 312
+ +++ +G+G++G V A D A+K + L
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 313 CDDFIEMVSNISQ-------LHHPNIMELV---GYCSEYGQHL-LVYEFRKNGSLHDFLH 361
C + + Q L HPN+++LV +E HL +V+E G + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE--DHLYMVFELVNQGPVME--- 127
Query: 362 LSDEDNKPLIWNSRVKIALGTAR--------ALEYLHEVCSLSVVHKNIKSANILLDNEL 413
+ + AR +EYLH ++H++IK +N+L+ +
Sbjct: 128 --------VPTLKPLSED--QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDG 174
Query: 414 NPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV--AMSGQYN-IKSDVYSFGVVMLELL 469
+ +++D G+++ +D L+N G+ + APE ++ DV++ GV + +
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 470 TGRKPFD 476
G+ PF
Sbjct: 235 FGQCPFM 241
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 31/220 (14%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+++ LGEG +G V A + +AVK +D + E + L+H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHE 65
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR----- 384
N+++ G+ E L E+ G L D + + + A+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQ 113
Query: 385 ---ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP---NADEALNNDAG 438
+ YLH + + H++IK N+LLD N ++SD GL + + N + LN G
Sbjct: 114 LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERLLNKMCG 169
Query: 439 S-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFD 476
+ Y APE+ +++ DV+S G+V+ +L G P+D
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 50/338 (14%), Positives = 94/338 (27%), Gaps = 87/338 (25%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F +G G FG V+ A+ D A+K+I E V +++L HP I
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLEHPGI 66
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKP---------------------- 369
+ E E + + P
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 370 ------------------------LIWNSRVKIALGTARALEYLHEVC-------SLSVV 398
+ L ++ S ++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-------------YGAPE 445
H+++K +NI + ++ D GL + M +E Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
Y+ K D++S G+++ ELL R R+ + P L
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQ-MERVRIITDVRNLKFPLL----------- 294
Query: 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + ++ + P P RP +++++
Sbjct: 295 -------FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 56/254 (22%), Positives = 95/254 (37%), Gaps = 52/254 (20%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSAL---PSEMCDDFIEMVSNISQLHH 328
++++ +G+G++G V A + + A+K ++ + + + + V + +LHH
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR---- 384
PNI L + LV E G L D L++ +D+ VK +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 385 --------------------------------ALEYLHEVCSLSVVHKNIKSANILL--D 410
AL YLH + + H++IK N L +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTN 204
Query: 411 NELNPQLSDCGLA----SNMPNADEALNNDAGS-GYGAPEV--AMSGQYNIKSDVYSFGV 463
+L D GL+ + AG+ + APEV + Y K D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 464 VMLELLTGRKPFDS 477
++ LL G PF
Sbjct: 265 LLHLLLMGAVPFPG 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 63/298 (21%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 268 MATGSFN-------VENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEM 319
M F + LGEG+F + + AVK I I
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITA 58
Query: 320 VSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSR 375
+ HPNI++L + LV E G L + + H S+ + ++
Sbjct: 59 LKLCE--GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK-- 114
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILL-DNELNPQL--SDCGLASNMPNADEA 432
A+ ++H + VVH+++K N+L D N ++ D G A P ++
Sbjct: 115 ------LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 433 LNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491
L + Y APE+ Y+ D++S GV++ +L+G+ PF +
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSH 212
Query: 492 PQLHDIDALAKMVDPALKGLY-----PVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ + +++ KG + K++S+ A D+I + +P R MS +
Sbjct: 213 DRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F +LG G F V+ Q GK+ A+K I S + ++ + ++ H NI
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENI 68
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
+ L + LV + G L D + +++D +I A++
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ--------VLSAVK 120
Query: 388 YLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
YLH +VH+++K N+L + ++D GL+ + ++ G+ GY A
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTACGTPGYVA 175
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
PEV Y+ D +S GV+ LL G PF
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 41/212 (19%), Positives = 84/212 (39%), Gaps = 24/212 (11%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG G FG V+R + + K K + + I + ++ H NI
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI---LNIARHRNI 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL-----HLSDEDNKPLIWNSRVKIALGTARAL 386
+ L + ++++EF + + + L++ + + AL
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV-----HQVCE---AL 115
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQL--SDCGLASNMPNADEALNNDAGS-GYGA 443
++LH S ++ H +I+ NI+ + + + G A + + + Y A
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYA 171
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
PEV + +D++S G ++ LL+G PF
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 33/258 (12%)
Query: 228 PPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRV 287
D K D + F + + KK V P V S+ D +++ LG G FG V
Sbjct: 16 GKYDGPKINDYDKFYED--IWKKYVPQPVEVKQGSVYDY------YDILEELGSGAFGVV 67
Query: 288 YRA-QFADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345
+R + A G+V K I++ + I + ++QLHHP ++ L + + +
Sbjct: 68 HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI---MNQLHHPKLINLHDAFEDKYEMV 124
Query: 346 LVYEFRKNGSLHDFL-----HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHK 400
L+ EF G L D + +S+ + + + A L+++H S+VH
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYM-----RQACE---GLKHMH---EHSIVHL 173
Query: 401 NIKSANILLDNELNPQL--SDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYNIKSD 457
+IK NI+ + + + D GLA+ + N DE + + + APE+ +D
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREPVGFYTD 232
Query: 458 VYSFGVVMLELLTGRKPF 475
+++ GV+ LL+G PF
Sbjct: 233 MWAIGVLGYVLLSGLSPF 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 56/315 (17%), Positives = 113/315 (35%), Gaps = 56/315 (17%)
Query: 275 VENLLGEGTFGRVYRA--QFADGKVLAVKKIDSSALPSEMCDDFIEMVS----NISQLHH 328
V+ + G G +Y A + +G+ + +K + S + M ++++ H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-----EAQAMAMAERQFLAEVVH 138
Query: 329 PNIMELVGYCSEYGQHL-----LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
P+I+++ + +H +V E+ SL + L + L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYG 442
AL YLH + +V+ ++K NI+L E +L D G S + + G+ G+
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----GTPGFQ 244
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
APE+ + +D+Y+ G + L +
Sbjct: 245 APEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------------- 286
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGND 562
D + Y + ++ + P+P R +E + A + V R +++ T
Sbjct: 287 --DDPVLKTYD-----SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPR 339
Query: 563 QGPTTPRGDNQDTQD 577
G +T ++ T
Sbjct: 340 PGLSTIFSPSRSTFG 354
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 57/294 (19%), Positives = 107/294 (36%), Gaps = 64/294 (21%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMV----SNISQ 325
+ V LLG G FG VY +D +A+K ++ + V + +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 326 LHH--PNIMELVGYCSEYGQHLLVYEFRKN-GSLHDFLHLSDEDNKPLIWNSRVKIALGT 382
+ ++ L+ + +L+ E + L DF+ R +
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT------------ERGALQEEL 150
Query: 383 AR--------ALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMPNADEAL 433
AR A+ + H + V+H++IK NIL+D N +L D G + + D
Sbjct: 151 ARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVY 205
Query: 434 NNDAGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491
+ G+ Y PE +Y+ + V+S G+++ +++ G PF+
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------ 253
Query: 492 PQLHDIDALAKMVDPALKGLYPVKS-LSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+I ++G + +S +I C+ P RP E+
Sbjct: 254 ----EI----------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 32/236 (13%)
Query: 266 LQMATGSFN----VENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMV 320
L + F V+ +G G++ R A AVK ID S D E +
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEI 66
Query: 321 SNISQL-HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSR 375
+ + HPNI+ L + +V E K G L D + S+ + +++
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT-- 124
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCGLASNMPNADE 431
+ +EYLH + VVH+++K +NIL N + ++ D G A + +
Sbjct: 125 ------ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 432 ALNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSL 486
L + + APEV Y+ D++S GV++ +LTG PF + + +
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 55/265 (20%), Positives = 105/265 (39%), Gaps = 44/265 (16%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSALP--SEMCDDFIEMVSN----ISQ 325
+ + LG G G V A + K +A++ I S D V + +
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALG 381
L+HP I+++ + + + +V E + G L D + L + K +
Sbjct: 197 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-------- 247
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDAG 438
A++YLH ++H+++K N+LL + + +++D G + + + G
Sbjct: 248 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCG 303
Query: 439 S-GYGAPEV---AMSGQYNIKSDVYSFGVVMLELLTGRKPF--DSSRPRLEQSLVR---- 488
+ Y APEV + YN D +S GV++ L+G PF ++ L+ +
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 489 WATPQLHDIDALAK-------MVDP 506
+ ++ A +VDP
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDP 388
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 52/272 (19%), Positives = 112/272 (41%), Gaps = 29/272 (10%)
Query: 213 DTKTFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGS 272
D + ++ + + + + + K+ P + + D
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH------ 158
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+++ LG G FG V+R A G A K + + + + + + +S L HP +
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTL 216
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL-----HLSDEDNKPLIWNSRVKIALGTARAL 386
+ L + + +++YEF G L + + +S+++ + + L
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM-----RQVCK---GL 268
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQL--SDCGLASNMPNADEALNNDAGS-GYGA 443
++H + VH ++K NI+ + + +L D GL +++ + +++ G+ + A
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAA 324
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
PEVA +D++S GV+ LL+G PF
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 51/337 (15%)
Query: 171 KRRRSRRSSTDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTFD---TAVSINLRP 227
+R R D + S + ++ ++ + F + NLR
Sbjct: 100 ERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRG 159
Query: 228 PPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRV 287
+ D+ + K ++ D F+V ++G G FG V
Sbjct: 160 DVFQKFIESDKFTRFCQW-------KNVELNIHLTMND-------FSVHRIIGRGGFGEV 205
Query: 288 YRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN-------ISQLHHPNIMELVGYCS 339
Y + AD GK+ A+K +D + + N +S P I+ + Y
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAF 261
Query: 340 EYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGTARALEYLHEVC 393
L + + G L HLS + ++ I L LE++H
Sbjct: 262 HTPDKLSFILDLMNGGDL--HYHLSQHGVFS---EADMRFYAAEIIL----GLEHMH--- 309
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQ- 451
+ VV++++K ANILLD + ++SD GLA + + + G+ GY APEV G
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVA 367
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488
Y+ +D +S G ++ +LL G PF + + + + R
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 41/117 (35%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L YL I H + G + D Q+ +L TLD S+N LSG LP S SSL +L + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 61 QFSGTI-DVLANLP--LDNLNIANNRFTGWVPEQLKNINLQK---DGNSWSSGPAPP 111
+ SG I D + ++ I+ NR TG +P N+NL N G A
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML-EGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 3/97 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ I+ N+L G++ F L +L+ +DLS N L G+ F S + ++L N +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 64 GTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
+ + L+ L++ NNR G +P+ L + L
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 29/116 (25%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
L +++++ N L+G + +FG + + L+ N+L+ +L +L+ L L+NN+
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256
Query: 63 SGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK---DGNSWSSGPAPPPP 113
GT+ L L L +LN++ N G +P+ N G +P P
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG-SPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 3/98 (3%)
Query: 1 MKTLKYLNIAH-NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L +L I N L G + +L L L ++ +SG +P S + +L +L
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 60 NQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI 95
N SGT+ +++LP L + NR +G +P+ +
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 2/84 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
K + +++A N L L G +L+ LDL N + G LPQ + L L SL + N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 61 QFSGTIDVLANLP-LDNLNIANNR 83
G I NL D ANN+
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 6/94 (6%)
Query: 11 HNQLQGQLNDMFGQLPSLSTLDLSFNTLSG--NLPQSFSSLSSLSSLYLQN-NQFSGTI- 66
+ G L D Q ++ LDLS L +P S ++L L+ LY+ N G I
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 67 DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
+A L L L I + +G +P+ L I L
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 10/87 (11%)
Query: 22 FGQLPSLS----TLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV---LANLP- 73
G +LS T D T G L + + +++L L + LANLP
Sbjct: 18 LGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77
Query: 74 LDNLNIAN-NRFTGWVPEQLKNI-NLQ 98
L+ L I N G +P + + L
Sbjct: 78 LNFLYIGGINNLVGPIPPAIAKLTQLH 104
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 58/293 (19%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM-VSNISQLHH 328
++ +G G FG + +++AVK I+ A E ++ + N L H
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRH 75
Query: 329 PNIMELVGY-CSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR-- 384
PNI+ HL ++ E+ G L++ + R AR
Sbjct: 76 PNIVRF--KEVILTPTHLAIIMEYASGGELYERI----------CNAGRFSED--EARFF 121
Query: 385 ------ALEYLHEVCSLSVVHKNIKSANILLDNELNPQL--SDCGLASNMPNADEALNND 436
+ Y H S+ + H+++K N LLD P+L D G S +
Sbjct: 122 FQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKST 177
Query: 437 AGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494
G+ Y APEV + +Y+ +DV+S GV + +L G PF+
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP---------------- 221
Query: 495 HDIDALAKMVDPALKGLYPVKSLSRF----ADVIALCVQPEPEFRPPMSEVVQ 543
+ K + L Y + R +I+ +P R + E+
Sbjct: 222 EEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 60/296 (20%), Positives = 115/296 (38%), Gaps = 66/296 (22%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMV----SNISQ 325
+ + LLG+G FG V+ D +A+K I + + + + +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 326 LH----HPNIMELVGYCSEYGQHLLVYEFRKNGS-LHDFLHLSDEDNKPLIWNSRVKIAL 380
+ HP ++ L+ + +LV E L D++ + +
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT------------EKGPLGE 138
Query: 381 GTAR--------ALEYLHEVCSLSVVHKNIKSANILLDNELNP-QLSDCGLASNMPNADE 431
G +R A+++ H S VVH++IK NIL+D +L D G + + DE
Sbjct: 139 GPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DE 193
Query: 432 ALNNDAGS-GYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489
+ G+ Y PE QY+ + + V+S G+++ +++ G PF+ +
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------- 243
Query: 490 ATPQLHDIDALAKMVDPALKGLYPVKS-LSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+I L+ + +S +I C+ P+P RP + E++
Sbjct: 244 ------EI----------LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-22
Identities = 44/120 (36%), Positives = 69/120 (57%), Gaps = 10/120 (8%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+K+L+YL++A N+ G++ + + G +L+ LDLS N G +P F S S L SL L +
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKNI--NLQK---DGNSWSSGPAPP 111
N FSG + D L + L L+++ N F+G +PE L N+ +L N++ SGP P
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF-SGPILP 386
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-22
Identities = 36/101 (35%), Positives = 47/101 (46%), Gaps = 3/101 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
TL+ L + +N G++ L +L LSFN LSG +P S SLS L L L N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
G I L + L+ L + N TG +P L N NL
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 493
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-21
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L + N L+G++ + +L TL L FN L+G +P S+ ++L+ + L NN
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
+ +G I + L L L ++NN F+G +P +L + +L
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L++L+++ N + G +L LD+S N LSG+ ++ S+ + L L + +N
Sbjct: 199 CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
QF G I L L L++A N+FTG +P+ L
Sbjct: 258 QFVGPIP-PLPLKSLQYLSLAENKFTGEIPDFLSG-ACDT 295
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-19
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ +L++++N L G + G +P L L+L N +SG++P L L+ L L +N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVPE--QLKNIN 96
+ G I ++ L L ++++NN +G +PE Q +
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP 730
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-19
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 4/97 (4%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQ--LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L L+++ N G + Q +L L L N +G +P + S+ S L SL+L N
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429
Query: 62 FSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNIN 96
SGTI L +L L +L + N G +P++L +
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-19
Identities = 37/104 (35%), Positives = 60/104 (57%), Gaps = 6/104 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQL-PSLSTLDLSFNTLSGNLPQSF--SSLSSLSSLYL 57
M+ LK L+++ N+ G+L + L SL TLDLS N SG + + + ++L LYL
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 58 QNNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
QNN F+G I L+N L +L+++ N +G +P L ++ L+
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-18
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 2/98 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ T NI G + F S+ LD+S+N LSG +P+ S+ L L L +N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNIN 96
SG+I D + +L L+ L++++N+ G +P+ + +
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-17
Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLND-MFGQLPSLSTLDLSFNTLSGNLPQSF---SSLSSLSSLY 56
LK+LN++ N L +L SL LDLS N++SG + L L
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184
Query: 57 LQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPE-----QLKNINL 97
+ N+ SG +D ++ L+ L++++N F+ +P L+++++
Sbjct: 185 ISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDI 230
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-16
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L ++++++N+L G++ G+L +L+ L LS N+ SGN+P SL L L N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 61 QFSGTI-DVLANLPLDNLNIANNRFTGWVPEQLKN 94
F+GTI + IA N G +KN
Sbjct: 549 LFNGTIPAAMFKQSGK---IAANFIAGKRYVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-16
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP--QSFSSLSSLSSLYLQ 58
+ L+ L ++++ + G ++ F SL++LDLS N+LSG + S S S L L +
Sbjct: 76 LTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVS 134
Query: 59 NNQFSGTIDV--LANLP-LDNLNIANNRFTGWVPEQLKNIN 96
+N V L L+ L+++ N +G +
Sbjct: 135 SNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-15
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 12/109 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDM--FGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYL 57
+L L+++ N L G + + G L L++S NTL S L+SL L L
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 58 QNNQFSGTI----DVLANLP-LDNLNIANNRFTGWVP----EQLKNINL 97
N SG + L +L I+ N+ +G V L+ +++
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDV 207
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-15
Identities = 18/92 (19%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 6 YLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT 65
+ + QG ++ +L + + +++ G+ +F + S+ L + N SG
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 66 I-DVLANLP-LDNLNIANNRFTGWVPEQLKNI 95
I + ++P L LN+ +N +G +P+++ ++
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-13
Identities = 22/115 (19%), Positives = 37/115 (32%), Gaps = 5/115 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L L +++N G + G SL LDL+ N +G +P + S +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI----NLQKDGNSWSSGPAPP 111
+ I + F G EQL + + G P
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY-GGHTSP 626
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 21/90 (23%), Positives = 40/90 (44%), Gaps = 8/90 (8%)
Query: 7 LNIAHNQLQ---GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
++++ L ++ L L +L LS + ++G++ F +SL+SL L N S
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 64 GTI---DVLANLP-LDNLNIANNRFTGWVP 89
G + L + L LN+++N
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 15/99 (15%)
Query: 27 SLSTLDLSFNTLS---GNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIANN 82
++++DLS L+ + S SL+ L SL+L N+ +G++ L +L+++ N
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
Query: 83 RFTGWVPE--------QLKNINLQKDGNSWSSGPAPPPP 113
+G V LK +N+ ++ P
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNV---SSNTLDFPGKVSG 146
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 24/209 (11%)
Query: 279 LGEGTFGRVYRA-QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVG 336
LG G F V + + G+ A K + + + + ++ + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 337 YCSEYGQHLLVYEFRKNGSLHDFL------HLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ +L+ E+ G + +S+ D LI K L + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI-----KQILE---GVYYLH 148
Query: 391 EVCSLSVVHKNIKSANILL-DNELNPQL--SDCGLASNMPNADEALNNDAGS-GYGAPEV 446
++VH ++K NILL + D G++ + L G+ Y APE+
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEI 204
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+D+++ G++ LLT PF
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSPF 233
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 273 FNVENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSAL--PSEMCDDFIEMVSN----ISQ 325
+ + LG G G V A + K +A+K I S D V + +
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALG 381
L+HP I+++ + + + +V E + G L D + L + K L
Sbjct: 72 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-----YQMLL 125
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDAG 438
A++YLH ++H+++K N+LL + + +++D G + + + G
Sbjct: 126 ---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCG 178
Query: 439 S-GYGAPEV---AMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476
+ Y APEV + YN D +S GV++ L+G PF
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
F +LG+G FG V Q GK+ A KK++ + M N + +++
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVN 242
Query: 328 HPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALG 381
++ L Y E L LV G L H+ + +R I
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDL--KFHIYHM-GQAGFPEARAVFYAAEICC- 297
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-G 440
LE LH +V++++K NILLD+ + ++SD GLA ++P G+ G
Sbjct: 298 ---GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-KGRVGTVG 350
Query: 441 YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y APEV + +Y D ++ G ++ E++ G+ PF
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F VE+ LG G VYR + K A+K + + ++ I + + +L HPNI
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGV---LLRLSHPNI 110
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALE 387
++L + LV E G L D + + S+ D + A+
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ--------ILEAVA 162
Query: 388 YLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
YLH +VH+++K N+L + +++D GL+ + + + G+ GY A
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTVCGTPGYCA 218
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
PE+ Y + D++S G++ LL G +PF
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
F +LG G FG V+ Q GK+ A KK++ L + ++++H
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVH 243
Query: 328 HPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWN-SRVK-----IAL 380
I+ L Y E L LV G + H+ + D + R I
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
LE+LH +++++++K N+LLD++ N ++SD GLA + AG+
Sbjct: 301 ----GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
G+ APE+ + +Y+ D ++ GV + E++ R PF +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 41/307 (13%), Positives = 94/307 (30%), Gaps = 53/307 (17%)
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQFAD---GKVLAVKKIDSS-ALPSEMCDDFIEMVSN 322
++A G + + G + ++A D + +A+ +D LP ++ + +
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84
Query: 323 ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGT 382
+S++ P + ++ L+V E+ + GSL + ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSL 138
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG 442
A A + H V + + + + + L+
Sbjct: 139 AAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAY-------------------PATM 176
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
+ D+ G + LL R P + R S + A
Sbjct: 177 PDANP-------QDDIRGIGASLYALLVNRWPLPEAGVR---SGLAPAERDTAGQPIEPA 226
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGND 562
+D + + + V A VQ + R S ++ + + A+ ++ D
Sbjct: 227 DIDRDIPF--------QISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPID 277
Query: 563 QGPTTPR 569
+ P +
Sbjct: 278 EAPVSAA 284
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 46/304 (15%)
Query: 191 APLAASSNEVQELKLVQSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKK 250
L + Q +K S V N KS K++ +
Sbjct: 12 VDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKS-------KRTSALAV 64
Query: 251 AVKAPTNVTSYSIADLQMATGSFN------VENLLGEGTFGRVYRA-QFADGKVLAVKKI 303
+ AP + I + G+ N +LG G FG+V++ + A G LA K I
Sbjct: 65 DIPAPPAPFDHRI--VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 304 DSSALPSEMCDDFIEMVSN----ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDF 359
+ + E V N ++QL H N+++L +LV E+ G L D
Sbjct: 123 KTRGM------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176
Query: 360 L-----HLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414
+ +L++ D + K + ++H + ++H ++K NIL N
Sbjct: 177 IIDESYNLTELDTILFM-----KQICE---GIRHMH---QMYILHLDLKPENILCVNRDA 225
Query: 415 PQL--SDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTG 471
Q+ D GLA E L + G+ + APEV + +D++S GV+ LL+G
Sbjct: 226 KQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 472 RKPF 475
PF
Sbjct: 285 LSPF 288
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 52/234 (22%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 253 KAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE 311
+ P D F +LGEG+F V A+ A + A+K ++ + E
Sbjct: 19 QPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE 71
Query: 312 MCDDFIEMVSNI-SQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKP 369
++ ++ S+L HP ++L + + + L + KNG L ++ +
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFD 128
Query: 370 LIWNSRVK-----IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424
+ + I ALEYLH ++H+++K NILL+ +++ Q++D G A
Sbjct: 129 ---ETCTRFYTAEIVS----ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK 178
Query: 425 NMPNADEALNNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
+ + ++ G Y +PE+ SD+++ G ++ +L+ G PF
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 46/296 (15%)
Query: 276 ENLLGEGTFGRVYRA-QFADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIME 333
E++LGEG RV + AVK I+ +EM+ H N++E
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ--GHRNVLE 75
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFL----HLSDEDNKPLIWNSRVKIALGTARALEYL 389
L+ + E + LV+E + GS+ + H ++ + ++ + A AL++L
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD--------VASALDFL 127
Query: 390 HEVCSLSVVHKNIKSANILLDNELNP---QLSDCGLASNM-------PNADEALNNDAGS 439
H + + H+++K NIL ++ ++ D L S + P + L GS
Sbjct: 128 H---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 440 -GYGAPEV-----AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493
Y APEV + Y+ + D++S GV++ LL+G PF A P
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 494 LHDIDALAKMVDPALKGLY-----PVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ L + + +G Y +S A D+I+ + + + R ++V+Q
Sbjct: 245 CQ--NMLFESI---QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 42/225 (18%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEM--VSNI------ 323
F + +G+G+FG+V Q D K+ A+K ++ +E V N+
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--------VERNEVRNVFKELQI 68
Query: 324 -SQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK---- 377
L HP ++ L Y + + + +V + G L HL + VK
Sbjct: 69 MQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFK---EETVKLFIC 122
Query: 378 -IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
+ + AL+YL + ++H+++K NILLD + ++D +A+ +P + +
Sbjct: 123 ELVM----ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTM 174
Query: 437 AGS-GYGAPEVAMSGQ---YNIKSDVYSFGVVMLELLTGRKPFDS 477
AG+ Y APE+ S + Y+ D +S GV ELL GR+P+
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 31/113 (27%), Positives = 52/113 (46%), Gaps = 8/113 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ +L+ L +A N Q D+F +L +L+ LDLS L P +F+SLSSL L + +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 60 NQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI--NLQK---DGNSWS 105
N F L L L+ + N ++L++ +L N ++
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 20/102 (19%), Positives = 39/102 (38%), Gaps = 4/102 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + N +Q F L SL L L+ L +L L + +N
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
+ +NL L++L++++N+ L+ + +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L +L+++ QL+ F L SL L++S N + L+SL L N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 61 QFSGTI-DVLANLP--LDNLNIANNRFTG 86
+ L + P L LN+ N F
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 5/103 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++ L++L+ H+ L+ +F L +L LD+S F+ LSSL L +
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
N F D+ L L L+++ + P ++ +LQ
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 26/115 (22%), Positives = 42/115 (36%), Gaps = 6/115 (5%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ K L+++ N L+ + F P L LDLS + ++ SLS LS+L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 63 SGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK---DGNSWSSGPAPP 111
+ L L L + ++ L++ N S P
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 29/98 (29%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLS----SL 55
+KTLK LN+AHN +Q +L + F L +L LDLS N + L + SL
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 56 YLQNNQFSGTI-DVLANLPLDNLNIANNRFTGWVPEQL 92
L N + + L L + NN + V +
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 27/95 (28%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS--GNLPQSFSSLSSLSSLYLQ 58
+K+LK L N+ + LPSL LDLS N LS G QS +SL L L
Sbjct: 324 LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 59 NNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQL 92
N L L++L+ ++ +
Sbjct: 382 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 21/77 (27%), Positives = 26/77 (33%), Gaps = 3/77 (3%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI-DVLANLP-LDNLNIANNR 83
S LDLSFN L SF S L L L + +L L L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 84 FTGWVPEQLKNI-NLQK 99
+ +LQK
Sbjct: 88 IQSLALGAFSGLSSLQK 104
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 4 LKYLNIAHNQLQGQLN------DMFGQLPSLSTLDLSFNTLS---GNLPQSFSSLSSLSS 54
L+ + + + + N L +L+ + L ++ F+ L+++SS
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 55 LYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSS 106
L + D N +L + N +F + +LK++ L N +
Sbjct: 287 FSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 19/121 (15%), Positives = 32/121 (26%), Gaps = 25/121 (20%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLS-------------------FNTLSGN 41
+ + ++ ++ + F L+L F + G
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 42 LPQSFSSLSSLSSLYLQNNQ--FSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNINL 97
S L SL L L N F G L L+++ N L L
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQL 398
Query: 98 Q 98
+
Sbjct: 399 E 399
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 7/88 (7%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQNNQF 62
L+++ N + F ++ L L L N S N+ + L+ L L +F
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 63 SGTIDVLANLP-----LDNLNIANNRFT 85
++ L NL I R
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 26/99 (26%), Positives = 41/99 (41%), Gaps = 2/99 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ LK LN+ HN+L + F +L+ L L N++ F +L +L L +N
Sbjct: 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131
Query: 61 QFSGTID-VLANLP-LDNLNIANNRFTGWVPEQLKNINL 97
S T L L L ++NN+ E+L
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 25/122 (20%), Positives = 41/122 (33%), Gaps = 19/122 (15%)
Query: 1 MKTLKYLNIAHNQLQ--------GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSL 52
++ L+ L++ HN L G L L L+L N + F L L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562
Query: 53 SSLYLQNNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNS 103
+ L N + V N L +LN+ N T + L +++ N
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM--RFNP 620
Query: 104 WS 105
+
Sbjct: 621 FD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 6/104 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L+ L++ N++ +L + L ++ + LS+N SF+ + SL L L+
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
Query: 60 NQFSGTID---VLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
L L L+++NN + L+ + L+
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 24/89 (26%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L LN+ N ++F L L +DL N L+ F++ SL SL LQ N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 61 QFSGTI-DVLANLP--LDNLNIANNRFTG 86
+ V L L++ N F
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 26/87 (29%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+ LN+ HNQL+ F + L++LD+ FNT+S P+ L L L LQ+N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 62 FSGTI-DVLANLP-LDNLNIANNRFTG 86
S A L L++ +N
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQK 111
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 25/96 (26%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSL--SSLSSLYLQ 58
K L L+++HN L QL +L L LS N + + SSL L L
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 59 NNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQL 92
+NQ + L L + N + + E+L
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 27/109 (24%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
++ L+ L +++N++Q ++ SL L+LS N + P F ++ L L+L
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 59 NNQFSGTID-----VLANLPLDNLNIANNRFTGWVPE---QLKNINLQK 99
N Q ++ LAN + NL+++N++ + LK NL
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 23/106 (21%), Positives = 45/106 (42%), Gaps = 8/106 (7%)
Query: 1 MKTLKYLNIAHNQLQGQ--LNDMFGQLP--SLSTLDLSFNTLSGNLPQSFSSLSSLSSLY 56
+ LKYL+++++ + N+ F L L L+L+ N +S +FS L L L
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 57 LQNNQFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
L N+ + L + + ++ N++ + +LQ
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 15/123 (12%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L L++++N L ND F LP L L +N + S L ++ L L+ +
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 64 GTI----------DVLANLP-LDNLNIANNRFTGWVPEQLKN-INLQK---DGNSWSSGP 108
+I L L++LN+ +N G INL+ + S
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 109 APP 111
Sbjct: 370 LTN 372
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 29/112 (25%), Positives = 44/112 (39%), Gaps = 13/112 (11%)
Query: 1 MKTLKYLNIAHNQLQG--QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ +L+ L + L+ F L +L+ LDLS N ++ L L L LQ
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 59 NNQFS---------GTIDVLANLP-LDNLNIANNRFTGWVPEQLKN-INLQK 99
+N + G I L L L LN+ +N F E K+ L+
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 19/106 (17%), Positives = 42/106 (39%), Gaps = 9/106 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFS-SLSSLSSLYLQN 59
+ LK +++ N L +F SL +L+L N ++ + F + +L+ L ++
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 60 NQFSGTIDVLANLPLDNLNIANNRFTGWV-------PEQLKNINLQ 98
N F T + +A ++ +N + P ++
Sbjct: 619 NPFDCTCESIAWF-VNWINETHTNIPELSSHYLCNTPPHYHGFPVR 663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQL--PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+++ L+++++QL N F L +L+ LDLS+N L+ SF+ L L +L+
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280
Query: 59 NNQFSGTI-DVLANLP-LDNLNIANNRFTG 86
N L L + LN+ +
Sbjct: 281 YNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN--LPQSFSSL--SSLSSLY 56
+K L++LN+ N + G ++MF L +L L LS + S ++F SL S L L
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387
Query: 57 LQNNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQ 91
L N+ S D + L L+ L++ N + Q
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 20/86 (23%), Positives = 41/86 (47%), Gaps = 5/86 (5%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ + + +H +L +D+ +++ L+L+ N L +F+ S L+SL + N
Sbjct: 5 SHEVADCSHLKLTQVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 63 SGTI-DVLANLP-LDNLNIANNRFTG 86
S ++ LP L LN+ +N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQ 87
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 273 FNVENL-LGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
F E +G GT+G VY+A+ D K A+K+I+ + + C + + +L H
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL----RELKH 77
Query: 329 PNIMELVGYCSEYGQHL--LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA--- 383
PN++ L + L++++ + HD H+ V++ G
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 384 -----RALEYLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALN 434
+ YLH + V+H+++K ANIL+ E + ++D G A + + L
Sbjct: 134 LYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 435 NDAGS----GYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
+ Y APE+ + + Y D+++ G + ELLT
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 56/290 (19%), Positives = 110/290 (37%), Gaps = 58/290 (20%)
Query: 276 ENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIME 333
+ +LG G G+V G+ A+K + S + E V + Q P+I+
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ------E-VDHHWQASGGPHIVC 86
Query: 334 LVGYC----SEYGQHLLVYEFRKNGSLHD------FLHLSDEDNKPLIWNSRVKIALGTA 383
++ L++ E + G L ++ + ++ +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD--------IG 138
Query: 384 RALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMPNADEALNNDAGS- 439
A+++LH S ++ H+++K N+L + + +L+D G A AL +
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTP 193
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
Y APEV +Y+ D++S GV+M LL G PF ++
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSNTGQAISPG 240
Query: 500 LAKMVDPALKGLY-----PVKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ + + G Y +S A +I L ++ +P R +++ +
Sbjct: 241 MKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 65/268 (24%), Positives = 105/268 (39%), Gaps = 44/268 (16%)
Query: 227 PPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
F S S + V ++ + F LLG+GTFG+
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------FEYLKLLGKGTFGK 163
Query: 287 VYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVS--NI-SQLHHPNIMELVGYCSEYG 342
V + G+ A+K + + ++ D+ ++ + HP + L Y +
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAK--DEVAHTLTENRVLQNSRHPFLTALK-YSFQTH 220
Query: 343 QHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGTARALEYLHEVCSLS 396
L V E+ G L F HLS E R + I AL+YLH +
Sbjct: 221 DRLCFVMEYANGGEL--FFHLSRERVFSE---DRARFYGAEIVS----ALDYLHS--EKN 269
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-------YGAPEVAMS 449
VV++++K N++LD + + +++D GL E + + A Y APEV
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y D + GVVM E++ GR PF +
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 42/225 (18%)
Query: 273 FNVENLLGEGTFGRVY----RAQFADGKVLAVKKIDSSALPSEMCDDFIEMVS--NI-SQ 325
F + +LG+G+FG+V+ + ++ A+K + + L D + +I +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 82
Query: 326 LHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IA 379
++HP I++L Y + L L+ +F + G L F LS E VK +A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTE---EDVKFYLAELA 136
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
L AL++LH SL ++++++K NILLD E + +L+D GL+ E+++++ +
Sbjct: 137 L----ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKA 183
Query: 440 G-------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y APEV + +D +SFGV+M E+LTG PF
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 42/263 (15%)
Query: 231 DRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRA 290
+S E K +KK N + + F+ LG G+FGRV
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQN--TAQLDQ-------FDRIKTLGTGSFGRVMLV 60
Query: 291 QFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLHHPNIMELVGYCSEYGQHL 345
+ + G A+K +D + + IE N + ++ P +++L +
Sbjct: 61 KHKESGNHYAMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGTARALEYLHEVCSLSVVHK 400
+V E+ G + F HL + I L EYLH SL ++++
Sbjct: 118 MVMEYVAGGEM--FSHLRRIGRFS---EPHARFYAAQIVL----TFEYLH---SLDLIYR 165
Query: 401 NIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEVAMSGQYNIKSD 457
++K N+L+D + Q++D G A + L G APE+ +S YN D
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIILSKGYNKAVD 220
Query: 458 VYSFGVVMLELLTGRKPFDSSRP 480
++ GV++ E+ G PF + +P
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQP 243
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 276 ENLLGEGTFGRVYRAQF-ADGKVLAVKKI-DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+LG G G+V + + A+K + D E +E+ SQ P+I+
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----VELHWRASQ--CPHIVR 119
Query: 334 LVGYC----SEYGQHLLVYEFRKNGSLHD------FLHLSDEDNKPLIWNSRVKIALGTA 383
+V + L+V E G L ++ + ++ I
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM----KSIG---- 171
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNP----QLSDCGLASNMPNADEALNNDAGS 439
A++YLH S+++ H+++K N+L ++ P +L+D G A + +L +
Sbjct: 172 EAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET-TSHNSLTTPCYT 226
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS 485
Y APEV +Y+ D++S GV+M LL G PF S+
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 56/266 (21%), Positives = 103/266 (38%), Gaps = 40/266 (15%)
Query: 225 LRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTF 284
P+ R K+ ++ + + K + D F + ++G G F
Sbjct: 41 CNNSPLRREKN--ILEYLEWA----KPFTSKVKQMRLHRED-------FEILKVIGRGAF 87
Query: 285 GRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVGYCSEYG 342
G V + + KV A+K ++ + ++ I L Y +
Sbjct: 88 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDD 146
Query: 343 QHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGTARALEYLHEVCSLS 396
+L LV ++ G L LS +++ + + + + A++ +H L
Sbjct: 147 NNLYLVMDYYVGGDL--LTLLSKFEDR--LPEEMARFYLAEMVI----AIDSVH---QLH 195
Query: 397 VVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGS-GYGAPEV-----AMS 449
VH++IK NIL+D + +L+D G M + + G+ Y +PE+
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPF 475
G+Y + D +S GV M E+L G PF
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 73/365 (20%), Positives = 121/365 (33%), Gaps = 124/365 (33%)
Query: 275 VENLLGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
+ LG G FG+V A + A + +AVK + A SE E+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 329 PNIMELVGYCS----------EYGQH--LLVYEFRKNGSLHDFL---------------- 360
N++ L+G C+ E+ + L Y K +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 361 -----------------------------------HLSDEDNKPLIWNSRVKIALGTARA 385
D L + + A+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYG--- 442
+E+L S +H+++ + NILL + ++ D GLA ++ + + G
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR----KGDARLP 258
Query: 443 ----APEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRP------------RLEQS 485
APE Y I+SDV+SFGV++ E+ + G P+ + R+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 318
Query: 486 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ TP+++ M+D C EP RP SE+V+ L
Sbjct: 319 --DYTTPEMYQT-----MLD---------------------CWHGEPSQRPTFSELVEHL 350
Query: 546 VRLVQ 550
L+Q
Sbjct: 351 GNLLQ 355
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 31/234 (13%)
Query: 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMV 320
+ ++++ F + ++G G F V + G+V A+K ++ +
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 321 SNI-SQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK- 377
++ I +L + + +L LV E+ G L LS + I +
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL--LTLLSKFGER--IPAEMARF 166
Query: 378 ----IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
I + A++ +H L VH++IK NILLD + +L+D G + AD +
Sbjct: 167 YLAEIVM----AIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTV 218
Query: 434 NNDAGSG---YGAPEV-------AMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
+ G Y +PE+ +G Y + D ++ GV E+ G+ PF +
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMV 320
I DL+M + V ++G G FG V + KV A+K + + F
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 321 SNI-SQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK- 377
+I + + P +++L Y + ++L +V E+ G L +S+ D + +
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL--VNLMSNYD----VPEKWARF 172
Query: 378 ----IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
+ L AL+ +H S+ +H+++K N+LLD + +L+D G M
Sbjct: 173 YTAEVVL----ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 434 NNDAGSG---YGAPEVAMS----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
+ A G Y +PEV S G Y + D +S GV + E+L G PF +
Sbjct: 226 CDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVS--NI-SQLHH 328
F+ LLG+GTFG+V + A G+ A+K + + ++ D+ V+ + H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRH 64
Query: 329 PNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGT 382
P + L Y + L V E+ G L F HLS E R + I
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVS-- 116
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-- 440
ALEYLH S VV+++IK N++LD + + +++D GL E +++ A
Sbjct: 117 --ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTF 165
Query: 441 -----YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y APEV Y D + GVVM E++ GR PF +
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 29/213 (13%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKI---------DSSALPSEMCDDFIEMVSN 322
+ +GEGT+G VY+A+ + G+++A+K+I S+A+ E +S
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI-RE--------ISL 72
Query: 323 ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALG 381
+ +LHHPNI+ L+ LV+EF + D + DE+ L +S++K
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQ-DSQIKIYLYQ 127
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
R + + H ++H+++K N+L++++ +L+D GLA + ++ +
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 441 YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
Y AP+V M S +Y+ D++S G + E++TG+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 21/103 (20%), Positives = 30/103 (29%), Gaps = 4/103 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
K LK+L + +L +L L N +S L L QNN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 61 QFS----GTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQK 99
+ L +LN+ N G P + Q
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS 206
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 26/102 (25%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ---SFSSLSSLSSLYL 57
+ LK LN++H+ L +F LP+L L+L N Q S +L L L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 58 QNNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNINL 97
S +L ++++++++NR T E L ++
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 24/114 (21%), Positives = 35/114 (30%), Gaps = 8/114 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L L + N L +L L +S + +L SLYL +N
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 61 QFSGTID-VLANLP-LDNLNIANNRFTGWVPE------QLKNINLQKDGNSWSS 106
S L L+ NN E Q N++L +GN +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 13/124 (10%)
Query: 1 MKTLKYLNIAHNQLQ--GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
++ L+ L+++H+ ++ N L L +L+LS+N ++F L L L
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 59 NNQFSGTID--VLANLP-LDNLNIANNRFTGWVPE------QLKNINLQKDGNSWSSGPA 109
+ NL L LN++++ + L+++NLQ GN + G
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ--GNHFPKGNI 466
Query: 110 PPPP 113
Sbjct: 467 QKTN 470
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 22/100 (22%), Positives = 37/100 (37%), Gaps = 3/100 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ + L + N L N F +L +L+ LDL+ + +F S L +L L N
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 63 SGTID-VLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
+ L+ L +L + L N L+
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 25/104 (24%), Positives = 43/104 (41%), Gaps = 10/104 (9%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+++ +N+ + ++ F L LDL+ LS LP LS+L L L N+F
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 63 SGTID-VLANLP-LDNLNIANNRFTGWVPE-------QLKNINL 97
+N P L +L+I N + L+ ++L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L+ L++ L +L L +L L LS N S S+ SL+ L ++ N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFTG 86
+ L NL L L+++++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 20/88 (22%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L ++ L F L ++ +DLS N L+ + ++ S L + L L +N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTG 86
S + +L L +N+ N
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 11/101 (10%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ +++++HN+L + L + L+L+ N +S LP LS ++ L+ N
Sbjct: 502 MNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
Query: 64 GTIDVLANLPLDN-LNIANNRFTGWV------PEQLKNINL 97
T N+ + P L+ + L
Sbjct: 561 CTCS---NIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRL 598
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 17/86 (19%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLS--TLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L + +F L +S +++L + +F S L L L
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289
Query: 62 FSGTIDVLANLP-LDNLNIANNRFTG 86
S L L L L ++ N+F
Sbjct: 290 LSELPSGLVGLSTLKKLVLSANKFEN 315
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 20/78 (25%), Positives = 27/78 (34%), Gaps = 3/78 (3%)
Query: 25 LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI-DVLANLP-LDNLNIANN 82
S L+ SFN L +FS L +L+ L L Q D + LD L + N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 83 RFTGWVPEQLKNI-NLQK 99
L L+
Sbjct: 92 PLIFMAETALSGPKALKH 109
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 10/107 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLS--TLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ LK L+ +N + + L + +L+L+ N ++G + + SL
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 59 NNQFSGT-IDVLANLPLDNL------NIANNRFTGWVPEQLKNINLQ 98
Q L N + +L ++ + + V E L ++++
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 19/104 (18%), Positives = 32/104 (30%), Gaps = 8/104 (7%)
Query: 3 TLKYLNIAHNQLQGQL--NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLS--SLYLQ 58
+ LN Q + + SL P F L +S S+ LQ
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 59 NNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
+ F + L L++ + +P L + L+K
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKK 305
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEM-----VSNISQLHHPNIM 332
+GEG++G V++ + D G+++A+KK + D I+ + + QL HPN++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF---LESED--DPVIKKIALREIRMLKQLKHPNLV 65
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L+ + LV+E+ H LH D + + + I T +A+ + H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-AGSGYGAPEVAM-SG 450
+ +H+++K NIL+ +L D G A + + +++ A Y +PE+ +
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 451 QYNIKSDVYSFGVVMLELLTGR 472
QY DV++ G V ELL+G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGV 200
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 27/117 (23%), Positives = 42/117 (35%), Gaps = 11/117 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ +L L +A N + ++F +L+ LDLS L F +L L L + +
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506
Query: 60 NQFSGTI-DVLANLP-LDNLNIANNRFTG------WVPEQLKNINLQKDGNSWSSGP 108
N L L L+ + NR P+ L NL NS +
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL--TNNSVACIC 561
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 3/97 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + N +Q F L SL L L+ L +L L + +N
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKN 94
+NL L +++++ N L+
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 22/85 (25%), Positives = 41/85 (48%), Gaps = 2/85 (2%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L++L+++ +++ + + L LS L L+ N + P SFS L+SL +L + +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 64 GTI-DVLANLP-LDNLNIANNRFTG 86
+ L L LN+A+N
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 27/119 (22%), Positives = 43/119 (36%), Gaps = 10/119 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQL--PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ +L YL+++ N L + L SL LDLSFN + +F L L L Q
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQ 407
Query: 59 NNQFSGTID--VLANLP-LDNLNIANNRFTGWVPEQLKN-INLQK---DGNSWSSGPAP 110
++ + +L L L+I+ +L GNS+
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 24/109 (22%), Positives = 48/109 (44%), Gaps = 12/109 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++ L++L+ H+ L+ F L L LD+S+ + F L+SL++L +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQ 98
N F +V AN L L+++ + + +L+ +N+
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMS 505
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 2/86 (2%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ K ++++ N L+ + F L LDLS + +++ L LS+L L N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 63 SGTI-DVLANLP-LDNLNIANNRFTG 86
+ L L+NL +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLAS 118
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 6/98 (6%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLS----SL 55
+ TLK LN+AHN + +L F L +L +DLS+N + L SL
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 56 YLQNNQFSGTID-VLANLPLDNLNIANNRFTGWVPEQL 92
+ N D + L L + N + + +
Sbjct: 187 DMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 27/89 (30%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSL--SSLSSLYLQ 58
+ LK L + N+ LPSLS LDLS N LS + S+S L +SL L L
Sbjct: 327 LPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 59 NNQFSGTIDVLANLP-LDNLNIANNRFTG 86
N L L +L+ ++
Sbjct: 385 FNGAIIMSANFMGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 21/77 (27%), Positives = 28/77 (36%), Gaps = 3/77 (3%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI-DVLANLP-LDNLNIANNR 83
S +DLSFN L SFS+ S L L L + L L NL + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 84 FTGWVPEQLKN-INLQK 99
+ P +L+
Sbjct: 92 IQSFSPGSFSGLTSLEN 108
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 13/99 (13%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 4 LKYLNIAHNQLQGQLN------DMFGQLPSLST--LDLSFNTLSGNLPQSFSSLSSLSSL 55
L + + + + N + L ++ L++ + F L+++S++
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
Query: 56 YLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
L DV + +L+I + + L
Sbjct: 291 SLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 17/110 (15%), Positives = 36/110 (32%), Gaps = 13/110 (11%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQNN 60
+ L+++ N + + D Q L L L N S N+ + +L+ L L
Sbjct: 181 QVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 61 QFSG----------TIDVLANLPLDNLNIANNRFTGWVPEQLKN-INLQK 99
+F ++ L ++ +D + + N+
Sbjct: 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 17/102 (16%), Positives = 34/102 (33%), Gaps = 10/102 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + +++A ++ + +L + L L L SL L N
Sbjct: 284 LANVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMN 338
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTG---WVPEQLKNINLQ 98
+ S LP L L+++ N + L +L+
Sbjct: 339 KGS-ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 16/101 (15%), Positives = 33/101 (32%), Gaps = 9/101 (8%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
T+ + + F L ++S + L+ ++ + SL + Q
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
Query: 63 SGTIDVLANLP-LDNLNIANNR----FTGWVPEQLKNINLQ 98
+LP L +L + N+ F L ++L
Sbjct: 320 KQFPT--LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLS 358
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKI---------DSSALPSEMCDDFIEMVSN 322
+ +GEGT+G V++A+ +++A+K++ SSAL E +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-RE--------ICL 54
Query: 323 ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALG 381
+ +L H NI+ L + LV+EF D D N L VK
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLD-PEIVKSFLFQ 109
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
+ L + H S +V+H+++K N+L++ +L++ GLA + + +
Sbjct: 110 LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 441 YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y P+V + Y+ D++S G + EL +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 8e-16
Identities = 55/291 (18%), Positives = 113/291 (38%), Gaps = 43/291 (14%)
Query: 207 QSSSSIDTKTFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADL 266
+ S + + F+ V + + F+ + + ++ + +
Sbjct: 277 KLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRD 336
Query: 267 QMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVK---K---IDSSALPSEMCDDFIEM 319
+M FN +LG+G+FG+V ++ ++ AVK K I + M + +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 320 VSNISQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK- 377
+ P + +L C + L V E+ G L H+
Sbjct: 397 LPG----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKE---PHAVF 446
Query: 378 ----IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
IA+ L +L S ++++++K N++LD+E + +++D G+ E +
Sbjct: 447 YAAEIAI----GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENI 493
Query: 434 NNDAGSG-------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
+ + Y APE+ Y D ++FGV++ E+L G+ PF+
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNIS------- 324
+ L+GEG++G V + + D G+++A+KK + D +MV I+
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--------LESDDDKMVKKIAMREIKLL 78
Query: 325 -QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
QL H N++ L+ C + + LV+EF H L + L + K
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQII 134
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-AGSGYG 442
+ + H S +++H++IK NIL+ +L D G A + E +++ A Y
Sbjct: 135 NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 443 APEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
APE+ + +Y DV++ G ++ E+ G
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 214 TKTFDTAVSINLRPPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSF 273
T +F + +P K ++D SK + VV + P + S+
Sbjct: 7 TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPD----------RPQEVSY 56
Query: 274 NVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
++G G+FG VY+A+ D G+++A+KK+ + E + + +L H NI+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRE-LQIMRKLDHCNIV 110
Query: 333 ELVGYCSEYGQHL------LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTARA 385
L + G+ LV ++ +++ + L VK+ + R+
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRS 168
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNP-QLSDCGLA----SNMPNADEALNNDAGSG 440
L Y+H S + H++IK N+LLD + +L D G A PN
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI----CSRY 221
Query: 441 YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
Y APE+ + Y DV+S G V+ ELL G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 273 FNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCD-DFIEMVSNI-SQL 326
F + +LG+G +G+V++ + GK+ A+K + + + D + NI ++
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 327 HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IAL 380
HP I++L+ Y + G L L+ E+ G L F+ L E I++
Sbjct: 79 KHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME---DTACFYLAEISM 132
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
AL +LH ++++++K NI+L+++ + +L+D GL E++++ +
Sbjct: 133 ----ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDGTVTH 179
Query: 441 -------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y APE+ M +N D +S G +M ++LTG PF
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 40/218 (18%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPS----EMCDDFIEMVSNISQLHHP 329
+G+GTFG V++A+ G+ +A+KK+ + P E + + L H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE--------IKILQLLKHE 76
Query: 330 NIMELVGYCSEYGQHL--------LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IAL 380
N++ L+ C LV++F + HD L S +K +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFT-LSEIKRVMQ 131
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
L Y+H ++H+++K+AN+L+ + +L+D GLA A + N +
Sbjct: 132 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 441 -----YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
Y PE+ + Y D++ G +M E+ T
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 42/220 (19%)
Query: 277 NLLGEGTFGRVYRAQ-FADGKVLAVKKI-------DSSALPS----EMCDDFIEMVSNIS 324
+G G +G VY+A+ G +A+K + LP E + ++ +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE-----VALLRRLE 69
Query: 325 QLHHPNIMEL----VGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-I 378
HPN++ L ++ + LV+E D D+ P + +K +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 125
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADE--A 432
R L++LH + +VH+++K NIL+ + +L+D GLA M
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182
Query: 433 LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
L Y APEV + Y D++S G + E+ +
Sbjct: 183 L------WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 48/244 (19%)
Query: 253 KAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE 311
+ P+ I D F + +LG+G+FG+V+ A+F + A+K + +
Sbjct: 6 ERPSLQIKLKIED-------FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--- 55
Query: 312 MCDDFIE--MV-SNISQL--HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDE 365
+ DD +E MV + L HP + + + ++L V E+ G L H+
Sbjct: 56 LMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSC 112
Query: 366 DNKPLIWNSRVK-----IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420
L SR I L L++LH S +V++++K NILLD + + +++D
Sbjct: 113 HKFDL---SRATFYAAEIIL----GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADF 162
Query: 421 GLASNMPNADEALNNDAGSG-------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRK 473
G+ E + DA + Y APE+ + +YN D +SFGV++ E+L G+
Sbjct: 163 GMCK------ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
Query: 474 PFDS 477
PF
Sbjct: 217 PFHG 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKI---------DSSALPSEMCDDFIEMVSNI 323
++ +GEGT+G VY+AQ G+ A+KKI S+ + E +S +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI-RE--------ISIL 54
Query: 324 SQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALGT 382
+L H NI++L + +LV+E D L D L + K L
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLE-SVTAKSFLLQL 109
Query: 383 ARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-Y 441
+ Y H V+H+++K N+L++ E +++D GLA ++ + Y
Sbjct: 110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 442 GAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
AP+V M S +Y+ D++S G + E++ G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 34/268 (12%)
Query: 227 PPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
S D D ++ + VK ++ ++ +F + +LG G +G+
Sbjct: 14 SSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE----NFELLKVLGTGAYGK 69
Query: 287 VYRAQFADGK----VLAVKKIDSSALPSEMCD-DFIEMVSNISQL--HHPNIMELVGYCS 339
V+ + G + A+K + + + + + + + P ++ L Y
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAF 128
Query: 340 EYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGTARALEYLHEVC 393
+ L L+ ++ G L F HLS + V+ I L ALE+LH
Sbjct: 129 QTETKLHLILDYINGGEL--FTHLSQRERFT---EHEVQIYVGEIVL----ALEHLH--- 176
Query: 394 SLSVVHKNIKSANILLDNELNPQLSDCGLA-SNMPNADEALNNDAGS-GYGAPEVAMSGQ 451
L +++++IK NILLD+ + L+D GL+ + + E + G+ Y AP++ G
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 452 --YNIKSDVYSFGVVMLELLTGRKPFDS 477
++ D +S GV+M ELLTG PF
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTV 264
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
++ ++G G+FG V++A+ + +A+KK+ + E + + + HPN+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRE-LQIMRIVKHPNV 94
Query: 332 MELVGYCSEYGQHL------LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL-GTAR 384
++L + G LV E+ +++ + + + +K+ + R
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLR 152
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNP-QLSDCGLA----SNMPNADEALNNDAGS 439
+L Y+H S+ + H++IK N+LLD +L D G A + PN S
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-----S 204
Query: 440 G-YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
Y APE+ + Y D++S G VM EL+ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 21/115 (18%), Positives = 48/115 (41%), Gaps = 17/115 (14%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLP-------SLSTLDLSFNTLSGNLPQSFSSLSSLS 53
+ + ++ ++N++ F L ++S+++LS N +S + FS+ S LS
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 54 SLYLQNNQFSG--------TIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
S+ L N + + N L ++++ N+ T + + + L
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPY 514
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 24/125 (19%), Positives = 46/125 (36%), Gaps = 16/125 (12%)
Query: 1 MKTLKYLNIAHNQLQG--QLNDMFGQLPS------LSTLDLSFNTL-SGNLPQSFSSLSS 51
+ ++ +N+A N+ QL D + L + + + +N L + + S +
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 52 LSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKN--INLQK---DGNSWS 105
L L NQ G + + L +LN+A N+ T +P ++ N
Sbjct: 332 LGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK 390
Query: 106 SGPAP 110
P
Sbjct: 391 YIPNI 395
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 24/110 (21%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG-------NLPQSFSSLSSLS 53
+ +N+++NQ+ ++F LS+++L N L+ + ++F + L+
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 54 SLYLQNNQFSGTID--VLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
S+ L+ N+ + D LP L ++++ N F+ P Q N L+
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 18/98 (18%), Positives = 42/98 (42%), Gaps = 4/98 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
MK L L +NQL+G+L FG L++L+L++N ++ + +L +N
Sbjct: 329 MKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 61 QFSGTIDVLA--NLP-LDNLNIANNRFTGWVPEQLKNI 95
+ ++ ++ + ++ + N + +
Sbjct: 388 KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 25/108 (23%), Positives = 47/108 (43%), Gaps = 10/108 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMF-GQLPSLSTLDLSFNTLSG-------NLPQSFSSLSSL 52
+ ++ L+ AHN+L+ N + +S +D S+N + L + ++
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 53 SSLYLQNNQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNINLQ 98
SS+ L NNQ S ++ + L ++N+ N T LK+ N
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 14/125 (11%), Positives = 39/125 (31%), Gaps = 19/125 (15%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ + ++ + + + + + +L L+ + + N
Sbjct: 205 LTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTG--WVPEQLKNI-------NLQK---DGNSWSS 106
+ L LP + +N+A NR + + + + +Q N+ +
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
Query: 107 GPAPP 111
P
Sbjct: 320 FPVET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 14/101 (13%), Positives = 32/101 (31%), Gaps = 10/101 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTL------DLSFNTLSGNLPQSFSSLSSLSS 54
+ L +++++N +L D N P+ + SL+
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570
Query: 55 LYLQNNQFSGTID-VLANLPLDNLNIANNRFTGWVPEQLKN 94
L + +N + + N + L+I +N +
Sbjct: 571 LQIGSNDIRKVNEKITPN--ISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 18/143 (12%), Positives = 36/143 (25%), Gaps = 26/143 (18%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L I + Q + + + N ++ + ++ L+ L Y+ N+
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
Query: 61 QFSGTIDV-------------LANLP--------LDNLNIANNRFTGWVPEQLKNI-NLQ 98
F L ++ + N +P LK + +Q
Sbjct: 217 PFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 99 K---DGNSWSSGPAPPPPPGTPP 118
N SG
Sbjct: 277 LINVACNRGISGEQLKDDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 19/118 (16%), Positives = 37/118 (31%), Gaps = 12/118 (10%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQN 59
+ L++ G++ D GQL L L L + N P+ S+ S
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 60 NQFSGTI----DVLANLPLDNLNIANNRFTGWVPE----QLKNINLQKDGNSWSSGPA 109
+ T L I ++ + + LK+ + + N+ +
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSK 200
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 13/100 (13%), Positives = 28/100 (28%), Gaps = 7/100 (7%)
Query: 22 FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID------VLANLPLD 75
++ L L SG +P + L+ L L L ++ + AN+ +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 76 NLNIANNRFTGWVPEQLKNINLQK-DGNSWSSGPAPPPPP 114
+ + + + +S P
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 11/108 (10%), Positives = 27/108 (25%), Gaps = 10/108 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMF----GQLPSLSTLDLSFNTLSGNLPQSFS--SLSSLSS 54
+ L+ L + + + S S L
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 55 LYLQNNQFSGTI--DVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQK 99
+ ++ +I L + +N T V + + + L++
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQ 210
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 12/112 (10%), Positives = 29/112 (25%), Gaps = 7/112 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN-----LPQSFSSLSSLSSL 55
+ P DL + ++ + + +S + +
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 56 YLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNINLQKDGNSWS 105
+N + + L L + N+ F E +N N + +
Sbjct: 189 GQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 11/61 (18%), Positives = 21/61 (34%), Gaps = 3/61 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+L L I N ++ +N+ P++S LD+ N L +
Sbjct: 565 CPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
Query: 61 Q 61
+
Sbjct: 622 K 622
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 64/242 (26%), Positives = 109/242 (45%), Gaps = 46/242 (19%)
Query: 254 APTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEM 312
P++ +D F+ ++G+G+FG+V A+ A+ AVK + A+ +
Sbjct: 28 GPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK- 79
Query: 313 CDDFIEMVS--NI--SQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDN 367
+ ++S N+ + HP ++ L + + L V ++ G L F HL E
Sbjct: 80 -KEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERC 135
Query: 368 KPLIWNSRVK-----IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422
R + IA AL YLH SL++V++++K NILLD++ + L+D GL
Sbjct: 136 FLE---PRARFYAAEIAS----ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL 185
Query: 423 ASNMPNADEALNNDAGSG-------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
E + +++ + Y APEV Y+ D + G V+ E+L G PF
Sbjct: 186 CK------ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 476 DS 477
S
Sbjct: 240 YS 241
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 4e-15
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSN----ISQLH 327
F + LG G+FGRV+ + G+ A+K + + + +E ++ +S +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV---VRLKQVEHTNDERLMLSIVT 64
Query: 328 HPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALG 381
HP I+ + + Q + ++ ++ + G L F L P N K + L
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFP---NPVAKFYAAEVCL- 117
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
ALEYLH S ++++++K NILLD + +++D G A +P+ L G
Sbjct: 118 ---ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGT 166
Query: 441 --YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
Y APEV + YN D +SFG+++ E+L G PF S
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 272 SFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSN-----IS- 324
+ + LGEG F VY+A+ +++A+KKI + + ++ I
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALREIKL 65
Query: 325 --QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IALG 381
+L HPNI+ L+ LV++F + D + +++ L S +K L
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLT-PSHIKAYMLM 120
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
T + LEYLH ++H+++K N+LLD +L+D GLA + + + A +
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-----Q 172
Query: 441 -----YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y APE+ + Y + D+++ G ++ ELL R PF
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 42/219 (19%)
Query: 277 NLLGEGTFGRVYRAQ--FADGKVLAVKKI---------DSSALPSEMCDDFIEMVSNISQ 325
+GEG +G+V++A+ G+ +A+K++ S + E + ++ ++
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-RE-----VAVLRHLET 70
Query: 326 LHHPNIMEL----VGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IA 379
HPN++ L ++ L LV+E D D+ +P + +K +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA----SNMPNADE--AL 433
R L++LH VVH+++K NIL+ + +L+D GLA M L
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 434 NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
Y APEV + Y D++S G + E+ +
Sbjct: 184 ------WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 55/266 (20%), Positives = 108/266 (40%), Gaps = 42/266 (15%)
Query: 275 VENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-----HH 328
+ LG G F V+ A+ + +A+K + + +E +D I+++ ++
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 329 PNIMELVG------YCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IAL 380
++ + G H+ +V+E +L + + PL VK I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPL---IYVKQISK 138
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ------LSDCGLASNMPNADEALN 434
L+Y+H C ++H +IK N+L++ +P+ ++D G A DE
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYT 193
Query: 435 NDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493
N + Y +PEV + + +D++S ++ EL+TG F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-------- 245
Query: 494 LHDIDALAKMVDPALKGLYPVKSLSR 519
D D +A++++ L G P L
Sbjct: 246 --DDDHIAQIIE--LLGELPSYLLRN 267
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 58/275 (21%), Positives = 108/275 (39%), Gaps = 52/275 (18%)
Query: 227 PPPIDRHKSFDEEDFSKKSIVVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGR 286
P + + ++ ++ +S + D F++ ++G G++ +
Sbjct: 15 PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAK 67
Query: 287 VYRAQFAD-GKVLAVK---K---IDSSALPSEMCDDFI-EMVSNISQLHHPNIMELVGYC 338
V + ++ A++ K D + + + E SN HP ++ L C
Sbjct: 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPFLVGLH-SC 121
Query: 339 SEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IALGTARALEYLHEV 392
+ L V E+ G L H+ + P + I+L AL YLHE
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQRQRKLPE---EHARFYSAEISL----ALNYLHE- 171
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-------YGAPE 445
++++++K N+LLD+E + +L+D G+ E L + Y APE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTTSTFCGTPNYIAPE 223
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
+ Y D ++ GV+M E++ GR PFD
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKI--------DSSALPSEMCDDFIEMVSN 322
++ + LGEGT+ VY+ + ++A+K+I +A+ E VS
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-RE--------VSL 53
Query: 323 ISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG- 381
+ L H NI+ L LV+E+ D D+ + VK+ L
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIIN-MHNVKLFLFQ 108
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG- 440
R L Y H V+H+++K N+L++ +L+D GLA + +N+ +
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 441 YGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
Y P++ + S Y+ + D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 45/229 (19%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVK---K---IDSSALPSEMCDDFI-EMVSNIS 324
F++ ++G G++ +V + ++ A+K K D + + + E SN
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-- 68
Query: 325 QLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----I 378
HP ++ L C + L V E+ G L H+ + P + I
Sbjct: 69 ---HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPE---EHARFYSAEI 119
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
+L AL YLH ++++++K N+LLD+E + +L+D G+ E L
Sbjct: 120 SL----ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDT 166
Query: 439 SG-------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480
+ Y APE+ Y D ++ GV+M E++ GR PFD
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIE--MV-SNISQL-- 326
FN +LG+G+FG+V ++ ++ AVK + + + DD +E MV + L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV---IQDDDVECTMVEKRVLALPG 78
Query: 327 HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----IAL 380
P + +L C + L V E+ G L H+ IA+
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKE---PHAVFYAAEIAI 132
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
L +L S ++++++K N++LD+E + +++D G+ E + + +
Sbjct: 133 ----GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTTK 179
Query: 441 -------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
Y APE+ Y D ++FGV++ E+L G+ PF+
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVK---K---IDSSALPSEMCDDFI-EMVSNIS 324
F +LG+G+FG+V A+ + G + AVK K + + M + I + N
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-- 82
Query: 325 QLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-----I 378
HP + +L C + L V EF G L H+ +R + I
Sbjct: 83 ---HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDE---ARARFYAAEI 133
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
AL +LH ++++++K N+LLD+E + +L+D G+ E + N
Sbjct: 134 IS----ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVT 180
Query: 439 SG-------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDS 477
+ Y APE+ Y D ++ GV++ E+L G PF++
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI----DSSALPSEMCDDFIEMVSNISQLHHPNIME 333
LGEGT+G VY+A + +A+K+I + +P I VS + +L H NI+E
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA----IREVSLLKELQHRNIIE 97
Query: 334 LVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG-TARALEYLHEV 392
L + L++E+ +N L ++ D P + +K L + + H
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYM-----DKNPDVSMRVIKSFLYQLINGVNFCH-- 149
Query: 393 CSLSVVHKNIKSANILLDNELNPQ-----LSDCGLASNMPNADEALNNDAGSG-YGAPEV 446
S +H+++K N+LL + + D GLA ++ + Y PE+
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208
Query: 447 AM-SGQYNIKSDVYSFGVVMLELLTGR 472
+ S Y+ D++S + E+L
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 7e-14
Identities = 19/111 (17%), Positives = 36/111 (32%), Gaps = 13/111 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG---------NLPQSFSSLSS 51
+K L + + + QL D LP L +L+++ N L +
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 52 LSSLYLQNNQFSGTID--VLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
+ Y+ N L + L L+ +N+ + N+ L
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTD 599
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 22/110 (20%), Positives = 49/110 (44%), Gaps = 12/110 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS-------GNLPQSFSSLSSLS 53
+ +++N++Q ++F +ST+ LS N ++ ++ + L+
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731
Query: 54 SLYLQNNQFSGTID--VLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
++ L+ N+ + D LP L N++++ N F+ P Q N L+
Sbjct: 732 TIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 17/113 (15%), Positives = 47/113 (41%), Gaps = 15/113 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFG-----QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSL 55
+ + ++ ++N++ + ++ + + ST+ LS+N + + F++ S +S++
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI 702
Query: 56 YLQNNQFS--------GTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
L NN + N L +++ N+ T + + + L
Sbjct: 703 ILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 7/99 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ + A++ + + N S+S+L L+ + L N
Sbjct: 447 LTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNINL 97
+ D L +LP L +LNIA NR + L
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 18/106 (16%), Positives = 44/106 (41%), Gaps = 7/106 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQN 59
M L L+ HN+++ L FG L+ L L +N + +P+ + + L +
Sbjct: 572 MVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH 628
Query: 60 NQFSGTIDV--LANLP-LDNLNIANNRFTGWVPEQLKNINLQKDGN 102
N+ ++ ++ + +++ + N+ +++ K N
Sbjct: 629 NKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 16/93 (17%), Positives = 38/93 (40%), Gaps = 8/93 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDM-FGQLPSLSTLDLSFNTLSGNLPQSFSSLS-----SLSS 54
++ L +HN+L+ N + + ++D S+N + S+ + S+
Sbjct: 618 TDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 55 LYLQNNQFSGTI-DVLANLP-LDNLNIANNRFT 85
+ L N+ ++ A + + ++NN T
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 18/120 (15%), Positives = 35/120 (29%), Gaps = 16/120 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSF------NTLSGNLPQSFSSLSSLSS 54
+ L +++++N L + N + P ++ SL
Sbjct: 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810
Query: 55 LYLQNNQFSG-TIDVLANLPLDNLNIANNRFT----GWVPEQLKN--INLQKDGNSWSSG 107
L + +N + L L+IA+N V ++ L D G
Sbjct: 811 LQIGSNDIRKVDEKLTPQ--LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 11/79 (13%), Positives = 29/79 (36%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ L++A +G++ D GQL L L ++ + + + + ++
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 64 GTIDVLANLPLDNLNIANN 82
+ LN+++
Sbjct: 385 MHYKKMFLDYDQRLNLSDL 403
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 13/116 (11%), Positives = 35/116 (30%), Gaps = 9/116 (7%)
Query: 7 LNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI 66
N + Q ++ L L+ G +P + L+ L L + + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 67 DV---------LANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPP 113
+ ++ + + + ++L +L +D + + P
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 16/126 (12%), Positives = 39/126 (30%), Gaps = 30/126 (23%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN------LPQSFSSLSSLSSL 55
+ L ++ + + + S + L + + ++ L+ L +
Sbjct: 396 QRLNLSDLLQDAINRNPE--MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQII 453
Query: 56 YLQNNQFSGTI--------------------DVLANLP-LDNLNIANNRFTGWVPEQLKN 94
Y N+ F+ +NL L ++ + N +P+ L +
Sbjct: 454 YFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 95 I-NLQK 99
+ LQ
Sbjct: 514 LPELQS 519
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 13/122 (10%), Positives = 36/122 (29%), Gaps = 13/122 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSF-SSLSSLSSLYLQN 59
+ LK L+ + + + + + + + + F L+ L
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 60 NQFSG-------TIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQK---DGNSWSSGP 108
+ + D +L + NR T + + ++ + LQ + ++
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 109 AP 110
Sbjct: 465 IA 466
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 44/223 (19%), Positives = 84/223 (37%), Gaps = 32/223 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSN---------I 323
+ V+ + G++G V ++G +A+K++ ++ + + +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 324 SQLHHPNIMELV-----GYCSEYGQHLLVYEFRKNGSLHDFLH-----LSDEDNKPLIWN 373
+ HHPNI+ L + LV E + L +H +S + + +++
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
L LH VVH+++ NILL + + + D LA
Sbjct: 143 --------ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 434 NNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
+ Y APE+ M + D++S G VM E+ + F
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
K + + L+ L + ++ LDLS N LS + + L L L +N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 64 GTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNINLQ 98
L +L L L++ NN + ++ ++
Sbjct: 72 -ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAA 107
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 18/118 (15%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++YL++ N++ ++ +L L+L +N + ++ + L +L L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSS 200
Query: 60 NQFSGTIDVLANLP-LDNLNIANNRFTGWVPE------QLKNINLQKDGNSWSSGPAP 110
N+ + + + +++ NN+ + + L++ +L GN + G
Sbjct: 201 NKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL--RGNGFHCGTLR 255
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 4/99 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
TL++LN+ +N + + L TLDLS N L+ + F S + ++ + L+NN
Sbjct: 168 SDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQ 98
+ L L++ ++ N F + N +
Sbjct: 225 KLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 5/94 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K L+++ N L L L+LS N L SLS+L +L L NN
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNN 90
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
+ V + ++ L+ ANN + + +
Sbjct: 91 YVQ-ELLVGPS--IETLHAANNNISRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 14/84 (16%), Positives = 31/84 (36%), Gaps = 3/84 (3%)
Query: 18 LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSG-TIDVLANLP-LD 75
++++ ++ ++L L S ++ L L N S + LA L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 76 NLNIANNRFTGWVPEQLKNINLQK 99
LN+++N + L+
Sbjct: 62 LLNLSSNVLYE-TLDLESLSTLRT 84
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 17/101 (16%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+++ L+ A+N + + L+ N ++ S + L L+ N+
Sbjct: 99 PSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 62 FSG--TIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
++ A+ L++LN+ N V Q+ L+
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKT 195
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 12/116 (10%), Positives = 24/116 (20%), Gaps = 6/116 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
K L+ ++ + L +D + Q + +L +
Sbjct: 312 RKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 61 Q----FSGTIDVLANLPLDNL-NIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPP 111
S A L + EQ L+ +
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQ 426
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 2/98 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L I + L SL+ LD+S + ++ ++L ++S+ L N
Sbjct: 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNIN 96
I L LP L +LNI + + E +N
Sbjct: 147 GAITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLN 184
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 14/84 (16%), Positives = 38/84 (45%), Gaps = 4/84 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K L I + + L +L L + ++ + + S L+SL+ L + ++
Sbjct: 65 AHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 61 QFSGT-IDVLANLP-LDNLNIANN 82
+ + + LP +++++++ N
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 18/104 (17%), Positives = 40/104 (38%), Gaps = 13/104 (12%)
Query: 1 MKTLKYLNIAHNQ---LQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYL 57
M +L Y+ +A+ L G ++ L ++ + S LS+L L +
Sbjct: 43 MNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRI 95
Query: 58 QNNQFSGT-IDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
+ I L+ L L L+I+++ + ++ + +
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 14/80 (17%), Positives = 30/80 (37%), Gaps = 5/80 (6%)
Query: 22 FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80
Q+ SL+ + L+ ++ +L ++ L + N + + ++ L L+ L I
Sbjct: 40 EAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRIM 96
Query: 81 NNRFTGWVPEQLKN-INLQK 99
T L +L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTL 116
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 21/85 (24%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS------GNLPQ---------- 44
+ +L L+I+H+ + LP ++++DLS+N LP+
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG 170
Query: 45 -----SFSSLSSLSSLYLQNNQFSG 64
L+ LY + G
Sbjct: 171 VHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKI--------DSSALPSEMCDDFIEMVSNISQLHHP 329
LG GT+ VY+ G +A+K++ S+A+ E +S + +L H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-RE--------ISLMKELKHE 63
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFL-HLSDEDNKPLIWNSRVK-IALGTARALE 387
NI+ L + LV+EF + L ++ + + + + VK + L
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG-----YG 442
+ H ++H+++K N+L++ +L D GLA +++ Y
Sbjct: 123 FCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE----VVTLWYR 175
Query: 443 APEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
AP+V M S Y+ D++S G ++ E++TG+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 7/101 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
M L L I +N++ L L+ L++ N +S + L+ L L + +N
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSN 275
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKN-INLQK 99
Q S I VL NL L++L + NN+ E + NL
Sbjct: 276 QISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 4/86 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ LK LN+ NQ+ + L L++L L+ N L + L++L++L+L N
Sbjct: 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
+ I LA+L +D+ + AN
Sbjct: 322 HITD-IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 24/103 (23%), Positives = 46/103 (44%), Gaps = 10/103 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L++ +NQ++ L SL N ++ ++++ L+SL + NN
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNN 231
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQ 98
+ + + LANL L L I N+ + +LK +N+
Sbjct: 232 KITD-LSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVG 273
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 9/103 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + LN+ N L+ + L+ L ++ + + ++L+ L SL L N
Sbjct: 131 LTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYN 187
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQ 98
Q I LA+L L N+ T P +L ++ +
Sbjct: 188 QIED-ISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIG 229
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 18/87 (20%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L I N++ L +L L L+ + +S ++L+ + SL L N
Sbjct: 87 LVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGAN 142
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTG 86
+ L+N+ L+ L + ++
Sbjct: 143 HNLSDLSPLSNMTGLNYLTVTESKVKD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 19/87 (21%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++++ L +A ++ + L +L L+L+ N ++ S+L L++LY+ N
Sbjct: 43 LESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTN 98
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTG 86
+ + I L NL L L + + +
Sbjct: 99 KIT-DISALQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 6/86 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + + + +L S++ L ++ ++ Q L++L L L N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGN 76
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
Q + I L+NL L NL I N+ T
Sbjct: 77 QITD-ISPLSNLVKLTNLYIGTNKIT 101
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 20/100 (20%), Positives = 37/100 (37%), Gaps = 3/100 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
K + + L+ L + ++ LDLS N LS + + L L L +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNINLQ 98
L +L L L++ NN + ++ ++
Sbjct: 69 VLY-ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAA 107
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 19/116 (16%), Positives = 49/116 (42%), Gaps = 9/116 (7%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++YL++ N++ ++ +L L+L +N + ++ + L +L L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSS 200
Query: 60 NQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKN-INLQK---DGNSWSSGPAP 110
N+ + + + +++ NN+ + + L+ NL+ GN + G
Sbjct: 201 NKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 4/99 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
TL++LN+ +N + + L TLDLS N L+ + F S + ++ + L+NN
Sbjct: 168 SDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQ 98
+ L L++ ++ N F + N +
Sbjct: 225 KLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 17/115 (14%), Positives = 37/115 (32%), Gaps = 5/115 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
LK L+++ N+L + F ++ + L N L + ++ +L L+ N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 61 QFSGT---IDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPP 112
F N + + + E+ + ++ P P
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 22/102 (21%), Positives = 35/102 (34%), Gaps = 18/102 (17%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN-----------------TLSGNLP 43
+K L+++ N L L L+LS N L+ N
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYV 92
Query: 44 QSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFT 85
Q S+ +L+ NN S + N+ +ANN+ T
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 15/87 (17%), Positives = 34/87 (39%), Gaps = 8/87 (9%)
Query: 18 LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSG-TIDVLANLP-LD 75
++++ ++ ++L L S ++ L L N S + LA L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 76 NLNIANNRFTGWVPE-----QLKNINL 97
LN+++N + L+ ++L
Sbjct: 62 LLNLSSNVLYE-TLDLESLSTLRTLDL 87
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 17/101 (16%), Positives = 42/101 (41%), Gaps = 7/101 (6%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+++ L+ A+N + +++ + + L+ N ++ S + L L+ N+
Sbjct: 99 PSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 62 FSG--TIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
++ A+ L++LN+ N V Q+ L+
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKT 195
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 48/240 (20%), Positives = 87/240 (36%), Gaps = 59/240 (24%)
Query: 266 LQMATGSFN-----VENLLGEGTFGRVYRAQF-ADGKVLAVKKI-DSSALPSEMCDDFIE 318
LQ+ + +LG G G+V + + A+K + D E +E
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----VE 62
Query: 319 MVSNISQLHHPNIMELVGYC----SEYGQHLLVYEFRKNGSLHD------FLHLSDEDNK 368
+ S P+I+ +V + L+V E G L ++ +
Sbjct: 63 LHWRAS--QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 369 PLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSDCGLASN 425
++ I A++YLH S+++ H+++K N+L ++ +L+D G A
Sbjct: 121 EIM----KSIG----EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-- 167
Query: 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS 485
E +Y+ D++S GV+M LL G PF S+
Sbjct: 168 ------------------KET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ +L+ L +A N Q D+F +L +L+ LDLS L P +F+SLSSL L + +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRF 84
NQ ++ + L L + + N +
Sbjct: 504 NQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 19/88 (21%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + N +Q F L SL L L+ L +L L + +N
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 61 QFS--GTIDVLANLP-LDNLNIANNRFT 85
+ +NL L++L++++N+
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 12/109 (11%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++ L++L+ H+ L+ +F L +L LD+S F+ LSSL L +
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQ 98
N F D+ L L L+++ + + L+ +N+
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMA 502
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 14/121 (11%)
Query: 1 MKTLKYLNIAHNQLQ--GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ +L++L+++ N L G + SL LDLSFN + + +F L L L Q
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 404
Query: 59 NNQFSGTID--VLANLP-LDNLNIANNRFTGWVPE------QLKNINLQKDGNSWSSGPA 109
++ + V +L L L+I++ L+ + + GNS+
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA--GNSFQENFL 462
Query: 110 P 110
P
Sbjct: 463 P 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 7/110 (6%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L+ L+++ ++Q + + L LSTL L+ N + +FS LSSL L +
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 64 GTID-VLANLP-LDNLNIANNRFT-GWVPEQLKNI-NLQK---DGNSWSS 106
+ + +L L LN+A+N +PE N+ NL+ N S
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 28/118 (23%), Positives = 43/118 (36%), Gaps = 12/118 (10%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ K L+++ N L+ + F P L LDLS + ++ SLS LS+L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 63 SG-TIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSWSSGPAPP 111
+ + L L L + LK +N+ N S P
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVA--HNLIQSFKLPE 143
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 29/98 (29%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 1 MKTLKYLNIAHNQLQ-GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLS----SL 55
+KTLK LN+AHN +Q +L + F L +L LDLS N + L + SL
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 56 YLQNNQFSG-TIDVLANLPLDNLNIANNRFTGWVPEQL 92
L N + + L L + NN + V +
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 25/130 (19%), Positives = 44/130 (33%), Gaps = 22/130 (16%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLS----TLDLSFNTLSGNLPQSFSSLSSLSSLY 56
+ L++L+++ N++Q L + +LDLS N ++ P +F + L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 57 LQNNQFS-----GTIDVLANLPLDNLN------------IANNRFTGWVPEQLKNINLQK 99
L+NN S I LA L + L + G ++ L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 100 DGNSWSSGPA 109
Sbjct: 267 LDYYLDDIID 276
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 20/63 (31%), Positives = 23/63 (36%), Gaps = 4/63 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIANN 82
S LDLSFN L SF S L L L + TI +L L L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 83 RFT 85
Sbjct: 87 PIQ 89
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 19/92 (20%), Positives = 27/92 (29%), Gaps = 18/92 (19%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ---SFSSLSSLSSLYL 57
+ L+ +N Q +L SL L + N S L SL L L
Sbjct: 306 WQHLELVNCKFGQFP------TLKLKSLKRLTFTSNKG-----GNAFSEVDLPSLEFLDL 354
Query: 58 QNNQFSG---TIDVLANLP-LDNLNIANNRFT 85
N S L L+++ N
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 16/115 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+YL + N LQ +D F L +L+ L L N +S ++F L SL L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 61 QFSGTI--DVLANLP-LDNLNIANNR--------FTGWVPEQLKNINLQKDGNSW 104
+ + + +L L L + N L+ + L + N W
Sbjct: 188 RVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL--RALQYLRL--NDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 16/86 (18%), Positives = 32/86 (37%), Gaps = 3/86 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ + + N++ F +L+ L L N L+ +F+ L+ L L L +N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
++ L L L++
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 15/110 (13%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQ 58
+ L+ L+++ N + F L L TL L L L F L++L LYLQ
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137
Query: 59 NNQFSGTI--DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQ 98
+N + D +L L +L + NR + VPE L + L
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLH 185
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 15/60 (25%), Positives = 29/60 (48%), Gaps = 4/60 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNLNIANN 82
+ + L N +S SF + +L+ L+L +N + ID L L+ L++++N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 3/107 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L +++++N+L+ + F ++ L L +S N L L + +L L L +N
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWS 105
L+NL + +N + NL N W
Sbjct: 312 HLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ ++ LN+ Q++ F ++ L + FN + P F ++ L+ L L+ N
Sbjct: 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 61 QFSGTID--VLANLP-LDNLNIANNRFT 85
S ++ + N P L L+++NN
Sbjct: 134 DLS-SLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L L + HN L P L +DLS+N L + F + L LY+ NN+
Sbjct: 234 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 64 GTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
+P L L++++N Q + L+
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLEN 328
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ K + ++ ++ + + L+L+ + +F+ ++ LY+ N
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFT 85
+ V N+P L L + N +
Sbjct: 110 AIR-YLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 17/101 (16%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN----------------TLSGNLPQ 44
L L++++N L+ +D F SL L LS N +S NL
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 205
Query: 45 SFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFT 85
+ + ++ L +N + + N+ L L + +N T
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 18/83 (21%), Positives = 35/83 (42%), Gaps = 10/83 (12%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L + N+++N L ++ LD S N+++ + L+ L LQ+N +
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR--GPVNVELTILKLQHNNLT 245
Query: 64 GTIDVLANLP-LDNLNIANNRFT 85
L N P L ++++ N
Sbjct: 246 -DTAWLLNYPGLVEVDLSYNELE 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 11/86 (12%), Positives = 21/86 (24%), Gaps = 4/86 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
++I L + + +T+ S + L L + Q
Sbjct: 28 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
I A + L + N
Sbjct: 88 E-EIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 3/107 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L +++++N+L+ + F ++ L L +S N L L + +L L L +N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWS 105
L+NL + +N + NL N W
Sbjct: 306 HLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ ++ LN+ Q++ F ++ L + FN + P F ++ L+ L L+ N
Sbjct: 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFT 85
S ++ + N P L L+++NN
Sbjct: 128 DLS-SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L L + HN L P L +DLS+N L + F + L LY+ NN+
Sbjct: 228 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 64 GTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
+P L L++++N Q + L+
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLEN 322
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 24/86 (27%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + N L +F P L+TL +S N L +F + +SL +L L +N
Sbjct: 116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
+ + +D L+ +P L + N++ N +
Sbjct: 176 RLT-HVD-LSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ K + ++ ++ + + L+L+ + +F+ ++ LY+ N
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFT 85
+ V N+P L L + N +
Sbjct: 104 AIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 17/101 (16%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN----------------TLSGNLPQ 44
L L++++N L+ +D F SL L LS N +S NL
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 199
Query: 45 SFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFT 85
+ + ++ L +N + + N+ L L + +N T
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 11/86 (12%), Positives = 21/86 (24%), Gaps = 4/86 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
++I L + + +T+ S + L L + Q
Sbjct: 22 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
I A + L + N
Sbjct: 82 E-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDF------IEMVSNIS 324
F VE + G+GTFG V + G +A+KK+ D ++++ +++
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---------IQDPRFRNRELQIMQDLA 74
Query: 325 QLHHPNIMEL--VGYCSEYGQH-----LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK 377
LHHPNI++L Y +V E+ +LH +K
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPP-PILIK 132
Query: 378 IAL-GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC--GLA----SNMPNAD 430
+ L R++ LH S++V H++IK N+L+ NE + L C G A + PN
Sbjct: 133 VFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 431 EALNNDAGSGYGAPEVAM-SGQYNIKSDVYSFGVVMLELLTGR 472
Y APE+ + Y D++S G + E++ G
Sbjct: 191 YI----CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 28/112 (25%), Positives = 49/112 (43%), Gaps = 8/112 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLN-----DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSL 55
+L+ L + N LQ D+F L L L L+ N L+ P FS L++L L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 56 YLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNIN-LQKDGNSWS 105
L +N+ + + L+ L+I+ N+ P+ +++ L N +
Sbjct: 510 SLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 30/136 (22%), Positives = 51/136 (37%), Gaps = 14/136 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDM-FGQLPSLSTLDLSFNTL-----SGNLPQSFSSLSSLSS 54
+ L+ L + N+ D + PSL L L N L + F LS L
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 55 LYLQNNQFSG-TIDVLANLP-LDNLNIANNRFT----GWVPEQLKNINLQKDGNSWSSGP 108
LYL +N + V ++L L L++ +NR T +P L+ +++ N +
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDIS--RNQLLAPN 542
Query: 109 APPPPPGTPPARKNNP 124
+ +N
Sbjct: 543 PDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 5/109 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K LK LN+A+N++ ++ F L +L L+LS+N L +F L ++ + LQ N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 61 QFSG-TIDVLANLP-LDNLNIANNRFTGW-VPEQLKNINLQKDGNSWSS 106
+ L L L++ +N T + +I L GN +
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLS--GNKLVT 395
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 22/102 (21%), Positives = 42/102 (41%), Gaps = 5/102 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNL--PQSFSSLSSLSSLYLQ 58
+ L+ L++ +++ D F L L L L F LS + F +L +L+ L L
Sbjct: 72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 59 NNQFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKNINL 97
NQ L L +++ ++N+ +L+ +
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 17/85 (20%), Positives = 39/85 (45%), Gaps = 2/85 (2%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
++++L+++H + + +F L L L+L++N ++ ++F L +L L L N
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 63 SG-TIDVLANLP-LDNLNIANNRFT 85
LP + +++ N
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 5/90 (5%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++ L+ L + + + F LP+L LDL + + P +F L L L L
Sbjct: 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106
Query: 60 NQFSGTI---DVLANLP-LDNLNIANNRFT 85
S + NL L L+++ N+
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 3/88 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNL-PQSFSSLSSLSSLYLQN 59
+ T + L ++ N ++ F L L L+L + ++F +L +L L L +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 60 NQFSG-TIDVLANLP-LDNLNIANNRFT 85
++ D L L L + +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 25/105 (23%), Positives = 47/105 (44%), Gaps = 11/105 (10%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLS--SLSSLYL 57
+K L L+++ NQ++ L+ FG+L SL ++D S N + L +LS L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 58 QNNQ--------FSGTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
N + ++ N+ L+ L+++ N +T + N
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 24/107 (22%), Positives = 42/107 (39%), Gaps = 10/107 (9%)
Query: 3 TLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSG-NLPQSFSSLSSLSSLYLQNN 60
T ++++ N+L+ + ++P L L L+ N S + Q+ S SL L+L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 61 QFSGTI------DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
DV L L L + +N P ++ L+
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLP--SLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ + ++ + F L S+ LDLS + + F +L L L L
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 59 NNQFSG-TIDVLANLP-LDNLNIANNRFT 85
N+ + + L L LN++ N
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 4/81 (4%)
Query: 8 NIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI- 66
IA + L + L + L LSFN + SF L L L L + TI
Sbjct: 7 RIAFYRFCN-LTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 67 -DVLANLP-LDNLNIANNRFT 85
+ NLP L L++ +++
Sbjct: 66 KEAFRNLPNLRILDLGSSKIY 86
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 22/126 (17%), Positives = 42/126 (33%), Gaps = 21/126 (16%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L+ L++ N L +PS+ + LS N L + + + ++L N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSEN 411
Query: 61 QFSG--TIDVLANLP-LDNLNIANNRFTG-------WVPEQLKNINLQKDGNSWSSGPAP 110
+ + L +P L L + NRF+ L+ + L N
Sbjct: 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG--ENMLQLAWET 469
Query: 111 PPPPGT 116
Sbjct: 470 ELCWDV 475
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 18/116 (15%), Positives = 38/116 (32%), Gaps = 22/116 (18%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLP------SLSTLDLSFN------------TLSGNL 42
KTL + ++A N L +++ +G+ L LD+S N +S +
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 43 PQSFSSLSSLSSLYLQNNQFS----GTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
S + + T LA + +L++++ +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 16/99 (16%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQ------------LPSLSTLDLSFNTLSGNLPQSFSSL- 49
L+ L+++ N + F + F+ + +F+ L
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264
Query: 50 -SSLSSLYLQNNQFSG-TIDVLANLP-LDNLNIANNRFT 85
SS+ L L + V L L LN+A N+
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/298 (20%), Positives = 105/298 (35%), Gaps = 82/298 (27%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-- 326
G ++V LG G F V+ + K +A+K + S+ +E D I ++ ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 95
Query: 327 HHPN---IMELVG---YCSEYGQHL-LVYEF-RKNGSLHDFLHLSDEDNKPLIWNSRVK- 377
+ PN +++L+ G H+ +V+E L ++ S+ PL VK
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH--HLLKWIIKSNYQGLPL---PCVKK 150
Query: 378 IALGTARALEYLHEVCSLSVVHKNIKSANILLDNE------------------------- 412
I + L+YLH C ++H +IK NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 413 ------------------------LNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVA 447
L +++D G A + D + Y + EV
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVL 265
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
+ YN +D++S + EL TG F+ D D +A +++
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFE----------PHSGEEYTRDEDHIALIIE 313
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 27/115 (23%), Positives = 43/115 (37%), Gaps = 11/115 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+YL+++ N L +F L +L L L N + +F ++ L LYL N
Sbjct: 87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 61 QFS----GTIDVLANLP-LDNLNIANNRFTGWVPE------QLKNINLQKDGNSW 104
Q S I LP L L++++N+ L N
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L ++HN L ++ F +P+L LDLS N L FS L +L L L NN
Sbjct: 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN 122
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQL 92
+ + ++ L L ++ N+ + P +L
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 22/87 (25%), Positives = 41/87 (47%), Gaps = 5/87 (5%)
Query: 3 TLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L+++HN L + +L +L +L LS N L+ ++F + +L L L +N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 62 FSGTI--DVLANLP-LDNLNIANNRFT 85
T+ + ++L L+ L + NN
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHIV 125
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 27/113 (23%), Positives = 41/113 (36%), Gaps = 14/113 (12%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
L L+I H L L L L+LS+N +S L L + L Q
Sbjct: 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
Query: 63 SGTI--DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSWS 105
+ + L L LN++ N+ T + E L+ + L D N +
Sbjct: 285 A-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL--DSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 3/101 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ LK L + N L + F L SL L L L+ ++ S L L L L++
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 61 QFSG-TIDVLANLP-LDNLNIANNRFTGWVPEQ-LKNINLQ 98
+ L L L I++ + + L +NL
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L + N+L+ +F L +L+ LD+S N + L F L +L SL + +N
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFT 85
I + L L+ L + T
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 23/85 (27%), Positives = 44/85 (51%), Gaps = 2/85 (2%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ L++ N+++ D F P L L+L+ N +S P +F++L +L +L L++N+
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 63 SG-TIDVLANLP-LDNLNIANNRFT 85
+ V L L L+I+ N+
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIV 117
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ +L+ L + L + L L L L ++ SF L L L + +
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 61 QFSGTI--DVLANLPLDNLNIANNRFT 85
+ T+ + L L L +L+I + T
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 24/109 (22%), Positives = 47/109 (43%), Gaps = 9/109 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L++LN+++N + M +L L + L L+ P +F L+ L L + N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFT-----GWVPEQLKNINLQKDG 101
Q + T+ V ++ L+ L + +N WV + +N +
Sbjct: 307 QLT-TLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQ 354
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L+ L + N + F L +L TL L N L F+ LS+L+ L + N
Sbjct: 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFT 85
+ + + +L L +L + +N
Sbjct: 115 KIV-ILLDYMFQDLYNLKSLEVGDNDLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 17/63 (26%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIANN 82
LDL N + F+S L L L N S + NL L L + +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 83 RFT 85
R
Sbjct: 91 RLK 93
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL----HHPNIME 333
LG G + V+ A + + + VK + ++ I L PNI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENLRGGPNIIT 95
Query: 334 L--VGYCSEYGQHLLVYEFRKNGSLHDFLH-LSDEDNKPLIWNSRVKIALGTARALEYLH 390
L + LV+E N L+D D + ++ +AL+Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKALDYCH 147
Query: 391 EVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLA-SNMPNADEALNNDAGSG-YGAPEVA 447
S+ ++H+++K N+++D+E +L D GLA P + N S + PE+
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELL 202
Query: 448 MSGQ-YNIKSDVYSFGVVMLELLTGRKPF 475
+ Q Y+ D++S G ++ ++ ++PF
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 16/114 (14%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ LKYLN+ ++ + + L L L++S N P SF LSSL L++ N+
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
Q S I + L L LN+A+N + +P L ++L N W
Sbjct: 253 QVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL--HHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 25/86 (29%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+YLN+ N +Q D F L L L L N++ +F+ L+SL++L L +N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
+ I L L L + NN
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 19/88 (21%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ-N 59
+ +L L + N L + F L L L L N + +F+ + SL L L
Sbjct: 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL 181
Query: 60 NQFSG-TIDVLANLP-LDNLNIANNRFT 85
+ + L L LN+
Sbjct: 182 KKLEYISEGAFEGLFNLKYLNLGMCNIK 209
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 28/98 (28%), Positives = 41/98 (41%), Gaps = 13/98 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L + N ++ F L SL+TL+L N L+ +F LS L L+L+NN
Sbjct: 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 61 QFSGTIDV--------LANLPLDNLN----IANNRFTG 86
+I L L L L I+ F G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 15/63 (23%), Positives = 23/63 (36%), Gaps = 4/63 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNLNIANN 82
+ L+L N + +F L L L L N I+ L L+ L + +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133
Query: 83 RFT 85
T
Sbjct: 134 WLT 136
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 34/278 (12%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLHHPNIME 333
+G G G V A + +A+KK+ P + + E+V + ++H NI+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVL-MKCVNHKNIIG 88
Query: 334 LV------GYCSEYGQHLLVYEFRKNGSLHDFLH--LSDEDNKPLIWNSRVKIALGTARA 385
L+ E+ +V E + +L + L E L++
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQMELDHERMSYLLYQ--------MLCG 139
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPE 445
+++LH S ++H+++K +NI++ ++ ++ D GLA + Y APE
Sbjct: 140 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPF--DSSRPRLEQSLVRWATPQLHDIDALAKM 503
V + Y D++S G +M E++ G F + + + + TP + L
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 504 VDPALKGL--YPVKSLSR-FADVIALCVQPEPEFRPPM 538
V ++ Y S + F DV+ + +
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 16/114 (14%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+YLN+A L+ ++ + L L LDLS N LS P SF L L L++ +
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
Q I + NL L +N+A+N T +P L+ I+L N W
Sbjct: 242 QIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL--HHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 27/107 (25%), Positives = 45/107 (42%), Gaps = 11/107 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLS-FNTLSGNLPQSFSSLSSLSSLYLQN 59
+ LK L + +N ++ + F ++PSL LDL LS +F LS+L L L
Sbjct: 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194
Query: 60 NQFSGTIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQ 98
I L L LD L+++ N + + L+ + +
Sbjct: 195 CNLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMI 239
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ LN+ NQ+Q + F L L L LS N + +F+ L++L++L L +N+
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
+ TI L L L + NN
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE 149
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 23/85 (27%), Positives = 41/85 (48%), Gaps = 4/85 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L+ L ++ N ++ F L +L+TL+L N L+ +F LS L L+L+NN
Sbjct: 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146
Query: 61 QFSGTI--DVLANLP-LDNLNIANN 82
+I +P L L++
Sbjct: 147 PIE-SIPSYAFNRIPSLRRLDLGEL 170
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 18/63 (28%), Positives = 24/63 (38%), Gaps = 4/63 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIANN 82
+ L+L N + SF L L L L N TI L L+ L + +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122
Query: 83 RFT 85
R T
Sbjct: 123 RLT 125
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 24/95 (25%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L L + HNQ++ N LP+L L L N LS +P L L +YL N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 61 Q--------FSGTIDVLANLPLDNLNIANNRFTGW 87
F + + +++ NN W
Sbjct: 275 NITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 24/85 (28%), Positives = 38/85 (44%), Gaps = 1/85 (1%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+TL L++ HN++Q + + L L L N + S S L +L L+L NN+
Sbjct: 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252
Query: 62 FSGTIDVLANLP-LDNLNIANNRFT 85
S L +L L + + N T
Sbjct: 253 LSRVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 7/95 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L+ L I+ N L ++ SL L + N + FS L +++ + + N
Sbjct: 101 LRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
Query: 61 QFSGTI---DVLANLPLDNLNIANNRFTGWVPEQL 92
+ L L+ L I+ + TG +P+ L
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 25/86 (29%), Positives = 36/86 (41%), Gaps = 5/86 (5%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L++ +N + D F L L L L N +S ++FS L L LY+ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 62 FSGTIDVLANLP--LDNLNIANNRFT 85
++ NLP L L I +NR
Sbjct: 114 LV---EIPPNLPSSLVELRIHDNRIR 136
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 30/126 (23%), Positives = 51/126 (40%), Gaps = 30/126 (23%)
Query: 1 MKTLKYLNIAHNQLQGQL--NDMFGQLPSLSTLDLSFNTLSG---NLPQS---------- 45
++ + + + N L+ F L L+ L +S L+G +LP++
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLDHNK 204
Query: 46 --------FSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNLNIANNRFTGWVPEQLKN 94
S L L L +NQ I+ L+ LP L L++ NN+ + VP L +
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
Query: 95 I-NLQK 99
+ LQ
Sbjct: 263 LKLLQV 268
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 9/69 (13%), Positives = 25/69 (36%), Gaps = 8/69 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMF------GQLPSLSTLDLSFNTLSGNL--PQSFSSLSSL 52
+K L+ + + N + + F + + + L N + P +F ++
Sbjct: 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322
Query: 53 SSLYLQNNQ 61
++ N +
Sbjct: 323 LAIQFGNYK 331
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 20/111 (18%), Positives = 37/111 (33%), Gaps = 13/111 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDM----FGQLPSLSTLDLSFN---TLSGNLPQSFSSLSSLS 53
L L+++ N G+ + + P+L L L T SG ++ L
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 54 SLYLQNNQFSGTIDVLANLPLDN---LNIANNRFT---GWVPEQLKNINLQ 98
L L +N + LN++ +P +L ++L
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLS 282
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDM-FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
L+ L+++HN L+ L++L+LSF L + LS L L
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSY 283
Query: 60 NQFSGTIDVLANLP-LDNLNIANNRFTG 86
N+ LP + NL++ N F
Sbjct: 284 NRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 31/112 (27%), Positives = 43/112 (38%), Gaps = 16/112 (14%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFS----SLSSLSSLYL 57
LK L+IA + P+LSTLDLS N G + +L L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 58 QNNQF---SGTIDVLANLP--LDNLNIANNRFTG-------WVPEQLKNINL 97
+N SG LA L L++++N P QL ++NL
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 10/95 (10%)
Query: 1 MKTLKYLNIAHNQLQGQ---LNDMFGQL-PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLY 56
L LN+ + + L ++ L P L L ++ + +LS+L
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 57 LQNNQFSGTIDVLANLP------LDNLNIANNRFT 85
L +N G +++ L L L + N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 22/108 (20%), Positives = 39/108 (36%), Gaps = 12/108 (11%)
Query: 3 TLKYLNIAHNQLQGQLND---MFGQLPSLSTLDLSFNTLSGNLPQSFSSL--SSLSSLYL 57
+LK L + ++ ++ + L L L ++G P L+ L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 58 QNNQFSGTIDVLANLP------LDNLNIANNRFTGWVPEQLKNI-NLQ 98
+N ++ LA L L L+IA + EQ++ L
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS 176
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 30/113 (26%), Positives = 43/113 (38%), Gaps = 12/113 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L+ L +A N++ ++ F L L L+LS N L + F +L L L L N
Sbjct: 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN 357
Query: 61 QFSG-TIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
LP L L + N+ VP+ L+ I L N W
Sbjct: 358 HIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL--HTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 24/121 (19%), Positives = 44/121 (36%), Gaps = 14/121 (11%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
++ L++L + + N+ F L SL L L +N +F+ L++L L L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQ 112
Query: 60 NQFSGTI---DVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSWSSGP 108
G + + L L+ L + +N P + ++L N S
Sbjct: 113 CNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT--FNKVKSIC 170
Query: 109 A 109
Sbjct: 171 E 171
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 23/107 (21%), Positives = 39/107 (36%), Gaps = 11/107 (10%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQNNQ 61
+ Y++++ N + F +L L L + T + +F LSSL L L NQ
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 62 FSG-TIDVLANLP-LDNLNIANNRFTG-WVPE-------QLKNINLQ 98
F L L+ L + G + L+ + L+
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 18/86 (20%), Positives = 36/86 (41%), Gaps = 6/86 (6%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF- 62
+K +++ +++ L +F L L L+ N ++ +F L+ L L L N
Sbjct: 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336
Query: 63 ---SGTIDVLANLPLDNLNIANNRFT 85
S + L L+ L+++ N
Sbjct: 337 SIDSRMFENLDK--LEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIANN 82
++ +DLS N+++ SFS L L L ++ I + L L L + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 83 RFT 85
+F
Sbjct: 90 QFL 92
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 15/105 (14%), Positives = 35/105 (33%), Gaps = 13/105 (12%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSS--LSSLYL 57
+ +L+ L + N ++ Q F + LDL+FN + + + + L L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187
Query: 58 QNNQF---------SGTIDVLANLP-LDNLNIANNRFTGWVPEQL 92
+ + L+++ N F + ++
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 22/101 (21%), Positives = 37/101 (36%), Gaps = 16/101 (15%)
Query: 11 HNQLQGQLNDMFGQLP--SLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS----G 64
H + N F L + T DLS + + L FS + L L L N+ +
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN 317
Query: 65 TIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQ 98
L + L LN++ N + +L+ ++L
Sbjct: 318 AFWGLTH--LLKLNLSQNFLG-SIDSRMFENLDKLEVLDLS 355
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG-NLPQSFSSLSSLSSLYLQN 59
+ +L++L+++ N L + FG L SL L+L N + F +L++L +L + N
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
+ I A L L+ L I + + LK+I ++
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 27/111 (24%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN---TLSGNLPQSFSSLSSLSSLYL 57
++ +K + + ++++ L SL LDLS N + SL +L L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 58 QNNQFS---GTIDVLANLP-LDNLNIANNRFT------GWVPEQLKNINLQ 98
N T ++L L L +L+I+ N F W PE+++ +NL
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQW-PEKMRFLNLS 418
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 30/105 (28%), Positives = 41/105 (39%), Gaps = 10/105 (9%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L+ L + +++ D F L SL LDLS N LS F LSSL L L N +
Sbjct: 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
Query: 64 --GTIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQ 98
G + NL L L I N + L + ++
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+K L+++ N++ + +L L L + ++ +F SL SL L L +N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 63 SG-TIDVLANLP-LDNLNIANNRFT 85
S + L L LN+ N +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 31/129 (24%), Positives = 47/129 (36%), Gaps = 30/129 (23%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN----------------TLSGNLPQ 44
+K L L+I+ N + D + L+LS +S N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD 444
Query: 45 SFSS-LSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNI 95
SFS L L LY+ N+ T+ + P L + I+ N+ VP+ L+ I
Sbjct: 445 SFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQKI 502
Query: 96 NLQKDGNSW 104
L N W
Sbjct: 503 WL--HTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 16/88 (18%), Positives = 29/88 (32%), Gaps = 5/88 (5%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
T++ L+I L L+ ++ L + + + + + L SL L L N
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 63 S----GTIDVLANLP-LDNLNIANNRFT 85
P L L ++ N
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 7/91 (7%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L+ L I + + ++ F L SL+ L++ +L QS S+ + L L
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 60 NQFS----GTIDVLANLPLDNLNIANNRFTG 86
++ + D+L+++ L + +
Sbjct: 182 SESAFLLEIFADILSSVR--YLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 15/108 (13%), Positives = 32/108 (29%), Gaps = 10/108 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ +L L I L+ + + + L L + + L LSS+ L L++
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 61 QFSG----------TIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQ 98
+ + L + + F + + L
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 10/84 (11%), Positives = 30/84 (35%), Gaps = 2/84 (2%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ ++ + ++ L + L +L +S L + + ++N++
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 64 G-TIDVLANLP-LDNLNIANNRFT 85
+L L+ L+++ N
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 22/97 (22%), Positives = 47/97 (48%), Gaps = 14/97 (14%)
Query: 25 LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIAN 81
++ +LDLSFN ++ + ++L L L++++ + TI D +L L++L++++
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83
Query: 82 NRFTGWVPE-------QLKNINLQKDGNSWSSGPAPP 111
N + + LK +NL GN + +
Sbjct: 84 NHLSS-LSSSWFGPLSSLKYLNL--MGNPYQTLGVTS 117
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 4 LKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
L++L+ H+ L+ +F L +L LD+S F+ LSSL L + N F
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
D+ L L L+++ +
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 5/89 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNL-PQSFSSLSSLSSLYLQN 59
++ L YL+I+H + N +F L SL L ++ N+ N P F+ L +L+ L L
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFT 85
Q + +L L LN+++N F
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 4 LKYLNIAHNQLQGQ--LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L L+++ N L + + SL LDLSFN + + +F L L L Q++
Sbjct: 54 LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 112
Query: 62 FS--GTIDVLANLP-LDNLNIANNRFT 85
V +L L L+I++
Sbjct: 113 LKQMSEFSVFLSLRNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 24/85 (28%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L +L+++ QL+ F L SL L++S N + L+SL L N
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
Query: 64 GTI--DVLANLP--LDNLNIANNRF 84
T L + P L LN+ N F
Sbjct: 237 -TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 24/86 (27%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS--GNLPQSFSSLSSLSSLYLQNN 60
+ L + N+LQ + +F +L L+ L LS N LS G QS +SL L L N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
L L++L+ ++
Sbjct: 89 GVITMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 20/64 (31%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSL-SSLSSLYLQN 59
+ +L+ LN++HN + L SL LD S N + + Q SSL+ L L
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
Query: 60 NQFS 63
N F+
Sbjct: 258 NDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 15/64 (23%), Positives = 23/64 (35%), Gaps = 4/64 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSG---TIDVLANLP-LDNLNIAN 81
S + L+L N L F L+ L+ L L +N S L L+++
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 82 NRFT 85
N
Sbjct: 88 NGVI 91
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 49/247 (19%), Positives = 91/247 (36%), Gaps = 61/247 (24%)
Query: 272 SFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKI--DSSALPSEMCDDFIEMVSNISQLHH 328
+++ LG G+FG V + GK A+KK+ D E + + L H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE--------LDIMKVLDH 59
Query: 329 PNIMEL--------------------VGYCSEYGQHLLVYEFRKNGSLHDFLHLS----- 363
NI++L + + + +L+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 364 -DEDNKPLI---WNSRVKIALG--------TARALEYLHEVCSLSVVHKNIKSANILLDN 411
+ ++ S I + RA+ ++H SL + H++IK N+L+++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNS 176
Query: 412 ELNP-QLSDCGLA----SNMPNADEALNNDAGSGYGAPEVAM-SGQYNIKSDVYSFGVVM 465
+ N +L D G A + P+ Y APE+ + + +Y D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYI----CSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 466 LELLTGR 472
EL+ G+
Sbjct: 233 GELILGK 239
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 29/115 (25%), Positives = 55/115 (47%), Gaps = 18/115 (15%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNN 60
K L+ +++++NQ+ D F L SL++L L N ++ LP+S F L SL L L N
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
Query: 61 QFS----GTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
+ + L N L+ L++ +N+ + + ++ ++L N +
Sbjct: 115 KINCLRVDAFQDLHN--LNLLSLYDNKLQT-IAKGTFSPLRAIQTMHL--AQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
T+ + + N ++ F L +DLS N +S P +F L SL+SL L N+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 63 ----SGTIDVLANLPLDNLNIANNRFT 85
+ L + L L + N+
Sbjct: 93 TELPKSLFEGLFS--LQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 6/64 (9%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS----GTIDVLANLPLDNLNIAN 81
+++ + L NT+ P +FS L + L NNQ S L + L++L +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS--LNSLVLYG 89
Query: 82 NRFT 85
N+ T
Sbjct: 90 NKIT 93
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 6/83 (7%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ + + N+L+ + MF L SL TL L N ++ SF LSS+ L L +NQ +
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 64 ----GTIDVLANLPLDNLNIANN 82
G D L + L LN+ N
Sbjct: 143 TVAPGAFDTLHS--LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 24/115 (20%), Positives = 50/115 (43%), Gaps = 18/115 (15%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNN 60
L+ +N ++N++ F ++ + L+ N L N+ F L SL +L L++N
Sbjct: 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
Query: 61 QFS----GTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
+ + + L++ + L++ +N+ T V L +NL N +
Sbjct: 116 RITCVGNDSFIGLSS--VRLLSLYDNQITT-VAPGAFDTLHSLSTLNL--LANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 18/84 (21%), Positives = 37/84 (44%), Gaps = 7/84 (8%)
Query: 7 LNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF--- 62
L + +N+ + +F +LP L ++ S N ++ +F S ++ + L +N+
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 63 -SGTIDVLANLPLDNLNIANNRFT 85
L + L L + +NR T
Sbjct: 97 QHKMFKGLES--LKTLMLRSNRIT 118
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-11
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L++L+ + L + + +L L L+LS N +SG L +L+ L L N
Sbjct: 41 FEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 61 QFS--GTIDVLANLP-LDNLNIANN 82
+ TI+ L L L +L++ N
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-05
Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 9/91 (9%)
Query: 2 KTLKYLNIAHNQLQ-GQLNDMFGQLPSLSTLDLSFNTLS--GNLPQSFSSLSSLSSLYLQ 58
+K L + +++ G+L + + L L L+ NLP L+ L L L
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELS 72
Query: 59 NNQFSGTIDVLA-NLP-LDNLNIANNRFTGW 87
+N+ SG ++VLA P L +LN++ N+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 7/100 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L +N ++NQL L L + ++ N ++ ++L++L+ L L NN
Sbjct: 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNN 122
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
Q + ID L NL L+ L +++N + + +LQ+
Sbjct: 123 QITD-IDPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQ 160
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 12/111 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + NQ+ L +L+ L+L+ N L S+L +L+ L L N
Sbjct: 264 LTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFN 319
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQKDGNSWSS 106
S I +++L L L NN+ + + ++ N S
Sbjct: 320 NISD-ISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSA--GHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L +NQ+ G L +L L L+ N L + +SL++L+ L L NN
Sbjct: 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 253
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNIN 96
Q S + L+ L L L + N+ + P L +
Sbjct: 254 QISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALT 290
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 10/103 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L++A+NQ+ L L+ L L N +S + L++L++L L N
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNEN 297
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQ 98
Q I ++NL L L + N + P +L+ +
Sbjct: 298 QLED-ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFY 339
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 8/100 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ +L+ L+ NQ+ L +L LD+S N +S + L++L SL NN
Sbjct: 155 LTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
Q S I L L LD L++ N+ + NL
Sbjct: 210 QISD-ITPLGILTNLDELSLNGNQLKD-IGTLASLTNLTD 247
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 11/104 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + +NQ+ D L +L+ L+LS NT+S + S L+SL L N
Sbjct: 111 LTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQK 99
+ LANL L+ L+I++N+ + L+++
Sbjct: 167 VTD--LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L + + +NQ+ L +L+ L L N ++ +L++L+ L L +N
Sbjct: 89 LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSN 144
Query: 61 QFSGTIDVLANLP-LDNLNIANN 82
S I L+ L L L+ N
Sbjct: 145 TISD-ISALSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 16/108 (14%), Positives = 43/108 (39%), Gaps = 7/108 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L +N++ L +++ L N +S P ++L+ ++ L L +
Sbjct: 330 LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 385
Query: 61 QFSG-TIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSS 106
++ ++ AN+ + N P + + + + +W+
Sbjct: 386 AWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNL 432
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 7/98 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + L ++ D L +L+ ++ S N L+ ++ +L+ L + + NN
Sbjct: 45 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DIT-PLKNLTKLVDILMNNN 100
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNIN 96
Q + I LANL L L + NN+ T P + L N+N
Sbjct: 101 QIAD-ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 137
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 3 TLKYLNIAHNQLQGQLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L I + +N +F L L ++ + + L +++L
Sbjct: 2 PLGSATITQDT---PINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTG 86
+ID + L L +N +NN+ T
Sbjct: 57 GIK-SIDGVEYLNNLTQINFSNNQLTD 82
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 1e-10
Identities = 86/655 (13%), Positives = 176/655 (26%), Gaps = 180/655 (27%)
Query: 6 YLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT 65
+++ + Q Q D+ + + S + + + + SGT
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK-EEIDHIIMSKDAVSGT 64
Query: 66 IDVLANLPLDNLNIANNRFTG--------WVPEQLKNINLQKDGNS----------WSSG 107
+ + L + +F ++ +K Q + ++
Sbjct: 65 LRLFWTLLSKQEEMVQ-KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 108 PAPPPPPGTPPARKNNPKHKSDSNKSPSE--SEGGSKKSGIGGGG----IAGILISLFVV 161
R + ++ E G+ G G + +S V
Sbjct: 124 Q--VFAKYNVS-R---LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177
Query: 162 ----GGIVAFFLVKRRRSRRSSTDIEKLDNQPFAPLAASSNEVQELKLVQSSSSIDTKTF 217
I F + + T +E L L+ T
Sbjct: 178 CKMDFKI---FWLNLKNCNSPETVLEMLQK-----------------LLYQIDPNWTSRS 217
Query: 218 DTAVSINLRPPPIDRHKS--FDEEDFSKKSIVV------KKAVKA-----PTNVTS--YS 262
D + +I LR I + + + ++V KA A +T+
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 263 IADLQMATGSFNVENLLGEGTFGRVY-RAQFADGKVLAVKKIDSSALPSEMCD------- 314
+ D A + ++ T ++ K L + D LP E+
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLL--KYLDCRPQD---LPREVLTTNPRRLS 331
Query: 315 -------DFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLS--DE 365
D + N ++ + ++ L E+RK F LS
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEPAEYRKM-----FDRLSVFPP 383
Query: 366 DNK-P-----LIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA-----NILLDN--- 411
P LIW +K + ++++ S+V K K + +I L+
Sbjct: 384 SAHIPTILLSLIWFDVIKSD-----VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438
Query: 412 -----ELNPQLSDC-GLASNMPNADEALNNDAG-----SGYGAPEVAMSGQYNIKSDVY- 459
L+ + D + + D G+ + + + V+
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 460 --SFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ-----LHDIDALAKMV---DPALK 509
F LE +K + W L + + DP +
Sbjct: 499 DFRF----LE----QK--------IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 510 GLYPVKSL-------------SRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
L V ++ S++ D++ + + E E + + + VQR
Sbjct: 543 RL--VNAILDFLPKIEENLICSKYTDLLRIALMAEDEA------IFEEAHKQVQR 589
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L++L++ + L +++ +LP L L+LS N + G L L +L+ L L N
Sbjct: 48 FVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105
Query: 61 QFS--GTIDVLANLP-LDNLNIANN 82
+ T++ L L L +L++ N
Sbjct: 106 KLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 9/90 (10%)
Query: 3 TLKYLNIAHNQLQ-GQLNDMFGQLPSLSTLDLSFNTLS--GNLPQSFSSLSSLSSLYLQN 59
++ L + + + G++ + + +L L L L NLP L L L L
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSE 80
Query: 60 NQFSGTIDVLA-NLP-LDNLNIANNRFTGW 87
N+ G +D+LA LP L +LN++ N+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 46/216 (21%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLH 327
+ +G G G V A + +A+KK+ P + + E+V + ++
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVL-MKCVN 119
Query: 328 HPNIMELV------GYCSEYGQHLLVYEFRKNGSLHDFLH--LSDEDNKPLIWNSRVKIA 379
H NI+ L+ E+ LV E + +L + L E L++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQMELDHERMSYLLYQ------ 172
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
+++LH S ++H+++K +NI++ ++ ++ D GLA +
Sbjct: 173 --MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
Y APEV + Y D++S G +M E++ + F
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 9/95 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L ++ N + N P L L L+ N L +P + + +YL NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 61 QFS-------GTIDVLANLP-LDNLNIANNRFTGW 87
S +++ +N W
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 5/86 (5%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L++ +N++ + F L +L TL L N +S P +F+ L L LYL NQ
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 62 FSGTIDVLANLP--LDNLNIANNRFT 85
++ +P L L + N T
Sbjct: 112 LK---ELPEKMPKTLQELRVHENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 21/84 (25%), Positives = 39/84 (46%), Gaps = 1/84 (1%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+L L++ N++ L +L+ L LSFN++S S ++ L L+L NN+
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 63 SGTIDVLANLP-LDNLNIANNRFT 85
LA+ + + + NN +
Sbjct: 253 VKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 10/105 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L ++ NQL+ M +L L + N ++ F+ L+ + + L N
Sbjct: 99 LVKLERLYLSKNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 61 QFSGTI---DVLANLP-LDNLNIANNRFTG---WVPEQLKNINLQ 98
+ + L + IA+ T +P L ++L
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 200
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 32/103 (31%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
MK L Y+ IA + + PSL+ L L N ++ S L++L+ L L N
Sbjct: 170 MKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226
Query: 61 QFSGTID--VLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQK 99
S +D LAN P L L++ NN+ VP L + +Q
Sbjct: 227 SIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQV 267
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 10/68 (14%), Positives = 24/68 (35%), Gaps = 8/68 (11%)
Query: 1 MKTLKYLNIAHNQLQG------QLNDMFGQLPSLSTLDLSFNTLSGNL--PQSFSSLSSL 52
K ++ + + +N + + S S + L N + P +F +
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 53 SSLYLQNN 60
+++ L N
Sbjct: 322 AAVQLGNY 329
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 2e-10
Identities = 29/188 (15%), Positives = 51/188 (27%), Gaps = 43/188 (22%)
Query: 279 LGEGTFGRVYRAQFADGKVLAVKKI---DSSALPSEMCDDFIEMVSNISQL--------- 326
+GEG FG V++ AD +A+K I + F E++ I
Sbjct: 28 IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 327 ---HHPNIMELV------GYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLI------ 371
+ L G + GS +D +D ++
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 372 -------------WNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418
+ I +L SL H+++ N+LL +L
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 419 DCGLASNM 426
+
Sbjct: 205 YTLNGKSS 212
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 3e-10
Identities = 20/88 (22%), Positives = 30/88 (34%), Gaps = 4/88 (4%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L L I + Q L L L L + + L P +F LS L L
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89
Query: 60 NQFSGTI--DVLANLPLDNLNIANNRFT 85
N ++ + L L L ++ N
Sbjct: 90 NALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 7e-04
Identities = 18/94 (19%), Positives = 29/94 (30%), Gaps = 11/94 (11%)
Query: 41 NLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIANNRFTGWVPE------- 90
+ +L+ LY++N Q + L L L NL I + +V
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 91 QLKNINLQKDGNSWSSGPAPPPPPGTPPARKNNP 124
+L +NL + S NP
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNP 114
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 35/111 (31%), Positives = 50/111 (45%), Gaps = 16/111 (14%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
++ L++AH L L QL ++ LDLS N L LP + ++L L L +N
Sbjct: 440 YADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 496
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPE--------QLKNINLQKDGN 102
+D +ANLP L L + NNR +L +NLQ GN
Sbjct: 497 ALE-NVDGVANLPRLQELLLCNNRLQQS-AAIQPLVSCPRLVLLNLQ--GN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 5e-07
Identities = 20/79 (25%), Positives = 28/79 (35%), Gaps = 9/79 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP--QSFSSLSSLSSLYLQ 58
++ L+ L + N L+ ++ LP L L L N L Q S L L LQ
Sbjct: 485 LRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQ 541
Query: 59 NNQFSGTID----VLANLP 73
N + LP
Sbjct: 542 GNSLCQEEGIQERLAEMLP 560
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP-QSFSSLSSLSSLYLQNNQ 61
+ + L + L+ + F LP++S + +S + L SF +LS ++ + ++N +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 62 FSGTI--DVLANLP-LDNLNIANNRFT 85
I D L LP L L I N
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 4 LKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQ--SFSSLSSLSSLYLQNN 60
+ ++ I + + + D +LP L L + L P S L + +N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDN 140
Query: 61 QFSGTI--DVLANLP--LDNLNIANNRFT 85
+ +I + L L + NN FT
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 25 LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIAN 81
PS TL L L +FS+L ++S +Y+ + + NL + ++ I N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 82 NR 83
R
Sbjct: 90 TR 91
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 17/91 (18%), Positives = 34/91 (37%), Gaps = 7/91 (7%)
Query: 1 MKTLKYLNIAHN-QLQGQLNDMFGQLPSLS-TLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
L I N + + F L + + TL L N + ++ + + L ++YL
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 59 NNQFSGTI--DVLANLP--LDNLNIANNRFT 85
N++ I D + L+++ T
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 30/113 (26%), Positives = 41/113 (36%), Gaps = 17/113 (15%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
L L+++ N+L L L L L N L LP + L L L NN
Sbjct: 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN 159
Query: 62 FS----GTIDVLANLPLDNLNIANNRFTGWVPE------QLKNINLQKDGNSW 104
+ G ++ L N LD L + N +P+ L L GN W
Sbjct: 160 LTELPAGLLNGLEN--LDTLLLQENSLYT-IPKGFFGSHLLPFAFL--HGNPW 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
L+++ N L L+ L+L L+ L +L L +L L +NQ
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL 89
Query: 63 SGTIDVLANLP-LDNLNIANNRFT 85
+ LP L L+++ NR T
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRF 84
+ L LS N L + + L+ L L + + + V LP L L++++N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQL 89
Query: 85 T 85
Sbjct: 90 Q 90
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 279 LGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLHHPNIME 333
+G G +G V A G +AVKK+ + P + + E+ + + H N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRL-LKHMKHENVIG 92
Query: 334 LV------GYCSEYGQHLLVYEFRKNGSLHDFLH---LSDEDNKPLIWNSRVKIALGTAR 384
L+ E+ LV L++ + L+D+ + LI+ R
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQ--------ILR 143
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAP 444
L+Y+H S ++H+++K +N+ ++ + ++ D GLA ADE A Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAP 198
Query: 445 EVAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
E+ ++ YN D++S G +M ELLTGR F
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 35/118 (29%), Positives = 49/118 (41%), Gaps = 18/118 (15%)
Query: 1 MKTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSL----SSL 55
+KTLK LN+AHN +Q +L + F L +L LDLS N + L + SL
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 56 YLQNNQFSGTID--VLANLPLDNLNIANNRFTGWVPEQ-------LKNINLQKDGNSW 104
L N + I + L L + N+ VP+ L+ I L N W
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWL--HTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 19/85 (22%), Positives = 34/85 (40%), Gaps = 3/85 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L L + N +Q F L SL L L+ L +L L + +N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 64 GTI--DVLANLP-LDNLNIANNRFT 85
+ +NL L++L++++N+
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP-QSFSSLSSLSSLYLQNNQ 61
+ K L+++ N L+ + F P L LDLS + + ++ SLS LS+L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 62 FS----GTIDVLANLPLDNLNIANNRFT 85
G L++ L L
Sbjct: 88 IQSLALGAFSGLSS--LQKLVAVETNLA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 20/63 (31%), Positives = 23/63 (36%), Gaps = 4/63 (6%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNLNIANN 82
S LDLSFN L SF S L L L + TI +L L L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 83 RFT 85
Sbjct: 87 PIQ 89
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 42/212 (19%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 275 VENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCD------DFIEMVSNISQLH 327
V ++G+G+FG+V +A + +A+K + + +E + + +
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDN 157
Query: 328 HPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
N++ ++ + H+ + +E +L++ + + K A + L
Sbjct: 158 TMNVIHMLEN-FTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVRKFAHSILQCL 213
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQ--LSDCGLASNMPNADEALNNDAGS-GYGA 443
+ LH ++H ++K NILL + + D G + + + S Y A
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQSRFYRA 267
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475
PEV + +Y + D++S G ++ ELLTG
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 28/113 (24%), Positives = 48/113 (42%), Gaps = 14/113 (12%)
Query: 1 MKTLKYLNIAHNQLQGQLND-MFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
MK+L+ L+I+ N + SL +L++S N L+ + + + L L +
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430
Query: 60 NQFSGTIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
N+ + L L LN+A+N+ VP+ L+ I L N W
Sbjct: 431 NKIKSIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLH--TNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 20/119 (16%), Positives = 42/119 (35%), Gaps = 13/119 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ N + + ++ LD S N L+ + ++ L+ L +L LQ N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358
Query: 61 QFS---GTIDVLANLP-LDNLNIANNRFTGWVPE-------QLKNINLQKDGNSWSSGP 108
Q ++ + L L+I+ N + + L ++N+ N +
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS--SNILTDTI 415
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 19/85 (22%), Positives = 31/85 (36%), Gaps = 3/85 (3%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+ LNI+ N + L L L +S N + F L L L +N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 62 FSG-TIDVLANLPLDNLNIANNRFT 85
+ N L +L+++ N F
Sbjct: 81 LVKISCHPTVN--LKHLDLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 12/87 (13%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K L + + + ++ +++ + + + S +S L NN
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFT 85
+ T+ + +L L+ L + N+
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 16/81 (19%), Positives = 32/81 (39%), Gaps = 3/81 (3%)
Query: 2 KTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
LK+L+++ N + FG + L L LS L + + L+ L +
Sbjct: 90 VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149
Query: 61 QFSGTI--DVLANLPLDNLNI 79
+ + L + ++L+I
Sbjct: 150 TYGEKEDPEGLQDFNTESLHI 170
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 11/93 (11%)
Query: 2 KTLKYLNIAHNQLQGQ-----LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLY 56
T+ Y +I++ +LQGQ + L +LS + + + S+++
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 57 LQNNQ----FSGTIDVLANLPLDNLNIANNRFT 85
+ ++ +L+ +NN T
Sbjct: 307 FTVSGTRMVHMLCPSKISP--FLHLDFSNNLLT 337
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLH 327
+ +G G +G V A G+ +A+KK+ P + + E++ + +
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLL-LKHMQ 81
Query: 328 HPNIMELV------GYCSEYGQHLLVYEFRKNGSLHDFLH--LSDEDNKPLIWNSRVKIA 379
H N++ L+ + LV F L + S+E + L++
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDLQKIMGLKFSEEKIQYLVYQ------ 134
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-AG 438
+ L+Y+H S VVH+++K N+ ++ + ++ D GLA + AD +
Sbjct: 135 --MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH---ADAEMTGYVVT 186
Query: 439 SGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
Y APEV +S YN D++S G +M E+LTG+ F
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN- 59
++ LK L I ++ L L LP L LDL T N P F + L L L++
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 60 NQFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKN 94
+ T+ + L L+ L++ +P +
Sbjct: 264 SNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 21/107 (19%), Positives = 36/107 (33%), Gaps = 3/107 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L + L Q D +L L + + L LP + + L +L L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQKDGNSWSS 106
+A+L L L+I +PE L + + + +
Sbjct: 138 PLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 13/110 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSS---------LSS 51
L+ L +A N L+ L L L L + LP+ +S L +
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
Query: 52 LSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKN-INLQK 99
L SL L+ +ANL L +L I N+ + + + + L++
Sbjct: 185 LQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 14/74 (18%), Positives = 25/74 (33%), Gaps = 5/74 (6%)
Query: 1 MKTLKYLNIAH-NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
LK L + + L L +L L LDL LP + L + + +
Sbjct: 252 RAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 60 NQFSGTIDVLANLP 73
+ + + + P
Sbjct: 311 HLQA---QLDQHRP 321
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
LK +++ +N L+ + PSL + N L LP +L L+++Y NN
Sbjct: 152 SSFLKIIDVDNNSLK----KLPDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNN 205
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQK 99
D+ + L+++ NN +PE L
Sbjct: 206 SLKKLPDLPLS--LESIVAGNNILEE-LPELQNLPFLTT 241
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 24/98 (24%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L+ + +N L+ +L + LP L+T+ N L LP SL +L +++N +
Sbjct: 217 LESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLP---DLPPSLEALNVRDNYLT 270
Query: 64 GTIDVLANLPLDNLNIANNRFTGW--VPEQLKNINLQK 99
++ +L L+++ N F+G +P L +N
Sbjct: 271 DLPELPQSLT--FLDVSENIFSGLSELPPNLYYLNASS 306
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 24/111 (21%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L YLN + N++ + PSL L++S N L LP + L L N
Sbjct: 297 PNLYYLNASSNEI----RSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNH 348
Query: 62 FSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPP 112
+ ++ N L L++ N P+ +++ + + + P P
Sbjct: 349 LAEVPELPQN--LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQ 396
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 24/115 (20%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ---------------SFSS 48
L+ L + N L +L ++ L SL + + LS P +
Sbjct: 93 LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQN 151
Query: 49 LSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPE-----QLKNINLQ 98
S L + + NN D+ + L+ + NN+ +PE L I
Sbjct: 152 SSFLKIIDVDNNSLKKLPDLPPS--LEFIAAGNNQLEE-LPELQNLPFLTAIYAD 203
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 21/109 (19%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L + +N L+ + PSL L++ N L+ +LP+ SL+ L +
Sbjct: 236 LPFLTTIYADNNLLK----TLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFS 290
Query: 61 QFSGTIDVLANLPLDN---------------LNIANNRFTGWVPEQLKN 94
S L L + LN++NN+ +P
Sbjct: 291 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR 338
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 23/110 (20%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+ L + + L + P L +L S N+L+ LP+ SL SL
Sbjct: 71 RQAHELELNNLGLS----SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 62 FSG----------------TIDVLANLP-LDNLNIANNRFTGWVPEQLKN 94
S + L N L +++ NN +P+ +
Sbjct: 126 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 21/126 (16%), Positives = 41/126 (32%), Gaps = 20/126 (15%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLS----------- 50
L+ + L ++ + S + +++ N P
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 51 --SLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSS 106
L L N S + P L++L + N T +PE +++ +L D N+ +
Sbjct: 70 DRQAHELELNNLGLS---SLPELPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKA 125
Query: 107 GPAPPP 112
PP
Sbjct: 126 LSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 19/134 (14%), Positives = 45/134 (33%), Gaps = 39/134 (29%)
Query: 1 MKTLKYLNIAHNQLQG----------------QLNDMFGQLPSLSTLDLSFNTLSGNLPQ 44
+L+ LN+++N+L L ++ +L L + +N L P
Sbjct: 316 PPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLR-EFPD 374
Query: 45 SFSSL----------------SSLSSLYLQNNQFSGTIDVLANLP--LDNLNIANNRFTG 86
S+ +L L+++ N ++P +++L + + R
Sbjct: 375 IPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR----EFPDIPESVEDLRMNSERVVD 430
Query: 87 WVPEQLKNINLQKD 100
+ + +D
Sbjct: 431 PYEFAHETTDKLED 444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 8/63 (12%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ LK L++ N L+ + S+ L ++ + + + L +++
Sbjct: 395 PQNLKQLHVETNPLR----EFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
Query: 61 QFS 63
Sbjct: 451 HHH 453
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 24/98 (24%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L+ L ++HN+++ +F L LD+S N L N+ ++SL L L N F
Sbjct: 78 LRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD 134
Query: 64 --GTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQ 98
NL L L ++ +F + +++L
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLS 172
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 20/107 (18%), Positives = 36/107 (33%), Gaps = 23/107 (21%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
K L+++ N + L L L LS N + +L F L L + +N+
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 62 FSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGP 108
L N+ + L++++L N + P
Sbjct: 112 -------LQNISCCPM------------ASLRHLDL--SFNDFDVLP 137
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 18/106 (16%), Positives = 38/106 (35%), Gaps = 11/106 (10%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF- 62
+ ++ + S + L+ + N + ++ Q S+L L +L LQ N
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 63 --SGTIDVLANLP-LDNLNIANNRFTGWV-------PEQLKNINLQ 98
+ N+ L+ L+++ N E + +NL
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 21/87 (24%), Positives = 42/87 (48%), Gaps = 9/87 (10%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLP-SLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+++ LN++ N L +F LP + LDL N + ++P+ + L +L L + +N
Sbjct: 428 ESILVLNLSSNMLT---GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483
Query: 61 QFSGTI--DVLANLP-LDNLNIANNRF 84
Q ++ V L L + + +N +
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 14/89 (15%), Positives = 27/89 (30%), Gaps = 6/89 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K+L ++ + ++ ++ LS + S SS + L N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 61 QFS----GTIDVLANLPLDNLNIANNRFT 85
F+ L L L + N
Sbjct: 364 VFTDSVFQGCSTLKRLQT--LILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 4 LKYLNIAHNQLQ--GQLNDMFGQLPSLSTLDLSFNTL-SGNLPQSFSSLSSLSSLYLQNN 60
L+ L + N L+ ++ M + SL TLD+S N+L S ++ + S+ L L +N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 61 QFSGTIDVLANLP--LDNLNIANNRFTGWVPE------QLKNINLQK 99
T V LP + L++ NNR +P+ L+ +N+
Sbjct: 439 ML--TGSVFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVAS 482
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 17/84 (20%), Positives = 31/84 (36%), Gaps = 3/84 (3%)
Query: 2 KTLKYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLS-SLSSLYLQN 59
+L++L+++ N + FG L L+ L LS + L S L L +
Sbjct: 121 ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180
Query: 60 NQFS-GTIDVLANLPLDNLNIANN 82
G + L L++ +
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFH 204
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLH 327
F +++LLGEG +G V A G+++A+KKI+ P + E + +
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE----PFDKPLFALRTLRE-IKILKHFK 67
Query: 328 HPNIMELV-----GYCSEYGQHLLVYEFRKNGSLHDFL---HLSDEDNKPLIWNSRVKIA 379
H NI+ + + + ++ E LH + LSD+ + I+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDLHRVISTQMLSDDHIQYFIYQ------ 120
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
T RA++ LH +V+H+++K +N+L+++ + ++ D GLA + + + G
Sbjct: 121 --TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 440 G-----------YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPF 475
Y APEV ++ Y+ DV+S G ++ EL R F
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 60/242 (24%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDS------SALPSEMCDDFIEMVSN 322
+F V +G+GTFGRV Q + K AVK + + SA E +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK-IE-----ADILKK 87
Query: 323 ISQLHHP---NIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNK------PLIW 372
I NI++ G Y H+ L++E SL++ + N I
Sbjct: 88 IQN-DDINNNNIVKYHG-KFMYYDHMCLIFE-PLGPSLYEII----TRNNYNGFHIEDIK 140
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
+ +AL YL + +S+ H ++K NILLD+ + +
Sbjct: 141 ----LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 433 LNN--------DAGSG---------------YGAPEVAMSGQYNIKSDVYSFGVVMLELL 469
D G Y APEV ++ +++ SD++SFG V+ EL
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253
Query: 470 TG 471
TG
Sbjct: 254 TG 255
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 4/86 (4%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+K L++++N++ N + +L L L+ N ++ SFSSL SL L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 63 SGTI--DVLANLP-LDNLNIANNRFT 85
S + L L LN+ N +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 18/113 (15%), Positives = 33/113 (29%), Gaps = 15/113 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L I + LQ + ++S L L L SS+ L L++
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 61 QF---------SGTIDVLANLP-LDNLNIANNRFTGWVPE-----QLKNINLQ 98
+G + L N+ I + + L +
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 28/92 (30%), Positives = 40/92 (43%), Gaps = 3/92 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L+ L + N + D F L SL LDLS+N LS F LSSL+ L L N +
Sbjct: 78 LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK 137
Query: 64 --GTIDVLANLP-LDNLNIANNRFTGWVPEQL 92
G + ++L L L + N + +
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 18/93 (19%), Positives = 39/93 (41%), Gaps = 8/93 (8%)
Query: 1 MKTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L+ L + + ++ F L L L++ + L P+S S+ ++S L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 60 NQFS----GTIDVLANLP---LDNLNIANNRFT 85
Q +DV +++ L + ++ F+
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 3/61 (4%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQN 59
T + + I L Q+ + Q+ L L+ S N L ++P F L+SL ++L
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310
Query: 60 N 60
N
Sbjct: 311 N 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 16/125 (12%), Positives = 43/125 (34%), Gaps = 19/125 (15%)
Query: 4 LKYLNIAHNQLQG-QLN-------DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSL 55
++ L + L + + + + + ++ +L + + + +S L L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 56 YLQNNQFSGTI--DVLANLP-LDNLNIANN------RFTGWVPEQLKNINLQKDGNSWSS 106
NQ ++ + L L + + N ++ L + ++ G++ S
Sbjct: 283 EFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCS 341
Query: 107 GPAPP 111
G P
Sbjct: 342 GSGKP 346
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 20/91 (21%), Positives = 42/91 (46%), Gaps = 14/91 (15%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNLNIANN 82
++ +LDLS N ++ +L +L L +N + TI+ ++L L++L+++ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 83 RFTGWVPE-------QLKNINLQKDGNSWSS 106
+ + L +NL GN + +
Sbjct: 111 YLSN-LSSSWFKPLSSLTFLNL--LGNPYKT 138
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ ++ + N+++ +L+ F L L TL ++ N + +L L+ L L NN
Sbjct: 41 LDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 61 QFS--GTIDVLANLP-LDNLNIANNRFT 85
G +D LA+L L L I N T
Sbjct: 99 SLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 18/91 (19%), Positives = 33/91 (36%), Gaps = 9/91 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS--GNLPQSFSSLSSLSSLYLQ 58
+ L++ ++ + ++ L +D S N + P L L +L +
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVN 72
Query: 59 NNQFSGTIDVLA-NLP-LDNLNIANNRFTGW 87
NN+ + L LP L L + NN
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 30/111 (27%), Positives = 41/111 (36%), Gaps = 16/111 (14%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+ L I N L L + +L TL++S N L+ +LP L LS
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 62 FSGTIDVLANLP--LDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSSGPA 109
L LP L L I N+ T +P + L N +S PA
Sbjct: 116 -------LPALPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDNQLASLPA 158
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 20/97 (20%), Positives = 41/97 (42%), Gaps = 12/97 (12%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L+ L+++ NQL L + +L L + +L + S L L + N+ +
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLP-------ALPSGLKELIVSGNRLT 234
Query: 64 GTIDVLANLPLDNLNIANNRFTGW--VPEQLKNINLQ 98
+ + L L ++ NR T +P L ++++
Sbjct: 235 SLPVLPSE--LKELMVSGNRLTSLPMLPSGLLSLSVY 269
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 7/110 (6%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
LK L ++ N+L L L +L + N L+ LP+S LSS +++ L+ N S
Sbjct: 243 LKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 64 G-TIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPP 111
T+ L + + RF + + PA
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 33/115 (28%), Positives = 47/115 (40%), Gaps = 22/115 (19%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L L I NQL + P L L +S N L+ +LP + S L L+ NNQ
Sbjct: 123 LCKLWIFGNQL----TSLPVLPPGLQELSVSDNQLA-SLP---ALPSELCKLWAYNNQ-- 172
Query: 64 GTIDVLANLP-----LDNLNIANNRFTGWVPEQLKN-INLQKDGNSWSSGPAPPP 112
L +LP L L++++N+ +P L N +S PA P
Sbjct: 173 -----LTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPS 221
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 7/87 (8%)
Query: 27 SLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTG 86
+ L++ + L+ LP + +++L + +N + + L L ++ N+ T
Sbjct: 41 GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTSLPALPPE--LRTLEVSGNQLTS 95
Query: 87 WVPEQLKNI-NLQKDGNSWSSGPAPPP 112
+P + L N + PA P
Sbjct: 96 -LPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 50/214 (23%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCD------DFIEMVSN 322
+ +++L+G+G+FG+V +A + + +A+K I + + +E+++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNK 109
Query: 323 ISQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
I+ L + + HL LV+E +L+D L + + + + N K A
Sbjct: 110 HDTEMKYYIVHLKRH-FMFRNHLCLVFEMLSY-NLYDLL--RNTNFRGVSLNLTRKFAQQ 165
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ--LSDCGLASNMPNADEALNNDAGS 439
AL +L LS++H ++K NILL N + D G + + + S
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQS 221
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
Y +PEV + Y++ D++S G +++E+ TG
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 16/107 (14%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQF 62
L+ L + N+LQ +F +L +L TL ++ N L LP F L +L+ L L NQ
Sbjct: 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 63 S----GTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQ 98
D L L L++ N +P+ LK + L
Sbjct: 122 KSLPPRVFDSLTK--LTYLSLGYNELQS-LPKGVFDKLTSLKELRLY 165
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 38/114 (33%), Positives = 50/114 (43%), Gaps = 18/114 (15%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQNNQ 61
L L + NQL+ +F L L+ L L +N L +LP+ F L+SL L L NNQ
Sbjct: 110 NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQ 168
Query: 62 FS----GTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
G D L L L + NN+ VPE +LK + L N W
Sbjct: 169 LKRVPEGAFDKLTE--LKTLKLDNNQLKR-VPEGAFDSLEKLKMLQL--QENPW 217
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 8/88 (9%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
K L++ N+L + F +L L L L+ N L LP F L +L +L++ +N+
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 62 F----SGTIDVLANLPLDNLNIANNRFT 85
G D L N L L + N+
Sbjct: 97 LQALPIGVFDQLVN--LAELRLDRNQLK 122
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 10/103 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L + NQ+ L +L L + +S +L ++LS L++L +N
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDN 183
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQ 98
+ S I LA+LP L +++ NN+ + P L + L
Sbjct: 184 KIS-DISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 25/86 (29%), Positives = 42/86 (48%), Gaps = 6/86 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + L ++ N L+ ++ L S+ TLDL+ ++ + LS+L LYL N
Sbjct: 84 LTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLN 139
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
Q + I LA L L L+I N + +
Sbjct: 140 QIT-NISPLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 10/104 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L + NQ+ L ++ L+LS N L + + L S+ +L L +
Sbjct: 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTST 117
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQK 99
Q + + LA L L L + N+ T P L+ +++
Sbjct: 118 QIT-DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 14/86 (16%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + + + + L ++TL ++ + L++L L L++N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
Q + + L NL + L ++ N
Sbjct: 74 QIT-DLAPLKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 10/82 (12%), Positives = 29/82 (35%), Gaps = 2/82 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L +++ +NQ+ +L + L+ T++ ++L + + +
Sbjct: 194 LPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
Query: 61 QFSGTIDVLANLPLDNLNIANN 82
+ N + N+ N
Sbjct: 252 APIAPATISDNGTYASPNLTWN 273
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 7/107 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ TL L+ ++ + +L L+ L + N ++ L S ++L+ L +N
Sbjct: 41 LATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSN 95
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWSS 106
+ + +DV L LN N+ T Q + L N+ +
Sbjct: 96 KLT-NLDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTE 141
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 19/100 (19%), Positives = 39/100 (39%), Gaps = 10/100 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L L+ + N++ +L+ Q L+ L+ N ++ L + L+ L +N
Sbjct: 169 QTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSN 222
Query: 61 QFSGTIDVLANLPLDNLNIANNRFT---GWVPEQLKNINL 97
+ + IDV L + + N T +L ++
Sbjct: 223 KLT-EIDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHC 261
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 21/80 (26%), Positives = 35/80 (43%), Gaps = 7/80 (8%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L +L+ + N+L +++ L L+ D S N L+ L S+LS L++L+
Sbjct: 214 LTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
Query: 64 GTIDVLANLPLDNLNIANNR 83
ID+ N L R
Sbjct: 268 -EIDLTHNTQLIYFQAEGCR 286
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 25/102 (24%), Positives = 37/102 (36%), Gaps = 11/102 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L YL N+L L+ L L+ L+ N L+ L S L+ L N
Sbjct: 84 NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARN 137
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVP----EQLKNINLQ 98
+ IDV N L L+ N+ + QL ++
Sbjct: 138 TLT-EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS 178
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 21/96 (21%), Positives = 31/96 (32%), Gaps = 7/96 (7%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L Y + +L+ L LD ++ L S L LYL N + +
Sbjct: 277 LIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
Query: 64 GTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQK 99
+DV N L +L+ N K L
Sbjct: 332 -ELDVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNN 365
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 6/96 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L YLN N+L Q P L+ L+ + NTL+ + S + L+ L N
Sbjct: 105 LTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLN 158
Query: 61 QFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNIN 96
+ +DV L L+ + N+ T Q K +N
Sbjct: 159 KKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN 194
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 17/85 (20%), Positives = 30/85 (35%), Gaps = 6/85 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L Y + + N L +L+ L L+TL L + + + L +
Sbjct: 232 LTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC 285
Query: 61 QFSGTIDVLANLPLDNLNIANNRFT 85
+ +DV N L L+ T
Sbjct: 286 RKIKELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 13/118 (11%), Positives = 34/118 (28%), Gaps = 11/118 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
L YL + + +L +L+ L +L + + S + +L++ +
Sbjct: 317 NPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEG 371
Query: 61 QFSGTIDVLANLPLDNLNIANNRF------TGWVPEQLKNINLQKDGNSWSSGPAPPP 112
Q + ++ + P + + +W + P
Sbjct: 372 QTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 19/91 (20%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
A ++Q QL +L++LD ++++ ++ L+ L+ L +N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 64 GTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
T+D+ N L L +N+ T L
Sbjct: 78 -TLDLSQNTNLTYLACDSNKLTNLDVTPLTK 107
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLH 327
+ + +GEG +G V A + +A+KKI P E E+ + +
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS----PFEHQTYCQRTLREIKI-LLRFR 83
Query: 328 HPNIMELV-----GYCSEYGQHLLVYEFRKNGSLHDFLH---LSDEDNKPLIWNSRVKIA 379
H NI+ + + +V + L+ L LS++ ++
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDL-METDLYKLLKTQHLSNDHICYFLYQ------ 136
Query: 380 LGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS 439
R L+Y+H S +V+H+++K +N+LL+ + ++ D GLA + + +
Sbjct: 137 --ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLT 189
Query: 440 G------YGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
Y APE+ ++ Y D++S G ++ E+L+ R F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 279 LGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLHHPNIME 333
+G G +G V A G +A+KK+ P + + E+ + + H N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRL-LKHMRHENVIG 88
Query: 334 LV------GYCSEYGQHLLVYEFRKNGSLHDFLH---LSDEDNKPLIWNSRVKIALGTAR 384
L+ ++ LV F L + L ++ + L++ +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPF-MGTDLGKLMKHEKLGEDRIQFLVYQ--------MLK 139
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND-AGSGYGA 443
L Y+H + ++H+++K N+ ++ + ++ D GLA AD + Y A
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRA 193
Query: 444 PEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPF 475
PEV ++ +Y D++S G +M E++TG+ F
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 6/77 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQN 59
K L +++++N++ N F + L TL LS+N L +P +F L SL L L
Sbjct: 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHG 111
Query: 60 NQFS----GTIDVLANL 72
N S G + L+ L
Sbjct: 112 NDISVVPEGAFNDLSAL 128
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 15/97 (15%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ L + NQ + L+ +DLS N +S QSFS+++ L +L L N+
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 63 S----GTIDVLANLPLDNLNIANNRFTGWVPEQLKNI 95
T D L +L L L++ N + +
Sbjct: 91 RCIPPRTFDGLKSLRL--LSLHGN--------DISVV 117
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 22/96 (22%), Positives = 46/96 (47%), Gaps = 10/96 (10%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
LK+L++ +NQL L + L ++ N L+ LP +SL L ++NNQ +
Sbjct: 122 LKHLDVDNNQLT-MLPE---LPALLEYINADNNQLT-MLP---ELPTSLEVLSVRNNQLT 173
Query: 64 GTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQK 99
++ + L+ L+++ N ++N + ++
Sbjct: 174 FLPELPES--LEALDVSTNLLESLPAVPVRNHHSEE 207
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 23/141 (16%), Positives = 43/141 (30%), Gaps = 11/141 (7%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSS----LYLQN 59
L+ L++ +NQL + SL LD+S N L +LP +
Sbjct: 162 LEVLSVRNNQL----TFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216
Query: 60 NQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNINLQKD-GNSWSSGPAPPPPPGTP 117
N+ + + + +L + + +N + + E L Q D T
Sbjct: 217 NRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
Query: 118 PARKNNPKHKSDSNKSPSESE 138
+ S+
Sbjct: 277 HRPLADAVTAWFPENKQSDVS 297
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 14/103 (13%), Positives = 38/103 (36%), Gaps = 7/103 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLST----LDLSFNTLSGNLPQSFSSLSSLSSLY 56
++L+ L+++ N L+ L + + N ++ ++P++ SL ++
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 57 LQNNQFSG-TIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQ 98
L++N S + L+ + Q ++
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 11/91 (12%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ L I N L L ++ L LD N LS LP +SL L + NNQ +
Sbjct: 82 ITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLP---ELPASLKHLDVDNNQLT 133
Query: 64 GTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
++ A L+ +N NN+ T +PE +
Sbjct: 134 MLPELPAL--LEYINADNNQLTM-LPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 23/108 (21%), Positives = 42/108 (38%), Gaps = 19/108 (17%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ N+ L + + S L L+ LS +LP + ++ L + N
Sbjct: 36 WEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQN 90
Query: 61 QFSGTIDVLANLP-----LDNLNIANNRFTGWVPEQLKNI-NLQKDGN 102
L +LP L+ L+ +NR + +PE ++ +L D N
Sbjct: 91 A-------LISLPELPASLEYLDACDNRLST-LPELPASLKHLDVDNN 130
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 15/94 (15%), Positives = 30/94 (31%), Gaps = 1/94 (1%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+T + N++ + + L T+ L N LS + +S S ++ +
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
Query: 62 FSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI 95
FS + L + F + I
Sbjct: 266 FSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 27/88 (30%), Positives = 48/88 (54%), Gaps = 12/88 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN---TLSGNLPQSFSSLSSLSSLYL 57
M+ L+ L++ N ++ ++ ++ +L L +S+N +LSG L +L LY+
Sbjct: 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYM 122
Query: 58 QNNQFS--GTIDVLANLP-LDNLNIANN 82
NN+ + G ID LA L L++L +A N
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 27/110 (24%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP--QSFSSLSSLSSLYLQ 58
TL+ L I++NQ+ L+ +L +L L +S N ++ N ++L L L L
Sbjct: 92 ADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLA 148
Query: 59 NNQFSGTID-----------VLANLP----LDNLNI-------ANNRFTG 86
N V+ LP LD + + AN G
Sbjct: 149 GNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGMPVDVDEREQANVARGG 198
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 18/83 (21%), Positives = 33/83 (39%), Gaps = 10/83 (12%)
Query: 7 LNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS--GNLPQSFSSLSSLSSLYLQNNQFSG 64
L+ ++ ++ L + L LS N + +L S + +L L L N
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSL----SGMENLRILSLGRNLIK- 83
Query: 65 TIDVLANLP--LDNLNIANNRFT 85
I+ L + L+ L I+ N+
Sbjct: 84 KIENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 13/73 (17%), Positives = 26/73 (35%), Gaps = 8/73 (10%)
Query: 31 LDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGW-- 87
L + + + S+L + L L N I L+ + L L++ N
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKKIEN 87
Query: 88 ---VPEQLKNINL 97
V + L+ + +
Sbjct: 88 LDAVADTLEELWI 100
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 48/251 (19%), Positives = 102/251 (40%), Gaps = 59/251 (23%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDD----FIEMVSNISQLH 327
+ + +L+G G++G V A + +V+A+KKI E D E ++ +++L+
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI---LRVFEDLIDCKRILRE-IAILNRLN 110
Query: 328 HPNIMELV-----GYCSEYGQHLLVYEFRKNGSLHDFLH----LSDEDNKPLIWNSRVKI 378
H ++++++ ++ + +V E + L++ K L++N
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEI-ADSDFKKLFRTPVYLTELHIKTLLYN----- 164
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
++Y+H S ++H+++K AN L++ + + ++ D GLA + + +
Sbjct: 165 ---LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 439 SG----------------------------YGAPEVAMSGQ-YNIKSDVYSFGVVMLELL 469
S Y APE+ + + Y DV+S G + ELL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 470 TGRKPFDSSRP 480
K +
Sbjct: 279 NMIKENVAYHA 289
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 14/105 (13%)
Query: 1 MKTLKYLNIAHNQLQGQLNDM--FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ + L + N+L D+ L +L L L N + +L S L L SL L+
Sbjct: 64 LPNVTKLFLNGNKLT----DIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLE 117
Query: 59 NNQFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQ 98
+N S I+ L +LP L++L + NN+ T +L ++L+
Sbjct: 118 HNGIS-DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE 161
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K LK L++ HN + +N LP L +L L N ++ S L+ L +L L++N
Sbjct: 108 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDN 163
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP-EQLKNIN 96
Q S I LA L L NL ++ N + LKN++
Sbjct: 164 QIS-DIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLD 200
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 17/88 (19%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ ++ + ++ ++ + G LP+++ L L+ N L+ ++ + ++L +L L+L
Sbjct: 42 LNSIDQIIANNSDIK----SVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLD 95
Query: 59 NNQFSGTIDVLANLP-LDNLNIANNRFT 85
N+ + L +L L +L++ +N +
Sbjct: 96 ENKIK-DLSSLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 17/138 (12%), Positives = 34/138 (24%), Gaps = 4/138 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L+ L ++ N + L L +L L+L S+L +++ +
Sbjct: 174 LTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 61 QFS--GTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQKDGNSWSSGPAPPPPPGTPP 118
I + N+ FT V + G P
Sbjct: 232 SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYT 291
Query: 119 ARKNNPKHKSDSNKSPSE 136
+ +
Sbjct: 292 VSYDVDGTVIKTKVEAGT 309
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 14/90 (15%), Positives = 35/90 (38%), Gaps = 10/90 (11%)
Query: 17 QLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP- 73
+ +F +L +++ + Q+ L+S+ + N+ ++ + LP
Sbjct: 10 PIKQIFPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYLPN 66
Query: 74 LDNLNIANNRFTGWVP----EQLKNINLQK 99
+ L + N+ T P + L + L +
Sbjct: 67 VTKLFLNGNKLTDIKPLTNLKNLGWLFLDE 96
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 10/104 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K LK L++ HN + +N LP L +L L N ++ S L+ L +L L++N
Sbjct: 111 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDN 166
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFTGWVP----EQLKNINLQK 99
Q S I LA L L NL ++ N + + L + L
Sbjct: 167 QIS-DIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 209
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 16/86 (18%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ ++ + ++ ++ + LP+++ L L+ N L+ ++ ++L +L L+L N
Sbjct: 45 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDEN 100
Query: 61 QFSGTIDVLANLP-LDNLNIANNRFT 85
+ + L +L L +L++ +N +
Sbjct: 101 KVK-DLSSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 10/86 (11%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ + L + N+L D+ L +L L L N + +L S L L SL L+
Sbjct: 67 LPNVTKLFLNGNKL----TDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLE 120
Query: 59 NNQFSGTIDVLANLP-LDNLNIANNR 83
+N S I+ L +LP L++L + NN+
Sbjct: 121 HNGIS-DINGLVHLPQLESLYLGNNK 145
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L L++ NQ+ + L L L LS N +S +L ++ + L +L L L +
Sbjct: 155 LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210
Query: 61 QFSGTIDVLANLPLDNLNIANN 82
+ + L N N
Sbjct: 211 ECL-NKPINHQSNLVVPNTVKN 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 62/252 (24%)
Query: 257 NVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDD 315
N+ + + + LG G G V+ A D K +A+KKI + D
Sbjct: 3 NIHGFDLGS------RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--------VLTD 48
Query: 316 FIEM------VSNISQLHHPNIMEL--------------VGYCSEYGQHLLVYEFRKNGS 355
+ + I +L H NI+++ VG +E +V E+
Sbjct: 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METD 107
Query: 356 LHDFLH---LSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412
L + L L +E + ++ R L+Y+H S +V+H+++K AN+ + N
Sbjct: 108 LANVLEQGPLLEEHARLFMYQ--------LLRGLKYIH---SANVLHRDLKPANLFI-NT 155
Query: 413 LNPQLSDC--GLASNMPNADEALNNDAGSG------YGAPEVAMSGQ-YNIKSDVYSFGV 463
+ L GLA M + S Y +P + +S Y D+++ G
Sbjct: 156 EDLVLKIGDFGLARIM--DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 464 VMLELLTGRKPF 475
+ E+LTG+ F
Sbjct: 214 IFAEMLTGKTLF 225
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 43/232 (18%), Positives = 84/232 (36%), Gaps = 44/232 (18%)
Query: 270 TGSFNVENLLGEGTFGRVYRA--QFADGKVLAVKKIDSSALPSEMCD------DFIEMVS 321
+ + LGEGTFG+V +A+K I + + + + ++ +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIK 74
Query: 322 NISQLHHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL 380
+ + + + + H+ + +E + +FL + + +P +A
Sbjct: 75 EKDKENKFLCVLMSD-WFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMAY 130
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNN----- 435
AL +LHE + H ++K NIL N L + + ++++ N
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN----EHKSCEEKSVKNTSIRV 183
Query: 436 -DAGSG---------------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTG 471
D GS Y PEV + + DV+S G ++ E G
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 48/240 (20%), Positives = 96/240 (40%), Gaps = 60/240 (25%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQ--FADGKVLAVKKI-------DSSALPSEMCDDFIEMV 320
+ + + + LGEG FG+V A G+ +AVK + +++ E I+++
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS--E-----IQVL 65
Query: 321 SNISQLHHPNIMELVGY--CSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNK----PLIWN 373
+++ + V E+ H+ +V+E S +DF+ ++N L
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFI----KENGFLPFRL--- 117
Query: 374 SRVK-IALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
++ +A +++ +LH + H ++K NIL + + + +
Sbjct: 118 DHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN----PKIKRDERT 170
Query: 433 LNN------DAGSG---------------YGAPEVAMSGQYNIKSDVYSFGVVMLELLTG 471
L N D GS Y APEV ++ ++ DV+S G +++E G
Sbjct: 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 18/87 (20%), Positives = 36/87 (41%), Gaps = 9/87 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ ++ N ++ +Q + G +L L LS N +S +L L+ L L +
Sbjct: 40 LSGVQNFNGDNSNIQ----SLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVN 93
Query: 59 NNQFSGTIDVLANLPLDNLNIANNRFT 85
N+ ++ + + L L + NN
Sbjct: 94 RNRLK-NLNGIPSACLSRLFLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 9/85 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFG-QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L+ L++ N+L ++ G LS L L N L S L +L L ++N
Sbjct: 84 LTKLEELSVNRNRL----KNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRN 137
Query: 60 NQFSGTIDVLANLP-LDNLNIANNR 83
N+ +I +L L L+ L++ N
Sbjct: 138 NKLK-SIVMLGFLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 12/79 (15%), Positives = 31/79 (39%), Gaps = 9/79 (11%)
Query: 8 NIAHNQLQGQLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT 65
+I +N +F L + +L +++ S LS + + N+ +
Sbjct: 2 SIQRPT---PINQVFPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-S 55
Query: 66 IDVLANLP-LDNLNIANNR 83
+ + L L++++N+
Sbjct: 56 LAGMQFFTNLKELHLSHNQ 74
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 23/59 (38%), Positives = 35/59 (59%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
++ L + N+++ N MF L L TL+L N +S +P SF L+SL+SL L +N F
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 8/87 (9%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQN 59
+ L L + NQL G + F + L L N + + F L L +L L +
Sbjct: 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYD 111
Query: 60 NQFS----GTIDVLANLPLDNLNIANN 82
NQ S G+ + L + L +LN+A+N
Sbjct: 112 NQISCVMPGSFEHLNS--LTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 17/112 (15%)
Query: 5 KYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
L + N+L + +FG+LP L L+L N L+G P +F S + L L N+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 64 ----GTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
L L LN+ +N+ + V L ++NL N +
Sbjct: 92 EISNKMFLGLHQ--LKTLNLYDNQISC-VMPGSFEHLNSLTSLNLA--SNPF 138
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP-QSFSSLSSLSSLYLQN- 59
+ L +L+ F L +++S N + + FS+L L + ++
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 60 NQFSGTI--DVLANLP-LDNLNIANNRFT 85
N I + NLP L L I+N
Sbjct: 90 NNLL-YINPEAFQNLPNLQYLLISNTGIK 117
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 21/116 (18%), Positives = 34/116 (29%), Gaps = 11/116 (9%)
Query: 1 MKTLKYLNIAH-NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
+ L + I N L + F LP+L L +S + L +Q+
Sbjct: 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137
Query: 60 NQFSGTI--DVLANLP--LDNLNIANNRFTGWVPE----QLKNINL-QKDGNSWSS 106
N TI + L L + N + + L D N+
Sbjct: 138 NINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 21/142 (14%), Positives = 42/142 (29%), Gaps = 10/142 (7%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ +N L+ ND+F LD+S + +L L + N +
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 237
Query: 64 GTIDVLANLP-LDNLNIANNR----FTGWVPE--QLKNINLQKDGNSWSSGPAPPPPPGT 116
+ L L L ++ F W + +L I + +
Sbjct: 238 -KLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRS 296
Query: 117 PPARKNNPKHKSDSNKSPSESE 138
A N + + + +E +
Sbjct: 297 SLAEDNESSYSRGFDMTYTEFD 318
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 46/249 (18%), Positives = 99/249 (39%), Gaps = 58/249 (23%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEM------VSNISQ 325
+ +++L+G G++G VY A K +A+KK+ + M +D I+ ++ +++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV------NRMFEDLIDCKRILREITILNR 81
Query: 326 LHHPNIMELV-----GYCSEYGQHLLVYEFRKNGSLHDFLH----LSDEDNKPLIWNSRV 376
L I+ L ++ + +V E + L L++E K +++N
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYN--- 137
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
++H ++H+++K AN LL+ + + ++ D GLA + + + +
Sbjct: 138 -----LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 437 AGSG-----------------------YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGR 472
Y APE+ + + Y D++S G + ELL
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 473 KPFDSSRPR 481
+ +
Sbjct: 250 QSHINDPTN 258
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 31/100 (31%), Positives = 42/100 (42%), Gaps = 16/100 (16%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQN 59
+ L L +A+NQL +F L L L L N L LP F L+ L L L
Sbjct: 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNT 140
Query: 60 NQFS----GTIDVLANLPLDNLNIANNRFTGWVPEQLKNI 95
NQ G D L N L L+++ N QL+++
Sbjct: 141 NQLQSIPAGAFDKLTN--LQTLSLSTN--------QLQSV 170
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 38/120 (31%), Positives = 53/120 (44%), Gaps = 18/120 (15%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQN 59
+ L +LN+ +NQLQ +F L L TL L+ N L+ +LP F L+ L LYL
Sbjct: 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGG 116
Query: 60 NQF----SGTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSWSSGP 108
NQ SG D L L L + N+ +P L+ ++L N S P
Sbjct: 117 NQLKSLPSGVFDRLTK--LKELRLNTNQLQS-IPAGAFDKLTNLQTLSLST--NQLQSVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/75 (32%), Positives = 35/75 (46%), Gaps = 6/75 (8%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
L L + NQL+ + +F +L L L L+ N L ++P F L++L +L L NQ
Sbjct: 108 QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQ 166
Query: 62 FS----GTIDVLANL 72
G D L L
Sbjct: 167 LQSVPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 23/59 (38%), Positives = 29/59 (49%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
LK L + NQLQ F +L +L TL LS N L +F L L ++ L NQF
Sbjct: 133 LKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 29/106 (27%), Positives = 43/106 (40%), Gaps = 16/106 (15%)
Query: 5 KYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQF- 62
+ L++ L + F L L+ L+L +N L L F L+ L +L L NNQ
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 63 ---SGTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQ 98
G D L LD L + N+ +P +LK + L
Sbjct: 97 SLPLGVFDHLTQ--LDKLYLGGNQLKS-LPSGVFDRLTKLKELRLN 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 16/100 (16%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQN 59
+ +L L + N+LQ N +F +L SL+ L+LS N L +LP F L+ L L L
Sbjct: 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNT 109
Query: 60 NQF----SGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI 95
NQ G D L L +L + N QLK++
Sbjct: 110 NQLQSLPDGVFDKLTQ--LKDLRLYQN--------QLKSV 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 27/87 (31%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
YL++ N L+ N +F +L SL+ L L N L F+ L+SL+ L L NQ
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88
Query: 63 ----SGTIDVLANLPLDNLNIANNRFT 85
+G D L L L + N+
Sbjct: 89 QSLPNGVFDKLTQ--LKELALNTNQLQ 113
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 35/120 (29%), Positives = 52/120 (43%), Gaps = 28/120 (23%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNN 60
LK L + NQLQ + +F +L +L+ L+L+ N L +LP+ F L++L+ L L N
Sbjct: 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167
Query: 61 QF----SGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI------NLQK------DGNSW 104
Q G D L L +L + N QLK++ L N W
Sbjct: 168 QLQSLPEGVFDKLTQ--LKDLRLYQN--------QLKSVPDGVFDRLTSLQYIWLHDNPW 217
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF- 62
++YL + N+L ++ +L +L+ L L+ N L F L++L L L NQ
Sbjct: 65 VRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
Query: 63 ---SGTIDVLANLPLDNLNIANNRFT 85
G D L N L LN+A+N+
Sbjct: 123 SLPDGVFDKLTN--LTYLNLAHNQLQ 146
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 52/247 (21%), Positives = 99/247 (40%), Gaps = 76/247 (30%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFI-------EMVSNIS 324
+ + LG+G +G V+++ G+V+AVKKI + + E I
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI------FDAFQNSTDAQRTFRE----IM 60
Query: 325 QLH----HPNIMELVG-YCSEYGQHL-LVYEFRKNGSLHDFLH---LSDEDNKPLIWNSR 375
L H NI+ L+ ++ + + LV+++ LH + L + +++
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDLHAVIRANILEPVHKQYVVYQ-- 117
Query: 376 VKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC-------GLASNMPN 428
+ ++YLH S ++H+++K +NILL+ ++C GL+ + N
Sbjct: 118 ------LIKVIKYLH---SGGLLHRDMKPSNILLN-------AECHVKVADFGLSRSFVN 161
Query: 429 ADEALNNDAGSG----------------------YGAPEVAMSGQ-YNIKSDVYSFGVVM 465
NN S Y APE+ + Y D++S G ++
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 466 LELLTGR 472
E+L G+
Sbjct: 222 GEILCGK 228
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 17/115 (14%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQN 59
+ LK L + NQL +F L L+ LDL N L+ LP + F L L L++
Sbjct: 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCC 121
Query: 60 NQFSGT---IDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
N+ + I+ L + L +L + N+ +P L + L GN W
Sbjct: 122 NKLTELPRGIERLTH--LTHLALDQNQLKS-IPHGAFDRLSSLTHAYLF--GNPW 171
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 27/98 (27%), Positives = 38/98 (38%), Gaps = 16/98 (16%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
+ L + NQ+ +F L +L L L N L LP F SL+ L+ L L NQ
Sbjct: 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQ 99
Query: 62 F----SGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI 95
S D L + L L + N +L +
Sbjct: 100 LTVLPSAVFDRLVH--LKELFMCCN--------KLTEL 127
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 18/114 (15%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
+ L + N+LQ + +F +L L+ L LS N + +LP F L+ L+ LYL N+
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENK 87
Query: 62 F----SGTIDVLANLPLDNLNIANNRFTGWVPE-------QLKNINLQKDGNSW 104
+G D L L L + N+ VP+ L+ I L N W
Sbjct: 88 LQSLPNGVFDKLTQ--LKELALDTNQLKS-VPDGIFDRLTSLQKIWL--HTNPW 136
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 15/99 (15%)
Query: 2 KTLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTL-----SGNLPQSFSSLSSL 52
L+ + N+L+ F L T+ + N + L + + L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 53 SSLYLQNNQFS--GTI---DVLANLP-LDNLNIANNRFT 85
L LQ+N F+ G+ L + P L L + + +
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 19/101 (18%), Positives = 31/101 (30%), Gaps = 17/101 (16%)
Query: 2 KTLKYLNIAHNQL-----QGQLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSL 52
+ L + + N + + L + L LDL NT + L + S +L
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246
Query: 53 SSLYLQNNQ--------FSGTIDVLANLPLDNLNIANNRFT 85
L L + L N+ L L + N
Sbjct: 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 20/58 (34%), Positives = 35/58 (60%), Gaps = 2/58 (3%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSSLYLQNN 60
L L++ +NQL +F +L L+ L L+ N L ++P+ +F +L SL+ ++L NN
Sbjct: 56 LTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 5e-05
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
T + L + NQ+ +F +L L+ LDL N L+ LP F L+ L+ L L +NQ
Sbjct: 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 4e-05
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 7/70 (10%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQ---LPSLSTLDLSFNTLSGN----LPQSFSSLSSLS 53
LK+L I + Q + +MF + LP L T+D+S L+ L + L
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 54 SLYLQNNQFS 63
+ ++ N S
Sbjct: 311 FINMKYNYLS 320
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 13/96 (13%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-----FSSLSSLSSLYLQ 58
L+ L N+L +F +L L+ LDL+ N L +S F +L SL+ +YL
Sbjct: 59 LQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL-----KSIPRGAFDNLKSLTHIYLY 113
Query: 59 NNQF---SGTIDVLANLPLDNLNIANNRFTGWVPEQ 91
NN + I L N D+ +I V +
Sbjct: 114 NNPWDCECRDIMYLRNWVADHTSIVMRWDGKAVNDP 149
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 16/60 (26%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS-FSSLSSLSSLYLQNNQ 61
+ L + +NQ+ +F L +L L + N L+ +P F L+ L+ L L +N
Sbjct: 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 36/186 (19%), Positives = 65/186 (34%), Gaps = 52/186 (27%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVK--------KIDSSALPSEM-------CDD 315
++ V +G+G FG +Y A + + D+ L +E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQ----HLLVYE---------FRKNG---SLHDF 359
I+ +L + + + G ++ + + N S
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 360 LHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ--L 417
L LS ++ LEY+HE VH +IK++N+LL+ + Q L
Sbjct: 155 LQLSLR----ILD------------ILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYL 195
Query: 418 SDCGLA 423
D GLA
Sbjct: 196 VDYGLA 201
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 4/76 (5%)
Query: 25 LPSLSTLDLSFNTLSG--NLPQSFSSLSSLSSLYLQNNQFS--GTIDVLANLPLDNLNIA 80
+P L +L+LS N L ++ +L L L N+ +D + L L+ L +
Sbjct: 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD 228
Query: 81 NNRFTGWVPEQLKNIN 96
N +Q I+
Sbjct: 229 GNSLCDTFRDQSTYIS 244
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 35/174 (20%), Positives = 58/174 (33%), Gaps = 26/174 (14%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVK--------KIDS--SALPSEMC------- 313
+ +++ G +Y A K+D+ L +E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 314 DDFIEMVSNISQLHHPNIMELVGYCSEYGQH-LLVYEFRKNGSLHDFLHLSDEDNKPLIW 372
+ + I +G+ ++ LV SL L +S L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP-SLGRSLQSALDVS--PKHVLSE 158
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ--LSDCGLAS 424
S +++A ALE+LHE VH N+ + NI +D E Q L+ G A
Sbjct: 159 RSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 579 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.51 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.45 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.41 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.41 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.39 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.39 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.34 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.34 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.33 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.31 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.31 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.31 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.3 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.29 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.27 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.27 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.26 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.25 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.25 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.23 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.23 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.22 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.22 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.21 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.2 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.2 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.19 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.19 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.16 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.16 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.15 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.15 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.1 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.09 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.07 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.07 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.07 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.06 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.06 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.04 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.04 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.04 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.04 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.03 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.03 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.02 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.02 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.02 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.02 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.02 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.02 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.01 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.01 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.01 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.01 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.0 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.0 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.98 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.97 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.96 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.96 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.95 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.92 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.92 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.91 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.91 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.89 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.88 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.87 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.87 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.85 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.85 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.79 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.76 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.75 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.74 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.74 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.71 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.71 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.69 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.67 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.66 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.65 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.64 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.54 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.54 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.49 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.49 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.49 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.47 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.36 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.32 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.31 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.0 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.99 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.88 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.77 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.68 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.18 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.17 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.98 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.9 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.84 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.8 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.68 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.41 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.18 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.29 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 93.63 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.21 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.66 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.66 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 89.36 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 88.89 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.57 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.36 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.64 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.13 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.65 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.55 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.29 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=442.87 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=214.7
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
++|.+.+.||+|+||.||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46788899999999999999864 4788999999754 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 345 LLVYEFRKNGSLHDFLHLSD---------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
++|||||++|+|.++|+... .....++|.+++.|+.|||.||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997432 2345799999999999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcc
Q 008055 416 QLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 491 (579)
||+|||+|+......... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.......
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------- 238 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------- 238 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 999999998654433221 2346789999999999999999999999999999999 999997643211
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+...+........|..++.++.+|+.+||+.||++||||++|++.|+++.+.
T Consensus 239 --------~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 239 --------VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp --------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111222345667788999999999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=443.57 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=209.8
Q ss_pred CCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+|.+.+.||+|+||.||+|+++ +++.||||+++.. .....+.|.+|++++++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45777899999999999999864 4789999999754 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 008055 345 LLVYEFRKNGSLHDFLHLSDE-----------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 413 (579)
++|||||++|+|.++++.... ...+++|.+++.|+.|||.||+|||++ +|+||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999975432 234699999999999999999999976 999999999999999999
Q ss_pred ceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 008055 414 NPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 489 (579)
.+||+|||+++........ ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.......
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------- 268 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------- 268 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 9999999999866443322 23456789999999999999999999999999999999 999997643211
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
+...+....+...|..++.++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 269 ----------~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 ----------AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ----------HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 111111122334566778899999999999999999999999999998875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=436.17 Aligned_cols=258 Identities=25% Similarity=0.438 Sum_probs=208.7
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|.+.+.||+|+||+||+|.+++ .||||+++......+..+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577888999999999999998753 59999998766666777899999999999999999999998864 56899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||++|+|.++++. ....+++.+++.|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999973 345699999999999999999999976 9999999999999999999999999999865432
Q ss_pred C---cccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh-
Q 008055 430 D---EALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK- 502 (579)
Q Consensus 430 ~---~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 502 (579)
. ......||+.|||||++.. ..|+.++|||||||++|||+||+.||......... .. .+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~----------~~~~~ 253 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IF----------MVGRG 253 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HH----------HHHTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HH----------HHhcC
Confidence 2 2234578999999999964 45899999999999999999999999764322110 00 0000
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
...+. ....+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 254 ~~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 254 YASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11111 12234567789999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=438.55 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=211.4
Q ss_pred CccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++++.+.||+|+||+||+|.+. +++.||||+++... .....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4566789999999999999863 46899999997543 3345678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC
Q 008055 346 LVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL 413 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~ 413 (579)
+|||||++|+|.++|+.... ....++|..++.|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999964321 124689999999999999999999976 999999999999999999
Q ss_pred ceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 008055 414 NPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRW 489 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 489 (579)
.+||+|||+++....... .....+|+.|||||++.++.|+.++|||||||++|||+| |..||......
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-------- 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------- 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999999999986543322 223456789999999999999999999999999999999 89999764321
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.+...+........|..++..+.+|+.+||+.||++||||+||++.|+.
T Consensus 255 ---------~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 ---------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ---------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---------HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111111222334567788899999999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=439.29 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=207.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||+||+|+.. +|+.||||++..........+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999764 69999999998877766777889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||+||+|.+++.. .....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999963 2345678999999999999999999976 9999999999999999999999999999876543
Q ss_pred Cc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.. .....||+.|||||++.+..|+.++|||||||++|||+||+.||....... .+.+++....
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~~~~~ 242 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----------------LVLKIISGSF 242 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHHHHHTCC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHHHHcCCC
Confidence 22 234568999999999999999999999999999999999999997643211 1111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223455678999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=436.86 Aligned_cols=272 Identities=24% Similarity=0.423 Sum_probs=223.0
Q ss_pred cCHHHHHHHhCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC-CCccc
Q 008055 261 YSIADLQMATGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH-PNIME 333 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~ 333 (579)
+...++++..++|++.+.||+|+||.||+|.+.. ++.||||+++.... ....+.|.+|+.++.+++| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 4556666777899999999999999999997642 36899999976543 3446789999999999965 89999
Q ss_pred eeeEEeeC-CeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 008055 334 LVGYCSEY-GQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHK 400 (579)
Q Consensus 334 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 400 (579)
++|+|.+. +..++|||||++|+|.++|+.... ....+++.+++.|+.|||+||+|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 99999764 578999999999999999974322 134589999999999999999999976 99999
Q ss_pred CCCCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCC
Q 008055 401 NIKSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFD 476 (579)
Q Consensus 401 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~ 476 (579)
||||+|||+++++.+||+|||+|+........ ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543322 23346778999999999999999999999999999998 999997
Q ss_pred CCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 477 SSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
..... ..+...+....+...|..++.++.+++.+||+.||++|||+.||++.|+.+++..
T Consensus 290 ~~~~~----------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 290 GVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCHH----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 64321 1111222222334456667789999999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=428.20 Aligned_cols=258 Identities=24% Similarity=0.257 Sum_probs=211.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.|++.+.||+|+||.||+|+++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46788899999999999999875 689999999976442 2468999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEecccccccCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASNMPN 428 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 428 (579)
||+||+|.++++. ...+++.++..|+.||+.||+|||++ +|+||||||+||||+.+| .+||+|||+|+....
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999963 34689999999999999999999965 999999999999999987 699999999987654
Q ss_pred CCc------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 429 ADE------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 429 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
... .....||+.|||||++.+..|+.++|||||||++|||+||+.||......... ..+..
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------------~~i~~ 270 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------------LKIAS 270 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-------------HHHHH
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------------HHHHc
Confidence 322 12246899999999999999999999999999999999999999764321100 01110
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccccc
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKR 557 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~~ 557 (579)
.+......+..++..+.+++.+||+.||++|||+.|+++.|...++....-++
T Consensus 271 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 271 --EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp --SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred --CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 00001123455677899999999999999999999999999999887665444
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=420.11 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=201.0
Q ss_pred cccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee----CCeEEEEE
Q 008055 274 NVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE----YGQHLLVY 348 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 348 (579)
++.+.||+|+||+||+|.+. ++..||+|++..........+.|.+|+.++++++|||||+++++|.+ .+..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999765 68899999998766666667889999999999999999999999865 35689999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccccCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGLASNMP 427 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 427 (579)
|||++|+|.++++. ...+++..+..|+.||+.||+|||++ ..+|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999963 35689999999999999999999976 223999999999999984 7899999999998643
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc-Cc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV-DP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 506 (579)
. .......||+.|||||++. ++|+.++|||||||++|||+||+.||....... .+...+ ..
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~----------------~~~~~i~~~ 245 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----------------QIYRRVTSG 245 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----------------HHHHHHTTT
T ss_pred C-CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH----------------HHHHHHHcC
Confidence 3 3344567899999999886 469999999999999999999999996533211 111111 11
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122334467899999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=428.13 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=207.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
..|++.+.||+|+||+||+|.++ +|+.||||++..... ...+.+.+|+.+++.++|||||+++++|.+.+..|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999875 699999999965432 234567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||+||+|.+++.. ..+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 152 y~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 152 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999862 3589999999999999999999976 9999999999999999999999999999876544
Q ss_pred C-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 D-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||......... ..+.....+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------------~~i~~~~~~~- 289 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------------KMIRDNLPPR- 289 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHSSCCC-
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------------HHHHcCCCCC-
Confidence 3 344567899999999999999999999999999999999999999764322110 0111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+.++.+|+.+||..||++|||+.|+++
T Consensus 290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1123445678999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=423.59 Aligned_cols=272 Identities=23% Similarity=0.325 Sum_probs=204.5
Q ss_pred CccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC----eEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG----QHLLV 347 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 347 (579)
+|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++++|.+.+ ..++|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 577889999999999999988 58999999996432 11222334566667899999999999997654 67999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV-----CSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
||||++|+|.++++. .+++|..+..++.|++.||+|||++ +.++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999973 4589999999999999999999964 134899999999999999999999999999
Q ss_pred cccCCCCCcc-----cccCCCCCccCccccccC------CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcc
Q 008055 423 ASNMPNADEA-----LNNDAGSGYGAPEVAMSG------QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 423 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 491 (579)
++........ ....+|+.|||||++.+. .++.++|||||||++|||+||.+||....... ..+..+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~-~p~~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-LPYYDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC-CTTTTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc-ccchhccc
Confidence 9765443221 234678999999999754 47789999999999999999998885432210 01111111
Q ss_pred ccccChhHH-hhhcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 492 PQLHDIDAL-AKMVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 492 ~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.......+ ..+.+..+++..| .+++..+.+|+.+||+.||++||||.||++.|+++.++.++
T Consensus 234 -~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 234 -SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp -SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred -ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 11111222 2223334444333 24567899999999999999999999999999999877654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=424.02 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=208.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||+||+|+.. +|+.||||++.+... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999764 789999999965432 2234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||+||+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999963 34689999999999999999999976 999999999999999999999999999987643
Q ss_pred CC---cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 AD---EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.. ...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||....... .+..+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----------------~~~~i~~ 248 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----------------IFAKIIK 248 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHc
Confidence 32 2345678999999999999999999999999999999999999997643211 1111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ...+|...+.++.+|+.+||+.||++|||+.|++.
T Consensus 249 ~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 249 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp T--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred C--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1 11244556678999999999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-53 Score=412.12 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=193.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||+||+|... +|+.||||++.+.... ......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999764 6999999999765433 344577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999863 35699999999999999999999976 999999999999999999999999999987766
Q ss_pred CCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.....+..||+.|||||++.+..+ +.++||||+||++|||+||+.||........ ...+...
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~----------------~~~i~~~- 227 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----------------FKNISNG- 227 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHT-
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHcC-
Confidence 555566789999999999998886 5799999999999999999999976432110 0011000
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 228 -~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 -VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11234455678999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=429.76 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=208.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.|++.+.||+|+||.||+|.++ +|+.||||++..... ...+.+.+|+.+++.++|||||+++++|.+.+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 46999999999999999999875 699999999976543 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||+||+|.++++. ..+++.++..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 229 y~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 229 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999862 3589999999999999999999976 9999999999999999999999999999876543
Q ss_pred C-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 D-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ..+.....+.+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------------~~i~~~~~~~~ 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------------KMIRDNLPPRL 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHSCCCCC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------------HHHHcCCCCCC
Confidence 3 344567899999999999999999999999999999999999999764322110 11111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+...+.++.+|+.+||..||++|||+.|+++
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122345678999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=419.67 Aligned_cols=243 Identities=24% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||+||+|+.. .++.||||++++..........+.+|+.++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 36999999999999999999763 46899999997655444444578889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||||+||+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999963 34689999999999999999999976 9999999999999999999999999999865
Q ss_pred CCCC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 427 PNAD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... ...+..||+.|||||++.+..|+.++|||||||++|||+||+.||....... .+..+..
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~~ 240 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----------------TMTMILK 240 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----------------HHHHHHc
Confidence 4333 3445678999999999999999999999999999999999999997643221 1111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
. ...+|...+.++.+|+.+||+.||++|||+
T Consensus 241 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 241 A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 112455566789999999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=400.38 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=187.7
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC--------
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-------- 342 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 342 (579)
+|++.+.||+|+||+||+|+.+ +|+.||||+++... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5889999999999999999865 78999999997544 2344577899999999999999999999987544
Q ss_pred ----eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 343 ----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 343 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
..|+|||||++|+|.+++.... ......+..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999996321 122356677889999999999999976 99999999999999999999999
Q ss_pred cccccccCCCCCc-------------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh
Q 008055 419 DCGLASNMPNADE-------------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS 485 (579)
Q Consensus 419 Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~ 485 (579)
|||+|+....... .....||+.|||||++.+..|+.++|||||||++|||++ ||...... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-~-- 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-V-- 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-H--
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-H--
Confidence 9999987644321 123468999999999999999999999999999999996 77532110 0
Q ss_pred hhhhccccccChhHHhhhcCccccCCCC---hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 486 LVRWATPQLHDIDALAKMVDPALKGLYP---VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+..... ..+| ......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ------------~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 ------------RTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ------------HHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------HHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111 1122 223345678999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=402.76 Aligned_cols=265 Identities=20% Similarity=0.323 Sum_probs=204.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee------CCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE------YGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 343 (579)
++|++.+.||+|+||+||+|.+. +|+.||||+++.........+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 47999999999999999999764 79999999998776666667788999999999999999999998753 367
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.|+|||||+ |+|.+++. ....+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 68999986 345799999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCC-----CcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc-ccccc
Q 008055 424 SNMPNA-----DEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA-TPQLH 495 (579)
Q Consensus 424 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~-~~~~~ 495 (579)
+.+... .......||+.|||||++.+. .++.++||||+||++|||++|++||.+...... ..+.... .+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 865432 223356789999999998875 469999999999999999999999976543211 1111111 11100
Q ss_pred C--------hhHHhhhcCccccCC---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 496 D--------IDALAKMVDPALKGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 496 ~--------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. .........+..... .....+.++.+|+.+||..||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000000000000 01123467899999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=389.35 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=198.2
Q ss_pred HhCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCe
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 343 (579)
..++|++.+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++++.+ +|||||++++++.+.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 4568999999999999999999753 46889999986543 245678899999888 79999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEecccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGL 422 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~ 422 (579)
.|+|||||++|+|.++++ .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999984 388999999999999999999976 99999999999999877 7999999999
Q ss_pred cccCCCCC-----------------------------cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCC
Q 008055 423 ASNMPNAD-----------------------------EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGR 472 (579)
Q Consensus 423 ~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~ 472 (579)
|+...... ......||++|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 97543321 12234689999999999875 4899999999999999999999
Q ss_pred CCCCCCCchhhh--hhhhhcc------------------cc--ccChhHHhhhc---C---ccc---------cCCCChh
Q 008055 473 KPFDSSRPRLEQ--SLVRWAT------------------PQ--LHDIDALAKMV---D---PAL---------KGLYPVK 515 (579)
Q Consensus 473 ~p~~~~~~~~~~--~~~~~~~------------------~~--~~~~~~~~~~~---~---~~~---------~~~~~~~ 515 (579)
.||........+ .+..... .. ..+.....+.. + +.. .......
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 999654432211 0100000 00 00001110000 0 000 0011123
Q ss_pred hHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 516 SLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 516 ~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.++.+|+.+||+.||++|||++|+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 4567899999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=385.13 Aligned_cols=280 Identities=34% Similarity=0.624 Sum_probs=231.8
Q ss_pred HHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 266 LQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+...+++|++.+.||+|+||.||+|.+++++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 344677899999999999999999998889999999987553 344678899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999975544455799999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||.............|.... .....+..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccHHH
Confidence 443221 12234677999999999999999999999999999999999999765443333333332211 11112334
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+++......+...+..+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 4555566667788899999999999999999999999999999998853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=410.23 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=210.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+.+..|+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57999999999999999999765 79999999997643 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC--CceEEecccccccCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE--LNPQLSDCGLASNMP 427 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfg~~~~~~ 427 (579)
||+||+|.+++. .....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999985 2345689999999999999999999976 99999999999999854 899999999999887
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc-
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP- 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 506 (579)
.........||+.|||||++.+..|+.++|||||||++|||++|+.||........ +..+...
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----------------~~~i~~~~ 372 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----------------LRNVKSCD 372 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------HHHHHTTC
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHHHhCC
Confidence 76666677899999999999999999999999999999999999999976543211 1111110
Q ss_pred -cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 -ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+........+.++.+||.+||+.||++|||+.|+++
T Consensus 373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111112234568899999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=408.70 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=202.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC----CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL----PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.+... ..........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 357999999999999999999775 699999999965322 112223334456677788999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
|+|||||+||+|.++|.. ...+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999963 34689999999999999999999965 99999999999999999999999999998
Q ss_pred cCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 425 NMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 425 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
..... ...+.+||+.|||||++.. ..|+.++|||||||++|||++|++||..........+ ....
T Consensus 341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i-------------~~~i 406 (689)
T 3v5w_A 341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DRMT 406 (689)
T ss_dssp ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH-------------HHHH
T ss_pred ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------HHhh
Confidence 76543 3456789999999999974 5799999999999999999999999965322111111 0011
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
.. ....+|...+.++.+|+.+||..||++|++ +.||++
T Consensus 407 ~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 10 112345556678999999999999999998 567653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=382.16 Aligned_cols=288 Identities=37% Similarity=0.631 Sum_probs=238.9
Q ss_pred ccccCHHHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeE
Q 008055 258 VTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGY 337 (579)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 337 (579)
...++..++....++|++.+.||+|+||.||+|...+++.||||++...... .....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567889999999999999999999999999999888999999999765432 223368899999999999999999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 008055 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQL 417 (579)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 417 (579)
+.+.+..++||||+++|+|.++++........+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999866556667999999999999999999999765559999999999999999999999
Q ss_pred ecccccccCCCCCc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc--hhhhhhhhhcccc
Q 008055 418 SDCGLASNMPNADE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP--RLEQSLVRWATPQ 493 (579)
Q Consensus 418 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~ 493 (579)
+|||++........ .....++..|+|||++.+..++.++|||||||++|||++|+.||+.... .......+|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999986643332 2234478899999999988999999999999999999999999963211 1122333444332
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.. ...+....+..+...++...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 256 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 22 233445566666777788889999999999999999999999999999964
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=371.55 Aligned_cols=267 Identities=29% Similarity=0.446 Sum_probs=212.0
Q ss_pred HHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 266 LQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+.+..++|++.+.||+|+||.||+|.. .++.||||++..........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334456899999999999999999987 5889999999877766666788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS--VVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999999996321 112489999999999999999999976 7 999999999999999999999999998
Q ss_pred ccCCCCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 424 SNMPNADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 424 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
+....... .....++..|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~----------------~~ 250 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV----------------AA 250 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----------------HH
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence 75443221 23456788999999999999999999999999999999999999764432111 11
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
..........+...+..+.+++.+||+.||++|||+.++++.|+.+++...
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 101111223445566789999999999999999999999999999986543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=366.41 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=213.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 347888999999999999999875 6899999998543 3556788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 87 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 87 EYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp ECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999973 345689999999999999999999976 999999999999999999999999999976543
Q ss_pred CCcc---------------cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 429 ADEA---------------LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 429 ~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
.... ....+++.|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------- 232 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------- 232 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------
Confidence 3221 13457889999999999999999999999999999999999986533211100
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
... .....+ ...+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 233 ~~~---~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 GLN---VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp SBC---HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhh---hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 001111 11233445678999999999999999999999999999886543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=368.87 Aligned_cols=249 Identities=22% Similarity=0.409 Sum_probs=212.5
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999987 57999999999776656666788899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999863 34589999999999999999999976 999999999999999999999999999987766
Q ss_pred CCcccccCCCCCccCccccccCCCC-ccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
........+++.|+|||++.+..++ .++|||||||++|||++|+.||......... ..+...
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~~i~~~- 229 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR----------------ERVLRG- 229 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHC-
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhC-
Confidence 5556667789999999999888875 7899999999999999999999765422111 011101
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....|...+..+.+++.+||..||++|||+.|+++
T Consensus 230 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 -KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11233445678899999999999999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.84 Aligned_cols=263 Identities=25% Similarity=0.457 Sum_probs=216.0
Q ss_pred hCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .......+.+|+.+++++ +||||++++++|.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 357889999999999999999752 35679999997653 344567899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999975332 124588999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||+++........ ....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 999999999999999866443321 22334568999999999999999999999999999999 999997643211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
+...+........+..++..+.+++.+||+.||++|||+.|+++.|+.++....
T Consensus 314 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 314 ---------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp ---------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111111122233455667789999999999999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=367.51 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=213.5
Q ss_pred hCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.++|++.+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 457899999999999999999874 35569999997543 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.++++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999962 345689999999999999999999976 999999999999999999999999999987
Q ss_pred CCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
....... ....++..|+|||++.+..++.++|||||||++|||++ |..||....... +
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~ 263 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----------------V 263 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----------------H
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----------------H
Confidence 6443221 11233557999999998999999999999999999999 999996643221 1
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
...+........+..++..+.+++.+||+.||++|||+.+|++.|+.+++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11111122223445667889999999999999999999999999999986544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.28 Aligned_cols=274 Identities=24% Similarity=0.356 Sum_probs=209.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC----eEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG----QHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 345 (579)
.++|++.+.||+|+||.||+|.+. ++.||||++.... .....+..|+..+++++||||+++++++.+.. ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 457999999999999999999876 7899999996432 33445566888899999999999999998744 479
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV-------CSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
+||||+++|+|.++++. ..+++..++.++.|++.||+|||+. ++.+|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999963 3489999999999999999999942 11289999999999999999999999
Q ss_pred cccccccCCCCCc---ccccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhc
Q 008055 419 DCGLASNMPNADE---ALNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA 490 (579)
Q Consensus 419 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~ 490 (579)
|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999976544332 223457889999999976 35677899999999999999999999764432211111111
Q ss_pred cccccChhHHhh-hcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 491 TPQLHDIDALAK-MVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 491 ~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
. .......+.. ..........+ ...+..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~ 321 (322)
T 3soc_A 254 G-QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321 (322)
T ss_dssp C-SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred c-cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 1111111211 12222222222 2456779999999999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.05 Aligned_cols=261 Identities=25% Similarity=0.460 Sum_probs=206.7
Q ss_pred hCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
..+|++.+.||+|+||.||+|.+. ++..||||+++... .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 347889999999999999999765 57789999997643 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.++++. ....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999962 345689999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
........ ...++..|+|||++....++.++|||||||++|||++ |+.||...... .+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----------------~~ 259 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------DV 259 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----------------HH
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HH
Confidence 64432211 1223457999999999999999999999999999998 99999654321 11
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
...+........+..++..+.+++.+||+.||++||++.+|++.|+.+++....
T Consensus 260 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 111222223333456678899999999999999999999999999999976543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=378.10 Aligned_cols=259 Identities=24% Similarity=0.444 Sum_probs=214.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|.+.+.||+|+||.||+|.+. +++.||||+++... .......|.+|+.+++.++||||+++++++.+.+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 457888999999999999999886 78999999997542 3444567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.++++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999963 234588999999999999999999976 999999999999999999999999999976543
Q ss_pred CCcccc---cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 429 ADEALN---NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 429 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
...... ..++..|+|||++....++.++|||||||++|||++ |..||....... ....+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----------------~~~~~ 328 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----------------TREFV 328 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----------------HHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHH
Confidence 221111 112457999999998899999999999999999999 999997643221 11112
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
....+...+..++..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 329 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 222223345566788999999999999999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.18 Aligned_cols=256 Identities=25% Similarity=0.472 Sum_probs=213.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3478899999999999999999988999999999765433 4678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999962 345689999999999999999999976 9999999999999999999999999999765443
Q ss_pred Cc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.. .....++..|+|||++....++.++||||||+++|+|++ |+.||........ ... +..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----------------~~~-~~~ 222 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VED-IST 222 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHH-HHT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----------------HHH-Hhc
Confidence 21 122334557999999998999999999999999999999 9999976432211 111 111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
......+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 223 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 122223444567899999999999999999999999999998854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=357.45 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=206.7
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 35799999999999999999975 5789999999865432 23567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999863 3588999999999999999999976 999999999999999999999999999876654
Q ss_pred CCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... .....+++.|+|||++.+..++.++|||||||++|||++|+.||........... +... ..
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------------~~~~--~~ 233 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------------IATN--GT 233 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHH--CS
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhC--CC
Confidence 332 2345678899999999999999999999999999999999999976433211100 0000 00
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111224455678999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=370.29 Aligned_cols=264 Identities=26% Similarity=0.444 Sum_probs=217.4
Q ss_pred hCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
.++|.+.+.||+|+||.||+|... .+..||||++.... .......+.+|+++++++ +||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457889999999999999999752 24579999997653 345567889999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999975432 124689999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986644322 222334568999999999999999999999999999999 99999764322
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.+.+.+........+..++.++.+++.+||+.||++|||+.+|++.|++++.....
T Consensus 301 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 --------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp --------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred --------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111112222333455667899999999999999999999999999999976554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=355.12 Aligned_cols=257 Identities=21% Similarity=0.418 Sum_probs=212.1
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||++.+.++..||+|++...... .+.+.+|++++..++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4578899999999999999999998999999999765433 4678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999963 234689999999999999999999976 9999999999999999999999999999765443
Q ss_pred Ccc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
... ....++..|+|||++....++.++||||||+++|||++ |+.||........ ...+..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-----------------~~~~~~ 236 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------------AEHIAQ 236 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----------------HHHHHT
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-----------------HHHHhc
Confidence 211 12334567999999998899999999999999999998 9999976443211 111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
......+...+..+.+++.+||+.||++|||+.++++.|++++.++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1222334445678999999999999999999999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=360.95 Aligned_cols=273 Identities=23% Similarity=0.368 Sum_probs=211.4
Q ss_pred hCCccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 342 (579)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 45789999999999999999974 368899999997543 4556788999999999999999999999854 45
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 689999999999999999632 34589999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChh
Q 008055 423 ASNMPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498 (579)
Q Consensus 423 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 498 (579)
+......... ....++..|+|||++.+..++.++||||||+++|||++|..||................... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH-HHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch-hHH
Confidence 9866443221 12234456999999999999999999999999999999999986532211111100000000 001
Q ss_pred HHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+...+........+..++.++.+++.+||+.||++|||+.++++.|+++.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11222222333344667778999999999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=352.38 Aligned_cols=282 Identities=32% Similarity=0.511 Sum_probs=227.3
Q ss_pred ccccCHHHHHHHhCCcccc------ceeccCCceEEEEEEeCCCcEEEEEEeCCCC--CCchhHHHHHHHHHHHhhcCCC
Q 008055 258 VTSYSIADLQMATGSFNVE------NLLGEGTFGRVYRAQFADGKVLAVKKIDSSA--LPSEMCDDFIEMVSNISQLHHP 329 (579)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~ 329 (579)
...+++.++..++..|... +.||+|+||.||+|.. +++.||+|++.... ......+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3578899999999999877 8999999999999986 58899999987543 2234567899999999999999
Q ss_pred CccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 008055 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL 409 (579)
Q Consensus 330 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill 409 (579)
||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999986432 245689999999999999999999976 99999999999999
Q ss_pred cCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhh
Q 008055 410 DNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQS 485 (579)
Q Consensus 410 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~ 485 (579)
+.++.+||+|||++........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999876543222 223456789999998764 58999999999999999999999997643211 111
Q ss_pred hhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 486 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
+..... .....+...++..+ ...+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 246 ~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111100 01112233334333 2346677889999999999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=369.97 Aligned_cols=267 Identities=23% Similarity=0.357 Sum_probs=216.0
Q ss_pred hCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 357889999999999999999853 46789999996433 34456678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEE
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---NPQL 417 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl 417 (579)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999975432 234689999999999999999999976 999999999999999555 5999
Q ss_pred ecccccccCCCC---CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 418 SDCGLASNMPNA---DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 418 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~----------- 294 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------- 294 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 999998643221 12223445778999999999999999999999999999998 999997643221
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccccc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKR 557 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~~ 557 (579)
+...+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.......
T Consensus 295 ------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~ 352 (367)
T 3l9p_A 295 ------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 352 (367)
T ss_dssp ------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred ------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccC
Confidence 1111111122233455667899999999999999999999999999999887665433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=362.61 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=208.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.+.|++.+.||+|+||.||+|... +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999875 68999999997654321 2357789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----ceEEecc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL----NPQLSDC 420 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Df 420 (579)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999995 345689999999999999999999976 999999999999998877 7999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
|++.............+|+.|+|||++.+..++.++|||||||++|+|++|..||........ +
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~----------------~ 227 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------------L 227 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------------H
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----------------H
Confidence 999877665555566788999999999998999999999999999999999999976432211 0
Q ss_pred hhhcCccc--cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+..... ...+....+..+.+|+.+||..||++|||+.|+++
T Consensus 228 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 228 ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11100000 00001233467899999999999999999999984
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=369.98 Aligned_cols=273 Identities=24% Similarity=0.441 Sum_probs=219.3
Q ss_pred ccCHHHHHHHhCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCcc
Q 008055 260 SYSIADLQMATGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIM 332 (579)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 332 (579)
.+...++++..++|++.+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|++++.++ +||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCccee
Confidence 445666777788999999999999999999973 246899999997543 344467799999999999 899999
Q ss_pred ceeeEEeeCC-eEEEEEEecCCCChhhhhcccCCC---------------------------------------------
Q 008055 333 ELVGYCSEYG-QHLLVYEFRKNGSLHDFLHLSDED--------------------------------------------- 366 (579)
Q Consensus 333 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------- 366 (579)
++++++.+.+ ..++||||+++|+|.++++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999998755 489999999999999999754321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 367 -----------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 367 -----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 12288999999999999999999976 9999999999999999999999999999765433
Q ss_pred Cc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 DE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .+...+.
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~ 310 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLK 310 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----------------HHHHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----------------HHHHHHH
Confidence 22 122345668999999999999999999999999999998 999997643211 1111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.......+...+.++.+++.+||+.||++|||+.++++.|+++++..
T Consensus 311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11122334455678999999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=352.57 Aligned_cols=255 Identities=23% Similarity=0.415 Sum_probs=211.8
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|..+++..||+|++...... .+.+.+|+..+.+++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4578999999999999999999998889999999765432 4678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999632 34589999999999999999999976 9999999999999999999999999999866543
Q ss_pred Ccc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
... ....++..|+|||++.+..++.++||||||+++|||++ |+.||......... ... ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~~-~~ 220 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV----------------LKV-SQ 220 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHH-HT
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH----------------HHH-Hc
Confidence 322 12233457999999998899999999999999999999 99999764432111 010 11
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
......+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11122234455689999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.75 Aligned_cols=262 Identities=27% Similarity=0.488 Sum_probs=215.5
Q ss_pred hCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 45788999999999999999975 245889999997543 34556788999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDE--------------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIK 403 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk 403 (579)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999975432 123588999999999999999999976 99999999
Q ss_pred CCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCC
Q 008055 404 SANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSR 479 (579)
Q Consensus 404 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~ 479 (579)
|+|||++.++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866443322 22334567999999998899999999999999999999 999997643
Q ss_pred chhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
... +...+........+...+..+.+++.+||+.||++|||+.++++.|++++.+.
T Consensus 258 ~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 258 PER-----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp GGG-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHH-----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 321 11111111122334556678999999999999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.83 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=209.8
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999775 6899999999877666666788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---NPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~~ 425 (579)
||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999885 245689999999999999999999976 999999999999998654 599999999987
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChhHHhhhc
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 504 (579)
...........+++.|+|||++.+..++.++|||||||++|+|++|+.||......... .+....
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------- 246 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-------------- 246 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------------
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 76555455567889999999999989999999999999999999999999764322110 000000
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+.++.+++.+||+.||++|||+.++++
T Consensus 247 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 -YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000111234578999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.10 Aligned_cols=267 Identities=22% Similarity=0.341 Sum_probs=203.5
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|...+++.||+|++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999999889999999997665555556788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++ |+|.+++. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 997 48888875 2345689999999999999999999976 9999999999999999999999999999876433
Q ss_pred C-cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc-cccccC---hhHHhh
Q 008055 430 D-EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA-TPQLHD---IDALAK 502 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~-~~~~~~---~~~~~~ 502 (579)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.... .+.... ...+..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2 2334467889999999876 5689999999999999999999999976443211 1111111 110000 000000
Q ss_pred hcCccccC-------CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVDPALKG-------LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+..... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 011223467899999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=351.28 Aligned_cols=253 Identities=21% Similarity=0.383 Sum_probs=211.5
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--CeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|.+. ++.||+|++..........+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46889999999999999999885 88999999988776667778899999999999999999999999876 7889999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS--VVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||+++|+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999732 233689999999999999999999976 6 999999999999999999999999987543
Q ss_pred CCCCcccccCCCCCccCccccccCCCCc---cchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNI---KSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
.. ....+++.|+|||++.+..++. ++|||||||++|||++|+.||....... .....
T Consensus 164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~ 223 (271)
T 3kmu_A 164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----------------IGMKV 223 (271)
T ss_dssp SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----------------HHHHH
T ss_pred cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----------------HHHHH
Confidence 22 2345678999999998766554 7999999999999999999997543221 11111
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.........+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122233345556778999999999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=357.19 Aligned_cols=250 Identities=19% Similarity=0.226 Sum_probs=207.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 467999999999999999999765 68899999986432 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--CCceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN--ELNPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~ 426 (579)
||+++|+|.+++. .....+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++...
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999986 2345689999999999999999999976 9999999999999987 789999999999887
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..........+++.|+|||++.+..++.++|||||||++|+|++|..||........ +..+...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~i~~~ 218 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------IENIMNA 218 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHT
T ss_pred CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH----------------HHHHHcC
Confidence 665555556788899999999988899999999999999999999999976432211 0000000
Q ss_pred cccC--CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKG--LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.... ......+.++.+++.+||..||++|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 0001335688999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=366.18 Aligned_cols=266 Identities=26% Similarity=0.457 Sum_probs=215.5
Q ss_pred HHHHhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe
Q 008055 266 LQMATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS 339 (579)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 339 (579)
+....++|++.+.||+|+||.||+|... +++.||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3445678999999999999999999874 34889999997554 3455678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 008055 340 EYGQHLLVYEFRKNGSLHDFLHLSDED--------------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVH 399 (579)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 399 (579)
+.+..++||||+++|+|.+++...... ...+++.+++.++.||+.||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999753221 25789999999999999999999976 9999
Q ss_pred cCCCCCCEEEcCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCC
Q 008055 400 KNIKSANILLDNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPF 475 (579)
Q Consensus 400 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~ 475 (579)
|||||+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999875533221 123345678999999998899999999999999999999 99999
Q ss_pred CCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 476 DSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
....... ....+.+ ......+..++..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 278 ~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMAHEE----------------VIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSCHHH----------------HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCChHH----------------HHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 7543211 1111111 1112234556678999999999999999999999999999887544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.67 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=210.6
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-eEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-QHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv 347 (579)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 3467889999999999999999886 7899999997643 3578999999999999999999999987655 79999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.++++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999742 233478999999999999999999976 99999999999999999999999999998553
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
... ....++..|+|||++....++.++|||||||++|||++ |+.||....... +...+..
T Consensus 341 ~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~~~i~~ 401 (450)
T 1k9a_A 341 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPRVEK 401 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----------------HHHHHHT
T ss_pred ccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHc
Confidence 321 22345678999999999999999999999999999999 999997543211 1111112
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..+...+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 402 ~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 402 GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 223344566778999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=355.77 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=209.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+..+++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999764 689999999865433 345567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999963 34689999999999999999999976 99999999999999999999999999997664
Q ss_pred CCCc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 428 NADE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 428 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... .....+++.|+|||++.+..++.++||||||+++|||++|+.||......... . .......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~-~~~~~~~----------- 229 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-I-KHIQDSV----------- 229 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-H-HHHSSCC-----------
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-H-HHhhccC-----------
Confidence 3322 22345788999999999999999999999999999999999999764422110 0 0000000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCC-ChHHHHHHHHHHHHHc
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRP-PMSEVVQALVRLVQRA 552 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~~~ 552 (579)
+......+...+..+.+++.+||+.||++|| +++++.+.|+.++...
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0111112334557899999999999999998 8999999988766433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.45 Aligned_cols=268 Identities=23% Similarity=0.425 Sum_probs=200.7
Q ss_pred HHhCCccccceeccCCceEEEEEEeCCC----cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFADG----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
+..++|++.+.||+|+||.||+|..... ..||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456899999999999999999976543 279999998766566667889999999999999999999999987665
Q ss_pred E------EEEEEecCCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 344 H------LLVYEFRKNGSLHDFLHLSD--EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 344 ~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
. ++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999986433 2233689999999999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcc
Q 008055 416 QLSDCGLASNMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 491 (579)
||+|||++.......... ...++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------- 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------- 248 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--------
Confidence 999999997654433221 2234557999999999999999999999999999999 9999976443211
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
...+. .......+...+..+.+++.+||+.||++|||+.++++.|+++++.....
T Consensus 249 --------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 249 --------YNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp --------HHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred --------HHHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 11111 11112234456678999999999999999999999999999999866553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=360.62 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=206.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|+.+ +|+.||+|++++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 47899999999999999999875 689999999965321 1234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999863 34688999999999999999999976 999999999999999999999999999976433
Q ss_pred -CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 -ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
........+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------~~~i~~~- 220 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------------FELILME- 220 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC-
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----------------HHHHHcC-
Confidence 2334455678899999999999999999999999999999999999975432110 0011111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
...++...+.++.+++.+||+.||++|| ++.|+++
T Consensus 221 -~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1123445667899999999999999999 8888875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.23 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=196.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||+||+|... +++.||||++............+..|+..+..+ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 47999999999999999999876 799999999876655545555566666666555 9999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 77999988632 45689999999999999999999976 999999999999999999999999999987765
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
........+|..|+|||++.+ .++.++|||||||++|||++|..|+..... ...+.....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~~~~~~ 269 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQLRQGYL 269 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHHTTTCC
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHhccCC
Confidence 555555667889999998875 799999999999999999999766643211 011111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...++...+..+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11112234568999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=348.75 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=199.4
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC--chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP--SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999875 889999998754322 23457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--------CCceEEec
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN--------ELNPQLSD 419 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~--------~~~~kl~D 419 (579)
|||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999985 346899999999999999999999872122999999999999986 67899999
Q ss_pred ccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 420 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
||++....... .....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~ 222 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----------------V 222 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----------------H
T ss_pred CCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 99997654332 224567889999999999999999999999999999999999997643221 1
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
.............+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1112222223334556677899999999999999999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=353.08 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=202.2
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 46888999999999999999875 788999998643 345788999999999999999999998874 48999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-eEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN-PQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~ 429 (579)
+++|+|.++++... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999997322 1234788999999999999999999742359999999999999998887 799999998755332
Q ss_pred CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 430 DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......... +.........
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------~~~~~~~~~~ 222 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---------------IMWAVHNGTR 222 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH---------------HHHHHHTTCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH---------------HHHHHhcCCC
Confidence 22345788999999999999999999999999999999999999753221110 0000001111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 510 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
...+...+..+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 22334556789999999999999999999999999999876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.91 Aligned_cols=256 Identities=20% Similarity=0.415 Sum_probs=204.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++|++.+.||+|+||.||+|.+. +++ .||+|.+.... .....+.+.+|+.++++++||||++++++|.+. ..+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 46889999999999999999864 444 35888876433 234467899999999999999999999999875 478
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999973 345689999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
........ ...++..|+|||++.+..++.++|||||||++|||++ |+.||....... +.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~ 229 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 229 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HH
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------HH
Confidence 54433222 2234568999999999999999999999999999999 999997644321 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..+........+..++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 12222222334555677899999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.95 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=207.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+.|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 36889999999999999999875 68999999997654321 23577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL----NPQLSDCG 421 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 421 (579)
+||||+++|+|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999985 245689999999999999999999976 999999999999999887 79999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
++.............+++.|+|||++....++.++|||||||++|+|++|..||........... +.
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------------~~ 230 (326)
T 2y0a_A 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------------VS 230 (326)
T ss_dssp TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------------HH
T ss_pred CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-------------HH
Confidence 99877655555556788999999999989999999999999999999999999976432211100 00
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. .............+..+.+++.+||+.||++|||+.++++
T Consensus 231 ~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 A-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H-TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h-cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000000001233467899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.46 Aligned_cols=259 Identities=23% Similarity=0.404 Sum_probs=202.4
Q ss_pred hCCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+..++.++||||+++++++. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4578999999999999999997643 4579999987543 3445678899999999999999999999985 56789
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999963 244689999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
....... ....++..|+|||++....++.++||||||+++|||++ |..||........ ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~----------------~~~ 229 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----------------IGR 229 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHH
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH----------------HHH
Confidence 6443222 12234568999999998899999999999999999997 9999976432211 111
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
+.. ......+..++..+.+++.+||+.||++|||+.++++.|++++++..
T Consensus 230 i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 230 IEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111 11122345567789999999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=348.40 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=206.9
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhH-----HHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMC-----DDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|++.+.||+|+||.||+|.. .+++.||+|++.......... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35799999999999999999977 478999999997654332222 67899999999999999999999997655
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCEEEcCCCc-----eE
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS--VVHKNIKSANILLDNELN-----PQ 416 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~-----~k 416 (579)
++||||+++|+|.+++. .....+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999886 3345789999999999999999999976 7 999999999999988776 99
Q ss_pred EecccccccCCCCCcccccCCCCCccCccccc--cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 417 LSDCGLASNMPNADEALNNDAGSGYGAPEVAM--SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 417 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|+|||+++.... ......++..|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 170 l~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---------- 237 (287)
T 4f0f_A 170 VADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---------- 237 (287)
T ss_dssp ECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----------
T ss_pred eCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----------
Confidence 999999975433 333456788999999984 455789999999999999999999999754322111
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
..............+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 238 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 238 ----FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ----HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111122223334455667889999999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.65 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=210.3
Q ss_pred ccCHHHHHHHhCC----------ccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC
Q 008055 260 SYSIADLQMATGS----------FNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328 (579)
Q Consensus 260 ~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h 328 (579)
.++.+++..+++. |+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence 3455555555443 677789999999999999876 79999999997544 2345778899999999999
Q ss_pred CCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 329 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
|||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999985 34689999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNAD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~ 487 (579)
++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~--- 250 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--- 250 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---
T ss_pred ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 9999999999999987665432 233456788999999999999999999999999999999999999754321110
Q ss_pred hhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+.....+.. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 251 ----------~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 ----------KRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ----------HHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----------HHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111111 112344568999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=354.86 Aligned_cols=264 Identities=25% Similarity=0.447 Sum_probs=215.5
Q ss_pred hCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45789999999999999999975 3568999999975542 34467889999999999 9999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE--------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999974322 123589999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 999999999999999866543321 12234567999999999999999999999999999999 999997643211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.....+........+...+..+.+++.+||+.||++|||+.++++.|++++.+..
T Consensus 256 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 --------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp --------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred --------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111111112222344556789999999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=356.22 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=201.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 57999999999999999999776 7899999999654432 234668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999985 345689999999999999999999976 9999999999999999999999999999765322
Q ss_pred C---cccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 D---EALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ......++..|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~-------------- 223 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE-------------- 223 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHT--------------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhc--------------
Confidence 2 1224567889999999987775 789999999999999999999997543211 11111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111111123445688999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=351.50 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=198.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh--cCCCCccceeeEEee----CCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ--LHHPNIMELVGYCSE----YGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~ 343 (579)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 45799999999999999999987 6899999998643 34556666666665 799999999998654 356
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH--------EVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
.++||||+++|+|.++++ ...+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 899999999999999995 346899999999999999999999 55 99999999999999999999
Q ss_pred EEecccccccCCCCCcc-----cccCCCCCccCccccccC------CCCccchHHhHHHHHHHHHhC----------CCC
Q 008055 416 QLSDCGLASNMPNADEA-----LNNDAGSGYGAPEVAMSG------QYNIKSDVYSFGVVMLELLTG----------RKP 474 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~elltg----------~~p 474 (579)
||+|||++......... ....++..|+|||++.+. .++.++|||||||++|||++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999998654333221 223678899999999876 556799999999999999999 777
Q ss_pred CCCCCchhhhhhhhhccccccChhHHhhhc-CccccCC-----CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 475 FDSSRPRLEQSLVRWATPQLHDIDALAKMV-DPALKGL-----YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
|....... .....+.... ....... ++...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 f~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPND------------PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSS------------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCC------------cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 75432210 0011111111 1111111 2234678899999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=350.26 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=203.9
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||.||+|...+++.||+|++............+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47899999999999999999988899999999976654444457888999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 99988863 335689999999999999999999976 99999999999999999999999999987654322
Q ss_pred -cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhh-ccccccChhHHhh--hc
Q 008055 431 -EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRW-ATPQLHDIDALAK--MV 504 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~--~~ 504 (579)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..+... ..+.......... ..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 22334568899999999764 589999999999999999999999976543211 111111 1110000000000 00
Q ss_pred Ccccc-------CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALK-------GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
++... ..+....+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11110 1112335678899999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=355.69 Aligned_cols=264 Identities=25% Similarity=0.445 Sum_probs=214.3
Q ss_pred hCCccccceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
.++|++.+.||+|+||.||+|... ++..||+|++.... .......+.+|+.+++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 457899999999999999999763 46789999997543 344567889999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDED------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 99999999999999999999743321 23488999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 999999999999999866543321 22334567999999998889999999999999999999 9999976432211
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
...+........+..++..+.+++.+||+.||++|||+.++++.|+.++.....
T Consensus 269 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 269 ----------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----------------HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111111112223445667899999999999999999999999999999976554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.55 Aligned_cols=272 Identities=19% Similarity=0.273 Sum_probs=211.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC--eEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG--QHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 347 (579)
++|.+.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 47899999999999999999876 589999999975432 233577889999999999999999999987655 78999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCceEEeccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCGLA 423 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg~~ 423 (579)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997432 223489999999999999999999976 99999999999999 77888999999999
Q ss_pred ccCCCCCcccccCCCCCccCccccc--------cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh--hhhhhhh---c
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAM--------SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL--EQSLVRW---A 490 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~--~~~~~~~---~ 490 (579)
+............++..|+|||++. ...++.++|||||||++|||++|+.||....... ...+... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 8876665555667888999999986 5678999999999999999999999996433211 1111110 0
Q ss_pred cccc-cChhHH----hhhc-CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 491 TPQL-HDIDAL----AKMV-DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 491 ~~~~-~~~~~~----~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.+.. ...... ..+. +.......+...+..+.+++.+||+.||++|||++|+++...+
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 0000 000000 0000 0011123456778899999999999999999999999987754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=368.05 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=207.0
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|.. .+|+.+|+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45799999999999999999976 47899999999877665566778899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD---NELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~ 425 (579)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999863 34689999999999999999999976 999999999999998 467899999999977
Q ss_pred CCCCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 426 MPNADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||........... +...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~-------------i~~~- 228 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-------------IKAG- 228 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------------HHHT-
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH-------------HHhC-
Confidence 654332 2345678899999999999999999999999999999999999976433211100 0000
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
............+.++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000011111234578999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=376.56 Aligned_cols=256 Identities=23% Similarity=0.436 Sum_probs=211.7
Q ss_pred HHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
+..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+++.++||||+++++++. .+..++|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 3456788999999999999999999889999999997644 23678999999999999999999999986 5678999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.++++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999632 123578899999999999999999976 99999999999999999999999999998764
Q ss_pred CCCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 428 NADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 428 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
..... ....++..|+|||++....++.++|||||||++|||+| |+.||....... +...+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~~~i 398 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----------------VIRAL 398 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------------HHHHH
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHH
Confidence 32211 12234567999999998999999999999999999999 999997643211 11111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
....+...+..++..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112222345567789999999999999999999999999998765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=358.83 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=206.7
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC--CCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH--PNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 347 (579)
..+|++.+.||+|+||.||++...+++.||||++..........+.+.+|+.++..++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45799999999999999999998899999999998776666667889999999999977 9999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|| +.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||++....
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 568899999963 35688999999999999999999976 999999999999997 5789999999998664
Q ss_pred CCCc---ccccCCCCCccCcccccc-----------CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 428 NADE---ALNNDAGSGYGAPEVAMS-----------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 428 ~~~~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
.... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------ 226 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------ 226 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------------
Confidence 4332 223467889999999865 67899999999999999999999999653221
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+...+++.....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 123333444444445555566789999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=360.17 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=209.8
Q ss_pred HhCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 341 (579)
..++|++.+.||+|+||.||+|.. .++..||+|++.... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 346799999999999999999986 245689999997543 234457889999999999 999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDED-------------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI 402 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl 402 (579)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9999999999999999999743221 13478999999999999999999976 9999999
Q ss_pred CCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCC
Q 008055 403 KSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSS 478 (579)
Q Consensus 403 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~ 478 (579)
||+|||++.++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999765432221 12334568999999999999999999999999999998 99999764
Q ss_pred CchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 479 RPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
... ..+...+........+...+..+.+++.+||+.||++|||+.++++.|+.++....
T Consensus 279 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 321 11111111222233345566789999999999999999999999999999886544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.06 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=205.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC---CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA---LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
+.|++.+.||+|+||.||+|... +++.||||++.... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46999999999999999999765 68999999985321 112235778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN---PQLSDCGLA 423 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~ 423 (579)
||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988865444455689999999999999999999976 9999999999999987654 999999999
Q ss_pred ccCCCCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 424 SNMPNADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 424 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
........ .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..........+..... ..
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~---~~------ 251 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY---KM------ 251 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC---CC------
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC---CC------
Confidence 87655433 234567889999999999999999999999999999999999997643211111111000 00
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 252 --~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 --NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0123468899999999999999999999984
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=363.15 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=206.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||++... +++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46899999999999999999765 58899999986432 12234577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+.+|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999996 345689999999999999999999976 999999999999999999999999999988766
Q ss_pred CCcccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
........+|+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.. .+.
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-------------~~~- 233 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH-------------TFE- 233 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH-------------HHH-
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH-------------HHh-
Confidence 666666788999999999974 458999999999999999999999997543221111110 000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCC-hHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVV 542 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl 542 (579)
.....++...+..+.+|+.+||+.||++||+ +.+++
T Consensus 234 -~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 234 -TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 0112344556678999999999999999998 66655
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=380.09 Aligned_cols=258 Identities=23% Similarity=0.448 Sum_probs=215.4
Q ss_pred HhCCccccceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
...+|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.++++++||||++++++|.+.+..++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34578899999999999999998764 88999999976542 367899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.++++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999742 345689999999999999999999976 99999999999999999999999999998764
Q ss_pred CCCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 428 NADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 428 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
..... ....++..|+|||++....++.++|||||||++|||++ |..||...... .+.+.+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~ 432 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELL 432 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHH
Confidence 33221 12233457999999999999999999999999999999 99999764321 111122
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
....+...+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 22333344566778999999999999999999999999999877643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=345.03 Aligned_cols=256 Identities=25% Similarity=0.462 Sum_probs=212.7
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3578899999999999999999988999999999765432 4678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999963 235688999999999999999999976 9999999999999999999999999998765432
Q ss_pred Cc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.. .....++..|+|||++....++.++||||||+++|||++ |+.||........ ...+ ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~i-~~ 220 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDI-ST 220 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHH-HT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----------------HHHH-hc
Confidence 21 112334567999999998899999999999999999999 8999976432110 0011 11
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
......+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111223344567899999999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=348.54 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=197.0
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc------------------------hhHHHHHHHHHHHh
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS------------------------EMCDDFIEMVSNIS 324 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~ 324 (579)
.++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 457999999999999999999764 68899999997553211 12356889999999
Q ss_pred hcCCCCccceeeEEee--CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 008055 325 QLHHPNIMELVGYCSE--YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNI 402 (579)
Q Consensus 325 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl 402 (579)
+++||||+++++++.+ .+..++||||+++|+|.+++. ...+++..++.++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 578999999999999988753 34689999999999999999999976 9999999
Q ss_pred CCCCEEEcCCCceEEecccccccCCCCCc-ccccCCCCCccCccccccCC---CCccchHHhHHHHHHHHHhCCCCCCCC
Q 008055 403 KSANILLDNELNPQLSDCGLASNMPNADE-ALNNDAGSGYGAPEVAMSGQ---YNIKSDVYSFGVVMLELLTGRKPFDSS 478 (579)
Q Consensus 403 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~elltg~~p~~~~ 478 (579)
||+|||++.++.+||+|||++........ .....++..|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999987654332 23456788999999997665 378899999999999999999999754
Q ss_pred CchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 479 RPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...... ..+.............+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMCLH----------------SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHHHH----------------HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHHH----------------HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 321110 0000001111112234568999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.84 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=200.5
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||.||+|... ..+|+|+++.........+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3568999999999999999999864 3599999987766667778899999999999999999999965 456789999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++. .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999986 2345689999999999999999999976 999999999999999999999999999875543
Q ss_pred CC---cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 429 AD---EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 429 ~~---~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
.. ......++..|+|||++. ...++.++||||||+++|||++|+.||........ +..... ..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---------~~ 241 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG---------RG 241 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH---------HT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc---------cc
Confidence 21 222345788999999986 56688899999999999999999999976432211 000000 00
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
...+. .......++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 242 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 242 SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00011 11123455678999999999999999999999999998775
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.69 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=206.7
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999986 57899999998643211 12245788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+ +|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899998853 34689999999999999999999987 99999999999999999999999999998776
Q ss_pred CCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.........+++.|+|||++.+..+ +.++|||||||++|+|++|+.||......... +.+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------~~i~- 221 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------KKVN- 221 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------CCCC-
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------HHHH-
Confidence 6655566778899999999988776 68999999999999999999999753221000 0000
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01112344556789999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.55 Aligned_cols=266 Identities=20% Similarity=0.285 Sum_probs=205.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47899999999999999999875 68999999998766656667888999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++ +|.+++. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 5655554 2345689999999999999999999976 9999999999999999999999999999866433
Q ss_pred C-cccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhh-hccccccChhHHhhhc
Q 008055 430 D-EALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVR-WATPQLHDIDALAKMV 504 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 504 (579)
. ......++..|+|||++.+.. ++.++|||||||++|||++|..||........ ..+.. ...+............
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2 223446678999999998766 79999999999999999998888643332111 11111 1111111111111110
Q ss_pred Cc---------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DP---------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+. ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0001122345678899999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.38 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=213.5
Q ss_pred CCccccc-eeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVEN-LLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
++|.+.+ .||+|+||.||+|.+. ++..||+|+++... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566666 8999999999999754 57889999997653 345567899999999999999999999999 5567999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++++|.+++. .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999986 2345689999999999999999999976 9999999999999999999999999999876
Q ss_pred CCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 427 PNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 427 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
....... ...++..|+|||++.+..++.++||||||+++|||++ |+.||....... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~ 223 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------VM 223 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----------------HH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----------------HH
Confidence 4433221 2234568999999998889999999999999999999 999997643211 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
..+........+..++..+.+++.+||+.||++||++.++++.|+++..+....
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 111111222345566789999999999999999999999999999999776653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=362.80 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=201.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 346 (579)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.... ......+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999876 5789999999765332 23345677888888776 89999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999863 34689999999999999999999976 9999999999999999999999999999863
Q ss_pred -CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh-hhc
Q 008055 427 -PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA-KMV 504 (579)
Q Consensus 427 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 504 (579)
..........+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+. .+.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL 275 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHHH
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHHHHHHHHh
Confidence 3334445567889999999999999999999999999999999999999643211000 000001111 111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
. ....+|...+.++.+|+.+||+.||++||++
T Consensus 276 ~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 276 E--KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp H--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred c--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1123455567789999999999999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=353.01 Aligned_cols=268 Identities=24% Similarity=0.408 Sum_probs=211.2
Q ss_pred CCccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC--Ce
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY--GQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 343 (579)
.+|++.+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3588899999999999999984 468999999997554 234467889999999999999999999999876 66
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999953 235689999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc--cCh
Q 008055 424 SNMPNADE----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL--HDI 497 (579)
Q Consensus 424 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 497 (579)
........ .....++..|+|||++.+..++.++||||||+++|||++|..|+...... ......+.. ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCH
Confidence 87654432 12234556799999999999999999999999999999999987532211 111111111 111
Q ss_pred hHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
..+...+........+...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1222222223333445667789999999999999999999999999999886
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.36 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=207.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 47999999999999999999775 68999999997543 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--CCceEEecccccccCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN--ELNPQLSDCGLASNMP 427 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 427 (579)
|+++|+|.+++. .....+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++....
T Consensus 129 ~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999986 2345689999999999999999999976 9999999999999974 4779999999998776
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.........+|..|+|||++.+..++.++|||||||++|||++|..||......... . .+.. ....
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--~-----------~i~~-~~~~ 268 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL--Q-----------NVKR-CDWE 268 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--H-----------HHHH-CCCC
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH--H-----------HHHh-CCCC
Confidence 555445567888999999999999999999999999999999999999764321110 0 0000 0001
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.........+.++.+++.+||+.||++|||+.++++
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111122345578999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.93 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=208.9
Q ss_pred hCCccccceeccCCceEEEEEEeCC-----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD-----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
..+|++.+.||+|+||.||+|.... +..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 4578888999999999999997643 2469999997544 344566789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999963 345689999999999999999999976 99999999999999999999999999997
Q ss_pred cCCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 425 NMPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 425 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
........ ....++..|+|||++....++.++|||||||++|||++ |+.||.......
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------------- 258 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------- 258 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----------------
Confidence 65433211 11233567999999999999999999999999999999 999996543211
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
+...+........+..++..+.+++.+||+.||++||++.++++.|+++++.....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 11111111122234456678999999999999999999999999999999765553
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=353.14 Aligned_cols=262 Identities=25% Similarity=0.457 Sum_probs=210.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcE--EEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKV--LAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||.||+|... ++.. +|+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 46889999999999999999764 5654 4999986533 233456788999999999 99999999999999999999
Q ss_pred EEEecCCCChhhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 347 VYEFRKNGSLHDFLHLSD------------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997432 2235789999999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+||+|||+++............++..|+|||++....++.++|||||||++|||++ |+.||.......
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------- 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------- 249 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----------
Confidence 99999999875443333333445678999999998889999999999999999998 999997643211
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
+...+........+...+..+.+++.+||+.||++|||+.++++.|+.++++..
T Consensus 250 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111112223344566789999999999999999999999999999997654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=351.70 Aligned_cols=266 Identities=23% Similarity=0.419 Sum_probs=206.9
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
.+..++|.+.+.||+|+||.||+|... .+..||+|++..........+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 344567999999999999999999764 3458999999877666666788999999999999999999999997654
Q ss_pred -----eEEEEEEecCCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 343 -----QHLLVYEFRKNGSLHDFLHLSD--EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 343 -----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 3599999999999999985332 2345799999999999999999999965 99999999999999999999
Q ss_pred EEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcc
Q 008055 416 QLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 491 (579)
||+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------- 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------- 258 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--------
Confidence 9999999976543321 112334568999999999999999999999999999999 8999976432211
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
...+. .......+..++..+.+++.+||+.||++|||+.++++.|+.++++.
T Consensus 259 --------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 --------YDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp --------HHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------HHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01111 11122334556678999999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=359.15 Aligned_cols=253 Identities=19% Similarity=0.293 Sum_probs=194.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||++... +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 357999999999999999999876 7899999999764432 356789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--eEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN--PQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~ 426 (579)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999863 34589999999999999999999976 9999999999999987765 999999999755
Q ss_pred CCCCcccccCCCCCccCccccccCCCCcc-chHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIK-SDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
..........+++.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ...+.....
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------~~~~~~~~~ 236 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY------------RKTIQRILS 236 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH------------HHHHHHHHT
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH------------HHHHHHHhc
Confidence 44444455678899999999988887655 89999999999999999999754321000 011111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111122345788999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=362.17 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=204.8
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC--CCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH--HPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 348 (579)
.+|++.+.||+|+||.||++...+++.||||++..........+.+.+|+.++..++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 359999999999999999999888999999999876666667788999999999996 599999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
| +.+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 568899999963 34688889999999999999999965 999999999999996 57999999999987644
Q ss_pred CCc---ccccCCCCCccCcccccc-----------CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 429 ADE---ALNNDAGSGYGAPEVAMS-----------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 429 ~~~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------- 273 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------- 273 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------------
Confidence 322 234567889999999865 46889999999999999999999999653221
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+..++++.....++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 274 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 --ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122333344444444455556789999999999999999999999853
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.59 Aligned_cols=262 Identities=23% Similarity=0.438 Sum_probs=218.6
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
+...+|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 34567999999999999999999876 48899999997543 346788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999642 345689999999999999999999987 9999999999999999999999999999866
Q ss_pred CCCCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 427 PNADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 427 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
...... ....++..|+|||++.+..++.++||||||+++|+|++ |..||....... +...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----------------~~~~ 224 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYEL 224 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHH
Confidence 543321 12234567999999999999999999999999999999 999997643221 1111
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
+........+..++..+.+++.+||+.||++|||+.++++.|+.+.++...
T Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 112222334455667899999999999999999999999999999987665
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.49 Aligned_cols=262 Identities=25% Similarity=0.416 Sum_probs=212.9
Q ss_pred HhCCccccc-eeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 269 ATGSFNVEN-LLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 269 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
...+|.+.+ .||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345788888 9999999999999542 468899999987665556678899999999999999999999999 56788
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999963 34589999999999999999999976 99999999999999999999999999998
Q ss_pred cCCCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 425 NMPNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 425 ~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
......... ...++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------- 228 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------- 228 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------
Confidence 765433221 1233567999999998889999999999999999999 999997644321
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
+...+........+..++..+.+++.+||+.||++|||+.++++.|+++..+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 11111111122344566788999999999999999999999999999999876654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.50 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=205.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcE----EEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKV----LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
..+|++.+.||+|+||.||+|.+. +++. ||+|.+..... ......+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 347889999999999999999764 4443 78888754432 233456778999999999999999999986 4678
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999999863 234688899999999999999999976 99999999999999999999999999998
Q ss_pred cCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------- 226 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----------------- 226 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-----------------
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-----------------
Confidence 76543322 22344568999999999999999999999999999999 9999976432211
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
...+........+..++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111111112223344556788999999999999999999999999988753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=347.48 Aligned_cols=264 Identities=16% Similarity=0.199 Sum_probs=210.6
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+..++.+ +|+|++++++++.+....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 45799999999999999999976 5789999999865432 23567888889888 899999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-----eEEecccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN-----PQLSDCGL 422 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfg~ 422 (579)
|||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 9999999973 244689999999999999999999965 9999999999999987776 99999999
Q ss_pred cccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 423 ASNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 423 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
+........ .....++..|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~------ 231 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE------ 231 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH------
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH------
Confidence 976644322 233457889999999999999999999999999999999999997643211111100
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.+................+..+.+++.+||+.||++|||+.+|++.|++++++...
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 232 ----RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp ----HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----HHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00000000000001123457899999999999999999999999999999986654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=356.17 Aligned_cols=274 Identities=24% Similarity=0.358 Sum_probs=214.9
Q ss_pred CCccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe--eCCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS--EYGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 343 (579)
++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 4788999999999999999984 468899999997643 445677899999999999999999999886 4567
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 89999999999999999632 23589999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
......... ....++..|+|||++.+..++.++||||||+++|+|++|..||........... .+ .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~ 252 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GC-ERDVPALSR 252 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-cc-ccccccHHH
Confidence 876543321 223455679999999998999999999999999999999999865322111100 00 001112223
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
+...+........+..++..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 3333334444455667788999999999999999999999999999988765544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=361.64 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=201.5
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 345 (579)
..++|++.+.||+|+||.||+|+.+ +++.||||++.+... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3568999999999999999999875 689999999965321 123456678899999887 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999863 34689999999999999999999976 999999999999999999999999999976
Q ss_pred CCCC-CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 426 MPNA-DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
.... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~ 237 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----------------LFEAIL 237 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 4332 23345568889999999998899999999999999999999999997643321 111111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh------HHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM------SEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~ 543 (579)
.. ...++...+..+.+++.+||+.||++||++ .++++
T Consensus 238 ~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 ND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 112344556789999999999999999998 66663
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.86 Aligned_cols=270 Identities=26% Similarity=0.410 Sum_probs=215.6
Q ss_pred ccccceeccCCceEEEEEEeC-----CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeEE
Q 008055 273 FNVENLLGEGTFGRVYRAQFA-----DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQHL 345 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 345 (579)
|++.+.||+|+||.||++.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+ ....+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488999999999999998653 68899999997653 34556789999999999999999999999987 46789
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999963 3489999999999999999999976 999999999999999999999999999987
Q ss_pred CCCCCc----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADE----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
...... .....++..|+|||++.+..++.++||||||+++|||++|..||........ ....+.... .....+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQ-MTVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHH-HHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccc-hhHHHHH
Confidence 654432 1223455679999999998999999999999999999999999965322110 011111100 0111223
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
..+........+..++..+.+++.+||+.||++|||+.++++.|+.+.++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 3333334444566777899999999999999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=347.01 Aligned_cols=259 Identities=24% Similarity=0.448 Sum_probs=212.3
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 4467899999999999999999998888999999976543 2567899999999999999999999986 45689999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 87 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999998632 123688999999999999999999976 999999999999999999999999999987654
Q ss_pred CCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... ....++..|+|||++....++.++||||||+++|||++ |+.||....... +...+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----------------~~~~~~ 224 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----------------VIQNLE 224 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHH
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----------------HHHHHh
Confidence 3322 12334568999999998889999999999999999999 999997643211 001111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.......+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 225 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111222344566789999999999999999999999999999986544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=360.79 Aligned_cols=273 Identities=19% Similarity=0.239 Sum_probs=207.1
Q ss_pred HhCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCch---------hHHHHHHHHHHHhhcCCCCccc
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSE---------MCDDFIEMVSNISQLHHPNIME 333 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~ 333 (579)
..++|++.+.||+|+||.||+|.+.. ++.||||++........ ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999998764 47899999865431100 0112344556677889999999
Q ss_pred eeeEEeeC----CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE
Q 008055 334 LVGYCSEY----GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL 409 (579)
Q Consensus 334 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill 409 (579)
+++++... ...++||||+ +|+|.+++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4589999999 9999999963 345799999999999999999999976 99999999999999
Q ss_pred c--CCCceEEecccccccCCCCCcc--------cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCC
Q 008055 410 D--NELNPQLSDCGLASNMPNADEA--------LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSR 479 (579)
Q Consensus 410 ~--~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~ 479 (579)
+ .++.+||+|||+++........ ....+|..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999765433221 22347889999999999999999999999999999999999997432
Q ss_pred chhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
.... ...+..... ...+..++++.+. ...++.++.+++..||+.||++||++.+|++.|++++++....
T Consensus 266 ~~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 266 KDPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp TCHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1110 000000000 0111122221111 1234578999999999999999999999999999999876653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.38 Aligned_cols=263 Identities=15% Similarity=0.195 Sum_probs=211.1
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 45799999999999999999976 5789999999875432 23577899999999 999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-----eEEecccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN-----PQLSDCGL 422 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfg~ 422 (579)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999 99999999732 45789999999999999999999976 9999999999999998887 99999999
Q ss_pred cccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 423 ASNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 423 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
+........ .....+|..|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---- 232 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---- 232 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH----
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH----
Confidence 986543322 23456788999999999999999999999999999999999999764322111110000
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.......... ......+ ++.+++..||+.||.+||++.+|++.|+++.++...
T Consensus 233 ---~~~~~~~~~~---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 233 ---GDTKRATPIE---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp ---HHHHHHSCHH---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ---HhhhccCCHH---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0000000000 0011234 899999999999999999999999999999987755
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=347.92 Aligned_cols=267 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4689999999999999999976 578999999997643 33455678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999975444566789999999999999999999976 999999999999999999999999999876543
Q ss_pred CCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...+....
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~ 254 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--------------CKKIEQCD 254 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH--------------HHHHHTTC
T ss_pred CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH--------------HHHhhccc
Confidence 322 223456789999999999999999999999999999999999996532211110 01111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.........+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11111234567899999999999999999999999999999876654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.02 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=208.3
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
+.++....++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4555666789999999999999999999876 478999999864221 11122347889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+..++|||||++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999963 245689999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCcc--cccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 421 GLASNMPNADEA--LNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 421 g~~~~~~~~~~~--~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
|+++........ ....+|+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---------- 289 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---------- 289 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH----------
Confidence 999766544332 2356889999999997 56789999999999999999999999976432211
Q ss_pred ccChhHHhhhcCccccCCCC---hhhHHHHHHHHHhcCCCCCCC--CCChHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYP---VKSLSRFADVIALCVQPEPEF--RPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 543 (579)
...++.......+| ...+.++.+|+.+||..+|++ ||++.|+++
T Consensus 290 ------~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 290 ------YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ------HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ------HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11111111011111 235578999999999999988 999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=353.30 Aligned_cols=257 Identities=20% Similarity=0.411 Sum_probs=204.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcE----EEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKV----LAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 457999999999999999999764 4443 5777775433 2345678999999999999999999999998754 8
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++|+||+.+|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999999963 345689999999999999999999976 99999999999999999999999999997
Q ss_pred cCCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 425 NMPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 425 ~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
......... ...++..|+|||++.+..++.++|||||||++|||++ |..||....... +
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~ 228 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 228 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------H
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------H
Confidence 664433222 2234557999999999999999999999999999999 999997654321 1
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
...+........+..++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111112222333455667899999999999999999999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=372.69 Aligned_cols=255 Identities=28% Similarity=0.467 Sum_probs=207.5
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+.++++++||||+++++++.+ +..++||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3457889999999999999999998888999999976543 25678999999999999999999999876 7789999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.++++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999632 234588999999999999999999976 999999999999999999999999999976543
Q ss_pred CCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 ADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... ....++..|+|||++....++.++|||||||++|||++ |+.||....... +...+.
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~~~i~ 395 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQVE 395 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHH
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHH
Confidence 2211 12234568999999999999999999999999999999 999997643211 111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
...+...+..++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 22223345567789999999999999999999999999998776
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=351.39 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=205.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|+.. +|+.||+|++.+... .....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46899999999999999999875 689999999965321 1123567788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999963 34689999999999999999999965 999999999999999999999999999986543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
......+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~~~~- 219 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKILNAE- 219 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHCC-
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhCC-
Confidence 2345578899999999999999999999999999999999999997643211 111111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
..++...+.++.+++.+||..||++|| ++.++++
T Consensus 220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 123445567899999999999999999 8888873
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.33 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=207.6
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
+.++....++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566788999999999999999999876 588999999864211 11123457789999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+..++||||+++|+|.++++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999862 3588999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCc--ccccCCCCCccCccccccCC----CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPNADE--ALNNDAGSGYGAPEVAMSGQ----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|+++....... .....+|+.|+|||++.... ++.++|||||||++|||++|+.||.......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------------ 280 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------ 280 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------------
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------------
Confidence 99987654432 23567889999999998665 8899999999999999999999997643211
Q ss_pred cChhHHhhhcCccccCCCC--hhhHHHHHHHHHhcCCCCCCC--CCChHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYP--VKSLSRFADVIALCVQPEPEF--RPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--Rps~~evl~ 543 (579)
....++.......++ ...+.++.+|+.+||..+|.+ ||++.||++
T Consensus 281 ----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 281 ----TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ----HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ----HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111111111111112 234578999999999999998 999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.06 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=210.9
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999765 6899999999776666666788899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---eEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN---PQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~~ 425 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988863 34589999999999999999999976 9999999999999986655 99999999987
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...........++..|+|||++.+..++.++||||||+++|+|++|+.||............. .. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------------~~-~ 223 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------------AG-A 223 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------HT-C
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-------------hc-c
Confidence 766555555677889999999999999999999999999999999999997644321110000 00 0
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 224 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111112345689999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=345.40 Aligned_cols=266 Identities=20% Similarity=0.309 Sum_probs=203.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999875 58999999997776655667788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999875 245689999999999999999999976 9999999999999999999999999999876533
Q ss_pred Cc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh-hhhhccccccChhHHh---hh
Q 008055 430 DE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS-LVRWATPQLHDIDALA---KM 503 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~ 503 (579)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... +............... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 22 234456778999999976 668999999999999999999999997755432211 1111111100000000 00
Q ss_pred cC----ccccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 VD----PALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ~~----~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. +...... ....+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000 0234567899999999999999999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=351.67 Aligned_cols=273 Identities=24% Similarity=0.438 Sum_probs=217.8
Q ss_pred cCHHHHHHHhCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccc
Q 008055 261 YSIADLQMATGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIME 333 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 333 (579)
+...++....++|++.+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+.++.++ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 34455566678899999999999999999974 356899999997654 334456789999999999 7999999
Q ss_pred eeeEEeeCC-eEEEEEEecCCCChhhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 008055 334 LVGYCSEYG-QHLLVYEFRKNGSLHDFLHLSDED------------NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHK 400 (579)
Q Consensus 334 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 400 (579)
+++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999987654 589999999999999999743221 12388999999999999999999976 99999
Q ss_pred CCCCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCC
Q 008055 401 NIKSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFD 476 (579)
Q Consensus 401 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~ 476 (579)
||||+|||++.++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999765443221 12334668999999999999999999999999999998 999997
Q ss_pred CCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 477 SSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
...... .+...+........+...+..+.+++.+||+.||++|||+.++++.|+.+++...
T Consensus 253 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhH----------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 543211 0001111111122334456789999999999999999999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=353.11 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=202.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46889999999999999999875 688999999976543 334456788899999887 899999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999863 24689999999999999999999976 99999999999999999999999999998643
Q ss_pred C-CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh-hhcC
Q 008055 428 N-ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA-KMVD 505 (579)
Q Consensus 428 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 505 (579)
. ........+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+. .+..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVILE 233 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHH
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc--------ccccHHHHHHHHHc
Confidence 2 23344567888999999999999999999999999999999999999643211000 000001111 1111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
. ...++...+..+.+++.+||+.||++||++
T Consensus 234 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 122455566789999999999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=357.33 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=204.6
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCe
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 343 (579)
....++|++.+.||+|+||.||+|+.+ +++.||+|++++... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999875 689999999965321 122355677888888876 99999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999963 34689999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCC-CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 424 SNMPNA-DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 424 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
+..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------~~~ 229 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----------------FHS 229 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHH
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHH
Confidence 764332 234456778899999999999999999999999999999999999976432211 001
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChH-HHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS-EVV 542 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl 542 (579)
+... ...++...+.++.+++.+||..||++||++. +++
T Consensus 230 i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 IRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1000 1123444567899999999999999999997 665
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=359.47 Aligned_cols=269 Identities=23% Similarity=0.324 Sum_probs=205.2
Q ss_pred hCCccccceeccC--CceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 270 TGSFNVENLLGEG--TFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 270 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
.++|++.+.||+| +||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3479999999999 99999999876 79999999998766666667888999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999998642 234589999999999999999999976 9999999999999999999999999987543
Q ss_pred CCCC--------cccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcccccc
Q 008055 427 PNAD--------EALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLH 495 (579)
Q Consensus 427 ~~~~--------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 495 (579)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 1122356778999999987 6799999999999999999999999976432211 000000000000
Q ss_pred Chh------------------HHhhhcC---------ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 496 DID------------------ALAKMVD---------PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 496 ~~~------------------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.. ....... ......++...+..+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 0000000 00001123345578999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=377.35 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=209.7
Q ss_pred CCccccc-eeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVEN-LLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
.++.+.+ .||+|+||.||+|.++ ++..||||+++... .....+.+.+|+.+++.++||||++++++|.. +..++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 3444444 7999999999999764 46689999997653 33456889999999999999999999999976 56999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++|+|.+++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 413 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999962 345689999999999999999999976 9999999999999999999999999999876
Q ss_pred CCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 427 PNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 427 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
....... ...++..|+|||++....++.++|||||||++|||++ |+.||....... +.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~ 549 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------VM 549 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----------------HH
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HH
Confidence 4432221 1223468999999999999999999999999999998 999997643321 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
..+....+...+..++..+.+|+.+||+.||++||++.+|++.|+.+......
T Consensus 550 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11122223345566778999999999999999999999999999999876544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=354.05 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=189.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 457999999999999999999876 57899999997543 2456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~ 425 (579)
||+++|+|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999986 245689999999999999999999976 9999999999999975 88999999999987
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...........++..|+|||++.+..++.++|||||||++|||++|..||........ ....+..
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~~i~~ 265 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---------------MFRRILN 265 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---------------HHHHHHT
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---------------HHHHHHh
Confidence 6544444455678899999999998999999999999999999999999965432210 0111111
Q ss_pred cc--ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PA--LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .........+..+.+++.+||+.||++|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111122345678999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=347.55 Aligned_cols=265 Identities=21% Similarity=0.359 Sum_probs=203.2
Q ss_pred HHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh--cCCCCccceeeEEeeC---
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ--LHHPNIMELVGYCSEY--- 341 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~--- 341 (579)
....++|++.+.||+|+||.||+|... ++.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 344568999999999999999999876 899999998532 23444555555544 4999999999999877
Q ss_pred -CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEcCCCCCCEEEcCCCce
Q 008055 342 -GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC-----SLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 789999999999999999962 35899999999999999999999531 2289999999999999999999
Q ss_pred EEecccccccCCCCCcc-----cccCCCCCccCccccccCCCCcc------chHHhHHHHHHHHHhC----------CCC
Q 008055 416 QLSDCGLASNMPNADEA-----LNNDAGSGYGAPEVAMSGQYNIK------SDVYSFGVVMLELLTG----------RKP 474 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~------~DvwslGv~l~elltg----------~~p 474 (579)
||+|||++......... ....++..|+|||++.+..++.+ +|||||||++|||++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999765443322 23467889999999987766654 9999999999999999 445
Q ss_pred CCCCCchhhhhhhhhccccccChhHHhh-hcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 475 FDSSRPRLEQSLVRWATPQLHDIDALAK-MVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
|...... ......+.. ..........+ ..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 262 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 262 YHDLVPS------------DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTSCS------------SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcCC------------CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5332111 011111111 11122222233 36778899999999999999999999999999999
Q ss_pred HHHccc
Q 008055 549 VQRANM 554 (579)
Q Consensus 549 ~~~~~~ 554 (579)
.+...+
T Consensus 330 ~~~~~~ 335 (337)
T 3mdy_A 330 SESQDI 335 (337)
T ss_dssp HHTTTC
T ss_pred Hhhccc
Confidence 876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=347.29 Aligned_cols=269 Identities=21% Similarity=0.332 Sum_probs=192.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 457899999999999999999765 689999999975542 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSD--EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 69999886432 2234689999999999999999999976 9999999999999999999999999999866
Q ss_pred CCCC-cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-ccccChhHHhh
Q 008055 427 PNAD-EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-PQLHDIDALAK 502 (579)
Q Consensus 427 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~ 502 (579)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+... +..........
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 4322 2334567889999999976 4689999999999999999999999976543221 11111110 00000000000
Q ss_pred h--cCccc------------cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 M--VDPAL------------KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~--~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ..+.. ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000 00111234568999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=358.85 Aligned_cols=258 Identities=25% Similarity=0.454 Sum_probs=199.8
Q ss_pred CccccceeccCCceEEEEEEeC--CC--cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe-eCCeEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA--DG--KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS-EYGQHLL 346 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l 346 (579)
.|++.+.||+|+||.||+|.+. ++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4677889999999999999764 22 368999986533 3455688999999999999999999999875 4568899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+++|+|.++++ .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999996 3345688999999999999999999976 9999999999999999999999999999765
Q ss_pred CCCCcc-----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 427 PNADEA-----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 427 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
...... ....++..|+|||++.+..++.++|||||||++|||++ |.+||.........
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---------------- 306 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---------------- 306 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH----------------
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH----------------
Confidence 432211 12234567999999999999999999999999999999 77888653321100
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
..+. .......+..++..+.+++.+||+.||++|||+.++++.|++++....
T Consensus 307 ~~~~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 307 VYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0000 111122345566789999999999999999999999999999997554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=343.06 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=207.2
Q ss_pred hCCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4578899999999999999997643 3469999997653 34456789999999999999999999999875 4578
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999963 235688999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
....... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.......... .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------------~~~- 228 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------------VLE- 228 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------------HHH-
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------------HHh-
Confidence 6443221 22334568999999998899999999999999999998 999997543221110 011
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.......+..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 229 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 229 ---KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 11111233445678999999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=345.85 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=208.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe--eCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS--EYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv 347 (579)
++|++.+.||+|+||.||++... +++.||+|++..........+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 47899999999999999999775 7899999999877666666788999999999999999999999874 46789999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEcCCCCCCEEEcCCCceEEecccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS-----VVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
|||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999975544556699999999999999999999987 6 99999999999999999999999999
Q ss_pred cccCCCCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 423 ASNMPNADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 423 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
+........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~i~ 229 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------------GKIR 229 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHH
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH-------------HHHh
Confidence 876644322 12345688999999999989999999999999999999999999764321100 0011
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
. ......+...+.++.+++.+||+.||++|||+.++++.+
T Consensus 230 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 E----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred h----cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1 111123445567899999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.81 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=208.7
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999875 7999999999643211 12356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999985 345689999999999999999999965 99999999999999999999999999998776
Q ss_pred CCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.........+++.|+|||++.+..+ +.++|||||||++|||++|+.||....... ....+.+.
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~ 231 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----------------LFKKICDG 231 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----------------HHHHHHTT
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----------------HHHHHhcC
Confidence 6555556678899999999988776 689999999999999999999997643211 11111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 232 ~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 I--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1 1123445578999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.12 Aligned_cols=250 Identities=19% Similarity=0.281 Sum_probs=204.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 345 (579)
..++|++.+.||+|+||.||+|+.+ +++.||+|++++... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4568999999999999999999876 478999999965321 123356778899999887 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999863 24589999999999999999999976 999999999999999999999999999986
Q ss_pred CCC-CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 426 MPN-ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
... ........+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~ 234 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------LFQSIM 234 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----------------HHHHHH
Confidence 432 233445678889999999999999999999999999999999999997643211 111111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh-----HHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM-----SEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~ 543 (579)
.. ...++...+.++.+++.+||..||++||++ .++++
T Consensus 235 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred hC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 112345566789999999999999999964 55553
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=354.78 Aligned_cols=265 Identities=24% Similarity=0.412 Sum_probs=213.6
Q ss_pred HhCCccccceeccCCceEEEEEEeCC------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFAD------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEY 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 341 (579)
..++|++.+.||+|+||.||+|.... ...||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 35689999999999999999998642 2479999997654 234567889999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDE----------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN 411 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~ 411 (579)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 999999999999999999864321 134678999999999999999999976 9999999999999999
Q ss_pred CCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhh
Q 008055 412 ELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 412 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~ 487 (579)
++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----- 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-----
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-----
Confidence 999999999999755332221 12234568999999999999999999999999999999 999997543211
Q ss_pred hhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.+...+........+...+..+.+++.+||+.||++|||+.++++.|+++.++..
T Consensus 275 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 275 -----------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp -----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 1111111112222344456789999999999999999999999999999887654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=358.99 Aligned_cols=277 Identities=20% Similarity=0.289 Sum_probs=215.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC--eEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG--QHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 347 (579)
++|.+.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 47899999999999999999876 589999999975432 233577889999999999999999999998655 78999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCceEEeccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQLSDCGLA 423 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg~~ 423 (579)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999997432 223489999999999999999999976 99999999999999 77788999999999
Q ss_pred ccCCCCCcccccCCCCCccCcccccc--------CCCCccchHHhHHHHHHHHHhCCCCCCCCCch--hhhhhhhhcccc
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMS--------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQ 493 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~--~~~~~~~~~~~~ 493 (579)
+............++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+.......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 88766555556678899999999865 56788999999999999999999999643221 111111110000
Q ss_pred cc-ChhHHhh-------hc-CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 494 LH-DIDALAK-------MV-DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 494 ~~-~~~~~~~-------~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.. ....+.. +. +.......+...+..+.+++.+||+.||++|||+.++++.+..++++.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 00 0000000 00 001112344677889999999999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.00 Aligned_cols=249 Identities=20% Similarity=0.324 Sum_probs=196.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC-------
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG------- 342 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 342 (579)
++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46899999999999999999876 79999999997554 2345678999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEecCCCChhhhhcccCCCCCCCCH
Q 008055 343 --------------------------------------------------QHLLVYEFRKNGSLHDFLHLSDEDNKPLIW 372 (579)
Q Consensus 343 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 372 (579)
..++||||+++|+|.+++.... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999997432 2234567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC-------------cccccCCCC
Q 008055 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD-------------EALNNDAGS 439 (579)
Q Consensus 373 ~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~~ 439 (579)
..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ......++.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78899999999999999976 99999999999999999999999999998765432 122345788
Q ss_pred CccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHH
Q 008055 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSR 519 (579)
Q Consensus 440 ~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (579)
.|+|||++.+..++.++|||||||++|||++|..|+.... . ......... ...........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~--------------~~~~~~~~~-~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----R--------------IITDVRNLK-FPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----H--------------HHHHHHTTC-CCHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----H--------------HHHHhhccC-CCcccccCChh
Confidence 9999999999999999999999999999999877652110 0 000000000 00011233457
Q ss_pred HHHHHHhcCCCCCCCCCChHHHHH
Q 008055 520 FADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 520 l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.+++.+||+.||++|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 789999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.30 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=205.5
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 689999999864321 1233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999963 24589999999999999999999976 999999999999999999999999999987643
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~~~~i~~~-- 253 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----------------IYEKIVSG-- 253 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHC--
T ss_pred C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----------------HHHHHHcC--
Confidence 2 334567889999999999999999999999999999999999997643211 11111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
...++...+..+.+++.+||+.||++||+ +.++++
T Consensus 254 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11234456678999999999999999998 787764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.91 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=206.9
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-------- 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 340 (579)
..+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 346999999999999999999876 79999999996543 346689999999999999999998854
Q ss_pred --------CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 341 --------YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 341 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
....++||||+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 45579999999999999999642 235688999999999999999999976 99999999999999999
Q ss_pred CceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccc
Q 008055 413 LNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 492 (579)
+.+||+|||++.............++..|+|||++.+..++.++||||||+++|||++|..||.... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~-------- 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----K-------- 226 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----H--------
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----H--------
Confidence 9999999999987766555555667889999999999999999999999999999999998873210 0
Q ss_pred cccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
........ ..+...+..+.+++.+||+.||++|||+.++++.|+.+.+....
T Consensus 227 ------~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 227 ------FFTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ------HHHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ------HHHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 00111111 12233456789999999999999999999999999887654443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=349.67 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=195.1
Q ss_pred hCCccccceeccCCceEEEEEEe----CCCcEEEEEEeCCCCCC--chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSALP--SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|++.+.||+|+||.||+++. .+++.||+|+++..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999987 47899999999765432 2334567889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999863 34588999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 424 SNMPNAD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 424 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
+...... ......++..|+|||++.+..++.++|||||||++|||++|+.||....... .+..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~ 232 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----------------TIDK 232 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHH
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----------------HHHH
Confidence 7543322 2334567889999999999999999999999999999999999997643211 1111
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
+... ...++...+..+.+++.+||+.||++|| ++.++++
T Consensus 233 i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 233 ILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 1123445567899999999999999999 6667764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=348.73 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=210.2
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh--cCCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ--LHHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~ 340 (579)
+.-.....++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 333445567899999999999999999987 4899999998532 35667788888876 799999999999987
Q ss_pred CC----eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEcCCCCCCEE
Q 008055 341 YG----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH--------EVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiH~Dlkp~Nil 408 (579)
.. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 65 78999999999999999963 35899999999999999999999 54 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCc-----ccccCCCCCccCccccccC------CCCccchHHhHHHHHHHHHhC------
Q 008055 409 LDNELNPQLSDCGLASNMPNADE-----ALNNDAGSGYGAPEVAMSG------QYNIKSDVYSFGVVMLELLTG------ 471 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~elltg------ 471 (579)
++.++.+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 99999999999999976544332 2334577899999999765 344789999999999999999
Q ss_pred ----CCCCCCCCchhhhhhhhhccccccChhHHh-hhcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHH
Q 008055 472 ----RKPFDSSRPRLEQSLVRWATPQLHDIDALA-KMVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEV 541 (579)
Q Consensus 472 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~ev 541 (579)
..||....... .....+. .+.........+ ..++..+.+++.+||+.||++|||+.+|
T Consensus 260 ~~~~~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSD------------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp CCCCCCTTTTTSCSS------------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccccccCccccCcCc------------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 67775432110 0011111 111222222222 3567789999999999999999999999
Q ss_pred HHHHHHHHHHccc
Q 008055 542 VQALVRLVQRANM 554 (579)
Q Consensus 542 l~~L~~i~~~~~~ 554 (579)
++.|+++.++...
T Consensus 328 ~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 328 KKTLSQLSQQEGI 340 (342)
T ss_dssp HHHHHHHHHTTC-
T ss_pred HHHHHHHHHHhcC
Confidence 9999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=355.05 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=200.3
Q ss_pred ccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 275 VENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3578999999999999764 68999999997643 24467889999999999999999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE--cCCCceEEecccccccCCCCCc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL--DNELNPQLSDCGLASNMPNADE 431 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~ 431 (579)
|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 171 GELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp CEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999998862 234689999999999999999999976 99999999999999 5678899999999988766555
Q ss_pred ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHhhhcCccccC
Q 008055 432 ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDPALKG 510 (579)
Q Consensus 432 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (579)
.....+++.|+|||++....++.++|||||||++|||++|+.||........ ..+..... ....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------------~~~~ 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW---------------DLED 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------------CSCS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------CCCh
Confidence 5556788999999999988999999999999999999999999976543211 11110000 0000
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH--HHHHH
Q 008055 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ--ALVRL 548 (579)
Q Consensus 511 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~i 548 (579)
......+.++.+|+.+||+.||++|||+.|+++ .+...
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 011234568999999999999999999999996 44433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.15 Aligned_cols=248 Identities=20% Similarity=0.308 Sum_probs=204.7
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457999999999999999999876 799999999987666566677888999999988 999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---------------
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE--------------- 412 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--------------- 412 (579)
|||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975444346789999999999999999999976 99999999999999844
Q ss_pred ----CceEEecccccccCCCCCcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh
Q 008055 413 ----LNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV 487 (579)
Q Consensus 413 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~ 487 (579)
..+||+|||++....... ...++..|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-------
T ss_pred cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-------
Confidence 479999999998765432 34578899999999765 567899999999999999999887643211
Q ss_pred hhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+.. ......+...+..+.+++.+||+.||++|||+.++++
T Consensus 237 ------------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ------------WHEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------------HHHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------HHHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 001111 1112234455678999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.43 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=199.9
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|.+.+.||+|+||.||++... ++..+|+|++..... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 6889999999999999999764 688999999875442 23367889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEecccccccCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNMP 427 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 427 (579)
+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865444456799999999999999999999976 99999999999999 456789999999998765
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.........++..|+|||++. ..++.++||||||+++|||++|+.||.............+..+ .
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------~ 243 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--------------N 243 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------C
T ss_pred CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--------------c
Confidence 554455566788999999875 5789999999999999999999999976543221111111111 1
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 001123467889999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=364.09 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=206.3
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEee
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSE 340 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 340 (579)
+.+.....++|++.+.||+|+||.||+++.+ +|+.||+|++.+... .......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455566789999999999999999999875 789999999964321 12233457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999632 34689999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCc--ccccCCCCCccCccccc-------cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhc
Q 008055 421 GLASNMPNADE--ALNNDAGSGYGAPEVAM-------SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWA 490 (579)
Q Consensus 421 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~ 490 (579)
|+++....... .....+|+.|+|||++. ...++.++|||||||++|||++|+.||....... ...+..+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 99987654433 22356889999999997 3568999999999999999999999997643321 11111100
Q ss_pred cccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCC---CChHHHHH
Q 008055 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR---PPMSEVVQ 543 (579)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~ 543 (579)
. ... ....+...+.++.+|+.+||. +|++| |++.|+++
T Consensus 287 ~----------~~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 E----------HLS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp H----------HCC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred c----------CcC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 000 011123455789999999999 99998 58888864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=344.89 Aligned_cols=270 Identities=22% Similarity=0.300 Sum_probs=199.6
Q ss_pred HHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC---CchhHHHHHHHHHHHhhc---CCCCccceeeEEee
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL---PSEMCDDFIEMVSNISQL---HHPNIMELVGYCSE 340 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~ 340 (579)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999986 4789999999864321 112234455566665554 59999999999977
Q ss_pred CC-----eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 341 YG-----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 341 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
.. ..++||||+. |+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 5799999996 6999998632 233489999999999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc-ccc
Q 008055 416 QLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA-TPQ 493 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~-~~~ 493 (579)
||+|||+++............+|..|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... .+.
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999999877655555556778999999999999999999999999999999999999976543221 1111110 000
Q ss_pred ccChh---HHh-hhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDID---ALA-KMVDPALK---GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~~---~~~-~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..... ... ....+... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 000 00000000 0011234568899999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.66 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=194.0
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|.. .+++.||+|++............+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45799999999999999999986 47899999999766544444455566666688899999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||++ |+|.+++.........+++..++.++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 588888765444567899999999999999999999963 2899999999999999999999999999987655
Q ss_pred CCcccccCCCCCccCcccc----ccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 429 ADEALNNDAGSGYGAPEVA----MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
........++..|+|||++ ....++.++|||||||++|||++|+.||........ .+....
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~ 227 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------------QLKQVV 227 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---------------HHHHHH
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---------------HHHHHh
Confidence 5444455788899999996 456789999999999999999999999975332111 111111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
........+...+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111222345678999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=343.36 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=205.9
Q ss_pred CCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe-eCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS-EYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 345 (579)
.+|++.+.||+|+||.||+|.+.+ ...+|+|.+.... .....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 358888999999999999997643 2368999987533 3455678899999999999999999999864 556889
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++. .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999996 2345688999999999999999999976 999999999999999999999999999976
Q ss_pred CCCCCc-----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 426 MPNADE-----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 426 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |.+||.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--------------- 242 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--------------- 242 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---------------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---------------
Confidence 644322 112334567999999999999999999999999999999 56666543221100
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
... ........+..++..+.+++.+||+.||++|||+.++++.|++++...
T Consensus 243 -~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 243 -VYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -HHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -HHH-hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 011112224445678999999999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.97 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=205.6
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCch------hHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE------MCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||.||+|.. .+++.||||++........ ....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45799999999999999999975 4789999999976543221 3446778999999999999999999999999
Q ss_pred eEEEEEEecCCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 343 QHLLVYEFRKNG-SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 343 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
..++||||+.+| +|.+++. ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999986 344689999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
++.............++..|+|||++.+..+ +.++|||||||++|||++|..||......
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 9987766555556678899999999988877 78999999999999999999999642110
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.... ...+...+.++.+++.+||+.||++|||+.++++.
T Consensus 237 ---~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01122345689999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=350.53 Aligned_cols=273 Identities=24% Similarity=0.374 Sum_probs=213.3
Q ss_pred hCCccccceeccCCceEEEEEEe-----CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC--
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-----ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG-- 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 342 (579)
.++|++.+.||+|+||.||++.+ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 34688999999999999999984 368999999997643 455678999999999999999999999987644
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 78999999999999999973 234689999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChh
Q 008055 423 ASNMPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498 (579)
Q Consensus 423 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 498 (579)
+......... ....++..|+|||++.+..++.++||||||+++|||++|..||.................. ....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ-MIVF 270 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH-HHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh-hhHH
Confidence 9876543321 1223455799999999888999999999999999999999998643211111000000000 0001
Q ss_pred HHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+.+.+........+..++..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12222222223334566778999999999999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=350.75 Aligned_cols=275 Identities=21% Similarity=0.341 Sum_probs=199.9
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHH--HhhcCCCCccceeeEEee-----CC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSN--ISQLHHPNIMELVGYCSE-----YG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~ 342 (579)
.++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 45799999999999999999976 68999999986432 3444444444 456899999999986532 33
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEcCCCCCCEEEcCCCceE
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC------SLSVVHKNIKSANILLDNELNPQ 416 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~iiH~Dlkp~Nill~~~~~~k 416 (579)
..++||||+++|+|.+++.. ...++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 67899999999999999963 33588899999999999999999431 11999999999999999999999
Q ss_pred EecccccccCCCCC---------cccccCCCCCccCcccccc-------CCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 417 LSDCGLASNMPNAD---------EALNNDAGSGYGAPEVAMS-------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 417 l~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
|+|||++....... ......+|..|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 1223457889999999976 4567899999999999999999777643221
Q ss_pred hh-hhhhhhhccccccChhHHhh-hcCccccCCCC------hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 481 RL-EQSLVRWATPQLHDIDALAK-MVDPALKGLYP------VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 481 ~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.. .................+.. ......+..++ ..++..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11 00000000000111111111 11112222222 236678999999999999999999999999999999766
Q ss_pred ccc
Q 008055 553 NMS 555 (579)
Q Consensus 553 ~~~ 555 (579)
...
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=341.79 Aligned_cols=258 Identities=23% Similarity=0.406 Sum_probs=206.3
Q ss_pred CccccceeccCCceEEEEEEeCC-C---cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE-EE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFAD-G---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH-LL 346 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l 346 (579)
.|.+.+.||+|+||.||+|.+.+ + ..+|+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 45667899999999999997532 2 379999997533 344567889999999999999999999999776655 99
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||+.+|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 101 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999963 345688999999999999999999976 9999999999999999999999999999765
Q ss_pred CCCCc-----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCC-CCCCCchhhhhhhhhccccccChhHH
Q 008055 427 PNADE-----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKP-FDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 427 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..| |....... +
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----------------~ 237 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----------------L 237 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----------------H
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----------------H
Confidence 43221 1223445689999999999999999999999999999995554 44332211 1
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
...+........+...+..+.+++.+||+.||++|||+.++++.|+++++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 238 THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11111111222344556789999999999999999999999999999997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=346.23 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=206.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++|++.+.||+|+||.||+|... +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46899999999999999999875 68999999997654322 23577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL----NPQLSDCG 421 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 421 (579)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999962 45689999999999999999999976 999999999999999887 79999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
++.............++..|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~-------- 234 (321)
T 2a2a_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANITSVS-------- 234 (321)
T ss_dssp TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHTTC--------
T ss_pred cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhcc--------
Confidence 998776555445566788999999999999999999999999999999999999764322110 0000000
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+..+.+++.+||+.||++|||+.++++
T Consensus 235 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 ----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000001233467899999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.05 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=195.5
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHH-HhhcCCCCccceeeEEeeCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSN-ISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+.... ......+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 47999999999999999999875 5889999999765432 2334455666666 5778999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999863 34688999999999999999999976 99999999999999999999999999997632
Q ss_pred -CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 -NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.........+|+.|+|||++.+..++.++|||||||++|||++|..||....... ....++..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~~~ 254 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNILNK 254 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----------------HHHHHHHS
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHhc
Confidence 2333445678899999999999999999999999999999999999997643211 11111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
. ..++...+..+.+++.+||+.||++||++.+.++.
T Consensus 255 ~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 255 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 1 12334456789999999999999999998644433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.37 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=190.3
Q ss_pred CCcccc-ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHh-hcCCCCccceeeEEee----CCe
Q 008055 271 GSFNVE-NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNIS-QLHHPNIMELVGYCSE----YGQ 343 (579)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~ 343 (579)
++|.+. +.||+|+||.||++... +++.||||++.. ...+.+|+.++. ..+||||+++++++.. .+.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 356665 78999999999999765 689999999963 235667777764 4589999999998865 567
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Df 420 (579)
.++||||+++|+|.+++... ....+++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence 89999999999999999732 234689999999999999999999976 9999999999999997 789999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDA 499 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 499 (579)
|+++............+|..|+|||++.+..++.++|||||||++|||++|+.||........ .... ..
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----------~~ 278 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------TR 278 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH----------HH
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH----------HH
Confidence 999876654444556778899999999999999999999999999999999999975432110 0000 00
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+. ..............+.++.+|+.+||+.||++|||+.++++.
T Consensus 279 i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 279 IR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HH-HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HH-cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000001111113456789999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.08 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=202.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-CeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-GQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 348 (579)
.++|++.+.||+|+||.||++... |+.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 457899999999999999999875 8899999997543 357789999999999999999999997544 5789999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999632 122378899999999999999999976 999999999999999999999999999875543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... +...+...
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----------------~~~~~~~~ 230 (278)
T 1byg_A 170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPRVEKG 230 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----------------HHHHHTTT
T ss_pred c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhcC
Confidence 2 223345778999999998999999999999999999998 999997543211 11111122
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.....+..++..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 223344556788999999999999999999999999999987543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=376.07 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=212.9
Q ss_pred HHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 266 LQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+++..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3445667899999999999999999998888999999976543 25679999999999999999999999876 6789
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.++++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999999632 234588999999999999999999976 999999999999999999999999999986
Q ss_pred CCCCCc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
...... .....++..|+|||++....++.++|||||||++|||++ |+.||....... +..
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----------------~~~ 475 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLD 475 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----------------HHH
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHH
Confidence 643221 112234568999999999999999999999999999999 999997643211 111
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.+....+...+..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 476 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 476 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112222345567788999999999999999999999999998765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=350.51 Aligned_cols=247 Identities=30% Similarity=0.426 Sum_probs=201.9
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 488899999999999999976 57899999999765432 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+. |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 135 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp CCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred cCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 997 688888752 235689999999999999999999976 9999999999999999999999999999765432
Q ss_pred CcccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
....+++.|+|||++. ...++.++|||||||++|||++|+.||........ +..+...
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----------------~~~~~~~ 268 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIAQN 268 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HHHHHHS
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----------------HHHHHhc
Confidence 3456788999999985 56789999999999999999999999965432110 0011111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
......+...+..+.+++.+||+.||++|||+.++++.
T Consensus 269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111223445689999999999999999999999853
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.52 Aligned_cols=264 Identities=18% Similarity=0.276 Sum_probs=209.0
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEE-eeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC-SEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+.+++.++|++++..+.++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999986 5789999999865442 24578899999999998877777665 567788999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEecccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLAS 424 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 424 (579)
|||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9999 9999999963 245689999999999999999999976 99999999999999 488899999999997
Q ss_pred cCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC
Q 008055 425 NMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 425 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
....... .....++..|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------- 228 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-------- 228 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH--------
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh--------
Confidence 6544322 233457889999999999999999999999999999999999997643211110000
Q ss_pred hhHHhh-hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 497 IDALAK-MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 497 ~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
.+.. ..... ........+..+.+++.+||+.||++|||+.++++.|+++..+....
T Consensus 229 --~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 229 --RISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp --HHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --hhcccccCCc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 0000 00000 00011234568999999999999999999999999999999877653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=348.14 Aligned_cols=258 Identities=18% Similarity=0.256 Sum_probs=206.9
Q ss_pred HHHhCCcccc-ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCe
Q 008055 267 QMATGSFNVE-NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 267 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 343 (579)
+...++|.+. +.||+|+||.||+|... +++.||+|++............+.+|+.++..+ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567777 89999999999999775 689999999987665556678899999999988 56999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Df 420 (579)
.++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999852 2345689999999999999999999976 9999999999999998 789999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
|++.............+++.|+|||++....++.++|||||||++|||++|+.||.......... .+
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------------~i 245 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL-------------NI 245 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------HH
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-------------HH
Confidence 99987765554455678889999999999999999999999999999999999997644321110 00
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .............+..+.+++.+||+.||++|||+.++++
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 246 SQ-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Hh-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 0111111222345678999999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.86 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=210.5
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
..++|++.+.||+|+||.||+|... +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 799999999965321 12235668899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||++||+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999998632 234589999999999999999999976 9999999999999999999999999999887
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..........+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+.
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-------------~~~i~~~i~- 402 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-------------REEVERLVK- 402 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-------------HHHHHHHHH-
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-------------HHHHHHHhh-
Confidence 665555566789999999999998999999999999999999999999976432110 011111110
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
.....++...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 403 ~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111233455667899999999999999999 6778764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.55 Aligned_cols=265 Identities=19% Similarity=0.292 Sum_probs=205.5
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEE-eeCCeEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC-SEYGQHLL 346 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 346 (579)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.++|++++..+.++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 346899999999999999999976 57899999987654322 3477899999999998888777766 66778899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLA 423 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~ 423 (579)
||||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 99999 9999999863 244689999999999999999999976 99999999999999 78899999999999
Q ss_pred ccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccc
Q 008055 424 SNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQL 494 (579)
Q Consensus 424 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~ 494 (579)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||......... .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 232 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 232 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc---
Confidence 76644322 12345678999999999999999999999999999999999999764322111 1100000
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
.....+ ........+..+.+++.+||+.||++|||+.++++.|++++++....
T Consensus 233 ------~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 233 ------KKMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp ------HHHHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ------ccccch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 000000 00001223568999999999999999999999999999999887753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.23 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=204.9
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe----eCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS----EYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~ 344 (579)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45799999999999999999986 578999999986532 455678899999999999999999999986 34578
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999976555567899999999999999999999976 99999999999999999999999999987
Q ss_pred cCCCCCcc----------cccCCCCCccCccccccCC---CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcc
Q 008055 425 NMPNADEA----------LNNDAGSGYGAPEVAMSGQ---YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 425 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 491 (579)
........ ....++..|+|||++.... ++.++||||||+++|||++|+.||....... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~------ 255 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DS------ 255 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SC------
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-ch------
Confidence 55321111 1223578899999987554 6899999999999999999999995311100 00
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
+............+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 256 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 256 --------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00000001111122345678999999999999999999999999997653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=376.63 Aligned_cols=250 Identities=25% Similarity=0.434 Sum_probs=206.4
Q ss_pred ceeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|.+. .++.||||+++.........+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999998765555667889999999999999999999999964 568899999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcc-
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA- 432 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 432 (579)
|+|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999962 45689999999999999999999976 9999999999999999999999999999876543321
Q ss_pred ---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 433 ---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 433 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
....++..|+|||++....++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----------------~~~~~i~~~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEKGE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHcCC
Confidence 12234567999999999999999999999999999999 99999765432 1112222223
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
....+..++.++.+++.+||+.||++|||+.+|++.|+++..+
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 3344566778999999999999999999999999999988754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=367.04 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=207.0
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|.+.+.||+|+||.||+|+.+ +|+.||+|++.+.... ......+..|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999875 6999999999653221 23356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||++||+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999975544456799999999999999999999976 99999999999999999999999999998765
Q ss_pred CCCcc-cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEA-LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+...
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~------------~~~~~~i~~~ 408 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRVLEQ 408 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH------------HHHHHHHHHC
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH------------HHHHHHHhhc
Confidence 54332 3347889999999999999999999999999999999999999764321000 0000111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCCh
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPM 538 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 538 (579)
...++...+..+.+++.+||+.||++||++
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 123445567789999999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=347.82 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=198.5
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCC----e
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG----Q 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 343 (579)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45799999999999999999976 57899999999765433 344567899999999999999999999987654 3
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.++++. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999963 34689999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc----ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNADE----ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~------ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVRED------ 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHCC------
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhcCC------
Confidence 76544322 122346889999999999999999999999999999999999997654321100 000000
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH-HHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV-QALVRLV 549 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl-~~L~~i~ 549 (579)
...........+..+.+++.+||+.||++||++.+++ ..|..+.
T Consensus 236 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 236 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000000123456899999999999999999766655 4555444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=346.96 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=210.3
Q ss_pred hCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.++|++.+.||+|+||.||+|.+ .++..||||++.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 45799999999999999999974 357789999996443 34456788999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEE
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDED---NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQL 417 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl 417 (579)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999754322 24588999999999999999999976 9999999999999984 456999
Q ss_pred ecccccccCCCCC---cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccc
Q 008055 418 SDCGLASNMPNAD---EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 418 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+|||++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------- 253 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------- 253 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-----------
Confidence 9999986442221 1122345678999999999999999999999999999998 999997543211
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
+...+........+..++..+.+++.+||+.||++|||+.++++.|+.+.+.....
T Consensus 254 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 254 ------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp ------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred ------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 11111111122234456678999999999999999999999999999998766554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.95 Aligned_cols=265 Identities=20% Similarity=0.369 Sum_probs=213.5
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEE
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 338 (579)
++++..++|++.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 33455678999999999999999999764 36789999997543 234456789999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 339 SEYGQHLLVYEFRKNGSLHDFLHLSD------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999986422 1124578999999999999999999976 99999999999999999
Q ss_pred CceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 008055 413 LNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 413 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~ 488 (579)
+.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----- 249 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----- 249 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-----
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-----
Confidence 9999999999875533221 112234668999999999999999999999999999999 8999976432110
Q ss_pred hccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
...+... .....+..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 250 -----------~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 -----------LRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -----------HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----------HHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111 1112344566789999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=338.31 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=205.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++|++.+.||+|+||.||+|... +++.||+|+++...... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999876 68999999987654321 23678899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL----NPQLSDCG 421 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 421 (579)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999863 34689999999999999999999976 999999999999998877 89999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
++.............++..|+|||++....++.++||||||+++|+|++|..||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---------- 225 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LTNISA---------- 225 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHT----------
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HHHhHh----------
Confidence 99876554444455678899999999989999999999999999999999999976432211 000000
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH--HHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ--ALVRLV 549 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~i~ 549 (579)
.............+..+.+++.+||+.||++|||+.++++ .++.+.
T Consensus 226 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 226 --VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000000001233467899999999999999999999997 444443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=350.62 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=200.7
Q ss_pred HHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCC---CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSA---LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
....++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34456799999999999999999976 468899999986432 23345678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDED------------------------------------NKPLIWNSRVKIALGTARAL 386 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~L 386 (579)
..++||||+++|+|.+++...... ...+++..++.++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998532111 12345677889999999999
Q ss_pred HHHHhcCCCCeEEcCCCCCCEEEcCCC--ceEEecccccccCCCCC-----cccccCCCCCccCcccccc--CCCCccch
Q 008055 387 EYLHEVCSLSVVHKNIKSANILLDNEL--NPQLSDCGLASNMPNAD-----EALNNDAGSGYGAPEVAMS--GQYNIKSD 457 (579)
Q Consensus 387 ~~LH~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~D 457 (579)
+|||+. +|+||||||+|||++.++ .+||+|||++....... ......+++.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999976 999999999999998776 89999999997543211 1234557889999999975 67899999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCC--CChhhHHHHHHHHHhcCCCCCCCC
Q 008055 458 VYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL--YPVKSLSRFADVIALCVQPEPEFR 535 (579)
Q Consensus 458 vwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~R 535 (579)
||||||++|||++|+.||........ +..+........ .....+..+.+++.+||+.||++|
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT----------------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH----------------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999976543211 111111111111 112345689999999999999999
Q ss_pred CChHHHHH
Q 008055 536 PPMSEVVQ 543 (579)
Q Consensus 536 ps~~evl~ 543 (579)
||+.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.35 Aligned_cols=255 Identities=18% Similarity=0.241 Sum_probs=206.4
Q ss_pred HhCCccccceeccCCceEEEEEE------eCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC---CCCccceeeEEe
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQ------FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH---HPNIMELVGYCS 339 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 339 (579)
..++|.+.+.||+|+||.||+|. ..+++.||+|++.... ...+..|+..+.+++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 45679999999999999999993 4568999999997543 456667777776665 999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-------
Q 008055 340 EYGQHLLVYEFRKNGSLHDFLHLSDE-DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN------- 411 (579)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~------- 411 (579)
..+..++||||+++|+|.++++.... ....+++..++.|+.|++.||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999975333 345799999999999999999999965 9999999999999998
Q ss_pred ----CCceEEecccccccCC---CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh
Q 008055 412 ----ELNPQLSDCGLASNMP---NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ 484 (579)
Q Consensus 412 ----~~~~kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~ 484 (579)
++.+||+|||+++... .........+|..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 8999999999996442 2333445668899999999999999999999999999999999999995422110
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCC-CChHHHHHHHHHHHHHcc
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR-PPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~L~~i~~~~~ 553 (579)
|. ....+... .....+.+++..|++.+|.+| |+++++.+.|++++.+..
T Consensus 293 ----~~-------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 ----CK-------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ----EE-------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----ee-------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00 00111110 124578899999999999998 788999999999887643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=347.24 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=202.1
Q ss_pred hCCccccceeccCCceEEEEEEeCC-C-------cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD-G-------KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 341 (579)
.++|.+.+.||+|+||.||+|.... + ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4578899999999999999997653 3 479999986533 34567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc-------
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN------- 414 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~------- 414 (579)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999973 234489999999999999999999976 9999999999999998887
Q ss_pred -eEEecccccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCC-CCCCCCCchhhhhhhhhcc
Q 008055 415 -PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGR-KPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 415 -~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~-~p~~~~~~~~~~~~~~~~~ 491 (579)
+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. +||.............
T Consensus 159 ~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--- 232 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--- 232 (289)
T ss_dssp EEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---
T ss_pred eeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---
Confidence 999999998655332 22345778999999987 67899999999999999999955 5554332211110000
Q ss_pred ccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
. ....+...+..+.+++.+||+.||++|||+.++++.|++++....
T Consensus 233 -------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 233 -------------D---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -------------T---TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -------------c---cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0 111122234568899999999999999999999999988775433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.25 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=204.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... ++..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 46999999999999999999775 577899999865432 235788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEecccccccC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASNM 426 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~ 426 (579)
|+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998863 34589999999999999999999976 99999999999999 78899999999999877
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..........++..|+|||++.+ .++.++||||||+++|||++|+.||.......... .+...
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----------------~~~~~ 222 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML----------------KIREG 222 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHC
T ss_pred cCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH----------------HHHhC
Confidence 66555566678889999998865 48999999999999999999999997644321110 00000
Q ss_pred cccCCCCh----hhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPV----KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ...+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 223 ~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 T--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp C--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01111 23568899999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=355.87 Aligned_cols=267 Identities=22% Similarity=0.367 Sum_probs=194.4
Q ss_pred HhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCC--eE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYG--QH 344 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 344 (579)
..++|++.+.||+|+||.||+|.. .+++.||||++............+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999976 47899999999766555666778889999999997 999999999997543 78
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++|||||+ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 689998862 4688999999999999999999976 99999999999999999999999999997
Q ss_pred cCCCC----------------------CcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCch
Q 008055 425 NMPNA----------------------DEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR 481 (579)
Q Consensus 425 ~~~~~----------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~ 481 (579)
..... .......+|++|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 11223457789999999976 67899999999999999999999999765432
Q ss_pred hh-hhhhhh-ccccccC--------hh----HHhhhc---CccccCCC------------ChhhHHHHHHHHHhcCCCCC
Q 008055 482 LE-QSLVRW-ATPQLHD--------ID----ALAKMV---DPALKGLY------------PVKSLSRFADVIALCVQPEP 532 (579)
Q Consensus 482 ~~-~~~~~~-~~~~~~~--------~~----~~~~~~---~~~~~~~~------------~~~~~~~l~~li~~cl~~dP 532 (579)
.. ..+... ..|.... .. .+.... .......+ +..++.++.+|+.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 11 111110 0110000 00 000000 00000000 11345689999999999999
Q ss_pred CCCCChHHHHHH
Q 008055 533 EFRPPMSEVVQA 544 (579)
Q Consensus 533 ~~Rps~~evl~~ 544 (579)
++|||+.|+++-
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=365.26 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=196.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... +|+.||||++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999764 68999999996432 1233456678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE-VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999863 3468999999999999999999996 5 9999999999999999999999999999764
Q ss_pred CCC-CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 427 PNA-DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+..
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----------------~~i~~ 363 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------------ELILM 363 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----------------HHHHh
Confidence 332 2334466788999999999999999999999999999999999999764322110 01110
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
. ...++...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 364 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 1123445567899999999999999999 9999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.06 Aligned_cols=264 Identities=18% Similarity=0.226 Sum_probs=198.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------G 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 342 (579)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999764 689999999976654556678889999999999999999999999654 4
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999975 5666663 2388999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-cccc---C-
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-PQLH---D- 496 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~---~- 496 (579)
++............+|+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ..+..... |... .
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 9877655445556788999999999999999999999999999999999999976543211 11111100 0000 0
Q ss_pred hhHHhhhcCc---------------cccCCC---ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 IDALAKMVDP---------------ALKGLY---PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ~~~~~~~~~~---------------~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.......+.. .+.... ......++.+|+.+||..||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001111110 000000 0112567999999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.56 Aligned_cols=271 Identities=24% Similarity=0.338 Sum_probs=206.6
Q ss_pred cCHHHHHHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-----CCCccce
Q 008055 261 YSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-----HPNIMEL 334 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l 334 (579)
+++.+.....++|++.+.||+|+||.||+|.. .+++.||||++... ......+..|+.+++.+. ||||+++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 33344445678999999999999999999987 47899999999642 344566778888888886 9999999
Q ss_pred eeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---
Q 008055 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN--- 411 (579)
Q Consensus 335 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~--- 411 (579)
++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 99999999999999999 99999999742 234589999999999999999999976 9999999999999975
Q ss_pred ----------------------CCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHH
Q 008055 412 ----------------------ELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELL 469 (579)
Q Consensus 412 ----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell 469 (579)
++.+||+|||++..... ......++..|+|||++.+..++.++|||||||++|||+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 78999999999976543 223456788999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccChhHHhhhc---------CccccCCC--------------------ChhhHHHH
Q 008055 470 TGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV---------DPALKGLY--------------------PVKSLSRF 520 (579)
Q Consensus 470 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~--------------------~~~~~~~l 520 (579)
+|+.||...................... ...... ........ +......+
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKN-MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHH-HHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHH-HHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999997654322111111111011100 000000 00000000 01112578
Q ss_pred HHHHHhcCCCCCCCCCChHHHHH
Q 008055 521 ADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 521 ~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+|+.+||+.||++|||+.|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 89999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=343.59 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=202.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999875 688999999975432 233457788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999963 24689999999999999999999976 99999999999999999999999999987654
Q ss_pred CCCc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 428 NADE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 428 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... .....++..|+|||++.+..++.++||||||+++|||++|+.||........... +....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------------~~~~~- 251 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-------------INQAI- 251 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-------------HHSCC-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-------------hccCC-
Confidence 3321 2234567899999999999999999999999999999999999976432211100 00000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCC-ChHHHHHHHHHHHHHcc
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRP-PMSEVVQALVRLVQRAN 553 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~~~~ 553 (579)
......+...+..+.+++.+||+.||++|| ++.++++.|++++....
T Consensus 252 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 252 -PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 000112334556899999999999999999 99999999988775544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=338.54 Aligned_cols=249 Identities=30% Similarity=0.466 Sum_probs=184.8
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4689999999999999999976 5789999999864321 1123467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999862 345689999999999999999999976 999999999999999999999999999976643
Q ss_pred CC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 AD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~ 228 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----------------TLNKVVLAD 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSC
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----------------HHHHHhhcc
Confidence 22 2233456789999999998889999999999999999999999997543210 000111001
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+...+.++.+++.+||+.||++|||+.++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1123445578999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=333.15 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=203.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46899999999999999999875 789999999865432 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999985 345689999999999999999999976 9999999999999999999999999998765322
Q ss_pred C---cccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 D---EALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ......++..|+|||++.+..+ +.++||||||+++|||++|+.||....... .....|..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-------------- 223 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE-------------- 223 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHT--------------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhh--------------
Confidence 2 1223456789999999987775 789999999999999999999997643211 11111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00000112334568899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.32 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=191.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC------chhHHHHHHHHHHHhhcCCCCccceeeEEeeC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP------SEMCDDFIEMVSNISQLHHPNIMELVGYCSEY 341 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 341 (579)
..++|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4678999999999999999999764 6899999998654221 122235789999999999999999999975 4
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEEe
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---NPQLS 418 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~ 418 (579)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 56899999999999999885 345689999999999999999999976 999999999999997544 59999
Q ss_pred cccccccCCCCCcccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccccc
Q 008055 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 495 (579)
|||+++............+++.|+|||++.. ..++.++|||||||++|+|++|+.||........ +..
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~------- 355 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD------- 355 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH-------
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH-------
Confidence 9999987765544455678899999999863 6688999999999999999999999975432100 000
Q ss_pred ChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.... ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 356 ---~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 ---QITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---HHHTTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHhcCC-CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 00000001123568899999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.39 Aligned_cols=248 Identities=20% Similarity=0.335 Sum_probs=200.8
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee----CCeEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE----YGQHLL 346 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 346 (579)
.|.+.+.||+|+||.||+|... ++..||+|++..........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4778889999999999999764 67899999998766666677889999999999999999999998865 456899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCEEEc-CCCceEEeccccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS--VVHKNIKSANILLD-NELNPQLSDCGLA 423 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~Nill~-~~~~~kl~Dfg~~ 423 (579)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999963 24588999999999999999999976 6 99999999999998 7899999999999
Q ss_pred ccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
...... ......++..|+|||++. +.++.++|||||||++|+|++|+.||......... ....
T Consensus 180 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---------------~~~~ 242 (290)
T 1t4h_A 180 TLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRV 242 (290)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---------------HHHH
T ss_pred cccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH---------------HHHH
Confidence 755432 233456788999999876 56999999999999999999999999754321110 0001
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
........++...+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1100111122233467999999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=346.35 Aligned_cols=266 Identities=20% Similarity=0.286 Sum_probs=194.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||||++............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 457999999999999999999754 7899999999876655555677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-----CCCceEEeccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-----NELNPQLSDCGLA 423 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-----~~~~~kl~Dfg~~ 423 (579)
||++ |+|.+++.. ...+++..++.|+.|++.||+|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 599999863 34589999999999999999999976 999999999999994 4556999999999
Q ss_pred ccCCCCC-cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhh-hccccccCh--
Q 008055 424 SNMPNAD-EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVR-WATPQLHDI-- 497 (579)
Q Consensus 424 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~-~~~~~~~~~-- 497 (579)
....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..+.. ...+.....
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 7654322 22334568899999999874 489999999999999999999999976543211 11111 011100000
Q ss_pred -hHHhhhc-------CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 498 -DALAKMV-------DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 498 -~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+. ...+....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000011224568899999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.20 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=199.0
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|..+ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 346999999999999999999775 6899999999765422 24577777777 799999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC----CceEEeccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE----LNPQLSDCGLA 423 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~ 423 (579)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999862 35689999999999999999999976 99999999999998543 35999999999
Q ss_pred ccCCCCC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 424 SNMPNAD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 424 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
....... ......+++.|+|||++.+..++.++|||||||++|||++|..||..........+.. .+..
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----------~i~~ 237 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----------RIGS 237 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----------HHHH
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----------HHcc
Confidence 8654432 2334567889999999988889999999999999999999999997532211111110 0000
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+...+....+..+.+|+.+||+.||++|||+.++++.
T Consensus 238 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 238 -GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111112234456789999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=361.93 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=203.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... ++..||+|++............+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 36999999999999999999875 68899999998766555556788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CceEEecccccccC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSDCGLASNM 426 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~ 426 (579)
|+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||++...
T Consensus 117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999998853 34688999999999999999999976 99999999999999764 55999999999877
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChhHHhhhcC
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 505 (579)
..........+++.|+|||++. ..++.++|||||||++|+|++|..||......... .+.....
T Consensus 190 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------- 254 (494)
T 3lij_A 190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY-------------- 254 (494)
T ss_dssp BTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------------
T ss_pred CCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 6655555667899999999886 57999999999999999999999999765432111 0000000
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH--HHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ--ALVRLV 549 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~i~ 549 (579)
..........+..+.+++.+||+.||++|||+.++++ .+.+..
T Consensus 255 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 255 -TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp -CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred -CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 0000001234567899999999999999999999985 344443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=344.46 Aligned_cols=266 Identities=19% Similarity=0.297 Sum_probs=201.2
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--------C
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--------Y 341 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 341 (579)
++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4799999999999999999987 578999999997766555556788899999999999999999999876 4
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
+..++||||+++ +|.+.+. .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 568999999975 7777775 2335689999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCC-----cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhcccc-
Q 008055 422 LASNMPNAD-----EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQ- 493 (579)
Q Consensus 422 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~- 493 (579)
++....... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 997654221 2233456788999999876 45899999999999999999999999875543211 111111100
Q ss_pred ---ccChhHH--hhhcCccccCCCC--h-----hhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 ---LHDIDAL--AKMVDPALKGLYP--V-----KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ---~~~~~~~--~~~~~~~~~~~~~--~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....... ............. . ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000 0000000000000 0 01356889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=344.42 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=203.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 47899999999999999999875 58999999997766555666778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999988764 244689999999999999999999976 9999999999999999999999999999765433
Q ss_pred C-cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhH-------
Q 008055 430 D-EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDA------- 499 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~------- 499 (579)
. ......++..|+|||++.+. .++.++|||||||++|+|++|+.||........ ..+.............
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2 22345678899999999865 689999999999999999999999976543211 1111111100000000
Q ss_pred HhhhcCccccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+...... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000001111111 1234578999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=351.71 Aligned_cols=261 Identities=20% Similarity=0.194 Sum_probs=196.1
Q ss_pred hCCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCCCch---------hHHHHHHHHHHHhhcCCCCccceee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPSE---------MCDDFIEMVSNISQLHHPNIMELVG 336 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~ 336 (579)
.++|.+.+.||+|+||.||+|... ++..+|+|++........ ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999875 578899999876532110 1234667888899999999999999
Q ss_pred EEee----CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC
Q 008055 337 YCSE----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE 412 (579)
Q Consensus 337 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~ 412 (579)
++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 67899999999 99999998632 2789999999999999999999976 99999999999999988
Q ss_pred C--ceEEecccccccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh
Q 008055 413 L--NPQLSDCGLASNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482 (579)
Q Consensus 413 ~--~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~ 482 (579)
+ .+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999976543221 133467889999999999999999999999999999999999995421111
Q ss_pred --hhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 483 --EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 483 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.........+.... .+.... .....+.++.+++.+||+.||++|||+.+|++.|++
T Consensus 268 ~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQ--SVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHHHHHTTTH--HHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHHHHHhhcccccH--HHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11110000000000 000000 011345689999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=340.58 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=199.7
Q ss_pred hCCccccceeccCCceEEEEEEeC--CCc--EEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--DGK--VLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
.++|++.+.||+|+||.||+|.+. +++ .||+|+++.... .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 347899999999999999999753 333 689999876543 2355678999999999999999999999998754 8
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999998632 34588999999999999999999976 99999999999999999999999999998
Q ss_pred cCCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 425 NMPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 425 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
........ ....++..|+|||++.+..++.++||||||+++|+|++ |+.||....... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~ 233 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------------I 233 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------H
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH----------------H
Confidence 76543322 12334557999999998889999999999999999999 999997643221 1
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+..+.........+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1111111122223445667899999999999999999999999999887643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=337.88 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=202.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... ++..||+|++...... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457999999999999999999765 5779999998543211 12346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999863 24588999999999999999999965 99999999999999999999999999986543
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||......... ..+..
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~----- 221 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------------KRISR----- 221 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------HHHHH-----
T ss_pred cc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-------------HHHHh-----
Confidence 32 233456788999999999999999999999999999999999999764322110 01110
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1122344456789999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.23 Aligned_cols=273 Identities=21% Similarity=0.319 Sum_probs=205.3
Q ss_pred HHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC----
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY---- 341 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 341 (579)
+...++|++.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 45567899999999999999999976 57899999998654321 23689999999999999999998443
Q ss_pred ----------------------------------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 008055 342 ----------------------------------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387 (579)
Q Consensus 342 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~ 387 (579)
...++||||++ |+|.+.+.........+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34889999997 5888887654455678999999999999999999
Q ss_pred HHHhcCCCCeEEcCCCCCCEEEc-CCCceEEecccccccCCCCCcccccCCCCCccCccccccC-CCCccchHHhHHHHH
Q 008055 388 YLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVM 465 (579)
Q Consensus 388 ~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l 465 (579)
|||+. +|+||||||+|||++ .++.+||+|||+++............++..|+|||++.+. .++.++|||||||++
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99965 999999999999998 6889999999999877666666667778899999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCchh-hhhhhhh-ccccccChhHHhh---------hcCccccCCCChhhHHHHHHHHHhcCCCCCCC
Q 008055 466 LELLTGRKPFDSSRPRL-EQSLVRW-ATPQLHDIDALAK---------MVDPALKGLYPVKSLSRFADVIALCVQPEPEF 534 (579)
Q Consensus 466 ~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 534 (579)
|||++|+.||....... ...+... ..|.......... .........++...+..+.+|+.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998654321 1111111 1111000000000 00000111133445678999999999999999
Q ss_pred CCChHHHHH--HHHHHH
Q 008055 535 RPPMSEVVQ--ALVRLV 549 (579)
Q Consensus 535 Rps~~evl~--~L~~i~ 549 (579)
|||+.|+++ .+.++.
T Consensus 313 R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SCCHHHHHTSGGGHHHH
T ss_pred CCCHHHHhcCHHHHHHH
Confidence 999999983 344443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=337.15 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=207.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46889999999999999999764 689999999976543 3446789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999985 34689999999999999999999976 9999999999999999999999999999765443
Q ss_pred Cc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 DE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
.. .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .+.. ..
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~----~~ 235 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-------------LIPK----NN 235 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHH----SC
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-------------Hhhc----CC
Confidence 32 233456788999999999999999999999999999999999997643221110 0111 11
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 545 (579)
....+...+..+.+++.+||+.||++|||+.++++..
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1122334556899999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.00 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=179.3
Q ss_pred cceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEEecCC
Q 008055 276 ENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
.+.||+|+||.||+|... +++.||||++.. .....+.+|+..+..+. ||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 378999999999999875 689999999954 23567788999999996 99999999999999999999999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---ceEEecccccccCCCCC
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---NPQLSDCGLASNMPNAD 430 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~ 430 (579)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999963 35689999999999999999999976 999999999999998765 89999999998654433
Q ss_pred c-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcccc
Q 008055 431 E-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509 (579)
Q Consensus 431 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||......... ......+..+......
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---------TSAVEIMKKIKKGDFS 234 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---------CCHHHHHHHHTTTCCC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---------ccHHHHHHHHHcCCCC
Confidence 2 23445688999999999999999999999999999999999999754321100 0000111111111111
Q ss_pred CC--CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 510 GL--YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 510 ~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .....+.++.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00 01234578999999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.32 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=204.4
Q ss_pred HHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 264 ADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
.+..+..++|++.+.||+|+||.||+|...+ .+|+|++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3344456789999999999999999998754 49999997665444455667889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999963 345689999999999999999999976 999999999999998 679999999997
Q ss_pred ccCCCC------CcccccCCCCCccCcccccc---------CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 008055 424 SNMPNA------DEALNNDAGSGYGAPEVAMS---------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 424 ~~~~~~------~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 488 (579)
...... .......++..|+|||++.. ..++.++|||||||++|||++|+.||..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--- 253 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW--- 253 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH---
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 654321 11223346778999999874 357889999999999999999999997644321100
Q ss_pred hccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.+.....+. ..+...+..+.+++.+||+.||++|||+.++++.|+++.++..
T Consensus 254 ----------~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 254 ----------QMGTGMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp ----------HHHTTCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred ----------HhccCCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000101111 1112344578999999999999999999999999998886544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.53 Aligned_cols=193 Identities=21% Similarity=0.400 Sum_probs=155.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-----CCeE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-----YGQH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~ 344 (579)
++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999765 78999999997765555667889999999999999999999999843 3578
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
|+||||+ +|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 579999886 345689999999999999999999976 99999999999999999999999999998
Q ss_pred cCCCCC----------------------------cccccCCCCCccCcccc-ccCCCCccchHHhHHHHHHHHHhC
Q 008055 425 NMPNAD----------------------------EALNNDAGSGYGAPEVA-MSGQYNIKSDVYSFGVVMLELLTG 471 (579)
Q Consensus 425 ~~~~~~----------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~elltg 471 (579)
...... ......+|++|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 654221 12234568899999986 456799999999999999999993
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.42 Aligned_cols=266 Identities=21% Similarity=0.347 Sum_probs=206.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 357999999999999999999775 68999999997653 3455678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999963 23588999999999999999999963 2899999999999999999999999999865422
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhc------------------
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA------------------ 490 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~------------------ 490 (579)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1223346788999999999999999999999999999999999999765432211111000
Q ss_pred --------cccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 491 --------TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 491 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.......+................+..+.+|+.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000111111111111112334678999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=345.88 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=206.1
Q ss_pred HHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC--c----hhHHHHHHHHHHHhhc-CCCCccceeeEE
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP--S----EMCDDFIEMVSNISQL-HHPNIMELVGYC 338 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 338 (579)
....++|++.+.||+|+||.||+|... +|+.||||++...... . ...+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567999999999999999999875 7999999998654321 1 2245678899999998 899999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 339 SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
...+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999863 34689999999999999999999976 99999999999999999999999
Q ss_pred cccccccCCCCCcccccCCCCCccCcccccc------CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccc
Q 008055 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMS------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 492 (579)
|||++.............+++.|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~------- 315 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR------- 315 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH-------
Confidence 9999987766555556678889999999863 358899999999999999999999997643211100
Q ss_pred cccChhHHhhhcCccccCCC--ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 493 QLHDIDALAKMVDPALKGLY--PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+......... ....+..+.+++.+||+.||++|||+.++++
T Consensus 316 ---------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 ---------MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---------HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---------HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000000 0123457899999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=349.60 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=206.5
Q ss_pred CCccccceeccCCceEEEEEEeCC---------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccc--------
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD---------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME-------- 333 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------- 333 (579)
++|++.+.||+|+||.||+|.... ++.||+|++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 579999999999999999998763 789999998653 35778999999999999998
Q ss_pred -------eeeEEee-CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 008055 334 -------LVGYCSE-YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 334 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~ 405 (579)
+++++.. .+..++||||+ +|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5677765 78899999999 99999999732 135689999999999999999999976 9999999999
Q ss_pred CEEEcCCC--ceEEecccccccCCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCC
Q 008055 406 NILLDNEL--NPQLSDCGLASNMPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475 (579)
Q Consensus 406 Nill~~~~--~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~ 475 (579)
|||++.++ .+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 899999999976543221 12236778999999999989999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccChhHHhhhcCccccC--CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 476 DSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG--LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
......... +.... ....... ..+.. ......+..+.+++.+||+.||++|||+.++++.|++++++..
T Consensus 269 ~~~~~~~~~-~~~~~-------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTED-IMKQK-------QKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHH-HHHHH-------HHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHH-HHHHH-------HhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 754311111 10000 0000000 00000 0012335789999999999999999999999999999998876
Q ss_pred cc
Q 008055 554 MS 555 (579)
Q Consensus 554 ~~ 555 (579)
..
T Consensus 340 ~~ 341 (352)
T 2jii_A 340 VS 341 (352)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=340.81 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=196.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC------chhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP------SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
.++|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457999999999999999999765 6889999999764321 122345789999999999999999999987654
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---eEEec
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN---PQLSD 419 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~D 419 (579)
.++||||+++|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999885 345689999999999999999999976 9999999999999987654 99999
Q ss_pred ccccccCCCCCcccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC
Q 008055 420 CGLASNMPNADEALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 420 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
||++.............++..|+|||++. ...++.++|||||||++|+|++|..||........ +..
T Consensus 161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-------- 230 (322)
T 2ycf_A 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD-------- 230 (322)
T ss_dssp CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH--------
T ss_pred CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH--------
Confidence 99998765543333456788999999974 46789999999999999999999999975432110 000
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.... ...........+..+.+++.+||+.||++|||+.++++
T Consensus 231 --~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 --QITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHHHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHhCc-cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 00000001223568899999999999999999999983
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.73 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=203.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||||++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46999999999999999999875 78999999986543333346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCceEEecccccccC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD---NELNPQLSDCGLASNM 426 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~ 426 (579)
|+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 102 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999998863 34689999999999999999999976 999999999999995 4567999999999877
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..........+++.|+|||++.+ .++.++|||||||++|+|++|+.||......... ..+...
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~~i~~~ 237 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----------------KRVETG 237 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHT
T ss_pred CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhC
Confidence 65555556678889999999865 5999999999999999999999999764432110 000000
Q ss_pred cccC--CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKG--LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0112345688999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=344.83 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=192.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEe--------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCS-------- 339 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------- 339 (579)
..+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+..+.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 347899999999999999999864 78999999985442 445677889999999995 999999999983
Q ss_pred eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCEEEcCCCceEE
Q 008055 340 EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLS--VVHKNIKSANILLDNELNPQL 417 (579)
Q Consensus 340 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~Nill~~~~~~kl 417 (579)
.....++||||+. |+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3445799999995 79999886422 244689999999999999999999976 7 999999999999999999999
Q ss_pred ecccccccCCCCCcc-------------cccCCCCCccCcccc---ccCCCCccchHHhHHHHHHHHHhCCCCCCCCCch
Q 008055 418 SDCGLASNMPNADEA-------------LNNDAGSGYGAPEVA---MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR 481 (579)
Q Consensus 418 ~Dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~---~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~ 481 (579)
+|||++......... ....++..|+|||++ ....++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999766443221 133467789999998 5667899999999999999999999999643211
Q ss_pred hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcccc
Q 008055 482 LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555 (579)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 555 (579)
...........+...+..+.+++.+||+.||++|||+.|+++.|+++.......
T Consensus 260 --------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 260 --------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred --------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 000111111112223346889999999999999999999999999998766543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.28 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=207.4
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46999999999999999999875 7899999999765433 345678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~ 425 (579)
||+.+|+|.+++. ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++..
T Consensus 106 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999886 245689999999999999999999976 99999999999999 5678999999999987
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...........+++.|+|||++.+ .++.++|||||||++|+|++|+.||......... ..+..
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~~i~~ 241 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL----------------KKVEK 241 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH----------------HHHHc
Confidence 766555556678899999999865 6999999999999999999999999765432111 01100
Q ss_pred ccccC--CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKG--LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..... ......+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00000 011234578999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=360.88 Aligned_cols=250 Identities=26% Similarity=0.317 Sum_probs=202.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc-----------hhHHHHHHHHHHHhhcCCCCccceeeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS-----------EMCDDFIEMVSNISQLHHPNIMELVGY 337 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~~ 337 (579)
.++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 457999999999999999999875 57899999997654321 345778899999999999999999999
Q ss_pred EeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---c
Q 008055 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL---N 414 (579)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~---~ 414 (579)
+.+.+..++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999998863 34589999999999999999999976 999999999999998776 6
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
+||+|||++.............+++.|+|||++. ..++.++|||||||++|+|++|..||..........
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------- 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK--------- 257 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------
Confidence 9999999998776655556677899999999986 569999999999999999999999997654321110
Q ss_pred cChhHHhhhcCccccCC--CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPALKGL--YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+........ .....+.++.+++.+||+.||.+|||+.|+++
T Consensus 258 -------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 -------KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -------HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 00123467999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=340.22 Aligned_cols=258 Identities=17% Similarity=0.289 Sum_probs=202.1
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEee--CCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSE--YGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 346 (579)
++|++.+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 5799999999999999999976 578999999996432 567889999999997 9999999999987 677899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASN 425 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 425 (579)
||||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 999999999999874 278899999999999999999976 999999999999999776 899999999987
Q ss_pred CCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh--hhhhccc-c--------
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS--LVRWATP-Q-------- 493 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~--~~~~~~~-~-------- 493 (579)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.....+ .
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 766555556677889999999977 678999999999999999999999996543321110 0000000 0
Q ss_pred -ccChhHHhhhcCc--------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 -LHDIDALAKMVDP--------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 -~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
............. ......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000000 0011122335678999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=345.67 Aligned_cols=263 Identities=19% Similarity=0.302 Sum_probs=199.3
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------G 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 342 (579)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35799999999999999999977 4789999999976655556677889999999999999999999999765 3
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999863 4588999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc-ccc------
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA-TPQ------ 493 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~-~~~------ 493 (579)
++.... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.... .+.
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987543 2334567889999999887 6799999999999999999999999976543211 1111110 000
Q ss_pred ccCh--hHHhhhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDI--DALAKMVDPALK---GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+... ......+..... .......+..+.+|+.+||..||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 000000000000 0112344678999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=335.67 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=207.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 47889999999999999999876 578999999865432 3445677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998863 34689999999999999999999976 999999999999999999999999999976643
Q ss_pred CC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 AD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~- 230 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----------------YLRIKKN- 230 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHTT-
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhhc-
Confidence 22 23334577899999999988899999999999999999999999976432211 0111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 231 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112234455789999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=344.63 Aligned_cols=265 Identities=18% Similarity=0.241 Sum_probs=195.9
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG------ 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 342 (579)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357999999999999999999764 6899999999876555566778899999999999999999999997654
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||++ |+|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 57888774 2478999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-c------cc
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-P------QL 494 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~------~~ 494 (579)
++............++..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..... + .+
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 9876544334455678899999999999999999999999999999999999976543211 11110000 0 00
Q ss_pred cC-h------------hHHhhhcCccccCC---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 495 HD-I------------DALAKMVDPALKGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 495 ~~-~------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.. . .............. .+...+..+.+|+.+||..||++|||+.|+++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 0 00000000000000 012236789999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.85 Aligned_cols=275 Identities=21% Similarity=0.323 Sum_probs=203.3
Q ss_pred CHHHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC---------chhHHHHHHHHHHHhhcCCCCcc
Q 008055 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP---------SEMCDDFIEMVSNISQLHHPNIM 332 (579)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv 332 (579)
.+.++....++|.+.+.||+|+||.||+|...+|+.||||++...... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456788889999999999999999999999888999999998653322 12247889999999999999999
Q ss_pred ceeeEEee-----CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCE
Q 008055 333 ELVGYCSE-----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANI 407 (579)
Q Consensus 333 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Ni 407 (579)
++++++.. ....++||||++ |+|.+++. .....+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999843 346899999997 68888886 3345789999999999999999999976 999999999999
Q ss_pred EEcCCCceEEecccccccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhh
Q 008055 408 LLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQS 485 (579)
Q Consensus 408 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~ 485 (579)
|++.++.+||+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp EECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999976555444445567889999999876 678999999999999999999999997654321 111
Q ss_pred hhhhcc-ccccC-----hhHHhhhcCccccC-------CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 486 LVRWAT-PQLHD-----IDALAKMVDPALKG-------LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 486 ~~~~~~-~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+..... +.... .............. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111 00000 00011111111100 011233567999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=342.52 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=207.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
..+|.+.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 347889999999999999999875 578999999865432 344567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998863 34689999999999999999999976 99999999999999999999999999998664
Q ss_pred CCC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NAD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||.......... .+.. .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------------~~~~---~ 256 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------------RIKK---N 256 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------HHHH---T
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------------HHhc---C
Confidence 322 2334557889999999999999999999999999999999999997643221100 0000 0
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 257 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 257 --EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011233455688999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=332.77 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=198.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .......+.+|+..++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999876 789999999864321 123356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999863 24588999999999999999999987 99999999999999999999999999998766
Q ss_pred CCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.........++..|+|||.+.+..+ +.++||||||+++|+|++|+.||......... ..+..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~~---- 225 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF-------------KKIRG---- 225 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHHH----
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-------------HHhhc----
Confidence 5444445567889999999987765 68999999999999999999999764321100 00000
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 226 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 -GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111234455789999999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=342.88 Aligned_cols=269 Identities=23% Similarity=0.336 Sum_probs=198.2
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC---chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP---SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 344 (579)
..++|++.+.||+|+||.||+|... +|+.||||++...... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4568999999999999999999875 6899999999754322 12235678999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++ +|.+++. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999975 8888886 2345688899999999999999999976 99999999999999999999999999998
Q ss_pred cCCCCC-cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhh-hcccccc---Ch
Q 008055 425 NMPNAD-EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVR-WATPQLH---DI 497 (579)
Q Consensus 425 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~-~~~~~~~---~~ 497 (579)
...... ......++..|+|||++.+. .++.++|||||||++|||++|.+||........ ..+.. ...+... +.
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 764332 23345678899999999754 489999999999999999999999976543211 11111 1111100 00
Q ss_pred hHHhhhcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 498 DALAKMVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
....+..........+ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000000011 2345789999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.48 Aligned_cols=264 Identities=18% Similarity=0.267 Sum_probs=207.1
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC-CCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH-PNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ..+..|+++++.++| +++..+..++...+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 46799999999999999999986 57899999998654432 347788999999977 4555566666778899999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEecccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLAS 424 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 424 (579)
|||+ +++|.+++.. ....+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++
T Consensus 82 me~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999 9999999963 245689999999999999999999976 99999999999999 688999999999998
Q ss_pred cCCCCCcc--------cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccC
Q 008055 425 NMPNADEA--------LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496 (579)
Q Consensus 425 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 496 (579)
........ ....++..|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----- 229 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----- 229 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH-----
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh-----
Confidence 66543321 14567889999999999999999999999999999999999997654321111111000
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
...+.... .. ....++.++.+++.+||+.+|++||++.+|++.|++++.+...
T Consensus 230 ~~~~~~~~-~~----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 230 EKKVATSI-EA----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HHHHHSCH-HH----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hccccccH-HH----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 00000000 00 0123356899999999999999999999999999999886643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.27 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=196.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 47899999999999999999875 7899999999654321 112234578999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 997 589988863 345689999999999999999999976 9999999999999999999999999999765433
Q ss_pred Cc-ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-c------cccChhH
Q 008055 430 DE-ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-P------QLHDIDA 499 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~------~~~~~~~ 499 (579)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+..... + .......
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 22 223456889999999876 5689999999999999999999999977543221 11111111 0 0000011
Q ss_pred HhhhcCccccCC----CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPALKGL----YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+..... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111111110000 01234567899999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=338.25 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=204.5
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC--CCCccceeeEEeeCCeEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH--HPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l 346 (579)
..++|++.+.||+|+||.||++...+++.||+|++..........+.+.+|+.++.+++ ||||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34579999999999999999999888999999999876666667788999999999997 5999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||++...
T Consensus 106 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999 568899999963 34688999999999999999999976 9999999999999975 89999999999765
Q ss_pred CCCCc---ccccCCCCCccCcccccc-----------CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccc
Q 008055 427 PNADE---ALNNDAGSGYGAPEVAMS-----------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATP 492 (579)
Q Consensus 427 ~~~~~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 492 (579)
..... .....++..|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----------- 245 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------- 245 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----------
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----------
Confidence 43322 123456889999999875 46888999999999999999999999654321
Q ss_pred cccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...+....++.....++...+..+.+++.+||+.||++|||+.++++.
T Consensus 246 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 112233333433344455556789999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=355.75 Aligned_cols=250 Identities=14% Similarity=0.169 Sum_probs=193.3
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHH---HHHhhcCCCCcccee-------eEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMV---SNISQLHHPNIMELV-------GYC 338 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~ 338 (579)
++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+ +.++.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4688899999999999999986 5699999999975432 334567888999 556666899999998 665
Q ss_pred eeCC-----------------eEEEEEEecCCCChhhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008055 339 SEYG-----------------QHLLVYEFRKNGSLHDFLHLSDE---DNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398 (579)
Q Consensus 339 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 398 (579)
.+.+ ..++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||++ +|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 5543 278999999 6899999964321 122455688889999999999999976 999
Q ss_pred EcCCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCCccCccccccC-----------CCCccchHHhHHHHHHH
Q 008055 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG-----------QYNIKSDVYSFGVVMLE 467 (579)
Q Consensus 399 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslGv~l~e 467 (579)
||||||+|||++.++.+||+|||+++.... ......+ ..|+|||++.+. .++.++|||||||++||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999999986433 2333455 899999999887 89999999999999999
Q ss_pred HHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH--HH
Q 008055 468 LLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ--AL 545 (579)
Q Consensus 468 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L 545 (579)
|++|+.||........ ...... .....+..+.+++.+||+.||++|||+.++++ .+
T Consensus 306 lltg~~Pf~~~~~~~~----------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 306 IWCADLPITKDAALGG----------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHSSCCC------CC----------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHCCCCCcccccccc----------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 9999999965332100 000000 01233468999999999999999999999985 44
Q ss_pred HHHH
Q 008055 546 VRLV 549 (579)
Q Consensus 546 ~~i~ 549 (579)
+++.
T Consensus 364 ~~~~ 367 (377)
T 3byv_A 364 EQLR 367 (377)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.94 Aligned_cols=199 Identities=22% Similarity=0.359 Sum_probs=169.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----Ce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 343 (579)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 458999999999999999999765 688999999987655556678899999999999999999999999765 57
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.|+||||++ |+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 69999986 345689999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc-----------------------ccccCCCCCccCcccc-ccCCCCccchHHhHHHHHHHHHhCCCCCC
Q 008055 424 SNMPNADE-----------------------ALNNDAGSGYGAPEVA-MSGQYNIKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 424 ~~~~~~~~-----------------------~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~elltg~~p~~ 476 (579)
+....... .....+|.+|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 86643321 2445678899999986 56679999999999999999998655553
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=344.81 Aligned_cols=269 Identities=19% Similarity=0.273 Sum_probs=204.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc---------------hhHHHHHHHHHHHhhcCCCCccce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS---------------EMCDDFIEMVSNISQLHHPNIMEL 334 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~niv~l 334 (579)
.++|++.+.||+|+||.||+|.. +++.||+|++....... .....+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45899999999999999999988 89999999986432111 112789999999999999999999
Q ss_pred eeEEeeCCeEEEEEEecCCCChhhhhcc----cCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEE
Q 008055 335 VGYCSEYGQHLLVYEFRKNGSLHDFLHL----SDEDNKPLIWNSRVKIALGTARALEYLHE-VCSLSVVHKNIKSANILL 409 (579)
Q Consensus 335 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~Nill 409 (579)
++++.+.+..++||||+++|+|.+++.. .......+++..++.++.|++.||+|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998321 12225679999999999999999999997 5 99999999999999
Q ss_pred cCCCceEEecccccccCCCCCcccccCCCCCccCccccccC-CCCc-cchHHhHHHHHHHHHhCCCCCCCCCch-h-hhh
Q 008055 410 DNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG-QYNI-KSDVYSFGVVMLELLTGRKPFDSSRPR-L-EQS 485 (579)
Q Consensus 410 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslGv~l~elltg~~p~~~~~~~-~-~~~ 485 (579)
+.++.+||+|||++...... ......++..|+|||++.+. .++. ++|||||||++|||++|+.||...... . ...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99999999999999865443 33445678899999999877 6666 999999999999999999999765431 1 111
Q ss_pred hhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 486 LVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.....+........................+..+.+++.+||+.||++|||+.|+++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110000000000000000000000111345678999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=350.91 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=197.5
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------CeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------GQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 344 (579)
+|++.+.||+|+||.||+|.+. +++.||||++..... .+.+|+++++.++||||++++++|... ...
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 5888999999999999999875 689999999865431 223689999999999999999988542 236
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-CceEEeccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLA 423 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~ 423 (579)
++||||+++ +|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999975 67766654334566799999999999999999999965 99999999999999965 56899999999
Q ss_pred ccCCCCCcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhh-ccccccChhHH
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRW-ATPQLHDIDAL 500 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~ 500 (579)
+............++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...+... ..|. ...+
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~---~~~~ 281 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT---REQI 281 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC---HHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC---HHHH
Confidence 877655555566788999999999764 78999999999999999999999997654321 1111111 1111 1111
Q ss_pred hhhcCccc--------c-----CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPAL--------K-----GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~--------~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+ .+.. . ..++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111 1110 0 0122344678999999999999999999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.99 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=195.4
Q ss_pred CCcccc-ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 271 GSFNVE-NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
+.|++. +.||+|+||.||+|... +++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 467774 78999999999999754 78999999997653 33467788999999884 799999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---eEEecccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN---PQLSDCGLAS 424 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~ 424 (579)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999963 24688999999999999999999976 9999999999999998776 9999999987
Q ss_pred cCCCCC--------cccccCCCCCccCcccccc-----CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcc
Q 008055 425 NMPNAD--------EALNNDAGSGYGAPEVAMS-----GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT 491 (579)
Q Consensus 425 ~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 491 (579)
...... ......++..|+|||++.. ..++.++|||||||++|||++|+.||........ .|..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~ 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC----GWDR 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS----CC--
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc----cccc
Confidence 553221 1123347789999999875 5588999999999999999999999976432110 0000
Q ss_pred ccccC--hhH-HhhhcCccccCCCCh----hhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 492 PQLHD--IDA-LAKMVDPALKGLYPV----KSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 492 ~~~~~--~~~-~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..... ... ...+.... ..++. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp --CCHHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccchhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000 000 01111000 11121 24568999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=330.90 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=198.6
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
+|.....||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 344556899999999999976 468899999997653 34457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEecccccccCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 429 (579)
+++++|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9999999999642 2234567888999999999999999976 9999999999999987 899999999999766443
Q ss_pred Cc-ccccCCCCCccCccccccCC--CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DE-ALNNDAGSGYGAPEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~-~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.. .....++..|+|||++.... ++.++||||||+++|+|++|+.||......... .......
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~~ 241 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---------------MFKVGMF 241 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---------------HHHHHHH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---------------HHhhccc
Confidence 22 23345678999999997653 789999999999999999999999643211100 0000000
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+...+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122334556678999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=370.64 Aligned_cols=250 Identities=19% Similarity=0.293 Sum_probs=206.2
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQH 344 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 344 (579)
...++|++.+.||+|+||.||+|... +++.||||++++... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45678999999999999999999765 688999999965321 123356678888888877 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
|+||||+++|+|.++++. ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999973 24689999999999999999999976 99999999999999999999999999998
Q ss_pred cCC-CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhh
Q 008055 425 NMP-NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503 (579)
Q Consensus 425 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (579)
... .........+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----------------~~~~i 554 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------LFQSI 554 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHH
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Confidence 643 2333445678999999999999999999999999999999999999997643211 11122
Q ss_pred cCccccCCCChhhHHHHHHHHHhcCCCCCCCCCCh-----HHHH
Q 008055 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPM-----SEVV 542 (579)
Q Consensus 504 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl 542 (579)
+.. ...++...+.++.+|+.+||+.||++||++ .||+
T Consensus 555 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 555 MEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp HSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred HhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 221 123455667889999999999999999998 5555
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.91 Aligned_cols=260 Identities=13% Similarity=0.110 Sum_probs=185.1
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhc--CCCCcccee-------eEEee
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQL--HHPNIMELV-------GYCSE 340 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~~ 340 (579)
.|.+.+.||+|+||.||+|.+. +++.||||++...... ....+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4888999999999999999865 7899999999876542 34455667775444444 699988755 44433
Q ss_pred C-----------------CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 008055 341 Y-----------------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSR------VKIALGTARALEYLHEVCSLSV 397 (579)
Q Consensus 341 ~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~i 397 (579)
. ...++||||++ |+|.+++... ...+.+..+ ..++.||+.||+|||++ +|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 2 34799999998 8999999743 223344555 77889999999999976 99
Q ss_pred EEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCC
Q 008055 398 VHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPF 475 (579)
Q Consensus 398 iH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~ 475 (579)
+||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999999866432 224456689999999987 67999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH--HHHHHH
Q 008055 476 DSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ--ALVRLV 549 (579)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~--~L~~i~ 549 (579)
.......... |..... ................+..+.+|+.+||+.||++|||+.++++ .++++.
T Consensus 294 ~~~~~~~~~~---~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 294 GLVTPGIKGS---WKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TBCCTTCTTC---CCBCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCcCcccccc---hhhhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 7653321111 000000 0000111111112345678999999999999999999999984 344443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=338.24 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=201.5
Q ss_pred HhCCccccceeccCCceEEEEEEe--CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc---CCCCccceeeEEe----
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQF--ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL---HHPNIMELVGYCS---- 339 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 339 (579)
..++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346899999999999999999987 4688999999865433222233445566555544 8999999999987
Q ss_pred -eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEe
Q 008055 340 -EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLS 418 (579)
Q Consensus 340 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 418 (579)
.....++||||++ |+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 6999998642 234589999999999999999999976 99999999999999999999999
Q ss_pred cccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhh-ccccccC
Q 008055 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRW-ATPQLHD 496 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~-~~~~~~~ 496 (579)
|||++.............++..|+|||++.+..++.++|||||||++|||++|+.||........ ..+... ..+....
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99999876544444456678899999999999999999999999999999999999986543211 111110 0000000
Q ss_pred h-------hHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 497 I-------DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 497 ~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ..............+....+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000000011122345678999999999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.63 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=205.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-------chhHHHHHHHHHHHhhcC-CCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-------SEMCDDFIEMVSNISQLH-HPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 340 (579)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999875 6899999999754321 123456788999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecc
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDC 420 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 420 (579)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999963 34689999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccc------cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAM------SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
|++.............++..|+|||++. ...++.++||||||+++|+|++|..||..........
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--------- 239 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--------- 239 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH---------
Confidence 9998776555555566788999999985 4568899999999999999999999997543221100
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+... ............+..+.+++.+||+.||++|||+.++++
T Consensus 240 ----~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 ----MIMSG-NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----HHHHT-CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----HHhcC-CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000 000011112345678999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.69 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=200.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3467999999999999999999775 58999999997543 246788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999862 245689999999999999999999976 99999999999999999999999999997654
Q ss_pred CCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .+.....
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~- 242 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-------------MIPTNPP- 242 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHHSCC-
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------HHhcCCC-
Confidence 3322 233456789999999999999999999999999999999999997543221110 0000000
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.....+...+..+.+++.+||+.||++|||+.++++
T Consensus 243 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 -PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011123345678999999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=332.43 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999775 5789999998543211 123467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999863 23588999999999999999999965 999999999999999999999999999876543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||........ ...+...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~~~-- 227 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----------------HRRIVNV-- 227 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHTT--
T ss_pred c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----------------HHHHhcc--
Confidence 2 23345678899999999999999999999999999999999999976432211 1111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...++...+..+.+++.+||+.||++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 112344456789999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.12 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=198.0
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe------E
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ------H 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~ 344 (579)
.+|++.+.||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||+++++++...+. .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 468999999999999999999887777999988654321 1268999999999999999999865433 7
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCceEEeccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLA 423 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~ 423 (579)
++||||++++ +...+.........+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999764 4443332223456789999999999999999999976 999999999999999 7899999999999
Q ss_pred ccCCCCCcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhh-ccccccChhHH
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRW-ATPQLHDIDAL 500 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~ 500 (579)
+............+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ...+... ..|.......+
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 877665555667788899999998765 58999999999999999999999997654321 1111111 11111000000
Q ss_pred h-hhcCccc--------cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 A-KMVDPAL--------KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~-~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ......+ ...++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 0000000 01122335578999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.24 Aligned_cols=273 Identities=23% Similarity=0.320 Sum_probs=195.9
Q ss_pred HHHHHHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 264 ADLQMATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 264 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
.+.....++|++.+.||+|+||.||+|... +++.||||++...... ...+.++++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 344566789999999999999999999875 6899999998654322 345677888888999999999999996644
Q ss_pred e-------EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCc
Q 008055 343 Q-------HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELN 414 (579)
Q Consensus 343 ~-------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~ 414 (579)
. .++||||+++ +|...+.........+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 3 7899999976 55555543334566788999999999999999999932 349999999999999997 899
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccc
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATP 492 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~ 492 (579)
+||+|||++.............++..|+|||++.+.. ++.++|||||||++|||++|+.||........ ..+.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 9999999998776655555667788999999987654 89999999999999999999999977543211 111111110
Q ss_pred cccChhHHhhhcC---------------ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 493 QLHDIDALAKMVD---------------PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 493 ~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ....+..+.. .......+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 P--SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp C--CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000000 00011122335678999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.77 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|.+.+.||+|+||.||++... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 347899999999999999999875 789999999975432 22456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE---cCCCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL---DNELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~ 425 (579)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999998863 24588999999999999999999976 99999999999999 7889999999999875
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.... ......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+... .
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------------~~i~~~-~ 223 (304)
T 2jam_A 159 EQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF-------------EKIKEG-Y 223 (304)
T ss_dssp CCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHC-C
T ss_pred cCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------------HHHHcC-C
Confidence 4332 223345788999999999999999999999999999999999999764321100 000000 0
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111222345678999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.14 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=196.7
Q ss_pred HHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee-----
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE----- 340 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----- 340 (579)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3567899999999999999999987 478999999996543 2346788999999998 89999999999976
Q ss_pred -CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 008055 341 -YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419 (579)
Q Consensus 341 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 419 (579)
.+..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 56889999999999999999743 234688999999999999999999976 999999999999999999999999
Q ss_pred ccccccCCCCC-cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccc
Q 008055 420 CGLASNMPNAD-EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 420 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 493 (579)
||++....... ......++..|+|||++. ...++.++|||||||++|+|++|..||..........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------- 244 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------- 244 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--------
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--------
Confidence 99987654322 223345678999999987 5668999999999999999999999996543221100
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+... ......+...+..+.+++.+||..||++|||+.++++
T Consensus 245 -----~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 -----LIPRN---PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHS---CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HhhcC---ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 0111112334568999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=346.67 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=200.6
Q ss_pred CCccccceeccCCceEEEEEEe----CCCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 343 (579)
++|++.+.||+|+||.||+++. .+++.||||+++.... .......+.+|+.++..+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4799999999999999999987 3789999999875332 112345567789999988 69999999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999963 24588999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc--ccccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNADE--ALNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
+....... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------------~~ 273 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AE 273 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HH
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-------------HH
Confidence 76543222 223467889999999985 34789999999999999999999999653221100 00
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQA 544 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 544 (579)
+..... .....++...+..+.+|+.+||..||++|| ++.++++.
T Consensus 274 ~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 274 ISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 100000 011233455667899999999999999999 88998864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.75 Aligned_cols=261 Identities=23% Similarity=0.406 Sum_probs=210.5
Q ss_pred HHhCCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ 343 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 343 (579)
+..++|++.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++. .+.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 345679999999999999999997742 4679999986543 3445678999999999999999999999985 467
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+++|+|.++++. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 8999999999999999963 344689999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 424 SNMPNADEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 424 ~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
+......... ...++..|+|||++....++.++|||||||++|||++ |..||........ +
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----------------~ 602 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----------------I 602 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------H
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH----------------H
Confidence 8764433221 2234568999999998899999999999999999997 9999976432211 0
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
.. +........+..++..+.+++.+||+.||++|||+.++++.|++++++..
T Consensus 603 ~~-i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 603 GR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp HH-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HH-HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 00 00111222345567789999999999999999999999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.36 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=203.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457999999999999999999875 7899999999765544455778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC---CceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE---LNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~ 425 (579)
||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999998853 24589999999999999999999976 99999999999999754 4699999999986
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...........++..|+|||.+.+ .++.++||||||+++|+|++|..||......... ..+..
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------------~~~~~ 236 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----------------KRVET 236 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH
T ss_pred ecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHc
Confidence 654443334446778999998865 5899999999999999999999999764322110 00000
Q ss_pred ccccCCC--ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLY--PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....... ....+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000000 1234568999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.39 Aligned_cols=263 Identities=19% Similarity=0.300 Sum_probs=187.2
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------C
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------G 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 342 (579)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999975 4789999999976655555677889999999999999999999998653 5
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++|||++ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 789999885 24689999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-cc------
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-PQ------ 493 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~~------ 493 (579)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+..... |.
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9765432 334567889999999886 6789999999999999999999999976543211 11111111 00
Q ss_pred ccCh--hHHhhhcCccccCC---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDI--DALAKMVDPALKGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~--~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+... ....+.+....... .....+..+.+|+.+||..||++|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 00000000000000 01123467899999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=338.46 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=180.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHH-HHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVS-NISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... +++.||||++...... .....+..|+. +++.++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 357889999999999999999875 7899999999765432 33344555555 67788999999999999999999999
Q ss_pred EEecCCCChhhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 348 YEFRKNGSLHDFLHLS-DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||+++ +|.+++... ......+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 887777521 12356789999999999999999999963 28999999999999999999999999999876
Q ss_pred CCCCcccccCCCCCccCcccc----ccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 427 PNADEALNNDAGSGYGAPEVA----MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
..........++..|+|||++ .+..++.++|||||||++|||++|+.||......... +... ..
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~-----------~~ 244 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LTQV-----------VK 244 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCC-----------CC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HHHH-----------hc
Confidence 554444444678899999998 4567899999999999999999999999753221100 0000 00
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+.+........+..+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011111122345678999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=343.67 Aligned_cols=200 Identities=21% Similarity=0.321 Sum_probs=171.6
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc------CCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL------HHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~ 342 (579)
..+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.+ +|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 457999999999999999999765 5899999999653 23345667777777666 6789999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc--eEEecc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN--PQLSDC 420 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Df 420 (579)
..++||||+. ++|.+++... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999995 6999988642 234589999999999999999999987 9999999999999999887 999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
|++..... ......+++.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99976533 23345678899999999999999999999999999999999999976543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.02 Aligned_cols=251 Identities=25% Similarity=0.440 Sum_probs=198.2
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 357999999999999999999876 58999999987543 334678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999998863 235689999999999999999999976 999999999999999999999999998753211
Q ss_pred C-CcccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 429 A-DEALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 429 ~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
. .......++..|+|||++. ...++.++||||||+++|+|++|..||........ ... +..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-----------~~~ 236 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK-----------IAK 236 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH-----------HHH
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHH-----------Hhc
Confidence 1 1122345678999999984 56789999999999999999999999976432211 000 000
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. .......+...+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 S--DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S--CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c--CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00011123445678999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.54 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=187.6
Q ss_pred HHhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
+..++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+..+++++||||+++++++...+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 44678999999999999999999764 689999999865432 2335678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 347 VYEFRKNGSLHDFLHLSD----EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999986321 1245689999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCc------ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhh-hhccccc
Q 008055 423 ASNMPNADE------ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLV-RWATPQL 494 (579)
Q Consensus 423 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~ 494 (579)
+........ .....++..|+|||++.. ..++.++||||||+++|||++|+.||............ ....+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 876543221 123456789999999875 56899999999999999999999999765432111000 0000000
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ...+ .......+..+.+++.+||+.||++|||+.++++
T Consensus 248 ~~-----~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ET-----GVQD----KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC--------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cc-----cccc----chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0000 1112234568999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=328.26 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=198.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC--chhHHHHHHHHHHHhhcCCCCccceeeEE--eeCCeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP--SEMCDDFIEMVSNISQLHHPNIMELVGYC--SEYGQH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~ 344 (579)
.++|++.+.||+|+||.||++... +++.||+|++...... ......+.+|+.+++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 6889999999653211 23457789999999999999999999998 445688
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
++||||+++| |.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77776532 345689999999999999999999976 99999999999999999999999999997
Q ss_pred cCCCC---CcccccCCCCCccCccccccCC--CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 425 NMPNA---DEALNNDAGSGYGAPEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 425 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
..... .......++..|+|||++.+.. ++.++||||||+++|||++|+.||......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~ 224 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------------EN 224 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------------HH
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------------HH
Confidence 65432 2223445788999999997644 478999999999999999999999764321100 00
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
+.. . ....+..++..+.+++.+||+.||++|||+.++++.
T Consensus 225 i~~---~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 IGK---G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHH---C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hhc---C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100 0 112334456789999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.37 Aligned_cols=263 Identities=21% Similarity=0.337 Sum_probs=203.2
Q ss_pred hCCccccceeccCCceEEEEEEe--CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC------ccceeeEEeeC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF--ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN------IMELVGYCSEY 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~ 341 (579)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.+++.++|++ ++++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 45899999999999999999976 36889999999643 244567888999888887654 99999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC----------
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---------- 411 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---------- 411 (579)
+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 88999998632 234688999999999999999999976 9999999999999987
Q ss_pred ---------CCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh
Q 008055 412 ---------ELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482 (579)
Q Consensus 412 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~ 482 (579)
++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999765432 234567889999999999999999999999999999999999997654322
Q ss_pred hhhhhhhccccccC-------------------------hhHHhhhcCccc-cCCCChhhHHHHHHHHHhcCCCCCCCCC
Q 008055 483 EQSLVRWATPQLHD-------------------------IDALAKMVDPAL-KGLYPVKSLSRFADVIALCVQPEPEFRP 536 (579)
Q Consensus 483 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rp 536 (579)
.............. .........+.. ....+...+..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 11111100000000 000001111000 1122345678899999999999999999
Q ss_pred ChHHHHH
Q 008055 537 PMSEVVQ 543 (579)
Q Consensus 537 s~~evl~ 543 (579)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.79 Aligned_cols=262 Identities=20% Similarity=0.328 Sum_probs=200.0
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeE----
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH---- 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 344 (579)
.++|.+.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 457999999999999999999765 689999999987665566678899999999999999999999999876654
Q ss_pred --EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 345 --LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 345 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 68888773 3489999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcc-c------c
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWAT-P------Q 493 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~------~ 493 (579)
++.... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..+..... + .
T Consensus 191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 976533 2334567889999999987 6789999999999999999999999976543211 11111000 0 0
Q ss_pred ccCh--hHHhhhcCccccCC---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDI--DALAKMVDPALKGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~--~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+... .............. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 00000000000000 11234578999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.20 Aligned_cols=264 Identities=19% Similarity=0.296 Sum_probs=200.8
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----Ce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 343 (579)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 357999999999999999999765 68899999997533 344557889999999999999999999998654 46
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999996 599998862 3589999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc----ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhcccccc--
Q 008055 424 SNMPNADE----ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLH-- 495 (579)
Q Consensus 424 ~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-- 495 (579)
........ .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 76643322 123467889999998764 4589999999999999999999999976543211 111111110000
Q ss_pred -----ChhHHhhhcCccccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 496 -----DIDALAKMVDPALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 496 -----~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
................. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000 1234567899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.21 Aligned_cols=262 Identities=19% Similarity=0.329 Sum_probs=200.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe-----
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ----- 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 343 (579)
.++|.+.+.||+|+||.||+|... +|+.||||++............+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357999999999999999999764 68999999998766555667788999999999999999999999977654
Q ss_pred -EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 344 -HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 344 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
.++||||+. |+|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 68888764 2489999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhc-cc------c
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWA-TP------Q 493 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~-~~------~ 493 (579)
+...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.... .+ .
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 8765332 233466889999999876 6789999999999999999999999976543211 1111100 00 0
Q ss_pred ccCh--hHHhhhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LHDI--DALAKMVDPALK---GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+.+. ............ .......+..+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000000001 1122345678999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=329.88 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=193.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe---------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS--------- 339 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------- 339 (579)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 357999999999999999999876 58999999986543 455678899999999999999999999873
Q ss_pred -----eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCC
Q 008055 340 -----EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NEL 413 (579)
Q Consensus 340 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~ 413 (579)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||++ +|+||||||+|||++ +++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 4467899999997 69999985 34688999999999999999999976 999999999999997 567
Q ss_pred ceEEecccccccCCCCC----cccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhh
Q 008055 414 NPQLSDCGLASNMPNAD----EALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLV 487 (579)
Q Consensus 414 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~ 487 (579)
.+||+|||++....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......... .+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998654321 1223345778999998875 67899999999999999999999999865432111 111
Q ss_pred hhccccccC--hhHHhhhcC----cccc-C-----CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 488 RWATPQLHD--IDALAKMVD----PALK-G-----LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 488 ~~~~~~~~~--~~~~~~~~~----~~~~-~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .+.... ...+..... .... . ......+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ES-IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HH-SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred Hh-cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 10 111000 000000000 0000 0 011234578999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.27 Aligned_cols=264 Identities=20% Similarity=0.302 Sum_probs=199.9
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC--------CCCccceeeEEe-
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH--------HPNIMELVGYCS- 339 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~- 339 (579)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46899999999999999999976 46889999999643 344577889999998885 888999999987
Q ss_pred ---eCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---
Q 008055 340 ---EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL--- 413 (579)
Q Consensus 340 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~--- 413 (579)
.....++||||+ +++|.+++.. .....+++..++.|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 556889999999 5666666642 23356899999999999999999999632 899999999999999775
Q ss_pred ----------------------------------------------ceEEecccccccCCCCCcccccCCCCCccCcccc
Q 008055 414 ----------------------------------------------NPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA 447 (579)
Q Consensus 414 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 447 (579)
.+||+|||++...... .....+|..|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence 7999999999766432 3345678899999999
Q ss_pred ccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh----h---hhhhhhcccc--------------ccChhHHhhhcCc
Q 008055 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL----E---QSLVRWATPQ--------------LHDIDALAKMVDP 506 (579)
Q Consensus 448 ~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~----~---~~~~~~~~~~--------------~~~~~~~~~~~~~ 506 (579)
.+..++.++|||||||++|||++|+.||....... . ..+....... .........+.+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997543211 0 0011110000 0000000000000
Q ss_pred ---------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ---------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0011235667788999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=330.20 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=182.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|... +++.||||++..........+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46888999999999999999875 78999999997665444444555666667888899999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+ ++.+..+... ....+++..++.++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 5555555432 245689999999999999999999962 28999999999999999999999999999766554
Q ss_pred CcccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 430 DEALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
.......++..|+|||++. ...++.++|||||||++|||++|+.||......... +. .+....
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~-----------~~~~~~ 246 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LT-----------KVLQEE 246 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HH-----------HHHHSC
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HH-----------HHhccC
Confidence 4444556788999999994 456889999999999999999999999753321110 00 000000
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+.. ......+..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 011234568999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.19 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=193.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-------- 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 340 (579)
.++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 347899999999999999999864 7899999999542 3446778899999999999999999998854
Q ss_pred -----CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCce
Q 008055 341 -----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415 (579)
Q Consensus 341 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 415 (579)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 4578999999999999999963 344678899999999999999999976 99999999999999999999
Q ss_pred EEecccccccCCCC---------------CcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCC
Q 008055 416 QLSDCGLASNMPNA---------------DEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSR 479 (579)
Q Consensus 416 kl~Dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~ 479 (579)
||+|||++...... .......++..|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999998765422 112234567789999999764 68999999999999999998 554211
Q ss_pred chhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ..... .+. .........++...+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~--~~~~~----------~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ER--VNILK----------KLR-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH--HHHHH----------HHH-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hH--HHHHH----------hcc-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 10 00000 000 01112223344556678999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=341.47 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=182.3
Q ss_pred Cccc-cceeccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe--eCCeEE
Q 008055 272 SFNV-ENLLGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS--EYGQHL 345 (579)
Q Consensus 272 ~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 345 (579)
.|++ .++||+|+||.||+|.++ +++.||||++..... ...+.+|+.++++++||||+++++++. .....+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3555 458999999999999875 578999999975543 356789999999999999999999995 467899
Q ss_pred EEEEecCCCChhhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE----cCCCceE
Q 008055 346 LVYEFRKNGSLHDFLHLSD-----EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL----DNELNPQ 416 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~k 416 (579)
+||||+. |+|.+++.... .....+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58888775321 1223589999999999999999999976 99999999999999 6778999
Q ss_pred EecccccccCCCCC----cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchh---------
Q 008055 417 LSDCGLASNMPNAD----EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL--------- 482 (579)
Q Consensus 417 l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~--------- 482 (579)
|+|||+++...... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999997654321 22335678899999999874 58999999999999999999999996543211
Q ss_pred -hhhhhh-hccccccChh---------HHhhhcCccccCC---------CChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 483 -EQSLVR-WATPQLHDID---------ALAKMVDPALKGL---------YPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 483 -~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
...+.. ...|....+. ............. .....+..+.+|+.+||+.||++|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000 0111100000 0000000000000 0011145788999999999999999999998
Q ss_pred H
Q 008055 543 Q 543 (579)
Q Consensus 543 ~ 543 (579)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.96 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=174.0
Q ss_pred hCCcccc-ceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee----CCe
Q 008055 270 TGSFNVE-NLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE----YGQ 343 (579)
Q Consensus 270 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 343 (579)
.++|.+. +.||+|+||.||+|... +++.||||++... .....+....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3478885 46999999999999876 6899999998642 1222333344567799999999999876 455
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Df 420 (579)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 89999999999999999732 235689999999999999999999976 9999999999999976 455999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
|++...... ......+++.|+|||++....++.++|||||||++|+|++|+.||.......... .... .+
T Consensus 176 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~--~~ 245 (336)
T 3fhr_A 176 GFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-------GMKR--RI 245 (336)
T ss_dssp TTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------hHHH--hh
Confidence 999765432 2334556889999999988889999999999999999999999996543211000 0000 00
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
...............+..+.+++.+||+.||++|||+.++++.
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 246 -RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000011111123456789999999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=330.15 Aligned_cols=264 Identities=22% Similarity=0.344 Sum_probs=199.4
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC-----Ce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY-----GQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 343 (579)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457999999999999999999875 68999999996433 334566788999999999999999999988654 67
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.++||||+. |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 699998862 4689999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCc-----------ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhh-
Q 008055 424 SNMPNADE-----------ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRW- 489 (579)
Q Consensus 424 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~- 489 (579)
........ .....++..|+|||++.. ..++.++|||||||++|||++|+.||......... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 76543221 112356778999998764 67899999999999999999999999765432111 11110
Q ss_pred cccccc------ChhHHhhhcCc--ccc-C---CCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 490 ATPQLH------DIDALAKMVDP--ALK-G---LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 490 ~~~~~~------~~~~~~~~~~~--~~~-~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+... ........... ... . ......+..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00000000000 000 0 001234568899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.51 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=170.5
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CC-----CccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HP-----NIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 568999999999999999999765 6889999999743 234566777888887774 44 4999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCceEEecc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD--NELNPQLSDC 420 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Df 420 (579)
..++||||++ |+|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 5999998743 234589999999999999999999953 35999999999999995 4788999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCc
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP 480 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~ 480 (579)
|++..... ......+++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99987643 23345678899999999999999999999999999999999999986543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.26 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=187.7
Q ss_pred CccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 45567889999999998777778999999998542 245678899999876 899999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC-------------Cc
Q 008055 351 RKNGSLHDFLHLSDEDNKP---LIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE-------------LN 414 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~-------------~~ 414 (579)
+. |+|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999743322221 13334678999999999999976 99999999999999754 48
Q ss_pred eEEecccccccCCCCCcc-----cccCCCCCccCcccccc-------CCCCccchHHhHHHHHHHHHh-CCCCCCCCCch
Q 008055 415 PQLSDCGLASNMPNADEA-----LNNDAGSGYGAPEVAMS-------GQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPR 481 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~ 481 (579)
+||+|||++......... ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543321 23457889999999975 568999999999999999999 99999654322
Q ss_pred hhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 482 LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .+..... ..+......+...+.++.+++.+||+.||++|||+.++++
T Consensus 247 ~~-~i~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ES-NIIRGIF------------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-HHHHTCC------------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHhcCCC------------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 1111000 0011111223456788999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.39 Aligned_cols=245 Identities=23% Similarity=0.394 Sum_probs=192.0
Q ss_pred HHHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhc----CCCCccceeeE
Q 008055 267 QMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQL----HHPNIMELVGY 337 (579)
Q Consensus 267 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~ 337 (579)
....++|++.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999976 468899999997654321 1223455688888888 89999999999
Q ss_pred EeeCCeEEEEEEe-cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCce
Q 008055 338 CSEYGQHLLVYEF-RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NELNP 415 (579)
Q Consensus 338 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~ 415 (579)
+...+..++|||| +.+++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999963 34589999999999999999999987 999999999999999 88999
Q ss_pred EEecccccccCCCCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 416 QLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 416 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
||+|||++...... ......++..|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-------- 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I-------- 245 (312)
T ss_dssp EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H--------
T ss_pred EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H--------
Confidence 99999999876543 3334567889999999987766 4589999999999999999999964211 0
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ...++...+..+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -----LEA------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----HHT------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----hhh------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11123445578999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=331.18 Aligned_cols=244 Identities=21% Similarity=0.369 Sum_probs=199.8
Q ss_pred HHhCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhcC--CCCccceeeEEee
Q 008055 268 MATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQLH--HPNIMELVGYCSE 340 (579)
Q Consensus 268 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 340 (579)
...++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3456899999999999999999975 478999999996543322 12245667889999885 5999999999999
Q ss_pred CCeEEEEEEecCC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCceEEe
Q 008055 341 YGQHLLVYEFRKN-GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLS 418 (579)
Q Consensus 341 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~ 418 (579)
.+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999976 899999863 34688999999999999999999976 999999999999999 78999999
Q ss_pred cccccccCCCCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccCh
Q 008055 419 DCGLASNMPNADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497 (579)
Q Consensus 419 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 497 (579)
|||++...... ......++..|+|||++....+ +.++|||||||++|||++|+.||..... .
T Consensus 193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~----------- 255 (320)
T 3a99_A 193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I----------- 255 (320)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-----------
T ss_pred eCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-----------
Confidence 99999876542 2334567889999999987766 6889999999999999999999964211 0
Q ss_pred hHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ...++...+..+.+++.+||+.||++|||+.++++
T Consensus 256 --~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 --IRG------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHC------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hcc------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01122344568999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.62 Aligned_cols=263 Identities=20% Similarity=0.283 Sum_probs=199.9
Q ss_pred hCCccccceeccCCceEEEEEEeC-CC-cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC------ccceeeEEeeC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DG-KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN------IMELVGYCSEY 341 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~ 341 (579)
.++|++.+.||+|+||.||+|... ++ +.||+|++... ......+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 468999999999999999999764 34 68999999643 344567788999998887766 89999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEE------------
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILL------------ 409 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill------------ 409 (579)
+..++||||+ +++|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 6677777653 2235689999999999999999999965 99999999999999
Q ss_pred -------cCCCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh
Q 008055 410 -------DNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL 482 (579)
Q Consensus 410 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~ 482 (579)
+.++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999765332 234567889999999999999999999999999999999999997654322
Q ss_pred hhh-hhhhcccccc------------------------ChhHHhhhcCccc-cCCCChhhHHHHHHHHHhcCCCCCCCCC
Q 008055 483 EQS-LVRWATPQLH------------------------DIDALAKMVDPAL-KGLYPVKSLSRFADVIALCVQPEPEFRP 536 (579)
Q Consensus 483 ~~~-~~~~~~~~~~------------------------~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rp 536 (579)
... +.....+... ..........+.. ........+..+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 111 1111000000 0000000000000 0112234567899999999999999999
Q ss_pred ChHHHHH
Q 008055 537 PMSEVVQ 543 (579)
Q Consensus 537 s~~evl~ 543 (579)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.35 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=185.4
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 346888999999999997666667899999999965432 2345789999988 8999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----CCceEEeccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-----ELNPQLSDCGLA 423 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfg~~ 423 (579)
||+. |+|.+++... ...+.+..++.++.||+.||+|||++ +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 6999998732 23344455678999999999999976 9999999999999953 235789999999
Q ss_pred ccCCCCC----cccccCCCCCccCccccc---cCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhcccccc
Q 008055 424 SNMPNAD----EALNNDAGSGYGAPEVAM---SGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLH 495 (579)
Q Consensus 424 ~~~~~~~----~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 495 (579)
+...... ......+|+.|+|||++. ...++.++|||||||++|||++ |..||.............
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~------- 243 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG------- 243 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT-------
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc-------
Confidence 8765432 223356788999999997 4567889999999999999999 999996543221111000
Q ss_pred ChhHHhhhcCccccC-CCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 496 DIDALAKMVDPALKG-LYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 496 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
...... ..+......+.+|+.+||+.||++|||+.+++
T Consensus 244 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 244 ---------ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp ---------CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---------cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 000000 11233456688999999999999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=313.11 Aligned_cols=236 Identities=15% Similarity=0.143 Sum_probs=187.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+..+..++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999875 5899999999866543 44567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||+++++|.+++.. . ....++..|+.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999852 1 35567889999999999999976 99999999999999999999998544
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
|++ .++.++|||||||++|||++|+.||......... ..............
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 226 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA-------- 226 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH--------
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh--------
Confidence 333 3688999999999999999999999764431100 00000000000000
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHcc
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRAN 553 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 553 (579)
......+..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 227 ----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 227 ----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp ----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0112345679999999999999999 99999999998875444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.87 Aligned_cols=271 Identities=21% Similarity=0.314 Sum_probs=209.7
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee------CCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE------YGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 343 (579)
++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 5799999999999999999976 468999999987543 34556789999999999999999999998765 677
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc---eEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN---PQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Df 420 (579)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997432 234688899999999999999999976 9999999999999997765 899999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
|++.............++..|+|||++.+..++.++|||||||++|+|++|..||...... ..|....... ...
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~-~~~ 242 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREK-SNE 242 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcc-cch
Confidence 9998776655555567888999999999999999999999999999999999999754221 1111100000 000
Q ss_pred hhhcC----------c--cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHH-----HHHHHHHHHHHc
Q 008055 501 AKMVD----------P--ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE-----VVQALVRLVQRA 552 (579)
Q Consensus 501 ~~~~~----------~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-----vl~~L~~i~~~~ 552 (579)
..... . ..........+..+.+++.+||..||++|||+.+ +.+.+..++...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000 0 0112234567889999999999999999999998 667777777544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.60 Aligned_cols=262 Identities=18% Similarity=0.302 Sum_probs=198.3
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-----------CCCccceeeE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-----------HPNIMELVGY 337 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 337 (579)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 35799999999999999999976 57899999999643 234566788888888776 8999999999
Q ss_pred EeeCC----eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---
Q 008055 338 CSEYG----QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD--- 410 (579)
Q Consensus 338 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--- 410 (579)
+...+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ .+|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccC
Confidence 87654 789999999 89999998642 234589999999999999999999963 2899999999999994
Q ss_pred ---CCCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh----h
Q 008055 411 ---NELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL----E 483 (579)
Q Consensus 411 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~----~ 483 (579)
..+.+||+|||++..... ......++..|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 445899999999976643 2334567889999999999999999999999999999999999997543210 0
Q ss_pred ---hhhhhhcccccc--------------C-----------hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCC
Q 008055 484 ---QSLVRWATPQLH--------------D-----------IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFR 535 (579)
Q Consensus 484 ---~~~~~~~~~~~~--------------~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 535 (579)
..+.....+.-. . ...+.... .....++...+..+.+|+.+||+.||++|
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh--hhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 011111000000 0 00000000 00123456778899999999999999999
Q ss_pred CChHHHHH
Q 008055 536 PPMSEVVQ 543 (579)
Q Consensus 536 ps~~evl~ 543 (579)
||+.|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=349.14 Aligned_cols=244 Identities=20% Similarity=0.337 Sum_probs=196.9
Q ss_pred hCCccccceeccCCceEEEEEEeC--CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCe----
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA--DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQ---- 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 343 (579)
.++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 368999999999999999999875 68999999986543 34456778999999999999999999999987665
Q ss_pred -EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 344 -HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 344 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
.|+||||+++++|.+++. ..+++.+++.|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 799999999999998764 2689999999999999999999976 99999999999999986 899999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
++..... ....+|+.|+|||++.+. ++.++|||||||++|+|++|..||...... .....
T Consensus 228 a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~----- 287 (681)
T 2pzi_A 228 VSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPED----- 287 (681)
T ss_dssp CEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTT-----
T ss_pred chhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccccc-----
Confidence 9876443 345678899999998765 488999999999999999999888642110 00000
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC-ChHHHHHHHHHHHHHc
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP-PMSEVVQALVRLVQRA 552 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~~~ 552 (579)
......+..+.+++.+||+.||++|| +++++.+.|..++++.
T Consensus 288 --------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 288 --------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp --------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred --------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 00112235788999999999999999 5677777787776543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.66 Aligned_cols=226 Identities=22% Similarity=0.348 Sum_probs=177.5
Q ss_pred CCcccc-ceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHH-hhcCCCCccceeeEEee----CCe
Q 008055 271 GSFNVE-NLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPNIMELVGYCSE----YGQ 343 (579)
Q Consensus 271 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~ 343 (579)
++|.+. +.||+|+||.||++.. .+++.||+|++.. ...+.+|+..+ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 356666 7899999999999976 4789999999953 24566777777 56699999999999876 678
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Df 420 (579)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 89999999999999999742 234689999999999999999999976 9999999999999998 788999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDA 499 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 499 (579)
|++.... +..++.++|||||||++|||++|+.||........ .....
T Consensus 165 g~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----------- 212 (299)
T 3m2w_A 165 GFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------- 212 (299)
T ss_dssp TTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-----------
T ss_pred ccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-----------
Confidence 9986432 24578899999999999999999999965432110 00000
Q ss_pred HhhhcCccccCCCC----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 500 LAKMVDPALKGLYP----VKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 500 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
.... .....+ ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 213 ---~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 ---RIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---SSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 000111 2345789999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.56 Aligned_cols=242 Identities=15% Similarity=0.158 Sum_probs=179.4
Q ss_pred CccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCC-CCchhHHHHHHHHHHHhhcCC-CCcccee-------------
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSA-LPSEMCDDFIEMVSNISQLHH-PNIMELV------------- 335 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~l~------------- 335 (579)
.|...+.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+.+++.++| +|...+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 477788999999999999985 579999999987433 223346778999999999977 3221111
Q ss_pred --------eEEee-----CCeEEEEEEecCCCChhhhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 008055 336 --------GYCSE-----YGQHLLVYEFRKNGSLHDFLHLS---DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVH 399 (579)
Q Consensus 336 --------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 399 (579)
.++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||+|||++ +|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 11111 12356777765 68999888421 22345688889999999999999999976 9999
Q ss_pred cCCCCCCEEEcCCCceEEecccccccCCCCCcccccCCCCCccCcccc----------ccCCCCccchHHhHHHHHHHHH
Q 008055 400 KNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA----------MSGQYNIKSDVYSFGVVMLELL 469 (579)
Q Consensus 400 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslGv~l~ell 469 (579)
|||||+|||++.++.+||+|||+++..... .....+ ..|+|||++ ....++.++|||||||++|||+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999998765432 333455 899999999 5556889999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHH
Q 008055 470 TGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 470 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 542 (579)
+|+.||........ ....+.. ....+..+.+|+.+||+.||++|||+.+++
T Consensus 312 tg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhh----------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999975432100 0000100 012346799999999999999999988875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=311.12 Aligned_cols=242 Identities=14% Similarity=0.135 Sum_probs=182.4
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCC------CchhHHHHHHHHHHHhhcC---------CCCccce
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSAL------PSEMCDDFIEMVSNISQLH---------HPNIMEL 334 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~l 334 (579)
.++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34688899999999999999987 689999999976532 2334577888999888875 6666665
Q ss_pred eeE-----------------Eee-------------CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH
Q 008055 335 VGY-----------------CSE-------------YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR 384 (579)
Q Consensus 335 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 384 (579)
.+. +.+ .+..++||||+++|++.+.+. ...+++..++.|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 554 332 688999999999997766663 245799999999999999
Q ss_pred HHHHHH-hcCCCCeEEcCCCCCCEEEcCCC--------------------ceEEecccccccCCCCCcccccCCCCCccC
Q 008055 385 ALEYLH-EVCSLSVVHKNIKSANILLDNEL--------------------NPQLSDCGLASNMPNADEALNNDAGSGYGA 443 (579)
Q Consensus 385 ~L~~LH-~~~~~~iiH~Dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~a 443 (579)
||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...+|..|+|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 999999 77 999999999999999887 8999999999865432 3467889999
Q ss_pred ccccccCCCCccchHHhHHHH-HHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc--CccccCCCChhhHHHH
Q 008055 444 PEVAMSGQYNIKSDVYSFGVV-MLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV--DPALKGLYPVKSLSRF 520 (579)
Q Consensus 444 PE~~~~~~~~~~~DvwslGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 520 (579)
||++.+.. +.++||||||++ .+++++|..||..... ..... ..+.... ........+...+.++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~----------~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLT----------DKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHH----------HHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHH----------HhhhhhhccCcccchhhhhhcCHHH
Confidence 99998666 899999998777 7888889999842100 00000 0000000 0000111134567889
Q ss_pred HHHHHhcCCCCCCCCCChHHHH
Q 008055 521 ADVIALCVQPEPEFRPPMSEVV 542 (579)
Q Consensus 521 ~~li~~cl~~dP~~Rps~~evl 542 (579)
.+|+.+||+.| |+.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=280.20 Aligned_cols=187 Identities=15% Similarity=0.026 Sum_probs=129.5
Q ss_pred eeccCCceEEEEEE-eCCCcEEEEEEeCCCCCC--------chhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEEE
Q 008055 278 LLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALP--------SEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 278 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 347 (579)
..+.|++|.+..++ .--|+.+|+|.+.+.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666776666552 335899999999754321 12346689999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
|||++|++|.++|.. ..+++.. +|+.||+.||+|||++ |||||||||+|||++++|.+||+|||+++...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999963 3445543 5899999999999976 99999999999999999999999999998765
Q ss_pred CCC-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCC
Q 008055 428 NAD-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475 (579)
Q Consensus 428 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~ 475 (579)
... ...+..+|++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 432 2334567889999999865 5677899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=254.38 Aligned_cols=184 Identities=13% Similarity=0.157 Sum_probs=146.4
Q ss_pred ccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCch------hHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSE------MCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..+.||+|+||.||+|.. .++.+++|+......... ..+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 578889998755443221 1345789999999999999997777777778889999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999863 457999999999999976 9999999999999999 999999999987755
Q ss_pred CCcc--------cccCCCCCccCcccccc--CCCCccchHHhHHHHHHHHHhCCCCCC
Q 008055 429 ADEA--------LNNDAGSGYGAPEVAMS--GQYNIKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 429 ~~~~--------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~p~~ 476 (579)
.... ....+|+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221 23457889999999986 668889999999999998888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-24 Score=211.55 Aligned_cols=155 Identities=12% Similarity=0.083 Sum_probs=123.0
Q ss_pred HHHHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCc----------------hhHHHHHHHHHHHhhc
Q 008055 263 IADLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPS----------------EMCDDFIEMVSNISQL 326 (579)
Q Consensus 263 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l 326 (579)
+..+......|.+.+.||+|+||.||+|...+|+.||+|.+....... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344455566778889999999999999988889999999996533211 1356788999999999
Q ss_pred CCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 008055 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406 (579)
Q Consensus 327 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N 406 (579)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 4 666665543 56699999999999998 421 12457999999999999976 99999999999
Q ss_pred EEEcCCCceEEecccccccCCCCCcccccCCCCCccCccccc
Q 008055 407 ILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAM 448 (579)
Q Consensus 407 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 448 (579)
||++ ++.+||+|||++... ..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET------------TSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC------------CCCCHHHHHH
Confidence 9999 999999999998643 3478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=176.16 Aligned_cols=139 Identities=19% Similarity=0.170 Sum_probs=106.4
Q ss_pred CccccceeccCCceEEEEEEe-CCCcE--EEEEEeCCCCCCc----------------------hhHHHHHHHHHHHhhc
Q 008055 272 SFNVENLLGEGTFGRVYRAQF-ADGKV--LAVKKIDSSALPS----------------------EMCDDFIEMVSNISQL 326 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l 326 (579)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 68888 9999975432110 1123578899999999
Q ss_pred CCCCc--cceeeEEeeCCeEEEEEEecCC-C----ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 008055 327 HHPNI--MELVGYCSEYGQHLLVYEFRKN-G----SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH-EVCSLSVV 398 (579)
Q Consensus 327 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ii 398 (579)
.|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88864 333332 357899999942 4 66665431 224457789999999999999 66 999
Q ss_pred EcCCCCCCEEEcCCCceEEecccccccC
Q 008055 399 HKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 399 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
||||||+|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.6e-18 Score=170.86 Aligned_cols=145 Identities=11% Similarity=0.135 Sum_probs=100.7
Q ss_pred HHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC------------chhHHHHH--------HHHHHHhh
Q 008055 266 LQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP------------SEMCDDFI--------EMVSNISQ 325 (579)
Q Consensus 266 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~--------~e~~~l~~ 325 (579)
+.....-|.+.+.||+|+||.||+|...+|+.||||+++..... ........ .|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 33333448999999999999999999999999999997542110 00111222 34455555
Q ss_pred cCCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCC
Q 008055 326 LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 326 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~ 405 (579)
+.+..+....-+.. ...++||||++|++|..+... .....++.|++.+|.|||++ |||||||||.
T Consensus 170 L~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~ 234 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEF 234 (397)
T ss_dssp HHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred HHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence 54333221111111 234799999999888765421 12456889999999999976 9999999999
Q ss_pred CEEEcCCCc----------eEEeccccccc
Q 008055 406 NILLDNELN----------PQLSDCGLASN 425 (579)
Q Consensus 406 Nill~~~~~----------~kl~Dfg~~~~ 425 (579)
|||+++++. +.|+||+.+-.
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999988763 89999997654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=163.92 Aligned_cols=107 Identities=27% Similarity=0.500 Sum_probs=94.8
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|..|++|++|+.|||++|+|+|.+|. +..++ |+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 36799999999999999999999999999999999999999999999999999999999999999875 77776 99999
Q ss_pred cccCcCCCCCccc--cccC-eeeccCCCCCCC
Q 008055 79 IANNRFTGWVPEQ--LKNI-NLQKDGNSWSSG 107 (579)
Q Consensus 79 l~~N~l~~~~p~~--l~~~-~~~~~~n~~~~~ 107 (579)
|++|+|+|.+|.. +..+ ...+.+|+..|+
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence 9999999999964 4444 345778874443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=129.35 Aligned_cols=93 Identities=19% Similarity=0.303 Sum_probs=62.8
Q ss_pred CCcEEeccCCcCCCCch-hhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 3 TLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
.+++|+|++|+|++..| ..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 45677777777775543 3466777777777777777766666677777777777777777776654 55554 777777
Q ss_pred ccCcCCCCCccccccC
Q 008055 80 ANNRFTGWVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~ 95 (579)
++|.|++..|..+..+
T Consensus 113 s~N~l~~~~~~~~~~l 128 (220)
T 2v70_A 113 RSNRITCVGNDSFIGL 128 (220)
T ss_dssp TTSCCCCBCTTSSTTC
T ss_pred CCCcCCeECHhHcCCC
Confidence 7777776666655544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-13 Score=123.99 Aligned_cols=104 Identities=27% Similarity=0.446 Sum_probs=87.5
Q ss_pred CCCcEEeccCCcCCCCchh-hhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQGQLND-MFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
.+|++|+|++|+|++..+. .|+.+++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 3789999999999976664 489999999999999999998899999999999999999999998865 66675 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|+|++.+|..+..+ .+...+|.+.
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 99999999888877655 3445555544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.41 E-value=5.1e-13 Score=126.37 Aligned_cols=105 Identities=23% Similarity=0.302 Sum_probs=87.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 4689999999999977777899999999999999999988899999999999999999999988765 56665 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.|++..|..+..+ .+...+|.+..
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 142 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCE
Confidence 9999998888777655 34455565544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=4.7e-13 Score=123.78 Aligned_cols=89 Identities=28% Similarity=0.349 Sum_probs=82.8
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 57899999999999999999999999999999999999998888899999999999999999998764 77775 99999
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|+|++..+
T Consensus 133 L~~N~l~c~c~ 143 (192)
T 1w8a_A 133 LASNPFNCNCH 143 (192)
T ss_dssp CTTCCBCCSGG
T ss_pred eCCCCccCcCc
Confidence 99999998876
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=121.45 Aligned_cols=103 Identities=22% Similarity=0.267 Sum_probs=84.4
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 47899999999998 7788999999999999999999988788899999999999999999998864 77775 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
++|.|++..+..+..+ .+...+|++.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 9999996655555544 3444555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=123.86 Aligned_cols=104 Identities=27% Similarity=0.323 Sum_probs=88.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 5799999999999998899999999999999999999866667789999999999999999998865 56665 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.|+ .+|..+..+ .+...+|.+..
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 149 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCC
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCc
Confidence 999999 778766554 44555665553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=118.72 Aligned_cols=84 Identities=29% Similarity=0.360 Sum_probs=39.5
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIA 80 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~ 80 (579)
+|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++. +..++ |+.|+|+
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 110 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL 110 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence 344455555555444444444455555555555555443333344445555555555555444432 33332 4455555
Q ss_pred cCcCCC
Q 008055 81 NNRFTG 86 (579)
Q Consensus 81 ~N~l~~ 86 (579)
+|+|++
T Consensus 111 ~N~~~c 116 (170)
T 3g39_A 111 NNPWDC 116 (170)
T ss_dssp SSCBCT
T ss_pred CCCCCC
Confidence 554443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=118.19 Aligned_cols=86 Identities=19% Similarity=0.275 Sum_probs=48.0
Q ss_pred cEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcccC
Q 008055 5 KYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIANN 82 (579)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~N 82 (579)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666664 4554432 5566666666666655555666666666666666666665543 34443 666666666
Q ss_pred cCCCCCccccc
Q 008055 83 RFTGWVPEQLK 93 (579)
Q Consensus 83 ~l~~~~p~~l~ 93 (579)
+|++..+..+.
T Consensus 92 ~l~~l~~~~~~ 102 (174)
T 2r9u_A 92 HLKSIPRGAFD 102 (174)
T ss_dssp CCCCCCTTTTT
T ss_pred ccceeCHHHhc
Confidence 66644443333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.6e-12 Score=115.37 Aligned_cols=104 Identities=23% Similarity=0.394 Sum_probs=81.5
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|++++..+..|+.+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 5789999999999977777788999999999999999976666788999999999999999988765 56665 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
++|.|++..+..+..+ .+...+|.+.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 9999986555444433 3444555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3.7e-12 Score=123.01 Aligned_cols=106 Identities=28% Similarity=0.395 Sum_probs=90.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 57899999999999998888899999999999999999987778889999999999999999988865 56665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..|..+..+ .+...+|.+..
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 169 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS 169 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence 99999997777666554 44555665553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.33 E-value=3.8e-12 Score=120.34 Aligned_cols=104 Identities=23% Similarity=0.301 Sum_probs=84.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 46899999999999988899999999999999999999965556678899999999999999998754 66775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSW 104 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~ 104 (579)
|++|.|++..+..+..+ .+...+|++
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 99999997777666544 334445544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.31 E-value=8.3e-12 Score=118.77 Aligned_cols=93 Identities=25% Similarity=0.329 Sum_probs=58.8
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+..+..+..++ |+.|+|
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLAL 142 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEEC
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEEC
Confidence 3566677777777765545556667777777777777765555556666777777777777765554455543 677777
Q ss_pred ccCcCCCCCccccc
Q 008055 80 ANNRFTGWVPEQLK 93 (579)
Q Consensus 80 ~~N~l~~~~p~~l~ 93 (579)
++|.|++..+..+.
T Consensus 143 ~~N~l~~~~~~~~~ 156 (229)
T 3e6j_A 143 DQNQLKSIPHGAFD 156 (229)
T ss_dssp CSSCCCCCCTTTTT
T ss_pred CCCcCCccCHHHHh
Confidence 77777654444443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.5e-12 Score=146.44 Aligned_cols=82 Identities=30% Similarity=0.541 Sum_probs=66.9
Q ss_pred CCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcccCcCCCCCccccccC----eee
Q 008055 25 LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIANNRFTGWVPEQLKNI----NLQ 98 (579)
Q Consensus 25 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~N~l~~~~p~~l~~~----~~~ 98 (579)
+++|+.|||++|+|+|.+|..|++|++|+.|+|++|+|+|.+|. +..++ |+.|||++|+++|.+|..+..+ .+.
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 56788888888888899999999999999999999999988865 77776 9999999999999999887766 344
Q ss_pred ccCCCCCC
Q 008055 99 KDGNSWSS 106 (579)
Q Consensus 99 ~~~n~~~~ 106 (579)
...|.+.+
T Consensus 711 ls~N~l~g 718 (768)
T 3rgz_A 711 LSNNNLSG 718 (768)
T ss_dssp CCSSEEEE
T ss_pred CcCCcccc
Confidence 55555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.31 E-value=8.4e-12 Score=120.51 Aligned_cols=105 Identities=24% Similarity=0.325 Sum_probs=89.4
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|++++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 4689999999999998888999999999999999999998888899999999999999999988864 66675 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.|++..+..+..+ .+...+|.+..
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCc
Confidence 9999997776655444 34455565543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.31 E-value=8.5e-12 Score=116.77 Aligned_cols=104 Identities=26% Similarity=0.356 Sum_probs=84.0
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|+|++..+..|+.+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 5789999999999977777789999999999999999976666788999999999999999988765 56665 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
++|.|++..+..+..+ .+...+|.+.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 9999997766555444 3444555544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.9e-12 Score=120.25 Aligned_cols=106 Identities=20% Similarity=0.320 Sum_probs=93.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 57899999999999988888999999999999999999988888899999999999999999998754 77775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..|..+..+ .+...+|++.|
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 99999999888877765 45666777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=121.20 Aligned_cols=106 Identities=27% Similarity=0.365 Sum_probs=88.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|.|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 57899999999999988888899999999999999999987777889999999999999999988865 56665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..|..+..+ .+...+|.+.+
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 99999998777655544 34455565543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.6e-12 Score=116.55 Aligned_cols=89 Identities=29% Similarity=0.389 Sum_probs=81.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 57899999999999988888999999999999999999988888999999999999999999988864 66675 99999
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|+|.+...
T Consensus 133 L~~N~~~C~c~ 143 (193)
T 2wfh_A 133 IGANPLYCDCN 143 (193)
T ss_dssp CCSSCEECSGG
T ss_pred eCCCCeecCCc
Confidence 99999986543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.8e-11 Score=118.95 Aligned_cols=144 Identities=15% Similarity=0.070 Sum_probs=110.7
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 347 (579)
.-..|++...++.|+++.||++... +..+++|+....... ....+.+|+.+++.+. +..+.++++++.+.+..++|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3456888888999999999999754 688999998642211 1235777888888774 67788899999988999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC---------------------------------- 393 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 393 (579)
|||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999987632 11123468889999999999810
Q ss_pred ----------------------CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 394 ----------------------SLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 394 ----------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799999764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=111.78 Aligned_cols=100 Identities=20% Similarity=0.261 Sum_probs=83.9
Q ss_pred CcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEccc
Q 008055 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIAN 81 (579)
Q Consensus 4 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~ 81 (579)
.+.|++++|+|+ .+|..+ .++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 577665 48999999999999998899999999999999999999998875 56775 99999999
Q ss_pred CcCCCCCccccccC----eeeccCCCCCC
Q 008055 82 NRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 82 N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|+|++..|..+..+ .+...+|++.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 99998777666554 44556666544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.27 E-value=7.9e-12 Score=113.79 Aligned_cols=89 Identities=27% Similarity=0.381 Sum_probs=80.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|+|++..+..|+.+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 47899999999999987777889999999999999999987777789999999999999999988875 56665 99999
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|+|++.+|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999998776
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.8e-11 Score=111.06 Aligned_cols=88 Identities=23% Similarity=0.279 Sum_probs=79.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 5799999999999998899999999999999999999976666679999999999999999998875 77775 999999
Q ss_pred ccCcCCCCCc
Q 008055 80 ANNRFTGWVP 89 (579)
Q Consensus 80 ~~N~l~~~~p 89 (579)
++|+|.+..+
T Consensus 113 ~~N~~~c~~~ 122 (174)
T 2r9u_A 113 YNNPWDCECR 122 (174)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCcccccc
Confidence 9999985443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.8e-12 Score=128.28 Aligned_cols=103 Identities=25% Similarity=0.453 Sum_probs=84.6
Q ss_pred CCCcEEeccCCcCCC--CchhhhCCCCCCCEEeccC-CcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCe
Q 008055 2 KTLKYLNIAHNQLQG--QLNDMFGQLPSLSTLDLSF-NTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDN 76 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~ 76 (579)
.+++.|+|++|+++| .+|..|+++++|+.|+|++ |++++.+|..|+++++|++|+|++|+|++.+|. +..++ |+.
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468889999999998 8888999999999999994 889989999999999999999999999876654 66665 999
Q ss_pred EEcccCcCCCCCccccccC----eeeccCCCC
Q 008055 77 LNIANNRFTGWVPEQLKNI----NLQKDGNSW 104 (579)
Q Consensus 77 l~l~~N~l~~~~p~~l~~~----~~~~~~n~~ 104 (579)
|+|++|.+++.+|..+..+ .+...+|.+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 9999999998888877655 334445544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=7.1e-12 Score=127.19 Aligned_cols=87 Identities=23% Similarity=0.185 Sum_probs=61.1
Q ss_pred CCCcEEeccC-CcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCCCCeEEc
Q 008055 2 KTLKYLNIAH-NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLPLDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~L~~l~l 79 (579)
++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++.+|..|.+|++|+.|+|++|+|++.++. +..++|+.|+|
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l 110 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVL 110 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEEC
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEe
Confidence 4577777775 777766666777777777777777777776666777777777777777777776654 44445777777
Q ss_pred ccCcCCCCC
Q 008055 80 ANNRFTGWV 88 (579)
Q Consensus 80 ~~N~l~~~~ 88 (579)
++|.|.+..
T Consensus 111 ~~N~~~c~c 119 (347)
T 2ifg_A 111 SGNPLHCSC 119 (347)
T ss_dssp CSSCCCCCG
T ss_pred eCCCccCCC
Confidence 777776543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.25 E-value=2.9e-11 Score=118.22 Aligned_cols=104 Identities=26% Similarity=0.369 Sum_probs=87.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.+++ + +.++.+++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 62 l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 5789999999999996 3 4799999999999999999988888889999999999999999998875 66665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..|..+..+ .+...+|.+..
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence 99999998777655544 44555565543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.25 E-value=2.1e-11 Score=120.37 Aligned_cols=104 Identities=34% Similarity=0.458 Sum_probs=86.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 578999999999998 7888899999999999999999987778899999999999999999988865 56665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|+|++..+..+..+ .+...+|.+.
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence 99999996555544433 3455566555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.2e-11 Score=111.97 Aligned_cols=104 Identities=28% Similarity=0.405 Sum_probs=80.3
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46789999999999876667788899999999999999876666678889999999999999887765 56664 89999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSW 104 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~ 104 (579)
|++|.|++..+..+..+ .+...+|.+
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 160 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCe
Confidence 99999987666545443 334445543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=8.8e-12 Score=141.71 Aligned_cols=105 Identities=27% Similarity=0.309 Sum_probs=83.0
Q ss_pred CCCcEEeccCCcCC-----CCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCe
Q 008055 2 KTLKYLNIAHNQLQ-----GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDN 76 (579)
Q Consensus 2 ~~L~~L~l~~n~l~-----~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~ 76 (579)
++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++.++......|+.
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~ 530 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI 530 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCE
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccE
Confidence 34555555555554 3334568889999999999999999888889999999999999999999886543455999
Q ss_pred EEcccCcCCCCCccccccC-eeeccCCCCCC
Q 008055 77 LNIANNRFTGWVPEQLKNI-NLQKDGNSWSS 106 (579)
Q Consensus 77 l~l~~N~l~~~~p~~l~~~-~~~~~~n~~~~ 106 (579)
|+|++|+|++.+|..+..+ .+...+|++.|
T Consensus 531 L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 531 LDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561 (844)
T ss_dssp EEEEEECCCCCCSCCCSSCCEEEEEEECCCC
T ss_pred EECCCCcCCCCChhHhCCcCEEEecCCCccc
Confidence 9999999999999888777 45666777655
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.23 E-value=5.7e-12 Score=125.95 Aligned_cols=95 Identities=37% Similarity=0.679 Sum_probs=82.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCC--CCCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANL--PLDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~--~L~~l 77 (579)
|++|++|+|++|++++.+|..|+.+++|+.|+|++|.|++.+|..|..+++|+.|+|++|+|++.+| .+..+ .|+.|
T Consensus 100 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L 179 (313)
T 1ogq_A 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179 (313)
T ss_dssp CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEE
T ss_pred CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEE
Confidence 5789999999999998899999999999999999999999999999999999999999999997665 36555 48999
Q ss_pred EcccCcCCCCCccccccC
Q 008055 78 NIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~ 95 (579)
+|++|.+++.+|..+..+
T Consensus 180 ~L~~N~l~~~~~~~~~~l 197 (313)
T 1ogq_A 180 TISRNRLTGKIPPTFANL 197 (313)
T ss_dssp ECCSSEEEEECCGGGGGC
T ss_pred ECcCCeeeccCChHHhCC
Confidence 999999998888877665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.22 E-value=2e-11 Score=122.90 Aligned_cols=103 Identities=17% Similarity=0.208 Sum_probs=81.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|+ .+|..|+.+++|+.|+|++|.|++ +|..+..+++|+.|+|++|++.+.+|. +..++ |+.|+
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 467888999999888 788888888999999999999884 677788888999999998888887764 66665 88999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|++.+.+|..+..+ .+...+|+..
T Consensus 260 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp CTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 99988888888777655 3444555544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.5e-11 Score=116.71 Aligned_cols=105 Identities=29% Similarity=0.381 Sum_probs=88.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.+++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 163 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELR 163 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeE
Confidence 57899999999999987778889999999999999999988888899999999999999999988765 66665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|.+++..+..+..+ .+...+|.+.
T Consensus 164 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (270)
T 2o6q_A 164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194 (270)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence 99999997776656544 3445556554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.21 E-value=7.2e-12 Score=110.55 Aligned_cols=102 Identities=24% Similarity=0.350 Sum_probs=81.4
Q ss_pred CCCcEEeccCCcCC-CCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQ-GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
++|+.|+|++|.++ +.+|..++.+++|+.|+|++|.|++. ..+.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46899999999998 78888889999999999999999965 7889999999999999999996554 55454 99999
Q ss_pred cccCcCCCC-CccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGW-VPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~-~p~~l~~~----~~~~~~n~~~ 105 (579)
+++|.+++. .|..+..+ .+...+|.+.
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 999999873 33555544 3445555544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.6e-11 Score=110.63 Aligned_cols=102 Identities=23% Similarity=0.350 Sum_probs=78.7
Q ss_pred CCCcEEeccCCcCC-CCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQ-GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57899999999998 78888888899999999999999865 7888899999999999999986554 44454 99999
Q ss_pred cccCcCCCCCc-cccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVP-EQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p-~~l~~~----~~~~~~n~~~ 105 (579)
|++|.|++..+ ..+..+ .+...+|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 99999986432 445444 3444555544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3e-11 Score=132.66 Aligned_cols=105 Identities=24% Similarity=0.241 Sum_probs=85.6
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
+++++|||++|+|++..|..|.+|++|+.|||++|+|++..|..|.+|++|++|+|++|+|++.++. |..+. |+.|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 3689999999999977778899999999999999999977777899999999999999999988764 77775 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|+|++..+..+..+ .+...+|.+..
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~ 162 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQS 162 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCcccc
Confidence 9999987666666554 34445555543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.19 E-value=7.1e-11 Score=116.58 Aligned_cols=103 Identities=29% Similarity=0.344 Sum_probs=84.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.|++. +. .+.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 54 l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 57899999999999954 43 388999999999999999 7899999999999999999999998854 77775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..+..+..+ .+...+|.+..
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 99999997766655443 34455565543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.19 E-value=5.1e-11 Score=119.83 Aligned_cols=103 Identities=23% Similarity=0.316 Sum_probs=89.6
Q ss_pred CCCCcEEeccCCcCCCCchhhhCC---------CCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCC
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQ---------LPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLAN 71 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~---------l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 71 (579)
|++|++|+|++|++.+.+|..++. +++|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++.++.+..
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~ 227 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHH 227 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGG
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhcc
Confidence 578999999999999999988765 999999999999999 8999999999999999999999998887877
Q ss_pred CC-CCeEEcccCcCCCCCccccccC----eeeccCCCC
Q 008055 72 LP-LDNLNIANNRFTGWVPEQLKNI----NLQKDGNSW 104 (579)
Q Consensus 72 ~~-L~~l~l~~N~l~~~~p~~l~~~----~~~~~~n~~ 104 (579)
++ |+.|+|++|.+.+.+|..+..+ .+...+|..
T Consensus 228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 265 (328)
T 4fcg_A 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265 (328)
T ss_dssp CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTT
T ss_pred CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCc
Confidence 75 9999999999999999887665 334444444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-11 Score=107.87 Aligned_cols=87 Identities=25% Similarity=0.320 Sum_probs=78.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc--cccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~-L~~l 77 (579)
+++|++|+|++|.+++. ..|+.+++|+.|+|++|.|++.+|..+..+++|+.|+|++|+|++.+ ..+..++ |+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 57899999999999976 78999999999999999999889988888999999999999999965 5577776 9999
Q ss_pred EcccCcCCCCCc
Q 008055 78 NIANNRFTGWVP 89 (579)
Q Consensus 78 ~l~~N~l~~~~p 89 (579)
++++|.+++..+
T Consensus 119 ~l~~N~l~~~~~ 130 (149)
T 2je0_A 119 DLFNCEVTNLND 130 (149)
T ss_dssp ECTTCGGGGSTT
T ss_pred eCcCCcccchHH
Confidence 999999997665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.5e-11 Score=123.86 Aligned_cols=105 Identities=27% Similarity=0.341 Sum_probs=84.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+ .+..++ |+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 5789999999999998778889999999999999999997777789999999999999999998765 477775 99999
Q ss_pred cccCcCCCCCcccc------ccC-eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQL------KNI-NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l------~~~-~~~~~~n~~~ 105 (579)
|++|.|++..+..+ ..+ .+...+|.+.
T Consensus 143 L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp CCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999986544443 222 3445555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=8.2e-11 Score=115.79 Aligned_cols=95 Identities=27% Similarity=0.364 Sum_probs=70.9
Q ss_pred CCCCcEEeccCCc-CCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQ-LQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l 77 (579)
|++|++|+|++|. +....|..|..+++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|
T Consensus 79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 4678888888886 7766677788888888888888888877777788888888888888888877654 55554 8888
Q ss_pred EcccCcCCCCCccccccC
Q 008055 78 NIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~ 95 (579)
+|++|.|++..+..+..+
T Consensus 159 ~l~~n~l~~~~~~~~~~l 176 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGL 176 (285)
T ss_dssp ECCSSCCCEECTTTTTTC
T ss_pred ECCCCcccccCHHHhcCc
Confidence 888888876555545443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=4e-11 Score=129.41 Aligned_cols=100 Identities=33% Similarity=0.445 Sum_probs=86.6
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEccc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIAN 81 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~~ 81 (579)
.|+.|+|++|+|++ +|. |+.|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++.+ .+..++ |+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCC
Confidence 58899999999996 676 999999999999999999 89999999999999999999999954 777775 99999999
Q ss_pred CcCCCCC-ccccccC----eeeccCCCCCC
Q 008055 82 NRFTGWV-PEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 82 N~l~~~~-p~~l~~~----~~~~~~n~~~~ 106 (579)
|.|++.+ |..+..+ .+...+|.+.+
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 9999887 8877666 45556666554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=5.3e-11 Score=115.33 Aligned_cols=135 Identities=21% Similarity=0.200 Sum_probs=98.0
Q ss_pred ccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC--ccceeeEEeeCCeEEEEEEe
Q 008055 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN--IMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 273 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 350 (579)
+.+..+.+.|..+.||++...+|..+++|...... ...+..|+..++.+.+.+ +.+++++....+..++||||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 44333334566699999987778889999976531 234667888887775444 45688888887889999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC------------------------------------- 393 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 393 (579)
++|.+|. .. . .. ...++.++++.|..||...
T Consensus 97 i~G~~l~--~~---~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SS---H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TS---C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cC---c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 21 0 11 2356778888888888641
Q ss_pred ------------------CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 394 ------------------SLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 394 ------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.3e-10 Score=113.38 Aligned_cols=106 Identities=24% Similarity=0.299 Sum_probs=88.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.|+...+..|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 57899999999999977677789999999999999999977777889999999999999999998865 66775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..+..+..+ .+...+|.+..
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence 99999997666555544 34445555443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.16 E-value=6.4e-11 Score=120.85 Aligned_cols=105 Identities=23% Similarity=0.264 Sum_probs=89.5
Q ss_pred CCCcEEeccCCcCCCCchhhhC-CCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFG-QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
..|+.|+|++|+|++..+..|. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..+. |+.|+
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 4589999999999988888887 999999999999999987778899999999999999999988764 67775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.|++..|..+..+ .+...+|.+..
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 99999998878777655 34455565544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.9e-11 Score=108.13 Aligned_cols=87 Identities=26% Similarity=0.369 Sum_probs=78.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc--cccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~-L~~l 77 (579)
+++|++|+|++|.|++. ..|+.+++|+.|+|++|+|++.+|..+.++++|+.|+|++|+|++.+ +.+..++ |+.|
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence 46899999999999976 78999999999999999999888988888999999999999999976 5677776 9999
Q ss_pred EcccCcCCCCCc
Q 008055 78 NIANNRFTGWVP 89 (579)
Q Consensus 78 ~l~~N~l~~~~p 89 (579)
++++|.+++..+
T Consensus 126 ~l~~N~l~~~~~ 137 (168)
T 2ell_A 126 DLFNCEVTNLND 137 (168)
T ss_dssp ECCSSGGGTSTT
T ss_pred EeeCCcCcchHH
Confidence 999999997655
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=5.4e-11 Score=125.30 Aligned_cols=105 Identities=21% Similarity=0.304 Sum_probs=88.3
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|.+++.+|..|+.+++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 5789999999999988899999999999999999999988888999999999999999999887654 66675 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.+++..|..+..+ .+...+|.+..
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcccccChhhccccccccEEECCCCcccc
Confidence 9999998888777655 34555665554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=3.9e-11 Score=131.75 Aligned_cols=105 Identities=30% Similarity=0.378 Sum_probs=76.2
Q ss_pred CCCcEEeccCCcC-CCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQL-QGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l-~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
++|+.|+|++|++ .+.+|+.|..+++|+.|+|++|+|++.+|..|.+|++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 5677777777764 345677778888888888888888877777888888888888888888877754 66664 88888
Q ss_pred cccCcCCCCCccccccC-----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI-----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~-----~~~~~~n~~~~ 106 (579)
|++|+|++..|..+..+ .+...+|++.|
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 88888887777766543 23445565544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.15 E-value=3.9e-11 Score=119.42 Aligned_cols=106 Identities=27% Similarity=0.385 Sum_probs=86.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCC-CCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG-NLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l 77 (579)
+++|++|+|++|.+++..|..|..+++|+.|+|++|.+++ .+|..+..+++|+.|+|++|+|++.++ .+..++ |+.|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 4689999999999998888889999999999999999986 588889999999999999999998865 466665 9999
Q ss_pred EcccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 78 NIANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
+|++|.+++..+..+..+ .+...+|.+.+
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 999999987766555443 34455555543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=5.3e-11 Score=117.13 Aligned_cols=106 Identities=26% Similarity=0.355 Sum_probs=90.6
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|.+++..|..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 57899999999999988899999999999999999999977777799999999999999999988764 66665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|.+++..|..+..+ .+...+|.+..
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 99999999888877655 34555565543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.15 E-value=5.3e-11 Score=110.32 Aligned_cols=87 Identities=17% Similarity=0.252 Sum_probs=68.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc-cccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI-DVLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-L~~l~ 78 (579)
+++|++|+|++|.++ .++.+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.. ..+..++ |+.|+
T Consensus 65 l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 467889999999776 2346888899999999999998778888888999999999999988754 3466665 89999
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|.+-+.+|
T Consensus 143 L~~n~~i~~~~ 153 (197)
T 4ezg_A 143 LSYNGAITDIM 153 (197)
T ss_dssp CCSCTBCCCCG
T ss_pred ccCCCCccccH
Confidence 99998333455
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=4.3e-11 Score=129.16 Aligned_cols=86 Identities=28% Similarity=0.376 Sum_probs=79.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCc--ccccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT--IDVLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-L~~l 77 (579)
|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++. ++.+..++ |+.|
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 578999999999999 889999999999999999999996 77 899999999999999999999 45687776 9999
Q ss_pred EcccCcCCCCCc
Q 008055 78 NIANNRFTGWVP 89 (579)
Q Consensus 78 ~l~~N~l~~~~p 89 (579)
+|++|+|++.+|
T Consensus 539 ~L~~N~l~~~~~ 550 (567)
T 1dce_A 539 NLQGNSLCQEEG 550 (567)
T ss_dssp ECTTSGGGGSSS
T ss_pred EecCCcCCCCcc
Confidence 999999998766
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.1e-11 Score=135.70 Aligned_cols=92 Identities=27% Similarity=0.317 Sum_probs=61.3
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|+..+..+..+. |+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeC
Confidence 456666677777666 66666667777777777777776 566667777777777777777765554565554 777777
Q ss_pred ccCcCCCCCcccccc
Q 008055 80 ANNRFTGWVPEQLKN 94 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~ 94 (579)
++|.|++.+|..+..
T Consensus 324 ~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 324 EGNPLEKQFLKILTE 338 (727)
T ss_dssp TTSCCCSHHHHHHHH
T ss_pred CCCccCCCChHHHhh
Confidence 777777666665543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.7e-10 Score=125.88 Aligned_cols=105 Identities=23% Similarity=0.346 Sum_probs=84.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.|++..|..|+.+++|+.|+|++|.|++..|..|+++++|+.|+|++|.|++.++. +..++ |+.|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 46888999999999887778888999999999999999887777888899999999999999887765 46665 89999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|.|++..|..+..+ .+...+|.+.
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 99999988877766554 3444455443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=118.23 Aligned_cols=100 Identities=17% Similarity=0.200 Sum_probs=83.2
Q ss_pred cEEeccCC-cCCCCchhhhCCCCCCCEEeccC-CcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcc
Q 008055 5 KYLNIAHN-QLQGQLNDMFGQLPSLSTLDLSF-NTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIA 80 (579)
Q Consensus 5 ~~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~ 80 (579)
..++++++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.++. |..++ |+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 898 5888 99999999999996 999988888999999999999999999999875 77776 9999999
Q ss_pred cCcCCCCCccccccC---eeeccCCCCCC
Q 008055 81 NNRFTGWVPEQLKNI---NLQKDGNSWSS 106 (579)
Q Consensus 81 ~N~l~~~~p~~l~~~---~~~~~~n~~~~ 106 (579)
+|+|++..|..+..+ .+...+|.+.|
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccC
Confidence 999997666666554 33445555544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.9e-10 Score=112.51 Aligned_cols=105 Identities=24% Similarity=0.251 Sum_probs=79.4
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
++|++|+|++|++++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++ .+..++ |+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 358888898888887777788888888899998888887767788888888888888888888774 366665 888888
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.+++..+..+..+ .+...+|.+..
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccce
Confidence 8888887666555444 33444554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=129.84 Aligned_cols=102 Identities=24% Similarity=0.277 Sum_probs=78.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
+.+|+.|+|++|.|. .+|..+..|++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+..+..+..+. |+.|+|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEEC
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEEC
Confidence 467888888888888 67777778888888888888888 788888888888888888888886655677765 888888
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
++|.|+ .+|..|..+ .+...+|.+.
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 888886 677666655 3344455543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.9e-10 Score=124.36 Aligned_cols=94 Identities=26% Similarity=0.379 Sum_probs=50.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
++|++|+|++|.+++..|..|+++++|+.|+|++|.|++..|..|++|++|++|+|++|+|++.++ .+..+. |+.|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 455555555555555445555555555555555555555555555555555555555555555442 244443 555555
Q ss_pred ccCcCCC-CCccccccC
Q 008055 80 ANNRFTG-WVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~-~~p~~l~~~ 95 (579)
++|.+++ .+|..+..+
T Consensus 136 ~~n~l~~~~lp~~~~~l 152 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNL 152 (606)
T ss_dssp CSSCCCCCCCCGGGGTC
T ss_pred CCCcccceechHhHhhc
Confidence 5555554 345444433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.3e-10 Score=120.41 Aligned_cols=106 Identities=25% Similarity=0.351 Sum_probs=86.3
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
+++|++|+|++|++++..|..|+++++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++.++ .+..++ |+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 4689999999999998888889999999999999999998888889999999999999999988865 466665 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|+|++..+..+..+ .+...+|++.|
T Consensus 378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 99999987666555443 44556666544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.7e-10 Score=111.43 Aligned_cols=95 Identities=27% Similarity=0.404 Sum_probs=63.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
+++|++|+|++|++++..+..|.++++|+.|+|++|.|++..|..|.++++|+.|+|++|++++..+ .+..++ |+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 3567777777777776666667777777777777777776666667777777777777777776654 255554 77777
Q ss_pred cccCcCCCC-CccccccC
Q 008055 79 IANNRFTGW-VPEQLKNI 95 (579)
Q Consensus 79 l~~N~l~~~-~p~~l~~~ 95 (579)
|++|.+++. +|..+..+
T Consensus 131 l~~n~l~~~~l~~~~~~l 148 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNL 148 (276)
T ss_dssp CCSSCCCCCCCCGGGGGC
T ss_pred CcCCccceecCchhhccC
Confidence 777777652 45555443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.2e-10 Score=113.85 Aligned_cols=106 Identities=25% Similarity=0.387 Sum_probs=89.0
Q ss_pred CCCCcEEeccCCcCCCCch-hhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccC-cc-cccCCCC-CCe
Q 008055 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSG-TI-DVLANLP-LDN 76 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~-~~~~~~~-L~~ 76 (579)
+++|++|+|++|.+++..+ ..|..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|.+++ .+ ..+..++ |+.
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 5789999999999997655 689999999999999999999899999999999999999999997 33 4577775 999
Q ss_pred EEcccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 77 LNIANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 77 l~l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|+|++|.+++..|..+..+ .+...+|.+..
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 9999999998888777654 34455565543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.06 E-value=4.2e-10 Score=115.96 Aligned_cols=95 Identities=21% Similarity=0.334 Sum_probs=64.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|.+++..+..|+.+++|+.|+|++|.+++..|..|.++++|+.|+|++|+|+..++. +..++ |+.|+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 45677777777777766666777777777777777777766666677777777777777777766554 35554 77777
Q ss_pred cccCcCCCCCccccccC
Q 008055 79 IANNRFTGWVPEQLKNI 95 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~ 95 (579)
|++|.+++..|..+..+
T Consensus 148 L~~n~l~~~~~~~~~~l 164 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQAT 164 (390)
T ss_dssp CCSSCCCBCCTTTTSSC
T ss_pred CCCCccCccChhhccCC
Confidence 77777776655555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-10 Score=123.95 Aligned_cols=104 Identities=19% Similarity=0.167 Sum_probs=79.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCcccc-CCCCCCeeEeecccccCcccccCCCCCCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFS-SLSSLSSLYLQNNQFSGTIDVLANLPLDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l 79 (579)
+++|+.|+|++|.|++..|..|+.+++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++.++......|+.|+|
T Consensus 119 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L 198 (487)
T 3oja_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDL 198 (487)
T ss_dssp CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEEC
T ss_pred cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEEC
Confidence 35678888888888888888888888999999999999888888876 78899999999999888755443234899999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
++|.|++.+|. +..+ .+...+|.+.
T Consensus 199 s~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 199 SSNKLAFMGPE-FQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CSSCCCEECGG-GGGGTTCSEEECTTSCCC
T ss_pred CCCCCCCCCHh-HcCCCCccEEEecCCcCc
Confidence 99999875554 4433 3445555554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.2e-10 Score=123.67 Aligned_cols=102 Identities=16% Similarity=0.251 Sum_probs=84.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhC-CCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFG-QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~ 78 (579)
|++|++|+|++|.|++.+|..|. .+++|+.|+|++|.|++. | .+..+++|+.|+|++|+|++.++.+..++ |+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWIS 220 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEE
Confidence 46899999999999998998887 799999999999999965 3 34569999999999999999888877775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|.|++ +|..+..+ .+...+|.+.
T Consensus 221 Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 221 LRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred ecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 99999996 66655443 3444555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.5e-10 Score=115.46 Aligned_cols=86 Identities=17% Similarity=0.223 Sum_probs=66.8
Q ss_pred CCCCcEEeccCCcCCCCchhhh--CCCCCCCEEeccCCcCCCCCCccccCC-----CCCCeeEeecccccCccc-ccCCC
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMF--GQLPSLSTLDLSFNTLSGNLPQSFSSL-----SSLSSLYLQNNQFSGTID-VLANL 72 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~~~~~-~~~~~ 72 (579)
+++|++|+|++|++++.+|..+ +.+++|+.|+|++|+|++. |..++.+ ++|+.|+|++|+|++.++ .+..+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 4578888888888888787765 7788888888888888865 7777776 788888888888887774 46666
Q ss_pred C-CCeEEcccCcCCCC
Q 008055 73 P-LDNLNIANNRFTGW 87 (579)
Q Consensus 73 ~-L~~l~l~~N~l~~~ 87 (579)
+ |+.|+|++|++.|.
T Consensus 173 ~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 173 PALSTLDLSDNPELGE 188 (312)
T ss_dssp SSCCEEECCSCTTCHH
T ss_pred CCCCEEECCCCCcCcc
Confidence 5 88888888887664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=2.9e-10 Score=119.26 Aligned_cols=90 Identities=21% Similarity=0.302 Sum_probs=45.9
Q ss_pred CCCcEEeccCCc-CCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQ-LQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
++|+.|+|++|+ +....+..|.++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 237 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEE
Confidence 455566665533 33222234555555555555555555 344 355555555555555555554432 44443 55555
Q ss_pred cccCcCCCCCccccc
Q 008055 79 IANNRFTGWVPEQLK 93 (579)
Q Consensus 79 l~~N~l~~~~p~~l~ 93 (579)
|++|.|++..|..+.
T Consensus 238 L~~n~l~~~~~~~~~ 252 (440)
T 3zyj_A 238 MIQSQIQVIERNAFD 252 (440)
T ss_dssp CTTCCCCEECTTSST
T ss_pred CCCCceeEEChhhhc
Confidence 555555554444443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=3e-10 Score=121.82 Aligned_cols=92 Identities=21% Similarity=0.180 Sum_probs=80.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCC-CCCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANL-PLDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~l~l~ 80 (579)
++|++|+|++|.+++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++. .+ .|+.|+|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~ 98 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLS 98 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEecc
Confidence 4789999999999988888999999999999999999988889999999999999999999965544 45 49999999
Q ss_pred cCcCCC-CCccccccC
Q 008055 81 NNRFTG-WVPEQLKNI 95 (579)
Q Consensus 81 ~N~l~~-~~p~~l~~~ 95 (579)
+|.+++ .+|..+..+
T Consensus 99 ~N~l~~~~~p~~~~~l 114 (520)
T 2z7x_B 99 FNAFDALPICKEFGNM 114 (520)
T ss_dssp SSCCSSCCCCGGGGGC
T ss_pred CCccccccchhhhccC
Confidence 999987 577776655
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.03 E-value=5.5e-10 Score=121.86 Aligned_cols=104 Identities=23% Similarity=0.272 Sum_probs=87.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.|++..|..|+++++|+.|+|++|.|++..+..|+++++|+.|+|++|.|++.++. +..++ |+.|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 57899999999999998888999999999999999999965555679999999999999999998874 77775 99999
Q ss_pred cccCcCCCCCccccccC-eeeccCCCC
Q 008055 79 IANNRFTGWVPEQLKNI-NLQKDGNSW 104 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~-~~~~~~n~~ 104 (579)
|++|.|++..+..+..+ .+...+|.+
T Consensus 178 L~~N~l~~~~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 178 LSSNRLTHVDLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CTTSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred CcCCCCCCcChhhhhhhhhhhcccCcc
Confidence 99999998766666655 334444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.03 E-value=1.6e-10 Score=104.97 Aligned_cols=100 Identities=21% Similarity=0.290 Sum_probs=76.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCC-CCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccccc-CCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQL-PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVL-ANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~-L~~l 77 (579)
+.+|+.|+|++|+++. +|. +..+ ++|+.|+|++|.|++. ..|..+++|+.|+|++|+|++.++.+ ..++ |+.|
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 3678999999999984 565 4444 4999999999999964 68899999999999999999877553 6665 9999
Q ss_pred EcccCcCCCCCcc--ccccC----eeeccCCCCC
Q 008055 78 NIANNRFTGWVPE--QLKNI----NLQKDGNSWS 105 (579)
Q Consensus 78 ~l~~N~l~~~~p~--~l~~~----~~~~~~n~~~ 105 (579)
+|++|.|+ .+|. .+..+ .+...+|.+.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 99999996 4554 45443 3445566554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.4e-10 Score=119.09 Aligned_cols=94 Identities=23% Similarity=0.376 Sum_probs=77.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|+|++..|..|.++++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 4678888999988887788888888899999988888887788888888888888888888887754 56665 888888
Q ss_pred ccCcCCCCCccccccC
Q 008055 80 ANNRFTGWVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~ 95 (579)
++|.+++..|..+..+
T Consensus 112 s~n~i~~~~~~~~~~l 127 (477)
T 2id5_A 112 SENKIVILLDYMFQDL 127 (477)
T ss_dssp TTSCCCEECTTTTTTC
T ss_pred CCCccccCChhHcccc
Confidence 8888887777666544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=9.2e-10 Score=112.10 Aligned_cols=142 Identities=15% Similarity=0.176 Sum_probs=104.6
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeC--CCCCCchhHHHHHHHHHHHhhcC--CCCccceeeEEeeC---CeEEEEE
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKID--SSALPSEMCDDFIEMVSNISQLH--HPNIMELVGYCSEY---GQHLLVY 348 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 348 (579)
.+.|+.|.++.||+....+ ..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 5678999999999998764 578888775 32211 12346677888888876 45678888888776 5589999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC----------------------------------- 393 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 393 (579)
||++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997775421 224677888899999999999999731
Q ss_pred --------------------CCCeEEcCCCCCCEEEcCCCc--eEEeccccccc
Q 008055 394 --------------------SLSVVHKNIKSANILLDNELN--PQLSDCGLASN 425 (579)
Q Consensus 394 --------------------~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~~~~ 425 (579)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 58999998753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.02 E-value=3.2e-10 Score=113.03 Aligned_cols=104 Identities=20% Similarity=0.245 Sum_probs=71.1
Q ss_pred CCCCcEEeccCCcCCCC--ch--hhhCCCCCCCEEeccCCcCCCCCCc----cccCCCCCCeeEeecccccCcc-cccCC
Q 008055 1 MKTLKYLNIAHNQLQGQ--LN--DMFGQLPSLSTLDLSFNTLSGNLPQ----SFSSLSSLSSLYLQNNQFSGTI-DVLAN 71 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~--~p--~~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~-~~~~~ 71 (579)
|++|++|+|++|++.+. ++ ..++.+++|+.|+|++|+|+ .+|. .+.++++|+.|+|++|+|++.. +.+..
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 246 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR 246 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence 46788999999988653 22 22367888888888888887 3444 2567788888888888888874 33444
Q ss_pred C----CCCeEEcccCcCCCCCccccc-cC-eeeccCCCCCC
Q 008055 72 L----PLDNLNIANNRFTGWVPEQLK-NI-NLQKDGNSWSS 106 (579)
Q Consensus 72 ~----~L~~l~l~~N~l~~~~p~~l~-~~-~~~~~~n~~~~ 106 (579)
+ .|+.|+|++|.|+ .+|..+. .+ .+....|.+.+
T Consensus 247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 247 CMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR 286 (310)
T ss_dssp CCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred ccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence 3 4888888888888 5665442 23 34445555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.02 E-value=2.7e-10 Score=103.42 Aligned_cols=86 Identities=27% Similarity=0.244 Sum_probs=72.6
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc--ccCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~l~ 78 (579)
++|++|+|++|.|++. +.|+.+++|+.|+|++|.|++..|..+..+++|+.|+|++|+|+..++ .+..++ |+.|+
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEE
Confidence 4899999999999965 679999999999999999996544555899999999999999987665 566665 99999
Q ss_pred cccCcCCCCCcc
Q 008055 79 IANNRFTGWVPE 90 (579)
Q Consensus 79 l~~N~l~~~~p~ 90 (579)
+++|+++ .+|.
T Consensus 120 l~~N~i~-~~~~ 130 (176)
T 1a9n_A 120 ILRNPVT-NKKH 130 (176)
T ss_dssp CCSSGGG-GSTT
T ss_pred ecCCCCC-CcHh
Confidence 9999998 4454
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=5.6e-10 Score=112.25 Aligned_cols=88 Identities=33% Similarity=0.459 Sum_probs=49.5
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
++|++|+|++|.++ .+|..+. ++|+.|+|++|.+++..|..|..+++|+.|+|++|+|++.++ .+..++ |+.|+|
T Consensus 171 ~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 247 (330)
T 1xku_A 171 KKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247 (330)
T ss_dssp TTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred CCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEEC
Confidence 45666666666665 2443332 556666666666665555566666666666666666665544 244443 666666
Q ss_pred ccCcCCCCCccccc
Q 008055 80 ANNRFTGWVPEQLK 93 (579)
Q Consensus 80 ~~N~l~~~~p~~l~ 93 (579)
++|.|+ .+|..+.
T Consensus 248 ~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 248 NNNKLV-KVPGGLA 260 (330)
T ss_dssp CSSCCS-SCCTTTT
T ss_pred CCCcCc-cCChhhc
Confidence 666665 4554443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.8e-10 Score=126.64 Aligned_cols=94 Identities=15% Similarity=0.281 Sum_probs=81.1
Q ss_pred CCCCcEEeccCCcCCCC-----------------chhhhC--CCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeeccc
Q 008055 1 MKTLKYLNIAHNQLQGQ-----------------LNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 61 (579)
|++|++|+|++|.|+|. +|..++ ++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 57899999999999986 999999 99999999999999999999999999999999999998
Q ss_pred -ccC-ccc-ccCCC-------CCCeEEcccCcCCCCCcc--ccccC
Q 008055 62 -FSG-TID-VLANL-------PLDNLNIANNRFTGWVPE--QLKNI 95 (579)
Q Consensus 62 -l~~-~~~-~~~~~-------~L~~l~l~~N~l~~~~p~--~l~~~ 95 (579)
|+| .+| .+..+ .|+.|+|++|.++ .+|. .+..+
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l 329 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKM 329 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTC
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccC
Confidence 998 554 35443 4899999999998 7887 66555
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3.8e-10 Score=118.78 Aligned_cols=92 Identities=20% Similarity=0.295 Sum_probs=50.1
Q ss_pred CCCCcEEeccCC-cCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeE
Q 008055 1 MKTLKYLNIAHN-QLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l 77 (579)
|++|+.|+|++| .+....+..|.++++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.++. +..++ |+.|
T Consensus 170 l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 247 (452)
T 3zyi_A 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247 (452)
T ss_dssp CTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE
T ss_pred CCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEE
Confidence 345666666663 3332223345666666666666666663 33 355566666666666666655432 44443 6666
Q ss_pred EcccCcCCCCCcccccc
Q 008055 78 NIANNRFTGWVPEQLKN 94 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~ 94 (579)
+|++|.+++..|..+..
T Consensus 248 ~L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 248 WVMNSQVSLIERNAFDG 264 (452)
T ss_dssp ECTTSCCCEECTTTTTT
T ss_pred EeCCCcCceECHHHhcC
Confidence 66666666555544443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.02 E-value=9.6e-11 Score=128.80 Aligned_cols=94 Identities=19% Similarity=0.353 Sum_probs=84.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCc-CCC-CCCccccCC------CCCCeeEeecccccCccc--ccC
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNT-LSG-NLPQSFSSL------SSLSSLYLQNNQFSGTID--VLA 70 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~~--~~~ 70 (579)
|++|++|+|++|++.|.+|..|+++++|+.|+|++|+ |+| .+|..++++ ++|+.|+|++|+|+..++ .+.
T Consensus 248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~ 327 (636)
T 4eco_A 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327 (636)
T ss_dssp CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHT
T ss_pred cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhc
Confidence 5789999999999999999999999999999999998 998 899999887 999999999999996666 688
Q ss_pred CCC-CCeEEcccCcCCCCCccccccC
Q 008055 71 NLP-LDNLNIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 71 ~~~-L~~l~l~~N~l~~~~p~~l~~~ 95 (579)
.++ |+.|+|++|.++|.+| .+..+
T Consensus 328 ~l~~L~~L~L~~N~l~g~ip-~~~~l 352 (636)
T 4eco_A 328 KMKKLGMLECLYNQLEGKLP-AFGSE 352 (636)
T ss_dssp TCTTCCEEECCSCCCEEECC-CCEEE
T ss_pred cCCCCCEEeCcCCcCccchh-hhCCC
Confidence 876 9999999999999999 66554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.7e-10 Score=129.88 Aligned_cols=93 Identities=23% Similarity=0.386 Sum_probs=73.1
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEec-cCCcCCCC----------------------------------------
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDL-SFNTLSGN---------------------------------------- 41 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l-~~N~l~g~---------------------------------------- 41 (579)
+++.|+|++|+|+|.+|+.|++|++|+.|+| ++|.++|.
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l 403 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403 (876)
T ss_dssp CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence 5678888888888888888888888888888 77655444
Q ss_pred ------------------------------------CCccccCCCCCCeeEeecccccC------------------ccc
Q 008055 42 ------------------------------------LPQSFSSLSSLSSLYLQNNQFSG------------------TID 67 (579)
Q Consensus 42 ------------------------------------~p~~~~~l~~L~~L~l~~N~l~~------------------~~~ 67 (579)
||..|++|++|+.|+|++|+|+| .|+
T Consensus 404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~ 483 (876)
T 4ecn_A 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483 (876)
T ss_dssp HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh
Confidence 77788888888888888888888 445
Q ss_pred ccC--CCC-CCeEEcccCcCCCCCccccccC
Q 008055 68 VLA--NLP-LDNLNIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 68 ~~~--~~~-L~~l~l~~N~l~~~~p~~l~~~ 95 (579)
.+. .++ |+.|+|++|.+.|.+|..+..+
T Consensus 484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred hhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 555 665 8888888888888888777655
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.01 E-value=5.8e-10 Score=117.39 Aligned_cols=94 Identities=26% Similarity=0.318 Sum_probs=83.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 4789999999999988899999999999999999999988889999999999999999999988865 66675 999999
Q ss_pred ccCcCCCCCccccccC
Q 008055 80 ANNRFTGWVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~ 95 (579)
++|.|++..+..+..+
T Consensus 155 ~~N~l~~~~~~~~~~l 170 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRV 170 (452)
T ss_dssp CSCCCCEECTTTTTTC
T ss_pred CCCCcceeCHhHHhcC
Confidence 9999996665555444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.8e-10 Score=122.30 Aligned_cols=106 Identities=24% Similarity=0.370 Sum_probs=79.1
Q ss_pred CCCCcEEeccCCcCCCCch-hhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeeccccc-Cccc-ccCCCC-CCe
Q 008055 1 MKTLKYLNIAHNQLQGQLN-DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS-GTID-VLANLP-LDN 76 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-~~~~-~~~~~~-L~~ 76 (579)
+++|++|+|++|.+.+..| ..|..+++|+.|+|++|.+++.+|..+.++++|+.|+|++|.++ +.+| .+..++ |+.
T Consensus 395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 4678888888888887665 46788888888888888888888888888888888888888887 3444 466665 888
Q ss_pred EEcccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 77 LNIANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 77 l~l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|+|++|.+++..|..+..+ .+...+|.+.+
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 508 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred EECCCCccccCChhhhhcccCCCEEeCCCCcCCC
Confidence 8888888888777766554 34445554443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=5.5e-10 Score=118.38 Aligned_cols=105 Identities=22% Similarity=0.271 Sum_probs=88.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.+++..|..|+++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 57899999999999988899999999999999999999966666789999999999999999988764 66675 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|.+++..|..+..+ .+...+|.+.
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 99999998877766655 3444455443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.00 E-value=6.5e-10 Score=120.43 Aligned_cols=102 Identities=20% Similarity=0.186 Sum_probs=84.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
++|++|+|++|.|++..|..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+..++. .++ |+.|+|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls 129 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLS 129 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECC
Confidence 5789999999999988888999999999999999999988899999999999999999999965544 554 9999999
Q ss_pred cCcCCC-CCccccccC----eeeccCCCCC
Q 008055 81 NNRFTG-WVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 81 ~N~l~~-~~p~~l~~~----~~~~~~n~~~ 105 (579)
+|.+++ .+|..+..+ .+...+|.+.
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~ 159 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCC
T ss_pred CCCccccCchHhhcccCcccEEecCCCccc
Confidence 999987 456666655 3344455543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.2e-10 Score=103.59 Aligned_cols=86 Identities=23% Similarity=0.341 Sum_probs=77.6
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeeccc-ccCcccccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ-FSGTIDVLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~-L~~l~ 78 (579)
|++|++|+|++|.+++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|. ++.. +.+..++ |+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEE
Confidence 5789999999999998888899999999999999999998889999999999999999998 5554 5666665 99999
Q ss_pred cccCcCCCC
Q 008055 79 IANNRFTGW 87 (579)
Q Consensus 79 l~~N~l~~~ 87 (579)
+++|.+++.
T Consensus 166 l~~n~i~~~ 174 (197)
T 4ezg_A 166 IQFDGVHDY 174 (197)
T ss_dssp CTTBCCCCC
T ss_pred CCCCCCcCh
Confidence 999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=8.4e-10 Score=120.64 Aligned_cols=105 Identities=21% Similarity=0.250 Sum_probs=90.9
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
++|++|+|++|.+++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.+| .+..++ |+.|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 579999999999998888899999999999999999998889999999999999999999999865 477776 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.+++..|..+..+ .+...+|....
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 142 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHS 142 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccc
Confidence 9999998777766655 34455555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.98 E-value=6.8e-10 Score=110.76 Aligned_cols=106 Identities=20% Similarity=0.247 Sum_probs=76.9
Q ss_pred CCCCcEEeccCCcCCCC--chhhh--CCCCCCCEEeccCCcCCC--CCC-ccccCCCCCCeeEeecccccCccc--ccCC
Q 008055 1 MKTLKYLNIAHNQLQGQ--LNDMF--GQLPSLSTLDLSFNTLSG--NLP-QSFSSLSSLSSLYLQNNQFSGTID--VLAN 71 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~--~p~~~--~~l~~L~~L~l~~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~ 71 (579)
|++|++|+|++|++.+. +|..+ +.+++|+.|+|++|+|++ .++ ..+.++++|+.|+|++|+|++.++ .+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 56889999999998765 34455 888999999999999983 223 334577899999999999998773 3444
Q ss_pred CC-CCeEEcccCcCCCCCccccc-cC-eeeccCCCCCCC
Q 008055 72 LP-LDNLNIANNRFTGWVPEQLK-NI-NLQKDGNSWSSG 107 (579)
Q Consensus 72 ~~-L~~l~l~~N~l~~~~p~~l~-~~-~~~~~~n~~~~~ 107 (579)
++ |+.|+|++|.|+ .+|..+. .+ .+...+|.+...
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDRN 289 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSSCCCSC
T ss_pred cCCCCEEECCCCccC-hhhhhccCCceEEECCCCCCCCC
Confidence 54 999999999998 7776654 33 344455655443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=5.9e-10 Score=113.27 Aligned_cols=94 Identities=26% Similarity=0.288 Sum_probs=77.7
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|++++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 4789999999999976666899999999999999999987788899999999999999999987765 67675 999999
Q ss_pred ccCcCCCCCc-cccccC
Q 008055 80 ANNRFTGWVP-EQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p-~~l~~~ 95 (579)
++|.+++..+ ..+..+
T Consensus 132 ~~n~l~~l~~~~~~~~l 148 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHL 148 (353)
T ss_dssp TTCCCSSSCSSCSCTTC
T ss_pred CCCCCcccCchhhhccC
Confidence 9999985433 244433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=9.3e-10 Score=120.30 Aligned_cols=105 Identities=24% Similarity=0.213 Sum_probs=78.7
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
.++++|+|++|.|++..|..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++ .+..++ |+.|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 357888888888887778888888888888888888887778888888888888888888887765 366665 888888
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
++|.+++..|..+..+ .+...+|.+..
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccc
Confidence 8888887555555444 33444454443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.97 E-value=7e-10 Score=111.68 Aligned_cols=87 Identities=28% Similarity=0.260 Sum_probs=44.5
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEccc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIAN 81 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~~ 81 (579)
+|++|+|++|.+++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+..++.+..++ |+.|++++
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~ 273 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHT 273 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCS
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCC
Confidence 44555555555554444555555555555555555554444455555555555555555554333344443 55555555
Q ss_pred CcCCCCCc
Q 008055 82 NRFTGWVP 89 (579)
Q Consensus 82 N~l~~~~p 89 (579)
|+|++..+
T Consensus 274 N~l~~~~~ 281 (332)
T 2ft3_A 274 NNITKVGV 281 (332)
T ss_dssp SCCCBCCT
T ss_pred CCCCccCh
Confidence 55554333
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=6.9e-10 Score=119.76 Aligned_cols=94 Identities=23% Similarity=0.280 Sum_probs=80.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|++++..|..|+++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++. +..++ |+.|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 4789999999999988888899999999999999999988888899999999999999999998875 77775 999999
Q ss_pred ccCcCCC-CCccccccC
Q 008055 80 ANNRFTG-WVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~-~~p~~l~~~ 95 (579)
++|.+++ .+|..+..+
T Consensus 106 s~n~l~~~~~~~~~~~l 122 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNL 122 (549)
T ss_dssp TTCCCSSSCSSCSCTTC
T ss_pred CCCcccccchhhhhhcc
Confidence 9999986 355555444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-09 Score=109.84 Aligned_cols=93 Identities=25% Similarity=0.303 Sum_probs=74.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEccc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIAN 81 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~ 81 (579)
++|++|+|++|.+++..|..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+..++.+. ..|+.|++++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~-~~L~~L~l~~ 132 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP-SSLVELRIHD 132 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC-TTCCEEECCS
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc-ccCCEEECCC
Confidence 468888888888887777788888889999999988887778888888889999998888886655443 4588888888
Q ss_pred CcCCCCCccccccC
Q 008055 82 NRFTGWVPEQLKNI 95 (579)
Q Consensus 82 N~l~~~~p~~l~~~ 95 (579)
|.+++..+..+..+
T Consensus 133 n~i~~~~~~~~~~l 146 (332)
T 2ft3_A 133 NRIRKVPKGVFSGL 146 (332)
T ss_dssp SCCCCCCSGGGSSC
T ss_pred CccCccCHhHhCCC
Confidence 88886655555544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.1e-09 Score=110.79 Aligned_cols=103 Identities=23% Similarity=0.277 Sum_probs=85.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.+++..|..|+++++|+.|+|++|+|+...+..|.++++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence 57899999999999988888999999999999999999954444468999999999999999998764 77775 99999
Q ss_pred cccCcCCCCCccccccC-eeeccCCC
Q 008055 79 IANNRFTGWVPEQLKNI-NLQKDGNS 103 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~-~~~~~~n~ 103 (579)
+++|.+++.....+..+ .+...+|.
T Consensus 172 l~~n~l~~~~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 172 LSSNRLTHVDLSLIPSLFHANVSYNL 197 (390)
T ss_dssp CCSSCCSBCCGGGCTTCSEEECCSSC
T ss_pred CCCCcCCccccccccccceeeccccc
Confidence 99999997655555555 33334443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.97 E-value=5.3e-10 Score=106.86 Aligned_cols=88 Identities=24% Similarity=0.371 Sum_probs=74.7
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCc-CCCCCCccccCCCCCCeeEeec-ccccCccc-ccCCCC-CCeE
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNT-LSGNLPQSFSSLSSLSSLYLQN-NQFSGTID-VLANLP-LDNL 77 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~~-~~~~~~-L~~l 77 (579)
.+|++|+|++|+|++..+..|+++++|+.|+|++|+ +++..+..|.++++|+.|+|++ |+|++.++ .+..++ |+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 468999999999997777789999999999999997 8866666899999999999998 99998775 366664 9999
Q ss_pred EcccCcCCCCCcc
Q 008055 78 NIANNRFTGWVPE 90 (579)
Q Consensus 78 ~l~~N~l~~~~p~ 90 (579)
++++|.+++ +|.
T Consensus 111 ~l~~n~l~~-lp~ 122 (239)
T 2xwt_C 111 GIFNTGLKM-FPD 122 (239)
T ss_dssp EEEEECCCS-CCC
T ss_pred eCCCCCCcc-ccc
Confidence 999999986 664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-09 Score=121.12 Aligned_cols=94 Identities=29% Similarity=0.374 Sum_probs=61.4
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|++|+|++|.|++..+..|+++++|+.|+|++|.+++..|..|+++++|+.|+|++|+|++.++. +..+. |+.|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 3566777777777766666677777777777777777766666666777777777777777666543 55554 677777
Q ss_pred ccCcCCCCCccccccC
Q 008055 80 ANNRFTGWVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~ 95 (579)
++|.+++..|..+..+
T Consensus 105 ~~n~l~~~~~~~~~~l 120 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQ 120 (680)
T ss_dssp CSSCCCCCCSCTTTTC
T ss_pred CCCccCccChhHcccc
Confidence 7776665555554443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.7e-10 Score=127.15 Aligned_cols=104 Identities=18% Similarity=0.232 Sum_probs=86.8
Q ss_pred CCCCcEEeccCCcCCC-----------------CchhhhC--CCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeeccc
Q 008055 1 MKTLKYLNIAHNQLQG-----------------QLNDMFG--QLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 61 (579)
|++|++|+|++|+|+| .+|+.++ +|++|+.|+|++|++.|.+|..|++|++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 5789999999999998 3899988 99999999999999999999999999999999999998
Q ss_pred -ccC-cccc-cCC-------C-CCCeEEcccCcCCCCCcc--ccccC----eeeccCCCCC
Q 008055 62 -FSG-TIDV-LAN-------L-PLDNLNIANNRFTGWVPE--QLKNI----NLQKDGNSWS 105 (579)
Q Consensus 62 -l~~-~~~~-~~~-------~-~L~~l~l~~N~l~~~~p~--~l~~~----~~~~~~n~~~ 105 (579)
|+| .+|. +.. + .|+.|+|++|.|+ .+|. .+..+ .+...+|.+.
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~ 586 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR 586 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc
Confidence 998 4542 332 2 4999999999999 8887 66655 3444555544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.5e-10 Score=111.93 Aligned_cols=84 Identities=18% Similarity=0.188 Sum_probs=45.1
Q ss_pred CCCcEEeccCCcCCCCch----hhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCc---ccc--cCCC
Q 008055 2 KTLKYLNIAHNQLQGQLN----DMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT---IDV--LANL 72 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p----~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---~~~--~~~~ 72 (579)
++|++|+|++|.+++..+ ..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+. ++. +..+
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 455666666666655333 2334556666666666666655555566666666666666665442 111 1233
Q ss_pred C-CCeEEcccCcCC
Q 008055 73 P-LDNLNIANNRFT 85 (579)
Q Consensus 73 ~-L~~l~l~~N~l~ 85 (579)
+ |+.|+|++|.++
T Consensus 197 ~~L~~L~Ls~N~l~ 210 (310)
T 4glp_A 197 PAIQNLALRNTGME 210 (310)
T ss_dssp CCCCSCBCCSSCCC
T ss_pred CCCCEEECCCCCCC
Confidence 3 555555555554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.3e-09 Score=118.19 Aligned_cols=83 Identities=27% Similarity=0.319 Sum_probs=38.2
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEcc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNIA 80 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l~ 80 (579)
+|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|++++.++ .+..++ |+.|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 34445555555544444444444555555555554444444444444444444444444444432 233332 4444444
Q ss_pred cCcCC
Q 008055 81 NNRFT 85 (579)
Q Consensus 81 ~N~l~ 85 (579)
+|.++
T Consensus 109 ~n~l~ 113 (570)
T 2z63_A 109 ETNLA 113 (570)
T ss_dssp TSCCC
T ss_pred ccccc
Confidence 44444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=1e-09 Score=111.49 Aligned_cols=77 Identities=18% Similarity=0.253 Sum_probs=35.2
Q ss_pred EeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcccCcC
Q 008055 7 LNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIANNRF 84 (579)
Q Consensus 7 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~N~l 84 (579)
.++++|+++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+|++|.+
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 444444444 3443332 2455555555555433333445555555555555555444332 33333 55555555555
Q ss_pred CC
Q 008055 85 TG 86 (579)
Q Consensus 85 ~~ 86 (579)
++
T Consensus 113 ~~ 114 (353)
T 2z80_A 113 SN 114 (353)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.8e-09 Score=108.55 Aligned_cols=93 Identities=25% Similarity=0.343 Sum_probs=75.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEccc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIAN 81 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~ 81 (579)
++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+..+..+. ..|+.|++++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~-~~L~~L~l~~ 130 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP-KTLQELRVHE 130 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCC-TTCCEEECCS
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhc-ccccEEECCC
Confidence 468889999999987777788899999999999999998778889999999999999999886554433 3588899999
Q ss_pred CcCCCCCccccccC
Q 008055 82 NRFTGWVPEQLKNI 95 (579)
Q Consensus 82 N~l~~~~p~~l~~~ 95 (579)
|.+++..+..+..+
T Consensus 131 n~l~~~~~~~~~~l 144 (330)
T 1xku_A 131 NEITKVRKSVFNGL 144 (330)
T ss_dssp SCCCBBCHHHHTTC
T ss_pred CcccccCHhHhcCC
Confidence 98887766555444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.4e-09 Score=114.00 Aligned_cols=94 Identities=26% Similarity=0.299 Sum_probs=80.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +..++ |+.|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 4689999999999988888999999999999999999987778899999999999999999988764 66665 999999
Q ss_pred ccCcCCCCCccccccC
Q 008055 80 ANNRFTGWVPEQLKNI 95 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~ 95 (579)
++|.|++..+..+..+
T Consensus 144 ~~N~i~~~~~~~~~~l 159 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRI 159 (440)
T ss_dssp CSCCCCEECTTTTTTC
T ss_pred CCCcccccCHHHhhhC
Confidence 9999986666555544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.5e-09 Score=118.66 Aligned_cols=87 Identities=23% Similarity=0.258 Sum_probs=76.8
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
|++|++|+|++|++++..|..|+++++|+.|+|++|.+++..|..|+++++|+.|+|++|+|++..+ .+..++ |+.|+
T Consensus 56 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~ 135 (606)
T 3t6q_A 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135 (606)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEE
T ss_pred CccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEE
Confidence 5789999999999998889999999999999999999998889999999999999999999998754 366665 99999
Q ss_pred cccCcCCCC
Q 008055 79 IANNRFTGW 87 (579)
Q Consensus 79 l~~N~l~~~ 87 (579)
|++|.+++.
T Consensus 136 L~~n~l~~~ 144 (606)
T 3t6q_A 136 LGSNHISSI 144 (606)
T ss_dssp CCSSCCCCC
T ss_pred CCCCccccc
Confidence 999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.94 E-value=7.6e-10 Score=105.80 Aligned_cols=94 Identities=18% Similarity=0.226 Sum_probs=78.5
Q ss_pred CCCCcEEeccCCc-CCCCchhhhCCCCCCCEEeccC-CcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CC--
Q 008055 1 MKTLKYLNIAHNQ-LQGQLNDMFGQLPSLSTLDLSF-NTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LD-- 75 (579)
Q Consensus 1 l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~-- 75 (579)
+++|++|+|++|. ++...+..|.++++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++.++ +..+. |+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIF 132 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSE
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccccc-cccccccccc
Confidence 5789999999997 8866667899999999999998 99997767789999999999999999998655 65664 77
Q ss_pred -eEEcccC-cCCCCCccccccC
Q 008055 76 -NLNIANN-RFTGWVPEQLKNI 95 (579)
Q Consensus 76 -~l~l~~N-~l~~~~p~~l~~~ 95 (579)
.|++++| .+++..+..+..+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l 154 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGL 154 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTT
T ss_pred cEEECCCCcchhhcCcccccch
Confidence 9999999 8987666556544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.2e-09 Score=117.03 Aligned_cols=105 Identities=24% Similarity=0.255 Sum_probs=76.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCC--CCCccccCCCCCCeeEeecccccCccc-c-cCCCC-CC
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG--NLPQSFSSLSSLSSLYLQNNQFSGTID-V-LANLP-LD 75 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~~~-L~ 75 (579)
+++|++|+|++|.+++.+|..|+.+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.+| . +..++ |+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4678888888888888788888888888888888888886 556778888888888888888888443 2 45554 88
Q ss_pred eEEcccCcCCCCCccccc-cC-eeeccCCCCC
Q 008055 76 NLNIANNRFTGWVPEQLK-NI-NLQKDGNSWS 105 (579)
Q Consensus 76 ~l~l~~N~l~~~~p~~l~-~~-~~~~~~n~~~ 105 (579)
.|+|++|.+++.+|..+. .+ .+...+|.+.
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 888888888777776552 33 3344444443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.92 E-value=7.5e-10 Score=110.71 Aligned_cols=98 Identities=26% Similarity=0.249 Sum_probs=81.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEccc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIAN 81 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~ 81 (579)
++|++|+|++|.|++..|..|+.+++|+.|+|++|.+++..| +..+++|+.|+|++|+|++.++. ..|+.|++++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~---~~L~~L~l~~ 108 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG---PSIETLHAAN 108 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEEC---TTCCEEECCS
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCC---CCcCEEECCC
Confidence 579999999999999888999999999999999999997554 99999999999999999976532 3589999999
Q ss_pred CcCCCCCccccccC-eeeccCCCC
Q 008055 82 NRFTGWVPEQLKNI-NLQKDGNSW 104 (579)
Q Consensus 82 N~l~~~~p~~l~~~-~~~~~~n~~ 104 (579)
|.+++..+..+..+ .+...+|.+
T Consensus 109 n~l~~~~~~~~~~L~~L~l~~N~l 132 (317)
T 3o53_A 109 NNISRVSCSRGQGKKNIYLANNKI 132 (317)
T ss_dssp SCCSEEEECCCSSCEEEECCSSCC
T ss_pred CccCCcCccccCCCCEEECCCCCC
Confidence 99988777666666 334444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.2e-09 Score=124.22 Aligned_cols=91 Identities=24% Similarity=0.310 Sum_probs=46.3
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCcc--ccCCCCCCeeEeecccccCccc--ccCCCC-CCe
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQS--FSSLSSLSSLYLQNNQFSGTID--VLANLP-LDN 76 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~ 76 (579)
++|++|+|++|.|++..|+.|+++++|+.|+|++|.|++.+|.. |.+|++|+.|+|++|.+++..+ .+..++ |+.
T Consensus 73 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~ 152 (844)
T 3j0a_A 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152 (844)
T ss_dssp TTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCE
T ss_pred CCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCE
Confidence 44555555555555444555555555555555555555444433 5555555555555555554432 244443 555
Q ss_pred EEcccCcCCCCCcccc
Q 008055 77 LNIANNRFTGWVPEQL 92 (579)
Q Consensus 77 l~l~~N~l~~~~p~~l 92 (579)
|+|++|.+++..|..+
T Consensus 153 L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 153 IDFSSNQIFLVCEHEL 168 (844)
T ss_dssp EEEESSCCCCCCSGGG
T ss_pred EECCCCcCCeeCHHHc
Confidence 5555555555444433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=117.48 Aligned_cols=95 Identities=29% Similarity=0.323 Sum_probs=78.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCc--ccccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT--IDVLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-L~~l 77 (579)
|++|++|+|++|++++..|+.|+++++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++. ++.+..++ |+.|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 57899999999999988888999999999999999999987777799999999999999999864 34577775 9999
Q ss_pred EcccCcCCCCCc-cccccC
Q 008055 78 NIANNRFTGWVP-EQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p-~~l~~~ 95 (579)
++++|.+.+.+| ..+..+
T Consensus 129 ~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp EEEESSSCCEECTTTTTTC
T ss_pred ECCCCccccccCHhhhhcc
Confidence 999998555555 455555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=2.6e-09 Score=118.44 Aligned_cols=105 Identities=20% Similarity=0.266 Sum_probs=89.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
+++|++|+|++|.+++..|..|+++++|+.|+|++|+|++..+..|+++++|++|+|++|+|++.++ .+..++ |+.|+
T Consensus 48 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 48 YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp GTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 4789999999999999999999999999999999999996555679999999999999999999885 477775 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
|++|.+++..|..+..+ .+...+|...
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred CCCCcccccCchhhcccccCCEEEccCCccc
Confidence 99999999888766554 3444455443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.3e-09 Score=116.05 Aligned_cols=105 Identities=25% Similarity=0.248 Sum_probs=79.8
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCC--CCCccccCCCCCCeeEeecccccCcc-cc-cCCCC-CC
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG--NLPQSFSSLSSLSSLYLQNNQFSGTI-DV-LANLP-LD 75 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~-~~-~~~~~-L~ 75 (579)
+++|++|+|++|.+++.+|..|+++++|+.|+|++|+|++ .+|..+.++++|+.|+|++|+|++.+ +. +..++ |+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 4678899999999988888888899999999999999886 23467888899999999999998844 33 55554 88
Q ss_pred eEEcccCcCCCCCcccc-ccC-eeeccCCCCC
Q 008055 76 NLNIANNRFTGWVPEQL-KNI-NLQKDGNSWS 105 (579)
Q Consensus 76 ~l~l~~N~l~~~~p~~l-~~~-~~~~~~n~~~ 105 (579)
.|+|++|.+++.+|..+ ..+ .+...+|.+.
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM 463 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc
Confidence 88888888888777666 344 3444445443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.4e-09 Score=108.64 Aligned_cols=103 Identities=19% Similarity=0.180 Sum_probs=71.0
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCcccc-CCCCCCeeEeecccccCcccccCCCCCCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFS-SLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~ 80 (579)
++|++|+|++|++++..+..|+.+++|+.|+|++|.|++..|..+. .+++|+.|+|++|+|++.++......|+.|+|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls 199 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLS 199 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECC
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECC
Confidence 5677778888888776677777888888888888888876666664 678888888888888876443332248888888
Q ss_pred cCcCCCCCccccccC----eeeccCCCCC
Q 008055 81 NNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 81 ~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
+|.|++..+. +..+ .+...+|.+.
T Consensus 200 ~N~l~~l~~~-~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 200 SNKLAFMGPE-FQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp SSCCCEECGG-GGGGTTCSEEECTTSCCC
T ss_pred CCcCCcchhh-hcccCcccEEECcCCccc
Confidence 8888854443 4333 3344445443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.88 E-value=6.9e-09 Score=100.68 Aligned_cols=81 Identities=22% Similarity=0.327 Sum_probs=58.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIA 80 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~ 80 (579)
|++|++|+|++|.|+ .+| .+..+++|+.|+|++|+|++ +|+ +.++++|+.|+|++|+|++.++... ..|+.|+|+
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~~~~-~~L~~L~L~ 114 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIPS-ACLSRLFLD 114 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTTCCC-SSCCEEECC
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCcccc-CcccEEEcc
Confidence 357788888888887 455 57778888888888888885 343 7788888888888888877554333 447777777
Q ss_pred cCcCCC
Q 008055 81 NNRFTG 86 (579)
Q Consensus 81 ~N~l~~ 86 (579)
+|.|++
T Consensus 115 ~N~l~~ 120 (263)
T 1xeu_A 115 NNELRD 120 (263)
T ss_dssp SSCCSB
T ss_pred CCccCC
Confidence 777775
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.7e-09 Score=107.39 Aligned_cols=184 Identities=21% Similarity=0.212 Sum_probs=120.4
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCC--ccceeeEEeeCC---eEEEEEE
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPN--IMELVGYCSEYG---QHLLVYE 349 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 349 (579)
.+.++.|....||+.. ..+++|+.... .....+..|...++.+. +.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 56888886432 34567888999988773 322 334444433332 3478999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC------------------------------------ 393 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 393 (579)
+++|.+|.+... ..++..++..++.+++..|..||+..
T Consensus 97 ~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 97 KIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp CCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred ccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999988765321 23567777888888888888888610
Q ss_pred -------------------CCCeEEcCCCCCCEEEcC--CCceEEecccccccCCCCCcccccCCC-----C--------
Q 008055 394 -------------------SLSVVHKNIKSANILLDN--ELNPQLSDCGLASNMPNADEALNNDAG-----S-------- 439 (579)
Q Consensus 394 -------------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~-----~-------- 439 (579)
...++|+|++|.||++++ ...+.|+||+.+............... .
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 135799999999999998 456789999987543221111000000 0
Q ss_pred Cc--cC-ccccccCCCCccchHHhHHHHHHHHHhCCCCC
Q 008055 440 GY--GA-PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPF 475 (579)
Q Consensus 440 ~y--~a-PE~~~~~~~~~~~DvwslGv~l~elltg~~p~ 475 (579)
.| .. |+... ......+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 11 22211 1122368999999999999998876
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.87 E-value=6.3e-09 Score=102.58 Aligned_cols=82 Identities=30% Similarity=0.404 Sum_probs=67.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|++++..+ +..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++. +.+..++ |+.|++
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYL 141 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEEC
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEc
Confidence 5789999999999986544 8899999999999999985 44 488899999999999999885 4555554 899999
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|.+++.
T Consensus 142 ~~n~l~~~ 149 (291)
T 1h6t_A 142 GNNKITDI 149 (291)
T ss_dssp CSSCCCCC
T ss_pred cCCcCCcc
Confidence 99998864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.87 E-value=6e-09 Score=103.61 Aligned_cols=84 Identities=30% Similarity=0.490 Sum_probs=66.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|.+++ ++ .+..+++|+.|+|++|+|++ +|. +..+++|+.|+|++|+|++.++ +..++ |+.|+|
T Consensus 84 l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 84 LTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEEC
T ss_pred CCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEc
Confidence 5688999999999885 34 68889999999999999885 443 8888899999999998888765 55554 888889
Q ss_pred ccCcCCCCCc
Q 008055 80 ANNRFTGWVP 89 (579)
Q Consensus 80 ~~N~l~~~~p 89 (579)
++|.+++..+
T Consensus 159 ~~n~l~~~~~ 168 (308)
T 1h6u_A 159 GNAQVSDLTP 168 (308)
T ss_dssp CSSCCCCCGG
T ss_pred cCCcCCCChh
Confidence 8888886443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.87 E-value=2.8e-09 Score=106.01 Aligned_cols=100 Identities=26% Similarity=0.434 Sum_probs=75.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|++++ ++. +..+++|+.|+|++|.+++. +. +..+++|+.|+|++|+|++.++ +..++ |+.|+|
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEEC
Confidence 5789999999999986 443 89999999999999999854 43 8889999999999999988666 66665 999999
Q ss_pred ccCcCCCCCc-cccccC-eeeccCCCCC
Q 008055 80 ANNRFTGWVP-EQLKNI-NLQKDGNSWS 105 (579)
Q Consensus 80 ~~N~l~~~~p-~~l~~~-~~~~~~n~~~ 105 (579)
++|.+++..+ ..+..+ .+...+|.+.
T Consensus 181 ~~n~l~~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 181 DDNKISDISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred CCCccCcChhhcCCCCCCEEEccCCccC
Confidence 9999986544 122223 3444555544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.87 E-value=6.7e-09 Score=102.39 Aligned_cols=82 Identities=20% Similarity=0.348 Sum_probs=69.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|+.|++++|.++. ++ .+..+++|+.|+|++|+|++. +. +.++++|+.|+|++|+|++.. .+..++ |+.|+|
T Consensus 45 l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred cCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCCCh-hhccCCCCCEEEC
Confidence 3578999999999984 44 488899999999999999964 44 999999999999999999854 466665 999999
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|.+++.
T Consensus 120 ~~n~i~~~ 127 (291)
T 1h6t_A 120 EHNGISDI 127 (291)
T ss_dssp TTSCCCCC
T ss_pred CCCcCCCC
Confidence 99999864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.85 E-value=5.8e-09 Score=113.20 Aligned_cols=84 Identities=33% Similarity=0.590 Sum_probs=49.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|+.|+|++|.|++ +| .|..|++|+.|+|++|.|++ + +.+..|++|+.|+|++|+|++. +.+..++ |+.|+|
T Consensus 86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSL 160 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEEC
T ss_pred CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEEC
Confidence 4566666666666664 33 46666666666666666664 2 3466666666666666666654 3444443 666666
Q ss_pred ccCcCCCCCc
Q 008055 80 ANNRFTGWVP 89 (579)
Q Consensus 80 ~~N~l~~~~p 89 (579)
++|.|++..|
T Consensus 161 s~N~l~~~~~ 170 (605)
T 1m9s_A 161 EDNQISDIVP 170 (605)
T ss_dssp CSSCCCCCGG
T ss_pred cCCcCCCchh
Confidence 6666665444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.85 E-value=6.2e-09 Score=101.01 Aligned_cols=81 Identities=35% Similarity=0.484 Sum_probs=66.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|+|++..+ |..+++|+.|+|++|+|++ +|... . ++|+.|+|++|+|++. +.+..++ |+.|+|
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~L 135 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRDT-DSLIHLKNLEILSI 135 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSBS-GGGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEccCCccCCC-hhhcCcccccEEEC
Confidence 5689999999999996544 8999999999999999985 55433 3 8999999999999985 4566665 999999
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|+|++.
T Consensus 136 s~N~i~~~ 143 (263)
T 1xeu_A 136 RNNKLKSI 143 (263)
T ss_dssp TTSCCCBC
T ss_pred CCCcCCCC
Confidence 99999864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.6e-10 Score=107.17 Aligned_cols=82 Identities=22% Similarity=0.271 Sum_probs=48.8
Q ss_pred CCcEEeccCCcCCCCchh------hhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CC
Q 008055 3 TLKYLNIAHNQLQGQLND------MFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LD 75 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~------~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~ 75 (579)
+++.++|+.|.++|.+|. .|+.+++|+.|+|++|.|++ +| .+.++++|+.|+|++|+|+..++.+..++ |+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCC
Confidence 455556666666655554 56666666666666666664 55 66666666666666666665443333333 66
Q ss_pred eEEcccCcCCC
Q 008055 76 NLNIANNRFTG 86 (579)
Q Consensus 76 ~l~l~~N~l~~ 86 (579)
.|+|++|.|++
T Consensus 97 ~L~L~~N~l~~ 107 (198)
T 1ds9_A 97 ELWISYNQIAS 107 (198)
T ss_dssp EEEEEEEECCC
T ss_pred EEECcCCcCCc
Confidence 66666666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1e-08 Score=111.23 Aligned_cols=100 Identities=29% Similarity=0.427 Sum_probs=79.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|+.|+|++|+|++ + +.+..|++|+.|+|++|.|++. ..|..|++|+.|+|++|+|++.++ +..++ |+.|+|
T Consensus 108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~L 182 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYL 182 (605)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEEC
Confidence 5789999999999996 4 3589999999999999999964 689999999999999999999887 66665 999999
Q ss_pred ccCcCCCCCccccccC----eeeccCCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI----NLQKDGNSWSSG 107 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~----~~~~~~n~~~~~ 107 (579)
++|.|++. | .+..+ .+...+|.+...
T Consensus 183 s~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 183 SKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred cCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 99999864 4 23333 344455554443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.79 E-value=9.6e-09 Score=110.38 Aligned_cols=77 Identities=30% Similarity=0.393 Sum_probs=49.2
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccC
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANN 82 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N 82 (579)
+|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++.++ +. ..|+.|+|++|
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~-~~L~~L~Ls~N 190 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP-ESLEALDVSTN 190 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC-TTCCEEECCSS
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh-CCCCEEECcCC
Confidence 45666666666664 444 46667777777777774 554 45677777777777777444 43 34777777777
Q ss_pred cCCCCCcc
Q 008055 83 RFTGWVPE 90 (579)
Q Consensus 83 ~l~~~~p~ 90 (579)
.|+ .+|.
T Consensus 191 ~L~-~lp~ 197 (571)
T 3cvr_A 191 LLE-SLPA 197 (571)
T ss_dssp CCS-SCCC
T ss_pred CCC-chhh
Confidence 776 4554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-08 Score=107.97 Aligned_cols=82 Identities=28% Similarity=0.362 Sum_probs=61.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++.++ +..++ |+.|++
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l 338 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFF 338 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEEC
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeEC
Confidence 4678888888888886444 7788888888888888886433 7778888888888888887766 44443 788888
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|.+++.
T Consensus 339 ~~n~l~~~ 346 (466)
T 1o6v_A 339 YNNKVSDV 346 (466)
T ss_dssp CSSCCCCC
T ss_pred CCCccCCc
Confidence 88877764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.75 E-value=3.3e-09 Score=113.95 Aligned_cols=95 Identities=27% Similarity=0.342 Sum_probs=66.8
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCC------
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPL------ 74 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L------ 74 (579)
+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+..++ +.. .|
T Consensus 139 l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~-~L~~~~~~ 208 (571)
T 3cvr_A 139 PALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV-RNHHSEET 208 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------C
T ss_pred CccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH-hhhccccc
Confidence 4678888888888885 665 57788888888888886 776 65 788888888888886555 433 45
Q ss_pred -CeEEcccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 75 -DNLNIANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 75 -~~l~l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
+.|+|++|.|+ .+|..+..+ .+...+|.+.+
T Consensus 209 L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred ceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 88888888887 467655444 34445555543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.74 E-value=2.1e-08 Score=101.36 Aligned_cols=88 Identities=27% Similarity=0.387 Sum_probs=51.7
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++ + +.+..+++|+.|+|++|+|++. +.+..++ |+.|+++
T Consensus 221 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~ 295 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLN 295 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECC
T ss_pred CcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECc
Confidence 456666666666664332 6666666666666666664 2 3466666666666666666654 3344443 6666666
Q ss_pred cCcCCCCCcccccc
Q 008055 81 NNRFTGWVPEQLKN 94 (579)
Q Consensus 81 ~N~l~~~~p~~l~~ 94 (579)
+|.+++..|..+..
T Consensus 296 ~n~l~~~~~~~l~~ 309 (347)
T 4fmz_A 296 NNQLGNEDMEVIGG 309 (347)
T ss_dssp SSCCCGGGHHHHHT
T ss_pred CCcCCCcChhHhhc
Confidence 66666655554443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.9e-08 Score=101.67 Aligned_cols=85 Identities=29% Similarity=0.466 Sum_probs=75.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++|++|+|++|.+++. +.+..+++|+.|+|++|.+++ + +.+..+++|+.|+|++|++++.++. +..++ |+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred CCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 57899999999999964 469999999999999999996 4 4689999999999999999988754 66665 99999
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|++++..|
T Consensus 318 L~~n~l~~~~~ 328 (347)
T 4fmz_A 318 LSQNHITDIRP 328 (347)
T ss_dssp CCSSSCCCCGG
T ss_pred ccCCccccccC
Confidence 99999998777
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.71 E-value=3.5e-08 Score=104.09 Aligned_cols=81 Identities=35% Similarity=0.492 Sum_probs=44.6
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
++|+.|+|++|++++ + +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++.++ +..++ |+.|+|+
T Consensus 221 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELN 295 (466)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECC
T ss_pred CCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcC
Confidence 456666666666653 2 245556666666666666654333 5555666666666666555444 33333 5555555
Q ss_pred cCcCCCC
Q 008055 81 NNRFTGW 87 (579)
Q Consensus 81 ~N~l~~~ 87 (579)
+|.+++.
T Consensus 296 ~n~l~~~ 302 (466)
T 1o6v_A 296 ENQLEDI 302 (466)
T ss_dssp SSCCSCC
T ss_pred CCcccCc
Confidence 5555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.1e-09 Score=101.54 Aligned_cols=83 Identities=23% Similarity=0.400 Sum_probs=74.3
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
+++|++|+|++|.|++ +| .+..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++.+ .+..++ |+.|+|
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEEC
Confidence 5789999999999996 77 8999999999999999999 78988888999999999999999854 555565 999999
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|.|++.
T Consensus 123 ~~N~i~~~ 130 (198)
T 1ds9_A 123 SNNKITNW 130 (198)
T ss_dssp SEEECCCH
T ss_pred CCCcCCch
Confidence 99999853
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.69 E-value=5.2e-08 Score=102.40 Aligned_cols=79 Identities=27% Similarity=0.257 Sum_probs=48.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
+++|++|+|++|...+.+ .++.+++|+.|+|++|+|++ +| +..+++|+.|+|++|+|++. .+..++ |+.|++
T Consensus 147 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~L 219 (457)
T 3bz5_A 147 NTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDC 219 (457)
T ss_dssp CTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEEC
T ss_pred CCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEEC
Confidence 356666666666554455 25666666666666666664 44 56666666666666666664 233443 666666
Q ss_pred ccCcCCC
Q 008055 80 ANNRFTG 86 (579)
Q Consensus 80 ~~N~l~~ 86 (579)
++|+|++
T Consensus 220 s~N~l~~ 226 (457)
T 3bz5_A 220 SSNKLTE 226 (457)
T ss_dssp CSSCCSC
T ss_pred cCCcccc
Confidence 6666665
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.67 E-value=5.3e-08 Score=102.35 Aligned_cols=80 Identities=24% Similarity=0.331 Sum_probs=64.3
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|.|++. | .|+.+++|+.|+|++|+|++ +| ++.+++|+.|+|++|+|++. + +..++ |+.|++
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L 113 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNC 113 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEEC
Confidence 46788899999988864 5 68888889999999998886 44 88888888888888888885 3 55564 888888
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|.+++.
T Consensus 114 ~~N~l~~l 121 (457)
T 3bz5_A 114 DTNKLTKL 121 (457)
T ss_dssp CSSCCSCC
T ss_pred CCCcCCee
Confidence 88888863
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.66 E-value=2.6e-08 Score=100.94 Aligned_cols=89 Identities=20% Similarity=0.211 Sum_probs=67.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCc-cccCCCCCCe-eEeecccccCcccc-cCCCC-CCeE
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQ-SFSSLSSLSS-LYLQNNQFSGTIDV-LANLP-LDNL 77 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~-L~l~~N~l~~~~~~-~~~~~-L~~l 77 (579)
++|++|+|++|+|+...++.|.+|++|+.|+|++|++.+.+|. .|.+|++|.. +.+++|+|++.++. +..++ |+.|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 4688888888888855556788888888888888888766664 5677887764 56677888887654 66665 8888
Q ss_pred EcccCcCCCCCcc
Q 008055 78 NIANNRFTGWVPE 90 (579)
Q Consensus 78 ~l~~N~l~~~~p~ 90 (579)
++++|.|++..+.
T Consensus 110 ~l~~n~l~~~~~~ 122 (350)
T 4ay9_X 110 LISNTGIKHLPDV 122 (350)
T ss_dssp EEEEECCSSCCCC
T ss_pred cccccccccCCch
Confidence 8888888765553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.65 E-value=8.3e-08 Score=100.73 Aligned_cols=78 Identities=31% Similarity=0.418 Sum_probs=47.3
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccC
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANN 82 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N 82 (579)
+|++|+|++|++++ +|. ..++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.++.+ ..|+.|++++|
T Consensus 112 ~L~~L~l~~n~l~~-l~~---~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~--~~L~~L~L~~n 183 (454)
T 1jl5_A 112 SLKSLLVDNNNLKA-LSD---LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP--PSLEFIAAGNN 183 (454)
T ss_dssp TCCEEECCSSCCSC-CCS---CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC--TTCCEEECCSS
T ss_pred CCcEEECCCCccCc-ccC---CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc--ccccEEECcCC
Confidence 44455555554442 221 11567777777777775 66 4777777777777777777644322 14777777777
Q ss_pred cCCCCCc
Q 008055 83 RFTGWVP 89 (579)
Q Consensus 83 ~l~~~~p 89 (579)
.+++ +|
T Consensus 184 ~l~~-l~ 189 (454)
T 1jl5_A 184 QLEE-LP 189 (454)
T ss_dssp CCSS-CC
T ss_pred cCCc-Cc
Confidence 7765 44
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.9e-08 Score=109.37 Aligned_cols=63 Identities=29% Similarity=0.336 Sum_probs=35.5
Q ss_pred CCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccCcCCCCCccccccC
Q 008055 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 26 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~l~~~ 95 (579)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++.++ ....|+.|+|++|.|+ .+|..+..+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~--~~~~L~~L~Ls~N~L~-~lp~~l~~l 283 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM--LPSGLLSLSVYRNQLT-RLPESLIHL 283 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc--ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence 556666666666663 44 344566666666666665443 1123666666666666 555554443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.59 E-value=5.4e-09 Score=109.82 Aligned_cols=100 Identities=18% Similarity=0.163 Sum_probs=60.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCC-------------CeeEeecccccCcccc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSL-------------SSLYLQNNQFSGTIDV 68 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L-------------~~L~l~~N~l~~~~~~ 68 (579)
++|++|++++|.| |.+|+.|++|++|+.|+|++|.++|.+|..++++.+| +.|++++|.|++.+..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 5789999999999 7999999999999999999999999999999998875 9999999999986542
Q ss_pred cCCCCCCeEEcccCcCCCCCccccccC-eeeccCCCCC
Q 008055 69 LANLPLDNLNIANNRFTGWVPEQLKNI-NLQKDGNSWS 105 (579)
Q Consensus 69 ~~~~~L~~l~l~~N~l~~~~p~~l~~~-~~~~~~n~~~ 105 (579)
. ..|+.|++++|.+++ +|..+..+ .+...+|.+.
T Consensus 90 ~--~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~ 124 (454)
T 1jl5_A 90 P--PHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 124 (454)
T ss_dssp C--TTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCS
T ss_pred c--CCCCEEEccCCcCCc-cccccCCCcEEECCCCccC
Confidence 1 248899999999987 67655555 3344444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.1e-08 Score=105.23 Aligned_cols=86 Identities=23% Similarity=0.376 Sum_probs=53.5
Q ss_pred CCCcEEeccCCcCC-CCch---hhhCCCCCCCEEeccCCcCC--C---CCCccccCCCCCCeeEeeccccc----Ccc-c
Q 008055 2 KTLKYLNIAHNQLQ-GQLN---DMFGQLPSLSTLDLSFNTLS--G---NLPQSFSSLSSLSSLYLQNNQFS----GTI-D 67 (579)
Q Consensus 2 ~~L~~L~l~~n~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----~~~-~ 67 (579)
++|++|+|++|+|+ +.+| ..|..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+ .
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 56777777777776 3444 35566677777777777766 2 33446666777777777777764 223 2
Q ss_pred ccCCCC-CCeEEcccCcCCCC
Q 008055 68 VLANLP-LDNLNIANNRFTGW 87 (579)
Q Consensus 68 ~~~~~~-L~~l~l~~N~l~~~ 87 (579)
.+..++ |+.|+|++|.|++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHH
T ss_pred HHccCCCcCEEECCCCCCchh
Confidence 344443 77777777776654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.2e-08 Score=104.85 Aligned_cols=106 Identities=23% Similarity=0.323 Sum_probs=84.0
Q ss_pred CCCCcEEeccCCcCC--C---CchhhhCCCCCCCEEeccCCcCC----CCCCccccCCCCCCeeEeecccccCc----c-
Q 008055 1 MKTLKYLNIAHNQLQ--G---QLNDMFGQLPSLSTLDLSFNTLS----GNLPQSFSSLSSLSSLYLQNNQFSGT----I- 66 (579)
Q Consensus 1 l~~L~~L~l~~n~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~l~~N~l~~~----~- 66 (579)
+++|++|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+|..+..+++|+.|+|++|.|++. +
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 468999999999998 3 45558899999999999999996 67899999999999999999999876 2
Q ss_pred ccc--CCC-CCCeEEcccCcCCC----CCcccc----ccC-eeeccCCCCCC
Q 008055 67 DVL--ANL-PLDNLNIANNRFTG----WVPEQL----KNI-NLQKDGNSWSS 106 (579)
Q Consensus 67 ~~~--~~~-~L~~l~l~~N~l~~----~~p~~l----~~~-~~~~~~n~~~~ 106 (579)
..+ ..+ .|+.|+|++|.|++ .+|..+ ..+ .+...+|.+.+
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 334 224 49999999999998 477655 333 44555665543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.49 E-value=2.5e-08 Score=95.89 Aligned_cols=83 Identities=22% Similarity=0.311 Sum_probs=64.0
Q ss_pred EeccCCcC---CCCchhhhCCCCCCCEEeccCCcCCC--CCCccccCCCCCCeeEeecccccCcc--cccCCCCCCeEEc
Q 008055 7 LNIAHNQL---QGQLNDMFGQLPSLSTLDLSFNTLSG--NLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLPLDNLNI 79 (579)
Q Consensus 7 L~l~~n~l---~~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~L~~l~l 79 (579)
++++.|.+ .+.++-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.. ..+..+.|+.|+|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L 227 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 227 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEEC
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEc
Confidence 45556632 22233333568999999999999998 55677889999999999999999863 3344457999999
Q ss_pred ccCcCCCCCc
Q 008055 80 ANNRFTGWVP 89 (579)
Q Consensus 80 ~~N~l~~~~p 89 (579)
++|++++.+|
T Consensus 228 ~~Npl~~~~~ 237 (267)
T 3rw6_A 228 DGNSLCDTFR 237 (267)
T ss_dssp TTSTTGGGCS
T ss_pred cCCcCccccC
Confidence 9999998776
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.49 E-value=3.4e-08 Score=100.51 Aligned_cols=88 Identities=24% Similarity=0.318 Sum_probs=58.9
Q ss_pred CCcEEeccCCcCCCCch----hhhCCCC-CCCEEeccCCcCCCCCCccccCC-----CCCCeeEeecccccCcccc----
Q 008055 3 TLKYLNIAHNQLQGQLN----DMFGQLP-SLSTLDLSFNTLSGNLPQSFSSL-----SSLSSLYLQNNQFSGTIDV---- 68 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~---- 68 (579)
+|++|+|++|.|++..+ ..|..++ +|+.|+|++|+|++..+..|..+ ++|+.|+|++|+|++..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 47777777777776555 6666777 77777777777776666666664 7777777777777765532
Q ss_pred -cCCC--CCCeEEcccCcCCCCCcc
Q 008055 69 -LANL--PLDNLNIANNRFTGWVPE 90 (579)
Q Consensus 69 -~~~~--~L~~l~l~~N~l~~~~p~ 90 (579)
+... .|+.|+|++|.|++..+.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~ 127 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSS 127 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHH
T ss_pred HHHhCCCCccEEECcCCcCCcHHHH
Confidence 2222 377777777777665543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.49 E-value=3.6e-07 Score=99.29 Aligned_cols=55 Identities=31% Similarity=0.370 Sum_probs=25.2
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT 65 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~ 65 (579)
+|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|++.
T Consensus 62 ~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l 116 (622)
T 3g06_A 62 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHL 116 (622)
T ss_dssp TCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCC
T ss_pred CCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCC
Confidence 3444555555444 2332 3444555555555544 2333 334445555555544443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.47 E-value=6.7e-08 Score=92.93 Aligned_cols=64 Identities=27% Similarity=0.477 Sum_probs=55.2
Q ss_pred CCCCcEEeccCCcCCC--CchhhhCCCCCCCEEeccCCcCCCCCCccccCCC--CCCeeEeecccccCcc
Q 008055 1 MKTLKYLNIAHNQLQG--QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLS--SLSSLYLQNNQFSGTI 66 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~~~~ 66 (579)
|++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.|++.+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF 236 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence 5789999999999998 5567888999999999999999965 4455555 9999999999999854
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.47 E-value=2.4e-08 Score=100.39 Aligned_cols=84 Identities=21% Similarity=0.221 Sum_probs=57.5
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCC-CCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN-LPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
++|+.|+|++|.+.+..+. +..+++|+.|+|++|.+++. +|..+..+++|+.|+|++|.+++..+ .+..++ |+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4677777777777766554 45677777777777777655 66677777777777777777765543 355554 77777
Q ss_pred cccC-cCCC
Q 008055 79 IANN-RFTG 86 (579)
Q Consensus 79 l~~N-~l~~ 86 (579)
|++| .+++
T Consensus 149 L~~~~~l~~ 157 (336)
T 2ast_B 149 LSGCSGFSE 157 (336)
T ss_dssp CTTCBSCCH
T ss_pred CCCCCCCCH
Confidence 7777 5654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.5e-06 Score=84.37 Aligned_cols=134 Identities=16% Similarity=0.134 Sum_probs=95.9
Q ss_pred eeccCCce-EEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 278 LLGEGTFG-RVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 278 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.+..|..+ .||+.... ++..+++|+-.. .....+..|...++.+. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556655 69998765 466788888643 23556778888887763 333667888999999999999999998
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC----------------------------------------- 393 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------- 393 (579)
++.+.... .......++.+++..|..||...
T Consensus 106 ~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 87765431 11223456667777777777530
Q ss_pred --------------CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 394 --------------SLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 394 --------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987767799999864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.36 E-value=6.8e-08 Score=97.04 Aligned_cols=91 Identities=21% Similarity=0.230 Sum_probs=68.6
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCC-cCCCC-CCccccCCCCCCeeEeecc-cccCc--ccccCCC--C
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN-TLSGN-LPQSFSSLSSLSSLYLQNN-QFSGT--IDVLANL--P 73 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~--~~~~~~~--~ 73 (579)
+++|++|+|++|.+++..|..|+.+++|+.|+|++| .+++. +|..+.++++|+.|+|++| .+++. +..+..+ .
T Consensus 117 ~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~ 196 (336)
T 2ast_B 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 196 (336)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccC
Confidence 468899999999988888888888999999999998 67753 6777888888999999888 88763 2334333 4
Q ss_pred CCeEEcccC--cCC-CCCccc
Q 008055 74 LDNLNIANN--RFT-GWVPEQ 91 (579)
Q Consensus 74 L~~l~l~~N--~l~-~~~p~~ 91 (579)
|+.|+|++| .++ +.+|..
T Consensus 197 L~~L~l~~~~~~~~~~~l~~~ 217 (336)
T 2ast_B 197 ITQLNLSGYRKNLQKSDLSTL 217 (336)
T ss_dssp CCEEECCSCGGGSCHHHHHHH
T ss_pred CCEEEeCCCcccCCHHHHHHH
Confidence 888888888 454 344443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.32 E-value=1.3e-07 Score=96.27 Aligned_cols=87 Identities=24% Similarity=0.272 Sum_probs=71.5
Q ss_pred CCcEEeccCCcCCCCchhhhCCC-----CCCCEEeccCCcCCCCCCccccC----C-CCCCeeEeecccccCcccc----
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQL-----PSLSTLDLSFNTLSGNLPQSFSS----L-SSLSSLYLQNNQFSGTIDV---- 68 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~----l-~~L~~L~l~~N~l~~~~~~---- 68 (579)
+|++|+|++|.|++..+..|..+ ++|+.|+|++|.|++..+..+.. + ++|+.|+|++|+|++....
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 79999999999998888888775 99999999999999777765444 4 8999999999999887632
Q ss_pred -cCC-C-CCCeEEcccCcCCCCCc
Q 008055 69 -LAN-L-PLDNLNIANNRFTGWVP 89 (579)
Q Consensus 69 -~~~-~-~L~~l~l~~N~l~~~~p 89 (579)
+.. . .|+.|+|++|.|+...+
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCH
T ss_pred HHHhCCCceeEEEccCCcCCHHHH
Confidence 333 2 59999999999986443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.31 E-value=8.3e-07 Score=89.74 Aligned_cols=88 Identities=17% Similarity=0.242 Sum_probs=71.9
Q ss_pred cEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc--cCCCC-CC-eEEcc
Q 008055 5 KYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV--LANLP-LD-NLNIA 80 (579)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~-L~-~l~l~ 80 (579)
+.++.++|+|+ .+|..+ .++|+.|+|++|+|+...+..|.+|++|+.|+|++|++.+.++. +..+. +. .+.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 57889999999 788766 46899999999999954456799999999999999999887753 66664 54 57888
Q ss_pred cCcCCCCCccccccC
Q 008055 81 NNRFTGWVPEQLKNI 95 (579)
Q Consensus 81 ~N~l~~~~p~~l~~~ 95 (579)
+|+|++..|..+..+
T Consensus 89 ~N~l~~l~~~~f~~l 103 (350)
T 4ay9_X 89 ANNLLYINPEAFQNL 103 (350)
T ss_dssp ETTCCEECTTSBCCC
T ss_pred CCcccccCchhhhhc
Confidence 999998778777655
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.4e-06 Score=82.02 Aligned_cols=136 Identities=17% Similarity=0.117 Sum_probs=93.7
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCC---CccceeeEEe-eCCeEEEEEEec
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP---NIMELVGYCS-EYGQHLLVYEFR 351 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 351 (579)
.+.++.|....||+. +..+++|+-.. ......+..|...++.+.+. .+.+.+.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 356888999999998 56788888522 23456788999999988652 2455666663 456678999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 008055 352 KNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV--------------------------------------- 392 (579)
Q Consensus 352 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------- 392 (579)
+|..|.+..- ..++..+...++.++++.|..||+.
T Consensus 96 ~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9988765321 1234445555555666666655542
Q ss_pred ------------------CCCCeEEcCCCCCCEEEcC---CCce-EEeccccccc
Q 008055 393 ------------------CSLSVVHKNIKSANILLDN---ELNP-QLSDCGLASN 425 (579)
Q Consensus 393 ------------------~~~~iiH~Dlkp~Nill~~---~~~~-kl~Dfg~~~~ 425 (579)
....++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 4554 8999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.8e-05 Score=80.02 Aligned_cols=83 Identities=8% Similarity=-0.028 Sum_probs=52.9
Q ss_pred ccee-ccCCceEEEEEEeC-------CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcC-C--CCccceeeEEeeC--
Q 008055 276 ENLL-GEGTFGRVYRAQFA-------DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLH-H--PNIMELVGYCSEY-- 341 (579)
Q Consensus 276 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 341 (579)
.+.| +.|....+|+.... ++..+++|+...... .......+..|+..++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999998654 266788887654220 0000133456666666553 2 3466778777654
Q ss_pred -CeEEEEEEecCCCChhh
Q 008055 342 -GQHLLVYEFRKNGSLHD 358 (579)
Q Consensus 342 -~~~~lv~e~~~~gsL~~ 358 (579)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45789999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.5e-05 Score=78.30 Aligned_cols=144 Identities=16% Similarity=0.212 Sum_probs=78.5
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh--cCCCCcccee-e--EEeeCCeEEEEEEec
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ--LHHPNIMELV-G--YCSEYGQHLLVYEFR 351 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~-~--~~~~~~~~~lv~e~~ 351 (579)
+.|+.|..+.||+....+| .+++|+.... ........+.++.+.. +..|.++... | +....+..+++|||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677899999987655 4889998652 1212222233333332 2234444311 1 123467789999999
Q ss_pred CCCChh--------------hhhcccCC-C--C-------CCCCHHHH-------------------------------H
Q 008055 352 KNGSLH--------------DFLHLSDE-D--N-------KPLIWNSR-------------------------------V 376 (579)
Q Consensus 352 ~~gsL~--------------~~l~~~~~-~--~-------~~l~~~~~-------------------------------~ 376 (579)
+|..+. ..+|.... . . ..-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 01121111 0 0 00122110 1
Q ss_pred HHHHHHHHHHHHHHh----------cCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 377 KIALGTARALEYLHE----------VCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 377 ~i~~~ia~~L~~LH~----------~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
.+...+..++++|++ .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224446667763 014689999999999999878889999999764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.09 E-value=2.8e-07 Score=96.80 Aligned_cols=86 Identities=27% Similarity=0.288 Sum_probs=47.7
Q ss_pred CCCcEEeccCCcCCCC----chhhhCCCCCCCEEeccCCcCCCCCCccccC-----CCCCCeeEeecccccCcc-----c
Q 008055 2 KTLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSS-----LSSLSSLYLQNNQFSGTI-----D 67 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~~~~-----~ 67 (579)
++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|+|++|.|++.. .
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5677777777777643 5666666777777777777765432222222 245566666666555431 1
Q ss_pred ccCCC-CCCeEEcccCcCCCC
Q 008055 68 VLANL-PLDNLNIANNRFTGW 87 (579)
Q Consensus 68 ~~~~~-~L~~l~l~~N~l~~~ 87 (579)
.+..+ .|+.|+|++|.+++.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~ 356 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDA 356 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHH
T ss_pred HHhhCCCccEEEccCCccccc
Confidence 12222 255555555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.05 E-value=4.9e-07 Score=94.98 Aligned_cols=105 Identities=18% Similarity=0.157 Sum_probs=76.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCC-----CCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecccccCccc-cc-
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQ-----LPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGTID-VL- 69 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~-----l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~~-~~- 69 (579)
+++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. +|..+..+++|+.|+|++|.|++... .+
T Consensus 283 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 362 (461)
T 1z7x_W 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362 (461)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence 478999999999997654444443 37999999999999865 56777888999999999999987542 22
Q ss_pred ---C--CCCCCeEEcccCcCCC----CCccccccC----eeeccCCCCC
Q 008055 70 ---A--NLPLDNLNIANNRFTG----WVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 70 ---~--~~~L~~l~l~~N~l~~----~~p~~l~~~----~~~~~~n~~~ 105 (579)
. ...|+.|+|++|.+++ .+|..+..+ .+...+|.+.
T Consensus 363 ~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 2 2359999999999986 667654333 3445555543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.00 E-value=9.3e-07 Score=90.03 Aligned_cols=85 Identities=22% Similarity=0.207 Sum_probs=56.2
Q ss_pred CCCcEEeccCCcCCCCchhhh-----CCCCCCCEEeccCCcCCC----CCCccccCCCCCCeeEeecccccCcc-----c
Q 008055 2 KTLKYLNIAHNQLQGQLNDMF-----GQLPSLSTLDLSFNTLSG----NLPQSFSSLSSLSSLYLQNNQFSGTI-----D 67 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~-----~ 67 (579)
++|+.|+|++|.|+..-...+ ...++|+.|+|++|.|+. .++..+..+++|+.|+|++|.|+..- .
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 367788888888865433333 345778888888888763 24445566778888888888876532 2
Q ss_pred ccCCC-CCCeEEcccCcCCC
Q 008055 68 VLANL-PLDNLNIANNRFTG 86 (579)
Q Consensus 68 ~~~~~-~L~~l~l~~N~l~~ 86 (579)
.+... .|+.|+|++|.|+.
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCH
T ss_pred HHhcCCCcCeEECCCCCCCH
Confidence 23333 38888888888764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.99 E-value=7.3e-06 Score=81.97 Aligned_cols=93 Identities=20% Similarity=0.159 Sum_probs=75.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCC-eeEeecccccCccc-ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLS-SLYLQNNQFSGTID-VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~~-~~~~~~-L~~l 77 (579)
+++|+.|+|++|+++.+.+..|.++.+|+.|+|++| ++..-+..|.+|.+|+ .|+|.+ +++...+ .|..+. |+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 468999999999999666778999999999999998 7766667899999999 999988 7776554 477775 9999
Q ss_pred EcccCcCCCCCccccccC
Q 008055 78 NIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~ 95 (579)
++++|.++..-+..|.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~ 320 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNG 320 (329)
T ss_dssp EECSSCCCEECTTTTCTT
T ss_pred EeCCCccCccchhhhcCC
Confidence 999999985555555443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.88 E-value=1.6e-06 Score=88.30 Aligned_cols=85 Identities=19% Similarity=0.233 Sum_probs=59.1
Q ss_pred CCCcEEeccCCcCCCCchhhh-CCCCCCCEEeccCCcCCCCCCccc-----cCCCCCCeeEeecccccCcc-----cccC
Q 008055 2 KTLKYLNIAHNQLQGQLNDMF-GQLPSLSTLDLSFNTLSGNLPQSF-----SSLSSLSSLYLQNNQFSGTI-----DVLA 70 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~l~~N~l~g~~p~~~-----~~l~~L~~L~l~~N~l~~~~-----~~~~ 70 (579)
++|+.|+|++|.|+......+ ..+++|+.|+|++|+|+..-...+ ...++|+.|+|++|.|+..- ..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 478899999998875433333 346788999999998875433333 24578999999999887532 2233
Q ss_pred CC-CCCeEEcccCcCCC
Q 008055 71 NL-PLDNLNIANNRFTG 86 (579)
Q Consensus 71 ~~-~L~~l~l~~N~l~~ 86 (579)
.. .|+.|+|++|.|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp TCSSCCEEECTTSSCHH
T ss_pred cCCCcCEEeCCCCCCCc
Confidence 33 48999999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.77 E-value=8.2e-06 Score=74.21 Aligned_cols=86 Identities=15% Similarity=0.168 Sum_probs=65.7
Q ss_pred CCCcEEeccCC-cCCC----CchhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecccccCcc-----c
Q 008055 2 KTLKYLNIAHN-QLQG----QLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGTI-----D 67 (579)
Q Consensus 2 ~~L~~L~l~~n-~l~~----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-----~ 67 (579)
++|++|+|++| .|.. .+...+...++|+.|+|++|.|... +...+...+.|+.|+|++|.|+..- .
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 57999999999 8864 2456677789999999999998732 3445666789999999999998632 3
Q ss_pred ccCCC-CCCeEEc--ccCcCCCC
Q 008055 68 VLANL-PLDNLNI--ANNRFTGW 87 (579)
Q Consensus 68 ~~~~~-~L~~l~l--~~N~l~~~ 87 (579)
.+... .|+.|+| ++|.|...
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHhCCCceEEEecCCCCCCCHH
Confidence 34433 4999999 88998743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00017 Score=70.47 Aligned_cols=78 Identities=19% Similarity=0.243 Sum_probs=54.6
Q ss_pred CccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC---CCccceeeEEeeCCeEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH---PNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~ 348 (579)
.+.-.+.+|.|..+.||+.+..||+.|.+|+-..... .....|..|...|+.+.- -.+.+++++. ..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 4555678999999999999999999999998754432 123456778887777632 1234444432 347899
Q ss_pred EecCCCC
Q 008055 349 EFRKNGS 355 (579)
Q Consensus 349 e~~~~gs 355 (579)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00017 Score=71.10 Aligned_cols=75 Identities=16% Similarity=0.168 Sum_probs=58.5
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC---CCCccceeeEEeeCCeEEEEEEecC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH---HPNIMELVGYCSEYGQHLLVYEFRK 352 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 352 (579)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 46789999999999976 4677888887532 2566778888877763 3567788888888889999999999
Q ss_pred CCCh
Q 008055 353 NGSL 356 (579)
Q Consensus 353 ~gsL 356 (579)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00021 Score=73.32 Aligned_cols=77 Identities=14% Similarity=0.095 Sum_probs=48.0
Q ss_pred cceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC--C---chhHHHHHHHHHHHhhcCC--CCcc-ceeeEEeeCCeEEE
Q 008055 276 ENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL--P---SEMCDDFIEMVSNISQLHH--PNIM-ELVGYCSEYGQHLL 346 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~l 346 (579)
.+.||.|.++.||++... +++.+++|....... . ......+..|.+.++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899998653221 0 0123455667777776632 3333 45543 3455689
Q ss_pred EEEecCCC
Q 008055 347 VYEFRKNG 354 (579)
Q Consensus 347 v~e~~~~g 354 (579)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.68 E-value=8.6e-06 Score=88.35 Aligned_cols=87 Identities=11% Similarity=0.125 Sum_probs=52.3
Q ss_pred CCCCcEEecc----CCcCCCC-----chhhhCCCCCCCEEeccCC--cCCCCCCccccC-CCCCCeeEeecccccCc-cc
Q 008055 1 MKTLKYLNIA----HNQLQGQ-----LNDMFGQLPSLSTLDLSFN--TLSGNLPQSFSS-LSSLSSLYLQNNQFSGT-ID 67 (579)
Q Consensus 1 l~~L~~L~l~----~n~l~~~-----~p~~~~~l~~L~~L~l~~N--~l~g~~p~~~~~-l~~L~~L~l~~N~l~~~-~~ 67 (579)
+++|+.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+..++. +++|+.|+|++|++++. ++
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 4567777775 6677653 4444666777777777632 355544444443 66777777777776652 22
Q ss_pred -ccCCCC-CCeEEcccCcCCCC
Q 008055 68 -VLANLP-LDNLNIANNRFTGW 87 (579)
Q Consensus 68 -~~~~~~-L~~l~l~~N~l~~~ 87 (579)
.+..++ |+.|+|++|.|++.
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHhcCcccCeeeccCCCCcHH
Confidence 234443 77777777776543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.68 E-value=6.6e-06 Score=74.83 Aligned_cols=84 Identities=20% Similarity=0.282 Sum_probs=66.3
Q ss_pred CCCcEEeccCCcCCCC----chhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEe--ecccccCcc-----
Q 008055 2 KTLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYL--QNNQFSGTI----- 66 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l--~~N~l~~~~----- 66 (579)
++|++|+|++|.|... +...+...+.|+.|+|++|.|+.. +...+...+.|+.|+| ++|.|+..-
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 5799999999999742 455566678999999999999843 4567788899999999 889998642
Q ss_pred cccCCC-CCCeEEcccCcCC
Q 008055 67 DVLANL-PLDNLNIANNRFT 85 (579)
Q Consensus 67 ~~~~~~-~L~~l~l~~N~l~ 85 (579)
..+... .|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 223222 4999999999885
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00034 Score=72.33 Aligned_cols=77 Identities=9% Similarity=0.048 Sum_probs=46.8
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccccCC--CCCccCccccccC---CCCccchHHhHHHHHHHH
Q 008055 394 SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDA--GSGYGAPEVAMSG---QYNIKSDVYSFGVVMLEL 468 (579)
Q Consensus 394 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~---~~~~~~DvwslGv~l~el 468 (579)
...++|+|+++.|||++.++ ++|+||+.+..-........... ...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999999876 99999998754322111100000 1235555544311 112234556778888887
Q ss_pred HhC
Q 008055 469 LTG 471 (579)
Q Consensus 469 ltg 471 (579)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.51 E-value=2.1e-05 Score=85.29 Aligned_cols=89 Identities=15% Similarity=0.169 Sum_probs=58.0
Q ss_pred CCcEEeccCCc-CCC-CchhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecccccCcc----c-ccCC
Q 008055 3 TLKYLNIAHNQ-LQG-QLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGTI----D-VLAN 71 (579)
Q Consensus 3 ~L~~L~l~~n~-l~~-~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~----~-~~~~ 71 (579)
+|++|+|++|. ++. .++....++++|+.|+|++|.+++. ++..+.++++|+.|+|++|.+++.. + .+..
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38888888876 211 1233344678888888888887765 4445566788888888888887322 2 2333
Q ss_pred CC-CCeEEcccCcCCCCCcccc
Q 008055 72 LP-LDNLNIANNRFTGWVPEQL 92 (579)
Q Consensus 72 ~~-L~~l~l~~N~l~~~~p~~l 92 (579)
++ |+.|+|++|.+.+ +|..+
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~ 239 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFF 239 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHH
T ss_pred CCCCcEEeccCccHHH-HHHHH
Confidence 44 8888888888775 44433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.46 E-value=2.2e-05 Score=85.02 Aligned_cols=86 Identities=14% Similarity=0.115 Sum_probs=56.2
Q ss_pred CCCCcEEecc--C----CcCCC-----CchhhhCCCCCCCEEeccCCcCCCCCCccccC-CCCCCeeEeecccccCcc-c
Q 008055 1 MKTLKYLNIA--H----NQLQG-----QLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSS-LSSLSSLYLQNNQFSGTI-D 67 (579)
Q Consensus 1 l~~L~~L~l~--~----n~l~~-----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-l~~L~~L~l~~N~l~~~~-~ 67 (579)
+++|+.|+|+ + |.+++ .++..+..+++|+.|+|++ ++++..+..+.. +++|+.|+|++|.+++.. .
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 4678888888 4 55652 1223366678888888866 666555555555 778888888888876543 2
Q ss_pred cc-CCCC-CCeEEcccCcCCCC
Q 008055 68 VL-ANLP-LDNLNIANNRFTGW 87 (579)
Q Consensus 68 ~~-~~~~-L~~l~l~~N~l~~~ 87 (579)
.+ ..++ |+.|+|++|.+++.
T Consensus 475 ~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp HHHHHCTTCCEEEEESCSCCHH
T ss_pred HHHhcCCCcCEEECcCCCCcHH
Confidence 22 3343 88888888887543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0059 Score=60.26 Aligned_cols=159 Identities=16% Similarity=0.193 Sum_probs=83.7
Q ss_pred cCHHHHHHHhCCccc-----cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-----CCCC
Q 008055 261 YSIADLQMATGSFNV-----ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-----HHPN 330 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~n 330 (579)
++.+++.....+|.+ .+.|+.|....+|+....+| .+++|+..... .. ..+..|...+..+ .-|.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~---~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CH---HHHHHHHHHHHHHHHCCCCCCc
Confidence 444555555555654 23466788899999987666 57889886531 11 2233444444433 2233
Q ss_pred cccee-e--EEeeCCeEEEEEEecCCCChhh--------------hhcccCCC-C-C-----C-CCHHHHHH--------
Q 008055 331 IMELV-G--YCSEYGQHLLVYEFRKNGSLHD--------------FLHLSDED-N-K-----P-LIWNSRVK-------- 377 (579)
Q Consensus 331 iv~l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~-~-----~-l~~~~~~~-------- 377 (579)
++... | +....+..+++|+|++|..+.. .+|..... . . . ..|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 33211 1 1123467789999998865321 01211000 0 0 0 11221100
Q ss_pred ----HHHHHHHHHHHHHhc----CCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 378 ----IALGTARALEYLHEV----CSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 378 ----i~~~ia~~L~~LH~~----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
+...+...++++++. ...+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455666532 13478999999999999987656899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0051 Score=60.88 Aligned_cols=142 Identities=18% Similarity=0.214 Sum_probs=78.5
Q ss_pred ceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCC--CccceeeE-----EeeCCeEEEEEE
Q 008055 277 NLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP--NIMELVGY-----CSEYGQHLLVYE 349 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e 349 (579)
..++ |....||+....+|+.+++|........ ...+..|...+..+... .+.+++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 8888999988777878999998644322 33445566665554211 13333332 223566789999
Q ss_pred ecCCCChh-----h------h---hcccCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 008055 350 FRKNGSLH-----D------F---LHLSDE-----DNKPLIWNSR----VKI---------------ALGTARALEYLHE 391 (579)
Q Consensus 350 ~~~~gsL~-----~------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~ 391 (579)
+++|..+. . . +|.... ....+.+... ..+ ...+...++.+.+
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 0 0 111100 0111222111 000 1111122333322
Q ss_pred c----CCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 392 V----CSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 392 ~----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
. ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1 134688999999999999 4 88999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00046 Score=58.44 Aligned_cols=56 Identities=21% Similarity=0.272 Sum_probs=30.7
Q ss_pred EEeccCCcCC-CCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeeccccc
Q 008055 6 YLNIAHNQLQ-GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63 (579)
Q Consensus 6 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 63 (579)
.++.++++|+ ..+|..+ .++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666664 2344322 235666666666666444444555666666666666543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00037 Score=69.39 Aligned_cols=77 Identities=18% Similarity=0.188 Sum_probs=66.0
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCC-EEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLS-TLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l 77 (579)
|.+|+.|+|++| ++.+-+.+|.++.+|+ .|+|++ +++..-+..|.+|++|+.|+|++|+++...+ .|..+. |+.|
T Consensus 249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 578999999998 8866778999999999 999999 7886667899999999999999999998775 466664 8877
Q ss_pred Ec
Q 008055 78 NI 79 (579)
Q Consensus 78 ~l 79 (579)
+.
T Consensus 327 y~ 328 (329)
T 3sb4_A 327 YK 328 (329)
T ss_dssp EC
T ss_pred cc
Confidence 63
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0041 Score=60.87 Aligned_cols=71 Identities=10% Similarity=0.007 Sum_probs=40.8
Q ss_pred cceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCc-cceeeEEeeCCeEEEEEEec-CC
Q 008055 276 ENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI-MELVGYCSEYGQHLLVYEFR-KN 353 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~ 353 (579)
.+.|+.|....+|+. ..+++|+........ .....|...++.+....+ .++++++ .+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 577889999999998 557888876432111 111245555544422222 3555443 33457899999 55
Q ss_pred CCh
Q 008055 354 GSL 356 (579)
Q Consensus 354 gsL 356 (579)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0026 Score=63.23 Aligned_cols=32 Identities=22% Similarity=0.236 Sum_probs=27.2
Q ss_pred CCCeEEcCCCCCCEEEcCC----CceEEeccccccc
Q 008055 394 SLSVVHKNIKSANILLDNE----LNPQLSDCGLASN 425 (579)
Q Consensus 394 ~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~~~ 425 (579)
...++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6789999998754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00011 Score=79.58 Aligned_cols=67 Identities=15% Similarity=0.191 Sum_probs=35.6
Q ss_pred CCCCCCCEEeccCCcCCCCCCcccc-CCCCCCeeEeecc-cccCc-ccc-cCCCC-CCeEEcccCcCCCCCc
Q 008055 23 GQLPSLSTLDLSFNTLSGNLPQSFS-SLSSLSSLYLQNN-QFSGT-IDV-LANLP-LDNLNIANNRFTGWVP 89 (579)
Q Consensus 23 ~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N-~l~~~-~~~-~~~~~-L~~l~l~~N~l~~~~p 89 (579)
..+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++. +..++ |+.|+|++|.+++..+
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~ 173 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG 173 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCG
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcch
Confidence 3456666666666666655555554 4566666666666 34331 122 22333 6666666666554433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00013 Score=73.57 Aligned_cols=87 Identities=20% Similarity=0.240 Sum_probs=58.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhC--CCCCCCEEeccC--CcCCCC-----CCccc--cCCCCCCeeEeecccccCccc-c
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFG--QLPSLSTLDLSF--NTLSGN-----LPQSF--SSLSSLSSLYLQNNQFSGTID-V 68 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~~~~~-~ 68 (579)
+++|+.|+|..+.++...-..++ .+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.++.... .
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 46899999999988754444454 789999999863 332221 11122 247899999999999875431 1
Q ss_pred c---CCC-CCCeEEcccCcCCCC
Q 008055 69 L---ANL-PLDNLNIANNRFTGW 87 (579)
Q Consensus 69 ~---~~~-~L~~l~l~~N~l~~~ 87 (579)
+ ..+ .|+.|+|++|.|++.
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHH
T ss_pred HHhCccCCCCCEEECCCCCCChH
Confidence 1 223 499999999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0029 Score=57.76 Aligned_cols=98 Identities=15% Similarity=0.122 Sum_probs=64.1
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCcccc
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALN 434 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 434 (579)
+|.+.|. ..+.+++++++|.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.|...+ ..+.
T Consensus 34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 7888887 346789999999999999998877621100 1 1223456899999999987764 1110
Q ss_pred cCCCCCccCccccccCCCCccchHHhHHHHHHHHHh
Q 008055 435 NDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT 470 (579)
Q Consensus 435 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt 470 (579)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1233577888763 345678899999999999885
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00028 Score=62.83 Aligned_cols=81 Identities=11% Similarity=0.109 Sum_probs=50.8
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCc-CCCCCCccccCC----CCCCeeEeecc-cccCcc-cccCCCC-C
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNT-LSGNLPQSFSSL----SSLSSLYLQNN-QFSGTI-DVLANLP-L 74 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N-~l~~~~-~~~~~~~-L 74 (579)
+|++|||+++.++..--..+.++++|+.|+|+++. |+..--..++.+ ++|+.|+|+++ +||..- ..+..++ |
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 46788888887765444556778888888888874 553222334443 36888888876 466421 2344444 7
Q ss_pred CeEEcccCc
Q 008055 75 DNLNIANNR 83 (579)
Q Consensus 75 ~~l~l~~N~ 83 (579)
+.|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 888887764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0032 Score=65.08 Aligned_cols=73 Identities=10% Similarity=0.106 Sum_probs=48.2
Q ss_pred cceeccCCceEEEEEEeCC--------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCc-cceeeEEeeCCeEEE
Q 008055 276 ENLLGEGTFGRVYRAQFAD--------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI-MELVGYCSEYGQHLL 346 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 346 (579)
.+.|+.|....||++...+ +..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568888899999998753 4788899884321 12445578777777643333 566666543 38
Q ss_pred EEEecCCCCh
Q 008055 347 VYEFRKNGSL 356 (579)
Q Consensus 347 v~e~~~~gsL 356 (579)
||||++|-+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0021 Score=65.81 Aligned_cols=91 Identities=14% Similarity=0.134 Sum_probs=61.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCC-----CCCCccccCCCCCCeeEeecccccCccc-ccCCCC-C
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLS-----GNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-L 74 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L 74 (579)
.+|+.|.|. |+++..-+..|.++++|+.|+|.+|.+. ..-+..|.+|++|+.|+|. |.++.... .|..+. |
T Consensus 248 ~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L 325 (401)
T 4fdw_A 248 SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKV 325 (401)
T ss_dssp CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSC
T ss_pred CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCc
Confidence 367888884 4566555778888888999888888765 3445678888888888888 44665443 355554 8
Q ss_pred CeEEcccCcCCCCCccccccC
Q 008055 75 DNLNIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 75 ~~l~l~~N~l~~~~p~~l~~~ 95 (579)
+.|.|.+| ++..-+..|.++
T Consensus 326 ~~l~lp~~-l~~I~~~aF~~~ 345 (401)
T 4fdw_A 326 TQLTIPAN-VTQINFSAFNNT 345 (401)
T ss_dssp CEEEECTT-CCEECTTSSSSS
T ss_pred cEEEECcc-ccEEcHHhCCCC
Confidence 88888555 543333444443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0059 Score=61.73 Aligned_cols=141 Identities=15% Similarity=0.154 Sum_probs=80.4
Q ss_pred ceeccCCceEEEEEEeC--------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEEE
Q 008055 277 NLLGEGTFGRVYRAQFA--------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 347 (579)
+.|..|-...+|++... +++.+++|+..... .....+.+|..+++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888899999764 24788898863321 12455567888877663 2223566666553 299
Q ss_pred EEecCCCChhhh-----------------hcccCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 008055 348 YEFRKNGSLHDF-----------------LHLSDE-DNKPL--IWNSRVKIALGTAR-------------------ALEY 388 (579)
Q Consensus 348 ~e~~~~gsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~~ia~-------------------~L~~ 388 (579)
|||++|.+|..- +|.... ..... .+.+..++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999987554210 121111 11112 23444545443321 2333
Q ss_pred HHh----c-CCCCeEEcCCCCCCEEEcCC----CceEEecccccc
Q 008055 389 LHE----V-CSLSVVHKNIKSANILLDNE----LNPQLSDCGLAS 424 (579)
Q Consensus 389 LH~----~-~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~~ 424 (579)
|.+ . ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 322 1 13468999999999999876 789999999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0093 Score=59.46 Aligned_cols=31 Identities=23% Similarity=0.294 Sum_probs=27.2
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 395 LSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 395 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4789999999999999888899999987653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.002 Score=54.45 Aligned_cols=56 Identities=23% Similarity=0.376 Sum_probs=46.0
Q ss_pred CEEeccCCcCC-CCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEcccCcCCC
Q 008055 29 STLDLSFNTLS-GNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNIANNRFTG 86 (579)
Q Consensus 29 ~~L~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l~~N~l~~ 86 (579)
..++.++++|+ ..+|..|. .+|+.|+|++|+|+.+++. +..++ |+.|+|++|.|..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 48999999997 45776543 4799999999999998864 66665 9999999999964
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00023 Score=71.78 Aligned_cols=87 Identities=15% Similarity=0.212 Sum_probs=60.5
Q ss_pred CCCCcEEeccC--CcCCCC-----chhhh--CCCCCCCEEeccCCcCCCCCCcccc---CCCCCCeeEeecccccCcc--
Q 008055 1 MKTLKYLNIAH--NQLQGQ-----LNDMF--GQLPSLSTLDLSFNTLSGNLPQSFS---SLSSLSSLYLQNNQFSGTI-- 66 (579)
Q Consensus 1 l~~L~~L~l~~--n~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~~~~-- 66 (579)
|++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+++..+..+. .+++|+.|+|+.|.|++.-
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~ 297 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH
Confidence 58999999863 222111 11223 3589999999999998754443443 5789999999999998742
Q ss_pred ---cccCCCC-CCeEEcccCcCCCC
Q 008055 67 ---DVLANLP-LDNLNIANNRFTGW 87 (579)
Q Consensus 67 ---~~~~~~~-L~~l~l~~N~l~~~ 87 (579)
..+..++ |+.|+|++|.|+..
T Consensus 298 ~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 298 LLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp HHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHhhcccCCcceEEECCCCcCCHH
Confidence 2223344 99999999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.011 Score=59.68 Aligned_cols=74 Identities=7% Similarity=0.035 Sum_probs=40.8
Q ss_pred cceeccCCceEEEEEEeCC---------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCC-ccceeeEEeeCCeEE
Q 008055 276 ENLLGEGTFGRVYRAQFAD---------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN-IMELVGYCSEYGQHL 345 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~ 345 (579)
.+.|+.|....+|+....+ +..+++|+..... ........|...++.+.... ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3467788889999997654 2678888865421 11111245666665553223 33566544 2 36
Q ss_pred EEEEecCCCCh
Q 008055 346 LVYEFRKNGSL 356 (579)
Q Consensus 346 lv~e~~~~gsL 356 (579)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.025 Score=58.73 Aligned_cols=74 Identities=11% Similarity=0.074 Sum_probs=45.4
Q ss_pred cceeccCCceEEEEEEeCC-CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCc-cceeeEEeeCCeEEEEEEecCC
Q 008055 276 ENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI-MELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 353 (579)
.+.|+.|-...+|++...+ +..+++|+..... .... ....|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4568888899999998765 4778888875422 1111 11467777777754444 46676663 2 359999987
Q ss_pred CCh
Q 008055 354 GSL 356 (579)
Q Consensus 354 gsL 356 (579)
-+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0024 Score=57.85 Aligned_cols=82 Identities=17% Similarity=0.208 Sum_probs=56.2
Q ss_pred CCCcEEeccCC-cCCC----CchhhhCCCCCCCEEeccCCcCCC----CCCccccCCCCCCeeEeecccccCcc-----c
Q 008055 2 KTLKYLNIAHN-QLQG----QLNDMFGQLPSLSTLDLSFNTLSG----NLPQSFSSLSSLSSLYLQNNQFSGTI-----D 67 (579)
Q Consensus 2 ~~L~~L~l~~n-~l~~----~~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~-----~ 67 (579)
++|++|+|++| +|.. .+-+.+..=+.|+.|+|++|.|.. .+-..+..-+.|+.|+|++|+|+..- .
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46889999885 7752 245567767789999999998862 23334445678999999999987532 2
Q ss_pred ccCC-CCCCeEEcccCc
Q 008055 68 VLAN-LPLDNLNIANNR 83 (579)
Q Consensus 68 ~~~~-~~L~~l~l~~N~ 83 (579)
.+.. -.|+.|+|++|.
T Consensus 121 aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQR 137 (197)
T ss_dssp HTTTTCCCSEEECCCCS
T ss_pred HHhhCCceeEEECCCCc
Confidence 2322 248899998653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.32 E-value=0.019 Score=58.56 Aligned_cols=91 Identities=7% Similarity=0.020 Sum_probs=70.8
Q ss_pred CCCCcEEeccCCcCC-----CCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCCC
Q 008055 1 MKTLKYLNIAHNQLQ-----GQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLPL 74 (579)
Q Consensus 1 l~~L~~L~l~~n~l~-----~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~L 74 (579)
|++|+.|+|.+|.+. ..-+..|.+|++|+.++|. |+++..-...|.+|.+|+.|+|.+| ++...+ .|..+.|
T Consensus 270 c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L 347 (401)
T 4fdw_A 270 CPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGI 347 (401)
T ss_dssp CTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCC
T ss_pred CCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCC
Confidence 578999999998875 3556789999999999999 4587555678999999999999665 654443 3666689
Q ss_pred CeEEcccCcCCCCCccccc
Q 008055 75 DNLNIANNRFTGWVPEQLK 93 (579)
Q Consensus 75 ~~l~l~~N~l~~~~p~~l~ 93 (579)
+.|++++|.+....+..+.
T Consensus 348 ~~l~l~~n~~~~l~~~~F~ 366 (401)
T 4fdw_A 348 KEVKVEGTTPPQVFEKVWY 366 (401)
T ss_dssp CEEEECCSSCCBCCCSSCC
T ss_pred CEEEEcCCCCccccccccc
Confidence 9999999988644444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.083 Score=54.06 Aligned_cols=74 Identities=8% Similarity=0.025 Sum_probs=44.7
Q ss_pred cceeccCCceEEEEEEeCC--------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEE
Q 008055 276 ENLLGEGTFGRVYRAQFAD--------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 346 (579)
.+.+..|-...+|+....+ +..+++|+..... .. .....+|..+++.+. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 3567778889999998753 5788898864432 11 112235555555553 222345555432 278
Q ss_pred EEEecCCCCh
Q 008055 347 VYEFRKNGSL 356 (579)
Q Consensus 347 v~e~~~~gsL 356 (579)
||||++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=93.63 E-value=0.034 Score=49.26 Aligned_cols=68 Identities=12% Similarity=0.065 Sum_probs=49.2
Q ss_pred chhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeeccc-ccCcc-cccCCC-----CCCeEEcccCc-CC
Q 008055 18 LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ-FSGTI-DVLANL-----PLDNLNIANNR-FT 85 (579)
Q Consensus 18 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~-~~~~~~-----~L~~l~l~~N~-l~ 85 (579)
+|.....-.+|+.|||+++.++..--..+.+|++|+.|+|+++. |+..- ..+..+ .|+.|+|+++. ++
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 34433333579999999999885544568899999999999985 76532 334432 49999999975 65
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.38 E-value=0.022 Score=51.55 Aligned_cols=83 Identities=19% Similarity=0.264 Sum_probs=57.6
Q ss_pred CCCcEEeccCCcCCC----CchhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecc---cccCcc----
Q 008055 2 KTLKYLNIAHNQLQG----QLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNN---QFSGTI---- 66 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N---~l~~~~---- 66 (579)
..|+.|+|++|+|.. .+-+.+..=+.|+.|+|++|.|+.. +-..+..-+.|+.|+|++| .|....
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 478999999999963 3445565668899999999999832 2234555678999999876 333221
Q ss_pred -ccc-CCCCCCeEEcccCcC
Q 008055 67 -DVL-ANLPLDNLNIANNRF 84 (579)
Q Consensus 67 -~~~-~~~~L~~l~l~~N~l 84 (579)
..+ .+..|+.|+++.|.+
T Consensus 150 a~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCcCeEeccCCCc
Confidence 122 223488899887764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.21 E-value=0.098 Score=53.04 Aligned_cols=78 Identities=15% Similarity=0.212 Sum_probs=42.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
.+|+.+.+.++ ++.+-..+|.++.+|+.++|.++ ++..-..+|.+|.+|+.++|..| ++...+ .|..+. |+.+++
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 45566666544 44333455666666666666543 54333455666666666666555 443322 244443 666666
Q ss_pred ccC
Q 008055 80 ANN 82 (579)
Q Consensus 80 ~~N 82 (579)
..|
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.66 E-value=0.21 Score=50.59 Aligned_cols=78 Identities=17% Similarity=0.290 Sum_probs=42.0
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
.+|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|.+|.+|+.++|..| ++..-+ .|..+. |+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 45666666655433 334556666667666664 3344333355666666666666543 332222 244443 666666
Q ss_pred ccC
Q 008055 80 ANN 82 (579)
Q Consensus 80 ~~N 82 (579)
..+
T Consensus 342 p~s 344 (394)
T 4gt6_A 342 PSS 344 (394)
T ss_dssp CTT
T ss_pred Ccc
Confidence 433
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.66 E-value=0.1 Score=52.87 Aligned_cols=81 Identities=15% Similarity=0.304 Sum_probs=60.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~ 78 (579)
+.+|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.+|.+|+.+.|..| ++..-. .|..+. |+.++
T Consensus 287 c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 287 CPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIE 363 (394)
T ss_dssp CTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEE
T ss_pred ccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEE
Confidence 3578888886 4566455678999999999999865 66444578999999999999755 654443 366664 99999
Q ss_pred cccCcC
Q 008055 79 IANNRF 84 (579)
Q Consensus 79 l~~N~l 84 (579)
+.+|..
T Consensus 364 ~~~~~~ 369 (394)
T 4gt6_A 364 YSGSRS 369 (394)
T ss_dssp ESSCHH
T ss_pred ECCcee
Confidence 988754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.30 E-value=0.22 Score=49.99 Aligned_cols=79 Identities=15% Similarity=0.162 Sum_probs=56.6
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCC-CCCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANL-PLDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~L~~l~l 79 (579)
.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.+|.+|+.+.|.+|.++...+. |..+ .|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 56788888766 55455667888888998888655 5534446788888999999888888765543 5565 4888888
Q ss_pred ccC
Q 008055 80 ANN 82 (579)
Q Consensus 80 ~~N 82 (579)
..|
T Consensus 318 p~~ 320 (379)
T 4h09_A 318 PTA 320 (379)
T ss_dssp CTT
T ss_pred Ccc
Confidence 654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.86 E-value=0.087 Score=53.64 Aligned_cols=29 Identities=28% Similarity=0.370 Sum_probs=24.3
Q ss_pred CeEEcCCCCCCEEE------cCCCceEEecccccc
Q 008055 396 SVVHKNIKSANILL------DNELNPQLSDCGLAS 424 (579)
Q Consensus 396 ~iiH~Dlkp~Nill------~~~~~~kl~Dfg~~~ 424 (579)
.++|+|+.+.|||+ +++..+.++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 445779999998875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=89.36 E-value=0.31 Score=49.25 Aligned_cols=58 Identities=16% Similarity=0.193 Sum_probs=48.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N 60 (579)
+.+|+.++|.++ ++.+-..+|.++.+|+.++|..| ++..-..+|.+|.+|+.++|..|
T Consensus 319 c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 319 CTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 468999999755 77555788999999999999887 77455678999999999999865
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=88.89 E-value=0.64 Score=46.54 Aligned_cols=90 Identities=13% Similarity=0.173 Sum_probs=61.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l~l 79 (579)
.+|+.+.+..+ +...-...|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++.... .+..+. |+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 45677777655 44345667888999999999876 56445567888999999998654 443333 355554 999999
Q ss_pred ccCcCCCCCcccccc
Q 008055 80 ANNRFTGWVPEQLKN 94 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~ 94 (579)
.+|.++..-...|.+
T Consensus 294 ~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 294 DNSAIETLEPRVFMD 308 (379)
T ss_dssp CCTTCCEECTTTTTT
T ss_pred cccccceehhhhhcC
Confidence 888876333344444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.57 E-value=1.5 Score=39.77 Aligned_cols=116 Identities=12% Similarity=0.171 Sum_probs=79.9
Q ss_pred CCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 008055 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSAN 406 (579)
Q Consensus 327 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N 406 (579)
.||+++.. .+-.+.+.+.+.++.-+. ...|-. -..++...++.++.+|+...++++ .-+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence 68888866 566666766666665432 222221 234677889999999988776666 34788999999
Q ss_pred EEEcCCCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCC
Q 008055 407 ILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 407 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~ 476 (579)
++++.++.+++.=.|+-..+.+ . ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P----------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDP----------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSC----------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCC----------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999988876433322 1 11222224457789999999998884
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.36 E-value=0.84 Score=29.72 Aligned_cols=11 Identities=18% Similarity=0.323 Sum_probs=4.4
Q ss_pred cchhHHHHHHH
Q 008055 150 GIAGILISLFV 160 (579)
Q Consensus 150 ~v~g~~~~~~~ 160 (579)
+++|++.++++
T Consensus 13 IA~gVVgGv~~ 23 (44)
T 2ks1_B 13 IATGMVGALLL 23 (44)
T ss_dssp STHHHHHHHHH
T ss_pred EEeehhHHHHH
Confidence 33444443333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.64 E-value=1 Score=29.34 Aligned_cols=23 Identities=30% Similarity=0.499 Sum_probs=10.7
Q ss_pred CCCcchhHHHHHHHHHHHHHHHH
Q 008055 147 GGGGIAGILISLFVVGGIVAFFL 169 (579)
Q Consensus 147 ~~~~v~g~~~~~~~~~~~~~~~~ 169 (579)
+++.++|-++.++++++.+.+++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~ 35 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFM 35 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeehhHHHHHHHHHHHHHHHHh
Confidence 44445554444445554444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.13 E-value=0.081 Score=54.96 Aligned_cols=63 Identities=5% Similarity=0.081 Sum_probs=18.1
Q ss_pred cccceeccCCceEEEEEEeCC-CcEEEE------EEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEe
Q 008055 274 NVENLLGEGTFGRVYRAQFAD-GKVLAV------KKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCS 339 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 339 (579)
.+.+.|| ||.||+|.+.. ..+||| |..+......+....|.++..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999998754 367888 776655555555667888888888899999999987754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.65 E-value=1.2 Score=28.87 Aligned_cols=10 Identities=40% Similarity=0.803 Sum_probs=4.0
Q ss_pred chhHHHHHHH
Q 008055 151 IAGILISLFV 160 (579)
Q Consensus 151 v~g~~~~~~~ 160 (579)
++|++.++++
T Consensus 13 A~gVVgGv~~ 22 (44)
T 2l2t_A 13 AAGVIGGLFI 22 (44)
T ss_dssp HHHHHHHHHH
T ss_pred EEeehHHHHH
Confidence 3344433433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.55 E-value=0.44 Score=30.98 Aligned_cols=23 Identities=30% Similarity=0.470 Sum_probs=10.0
Q ss_pred CCCcchhHHHHHHHHHHHHHHHH
Q 008055 147 GGGGIAGILISLFVVGGIVAFFL 169 (579)
Q Consensus 147 ~~~~v~g~~~~~~~~~~~~~~~~ 169 (579)
+++.++|-++.++++++.+.+++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~ 34 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYV 34 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeehHHHHHHHHHHHHHHHHh
Confidence 34444444444444444443333
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.07 E-value=1.2 Score=28.01 Aligned_cols=15 Identities=27% Similarity=0.751 Sum_probs=8.4
Q ss_pred CCCCcchhHHHHHHH
Q 008055 146 IGGGGIAGILISLFV 160 (579)
Q Consensus 146 ~~~~~v~g~~~~~~~ 160 (579)
.+.+.++|++++.++
T Consensus 8 ls~GaIAGiVvG~v~ 22 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLL 22 (38)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred CCCCceeeeehHHHH
Confidence 445566666665443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.29 E-value=3.7 Score=37.36 Aligned_cols=115 Identities=14% Similarity=0.175 Sum_probs=77.9
Q ss_pred CCCCccceeeEEeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEcCCCCC
Q 008055 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE-YLHEVCSLSVVHKNIKSA 405 (579)
Q Consensus 327 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~iiH~Dlkp~ 405 (579)
.||++ -..+-.+.+.+.+.++.-+++.=+..+ ..++...++.++.+|+.... +++ .-+|=-|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 67887 444556777888888765443222233 23677888999998877665 555 4578899999
Q ss_pred CEEEcCCCceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCC
Q 008055 406 NILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFD 476 (579)
Q Consensus 406 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~ 476 (579)
|++++.++.++|.-.|+-..+ +|.- .+..-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL----------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999988864332 2221 1111223456788888998888773
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 579 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.004 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.002 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 4e-67
Identities = 72/286 (25%), Positives = 134/286 (46%), Gaps = 27/286 (9%)
Query: 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPN 330
G V +G G+FG VY+ ++ +AVK ++ +A + F V + + H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ +GY + Q +V ++ + SL+ LH + IA TA+ ++YLH
Sbjct: 66 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA--LNNDAGS-GYGAPEVA 447
S++H+++KS NI L +L ++ D GLA+ + +GS + APEV
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 448 M---SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
Y+ +SDVY+FG+V+ EL+TG+ P+ + R + + D+ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
A+K ++A C++ + + RP +++ ++ L +
Sbjct: 239 PKAMK------------RLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-62
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 27/280 (9%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+G G FG V+ + + +A+K I A+ E DFIE + +L HP ++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLV 63
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+L G C E LV+EF ++G L D+L + + + L + YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS--GYGAPEVAMSG 450
C V+H+++ + N L+ ++SD G+ + + + + +PEV
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510
+Y+ KSDV+SFGV+M E+ + K +R E + DI ++ P L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 228
Query: 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ ++ C + PE RP S +++ L + +
Sbjct: 229 -------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-61
Identities = 62/275 (22%), Positives = 118/275 (42%), Gaps = 27/275 (9%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+ LG G FG V+ + +AVK + S D F+ + + QL H ++
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLV 71
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L ++ ++ E+ +NGSL DFL L N + +A A + ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS--GYGAPEVAMSG 450
+ +H+++++ANIL+ + L+ +++D GLA + + + A + APE G
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510
+ IKSDV+SFG+++ E++T + E + + ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNLERGYRM 229
Query: 511 LYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ P ++ LC + PE RP + L
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-61
Identities = 63/304 (20%), Positives = 122/304 (40%), Gaps = 33/304 (10%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMEL 334
++ +G+G FG V+R ++ G+ +AVK S S + L H NI+
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGF 62
Query: 335 VGYCSE----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ ++ + Q LV ++ ++GSL D+L+ + +K+AL TA L +LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 117
Query: 391 EVC-----SLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-----G 440
++ H+++KS NIL+ ++D GLA +A + ++
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 441 YGAPEVAMS------GQYNIKSDVYSFGVVMLELLTGRKPF----DSSRPRLEQSLVRWA 490
Y APEV + ++D+Y+ G+V E+ D P + +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
++ + K+ ++L A ++ C R + + L +L Q
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 551 RANM 554
+ +
Sbjct: 298 QEGI 301
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 9e-60
Identities = 68/319 (21%), Positives = 134/319 (42%), Gaps = 44/319 (13%)
Query: 258 VTSYSIADLQMATGSFN---------VENLLGEGTFGRVYRAQFA----DGKVLAVKKID 304
+ ++ D A F +E ++G G FG V +A+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 305 SSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSD 364
S + DF+ S + Q HPN++ L G ++ +++ EF +NGSL FL
Sbjct: 64 SGYTEKQR-RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--- 119
Query: 365 EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424
+++ V + G A ++YL ++ VH+++ + NIL+++ L ++SD GL+
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 425 NMPNADEALNNDAGSG------YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDS 477
+ + + G + APE ++ SDV+S+G+VM E+++ G +P+
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 478 SRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
+ ++ + P+ S ++ C Q + RP
Sbjct: 237 MTN-----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 538 MSEVVQALVRLVQRANMSK 556
++V L ++++ N K
Sbjct: 280 FGQIVNTLDKMIRNPNSLK 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-59
Identities = 59/306 (19%), Positives = 118/306 (38%), Gaps = 37/306 (12%)
Query: 266 LQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS 324
+++ F + LG G G V++ G V+A K I P + + I + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLH 59
Query: 325 QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR 384
+ + P I+ G G+ + E GSL L + K+++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGA 443
L YL E ++H+++K +NIL+++ +L D G++ + D N+ G+ Y +
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMS 171
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWAT------------ 491
PE Y+++SD++S G+ ++E+ GR P + + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 492 --------------PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
P + + L +V+ L F D + C+ P R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 538 MSEVVQ 543
+ +++
Sbjct: 292 LKQLMV 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-59
Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 33/299 (11%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
+ ++G G FG VY+ +A+K + + + DF+ + Q
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQF 66
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
H NI+ L G S+Y +++ E+ +NG+L FL E + V + G A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 123
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS----GYG 442
+YL + VH+++ + NIL+++ L ++SD GL+ + + EA +G +
Sbjct: 124 KYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 443 APEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
APE ++ SDV+SFG+VM E++T + E + K
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMK 224
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMSKRTIGN 561
++ + P+ S ++ C Q E RP +++V L +L++ + S +T+ +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD-SLKTLAD 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-59
Identities = 55/279 (19%), Positives = 121/279 (43%), Gaps = 29/279 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
LG G FG V ++ +A+K I ++ D+FIE + L H ++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 62
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+L G C++ ++ E+ NG L ++L E +++ A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS--GYGAPEVAMSG 450
+H+++ + N L++++ ++SD GL+ + + + + + + PEV M
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 451 QYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
+++ KSD+++FGV+M E+ + G+ P++ A+ + L+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQGLR 219
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548
P + + ++ C + + RP ++ ++ +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-59
Identities = 63/277 (22%), Positives = 116/277 (41%), Gaps = 29/277 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+ +G+G FG V + G +AVK I + A F+ S ++QL H N++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLV 63
Query: 333 ELVGYCSEYGQHL-LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+L+G E L +V E+ GSL D+L L + +K +L A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE- 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQ 451
+ VH+++ + N+L+ + ++SD GL + + + APE +
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAPEALREKK 176
Query: 452 YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGL 511
++ KSDV+SFG+++ E+ + + P + + V+ K
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIP----------------LKDVVPRVEKGYKMD 220
Query: 512 YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548
P +V+ C + RP ++ + L +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 2e-58
Identities = 61/286 (21%), Positives = 131/286 (45%), Gaps = 27/286 (9%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+++ LG G +G VY + +AVK + + E +F++ + + ++ HPN+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNL 75
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L+G C+ ++ EF G+L D+L + + + + + +A + A+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS--GYGAPEVAMS 449
+ +H+++ + N L+ +++D GL+ M + A + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
+++IKSDV++FGV++ E+ T D+ + ++++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYR 234
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555
P + +++ C Q P RP +E+ QA + Q +++S
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-57
Identities = 60/277 (21%), Positives = 120/277 (43%), Gaps = 23/277 (8%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ V +G G++GR + + +DGK+L K++D ++ + V+ + +L HPNI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 332 MELVGYCSEYGQHLL--VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ + L V E+ + G L + ++ + L +++ AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 390 HE--VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEV 446
H +V+H+++K AN+ LD + N +L D GLA + + G+ Y +PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
YN KSD++S G ++ EL PF + + + K+ +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------------ELAGKIREG 229
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + P + ++I + + RP + E+++
Sbjct: 230 KFRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-57
Identities = 66/302 (21%), Positives = 124/302 (41%), Gaps = 43/302 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
+ LG G FG+V A +AVK + SA +E + + + +S L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYL 83
Query: 327 -HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH--------------LSDEDNKPLI 371
+H NI+ L+G C+ G L++ E+ G L +FL + ++D L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 372 WNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADE 431
+ + A+ + +L S + +H+++ + NILL + ++ D GLA ++ N
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 432 ALNNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488
+ + APE + Y +SDV+S+G+ + EL + P +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256
Query: 489 WATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548
KM+ + L P + + D++ C +P RP ++VQ + +
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 549 VQ 550
+
Sbjct: 306 IS 307
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-57
Identities = 64/278 (23%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 276 ENLLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
+ LG G FG V + + K +AVK + + A + D+ + + + QL +P I+
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
++G C E +LV E + G L+ +L N+ + + +++ + ++YL E
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE- 125
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS----GYGAPEVAM 448
+ VH+++ + N+LL + ++SD GL+ + + + APE
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 449 SGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
+++ KSDV+SFGV+M E + G+KP+ + + M++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKG 226
Query: 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ P D++ LC + E RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-57
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 27/276 (9%)
Query: 272 SFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
S +E LG+G FG V+ + +A+K + + E F++ + +L H +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKL 74
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L S +V E+ GSL DFL E K L V +A A + Y+
Sbjct: 75 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS--GYGAPEVAMS 449
+ VH+++++ANIL+ L +++D GLA + + + A + APE A+
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
G++ IKSDV+SFG+++ EL T + E + V+ +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYR 232
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
P + D++ C + EPE RP + L
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-56
Identities = 66/303 (21%), Positives = 120/303 (39%), Gaps = 50/303 (16%)
Query: 273 FNVENLLGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
+LG G FG+V A + +AVK + A SE + + + ++QL
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKMMTQL 97
Query: 327 -HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH-------------------LSDED 366
H NI+ L+G C+ G L++E+ G L ++L +ED
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 367 NKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426
L + + A A+ +E+L S VH+++ + N+L+ + ++ D GLA ++
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 427 PNADEALNNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRL 482
+ + + APE G Y IKSDV+S+G+++ E+ + G P+
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY------- 267
Query: 483 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 542
P + K++ K P + ++ C + RP +
Sbjct: 268 ---------PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 543 QAL 545
L
Sbjct: 319 SFL 321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-56
Identities = 60/290 (20%), Positives = 121/290 (41%), Gaps = 34/290 (11%)
Query: 265 DLQMATGSFNVENL-LGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMV 320
L + + + ++ LG G FG V + + +A+K + ++ ++ +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREA 60
Query: 321 SNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIAL 380
+ QL +P I+ L+G C + +LV E G LH FL + + ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLH 116
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS- 439
+ ++YL E + VH+++ + N+LL N ++SD GL+ + D +
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 440 ---GYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLH 495
+ APE +++ +SDV+S+GV M E L+ G+KP+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-----------------M 216
Query: 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQAL 545
+ ++ + P + +++ C + E RP V Q +
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-56
Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 33/288 (11%)
Query: 274 NVENLLGEGTFGRVYRAQFADGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+ ++G G FG VY D AVK ++ E+ F+ + HP
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHP 88
Query: 330 NIMELVGYCSEY-GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
N++ L+G C G L+V + K+G L +F+ + + L A+ +
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM-- 143
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-----GYGA 443
+ S VH+++ + N +LD + +++D GLA +M + + ++ + A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
E + ++ KSDV+SFGV++ EL+T P + +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------------ITVY 246
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551
+ + L P +V+ C P+ E RP SE+V + +
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 1e-55
Identities = 71/318 (22%), Positives = 132/318 (41%), Gaps = 49/318 (15%)
Query: 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQ------FADGKVLAVKKIDSSALPSEMCDD 315
+ L+ + +GEG FGRV++A+ + ++AVK + A +M D
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQAD 62
Query: 316 FIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH-------------- 361
F + +++ +PNI++L+G C+ L++E+ G L++FL
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 362 ------LSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNP 415
+S PL ++ IA A + YL E VH+++ + N L+ +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVV 179
Query: 416 QLSDCGLASNMPNADE--ALNNDAGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR 472
+++D GL+ N+ +AD A NDA + PE +Y +SDV+++GVV+ E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 473 KPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEP 532
E + + D + P +++ LC P
Sbjct: 240 LQPYYGMAHEEV---------------IYYVRDGNILAC-PENCPLELYNLMRLCWSKLP 283
Query: 533 EFRPPMSEVVQALVRLVQ 550
RP + + L R+ +
Sbjct: 284 ADRPSFCSIHRILQRMCE 301
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 7e-55
Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 30/274 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE-MCDDFIEMVSNISQLHHPN 330
F + LG+G FG VY A+ +LA+K + + L + V S L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
I+ L GY + + L+ E+ G+++ L A AL Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCH 123
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
S V+H++IK N+LL + +++D G + + P G+ Y PE+
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLCGTLDYLPPEMIEG 178
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
++ K D++S GV+ E L G+ PF+++ + + D V +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTEGAR 232
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
D+I+ ++ P RP + EV++
Sbjct: 233 ------------DLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 2e-54
Identities = 80/308 (25%), Positives = 132/308 (42%), Gaps = 44/308 (14%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPN 330
F+ +G G+FG VY A+ + +V+A+KK+ S S E D I+ V + +L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
++ G LV E+ + KPL + G + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
S +++H+++K+ NILL +L D G AS M A N+ G+ + APEV ++
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILA 185
Query: 450 ---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
GQY+ K DV+S G+ +EL + P ++ + AL +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL----------------FNMNAMSALYHIAQN 229
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ-----------ALVRLVQRANMS 555
L F + + C+Q P+ RP +++ ++ L+QR +
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289
Query: 556 KRTIGNDQ 563
R + N Q
Sbjct: 290 VRELDNLQ 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 7e-54
Identities = 62/294 (21%), Positives = 123/294 (41%), Gaps = 36/294 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVL---AVKKIDSSALPSEMCDDFIEMVSNISQL-HH 328
++++GEG FG+V +A+ + A+K++ A + DF + + +L HH
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHH 70
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH------------LSDEDNKPLIWNSRV 376
PNI+ L+G C G L E+ +G+L DFL +++ L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 377 KIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND 436
A AR ++YL +H+++ + NIL+ +++D GL+ +
Sbjct: 131 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 437 AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHD 496
+ A E Y SDV+S+GV++ E+++ E
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------- 234
Query: 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
L + + + P+ D++ C + +P RP ++++ +L R+++
Sbjct: 235 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-53
Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 32/279 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG+G FG+VY+AQ + A K ID+ + E +D++ + ++ HPNI
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNI 71
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L+ ++ EF G++ + E +PL + + T AL YLH
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH- 127
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSG 450
++H+++K+ NIL + + +L+D G+++ + ++ G+ + APEV M
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 451 Q-----YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
Y+ K+DV+S G+ ++E+ P L+ + L K+
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHE----------------LNPMRVLLKIAK 229
Query: 506 PALKGLYPVKSLSR-FADVIALCVQPEPEFRPPMSEVVQ 543
L S F D + C++ + R S+++Q
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-53
Identities = 64/277 (23%), Positives = 122/277 (44%), Gaps = 29/277 (10%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
+ +G+G G VY A A G+ +A+++++ P + + I + + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKN 76
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
PNI+ + + +V E+ GSL D + + + +ALE+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVA 447
LH S V+H++IKS NILL + + +L+D G + + + G+ + APEV
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRP-RLEQSLVRWATPQLHDIDALAKMVDP 506
Y K D++S G++ +E++ G P+ + P R + TP+L + + L+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI--- 245
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
F D + C+ + E R E++Q
Sbjct: 246 -------------FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-53
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 33/286 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQF----ADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLH 327
+ LG+G+FG V R ++ +AVK + L E DDFI V+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
H N++ L G +V E GSL D L + + + + A+ A +
Sbjct: 70 HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMG 125
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG----YGA 443
YL S +H+++ + N+LL ++ D GL +P D+ + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502
PE + ++ SD + FGV + E+ T G++P+ L+ L K
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW----------------IGLNGSQILHK 226
Query: 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548
+ + P +V+ C +PE RP + L+
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-52
Identities = 50/278 (17%), Positives = 104/278 (37%), Gaps = 30/278 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +G G+F VY+ + +A ++ L F E + L HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 332 MELVGYCSEYGQH----LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
+ + +LV E +G+L +L K + + L+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQ 126
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELN-PQLSDCGLASNMPNADEALNNDAGS-GYGAPE 445
+LH + ++H+++K NI + ++ D GLA+ G+ + APE
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPE 183
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505
+ +Y+ DVY+FG+ MLE+ T P+ + + ++
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVTS 227
Query: 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ ++ ++I C++ + R + +++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-52
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 40/300 (13%)
Query: 273 FNVENLLGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
+ LG G FG+V A + A + +AVK + A SE E+ I
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 327 HHPNIMELVGYCSEYGQHL-LVYEFRKNGSLHDFLH------------LSDEDNKPLIWN 373
HH N++ L+G C++ G L ++ EF K G+L +L D L
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 374 SRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433
+ + A+ +E+L S +H+++ + NILL + ++ D GLA ++ + +
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 434 NNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA 490
+ APE Y I+SDV+SFGV++ E+ +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------------- 237
Query: 491 TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
P + + + + + P + + C EP RP SE+V+ L L+Q
Sbjct: 238 -PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 7e-51
Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 42/301 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQF--------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNIS 324
+ LGEG FG+V A+ +AVK + S A ++ D EM
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 325 QLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH------------LSDEDNKPLIW 372
H NI+ L+G C++ G ++ E+ G+L ++L S + L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 373 NSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEA 432
V A AR +EYL S +H+++ + N+L+ + +++D GLA ++ + D
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 433 LNNDAGSG---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW 489
G + APE Y +SDV+SFGV++ E+ T P
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------- 242
Query: 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549
++ L K++ + P + ++ C P RP ++V+ L R+V
Sbjct: 243 -------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 550 Q 550
Sbjct: 296 A 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-50
Identities = 59/276 (21%), Positives = 112/276 (40%), Gaps = 28/276 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+++ LGEG +G V A + +AVK +D + ++ + + L+H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENV 65
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++ G+ E L E+ G L D + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP--NADEALNNDAGS-GYGAPEVAM 448
+ + H++IK N+LLD N ++SD GLA+ N + LN G+ Y APE+
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 449 SGQYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
+++ DV+S G+V+ +L G P+D ++ + K +D A
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---KKIDSA 235
Query: 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
++ + P R + ++ +
Sbjct: 236 PL------------ALLHKILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 6e-50
Identities = 59/284 (20%), Positives = 107/284 (37%), Gaps = 30/284 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
+ +GEG FG V++ + +A+K + S + F++ + Q H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDH 67
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
P+I++L+G +E ++ E G L FL L S + A + AL Y
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAY 123
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG--SGYGAPEV 446
L VH++I + N+L+ + +L D GL+ M ++ + + APE
Sbjct: 124 LESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
++ SDV+ FGV M E+L + I +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRIENGERL 228
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ P ++ C +P RP +E+ L +++
Sbjct: 229 PMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 53/286 (18%), Positives = 119/286 (41%), Gaps = 32/286 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVK---KIDSSALPSEMCDDFIEMVSNISQLHH 328
F +LG G FG VY+ + +G+ + + K A + + ++ ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
P++ L+G C L+ + G L D++ E + + + A+ + Y
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPE 445
L +VH+++ + N+L+ + +++D GLA + ++ + + G + A E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504
+ Y +SDV+S+GV + EL+T G KP+D ++ ++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-----------------IPASEISSIL 226
Query: 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
+ + P ++ C + + RP E++ ++ +
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 56/293 (19%), Positives = 120/293 (40%), Gaps = 35/293 (11%)
Query: 273 FNVENLLGEGTFGRVYRA------QFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL 326
+ LG+G+FG VY + +A+K ++ +A E +F+ S + +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEF 80
Query: 327 HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLH------LSDEDNKPLIWNSRVKIAL 380
+ +++ L+G S+ L++ E G L +L ++ P + +++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG 440
A + YL + VH+++ + N ++ + ++ D G+ ++ D G
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 441 ---YGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497
+ +PE G + SDV+SFGVV+ E+ T + L +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------QGLSNE 242
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550
L +++ L P +++ +C Q P+ RP E++ ++ ++
Sbjct: 243 QVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (429), Expect = 3e-48
Identities = 58/300 (19%), Positives = 120/300 (40%), Gaps = 31/300 (10%)
Query: 247 VVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDS 305
+ K+ P + + D +++ LG G FG V+R A G A K + +
Sbjct: 8 IWKQYYPQPVEIKHDHVLD------HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61
Query: 306 SALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE 365
+ + + + +S L HP ++ L + + +++YEF G L + + +
Sbjct: 62 PHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---D 116
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ--LSDCGLA 423
++ + + V+ + L ++HE VH ++K NI+ + + + L D GL
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 424 SNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE 483
+++ + + APEVA +D++S GV+ LL+G PF +
Sbjct: 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--D 231
Query: 484 QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
++L + + D+ + K D I + +P R + + ++
Sbjct: 232 ETLRNVKSCDWNMDDSAFSGISEDGK------------DFIRKLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 55/277 (19%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNI-SQLHHPN 330
F +LGEG+F V A+ A + A+K ++ + E ++ ++ S+L HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
++L + + + KNG L ++ ALEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSG---YGAPEVA 447
++H+++K NILL+ +++ Q++D G A + + ++ G Y +PE+
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 448 MSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507
SD+++ G ++ +L+ G PF + ++ K++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAG----------------NEYLIFQKIIK-- 224
Query: 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544
L+ +P K + D++ + + R E+
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (420), Expect = 6e-47
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 31/300 (10%)
Query: 247 VVKKAVKAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDS 305
+ KK V P V S+ D +++ LG G FG V+R A G+V K I++
Sbjct: 11 IWKKYVPQPVEVKQGSVYD------YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 306 SALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDE 365
+ +S ++QLHHP ++ L + + +L+ EF G L D +
Sbjct: 65 PYPLDK--YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---A 119
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ--LSDCGLA 423
++ + + L+++H S+VH +IK NI+ + + + D GLA
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
Query: 424 SNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE 483
+ + + A + + APE+ +D+++ GV+ LL+G PF
Sbjct: 177 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--L 234
Query: 484 QSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
++L + V P K D I +Q EP R + + ++
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAK------------DFIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 4e-46
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 36/286 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-------EMCDDFIEMVSNIS 324
+ + +LG G V R K AVK ID + S E+ + ++ V +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 325 QLH-HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
++ HPNI++L LV++ K G L D+L + L KI
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALL 120
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
+ LH L++VH+++K NILLD+++N +L+D G + + ++ Y A
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 444 PEVAMSGQ------YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDI 497
PE+ Y + D++S GV+M LL G PF + L ++ Q
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-- 235
Query: 498 DALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
P D+++ + +P+ R E +
Sbjct: 236 -------SPEWDDYSD-----TVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (409), Expect = 4e-46
Identities = 59/290 (20%), Positives = 112/290 (38%), Gaps = 32/290 (11%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE-MCDDFIEMVSNISQLH 327
+ + + +LG G V+ A+ + +AVK + + F N + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 328 HPNIMELVGYC----SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
HP I+ + +V E+ +L D +H P+ +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG----S 439
+AL + ++H+++K ANI++ ++ D G+A + ++ ++ A +
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 440 GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499
Y +PE A + +SDVYS G V+ E+LTG PF P + A
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSA 236
Query: 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-MSEVVQALVRL 548
+ + L V+ + PE R +E+ LVR+
Sbjct: 237 RHEGLSADLD------------AVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 6e-46
Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 29/270 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSEMCDDF----IEMVSNISQLH 327
F+V ++G G FG VY + AD GK+ A+K +D + + + M+S +S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
P I+ + + + + G LH L + A LE
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLE 121
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA 447
++H + VV++++K ANILLD + ++SD GLA + + + GY APEV
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL 177
Query: 448 MSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
G Y+ +D +S G ++ +LL G PF + + + + R ++ P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---DSFSP 234
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRP 536
L+ ++ +Q + R
Sbjct: 235 ELR------------SLLEGLLQRDVNRRL 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-45
Identities = 51/274 (18%), Positives = 99/274 (36%), Gaps = 26/274 (9%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + LG G FG V+R + K K + + + +S ++ H NI
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHRNI 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L + ++++EF + + ++ L V AL++LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 392 VCSLSVVHKNIKSANILLDNELNPQ--LSDCGLASNMPNADEALNNDAGSGYGAPEVAMS 449
S ++ H +I+ NI+ + + + G A + D Y APEV
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
+ +D++S G ++ LL+G PF + +Q + + + K +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
D + + E + R SE +Q
Sbjct: 236 ------------DFVDRLLVKERKSRMTASEALQ 257
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-44
Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 20/285 (7%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
F +GEGT+G VY+A+ G+V+A+KKI + I +S + +L+HPNI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
++L+ + LV+EF + L F+ S + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG-SGYGAPEVAMSG 450
V+H+++K N+L++ E +L+D GLA ++ Y APE+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 451 QYN-IKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
+Y D++S G + E++T R F + + ++ P K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 510 GLYPVKSLSRFA-----------DVIALCVQPEPEFRPPMSEVVQ 543
+P + F+ +++ + +P R +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (398), Expect = 1e-44
Identities = 59/284 (20%), Positives = 115/284 (40%), Gaps = 20/284 (7%)
Query: 273 FNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIM 332
++ +GEGT+G VY+AQ G+ A+KKI + I +S + +L H NI+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
+L + +LV+E L + L + Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM-SG 450
V+H+++K N+L++ E +++D GLA ++ + Y AP+V M S
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRP-----RLEQSLVRWATPQLHDIDALAKMV- 504
+Y+ D++S G + E++ G F R+ + L + ++ L K
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 505 -----DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+P + D+++ ++ +P R + ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 3e-44
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 32/278 (11%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
++ ++LG G F V A+ K++A+K I AL + ++ + ++ HPNI
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNI 69
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L G L+ + G L D + + ++ A++YLH+
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSG 450
+ + K LD + +SD GL+ + L+ G+ GY APEV
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEVLAQK 184
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRP-----RLEQSLVRWATPQLHDIDALAKMVD 505
Y+ D +S GV+ LL G PF ++ ++ + +P DI AK
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK--- 241
Query: 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
D I ++ +PE R + +Q
Sbjct: 242 ----------------DFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 58/289 (20%), Positives = 108/289 (37%), Gaps = 23/289 (7%)
Query: 273 FNVENLLGEGTFGRVYRAQFA--DGKVLAVKKIDSSALPSEMCDDF---IEMVSNISQLH 327
+ +GEG +G+V++A+ G+ +A+K++ M + ++ ++
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 328 HPNIMELVGYC----SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
HPN++ L C ++ L + + L +L E + + +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGA 443
R L++LH S VVH+++K NIL+ + +L+D GLA + Y A
Sbjct: 127 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQLHDIDALA 501
PEV + Y D++S G + E+ + F S L + L P D
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 502 KMVDPALKGLYP------VKSLSRFA-DVIALCVQPEPEFRPPMSEVVQ 543
+ A V + D++ C+ P R +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-43
Identities = 58/268 (21%), Positives = 104/268 (38%), Gaps = 29/268 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQLHHP 329
F + +LG+G+FG+V+ A+F + A+K + + ++ +E HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ + V E+ G L + + A L++L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFL 119
Query: 390 HEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAM 448
H +V++++K NILLD + + +++D G+ D N G+ Y APE+ +
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 449 SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508
+YN D +SFGV++ E+L G+ PF +R P ++
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW------LEKEA 230
Query: 509 KGLYPVKSLSRFADVIALCVQPEPEFRP 536
K D++ EPE R
Sbjct: 231 K------------DLLVKLFVREPEKRL 246
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 30/280 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSE----MCDDFIEMVSNISQLH 327
++ LG G F V + + + G A K I S +D VS + ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 328 HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALE 387
HPN++ L +L+ E G L DFL + + L + +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVY 127
Query: 388 YLHEVCSLSVVHKNIKSANILLDNELNPQ----LSDCGLASNMPNADEALNNDAGSGYGA 443
YLH + + H ++K NI+L + P+ + D GLA + +E N + A
Sbjct: 128 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 444 PEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKM 503
PE+ +++D++S GV+ LL+G PF + A
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------------QETLANVSA 230
Query: 504 VDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
V+ + Y + + D I + +P+ R + + +Q
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (382), Expect = 6e-42
Identities = 60/279 (21%), Positives = 114/279 (40%), Gaps = 36/279 (12%)
Query: 261 YSIADLQMATGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-EMCDDFIE 318
YS+ D F + LG G+FGRV+ + +G+ A+K + + + + +
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 319 MVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI 378
+S + HP I+ + G + Q ++ ++ + G L L S P+ ++
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAG 438
L L + S ++++++K NILLD + +++D G A +P+ L
Sbjct: 114 CL-------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD 166
Query: 439 SGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDID 498
Y APEV + YN D +SFG+++ E+L G PF S + A +
Sbjct: 167 --YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF- 223
Query: 499 ALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP 537
+ +K D+++ + + R
Sbjct: 224 -----FNEDVK------------DLLSRLITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-42
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 23/283 (8%)
Query: 277 NLLGEGTFGRVYRAQF-ADGKVLAVKKID---SSALPSEMCDDFIEMVSNISQLHHPNIM 332
+ LGEG F VY+A+ +++A+KKI S + + + + +L HPNI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 333 ELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV 392
L+ LV++F + ++ L + L T + LEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 393 CSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSGQ 451
++H+++K N+LLD +L+D GLA + + + A + + Y APE+ +
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 452 -YNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQLHDIDALAKMVDPAL 508
Y + D+++ G ++ ELL L + TP + + D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 509 KGLYPVKSLSR--------FADVIALCVQPEPEFRPPMSEVVQ 543
+P L D+I P R ++ ++
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (373), Expect = 6e-41
Identities = 39/300 (13%), Positives = 95/300 (31%), Gaps = 36/300 (12%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HH 328
+ V +GEG+FG ++ + + +A+K + ++ D++ L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY----KLLAGC 60
Query: 329 PNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
I + + E ++LV + L D + + A ++
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 389 LHEVCSLSVVHKNIKSANILLDNELNPQ-----LSDCGLA-------SNMPNADEALNND 436
+H S+V+++IK N L+ + + D G+ + N
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 437 AGS-GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495
+G+ Y + + + + + D+ + G V + L G P+ +
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----------TNKQ 223
Query: 496 DIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555
+ + + F + + P + ++++R N +
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 7e-41
Identities = 47/299 (15%), Positives = 96/299 (32%), Gaps = 36/299 (12%)
Query: 271 GSFNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+ + +G G+FG +Y A G+ +A+K +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC----VKTKHPQLHIESKIYKMMQGG 62
Query: 330 NIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+ + +C G + ++ SL D + ++ + + +A +EY+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYI 119
Query: 390 HEVCSLSVVHKNIKSANIL---LDNELNPQLSDCGLASNMPNADEALNNDAGS------- 439
H S + +H+++K N L + D GLA +A +
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 440 -GYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR-LEQSLVRWATPQLHD- 496
Y + + + + + D+ S G V++ G P+ + Q R + ++
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANMS 555
I+ L K + C + +P S + Q L R S
Sbjct: 237 IEVLCKGYPSEFA------------TYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-41
Identities = 54/277 (19%), Positives = 101/277 (36%), Gaps = 29/277 (10%)
Query: 275 VENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIME 333
+LG G G+V + + A+K + +E+ P+I+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRA--SQCPHIVR 69
Query: 334 LVGYC----SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYL 389
+V + L+V E G L + D ++ +I A++YL
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 390 HEVCSLSVVHKNIKSANILLDNELNP---QLSDCGLASNMPNADEALNNDAGSGYGAPEV 446
H S+++ H+++K N+L ++ +L+D G A + + Y APEV
Sbjct: 128 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 447 AMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
+Y+ D++S GV+M LL G PF S+ + +M
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----------LAISPGMKTRIRMGQY 234
Query: 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ +I ++ EP R ++E +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 66/311 (21%), Positives = 117/311 (37%), Gaps = 30/311 (9%)
Query: 253 KAPTNVTSYSIADLQMATGSFNVENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSSALPSE 311
K T V + + S+ ++G G+FG VY+A+ D G+++A+KK+
Sbjct: 2 KVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---- 57
Query: 312 MCDDFIEMVSNISQLHHPNIMELVGYCSEYGQH------LLVYEFRKNGSLHDFLHLSDE 365
+ + +L H NI+ L + G+ LV ++ H S
Sbjct: 58 --RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-R 114
Query: 366 DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ-LSDCGLAS 424
+ L R+L Y+H S + H++IK N+LLD + L D G A
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 425 NMPNADEALNNDAGSGYGAP-EVAMSGQYNIKSDVYSFGVVMLELLTGRKPF--DSSRPR 481
+ + ++ Y AP + + Y DV+S G V+ ELL G+ F DS +
Sbjct: 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
Query: 482 LEQSLVRWATPQLHDIDA---------LAKMVDPALKGLYPVKSLSRFADVIALCVQPEP 532
L + + TP I ++ ++ ++ + + ++ P
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 533 EFRPPMSEVVQ 543
R E
Sbjct: 292 TARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-39
Identities = 53/286 (18%), Positives = 110/286 (38%), Gaps = 22/286 (7%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +GEGT+G V++A+ +++A+K++ + + + + +L H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L + LV+EF D D N L + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAP--EVAMS 449
V+H+++K N+L++ +L++ GLA + + + + P + +
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPF---DSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506
Y+ D++S G + EL +P + +L++ TP ++ K+ D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 507 ALKGLYPVKSLSR---------FADVIALCVQPEPEFRPPMSEVVQ 543
+YP + D++ ++ P R E +Q
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 56/297 (18%), Positives = 112/297 (37%), Gaps = 32/297 (10%)
Query: 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH 328
+ + +GEG +G V A + +A+KKI C + + + + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRH 65
Query: 329 PNIMELVGYC----SEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTAR 384
NI+ + E + + + L+ L + L + R
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILR 120
Query: 385 ALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNND----AGSG 440
L+Y+H S +V+H+++K +N+LL+ + ++ D GLA + A
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 441 YGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQLHDI 497
Y APE+ ++ + Y D++S G ++ E+L+ R F L L +P D+
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 498 DALAKMVDPALKGLYPVKSL-----------SRFADVIALCVQPEPEFRPPMSEVVQ 543
+ + + P K+ S+ D++ + P R + + +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-37
Identities = 51/283 (18%), Positives = 98/283 (34%), Gaps = 42/283 (14%)
Query: 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQ 325
+ V LLG G FG VY +D +A+K ++ + V + +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 326 LH--HPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTA 383
+ ++ L+ + +L+ E + + L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 120
Query: 384 RALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMPNADEALNNDAGS-GY 441
A+ + H V+H++IK NIL+D N +L D G + + D + G+ Y
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVY 175
Query: 442 GAPEVAMSGQYNIKS-DVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500
PE +Y+ +S V+S G+++ +++ G PF+ + +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF------------F 223
Query: 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ V + +I C+ P RP E+
Sbjct: 224 RQRVSSECQ------------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 9e-37
Identities = 49/287 (17%), Positives = 100/287 (34%), Gaps = 22/287 (7%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +G G +G V A G +A+KK+ + + + H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 332 MELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHE 391
+ L+ + +F ++ L + + + L Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH- 138
Query: 392 VCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMSG 450
+ ++H+++K N+ ++ + ++ D GLA D + + Y APEV ++
Sbjct: 139 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNW 193
Query: 451 Q-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA--TPQLHDIDALAKMVDPA 507
Y D++S G +M E++TG+ F S + + TP + L
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 508 LKGLYPVKSLSRFA-----------DVIALCVQPEPEFRPPMSEVVQ 543
P FA +++ + + E R E +
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 57/269 (21%), Positives = 103/269 (38%), Gaps = 28/269 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPN 330
F+ LLG+GTFG+V + A G+ A+K + + + + + + HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+ L + + V E+ G L L + A + L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYG---AEIVSALE 119
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-GYGAPEVAMS 449
+ S VV+++IK N++LD + + +++D GL + + G+ Y APEV
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 450 GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALK 509
Y D + GVVM E++ GR PF + L+ + + + P K
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------RTLSPEAK 233
Query: 510 GLYPVKSLSRFADVIALCVQPEPEFRPPM 538
++A ++ +P+ R
Sbjct: 234 ------------SLLAGLLKKDPKQRLGG 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-36
Identities = 52/302 (17%), Positives = 112/302 (37%), Gaps = 36/302 (11%)
Query: 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHP 329
+ +G+GTFG V++A+ G+ +A+KK+ + + + L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 330 NIMELVGYCSEY--------GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALG 381
N++ L+ C G LV++F ++ + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVM-- 123
Query: 382 TARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGS-- 439
L L+ + ++H+++K+AN+L+ + +L+D GLA A + N +
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 440 ---GYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRP--------RLEQSLV 487
Y PE+ + + Y D++ G +M E+ T + +L S+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 488 RWATPQLHDIDALAKMVDPALKGLYPVKSLSRFA------DVIALCVQPEPEFRPPMSEV 541
P + + + K+ + L + D+I + +P R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 542 VQ 543
+
Sbjct: 303 LN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 9e-36
Identities = 53/267 (19%), Positives = 100/267 (37%), Gaps = 29/267 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-EMCDDFIEMVSNISQLHHPN 330
F+ LG G+FGRV + G A+K +D + + + + + ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 331 IMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLH 390
+++L + +V E+ G + L A EYLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 391 EVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSG 450
SL ++++++K N+L+D + Q++D G A + L APE+ +S
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE--ALAPEIILSK 213
Query: 451 QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKG 510
YN D ++ GV++ E+ G PF + +P + +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----------------- 256
Query: 511 LYPVKSLSRFADVIALCVQPEPEFRPP 537
+P S D++ +Q + R
Sbjct: 257 -FPSHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 55/281 (19%), Positives = 110/281 (39%), Gaps = 36/281 (12%)
Query: 273 FNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSALPS--EMCDDFIEMVSNISQL 326
F + +LG G +G+V+ + GK+ A+K + + + + + + +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 327 -HHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
P ++ L + L+ ++ G L L + + + +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ-------IYVGEI 138
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM--PNADEALNNDAGSGYGA 443
+ L + L +++++IK NILLD+ + L+D GL+ + A + Y A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 444 PEVAMSGQ--YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501
P++ G ++ D +S GV+M ELLTG PF + ++ A
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF----------------TVDGEKNSQA 242
Query: 502 KMVDPALKGLYPV-KSLSR-FADVIALCVQPEPEFRPPMSE 540
++ LK P + +S D+I + +P+ R
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 51/292 (17%), Positives = 110/292 (37%), Gaps = 32/292 (10%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ + +G G +G V A G +AVKK+ + + + H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 332 MELVGYCSE-----YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARAL 386
+ L+ + + + L++ + + L + + R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGL 134
Query: 387 EYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPEV 446
+Y+H ++H+++K +N+ ++ + ++ D GLA + + A Y APE+
Sbjct: 135 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 189
Query: 447 AMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSS--------------RPRLEQSLVRWAT 491
++ YN D++S G +M ELLTGR F + P E +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 492 PQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543
+ I +L +M ++ + D++ + + + R ++ +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 1e-31
Identities = 55/297 (18%), Positives = 107/297 (36%), Gaps = 41/297 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQ-FADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPN 330
+ + LG G + V+ A + + + VK + + + L PN
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPN 91
Query: 331 IMELVGYCSEYGQHL--LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEY 388
I+ L + LV+E N + L +AL+Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDY 144
Query: 389 LHEVCSLSVVHKNIKSANILLDNE-LNPQLSDCGLASNMPNADEALNNDAGSGYGAPEVA 447
H + ++H+++K N+++D+E +L D GLA E A + PE+
Sbjct: 145 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 448 MSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA---TPQLHD-IDALAK 502
+ Q Y+ D++S G ++ ++ ++PF +Q + T L+D ID
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 503 MVDPALKGLYPVKSLSRFA----------------DVIALCVQPEPEFRPPMSEVVQ 543
+DP + S R+ D + ++ + + R E ++
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (296), Expect = 7e-30
Identities = 52/317 (16%), Positives = 119/317 (37%), Gaps = 46/317 (14%)
Query: 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ---- 325
+ + LG G F V+ A+ + +A+K + + +E +D I+++ ++
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 326 ----LHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVK-IAL 380
+ +I++L+ + + G + + + L L + I VK I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 381 GTARALEYLHEVCSLSVVHKNIKSANILLDNELNP----QLSDCGLASNMPNADEALNND 436
L+Y+H ++H +IK N+L++ +P Q+ L + + N+
Sbjct: 133 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 437 AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--------------- 481
Y +PEV + + +D++S ++ EL+TG F+
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 482 ---LEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSR------------FADVIAL 526
L L+R ++ + + + +P++ + +D ++
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 527 CVQPEPEFRPPMSEVVQ 543
+Q +P R +V
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-29
Identities = 48/302 (15%), Positives = 102/302 (33%), Gaps = 41/302 (13%)
Query: 273 FNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNI 331
+ +G G G V A + +A+KK+ + + ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 332 MELVGYCS------EYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARA 385
+ L+ + E+ LV E D + +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER-------MSYLLYQMLCG 131
Query: 386 LEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEALNNDAGSGYGAPE 445
+++LH ++H+++K +NI++ ++ ++ D GLA + Y APE
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 446 VAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPR--LEQSLVRWATPQLHDIDALAKM 503
V + Y D++S G +M E++ + F + + + TP + L
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 504 VDPALKGLYPVKSLSR----------------------FADVIALCVQPEPEFRPPMSEV 541
V ++ L+ D+++ + +P R + +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 542 VQ 543
+Q
Sbjct: 309 LQ 310
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 23/211 (10%), Positives = 57/211 (27%), Gaps = 41/211 (19%)
Query: 275 VENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIE---------------- 318
+ L+GEG V+ VK + + +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 319 MVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKI 378
+ +L + ++ + + ++ E + + + ++
Sbjct: 64 EFRALQKLQGLAVPKVY----AWEGNAVLMELIDAK-----------ELYRVRVENPDEV 108
Query: 379 ALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA--SNMPNADEALNND 436
+ + +VH ++ N+L+ E + D + E L D
Sbjct: 109 LDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERD 164
Query: 437 AGSGYGAPEVAMSGQYNIKSDVYSFGVVMLE 467
+ S Y + D+ S +L+
Sbjct: 165 VRNIIT----YFSRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 2e-12
Identities = 21/83 (25%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+K L YL + N + L L L + N +S S ++L++++ L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 61 QFSGTIDVLANLP-LDNLNIANN 82
Q S LANL + L + +
Sbjct: 362 QISDLTP-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 5e-10
Identities = 24/85 (28%), Positives = 40/85 (47%), Gaps = 8/85 (9%)
Query: 19 NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNL 77
L +L+ L L FN +S P SSL+ L L+ NN+ S + LANL ++ L
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWL 356
Query: 78 NIANNRFTGWVP----EQLKNINLQ 98
+ +N+ + P ++ + L
Sbjct: 357 SAGHNQISDLTPLANLTRITQLGLN 381
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 28/121 (23%), Positives = 45/121 (37%), Gaps = 27/121 (22%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP----------------- 43
+ L L++A+NQ+ L L+ L L N +S P
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 44 ---QSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI-NLQ 98
S+L +L+ L L N S +++L L L ANN+ + L N+ N+
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 99 K 99
Sbjct: 355 W 355
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 23/82 (28%), Positives = 39/82 (47%), Gaps = 8/82 (9%)
Query: 21 MFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79
+ +L +L +L + N +S P + +L L L NQ I LA+L L +L++
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGTLASLTNLTDLDL 248
Query: 80 ANNRFTGWVP----EQLKNINL 97
ANN+ + P +L + L
Sbjct: 249 ANNQISNLAPLSGLTKLTELKL 270
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 10/56 (17%), Positives = 22/56 (39%), Gaps = 4/56 (7%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLY 56
+ + L ++ D L +L+ ++ S N L+ P +L+ L +
Sbjct: 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 1e-11
Identities = 19/62 (30%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
K L L++ +N++ G L QL L +L++SFN L G +P +L NN
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
Query: 61 QF 62
+
Sbjct: 302 KC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.5 bits (150), Expect = 3e-11
Identities = 23/80 (28%), Positives = 29/80 (36%), Gaps = 1/80 (1%)
Query: 6 YLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGT 65
G +L+ LDL N + G LPQ + L L SL + N G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 66 IDVLANLP-LDNLNIANNRF 84
I NL D ANN+
Sbjct: 284 IPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 11/43 (25%), Positives = 17/43 (39%), Gaps = 1/43 (2%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP 43
+K L LN++ N L G++ G L + N P
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.9 bits (141), Expect = 4e-10
Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 1/97 (1%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
L++ +N++ + F L +L TL L N +S P +F+ L L LYL NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 62 FSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINLQ 98
+ L L + N T +N
Sbjct: 91 LK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 24/100 (24%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
MK L Y+ IA + + PSL+ L L N ++ S L++L+ L L N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 61 QFSGTIDVLANLP--LDNLNIANNRFTGWVPEQLKNINLQ 98
S + L L++ NN+ + +Q
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 0.001
Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ L + G N F + LS + ++ ++ +PQ SL+ L+L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181
Query: 61 QFSGTI-DVLANL-PLDNLNIANNRFTGW 87
+ + L L L L ++ N +
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAV 210
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.5 bits (88), Expect = 0.002
Identities = 23/134 (17%), Positives = 38/134 (28%), Gaps = 35/134 (26%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNL------------------ 42
+L L++ N++ L +L+ L LSFN++S
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 43 -----PQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKNINL 97
P + + +YL NN S P N A+ ++L
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS----------YSGVSL 279
Query: 98 QKDGNSWSSGPAPP 111
N P
Sbjct: 280 --FSNPVQYWEIQP 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.7 bits (86), Expect = 0.003
Identities = 21/117 (17%), Positives = 39/117 (33%), Gaps = 24/117 (20%)
Query: 1 MKTLKYLNIAHNQLQ---------------------GQLNDMFGQLPSLSTLDLSF--NT 37
+ L+ L ++ NQL+ +F L + ++L
Sbjct: 78 LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137
Query: 38 LSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQLKN 94
SG +F + LS + + + + TI L L++ N+ T LK
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKG 193
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 4e-09
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 11 HNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLA 70
N ++ + PSL L++S N L LP + L L N + ++
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAEVPELPQ 324
Query: 71 NLPLDNLNIANNRFTGW--VPEQLKNINL 97
N L L++ N + +PE ++++ +
Sbjct: 325 N--LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 7e-09
Identities = 18/81 (22%), Positives = 38/81 (46%), Gaps = 10/81 (12%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+L+ LN+++N+L ++ P L L SFN L+ +P +L L+++ N
Sbjct: 283 PPSLEELNVSNNKLI----ELPALPPRLERLIASFNHLA-EVP---ELPQNLKQLHVEYN 334
Query: 61 QFSGTIDVLANLPLDNLNIAN 81
D+ ++ +L + +
Sbjct: 335 PLREFPDIPESVE--DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 18/81 (22%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 33 LSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQL 92
N S + SL L + NN+ + L+ L + N VPE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPR--LERLIASFNHLAE-VPELP 323
Query: 93 KNI-NLQKDGNSWSSGPAPPP 112
+N+ L + N P P
Sbjct: 324 QNLKQLHVEYNPLREFPDIPE 344
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.1 bits (84), Expect = 0.004
Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 8/86 (9%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQ 61
+ L + + L L ++ P L +L S N+L+ LP SL SL + NN
Sbjct: 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELP---ELPQSLKSLLVDNNN 89
Query: 62 FSGTIDVLANLPLDNLNIANNRFTGW 87
D+ L ++
Sbjct: 90 LKALSDLPPLLEYLGVSNNQLEKLPE 115
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 20/89 (22%), Positives = 28/89 (31%), Gaps = 10/89 (11%)
Query: 1 MKTLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSS-----LSS 51
L+ L +A + L SL LDLS N L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 52 LSSLYLQNNQFSGTI-DVLANLPLDNLNI 79
L L L + +S + D L L D ++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 15/92 (16%), Positives = 34/92 (36%), Gaps = 11/92 (11%)
Query: 19 NDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGT-----IDVL 69
+ L L L+ +S + L + + SL L L NN ++ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 70 ANLP--LDNLNIANNRFTGWVPEQLKNINLQK 99
L+ L + + ++ + ++L+ + K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 14/83 (16%), Positives = 27/83 (32%), Gaps = 11/83 (13%)
Query: 27 SLSTLDLSFNTLSGN-LPQSFSSLSSLSSLYLQNNQFSGTI-----DVLANLP-LDNLNI 79
+ +LD+ LS + L + L + + L P L LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 80 ANNRFTG----WVPEQLKNINLQ 98
+N V + L+ + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCK 85
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 9/68 (13%), Positives = 20/68 (29%), Gaps = 4/68 (5%)
Query: 1 MKTLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLY 56
++ + + + L ++ P+L+ L+L N L S
Sbjct: 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 85
Query: 57 LQNNQFSG 64
+Q
Sbjct: 86 IQKLSLQN 93
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 6e-08
Identities = 21/123 (17%), Positives = 40/123 (32%), Gaps = 25/123 (20%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLS---------- 50
+ L +L + N++ F L SL L L N ++ P +F L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 51 --------------SLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNRFTGWVPEQLKNI 95
+L L L +N + L +++ +P++L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 96 NLQ 98
+L+
Sbjct: 272 DLK 274
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 20/93 (21%), Positives = 35/93 (37%), Gaps = 14/93 (15%)
Query: 11 HNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLA 70
+N L + L +L TL L N+L +P+ F L +L N + ++L
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILY 215
Query: 71 NLPLDNLNIANNRFTGWVPEQLKNINLQKDGNS 103
F W+ + +N+ + K G
Sbjct: 216 -------------FRRWLQDNAENVYVWKQGVD 235
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 8/37 (21%), Positives = 13/37 (35%)
Query: 26 PSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQF 62
+ L LS N L + + L+ L L +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 4e-06
Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 28/107 (26%)
Query: 5 KYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSL------------ 52
+ L++AH L + QL ++ LDLS N L P + ++L L
Sbjct: 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 53 ----------SSLYLQNNQFSGTIDV--LANLP-LDNLNIANNRFTG 86
L L NN+ + + L + P L LN+ N
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 8e-05
Identities = 18/95 (18%), Positives = 27/95 (28%), Gaps = 24/95 (25%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLST----------------------LDLSFNTL 38
+ + +L+++HN+L+ L L L L N L
Sbjct: 19 LLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRL 77
Query: 39 -SGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANL 72
Q S L L LQ N + L
Sbjct: 78 QQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 5e-04
Identities = 17/86 (19%), Positives = 27/86 (31%), Gaps = 5/86 (5%)
Query: 30 TLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVP 89
L L+ L+ L ++ L L +N+ LA L + A++ V
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 90 EQLKNINLQK---DGNSWSSGPAPPP 112
LQ+ N A P
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQP 85
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 4/55 (7%)
Query: 5 KYLNIAHNQLQG-QLNDMFGQLPSLSTLDLSFNTLSG--NLPQS-FSSLSSLSSL 55
+ L + +N+LQ P L L+L N+L + + L S+SS+
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 4e-06
Identities = 11/61 (18%), Positives = 21/61 (34%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNN 60
+ + +N L+ ND+F LD+S + +L L + N
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
Query: 61 Q 61
+
Sbjct: 236 K 236
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 2e-05
Identities = 20/95 (21%), Positives = 35/95 (36%), Gaps = 5/95 (5%)
Query: 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSG--NLPQSFSSLSSLSSLYLQ 58
LN + L + +P L +L+LS N L ++ +L L L
Sbjct: 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99
Query: 59 NNQFS--GTIDVLANLPLDNLNIANNRFTGWVPEQ 91
N+ +D + L L+ L + N + +Q
Sbjct: 100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 2e-04
Identities = 18/73 (24%), Positives = 31/73 (42%), Gaps = 2/73 (2%)
Query: 1 MKTLKYLNIAHNQLQGQ--LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQ 58
+ L LN+++N+L ++ + + P+L L+LS N L L L+L
Sbjct: 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD 123
Query: 59 NNQFSGTIDVLAN 71
N S T +
Sbjct: 124 GNSLSDTFRDQST 136
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 2e-05
Identities = 15/78 (19%), Positives = 26/78 (33%), Gaps = 11/78 (14%)
Query: 6 YLNIAHNQLQGQLNDMFGQ------LPSLSTLDLSFNTLSGNLPQS-----FSSLSSLSS 54
L + L + L TL L +N + + ++ + L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 55 LYLQNNQFSGTIDVLANL 72
L L N+FS DV+ +
Sbjct: 307 LELNGNRFSEEDDVVDEI 324
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 5/65 (7%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYL 57
K+LK I + + + + S+ + LS NT+ L ++ +S L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 58 QNNQF 62
+
Sbjct: 67 SDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 10/65 (15%), Positives = 24/65 (36%), Gaps = 6/65 (9%)
Query: 1 MKTLKYLNIAHNQLQGQ-----LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSL 55
L+ L + +N+++ + ++P L L+L+ N S + + S
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFST 330
Query: 56 YLQNN 60
+
Sbjct: 331 RGRGE 335
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 4e-05
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 1/89 (1%)
Query: 11 HNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLA 70
N+++ N MF L L TL+L N +S +P SF L+SL+SL L +N F+ +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 71 NLPLDN-LNIANNRFTGWVPEQLKNINLQ 98
++ P +++++ ++
Sbjct: 147 FAEWLRKKSLNGGAARCGAPSKVRDVQIK 175
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 20/64 (31%), Positives = 30/64 (46%), Gaps = 4/64 (6%)
Query: 19 NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNL 77
L L+TL N +S P +SL +L ++L+NNQ S + LAN L +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-VSPLANTSNLFIV 222
Query: 78 NIAN 81
+ N
Sbjct: 223 TLTN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 4/101 (3%)
Query: 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGN-LPQSFSSLSSLSSLYLQNN 60
+ + + + L + F + +DLS + + + L S S L +L L+
Sbjct: 23 QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81
Query: 61 QFSGTI-DVLANLP-LDNLNIANNRFTGWVPEQLKNINLQK 99
+ S I + LA L LN++ Q + +
Sbjct: 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 11/38 (28%), Positives = 17/38 (44%), Gaps = 2/38 (5%)
Query: 22 FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN 59
L L L LS N +S ++ + L +L L L +
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.002
Identities = 11/64 (17%), Positives = 25/64 (39%), Gaps = 3/64 (4%)
Query: 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFS 63
+ L++ ++ + ++ L +D S N + F L L +L + NN+
Sbjct: 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRIC 76
Query: 64 GTID 67
+
Sbjct: 77 RIGE 80
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.003
Identities = 12/69 (17%), Positives = 23/69 (33%), Gaps = 3/69 (4%)
Query: 22 FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80
+ LDL + + ++L ++ +N+ +D L L L +
Sbjct: 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVN 71
Query: 81 NNRFTGWVP 89
NNR
Sbjct: 72 NNRICRIGE 80
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.0 bits (84), Expect = 0.003
Identities = 11/34 (32%), Positives = 17/34 (50%), Gaps = 2/34 (5%)
Query: 22 FGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSL 55
L +L LD+S N +S + L++L SL
Sbjct: 168 LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 579 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.37 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.27 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.26 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.25 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.2 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.2 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.14 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.11 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.05 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.0 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.99 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.96 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.89 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.75 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.7 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.64 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.55 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.52 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.5 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.44 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.39 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.29 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.07 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.05 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.42 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.38 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.23 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.04 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.12 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.01 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.88 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=416.93 Aligned_cols=255 Identities=24% Similarity=0.466 Sum_probs=205.6
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||.||+|.+.+++.||||+++.... ..++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 47888999999999999999999899999999976443 246799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++. .....+++..++.|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999986 3345689999999999999999999976 99999999999999999999999999998665433
Q ss_pred cc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhC-CCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTG-RKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ....+|..|+|||++.+..++.++|||||||++|||+|+ .+||...... .+...+...
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----------------~~~~~i~~~ 218 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVEDISTG 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----------------HHHHHHHHT
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHhc
Confidence 22 234567899999999999999999999999999999995 5555443221 111111112
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+...|..++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 22334556678899999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=422.15 Aligned_cols=260 Identities=26% Similarity=0.460 Sum_probs=209.2
Q ss_pred HhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
..++|++.+.||+|+||+||+|+++ ..||||+++.........+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3568999999999999999999865 359999998776666778899999999999999999999998764 5689999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||++|+|.++++. ....+++..+..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999963 345699999999999999999999976 999999999999999999999999999976643
Q ss_pred CCc---ccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 429 ADE---ALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 429 ~~~---~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
... .....+|+.|||||++.. ..|+.++|||||||++|||+||+.||........... .+..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~------------~~~~ 224 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------------MVGR 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------------HHHH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH------------HHhc
Confidence 222 233467889999999864 3589999999999999999999999976433211100 0000
Q ss_pred -hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 503 -MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 503 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
...+. ....+..++.++.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 225 ~~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 225 GYLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp TSCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01111 112344566789999999999999999999999999998875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=415.68 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=202.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--CCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--YGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 347 (579)
++|++.+.||+|+||+||+|+.+ +|+.||||++..........+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 47999999999999999999765 68999999998877766677889999999999999999999999864 4568999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC--SLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
||||++|+|.+++.........+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999755555678999999999999999999999761 13599999999999999999999999999987
Q ss_pred CCCCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 426 MPNADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
...... .....+|+.|+|||++.+..|+.++|||||||++|||+||+.||........ ...+.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~----------------~~~i~ 227 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL----------------AGKIR 227 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH----------------HHHHH
Confidence 654332 2345678899999999999999999999999999999999999976432210 11111
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
... ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 11234456678999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-53 Score=417.86 Aligned_cols=257 Identities=25% Similarity=0.481 Sum_probs=205.5
Q ss_pred CCccccceeccCCceEEEEEEeCC-C---cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-G---KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||+||+|.++. + ..||||.+.... .....+.|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 467888999999999999998752 3 368899886544 34556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||||++|+|.+++. .....+++.+++.|+.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999886 3345689999999999999999999976 9999999999999999999999999999876
Q ss_pred CCCCccc------ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 427 PNADEAL------NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 427 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
....... ...+++.|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----------------~ 241 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----------------D 241 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------H
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 5433221 1234678999999999999999999999999999998 89999754321 1
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+...+....+...+..++..+.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111222233344566778999999999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=414.81 Aligned_cols=255 Identities=24% Similarity=0.437 Sum_probs=210.7
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 457889999999999999999999889999999976543 35679999999999999999999998764 56799999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|.+++... ....+++..++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 y~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999987532 234689999999999999999999976 9999999999999999999999999999877543
Q ss_pred Ccc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCC-CCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKP-FDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
... ....++..|+|||++....++.++|||||||++|||+||..| |...... .+.+.+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----------------~~~~~i~~ 225 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----------------EVIQNLER 225 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHT
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHh
Confidence 322 234567789999999999999999999999999999996554 4432211 11111112
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
..+...+..++.++.+|+.+||+.||++||||++|++.|+.+..
T Consensus 226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 22333455677889999999999999999999999999998874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-53 Score=420.75 Aligned_cols=262 Identities=22% Similarity=0.406 Sum_probs=217.5
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
..++|++.+.||+|+||+||+|.+. +++.||||+++.... ..+.|.+|+.++++++|||||+++++|.+.+..++|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3457888999999999999999876 588999999976543 356799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||||++|+|.+++.. .....+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 92 ~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999863 2345789999999999999999999976 99999999999999999999999999998765
Q ss_pred CCCccc--ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 428 NADEAL--NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 428 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...... ...++..|+|||++.+..|+.++|||||||++|||++|..||..... ...+.+.+.
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------------~~~~~~~i~ 230 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYELLE 230 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------HHHHHHHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----------------HHHHHHHHh
Confidence 433221 22356789999999999999999999999999999997666543221 112222233
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
...+...+..++.++.+|+.+||+.||++|||++||++.|+.+.++..+
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~ 279 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence 3344455666778999999999999999999999999999887655443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=408.67 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=202.6
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||+||+|.++ +|+.||||++..... .+..+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46999999999999999999875 689999999976543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999985 345799999999999999999999976 9999999999999999999999999999866432
Q ss_pred C---cccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 430 D---EALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ......||+.|||||++.+..+ +.++|||||||++|||++|+.||........ ... ....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~--------------~~~~ 221 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS--------------DWKE 221 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHH--------------HHHT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHH--------------HHhc
Confidence 2 2234568899999999988876 5789999999999999999999975432111 111 1111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...........+.++.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111112344578899999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=404.45 Aligned_cols=251 Identities=22% Similarity=0.429 Sum_probs=213.1
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||+||+|++++++.||||+++..... .+.|.+|+.++++++||||++++|+|.+.+..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 578899999999999999999998999999999865433 56899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+++|+|.+++. .....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999999976 3345688999999999999999999976 99999999999999999999999999997654433
Q ss_pred cc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 431 EA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 431 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. ....++..|+|||++.+..++.++|||||||++|||+| |+.||....... +...+...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----------------~~~~i~~~ 217 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQG 217 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----------------HHHHHHTT
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----------------HHHHHHhC
Confidence 22 22446778999999999999999999999999999998 899997654221 11111122
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVR 547 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 547 (579)
.+...|..++.++.+|+.+||+.||++|||++++++.|.+
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2334556677899999999999999999999999998854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=407.22 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=211.4
Q ss_pred CCccccce-eccCCceEEEEEEeC---CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENL-LGEGTFGRVYRAQFA---DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 346 (579)
++|.+.+. ||+|+||.||+|.++ ++..||||+++... .....+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666674 999999999999764 35579999997543 34556789999999999999999999999865 56899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccC
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNM 426 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 426 (579)
|||||++|+|.+++. .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999885 3345799999999999999999999976 9999999999999999999999999999876
Q ss_pred CCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 427 PNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 427 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
....... ...+++.|+|||++....++.++|||||||++|||+| |+.||...... .+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----------------~~~ 222 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVM 222 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHH
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----------------HHH
Confidence 5443222 2345678999999999999999999999999999998 99999764321 111
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..+....+...|..++.++.+|+.+||+.||++||||.+|++.|+.+..+
T Consensus 223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11112223345667778999999999999999999999999999887654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=407.54 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=207.4
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4699999999999999999976 4799999999875442 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||++|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 y~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999999998752 3589999999999999999999976 9999999999999999999999999999876543
Q ss_pred C-cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 430 D-EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......... . .+... ...
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~-----------~~~~~--~~~ 234 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y-----------LIATN--GTP 234 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--H-----------HHHHH--CSC
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--H-----------HHHhC--CCC
Confidence 3 334556889999999999999999999999999999999999999754322110 0 00000 011
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234556678999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=406.01 Aligned_cols=249 Identities=25% Similarity=0.438 Sum_probs=204.8
Q ss_pred ceeccCCceEEEEEEeCC---CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEecCC
Q 008055 277 NLLGEGTFGRVYRAQFAD---GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEFRKN 353 (579)
Q Consensus 277 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 353 (579)
+.||+|+||.||+|.+++ ++.||||+++.........+.|.+|+.++++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999997643 4689999998766556667889999999999999999999999865 567899999999
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCCccc
Q 008055 354 GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNADEAL 433 (579)
Q Consensus 354 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 433 (579)
|+|.++++. ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999863 45689999999999999999999976 99999999999999999999999999998765433221
Q ss_pred ----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 434 ----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 434 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----------------~~~~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----------------HHHHHHHcCC
Confidence 2346778999999999999999999999999999998 89999764321 1112222223
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
+...|..++.++.+|+.+||+.||++|||+++|++.|+....
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 344566777899999999999999999999999999887653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=405.02 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=208.0
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+... .......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999875 689999999864322 1234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999963 34689999999999999999999976 999999999999999999999999999976644
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 159 ~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i~~~-- 219 (263)
T d2j4za1 159 S-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------TYKRISRV-- 219 (263)
T ss_dssp C-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHTT--
T ss_pred C-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcC--
Confidence 3 3345678899999999999999999999999999999999999997643211 11111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
...+|...+.++.+|+.+||+.||++|||++|+++
T Consensus 220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12234556678999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=405.37 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=207.2
Q ss_pred CCccccceeccCCceEEEEEEeCCC-----cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADG-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
+.|++.++||+|+||.||+|.+++. ..||||++.... .......|.+|+.++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4688899999999999999987642 479999996544 3444667999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|||||.+|++.+++. .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999998875 3345799999999999999999999976 999999999999999999999999999987
Q ss_pred CCCCCcc----cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEA----LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
....... ....+|..|+|||++.+..++.++|||||||++|||++|..||...... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~~ 223 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEVM 223 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HHHH
Confidence 6443221 1234577899999999999999999999999999999965554332111 1122
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
+.+....+...+..++.++.+|+.+||+.||++||||.||++.|+.+++.
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 22223334455667778999999999999999999999999999998864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=399.33 Aligned_cols=248 Identities=20% Similarity=0.339 Sum_probs=199.9
Q ss_pred cccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee----CCeEEEEE
Q 008055 274 NVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE----YGQHLLVY 348 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 348 (579)
+..+.||+|+||+||+|.+. +++.||+|++..........+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999775 68899999998766666667889999999999999999999999865 35679999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc-CCCceEEecccccccCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD-NELNPQLSDCGLASNMP 427 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 427 (579)
||+++|+|.+++.. ...+++..+..++.||++||+|||++ ..+|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999963 34689999999999999999999976 22399999999999996 57899999999997643
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
. .......||+.|+|||++.+ +++.++|||||||++|||++|+.||........ +. ..+....
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~-------------~~i~~~~ 229 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY-------------RRVTSGV 229 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH-------------HHHTTTC
T ss_pred C-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH-------------HHHHcCC
Confidence 3 33345678999999998864 699999999999999999999999965332110 00 0111111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
....++...+.++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122334567899999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=405.13 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=205.2
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 5889999999999999999875 68999999997653 34467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
|++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999998752 245699999999999999999999976 99999999999999999999999999987653322
Q ss_pred -cccccCCCCCccCccccc-----cCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 431 -EALNNDAGSGYGAPEVAM-----SGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
......+|+.|+|||++. ...|+.++|||||||++|||+||+.||........ +..+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~----------------~~~i~ 228 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV----------------LLKIA 228 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----------------HHHHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH----------------HHHHH
Confidence 223467889999999984 45689999999999999999999999976432210 11111
Q ss_pred Cc-cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DP-ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ......+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0111234456678999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=416.15 Aligned_cols=267 Identities=21% Similarity=0.345 Sum_probs=208.0
Q ss_pred HhCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEE
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 347 (579)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++... .......+.+|+.+++.++|||||+++++|.+.+..++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3567999999999999999999864 78999999997653 344467889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||||++|+|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999963 34589999999999999999999962 289999999999999999999999999997653
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhc-----------------
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWA----------------- 490 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~----------------- 490 (579)
. .......||+.|+|||++.+..|+.++|||||||++|||++|+.||........+......
T Consensus 157 ~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 D-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 2233467899999999999999999999999999999999999999764432211110000
Q ss_pred ---------cccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 491 ---------TPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 491 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+........................+.++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000111111111111111224568999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=411.22 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=207.9
Q ss_pred hCCccccceeccCCceEEEEEEeCC-C-----cEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD-G-----KVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||+||+|++.. + ..||+|.+..... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 4578899999999999999997643 2 3689999865442 33456789999999988 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE-------------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIK 403 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk 403 (579)
..++|||||++|+|.++++.... ....+++..++.|+.||++||+|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999974321 123589999999999999999999976 99999999
Q ss_pred CCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCC
Q 008055 404 SANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSR 479 (579)
Q Consensus 404 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~ 479 (579)
|+|||++.++.+||+|||+|+........ ....+|+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999765443322 23345788999999999999999999999999999998 899997543
Q ss_pred chhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 008055 480 PRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALV 546 (579)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 546 (579)
.. ..+.+++....+...|..++.++.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1122222233344456677789999999999999999999999999885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-51 Score=406.25 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=192.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.+.|++.+.||+|+||+||+|..+ +++.||||++....... ....+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356999999999999999999875 68999999997655432 2456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc---CCCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD---NELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~ 425 (579)
|||+||+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999996 345799999999999999999999976 999999999999995 578999999999987
Q ss_pred CCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
...........||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ...+..
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----------------~~~i~~ 223 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----------------FEQILK 223 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHHHT
T ss_pred ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH----------------HHHHhc
Confidence 7655555567789999999999999999999999999999999999999976432211 111111
Q ss_pred c--cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 P--ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 ~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ......+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 1111223455678999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=403.59 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=205.1
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.++|++.+.||+|+||.||+|.+++++.||||+++..... .+.|.+|+.++++++|||||+++++|.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 3579999999999999999999998889999999765432 4679999999999999999999999854 56899999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+++|+|..++... ....++|.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 92 y~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999988642 234689999999999999999999976 9999999999999999999999999999866433
Q ss_pred Cc--ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 430 DE--ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 430 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.. .....+++.|+|||++..+.++.++|||||||++|||++|..||...... ..+...+...
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------------~~~~~~i~~~ 230 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQVERG 230 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHTT
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHhc
Confidence 32 22345678999999999999999999999999999999966555332211 1111111122
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
.+...+..++.++.+++.+||+.||++|||+++|++.|+...
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 233455667789999999999999999999999999887655
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=402.89 Aligned_cols=246 Identities=28% Similarity=0.397 Sum_probs=204.1
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
.|+..+.||+|+||+||+|... +++.||||++...... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999764 7889999999766543 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
||++|+|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999987664 245689999999999999999999976 999999999999999999999999999986543
Q ss_pred CcccccCCCCCccCcccccc---CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 430 DEALNNDAGSGYGAPEVAMS---GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 430 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .+......
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----------------~~~~i~~~ 229 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIAQN 229 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHHHHHS
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhC
Confidence 334678999999999864 458999999999999999999999997543211 11111111
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111123345678999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-50 Score=407.16 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=209.8
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47999999999999999999864 78999999997543 3445778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC--CCceEEecccccccCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN--ELNPQLSDCGLASNMP 427 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 427 (579)
||++|+|.+++. .....+++..+..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 104 ~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999985 2345699999999999999999999976 9999999999999964 5789999999999887
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHhhhcCc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.........+|+.|||||++.+..++.++|||||||++|||++|+.||........ ..+... ..
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------------~~ 242 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC---------------DW 242 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------------CC
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------CC
Confidence 76666677889999999999999999999999999999999999999976432211 111100 00
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..........+.++.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111112344578999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=403.00 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=206.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||+||+|... +|+.||||++.+... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999874 789999999864321 2234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998863 35689999999999999999999976 999999999999999999999999999987653
Q ss_pred CC---cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 429 AD---EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 429 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~~i~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------------IFQKIIK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----------------HHHHHHc
Confidence 32 2234568899999999999999999999999999999999999997643211 1111111
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQA 544 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 544 (579)
. ...++...+.++.+|+.+||+.||++|||++|++..
T Consensus 225 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 225 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1 112445566789999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-50 Score=406.09 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=210.7
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
+.|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3699999999999999999986 479999999997654 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEc--CCCceEEecccccccCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLD--NELNPQLSDCGLASNMP 427 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~ 427 (579)
||++|+|.+++. ....++++.+++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 107 ~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998875 3345799999999999999999999976 999999999999998 67899999999999887
Q ss_pred CCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 428 NADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 428 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
.........+++.|+|||++.+..++.++|||||||++|||+||+.||......... ..+.. .+..
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------------~~i~~-~~~~ 246 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------------QNVKR-CDWE 246 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------------HHHHH-CCCC
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHh-CCCC
Confidence 766666678899999999999999999999999999999999999999764332110 00000 1111
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.........+.++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223445678999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=398.86 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=208.9
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC----chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP----SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++|++.+.||+|+||+||+|..+ +|+.||||++++.... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 47999999999999999999874 7899999999754432 224578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC----ceEEeccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL----NPQLSDCG 421 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 421 (579)
+|||||++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999963 34699999999999999999999976 999999999999998776 49999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
++.............+++.|+|||++.+..++.++|||||||++|||++|+.||........ +.
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----------------~~ 226 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------------LA 226 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HH
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH----------------HH
Confidence 99887766666667788899999999999999999999999999999999999976432211 01
Q ss_pred hhcCccc--cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 KMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.+..... ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100000 00011234567899999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=393.50 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=203.6
Q ss_pred hCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-CCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-YGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 348 (579)
.++|++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 346888899999999999999985 7889999997543 34678999999999999999999999854 46789999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+++|+|.+++... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999632 223589999999999999999999976 999999999999999999999999999986543
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
. .....++..|+|||++.+..++.++|||||||++|||+| |++||...... .+...+...
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----------------~~~~~i~~~ 216 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKG 216 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHTTT
T ss_pred C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHcC
Confidence 2 233456779999999999999999999999999999998 78888654321 112222233
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
.+..++..++.++.+|+.+||+.||++||||.++++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 4445566777899999999999999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=397.15 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=203.6
Q ss_pred hCCccccceeccCCceEEEEEEeCC----CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD----GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.++|++.+.||+|+||.||+|.+.. +..||||.++... .....+.|.+|+.++++++|||||++++++. .+..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4578999999999999999997653 3568899886543 3455678999999999999999999999986 46789
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++. .....+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999999875 2345789999999999999999999976 999999999999999999999999999986
Q ss_pred CCCCCcc--cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHhh
Q 008055 426 MPNADEA--LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALAK 502 (579)
Q Consensus 426 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (579)
....... ....+|+.|+|||++....++.++|||||||++|||+| |.+||....... ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------------~~~~ 221 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------------VIGR 221 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----------------HHHH
Confidence 6443322 23345678999999999999999999999999999998 899997644321 1111
Q ss_pred hcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 503 MVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 503 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
+. .......+..++.++.+|+.+||+.||++|||+.||++.|+.++++.
T Consensus 222 i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 222 IE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11 11222345667789999999999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-50 Score=402.11 Aligned_cols=264 Identities=25% Similarity=0.433 Sum_probs=214.9
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEE
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYC 338 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 338 (579)
+++..+++|++.+.||+|+||+||+|+++ +++.||||+++... ..+..+.|.+|+.++++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 34455678999999999999999999864 45789999997543 345567899999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhcccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008055 339 SEYGQHLLVYEFRKNGSLHDFLHLSD--------------------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVV 398 (579)
Q Consensus 339 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 398 (579)
.+.+..++||||+++|+|.++++... .....+++..++.|+.|++.||+|||++ +|+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999986422 1223588999999999999999999976 999
Q ss_pred EcCCCCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCC-CC
Q 008055 399 HKNIKSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR-KP 474 (579)
Q Consensus 399 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~-~p 474 (579)
||||||+|||++.++.+||+|||+++........ ....+++.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999999765433222 2345667899999999999999999999999999999985 67
Q ss_pred CCCCCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHH
Q 008055 475 FDSSRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLV 549 (579)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 549 (579)
|....... .+..+.+. .....+..++.++.+|+.+||+.||++||||.||++.|++|.
T Consensus 243 ~~~~~~~e----------------~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE----------------VIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH----------------HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH----------------HHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 76543221 11111111 122345566788999999999999999999999999998874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=397.84 Aligned_cols=261 Identities=25% Similarity=0.441 Sum_probs=211.3
Q ss_pred CCccccceeccCCceEEEEEEeCC-Cc--EEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD-GK--VLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 346 (579)
++|++.+.||+|+||.||+|.+++ |. .||||+++.... .+..+.|.+|+++++++ +|||||+++++|.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 468888999999999999997753 44 578888764432 33456799999999998 79999999999999999999
Q ss_pred EEEecCCCChhhhhccc------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCc
Q 008055 347 VYEFRKNGSLHDFLHLS------------DEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELN 414 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 414 (579)
||||+++|+|.++++.. ......+++.+++.++.|||.||.|||++ +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999643 12346799999999999999999999976 9999999999999999999
Q ss_pred eEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCC-CCCCCCCchhhhhhhhhcccc
Q 008055 415 PQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGR-KPFDSSRPRLEQSLVRWATPQ 493 (579)
Q Consensus 415 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~ 493 (579)
+||+|||+++............+|..|+|||.+....++.++|||||||++|||++|. +||......
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------------ 233 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------------ 233 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------
T ss_pred eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------------
Confidence 9999999998665544444556788999999999999999999999999999999965 567543321
Q ss_pred ccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 494 LHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.+...+....+...+..++.++.+|+.+||+.||++||||+||++.|+.++++.
T Consensus 234 -----~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 234 -----ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -----HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -----HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111112222233445667789999999999999999999999999999998644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=398.15 Aligned_cols=255 Identities=20% Similarity=0.428 Sum_probs=207.2
Q ss_pred CCccccceeccCCceEEEEEEeC-CCc----EEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGK----VLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
.+|++.+.||+|+||+||+|.+. +|+ .||+|+++... .....+.|.+|+.++++++|||||+++|+|.+ +..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCee
Confidence 36999999999999999999765 443 58999886543 23456789999999999999999999999986 4567
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
++|||+.+|+|.+++. .....+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 8899999999999886 3456789999999999999999999976 999999999999999999999999999987
Q ss_pred CCCCCccc---ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHHh
Q 008055 426 MPNADEAL---NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDALA 501 (579)
Q Consensus 426 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (579)
........ ...+|..|+|||++.++.++.++|||||||++|||+| |.+||....... +.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----------------~~ 223 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 223 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----------------HH
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----------------HH
Confidence 65433322 2346789999999999999999999999999999999 889997643221 11
Q ss_pred hhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 502 KMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
..+....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1222223334556677899999999999999999999999999988865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=397.02 Aligned_cols=271 Identities=23% Similarity=0.411 Sum_probs=206.3
Q ss_pred CHHHHHHHhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccce
Q 008055 262 SIADLQMATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMEL 334 (579)
Q Consensus 262 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 334 (579)
...++++..++|++.+.||+|+||.||+|.+. +++.||||+++.... ....+.+..|...+.++ +|+||+.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 34455555678999999999999999999753 346899999975443 34456777788877766 78999999
Q ss_pred eeEEeeC-CeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcC
Q 008055 335 VGYCSEY-GQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKN 401 (579)
Q Consensus 335 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D 401 (579)
++++.+. ...++|||||++|+|.++++.... ....+++.+++.++.||++||+|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9988654 568999999999999999964322 134589999999999999999999976 999999
Q ss_pred CCCCCEEEcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhC-CCCCCC
Q 008055 402 IKSANILLDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTG-RKPFDS 477 (579)
Q Consensus 402 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg-~~p~~~ 477 (579)
|||+|||+++++.+||+|||+|+........ ....+|+.|+|||++.+..++.++|||||||++|||+|| .+||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865443322 234567799999999999999999999999999999996 567765
Q ss_pred CCchhhhhhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHc
Q 008055 478 SRPRLEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRA 552 (579)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 552 (579)
.... ..+...+....+...+..++.++.+++.+||+.||++|||+.||++.|+++++..
T Consensus 240 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 240 VKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp CCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHH----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 3321 1111111122233345566778999999999999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=391.27 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=200.7
Q ss_pred CCccccceeccCCceEEEEEEeCC--C--cEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFAD--G--KVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++|++.+.||+|+||.||+|++.. + ..||||+++.... ..+..+.|.+|+.++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468999999999999999997642 2 3789999876543 34456789999999999999999999999975 4678
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+||||+++|+|.+++.. ....+++..++.++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998763 245689999999999999999999976 999999999999999999999999999987
Q ss_pred CCCCCccc----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 426 MPNADEAL----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 426 ~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
........ ...++..|+|||++.+..++.++|||||||++|||+| |+.||...... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------~~~ 224 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QIL 224 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----------------HHH
Confidence 65443321 2234568999999999999999999999999999998 89999754321 112
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRL 548 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 548 (579)
..+.....+...+..++..+.+|+.+||+.||++||||.+|++.|++.
T Consensus 225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222233333444566778999999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=397.04 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=208.2
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|+. .+|+.||||++++... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4699999999999999999986 4799999999975432 2234677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999863 45688999999999999999999976 999999999999999999999999999987644
Q ss_pred C-CcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCcc
Q 008055 429 A-DEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPA 507 (579)
Q Consensus 429 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (579)
. .......||+.|+|||++.+..|+.++|||||||++|||++|++||........ .......
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----------------~~~i~~~- 220 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------------FELILME- 220 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC-
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH----------------HHHHhcC-
Confidence 3 334456789999999999999999999999999999999999999976443210 0011101
Q ss_pred ccCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 508 LKGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 508 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
...+|...+.++.+||.+||+.||++|++ +.|+++
T Consensus 221 -~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12345556678999999999999999995 777775
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-49 Score=385.63 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=204.9
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCC-chhHHHHHHHHHHHhhcCCCCccceeeEEeeCC----e
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALP-SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG----Q 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 343 (579)
.++|++.+.||+|+||.||+|.. .+|+.||||+++..... ......+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 45799999999999999999976 47999999999876543 445678999999999999999999999987644 4
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.|+||||++||+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998853 34689999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCC----cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNAD----EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
....... ......+|+.|+|||++.+..++.++|||||||++|||+||+.||......... .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--~~----------~ 226 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQ----------H 226 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH----------H
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH--HH----------H
Confidence 6553322 223346788999999999999999999999999999999999999764432110 00 0
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCC-ChHHHHHHHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRP-PMSEVVQALVRLV 549 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~ 549 (579)
+.. ++..........+.++.+++.+||+.||++|| |++++++.|.++.
T Consensus 227 ~~~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 227 VRE--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHC--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Hhc--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 00001112234557899999999999999999 8999999998775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-48 Score=382.50 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=208.1
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCc-------hhHHHHHHHHHHHhhcC-CCCccceeeEEeeC
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPS-------EMCDDFIEMVSNISQLH-HPNIMELVGYCSEY 341 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 341 (579)
++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999986 478999999997654332 22346889999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
+..|+|||||++|+|.++++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999963 34689999999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCccCcccccc------CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhcccccc
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMS------GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLH 495 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 495 (579)
+++............+|..|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----------- 224 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----------- 224 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-----------
Confidence 9988766555556678899999999863 34788999999999999999999999765432111
Q ss_pred ChhHHhhhcCc--cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 496 DIDALAKMVDP--ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 496 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..+... ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 -----RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111 1111223356678999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=389.39 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=204.7
Q ss_pred cceeccCCceEEEEEEeCCC----cEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-CCeEEEEEEe
Q 008055 276 ENLLGEGTFGRVYRAQFADG----KVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-YGQHLLVYEF 350 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 350 (579)
.++||+|+||+||+|.+.++ ..||||+++... .....++|.+|++++++++||||++++|++.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 47899999999999987542 368999997533 45556889999999999999999999999875 5689999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
|++|+|.++++ .....+.+..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999986 3455678889999999999999999976 99999999999999999999999999998764432
Q ss_pred ccc-----ccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcC
Q 008055 431 EAL-----NNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 431 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (579)
... ...++..|+|||.+....++.++||||||+++|||+||..||...... ..+.. . +.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~----------~----i~ 248 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV----------Y----LL 248 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----------H----HH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH----------H----HH
Confidence 221 234567899999999999999999999999999999988777542211 00111 1 11
Q ss_pred ccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 506 PALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 506 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
...+...|..++.++.+|+.+||+.||++||||.||++.|+.++++
T Consensus 249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122334556678899999999999999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=390.64 Aligned_cols=261 Identities=26% Similarity=0.450 Sum_probs=210.0
Q ss_pred hCCccccceeccCCceEEEEEEeCC--------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEee
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFAD--------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSE 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 340 (579)
.++|++.+.||+|+||.||+|+... +..||||+++... .......+.+|...+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4578889999999999999997532 3479999997654 344567788888888887 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 341 YGQHLLVYEFRKNGSLHDFLHLSDE------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 341 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
.+..++|||||++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999964432 234689999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCc---ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADE---ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||+++....... .....+++.|+|||.+.++.|+.++|||||||++|||++ |.+||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999976543322 223456678999999999999999999999999999998 78888654322
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
.+.+.+....+...+..++..+.+|+.+||+.||++|||+.||++.|++++.-
T Consensus 245 --------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 --------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11122222333345556678899999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.5e-49 Score=391.29 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=206.5
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999999999999874 689999999964321 1234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
|||+||+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999886 345678889999999999999999965 999999999999999999999999999987654
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....||+.|+|||++.+..|+.++|||||||++|||++|+.||....... ....+...
T Consensus 157 ~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~~-- 216 (316)
T d1fota_ 157 V--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----------------TYEKILNA-- 216 (316)
T ss_dssp C--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHHC--
T ss_pred c--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----------------HHHHHHcC--
Confidence 3 345678999999999999999999999999999999999999997643211 11111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
...++...+.++.+++.+||..||++|+ |++++++
T Consensus 217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1123445667899999999999999996 8999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=390.32 Aligned_cols=262 Identities=25% Similarity=0.452 Sum_probs=215.7
Q ss_pred hCCccccceeccCCceEEEEEEe------CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc-CCCCccceeeEEeeCC
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF------ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL-HHPNIMELVGYCSEYG 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 342 (579)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.... ......|.+|+.+++.+ +|||||+++++|.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 45788899999999999999975 2467899999976543 44566789999999998 7999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEE
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDE--------------DNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANIL 408 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 408 (579)
..++|||||++|+|.++++.... ....+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 99999999999999999975331 233689999999999999999999976 9999999999999
Q ss_pred EcCCCceEEecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHh-CCCCCCCCCchhhh
Q 008055 409 LDNELNPQLSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLT-GRKPFDSSRPRLEQ 484 (579)
Q Consensus 409 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~p~~~~~~~~~~ 484 (579)
++.++.+||+|||+++........ ....+++.|+|||++....++.++|||||||++|||+| |.+||......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 999999999999999876543322 22345779999999999999999999999999999999 56666443221
Q ss_pred hhhhhccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHH
Q 008055 485 SLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQR 551 (579)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 551 (579)
..+.+++....+...+...+..+.+|+.+||+.||++||||.+|+++|++++.+
T Consensus 255 -------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 122223333344445566678999999999999999999999999999988865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=389.87 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=207.1
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
.++|++.+.||+|+||+||+|.++ +++.||||+++... .....+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 357999999999999999999875 68899999997653 23456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCC--CceEEecccccccC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNE--LNPQLSDCGLASNM 426 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfg~~~~~ 426 (579)
|||+||+|.+++. .....+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||++...
T Consensus 81 E~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999996 2344689999999999999999999976 99999999999999854 57999999999887
Q ss_pred CCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 427 PNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 427 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
..........+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ +..+...
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----------------~~~i~~~ 218 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------IENIMNA 218 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHT
T ss_pred ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhC
Confidence 666656666788999999999999999999999999999999999999976443210 1111100
Q ss_pred cccCCCC----hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 507 ALKGLYP----VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 507 ~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .++ ...+.++.+|+.+||..||++|||+.|+++
T Consensus 219 ~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 219 EY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 111 123567899999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=385.79 Aligned_cols=271 Identities=23% Similarity=0.351 Sum_probs=204.9
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHH--HHHHHHhhcCCCCccceeeEEeeCC----eE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFI--EMVSNISQLHHPNIMELVGYCSEYG----QH 344 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~~~----~~ 344 (579)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... ...+. .|+..+..++||||++++++|.+.+ ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 3577889999999999999987 58899999986432 33333 3455556789999999999997654 67
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCEEEcCCCceEEec
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV-----CSLSVVHKNIKSANILLDNELNPQLSD 419 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiH~Dlkp~Nill~~~~~~kl~D 419 (579)
++|||||++|+|.++++. ..++|..++.++.|+|.||+|||.. ..++|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 999999999999999973 3589999999999999999999963 135999999999999999999999999
Q ss_pred ccccccCCCCCc-----ccccCCCCCccCccccccC------CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhh
Q 008055 420 CGLASNMPNADE-----ALNNDAGSGYGAPEVAMSG------QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVR 488 (579)
Q Consensus 420 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~ 488 (579)
||+++....... .....+|+.|+|||++... .++.++|||||||++|||+||..||......... ...
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~ 230 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYD 230 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhh
Confidence 999976644322 1234578899999998754 3678999999999999999999888543221110 000
Q ss_pred hccccccChhHH-hhhcCccccCCCC-----hhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 489 WATPQLHDIDAL-AKMVDPALKGLYP-----VKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 489 ~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.. +.......+ ....+..++...+ ......+.+|+.+||+.||++|||+.||++.|+++.++.++
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 231 LV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TS-CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred cc-cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 00 011111111 2223333333332 34556799999999999999999999999999999988765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-48 Score=393.62 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=201.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC----chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP----SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHL 345 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 345 (579)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.... .........++.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999875 6899999998643221 112233344577778889999999999999999999
Q ss_pred EEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccccc
Q 008055 346 LVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASN 425 (579)
Q Consensus 346 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 425 (579)
+|||||++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999963 35678999999999999999999976 999999999999999999999999999987
Q ss_pred CCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhc
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMV 504 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (579)
.... ......||+.|+|||++.. ..|+.++|||||||++|||+||+.||..........+ ....
T Consensus 157 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--------------~~~~ 221 (364)
T d1omwa3 157 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------------DRMT 221 (364)
T ss_dssp CSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--------------HHHS
T ss_pred cCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhc
Confidence 6543 3445678999999999975 5689999999999999999999999976432211111 1110
Q ss_pred CccccCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 505 DPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 505 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
......++...+.++.+||.+||+.||++||| ++|+++
T Consensus 222 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 -LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11112234456678999999999999999999 577764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=390.14 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=199.0
Q ss_pred CCccccc-eeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhh-cCCCCccceeeEEee----CCe
Q 008055 271 GSFNVEN-LLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQ-LHHPNIMELVGYCSE----YGQ 343 (579)
Q Consensus 271 ~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~ 343 (579)
++|.+.+ .||+|+||+||+|.. .+++.||||+++. ...+.+|+.++.+ .+|||||+++++|.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4688764 699999999999976 5789999999964 2456778888655 489999999999865 467
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEecc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDC 420 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Df 420 (579)
.|+|||||+||+|.+++.. .....+++.+++.|+.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 8999999999999999963 2245799999999999999999999976 9999999999999985 467999999
Q ss_pred cccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh-hhhhhhhccccccChhH
Q 008055 421 GLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL-EQSLVRWATPQLHDIDA 499 (579)
Q Consensus 421 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 499 (579)
|+++............+|+.|+|||++.+..|+.++|||||||++|+|+||+.||....... ...+.
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~------------ 226 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------ 226 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH------------
Confidence 99988777666667788999999999999999999999999999999999999996532210 00000
Q ss_pred HhhhcCccc--cCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 500 LAKMVDPAL--KGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
........ ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000000 00111245678999999999999999999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-48 Score=391.72 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=206.3
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|+++ +|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 37999999999999999999875 799999999864321 1234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCC
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPN 428 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 428 (579)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999863 34689999999999999999999976 999999999999999999999999999987653
Q ss_pred CCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCccc
Q 008055 429 ADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDPAL 508 (579)
Q Consensus 429 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (579)
. .....+|+.|||||++.+..++.++|||||||++|||+||+.||........ +..+...
T Consensus 194 ~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------~~~i~~~-- 253 (350)
T d1rdqe_ 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----------------YEKIVSG-- 253 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHHC--
T ss_pred c--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH----------------HHHHhcC--
Confidence 2 3345688999999999999999999999999999999999999976432110 1111111
Q ss_pred cCCCChhhHHHHHHHHHhcCCCCCCCCC-----ChHHHHH
Q 008055 509 KGLYPVKSLSRFADVIALCVQPEPEFRP-----PMSEVVQ 543 (579)
Q Consensus 509 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~ 543 (579)
....+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 254 ~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1123445567899999999999999994 8999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=389.35 Aligned_cols=261 Identities=21% Similarity=0.364 Sum_probs=212.6
Q ss_pred HhCCccccceeccCCceEEEEEEeC------CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC
Q 008055 269 ATGSFNVENLLGEGTFGRVYRAQFA------DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG 342 (579)
Q Consensus 269 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 342 (579)
..++|++.+.||+|+||.||+|.+. +++.||||+++... .......|.+|+.++++++||||++++++|...+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 3467889999999999999999763 35789999997544 3455667899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceE
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSD------EDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQ 416 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 416 (579)
..++||||+++|+|.+++.... .....+++..+..++.|+|+||.|||++ +|+||||||+|||++.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence 9999999999999999985321 2234578999999999999999999976 999999999999999999999
Q ss_pred EecccccccCCCCCcc---cccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhC-CCCCCCCCchhhhhhhhhccc
Q 008055 417 LSDCGLASNMPNADEA---LNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTG-RKPFDSSRPRLEQSLVRWATP 492 (579)
Q Consensus 417 l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~ 492 (579)
|+|||+++........ ....+++.|+|||.+.+..++.++|||||||++|||+|| .+||......
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----------- 242 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----------- 242 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----------
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence 9999999765443322 223467899999999999999999999999999999998 4777553321
Q ss_pred cccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHH
Q 008055 493 QLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQ 550 (579)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 550 (579)
..+..+.+. .....+..++..+.+++.+||+.||++|||+.+|++.|++.++
T Consensus 243 -----~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 -----QVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----HHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----HHHHHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111221 2233455667889999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=386.55 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=202.7
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCC-CchhHHHHHHHHHHHh-hcCCCCccceeeEEeeCCeEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSAL-PSEMCDDFIEMVSNIS-QLHHPNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 347 (579)
++|++.+.||+|+||+||+|..+ +++.||||++++... .....+.+..|..++. .++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47999999999999999999775 689999999964321 1223455666666654 68999999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCC
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMP 427 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 427 (579)
||||++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999963 34688999999999999999999976 99999999999999999999999999998654
Q ss_pred CCCc-ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHHhhhcCc
Q 008055 428 NADE-ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDALAKMVDP 506 (579)
Q Consensus 428 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (579)
.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----------------~~i~~- 217 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----------------HSIRM- 217 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH-
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH----------------HHHHc-
Confidence 4333 33456788999999999999999999999999999999999999764432110 00100
Q ss_pred cccCCCChhhHHHHHHHHHhcCCCCCCCCCChH-HHHH
Q 008055 507 ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS-EVVQ 543 (579)
Q Consensus 507 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~ 543 (579)
....+|...+.++.+|+.+||..||++|||+. ++++
T Consensus 218 -~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 -DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11233455667899999999999999999996 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=379.35 Aligned_cols=267 Identities=23% Similarity=0.333 Sum_probs=200.4
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4799999999999999999976 579999999997665545556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
|+.++ +.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99754 4444432 2355699999999999999999999976 9999999999999999999999999999766443
Q ss_pred C-cccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hh-hhhhccccccChhHHhhhcC
Q 008055 430 D-EALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QS-LVRWATPQLHDIDALAKMVD 505 (579)
Q Consensus 430 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 505 (579)
. ......+++.|+|||++.... ++.++|||||||++|+|++|+.||........ .. ......+.-..........+
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3 334456788999999987665 47899999999999999999999976543211 11 11111111000000100000
Q ss_pred --ccccC----C---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 506 --PALKG----L---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 506 --~~~~~----~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
..... . .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 0 01123467899999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=378.37 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=195.3
Q ss_pred ccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCC---chhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 275 VENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALP---SEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 275 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
..++||+|+||+||+|+.+ +|+.||||+++..... ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999875 6899999999754432 12245688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+.++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 99887776653 455688899999999999999999976 99999999999999999999999999997665433
Q ss_pred -cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhh-ccccccC---hhHHhhh
Q 008055 431 -EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRW-ATPQLHD---IDALAKM 503 (579)
Q Consensus 431 -~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~-~~~~~~~---~~~~~~~ 503 (579)
......+|+.|+|||++... .|+.++|||||||++|||++|++||........ ..+.+. ..+.... .......
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 23345678899999998754 579999999999999999999999976443211 111111 0110000 0000000
Q ss_pred cCccccCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 VDPALKGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
......... ....+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 1123467999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=379.62 Aligned_cols=267 Identities=20% Similarity=0.282 Sum_probs=200.3
Q ss_pred hCCccccceeccCCceEEEEEEeC-C-CcEEEEEEeCCCCCCchhHHHHHHHHHHHh---hcCCCCccceeeEEee----
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-D-GKVLAVKKIDSSALPSEMCDDFIEMVSNIS---QLHHPNIMELVGYCSE---- 340 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~---- 340 (579)
.++|++.+.||+|+||+||+|++. + ++.||||+++...........+.+|+.+++ ..+||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 458999999999999999999873 4 667999998654333333334445555554 4589999999999853
Q ss_pred -CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEec
Q 008055 341 -YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSD 419 (579)
Q Consensus 341 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 419 (579)
....+++|||+++|++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 357899999998877765443 3456789999999999999999999976 999999999999999999999999
Q ss_pred ccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhh---------
Q 008055 420 CGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRW--------- 489 (579)
Q Consensus 420 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~--------- 489 (579)
||+++............+|+.|+|||++.+..|+.++||||+||++|||++|+.||........ ..+...
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 9999877666666677889999999999999999999999999999999999999976543211 111111
Q ss_pred ccccccChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 490 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
............. ........+....+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhcc-ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000000 0000011122344568899999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-47 Score=374.14 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=205.4
Q ss_pred CCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEEe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYEF 350 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 350 (579)
++|++.+.||+|+||+||+|++++|+.||||+++.........+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57999999999999999999999999999999977655555578899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCCC
Q 008055 351 RKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNAD 430 (579)
Q Consensus 351 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 430 (579)
+.++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877776654 356799999999999999999999976 99999999999999999999999999997654332
Q ss_pred c-ccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhhhccccccCh---hHHhhh
Q 008055 431 E-ALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVRWATPQLHDI---DALAKM 503 (579)
Q Consensus 431 ~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~ 503 (579)
. .....+++.|+|||.+... .++.++|||||||++|||++|+.||........ ........+..... ......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2 3344577899999998754 568999999999999999999999976543211 11111111111111 111110
Q ss_pred c------CccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 504 V------DPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 504 ~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. .+..........+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000011122334568899999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=374.21 Aligned_cols=241 Identities=22% Similarity=0.376 Sum_probs=197.1
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCc----hhHHHHHHHHHHHhhcC--CCCccceeeEEeeCCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPS----EMCDDFIEMVSNISQLH--HPNIMELVGYCSEYGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 343 (579)
++|++.+.||+|+||+||+|... +|+.||||++....... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999764 78999999987543321 11234668999999886 8999999999999999
Q ss_pred EEEEEEecCC-CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-CCceEEeccc
Q 008055 344 HLLVYEFRKN-GSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-ELNPQLSDCG 421 (579)
Q Consensus 344 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 421 (579)
.++||||+.+ +++.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 678887752 35689999999999999999999976 9999999999999985 4799999999
Q ss_pred ccccCCCCCcccccCCCCCccCccccccCCC-CccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhHH
Q 008055 422 LASNMPNADEALNNDAGSGYGAPEVAMSGQY-NIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDAL 500 (579)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (579)
+++.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+..
T Consensus 157 ~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~------------ 218 (273)
T d1xwsa_ 157 SGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR------------ 218 (273)
T ss_dssp TCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH------------
T ss_pred cceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhh------------
Confidence 9976543 23345678899999999987765 577999999999999999999996421 0000
Q ss_pred hhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 501 AKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
. ...++...+.++.+|+.+||+.||++|||++|+++
T Consensus 219 -~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 -G------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -C------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -c------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 01123345578999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=368.11 Aligned_cols=260 Identities=21% Similarity=0.284 Sum_probs=197.3
Q ss_pred CccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeC------CeE
Q 008055 272 SFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEY------GQH 344 (579)
Q Consensus 272 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 344 (579)
+|+..++||+|+||+||+|+.. +|+.||||++...... +.+|+.++++++||||++++++|... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5788899999999999999875 6999999999764321 23689999999999999999998543 357
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLA 423 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~ 423 (579)
++|||||++|.+.. +.........+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 89999997654443 332233456799999999999999999999965 999999999999999775 8999999999
Q ss_pred ccCCCCCcccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhh-hhhhhhccccccChhHHh
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE-QSLVRWATPQLHDIDALA 501 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 501 (579)
.............++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..+........ ...+.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~--~~~~~ 248 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIR 248 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC--HHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh--HHhhh
Confidence 88776666667788999999998875 5689999999999999999999999976543211 11111111000 00111
Q ss_pred hhcC----cc--------ccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 502 KMVD----PA--------LKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 502 ~~~~----~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.... .. .........+.++.+|+.+||..||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 00 001112335568999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=369.76 Aligned_cols=263 Identities=19% Similarity=0.307 Sum_probs=198.7
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC------
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG------ 342 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 342 (579)
.++|++.+.||+|+||+||+|... +|+.||||+++.........+.+.+|+++++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 458999999999999999999764 6999999999876666666788999999999999999999999997654
Q ss_pred eEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccc
Q 008055 343 QHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGL 422 (579)
Q Consensus 343 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 422 (579)
..++||||+ +++|..+++ ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 667887765 34689999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCcccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhcc-c------c
Q 008055 423 ASNMPNADEALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWAT-P------Q 493 (579)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~-~------~ 493 (579)
++.... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||......... ....... + .
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 987643 23456678899999998764 5689999999999999999999999765432111 1111000 0 0
Q ss_pred cc--ChhHHhhhcCcccc---CCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 494 LH--DIDALAKMVDPALK---GLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 494 ~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. .............. .......+..+.+|+.+||..||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000110100000 0112234567899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=363.04 Aligned_cols=266 Identities=18% Similarity=0.267 Sum_probs=197.0
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee--------C
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE--------Y 341 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 341 (579)
++|++.+.||+|+||+||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5799999999999999999986 479999999997766556667889999999999999999999998854 3
Q ss_pred CeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccc
Q 008055 342 GQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCG 421 (579)
Q Consensus 342 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 421 (579)
+..++||||+.++.+..+.. ....++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 46899999998877665543 455688899999999999999999976 99999999999999999999999999
Q ss_pred ccccCCCCC-----cccccCCCCCccCccccccC-CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccc
Q 008055 422 LASNMPNAD-----EALNNDAGSGYGAPEVAMSG-QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQL 494 (579)
Q Consensus 422 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~ 494 (579)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... .+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997654322 22334578899999998765 6899999999999999999999999765433221 1111111000
Q ss_pred cC-h-----hHHhhhcCccccCCCC-------hhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HD-I-----DALAKMVDPALKGLYP-------VKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~-~-----~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. . ................ ......+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0 0000000000000000 112346789999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=357.21 Aligned_cols=266 Identities=20% Similarity=0.275 Sum_probs=208.1
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCCeEEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYGQHLLVYE 349 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 349 (579)
++|++.+.||+|+||+||+|+. .+++.||||+++...........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999986 478999999997766556677899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccccCCCC
Q 008055 350 FRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLASNMPNA 429 (579)
Q Consensus 350 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 429 (579)
++.+++|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988775 345688999999999999999999976 9999999999999999999999999999877554
Q ss_pred Cccc-ccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhh--hhhhh-hccccccChhHHhhhc
Q 008055 430 DEAL-NNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLE--QSLVR-WATPQLHDIDALAKMV 504 (579)
Q Consensus 430 ~~~~-~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 504 (579)
.... ...++..|+|||++.... ++.++|||||||++|||++|+.||........ ..+.. +..+............
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 4333 334566899999987665 68999999999999999999999754332211 11111 1111111100011110
Q ss_pred Cc---------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 505 DP---------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 505 ~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
+. .............+.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011122344567899999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-44 Score=357.19 Aligned_cols=262 Identities=19% Similarity=0.254 Sum_probs=200.4
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCcccee-eEEeeCCeEEEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELV-GYCSEYGQHLLVY 348 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lv~ 348 (579)
++|++.+.||+|+||.||+|.+ .+|+.||||++..... ...+..|+++++.++|+|++..+ +++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4699999999999999999976 4689999999875432 23467899999999887766554 5557778899999
Q ss_pred EecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC---CCceEEeccccccc
Q 008055 349 EFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN---ELNPQLSDCGLASN 425 (579)
Q Consensus 349 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~ 425 (579)
||+ +|+|...+. .....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+++.
T Consensus 83 e~~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEc-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999 566766654 2345789999999999999999999976 9999999999999864 45799999999987
Q ss_pred CCCCCc--------ccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhccccccC
Q 008055 426 MPNADE--------ALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWATPQLHD 496 (579)
Q Consensus 426 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 496 (579)
...... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||......... ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~----- 230 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----- 230 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-----
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-----
Confidence 644322 22346788999999999999999999999999999999999999764332111 1101000
Q ss_pred hhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 497 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.....+ .......++.++.+++.+||+.+|++||+++++.+.|+++..+...
T Consensus 231 ----~~~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 231 ----KKMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp ----HHHHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ----ccCCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 000000 0001223457899999999999999999999999999998876554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-44 Score=353.74 Aligned_cols=264 Identities=16% Similarity=0.201 Sum_probs=206.9
Q ss_pred hCCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC-CCccceeeEEeeCCeEEEE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH-PNIMELVGYCSEYGQHLLV 347 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 347 (579)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ..+.+|++.++.+.| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999865 6899999998654322 345667778887765 8999999999999999999
Q ss_pred EEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcC-----CCceEEecccc
Q 008055 348 YEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDN-----ELNPQLSDCGL 422 (579)
Q Consensus 348 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfg~ 422 (579)
|||+ +|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 9999 7899998863 345689999999999999999999965 9999999999999974 57899999999
Q ss_pred cccCCCCC--------cccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccc
Q 008055 423 ASNMPNAD--------EALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQL 494 (579)
Q Consensus 423 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 494 (579)
++...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~------ 226 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE------ 226 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH------
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH------
Confidence 98654321 1223467899999999999999999999999999999999999997543321111100
Q ss_pred cChhHHhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHHHHHccc
Q 008055 495 HDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVRLVQRANM 554 (579)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 554 (579)
.+...............++.++.+++..|+..+|++||+++.+.+.|++++++...
T Consensus 227 ----~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 227 ----RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp ----HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----HHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 00000000000001123456899999999999999999999999999999877654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-44 Score=360.18 Aligned_cols=258 Identities=18% Similarity=0.290 Sum_probs=200.1
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEee--CCeEEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSE--YGQHLL 346 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 346 (579)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+.+++.+. ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 3799999999999999999987 478999999996532 567889999999995 9999999999874 456899
Q ss_pred EEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC-ceEEeccccccc
Q 008055 347 VYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL-NPQLSDCGLASN 425 (579)
Q Consensus 347 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 425 (579)
|||||++|+|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 99999999997764 3589999999999999999999976 999999999999998655 689999999988
Q ss_pred CCCCCcccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhhh--hhhhccc----------
Q 008055 426 MPNADEALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQS--LVRWATP---------- 492 (579)
Q Consensus 426 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~--~~~~~~~---------- 492 (579)
...........+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||.......... +.....+
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 77666666677888999999987654 7999999999999999999999997654322111 1100000
Q ss_pred cccChhHHhhhcCc--------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 493 QLHDIDALAKMVDP--------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 493 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.............. ..........+.++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 0011112334568999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=361.18 Aligned_cols=265 Identities=19% Similarity=0.297 Sum_probs=195.8
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEeeCC----eE
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSEYG----QH 344 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 344 (579)
+.+|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35799999999999999999975 589999999997544 3455678899999999999999999999986543 33
Q ss_pred EEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 345 LLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 345 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
+++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 555666779999999862 3589999999999999999999976 99999999999999999999999999997
Q ss_pred cCCCCCc----ccccCCCCCccCcccccc-CCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhh--ccccc---
Q 008055 425 NMPNADE----ALNNDAGSGYGAPEVAMS-GQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRW--ATPQL--- 494 (579)
Q Consensus 425 ~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~--~~~~~--- 494 (579)
....... .....+++.|+|||++.. ..++.++||||+||++|||++|+.||.............. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 6543322 233456779999999854 4678999999999999999999999976543211111100 00000
Q ss_pred ---cChhHHhhhc-CccccCC----CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 ---HDIDALAKMV-DPALKGL----YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ---~~~~~~~~~~-~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.......... .+..... .....+.++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0000000 01123357899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=363.03 Aligned_cols=263 Identities=17% Similarity=0.227 Sum_probs=193.5
Q ss_pred CCccccceeccCCceEEEEEEeC-CCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee------CCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA-DGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE------YGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 343 (579)
++|++.+.||+|+||+||+|++. +|+.||||++............+.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999875 69999999998776666667789999999999999999999999853 468
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.|+|||||.++.+ +.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 8999999976544 4442 3478999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhh-hh-------ccccc
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLV-RW-------ATPQL 494 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~-~~-------~~~~~ 494 (579)
+............+|+.|+|||++.+..++.++||||+||++|||++|+.||......... .+. .. .....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 8776666666667889999999999999999999999999999999999999765432111 110 00 00000
Q ss_pred cChh------------HHhhhcCccccCC---CChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDID------------ALAKMVDPALKGL---YPVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.... ............. .....+.++.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000111111111 11234678999999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=359.72 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=200.1
Q ss_pred CCccccceeccCCceEEEEEEeC----CCcEEEEEEeCCCCC--CchhHHHHHHHHHHHhhcCC-CCccceeeEEeeCCe
Q 008055 271 GSFNVENLLGEGTFGRVYRAQFA----DGKVLAVKKIDSSAL--PSEMCDDFIEMVSNISQLHH-PNIMELVGYCSEYGQ 343 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 343 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 46999999999999999999752 478999999975432 12335667899999999976 899999999999999
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.+++|||+.+|+|.+++.. ...+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999863 33567888999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCC--cccccCCCCCccCccccccC--CCCccchHHhHHHHHHHHHhCCCCCCCCCchhhhhhhhhccccccChhH
Q 008055 424 SNMPNAD--EALNNDAGSGYGAPEVAMSG--QYNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQSLVRWATPQLHDIDA 499 (579)
Q Consensus 424 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (579)
+...... ......+++.|+|||.+... .++.++|||||||++|||++|+.||........ ...
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-------------~~~ 243 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------------QAE 243 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-------------HHH
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHH
Confidence 7664332 23345678899999999754 468899999999999999999999976432110 001
Q ss_pred HhhhcCccccCCCChhhHHHHHHHHHhcCCCCCCCCCC-----hHHHHH
Q 008055 500 LAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPP-----MSEVVQ 543 (579)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~ 543 (579)
+.... ......++...+.++.+|+.+||+.||++||| ++|+++
T Consensus 244 i~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRI-LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhc-ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10000 00112234556789999999999999999995 778875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=354.72 Aligned_cols=263 Identities=19% Similarity=0.299 Sum_probs=198.8
Q ss_pred hCCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCCCCccceeeEEee-----CCe
Q 008055 270 TGSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHHPNIMELVGYCSE-----YGQ 343 (579)
Q Consensus 270 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 343 (579)
.++|++.+.||+|+||+||+|+. .+|+.||||++..........+.+.+|+.+++.++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45799999999999999999976 579999999998776666667788999999999999999999999853 334
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEEeccccc
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQLSDCGLA 423 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 423 (579)
.+++|+|+.+|+|.++++ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 567778888999999985 34699999999999999999999976 9999999999999999999999999998
Q ss_pred ccCCCCCcccccCCCCCccCccccccCC-CCccchHHhHHHHHHHHHhCCCCCCCCCchhhh-hhhhhcc-c------cc
Q 008055 424 SNMPNADEALNNDAGSGYGAPEVAMSGQ-YNIKSDVYSFGVVMLELLTGRKPFDSSRPRLEQ-SLVRWAT-P------QL 494 (579)
Q Consensus 424 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~p~~~~~~~~~~-~~~~~~~-~------~~ 494 (579)
.... .......++..|+|||...+.. ++.++|||||||++|+|++|+.||......... .+..... + ..
T Consensus 169 ~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 169 RHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 7543 2334455677899999877654 689999999999999999999999765432111 1111100 0 00
Q ss_pred cChhHHhhhcCccc-cCCC-----ChhhHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 008055 495 HDIDALAKMVDPAL-KGLY-----PVKSLSRFADVIALCVQPEPEFRPPMSEVVQ 543 (579)
Q Consensus 495 ~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 543 (579)
.. ........... .... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 247 SS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CC-HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 00000000000 0000 1224567899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-38 Score=318.71 Aligned_cols=265 Identities=17% Similarity=0.238 Sum_probs=190.2
Q ss_pred CCccccceeccCCceEEEEEEe-CCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-----------CCCccceeeEE
Q 008055 271 GSFNVENLLGEGTFGRVYRAQF-ADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-----------HPNIMELVGYC 338 (579)
Q Consensus 271 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 338 (579)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 479999999997542 33456778888877764 57899999887
Q ss_pred ee--CCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCC---
Q 008055 339 SE--YGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNEL--- 413 (579)
Q Consensus 339 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~--- 413 (579)
.. ....+++|+++..+........ ......+++..+..++.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccc
Confidence 54 4567777877766544333221 23455688899999999999999999972 3999999999999998665
Q ss_pred ---ceEEecccccccCCCCCcccccCCCCCccCccccccCCCCccchHHhHHHHHHHHHhCCCCCCCCCchh----hhhh
Q 008055 414 ---NPQLSDCGLASNMPNADEALNNDAGSGYGAPEVAMSGQYNIKSDVYSFGVVMLELLTGRKPFDSSRPRL----EQSL 486 (579)
Q Consensus 414 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~p~~~~~~~~----~~~~ 486 (579)
.++++|||.+..... ......+++.|+|||++....++.++||||+||++++|++|+.||....... ...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 389999999876533 3345667889999999999999999999999999999999999996543210 0000
Q ss_pred hhh--ccccccChh-----HHhhhcC---------c----------cccCCCChhhHHHHHHHHHhcCCCCCCCCCChHH
Q 008055 487 VRW--ATPQLHDID-----ALAKMVD---------P----------ALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE 540 (579)
Q Consensus 487 ~~~--~~~~~~~~~-----~~~~~~~---------~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 540 (579)
... ......... ......+ . ..........+.++.+|+.+||..||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000 000000000 0000000 0 0112334567788999999999999999999999
Q ss_pred HHH
Q 008055 541 VVQ 543 (579)
Q Consensus 541 vl~ 543 (579)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.1e-24 Score=195.10 Aligned_cols=166 Identities=12% Similarity=0.086 Sum_probs=119.5
Q ss_pred cccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCC----------------chhHHHHHHHHHHHhhcCCCCccceeeE
Q 008055 274 NVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALP----------------SEMCDDFIEMVSNISQLHHPNIMELVGY 337 (579)
Q Consensus 274 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 337 (579)
.+.+.||+|+||.||+|...+|+.||||+++..... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999889999999987532111 0112334567888999999999988765
Q ss_pred EeeCCeEEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCEEEcCCCceEE
Q 008055 338 CSEYGQHLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVCSLSVVHKNIKSANILLDNELNPQL 417 (579)
Q Consensus 338 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 417 (579)
.. .+++|||++++.+.+ +.......++.|++.+|+|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred cC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 32 379999998765543 22334567999999999999976 99999999999999975 5899
Q ss_pred ecccccccCCCCCcccccCCCCCccCcc-----ccccCCCCccchHHhHHHHH
Q 008055 418 SDCGLASNMPNADEALNNDAGSGYGAPE-----VAMSGQYNIKSDVYSFGVVM 465 (579)
Q Consensus 418 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DvwslGv~l 465 (579)
+|||+|......... .|.... .....+|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999998765432211 111110 01235678899999975433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.37 E-value=6.7e-13 Score=120.48 Aligned_cols=94 Identities=27% Similarity=0.438 Sum_probs=82.7
Q ss_pred CCCcEEeccCCcCCCCc-hhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 2 KTLKYLNIAHNQLQGQL-NDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
+++++|+|++|.|++.+ +..|.++++|+.|+|++|++++.++..+..+++|+.|+|++|+|++.++. |..++ |+.|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 47899999999998644 66789999999999999999999999999999999999999999998865 77776 99999
Q ss_pred cccCcCCCCCccccccC
Q 008055 79 IANNRFTGWVPEQLKNI 95 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~ 95 (579)
|++|.|++..|..|..+
T Consensus 109 L~~N~l~~i~~~~f~~l 125 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHL 125 (192)
T ss_dssp CCSSCCCEECTTSSTTC
T ss_pred cCCccccccCHHHhcCC
Confidence 99999998777776655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.27 E-value=6.1e-12 Score=105.00 Aligned_cols=97 Identities=34% Similarity=0.462 Sum_probs=76.4
Q ss_pred cEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcccCc
Q 008055 5 KYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIANNR 83 (579)
Q Consensus 5 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~~N~ 83 (579)
|+|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .+|+.|+.+++|+.|+|++|+|++.+ .+..++ |+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCc
Confidence 68999999998 555 4889999999999999998 68888999999999999999999764 466665 9999999999
Q ss_pred CCCCCc-cccccC----eeeccCCCCC
Q 008055 84 FTGWVP-EQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 84 l~~~~p-~~l~~~----~~~~~~n~~~ 105 (579)
|+.... ..+..+ .+...+|+.+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 985432 344433 3455566554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.26 E-value=3.3e-12 Score=115.81 Aligned_cols=89 Identities=28% Similarity=0.349 Sum_probs=81.5
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|+.|+|++|.+.+..++.|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..++ |+.|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 57899999999999999999999999999999999999988888899999999999999999998865 66775 99999
Q ss_pred cccCcCCCCCc
Q 008055 79 IANNRFTGWVP 89 (579)
Q Consensus 79 l~~N~l~~~~p 89 (579)
|++|.+.+..+
T Consensus 133 L~~N~~~~~~~ 143 (192)
T d1w8aa_ 133 LASNPFNCNCH 143 (192)
T ss_dssp CTTCCBCCSGG
T ss_pred ccccccccccc
Confidence 99999986554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.25 E-value=4.7e-12 Score=105.73 Aligned_cols=83 Identities=28% Similarity=0.396 Sum_probs=73.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc--ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~l 77 (579)
|++|++|+|++|.|+ .+|+.|+.+++|+.|+|++|.|++ +| .+.++++|+.|++++|+|+..++ .+..++ |+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEE
Confidence 578999999999999 678889999999999999999994 55 59999999999999999998763 466665 9999
Q ss_pred EcccCcCCC
Q 008055 78 NIANNRFTG 86 (579)
Q Consensus 78 ~l~~N~l~~ 86 (579)
++++|+++.
T Consensus 96 ~l~~N~i~~ 104 (124)
T d1dcea3 96 NLQGNSLCQ 104 (124)
T ss_dssp ECTTSGGGG
T ss_pred ECCCCcCCc
Confidence 999999974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.20 E-value=5.6e-12 Score=123.64 Aligned_cols=93 Identities=25% Similarity=0.462 Sum_probs=84.9
Q ss_pred CCcEEeccCCcCCC--CchhhhCCCCCCCEEeccC-CcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeE
Q 008055 3 TLKYLNIAHNQLQG--QLNDMFGQLPSLSTLDLSF-NTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNL 77 (579)
Q Consensus 3 ~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l 77 (579)
+++.|+|++|+++| .+|+.+++|++|+.|+|++ |+|+|.+|..|++|++|++|+|++|+|++.++. +..+. |+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 58899999999998 4789999999999999997 899999999999999999999999999998865 55554 9999
Q ss_pred EcccCcCCCCCccccccC
Q 008055 78 NIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~ 95 (579)
++++|.+.+.+|..+..+
T Consensus 131 ~l~~N~~~~~~p~~l~~l 148 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSL 148 (313)
T ss_dssp ECCSSEEESCCCGGGGGC
T ss_pred ccccccccccCchhhccC
Confidence 999999999999888776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=1.5e-11 Score=107.18 Aligned_cols=85 Identities=24% Similarity=0.207 Sum_probs=57.4
Q ss_pred CCCCcEEeccCC-cCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCCCCeEE
Q 008055 1 MKTLKYLNIAHN-QLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLPLDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~L~~l~ 78 (579)
+++|+.|+|++| .|+...++.|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+|+..++. +..++|+.|+
T Consensus 30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~ 109 (156)
T d2ifga3 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELV 109 (156)
T ss_dssp CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEE
T ss_pred ccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccc
Confidence 356677777655 36655556677777777777777777765566677777777777777777766544 4444577777
Q ss_pred cccCcCC
Q 008055 79 IANNRFT 85 (579)
Q Consensus 79 l~~N~l~ 85 (579)
|++|+|.
T Consensus 110 L~~Np~~ 116 (156)
T d2ifga3 110 LSGNPLH 116 (156)
T ss_dssp CCSSCCC
T ss_pred cCCCccc
Confidence 7777775
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.14 E-value=1e-11 Score=121.66 Aligned_cols=95 Identities=27% Similarity=0.521 Sum_probs=87.6
Q ss_pred CCCCcEEeccC-CcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc-ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAH-NQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID-VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-L~~l 77 (579)
|++|++|+|++ |+++|.+|..|++|++|+.|+|++|+|++..|..+..+..|+.+++++|++.+.+| .+..++ |+.+
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 67999999997 89999999999999999999999999999999999999999999999999999886 477776 9999
Q ss_pred EcccCcCCCCCccccccC
Q 008055 78 NIANNRFTGWVPEQLKNI 95 (579)
Q Consensus 78 ~l~~N~l~~~~p~~l~~~ 95 (579)
++++|.++|.+|..+..+
T Consensus 155 ~l~~n~l~~~ip~~~~~l 172 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSF 172 (313)
T ss_dssp ECCSSCCEEECCGGGGCC
T ss_pred eccccccccccccccccc
Confidence 999999999999877654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=3.6e-11 Score=105.34 Aligned_cols=83 Identities=22% Similarity=0.322 Sum_probs=71.9
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
.+|++|+|++|+|+ .+++.+..+++|+.|||++|.|+ .++ .|..+++|+.|+|++|+|+..++. +..++ |+.|+|
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 46899999999999 56777788999999999999999 564 589999999999999999988765 44454 999999
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|+|+..
T Consensus 95 ~~N~i~~~ 102 (162)
T d1a9na_ 95 TNNSLVEL 102 (162)
T ss_dssp CSCCCCCG
T ss_pred cccccccc
Confidence 99999853
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=1.4e-10 Score=111.71 Aligned_cols=95 Identities=26% Similarity=0.382 Sum_probs=67.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++.++. +..++ |+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 45677777777777766666677777777777777777765566677777777777777777776643 55554 77777
Q ss_pred cccCcCCCCCccccccC
Q 008055 79 IANNRFTGWVPEQLKNI 95 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~ 95 (579)
+++|++++..|..|..+
T Consensus 184 l~~N~l~~i~~~~f~~l 200 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDL 200 (284)
T ss_dssp CCSSCCCEECTTTTTTC
T ss_pred hhhccccccChhHhhhh
Confidence 77777777767666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=6.3e-10 Score=105.91 Aligned_cols=104 Identities=34% Similarity=0.459 Sum_probs=78.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|++|+|++|+|++ ++..+.++++|+.|+|++|.+.+..+..+..+.+|+.|++++|.|++.++. +..++ |+.|+
T Consensus 76 l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcc
Confidence 5789999999999984 566788889999999999888877777778888888888888888877654 44454 88888
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWS 105 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~ 105 (579)
+++|+|++..+..+..+ .+...+|.+.
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cccccccccCccccccccccceeecccCCCc
Confidence 88888887666655544 3445555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=6.2e-10 Score=96.57 Aligned_cols=103 Identities=15% Similarity=0.121 Sum_probs=82.0
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCC-cCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFN-TLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
....++++++++. .+|..+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...+. |..++ |+.|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 4567899999998 57888999999999999876 58866667899999999999999999998754 77775 999999
Q ss_pred ccCcCCCCCccccccC---eeeccCCCCCC
Q 008055 80 ANNRFTGWVPEQLKNI---NLQKDGNSWSS 106 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~~---~~~~~~n~~~~ 106 (579)
++|+|+...+..+..+ .+...+|++.|
T Consensus 88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 88 SFNALESLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred cCCCCcccChhhhccccccccccCCCcccC
Confidence 9999995555555444 34455666543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.96 E-value=2.2e-10 Score=100.15 Aligned_cols=84 Identities=27% Similarity=0.307 Sum_probs=71.6
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCccc--ccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTID--VLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-L~~l 77 (579)
|++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+|+...+..+..+++|+.|+|++|+|+...+ .+..++ |+.|
T Consensus 40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L 117 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117 (162)
T ss_dssp TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEE
T ss_pred cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchh
Confidence 578999999999999 454 58999999999999999996555556789999999999999997653 466665 9999
Q ss_pred EcccCcCCC
Q 008055 78 NIANNRFTG 86 (579)
Q Consensus 78 ~l~~N~l~~ 86 (579)
++++|+++.
T Consensus 118 ~l~~N~i~~ 126 (162)
T d1a9na_ 118 CILRNPVTN 126 (162)
T ss_dssp ECCSSGGGG
T ss_pred hcCCCcccc
Confidence 999999973
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=9.1e-10 Score=104.80 Aligned_cols=105 Identities=25% Similarity=0.293 Sum_probs=89.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~ 78 (579)
|++|+.|+|++|.+....+..+..+.+|+.|++++|.+++..+..+..+++|+.|++++|+|++.++. +..+. |+.|+
T Consensus 99 l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence 57899999999999988888899999999999999999977777888899999999999999998865 66675 99999
Q ss_pred cccCcCCCCCccccccC----eeeccCCCCCC
Q 008055 79 IANNRFTGWVPEQLKNI----NLQKDGNSWSS 106 (579)
Q Consensus 79 l~~N~l~~~~p~~l~~~----~~~~~~n~~~~ 106 (579)
|++|+|+ .+|+.+..+ .+...+|++.|
T Consensus 179 Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 9999999 788766544 35566777654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=2.2e-09 Score=103.14 Aligned_cols=93 Identities=29% Similarity=0.367 Sum_probs=53.4
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-cCCCC-CCeEEc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-LANLP-LDNLNI 79 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-L~~l~l 79 (579)
.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++.++. +..++ |+.|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 3456666666666654455555666666666666666655555556666666666666666655432 44443 666666
Q ss_pred ccCcCCCCCcccccc
Q 008055 80 ANNRFTGWVPEQLKN 94 (579)
Q Consensus 80 ~~N~l~~~~p~~l~~ 94 (579)
++|.+.+..|..+..
T Consensus 209 ~~N~i~~~~~~~~~~ 223 (284)
T d1ozna_ 209 FANNLSALPTEALAP 223 (284)
T ss_dssp CSSCCSCCCHHHHTT
T ss_pred ccccccccccccccc
Confidence 666666555544433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.89 E-value=1.7e-09 Score=104.98 Aligned_cols=87 Identities=24% Similarity=0.280 Sum_probs=71.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
+++|+.|+|++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+..++.+..++ |+.|+|
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYL 249 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEEC
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEEC
Confidence 3578888888888888888888888888888888888887778888888888888888888887766676665 888888
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|+|+..
T Consensus 250 s~N~i~~i 257 (305)
T d1xkua_ 250 HNNNISAI 257 (305)
T ss_dssp CSSCCCCC
T ss_pred CCCccCcc
Confidence 88888743
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.75 E-value=8.3e-09 Score=99.97 Aligned_cols=84 Identities=20% Similarity=0.341 Sum_probs=73.6
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc-c------CCC-
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV-L------ANL- 72 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~------~~~- 72 (579)
++.+++|++++|.+++..+..|.++++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|+..... + ..+
T Consensus 194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~ 272 (305)
T d1xkua_ 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 272 (305)
T ss_dssp CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSC
T ss_pred cccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccC
Confidence 467899999999999888999999999999999999999 7899999999999999999999976532 2 222
Q ss_pred CCCeEEcccCcCC
Q 008055 73 PLDNLNIANNRFT 85 (579)
Q Consensus 73 ~L~~l~l~~N~l~ 85 (579)
.|+.|+|++|+++
T Consensus 273 ~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 273 SYSGVSLFSNPVQ 285 (305)
T ss_dssp CCSEEECCSSSSC
T ss_pred CCCEEECCCCcCc
Confidence 3899999999986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.70 E-value=8.9e-09 Score=102.92 Aligned_cols=83 Identities=33% Similarity=0.484 Sum_probs=57.1
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
..++.++++.|++++. ..+..+++|+.|+|++|+|++. + .+..+++|+.|+|++|+|++.. .+..++ |+.|+++
T Consensus 285 ~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 285 TALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAG 359 (384)
T ss_dssp TTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECC
T ss_pred cccccccccccccccc--cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECC
Confidence 4567777777777742 2467777777777777777753 3 3677777777777777777643 455554 7777777
Q ss_pred cCcCCCCCc
Q 008055 81 NNRFTGWVP 89 (579)
Q Consensus 81 ~N~l~~~~p 89 (579)
+|+|++.+|
T Consensus 360 ~N~l~~l~~ 368 (384)
T d2omza2 360 HNQISDLTP 368 (384)
T ss_dssp SSCCCBCGG
T ss_pred CCcCCCChh
Confidence 777776544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.68 E-value=3.2e-10 Score=102.72 Aligned_cols=83 Identities=23% Similarity=0.419 Sum_probs=63.9
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|+|+ .++ .|.+|++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|+.. +.+..++ |+.|+|
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-cccccccccccccc
Confidence 567888888888888 454 4788888888888888888 5776666667888888888888864 3344554 888888
Q ss_pred ccCcCCCC
Q 008055 80 ANNRFTGW 87 (579)
Q Consensus 80 ~~N~l~~~ 87 (579)
++|+|+..
T Consensus 123 ~~N~i~~~ 130 (198)
T d1m9la_ 123 SNNKITNW 130 (198)
T ss_dssp SEEECCCH
T ss_pred ccchhccc
Confidence 88888743
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.64 E-value=7e-08 Score=87.01 Aligned_cols=80 Identities=25% Similarity=0.385 Sum_probs=52.8
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
.+|++|+|++|.++. ++ .+..+++|+.|+|++|+|++. ++ +.++++|+.|++++|.+....+ +..++ |+.|+++
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccccccc-ccccccccccccc
Confidence 467777777777763 33 366677777777777777743 32 7777777777777777765443 44444 7777777
Q ss_pred cCcCCC
Q 008055 81 NNRFTG 86 (579)
Q Consensus 81 ~N~l~~ 86 (579)
+|.+..
T Consensus 115 ~~~~~~ 120 (199)
T d2omxa2 115 NNQITD 120 (199)
T ss_dssp SSCCCC
T ss_pred cccccc
Confidence 776654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=1.2e-07 Score=86.16 Aligned_cols=80 Identities=20% Similarity=0.378 Sum_probs=62.3
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
.+|++|++++|.++. ++ .+..+++|+.|+|++|+|++ ++ .+++|++|+.|+|++|+|++.+ .+..++ |+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccccc-cccccccccccccc
Confidence 468888999998874 33 37788899999999999885 44 3678888999999999888754 455554 8888988
Q ss_pred cCcCCC
Q 008055 81 NNRFTG 86 (579)
Q Consensus 81 ~N~l~~ 86 (579)
+|.+..
T Consensus 121 ~~~~~~ 126 (210)
T d1h6ta2 121 HNGISD 126 (210)
T ss_dssp TSCCCC
T ss_pred cccccc
Confidence 888763
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.55 E-value=5.3e-08 Score=89.79 Aligned_cols=82 Identities=26% Similarity=0.352 Sum_probs=62.3
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
+.++.+.++++.+.... .+..+++|+.|++++|.+++. + .+.++++|+.|+|++|+|++..+ +..++ |+.|+|+
T Consensus 129 ~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLK 203 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECT
T ss_pred cchhhhhchhhhhchhh--hhccccccccccccccccccc-h-hhcccccceecccCCCccCCChh-hcCCCCCCEEECc
Confidence 46778888888887543 367788899999999888743 3 37888899999999998887543 55554 8899999
Q ss_pred cCcCCCCC
Q 008055 81 NNRFTGWV 88 (579)
Q Consensus 81 ~N~l~~~~ 88 (579)
+|+|++..
T Consensus 204 ~N~lt~i~ 211 (227)
T d1h6ua2 204 NNQISDVS 211 (227)
T ss_dssp TSCCCBCG
T ss_pred CCcCCCCc
Confidence 99888543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.52 E-value=1.4e-07 Score=84.97 Aligned_cols=81 Identities=26% Similarity=0.436 Sum_probs=65.1
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|++|++|+|++|+|++..| |+++++|+.|++++|.+. .++ .+.+++.|+.|++++|.+....+ +..++ |+.|++
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l 135 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLEL 135 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEEC
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccccc-cchhhhhHHhhh
Confidence 5788999999999986443 889999999999999888 455 48889999999999888887543 44554 899999
Q ss_pred ccCcCCC
Q 008055 80 ANNRFTG 86 (579)
Q Consensus 80 ~~N~l~~ 86 (579)
++|.+..
T Consensus 136 ~~n~l~~ 142 (199)
T d2omxa2 136 SSNTISD 142 (199)
T ss_dssp CSSCCCC
T ss_pred hhhhhcc
Confidence 9998873
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.50 E-value=2e-09 Score=97.30 Aligned_cols=84 Identities=27% Similarity=0.439 Sum_probs=71.7
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc--cccCCCC-CCeE
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI--DVLANLP-LDNL 77 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~-L~~l 77 (579)
|++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+... ..+..++ |+.|
T Consensus 69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T d1m9la_ 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred CccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhccccccccccCCCcccee
Confidence 478999999999998 577767777899999999999994 44 5889999999999999999865 3577776 9999
Q ss_pred EcccCcCCCC
Q 008055 78 NIANNRFTGW 87 (579)
Q Consensus 78 ~l~~N~l~~~ 87 (579)
+|++|++...
T Consensus 146 ~L~~N~l~~~ 155 (198)
T d1m9la_ 146 LLAGNPLYND 155 (198)
T ss_dssp EECSSHHHHH
T ss_pred ecCCCccccC
Confidence 9999998643
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.44 E-value=1.3e-07 Score=86.02 Aligned_cols=79 Identities=32% Similarity=0.399 Sum_probs=36.2
Q ss_pred CCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEcc
Q 008055 2 KTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNIA 80 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l~ 80 (579)
++|++|+|++|.|++. + .++.+++|+.|+|++|+|++ +| .+.++++|+.|++++|.+.... .+..++ ++.++++
T Consensus 68 ~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLG 142 (210)
T ss_dssp TTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECC
T ss_pred CCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccccccccccccc-cccccccccccccc
Confidence 4455555555555432 2 13445555555555555542 33 3444555555555555444322 222222 4555555
Q ss_pred cCcCC
Q 008055 81 NNRFT 85 (579)
Q Consensus 81 ~N~l~ 85 (579)
+|.++
T Consensus 143 ~n~l~ 147 (210)
T d1h6ta2 143 NNKIT 147 (210)
T ss_dssp SSCCC
T ss_pred ccccc
Confidence 55544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=6.3e-07 Score=84.22 Aligned_cols=148 Identities=16% Similarity=0.120 Sum_probs=97.6
Q ss_pred HHHHHhCCccccceeccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCe
Q 008055 265 DLQMATGSFNVENLLGEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQ 343 (579)
Q Consensus 265 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 343 (579)
++...-+.|+..+..+-++.+.||+... +++.+.+|+....... ....+..|...+..+. +--+.+++.+..+.+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 4455556777666655455578999865 4566778887543211 1223456666665552 3335677888888899
Q ss_pred EEEEEEecCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 008055 344 HLLVYEFRKNGSLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEVC------------------------------ 393 (579)
Q Consensus 344 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------ 393 (579)
.++||++++|.++.+... .. .....++.++++.+..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~----~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYE----DE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTT----TC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccc----cc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 999999999988765432 00 112335566666677777431
Q ss_pred --------------------------CCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 394 --------------------------SLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 394 --------------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 2237999999999999987666799999764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.39 E-value=2e-07 Score=92.83 Aligned_cols=84 Identities=26% Similarity=0.423 Sum_probs=71.2
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
|.+|++|+|++|+|+. + +.+..|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++..+ +..++ |+.|++
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~~ 117 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTL 117 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccccccc-cccccccccccc
Confidence 3689999999999984 4 358889999999999999995 55 39999999999999999998655 55665 999999
Q ss_pred ccCcCCCCCc
Q 008055 80 ANNRFTGWVP 89 (579)
Q Consensus 80 ~~N~l~~~~p 89 (579)
++|.+++..+
T Consensus 118 ~~~~~~~~~~ 127 (384)
T d2omza2 118 FNNQITDIDP 127 (384)
T ss_dssp CSSCCCCCGG
T ss_pred cccccccccc
Confidence 9999986544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=4.3e-07 Score=84.27 Aligned_cols=84 Identities=21% Similarity=0.280 Sum_probs=56.7
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCC-ccccCCCCCCeeEeec-ccccCcccc-cCCCC-CCeEE
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLP-QSFSSLSSLSSLYLQN-NQFSGTIDV-LANLP-LDNLN 78 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~-N~l~~~~~~-~~~~~-L~~l~ 78 (579)
++++|+|++|+|+...+..|.++++|+.|+|++|.+...+| ..|.+++.++.|++.. |++....+. +..++ |+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 67777777777775444567777777777777777765444 3566777777777653 566655543 55554 77777
Q ss_pred cccCcCCC
Q 008055 79 IANNRFTG 86 (579)
Q Consensus 79 l~~N~l~~ 86 (579)
+++|.+..
T Consensus 110 l~~~~l~~ 117 (242)
T d1xwdc1 110 ISNTGIKH 117 (242)
T ss_dssp EESCCCCS
T ss_pred cchhhhcc
Confidence 77777764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.24 E-value=1e-06 Score=80.84 Aligned_cols=81 Identities=26% Similarity=0.418 Sum_probs=53.4
Q ss_pred CCCCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCC-CCeEEc
Q 008055 1 MKTLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLP-LDNLNI 79 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-L~~l~l 79 (579)
+++|+.|+++++...+.. .+...+.+..+.++++.+... ..+.++++|+.|++++|.+++..+ +..++ |+.|+|
T Consensus 106 l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~L 180 (227)
T d1h6ua2 106 LQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKA 180 (227)
T ss_dssp CTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred cccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccchh-hcccccceeccc
Confidence 456777777777776433 256667777777777777643 235666777777777777765544 44443 777777
Q ss_pred ccCcCCC
Q 008055 80 ANNRFTG 86 (579)
Q Consensus 80 ~~N~l~~ 86 (579)
++|.+++
T Consensus 181 s~n~l~~ 187 (227)
T d1h6ua2 181 DDNKISD 187 (227)
T ss_dssp CSSCCCC
T ss_pred CCCccCC
Confidence 7777764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=5.4e-08 Score=84.57 Aligned_cols=71 Identities=21% Similarity=0.274 Sum_probs=55.7
Q ss_pred hhhhCCCCCCCEEeccCCcCCCC--CCccccCCCCCCeeEeecccccCccc--ccCCCCCCeEEcccCcCCCCCc
Q 008055 19 NDMFGQLPSLSTLDLSFNTLSGN--LPQSFSSLSSLSSLYLQNNQFSGTID--VLANLPLDNLNIANNRFTGWVP 89 (579)
Q Consensus 19 p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~L~~l~l~~N~l~~~~p 89 (579)
+..+..+++|+.|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+ .+..+.|+.|++++|+++....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 33445689999999999999853 23456789999999999999998764 2455569999999999986544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=3.7e-06 Score=78.35 Aligned_cols=130 Identities=23% Similarity=0.216 Sum_probs=84.1
Q ss_pred eeccCCc-eEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC--CCCccceeeEEeeCCeEEEEEEecCCC
Q 008055 278 LLGEGTF-GRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH--HPNIMELVGYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 278 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g 354 (579)
.+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||++++|-
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445554 689999888888889998754432 23445555555442 233566788888888999999999886
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 008055 355 SLHDFLHLSDEDNKPLIWNSRVKIALGTARALEYLHEV------------------------------------------ 392 (579)
Q Consensus 355 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 392 (579)
++.+.. .. ...++.++++.|.-||..
T Consensus 92 ~~~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 553311 11 111223344444444431
Q ss_pred -------------CCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 393 -------------CSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 393 -------------~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 02247999999999999987667899999764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.07 E-value=6.8e-06 Score=80.02 Aligned_cols=77 Identities=31% Similarity=0.446 Sum_probs=61.6
Q ss_pred CCcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccC
Q 008055 3 TLKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANN 82 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N 82 (579)
+|+.|+|++|+|+ .+|+. +++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++...... ..|+.|++++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~~lp--~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALSDLP--PLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCCSCC--TTCCEEECCSS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhhhhc--ccccccccccc
Confidence 6899999999998 67853 578999999999999 788764 57899999999988653211 13899999999
Q ss_pred cCCCCCcc
Q 008055 83 RFTGWVPE 90 (579)
Q Consensus 83 ~l~~~~p~ 90 (579)
.++ .+|.
T Consensus 109 ~l~-~lp~ 115 (353)
T d1jl5a_ 109 QLE-KLPE 115 (353)
T ss_dssp CCS-SCCC
T ss_pred ccc-cccc
Confidence 998 4553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.05 E-value=3.9e-07 Score=78.94 Aligned_cols=66 Identities=27% Similarity=0.347 Sum_probs=53.4
Q ss_pred CCCCcEEeccCCcCCCC--chhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcc
Q 008055 1 MKTLKYLNIAHNQLQGQ--LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTI 66 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~--~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~ 66 (579)
+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+..-+-......+|+.|+|++|.++...
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 57899999999999864 3466788999999999999999533324445568999999999998754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.89 E-value=1.8e-05 Score=72.79 Aligned_cols=89 Identities=18% Similarity=0.301 Sum_probs=70.2
Q ss_pred CcEEeccCCcCCCCchhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccc--cCCCC-CCeEEcc
Q 008055 4 LKYLNIAHNQLQGQLNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDV--LANLP-LDNLNIA 80 (579)
Q Consensus 4 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~-L~~l~l~ 80 (579)
.+.++.++++++ .+|+.+. ++++.|+|++|+|+...+..|.++++|+.|+|++|.+...++. +..+. +..|.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 367899999998 7886553 5899999999999955556799999999999999999887643 55564 8888875
Q ss_pred -cCcCCCCCccccccC
Q 008055 81 -NNRFTGWVPEQLKNI 95 (579)
Q Consensus 81 -~N~l~~~~p~~l~~~ 95 (579)
.|++....+..+..+
T Consensus 87 ~~n~l~~~~~~~~~~l 102 (242)
T d1xwdc1 87 KANNLLYINPEAFQNL 102 (242)
T ss_dssp CCTTCCEECTTSEECC
T ss_pred cccccccccccccccc
Confidence 578887777666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.76 E-value=3.2e-05 Score=75.06 Aligned_cols=62 Identities=26% Similarity=0.324 Sum_probs=47.0
Q ss_pred CCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeecccccCcccccCCCCCCeEEcccCcCCCCCccc
Q 008055 23 GQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQNNQFSGTIDVLANLPLDNLNIANNRFTGWVPEQ 91 (579)
Q Consensus 23 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~ 91 (579)
..+++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+..+... -.|+.|+|++|+|+ .+|..
T Consensus 281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~l~~~~--~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAEVPELP--QNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSCCCCCC--TTCCEEECCSSCCS-SCCCC
T ss_pred ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCcccccc--CCCCEEECcCCcCC-CCCcc
Confidence 34678999999999998 67754 568889999999998654321 14889999999988 55543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.50 E-value=8.5e-06 Score=82.33 Aligned_cols=84 Identities=18% Similarity=0.294 Sum_probs=54.8
Q ss_pred CCcEEeccCCcCCCC-chhhhCCCCCCCEEeccCCcCCC----CCCccccCCCCCCeeEeecccccCcc-----cccCC-
Q 008055 3 TLKYLNIAHNQLQGQ-LNDMFGQLPSLSTLDLSFNTLSG----NLPQSFSSLSSLSSLYLQNNQFSGTI-----DVLAN- 71 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~- 71 (579)
+|+.|||++|++++. +...+..+++|++|+|++|.|+- .+...+..+++|+.|||++|.|+..- ..+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577888888888753 23445567777888888887762 33445667778888888888775321 12221
Q ss_pred -CCCCeEEcccCcCCC
Q 008055 72 -LPLDNLNIANNRFTG 86 (579)
Q Consensus 72 -~~L~~l~l~~N~l~~ 86 (579)
.+|+.|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~ 98 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTG 98 (460)
T ss_dssp TCCCCEEECTTSCCBG
T ss_pred CCCCCEEECCCCCccc
Confidence 247888888887764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.45 E-value=1.1e-05 Score=76.39 Aligned_cols=84 Identities=24% Similarity=0.336 Sum_probs=63.6
Q ss_pred CCCcEEeccCCcCCCC-chhhhCCCCCCCEEeccCCcCCCCCCccccCCCCCCeeEeec-ccccCcc--cccCCCC-CCe
Q 008055 2 KTLKYLNIAHNQLQGQ-LNDMFGQLPSLSTLDLSFNTLSGNLPQSFSSLSSLSSLYLQN-NQFSGTI--DVLANLP-LDN 76 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~--~~~~~~~-L~~ 76 (579)
.+|++|||+++.++.. ++..+..+++|+.|+|+++.+++..+..++.+++|+.|+|++ +.++... ..+..++ |+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4689999999888743 456678899999999999998887888888899999999988 4666321 2233444 899
Q ss_pred EEcccC-cCC
Q 008055 77 LNIANN-RFT 85 (579)
Q Consensus 77 l~l~~N-~l~ 85 (579)
|+++++ .++
T Consensus 126 L~ls~c~~~~ 135 (284)
T d2astb2 126 LNLSWCFDFT 135 (284)
T ss_dssp EECCCCTTCC
T ss_pred cccccccccc
Confidence 999874 443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.44 E-value=1.8e-05 Score=77.06 Aligned_cols=61 Identities=23% Similarity=0.315 Sum_probs=27.4
Q ss_pred CCcEEeccCCcCCCC----chhhhCCCCCCCEEeccCCcCCCC-----CCccccCCCCCCeeEeeccccc
Q 008055 3 TLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGN-----LPQSFSSLSSLSSLYLQNNQFS 63 (579)
Q Consensus 3 ~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~ 63 (579)
.|+.|++++|.++.. +...+..++.|+.|+|++|.|+.. +...+..+++|+.|+|++|.|+
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 445555555554321 222233445555555555554421 1223444455555555555543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.44 E-value=0.00045 Score=68.15 Aligned_cols=77 Identities=14% Similarity=0.104 Sum_probs=45.6
Q ss_pred cceeccCCceEEEEEEeCC-CcEEEEEEeCCC------CCCchhHHHHHHHHHHHhhc-CC--CCccceeeEEeeCCeEE
Q 008055 276 ENLLGEGTFGRVYRAQFAD-GKVLAVKKIDSS------ALPSEMCDDFIEMVSNISQL-HH--PNIMELVGYCSEYGQHL 345 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~ 345 (579)
.+.||.|....||++...+ ++.++||.-... ... ....+...|...++.+ .+ ..+.+++.+ +.+..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 3468999999999997654 678888864321 111 1123344566666544 22 334455544 455678
Q ss_pred EEEEecCCCC
Q 008055 346 LVYEFRKNGS 355 (579)
Q Consensus 346 lv~e~~~~gs 355 (579)
+|||++++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.42 E-value=5.3e-05 Score=71.56 Aligned_cols=81 Identities=28% Similarity=0.354 Sum_probs=62.3
Q ss_pred CCCcEEeccCC--cCCCC-chhhhCCCCCCCEEeccCC-cCCCCCCccccCCCCCCeeEeec-ccccCcc-cccCCCC-C
Q 008055 2 KTLKYLNIAHN--QLQGQ-LNDMFGQLPSLSTLDLSFN-TLSGNLPQSFSSLSSLSSLYLQN-NQFSGTI-DVLANLP-L 74 (579)
Q Consensus 2 ~~L~~L~l~~n--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~-~~~~~~~-L 74 (579)
++|+.|+|++. .++.. +...+.++++|+.|+|++| .+++..+..+.++++|++|+|++ +.+++.. ..+..++ |
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 57999999864 35432 3444567899999999986 68877888899999999999999 5777543 3355555 9
Q ss_pred CeEEcccC
Q 008055 75 DNLNIANN 82 (579)
Q Consensus 75 ~~l~l~~N 82 (579)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 99999887
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.38 E-value=9.4e-06 Score=81.98 Aligned_cols=86 Identities=22% Similarity=0.362 Sum_probs=65.5
Q ss_pred CCCCcEEeccCCcCCC----CchhhhCCCCCCCEEeccCCcCCCC----CCcccc-CCCCCCeeEeecccccCcc-----
Q 008055 1 MKTLKYLNIAHNQLQG----QLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFS-SLSSLSSLYLQNNQFSGTI----- 66 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~~~~----- 66 (579)
|++|++|+|++|+|+. .+...+..+++|+.|||++|.|+.. +...+. ...+|+.|+|++|+|+...
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~ 105 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccccc
Confidence 4789999999999973 3556678999999999999998621 222232 2358999999999998642
Q ss_pred cccCCCC-CCeEEcccCcCCC
Q 008055 67 DVLANLP-LDNLNIANNRFTG 86 (579)
Q Consensus 67 ~~~~~~~-L~~l~l~~N~l~~ 86 (579)
..+...+ |+.|+|++|.++.
T Consensus 106 ~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 106 STLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp HHTTSCTTCCEEECCSSBCHH
T ss_pred chhhccccccccccccccchh
Confidence 2355554 9999999999874
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.23 E-value=3.1e-05 Score=75.42 Aligned_cols=86 Identities=23% Similarity=0.289 Sum_probs=66.0
Q ss_pred CCCCcEEeccCCcCCCC-----chhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecccccCcc-----
Q 008055 1 MKTLKYLNIAHNQLQGQ-----LNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGTI----- 66 (579)
Q Consensus 1 l~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~----- 66 (579)
+.+|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|.|++.-
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~ 264 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 264 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence 35799999999998732 344577789999999999998632 4456788999999999999998642
Q ss_pred cccC---CCCCCeEEcccCcCCC
Q 008055 67 DVLA---NLPLDNLNIANNRFTG 86 (579)
Q Consensus 67 ~~~~---~~~L~~l~l~~N~l~~ 86 (579)
..+. ...|+.|++++|.|+.
T Consensus 265 ~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 265 DAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBH
T ss_pred HHhhhccCCCCCEEECCCCcCCh
Confidence 2222 2359999999999864
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.04 E-value=0.00014 Score=62.49 Aligned_cols=84 Identities=17% Similarity=0.206 Sum_probs=61.9
Q ss_pred CCCcEEeccCC-cCCCC----chhhhCCCCCCCEEeccCCcCCC----CCCccccCCCCCCeeEeecccccCcc-----c
Q 008055 2 KTLKYLNIAHN-QLQGQ----LNDMFGQLPSLSTLDLSFNTLSG----NLPQSFSSLSSLSSLYLQNNQFSGTI-----D 67 (579)
Q Consensus 2 ~~L~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~-----~ 67 (579)
++|++|+|+++ .++.. +-..+...+.|+.|+|++|.|.. .+...+...+.|+.|+|++|.|+..- .
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 67999999974 46532 34457778899999999999862 23334556789999999999998632 2
Q ss_pred ccCCC-CCCeEEcccCcCC
Q 008055 68 VLANL-PLDNLNIANNRFT 85 (579)
Q Consensus 68 ~~~~~-~L~~l~l~~N~l~ 85 (579)
.+..- .|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 33333 4999999999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.0036 Score=59.68 Aligned_cols=68 Identities=21% Similarity=0.173 Sum_probs=44.3
Q ss_pred ceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcCC---C--Ccccee--eEEeeCCeEEEEEEecCCC
Q 008055 284 FGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQLHH---P--NIMELV--GYCSEYGQHLLVYEFRKNG 354 (579)
Q Consensus 284 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~--niv~l~--~~~~~~~~~~lv~e~~~~g 354 (579)
--.||++..++|+.|++|+....... ..++.+|+..+..+.. | ..+..- ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 46899999999999999998765433 3456667666655532 1 111111 1234567788999999763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.0069 Score=57.25 Aligned_cols=162 Identities=14% Similarity=0.128 Sum_probs=81.8
Q ss_pred cCHHHHHHHhCCcccccee-----ccCCceEEEEEEeCCCcEEEEEEeCCCCCCchhHHHHHHHHHHHhhc--CCCCccc
Q 008055 261 YSIADLQMATGSFNVENLL-----GEGTFGRVYRAQFADGKVLAVKKIDSSALPSEMCDDFIEMVSNISQL--HHPNIME 333 (579)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~ 333 (579)
.+.+++.....+|.+.++. ..|---+.|+....+|+ +++|+..... .......+.+-+..|..- .-|..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccce
Confidence 4567777777888875544 35556778999877665 8899986532 222233333333333322 2222222
Q ss_pred ee-e--EEeeCCeEEEEEEecCCCChhh--------------hhcccC---CCCC--CCCH------------------H
Q 008055 334 LV-G--YCSEYGQHLLVYEFRKNGSLHD--------------FLHLSD---EDNK--PLIW------------------N 373 (579)
Q Consensus 334 l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~---~~~~--~l~~------------------~ 373 (579)
.. | +....+....++.+..+..... .++... .... .... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 21 1 1233456677777776642210 000000 0000 0000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCEEEcCCCceEEecccccc
Q 008055 374 SRVKIALGTARALEYLHE-VCSLSVVHKNIKSANILLDNELNPQLSDCGLAS 424 (579)
Q Consensus 374 ~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 424 (579)
.....+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 125579999999999999988777899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.12 E-value=0.016 Score=56.66 Aligned_cols=73 Identities=10% Similarity=0.056 Sum_probs=46.4
Q ss_pred cceeccCCceEEEEEEeCC--------CcEEEEEEeCCCCCCchhHHHHHHHHHHHhhcC-CCCccceeeEEeeCCeEEE
Q 008055 276 ENLLGEGTFGRVYRAQFAD--------GKVLAVKKIDSSALPSEMCDDFIEMVSNISQLH-HPNIMELVGYCSEYGQHLL 346 (579)
Q Consensus 276 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 346 (579)
.+.|+-|-.-.+|++...+ .+.|.+++..... . .....+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3568888889999998654 3456777765322 1 233456777776663 3333467777653 68
Q ss_pred EEEecCCCCh
Q 008055 347 VYEFRKNGSL 356 (579)
Q Consensus 347 v~e~~~~gsL 356 (579)
||||++|-.|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987433
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.01 E-value=0.0012 Score=56.48 Aligned_cols=83 Identities=20% Similarity=0.214 Sum_probs=60.0
Q ss_pred CCCcEEeccCCcCCC----CchhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecccccCcc-------
Q 008055 2 KTLKYLNIAHNQLQG----QLNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGTI------- 66 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~------- 66 (579)
++|+.|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-..+...+.|+.|+|++|++...-
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 579999999999963 3445566678999999999999842 2335677789999999999766421
Q ss_pred -cccC-CCCCCeEEcccCcC
Q 008055 67 -DVLA-NLPLDNLNIANNRF 84 (579)
Q Consensus 67 -~~~~-~~~L~~l~l~~N~l 84 (579)
..+. +..|+.|+++.+..
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCccEeeCcCCCc
Confidence 1222 22488888876643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.96 E-value=0.0034 Score=53.35 Aligned_cols=84 Identities=15% Similarity=0.187 Sum_probs=54.8
Q ss_pred CCCcEEeccC-CcCCCC----chhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEeecccccCcc-----c
Q 008055 2 KTLKYLNIAH-NQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYLQNNQFSGTI-----D 67 (579)
Q Consensus 2 ~~L~~L~l~~-n~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~-----~ 67 (579)
++|++|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...+.|+.|++++|.++..- .
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 6788999987 456422 334566788899999999988633 2224556788999999988886432 2
Q ss_pred ccCCC-CCCeEEc--ccCcCC
Q 008055 68 VLANL-PLDNLNI--ANNRFT 85 (579)
Q Consensus 68 ~~~~~-~L~~l~l--~~N~l~ 85 (579)
.+... .|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 23333 3766444 566664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.88 E-value=0.01 Score=50.19 Aligned_cols=83 Identities=20% Similarity=0.289 Sum_probs=59.3
Q ss_pred CCCcEEeccCCcCCCC----chhhhCCCCCCCEEeccCCcCCCC----CCccccCCCCCCeeEe--ecccccCcc-----
Q 008055 2 KTLKYLNIAHNQLQGQ----LNDMFGQLPSLSTLDLSFNTLSGN----LPQSFSSLSSLSSLYL--QNNQFSGTI----- 66 (579)
Q Consensus 2 ~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l--~~N~l~~~~----- 66 (579)
++|+.|+|++|.++.. +-..+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+....
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 6799999999998743 334566689999999999998732 3346677889987555 567775422
Q ss_pred cccCCC-CCCeEEcccCcC
Q 008055 67 DVLANL-PLDNLNIANNRF 84 (579)
Q Consensus 67 ~~~~~~-~L~~l~l~~N~l 84 (579)
..+... .|+.|+++.|..
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 233233 499999987754
|